Compound ID,Uniprot ID,Compound Name,Standard inchi key,Max Phase,Target Pref Name,Gene Names,Target Class,Wild type or mutant,Mutation information,PubMed ID,End Point Standard Type,End Point Standard Relation,End Point Standard Value,End Point Standard Units,Endpoint Mode of Action,Assay Format,Assay Type,Assay Sub Type,Inhibitor Type,Detection Technology,Compound concentration value,Compound concentration value units,Substrate type,Substrate Type Standard Relation,Substrate Type Standard Value,Substrate Type Standard Units,Assay cell line,Assay Description,Activity Comments,Title,Journal,Year,Volume,Issue,Authors,Annotation Comments,Assay ID,DTC Tid,DTC Activity ID,DTC Molregno,Record ID,DTC Document ID
CHEMBL100081,P45452,,QDBZCMIHMMMYES-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11677139,IC50,=,56,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-13.,,The discovery of anthranilic acid-based MMP inhibitors. Part 3: incorporation of basic amines.,Bioorg. Med. Chem. Lett.,2001,11,22,"Levin JI, Chen JM, Du MT, Nelson FC, Wehr T, DiJoseph JF, Killar LM, Skala S, Sung A, Sharr MA, Roth CE, Jin G, Cowling R, Di L, Sherman M, Xu ZB, March CJ, Mohler KM, Black RA, Skotnicki JS",,106763,DTCT0024002,1609704,DTCC00269343,453142,4590
CHEMBL100100,P45452,,ZRDGYJAMDSHROJ-RPBOFIJWSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10522712,IC50,=,8,NM,,,,,,,,,,,,,,Inhibition of Coll-3 MMP-13,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,101904,DTCT0024002,1453249,DTCC00264536,982314,3373
CHEMBL100100,P45452,,ZRDGYJAMDSHROJ-RPBOFIJWSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,IC50,=,7.94,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258639,DTCC00264536,972938,24803
CHEMBL100134,P45452,,AWDZLFOJMUGNPS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11677139,IC50,=,7,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-13.,,The discovery of anthranilic acid-based MMP inhibitors. Part 3: incorporation of basic amines.,Bioorg. Med. Chem. Lett.,2001,11,22,"Levin JI, Chen JM, Du MT, Nelson FC, Wehr T, DiJoseph JF, Killar LM, Skala S, Sung A, Sharr MA, Roth CE, Jin G, Cowling R, Di L, Sherman M, Xu ZB, March CJ, Mohler KM, Black RA, Skotnicki JS",,106763,DTCT0024002,1600777,DTCC00269627,841776,4590
CHEMBL100146,P45452,,ZLOBLTFULLQWKZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12270165,IC50,=,26,NM,,,,,,,,,,,,,,Concentration required in vitro to inhibit Matrix metalloprotease-13,,Benzodiazepine inhibitors of the MMPs and TACE.,Bioorg. Med. Chem. Lett.,2002,12,20,"Nelson FC, Delos Santos E, Levin JI, Chen JM, Skotnicki JS, DiJoseph JF, Sharr MA, Sung A, Killar LM, Cowling R, Jin G, Roth CE, Albright JD",,106631,DTCT0024002,1532839,DTCC00263161,1882578,5143
CHEMBL100273,P45452,,CVJMAXDBGIRLPL-MNOVXSKESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10522712,IC50,=,2000,NM,,,,,,,,,,,,,,Inhibition of Coll-3 MMP-13,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,101904,DTCT0024002,1478679,DTCC00264430,885728,3373
CHEMBL100273,P45452,,CVJMAXDBGIRLPL-MNOVXSKESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,IC50,=,1995.26,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258626,DTCC00264430,876665,24803
CHEMBL100280,P45452,,WGMQZHYPIKBUML-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11677139,IC50,=,14,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-13.,,The discovery of anthranilic acid-based MMP inhibitors. Part 3: incorporation of basic amines.,Bioorg. Med. Chem. Lett.,2001,11,22,"Levin JI, Chen JM, Du MT, Nelson FC, Wehr T, DiJoseph JF, Killar LM, Skala S, Sung A, Sharr MA, Roth CE, Jin G, Cowling R, Di L, Sherman M, Xu ZB, March CJ, Mohler KM, Black RA, Skotnicki JS",,106763,DTCT0024002,1612117,DTCC00269055,1968639,4590
CHEMBL100512,P45452,,YIIGCCOQJNYBNF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11677139,IC50,=,12,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-13.,,The discovery of anthranilic acid-based MMP inhibitors. Part 3: incorporation of basic amines.,Bioorg. Med. Chem. Lett.,2001,11,22,"Levin JI, Chen JM, Du MT, Nelson FC, Wehr T, DiJoseph JF, Killar LM, Skala S, Sung A, Sharr MA, Roth CE, Jin G, Cowling R, Di L, Sherman M, Xu ZB, March CJ, Mohler KM, Black RA, Skotnicki JS",,106763,DTCT0024002,1621222,DTCC00269127,1326740,4590
CHEMBL100564,P45452,,CFEKPCYWRLBSBI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11677139,IC50,=,6,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-13.,,The discovery of anthranilic acid-based MMP inhibitors. Part 3: incorporation of basic amines.,Bioorg. Med. Chem. Lett.,2001,11,22,"Levin JI, Chen JM, Du MT, Nelson FC, Wehr T, DiJoseph JF, Killar LM, Skala S, Sung A, Sharr MA, Roth CE, Jin G, Cowling R, Di L, Sherman M, Xu ZB, March CJ, Mohler KM, Black RA, Skotnicki JS",,106763,DTCT0024002,1603358,DTCC00269128,422247,4590
CHEMBL100570,P45452,,RNCWXNOSFWYLTA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15163180,KI,=,55,NM,,,,,,,,,,,,,,Inhibition of recombinant human Matrix metalloprotease-13,,Sultam hydroxamates as novel matrix metalloproteinase inhibitors.,J. Med. Chem.,2004,47,12,"Cherney RJ, Mo R, Meyer DT, Hardman KD, Liu RQ, Covington MB, Qian M, Wasserman ZR, Christ DD, Trzaskos JM, Newton RC, Decicco CP",,106611,DTCT0024002,674931,DTCC00106694,970630,18131
CHEMBL100570,P45452,,RNCWXNOSFWYLTA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16289878,KI,=,55,NM,,,,,,,,,,,,,,Binding affinity to MMP13,,Conversion of potent MMP inhibitors into selective TACE inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,4,"Cherney RJ, King BW, Gilmore JL, Liu RQ, Covington MB, Duan JJ, Decicco CP",,334537,DTCT0024002,469045,DTCC00106694,984001,20373
CHEMBL100570,P45452,,RNCWXNOSFWYLTA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19095454,KI,=,55,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Current perspective of TACE inhibitors: a review.,Bioorg. Med. Chem.,2009,17,2,"DasGupta S, Murumkar PR, Giridhar R, Yadav MR",,495051,DTCT0024002,2594690,DTCC00106694,985007,32093
CHEMBL100584,P45452,,IFHBUYGFCSEHIF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11212095,IC50,=,67,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,General synthesis of alpha-substituted 3-bisaryloxy propionic acid derivatives as specific MMP inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,3,"Chollet AM, Le Diguarher T, Murray L, Bertrand M, Tucker GC, Sabatini M, Pierré A, Atassi G, Bonnet J, Casara P",,106483,DTCT0024002,628945,DTCC00269547,161928,4635
CHEMBL100754,P45452,,CMALBPMZEURNBK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15163180,KI,=,206,NM,,,,,,,,,,,,,,Inhibition of recombinant human Matrix metalloprotease-13,,Sultam hydroxamates as novel matrix metalloproteinase inhibitors.,J. Med. Chem.,2004,47,12,"Cherney RJ, Mo R, Meyer DT, Hardman KD, Liu RQ, Covington MB, Qian M, Wasserman ZR, Christ DD, Trzaskos JM, Newton RC, Decicco CP",,106611,DTCT0024002,693865,DTCC00269176,1326745,18131
CHEMBL100777,P45452,,QAFRSDWNZLQCBN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11677139,IC50,=,3,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-13.,,The discovery of anthranilic acid-based MMP inhibitors. Part 3: incorporation of basic amines.,Bioorg. Med. Chem. Lett.,2001,11,22,"Levin JI, Chen JM, Du MT, Nelson FC, Wehr T, DiJoseph JF, Killar LM, Skala S, Sung A, Sharr MA, Roth CE, Jin G, Cowling R, Di L, Sherman M, Xu ZB, March CJ, Mohler KM, Black RA, Skotnicki JS",,106763,DTCT0024002,1633953,DTCC00269096,1935386,4590
CHEMBL100805,P45452,,XYVVUCAHUUIYFV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11212095,IC50,=,65,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,General synthesis of alpha-substituted 3-bisaryloxy propionic acid derivatives as specific MMP inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,3,"Chollet AM, Le Diguarher T, Murray L, Bertrand M, Tucker GC, Sabatini M, Pierré A, Atassi G, Bonnet J, Casara P",,106483,DTCT0024002,637874,DTCC00269559,582958,4635
CHEMBL100950,P45452,,LYVGWVHFXOYMDJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11677139,IC50,=,11,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-13.,,The discovery of anthranilic acid-based MMP inhibitors. Part 3: incorporation of basic amines.,Bioorg. Med. Chem. Lett.,2001,11,22,"Levin JI, Chen JM, Du MT, Nelson FC, Wehr T, DiJoseph JF, Killar LM, Skala S, Sung A, Sharr MA, Roth CE, Jin G, Cowling R, Di L, Sherman M, Xu ZB, March CJ, Mohler KM, Black RA, Skotnicki JS",,106763,DTCT0024002,1630087,DTCC00268342,1714206,4590
CHEMBL101121,P45452,,VVZTYGQJDUUATC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11212095,IC50,=,7,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,General synthesis of alpha-substituted 3-bisaryloxy propionic acid derivatives as specific MMP inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,3,"Chollet AM, Le Diguarher T, Murray L, Bertrand M, Tucker GC, Sabatini M, Pierré A, Atassi G, Bonnet J, Casara P",,106483,DTCT0024002,619918,DTCC00269629,2001205,4635
CHEMBL101210,P45452,,FMQWWPFJFLUCHZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11677139,IC50,=,6,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-13.,,The discovery of anthranilic acid-based MMP inhibitors. Part 3: incorporation of basic amines.,Bioorg. Med. Chem. Lett.,2001,11,22,"Levin JI, Chen JM, Du MT, Nelson FC, Wehr T, DiJoseph JF, Killar LM, Skala S, Sung A, Sharr MA, Roth CE, Jin G, Cowling R, Di L, Sherman M, Xu ZB, March CJ, Mohler KM, Black RA, Skotnicki JS",,106763,DTCT0024002,1627642,DTCC00269368,193780,4590
CHEMBL101413,P45452,,AJXYMDJBIXFLCO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11677139,IC50,=,43,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-13.,,The discovery of anthranilic acid-based MMP inhibitors. Part 3: incorporation of basic amines.,Bioorg. Med. Chem. Lett.,2001,11,22,"Levin JI, Chen JM, Du MT, Nelson FC, Wehr T, DiJoseph JF, Killar LM, Skala S, Sung A, Sharr MA, Roth CE, Jin G, Cowling R, Di L, Sherman M, Xu ZB, March CJ, Mohler KM, Black RA, Skotnicki JS",,106763,DTCT0024002,1615941,DTCC00269089,422246,4590
CHEMBL101612,P45452,,LGVIBWRSRHZDQG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11677139,IC50,=,0.7,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,The discovery of anthranilic acid-based MMP inhibitors. Part 3: incorporation of basic amines.,Bioorg. Med. Chem. Lett.,2001,11,22,"Levin JI, Chen JM, Du MT, Nelson FC, Wehr T, DiJoseph JF, Killar LM, Skala S, Sung A, Sharr MA, Roth CE, Jin G, Cowling R, Di L, Sherman M, Xu ZB, March CJ, Mohler KM, Black RA, Skotnicki JS",,106645,DTCT0024002,1602206,DTCC00269291,776640,4590
CHEMBL101789,P45452,,XBJDUGZISLIDRA-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15163180,KI,<,5,NM,,,,,,,,,,,,,,Inhibition of recombinant human Matrix metalloprotease-13,,Sultam hydroxamates as novel matrix metalloproteinase inhibitors.,J. Med. Chem.,2004,47,12,"Cherney RJ, Mo R, Meyer DT, Hardman KD, Liu RQ, Covington MB, Qian M, Wasserman ZR, Christ DD, Trzaskos JM, Newton RC, Decicco CP",,106611,DTCT0024002,678778,DTCC00269210,1968643,18131
CHEMBL10180,P45452,,MOVLHCHTKCWLQE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11297453,IC50,=,89,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-13 in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,106481,DTCT0024002,939252,DTCC00138525,1016783,16645
CHEMBL101864,P45452,,DPCXVXNEMYTZOE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11677139,IC50,=,5,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-13.,,The discovery of anthranilic acid-based MMP inhibitors. Part 3: incorporation of basic amines.,Bioorg. Med. Chem. Lett.,2001,11,22,"Levin JI, Chen JM, Du MT, Nelson FC, Wehr T, DiJoseph JF, Killar LM, Skala S, Sung A, Sharr MA, Roth CE, Jin G, Cowling R, Di L, Sherman M, Xu ZB, March CJ, Mohler KM, Black RA, Skotnicki JS",,106763,DTCT0024002,1631273,DTCC00268937,1326739,4590
CHEMBL10193,P45452,,QIKCPSHYSFYKBM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11297453,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-13 in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,106481,DTCT0024002,956225,DTCC00138519,272574,16645
CHEMBL101981,P45452,,CNEKWCSJAXATCC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11677139,IC50,=,84,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-13.,,The discovery of anthranilic acid-based MMP inhibitors. Part 3: incorporation of basic amines.,Bioorg. Med. Chem. Lett.,2001,11,22,"Levin JI, Chen JM, Du MT, Nelson FC, Wehr T, DiJoseph JF, Killar LM, Skala S, Sung A, Sharr MA, Roth CE, Jin G, Cowling R, Di L, Sherman M, Xu ZB, March CJ, Mohler KM, Black RA, Skotnicki JS",,106763,DTCT0024002,1632654,DTCC00269080,1903394,4590
CHEMBL102057,P45452,,CLPQPSHMBDAYLR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11677139,IC50,=,4,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-13.,,The discovery of anthranilic acid-based MMP inhibitors. Part 3: incorporation of basic amines.,Bioorg. Med. Chem. Lett.,2001,11,22,"Levin JI, Chen JM, Du MT, Nelson FC, Wehr T, DiJoseph JF, Killar LM, Skala S, Sung A, Sharr MA, Roth CE, Jin G, Cowling R, Di L, Sherman M, Xu ZB, March CJ, Mohler KM, Black RA, Skotnicki JS",,106763,DTCT0024002,1600785,DTCC00269097,1196589,4590
CHEMBL102415,P45452,,RNMJVOBQCWORLK-GFOWMXPYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11543676,IC50,=,5.5,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,Design and synthesis of matrix metalloproteinase inhibitors guided by molecular modeling. Picking the S(1) pocket using conformationally constrained inhibitors.,J. Med. Chem.,2001,44,19,"Hanessian S, MacKay DB, Moitessier N",,106482,DTCT0024002,1202335,DTCC00273885,226190,16385
CHEMBL102438,P45452,,BSGLIFPGYIIUAJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11543675,IC50,=,0.7,NM,,,,,,,,,,,,,,In vitro inhibition of human matrix metalloprotease-13,,"N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: further probing of the S(1), S(1)', and S(2)' pockets.",J. Med. Chem.,2001,44,19,"Hanessian S, Moitessier N, Gauchet C, Viau M",,106474,DTCT0024002,1389497,DTCC00273957,885822,16392
CHEMBL102441,P45452,,AGLYKFTUNLOGBT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11543675,IC50,=,407,NM,,,,,,,,,,,,,,In vitro inhibition of human matrix metalloprotease-13,,"N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: further probing of the S(1), S(1)', and S(2)' pockets.",J. Med. Chem.,2001,44,19,"Hanessian S, Moitessier N, Gauchet C, Viau M",,106474,DTCT0024002,1379269,DTCC00273131,465265,16392
CHEMBL102459,P45452,,YMFBAKCSKQKFMX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11212095,IC50,=,101,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,General synthesis of alpha-substituted 3-bisaryloxy propionic acid derivatives as specific MMP inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,3,"Chollet AM, Le Diguarher T, Murray L, Bertrand M, Tucker GC, Sabatini M, Pierré A, Atassi G, Bonnet J, Casara P",,106483,DTCT0024002,650234,DTCC00269592,1326752,4635
CHEMBL10257,P45452,,ZOSFRKHRZHSICA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11297453,IC50,=,35,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-13 in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,106481,DTCT0024002,969087,DTCC00138526,110709,16645
CHEMBL10257,P45452,,ZOSFRKHRZHSICA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12217355,IC50,=,34.67,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant human matrix metalloprotease-13,,Analogue based design of MMP-13 (Collagenase-3) inhibitors.,Bioorg. Med. Chem. Lett.,2002,12,19,"Sarma JA, Rambabu G, Srikanth K, Raveendra D, Vithal M",,106465,DTCT0024002,783792,DTCC00138526,108398,5083
CHEMBL10266,P45452,,DPDQSBRVGYFIHD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11297453,IC50,=,88,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-13 in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,106481,DTCT0024002,956062,DTCC00138497,919742,16645
CHEMBL102698,P45452,,WYWVSRVZNIIISU-BPGUCPLFSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11543676,IC50,=,17,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,Design and synthesis of matrix metalloproteinase inhibitors guided by molecular modeling. Picking the S(1) pocket using conformationally constrained inhibitors.,J. Med. Chem.,2001,44,19,"Hanessian S, MacKay DB, Moitessier N",,106482,DTCT0024002,1194616,DTCC00273956,97110,16385
CHEMBL102785,P45452,,PECNGMJVFOGIBW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11543675,IC50,=,0.8,NM,,,,,,,,,,,,,,In vitro inhibition of human matrix metalloprotease-13,,"N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: further probing of the S(1), S(1)', and S(2)' pockets.",J. Med. Chem.,2001,44,19,"Hanessian S, Moitessier N, Gauchet C, Viau M",,106474,DTCT0024002,1398099,DTCC00273055,723954,16392
CHEMBL102798,P45452,,MAOGHLYYLNCNCI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11543675,IC50,=,0.5,NM,,,,,,,,,,,,,,In vitro inhibition of human matrix metalloprotease-13,,"N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: further probing of the S(1), S(1)', and S(2)' pockets.",J. Med. Chem.,2001,44,19,"Hanessian S, Moitessier N, Gauchet C, Viau M",,106474,DTCT0024002,1399292,DTCC00273086,2077525,16392
CHEMBL10296,P45452,,AWDSUFIHUSMPAR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11297453,IC50,=,344,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-13 in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,106481,DTCT0024002,956233,DTCC00138702,726065,16645
CHEMBL10335,P45452,,XZFOATQBCODVSR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11297453,IC50,=,103,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-13 in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,106481,DTCT0024002,965340,DTCC00138703,822790,16645
CHEMBL10335,P45452,,XZFOATQBCODVSR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12217355,IC50,=,102.33,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant human matrix metalloprotease-13,,Analogue based design of MMP-13 (Collagenase-3) inhibitors.,Bioorg. Med. Chem. Lett.,2002,12,19,"Sarma JA, Rambabu G, Srikanth K, Raveendra D, Vithal M",,106465,DTCT0024002,794849,DTCC00138703,820414,5083
CHEMBL103418,P45452,,QVCXUWWKONKLBL-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15163180,KI,=,1.2,NM,,,,,,,,,,,,,,Inhibition of recombinant human Matrix metalloprotease-13,,Sultam hydroxamates as novel matrix metalloproteinase inhibitors.,J. Med. Chem.,2004,47,12,"Cherney RJ, Mo R, Meyer DT, Hardman KD, Liu RQ, Covington MB, Qian M, Wasserman ZR, Christ DD, Trzaskos JM, Newton RC, Decicco CP",,106611,DTCT0024002,656625,DTCC00269253,1003161,18131
CHEMBL103418,P45452,,QVCXUWWKONKLBL-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18083558,KI,=,1.2,NM,,,,,,,,,,,,,,Inhibition of MMP13,,beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 2. Optimization of alpha-amino substituents.,Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Huang Z, Karnachi P, Wilson LJ, Rhodes KJ, Lagu B, Murray WV",,461909,DTCT0024002,2278521,DTCC00269253,1021673,25112
CHEMBL103442,P45452,,KFTWEWMQNRZZNL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11212095,IC50,=,42,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,General synthesis of alpha-substituted 3-bisaryloxy propionic acid derivatives as specific MMP inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,3,"Chollet AM, Le Diguarher T, Murray L, Bertrand M, Tucker GC, Sabatini M, Pierré A, Atassi G, Bonnet J, Casara P",,106483,DTCT0024002,621142,DTCC00269617,1003168,4635
CHEMBL103563,P45452,,QAIMUZSIIGFZOG-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15163180,KI,<,5,NM,,,,,,,,,,,,,,Inhibition of recombinant human Matrix metalloprotease-13,,Sultam hydroxamates as novel matrix metalloproteinase inhibitors.,J. Med. Chem.,2004,47,12,"Cherney RJ, Mo R, Meyer DT, Hardman KD, Liu RQ, Covington MB, Qian M, Wasserman ZR, Christ DD, Trzaskos JM, Newton RC, Decicco CP",,106611,DTCT0024002,692556,DTCC00269250,324184,18131
CHEMBL104021,P45452,,NKRKWSFHPLAZOP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11543675,IC50,=,11.8,NM,,,,,,,,,,,,,,In vitro inhibition of human matrix metalloprotease-13,,"N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: further probing of the S(1), S(1)', and S(2)' pockets.",J. Med. Chem.,2001,44,19,"Hanessian S, Moitessier N, Gauchet C, Viau M",,106474,DTCT0024002,1381858,DTCC00106784,1240704,16392
CHEMBL104022,P45452,,TWQZYQBXMVVVCY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11543675,IC50,=,12,NM,,,,,,,,,,,,,,In vitro inhibition of human matrix metalloprotease-13,,"N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: further probing of the S(1), S(1)', and S(2)' pockets.",J. Med. Chem.,2001,44,19,"Hanessian S, Moitessier N, Gauchet C, Viau M",,106474,DTCT0024002,1385696,DTCC00273200,433728,16392
CHEMBL104022,P45452,,TWQZYQBXMVVVCY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16392792,IC50,=,12,NM,,,,,,,,,,,,,,Binding affinity to MMP13,,Matrix metalloproteinase target family landscape: a chemometrical approach to ligand selectivity based on protein binding site analysis.,J. Med. Chem.,2006,49,1,"Pirard B, Matter H",,329823,DTCT0024002,1880219,DTCC00273200,423989,20214
CHEMBL10431,P45452,,SBPZKNUSQCPAAY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11297453,IC50,=,116,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-13 at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,106463,DTCT0024002,954777,DTCC00138456,2015345,16645
CHEMBL10431,P45452,,SBPZKNUSQCPAAY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12217355,IC50,=,114.82,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant human matrix metalloprotease-13,,Analogue based design of MMP-13 (Collagenase-3) inhibitors.,Bioorg. Med. Chem. Lett.,2002,12,19,"Sarma JA, Rambabu G, Srikanth K, Raveendra D, Vithal M",,106465,DTCT0024002,808808,DTCC00138456,2012976,5083
CHEMBL104446,P45452,,BMPCLJPYXFVWKY-ARLHGKGLSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11543676,IC50,=,519,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,Design and synthesis of matrix metalloproteinase inhibitors guided by molecular modeling. Picking the S(1) pocket using conformationally constrained inhibitors.,J. Med. Chem.,2001,44,19,"Hanessian S, MacKay DB, Moitessier N",,106482,DTCT0024002,1194611,DTCC00273526,1228796,16385
CHEMBL10454,P45452,,UXURFMZZZWZYFW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11297453,IC50,=,21,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-13 in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,106481,DTCT0024002,936726,DTCC00138391,693756,16645
CHEMBL10454,P45452,,UXURFMZZZWZYFW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11472202,IC50,=,21,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,106478,DTCT0024002,1321641,DTCC00138391,578578,16328
CHEMBL10454,P45452,,UXURFMZZZWZYFW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12217355,IC50,=,20.89,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant human matrix metalloprotease-13,,Analogue based design of MMP-13 (Collagenase-3) inhibitors.,Bioorg. Med. Chem. Lett.,2002,12,19,"Sarma JA, Rambabu G, Srikanth K, Raveendra D, Vithal M",,106465,DTCT0024002,787711,DTCC00138391,691443,5083
CHEMBL104599,P45452,,XOOXBIFEOHDRHE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11543675,IC50,=,3.2,NM,,,,,,,,,,,,,,In vitro inhibition of human matrix metalloprotease-13,,"N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: further probing of the S(1), S(1)', and S(2)' pockets.",J. Med. Chem.,2001,44,19,"Hanessian S, Moitessier N, Gauchet C, Viau M",,106474,DTCT0024002,1398104,DTCC00273602,1564726,16392
CHEMBL10469,P45452,,TZGXQAYCVFGRLH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11297453,IC50,=,231,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-13 in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,106481,DTCT0024002,936722,DTCC00138421,1695954,16645
CHEMBL10469,P45452,,TZGXQAYCVFGRLH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12217355,IC50,=,229.09,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant human matrix metalloprotease-13,,Analogue based design of MMP-13 (Collagenase-3) inhibitors.,Bioorg. Med. Chem. Lett.,2002,12,19,"Sarma JA, Rambabu G, Srikanth K, Raveendra D, Vithal M",,106465,DTCT0024002,794848,DTCC00138421,1693630,5083
CHEMBL104722,P45452,,CQIQKDQFHVTTKM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11543675,IC50,=,20,NM,,,,,,,,,,,,,,In vitro inhibition of human matrix metalloprotease-13,,"N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: further probing of the S(1), S(1)', and S(2)' pockets.",J. Med. Chem.,2001,44,19,"Hanessian S, Moitessier N, Gauchet C, Viau M",,106474,DTCT0024002,1385700,DTCC00273620,659487,16392
CHEMBL10492,P45452,,YUOAPDQYFOIVNS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11297453,IC50,=,1691,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-13 in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,106481,DTCT0024002,964049,DTCC00138706,1695957,16645
CHEMBL10492,P45452,,YUOAPDQYFOIVNS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12217355,IC50,=,1698.24,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant human matrix metalloprotease-13,,Analogue based design of MMP-13 (Collagenase-3) inhibitors.,Bioorg. Med. Chem. Lett.,2002,12,19,"Sarma JA, Rambabu G, Srikanth K, Raveendra D, Vithal M",,106465,DTCT0024002,804587,DTCC00138706,1693627,5083
CHEMBL105142,P45452,,FCYBWLNLMVDLRH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11543675,IC50,=,96,NM,,,,,,,,,,,,,,In vitro inhibition of human matrix metalloprotease-13,,"N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: further probing of the S(1), S(1)', and S(2)' pockets.",J. Med. Chem.,2001,44,19,"Hanessian S, Moitessier N, Gauchet C, Viau M",,106474,DTCT0024002,1401773,DTCC00273509,1207889,16392
CHEMBL105279,P45452,,ACXYSVKNGLLDLY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11543675,IC50,=,5.3,NM,,,,,,,,,,,,,,In vitro inhibition of human matrix metalloprotease-13,,"N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: further probing of the S(1), S(1)', and S(2)' pockets.",J. Med. Chem.,2001,44,19,"Hanessian S, Moitessier N, Gauchet C, Viau M",,106474,DTCT0024002,1369050,DTCC00273107,1500350,16392
CHEMBL105311,P45452,,SWRNCXLTVBBIMK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11543675,IC50,=,0.4,NM,,,,,,,,,,,,,,In vitro inhibition of human matrix metalloprotease-13,,"N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: further probing of the S(1), S(1)', and S(2)' pockets.",J. Med. Chem.,2001,44,19,"Hanessian S, Moitessier N, Gauchet C, Viau M",,106474,DTCT0024002,1402985,DTCC00274052,205240,16392
CHEMBL105422,P45452,,AXBFSSCCVFPFFC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11543675,IC50,=,23,NM,,,,,,,,,,,,,,In vitro inhibition of human matrix metalloprotease-13,,"N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: further probing of the S(1), S(1)', and S(2)' pockets.",J. Med. Chem.,2001,44,19,"Hanessian S, Moitessier N, Gauchet C, Viau M",,106474,DTCT0024002,1371784,DTCC00273155,1079676,16392
CHEMBL105535,P45452,,SSFOEYVZLXDDTG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11543675,IC50,=,16.2,NM,,,,,,,,,,,,,,In vitro inhibition of human matrix metalloprotease-13,,"N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: further probing of the S(1), S(1)', and S(2)' pockets.",J. Med. Chem.,2001,44,19,"Hanessian S, Moitessier N, Gauchet C, Viau M",,106474,DTCT0024002,1384509,DTCC00273105,659486,16392
CHEMBL10590,P45452,,ZSZSGGNFCMWYDF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11297453,IC50,=,145,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-13 at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,106463,DTCT0024002,950662,DTCC00138558,403686,16645
CHEMBL10590,P45452,,ZSZSGGNFCMWYDF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12217355,IC50,=,144.54,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant human matrix metalloprotease-13,,Analogue based design of MMP-13 (Collagenase-3) inhibitors.,Bioorg. Med. Chem. Lett.,2002,12,19,"Sarma JA, Rambabu G, Srikanth K, Raveendra D, Vithal M",,106465,DTCT0024002,775248,DTCC00138558,401220,5083
CHEMBL105962,P45452,,ZPNXAVJYHSAOKF-SJBAFXMYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11543676,IC50,=,18.1,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,Design and synthesis of matrix metalloproteinase inhibitors guided by molecular modeling. Picking the S(1) pocket using conformationally constrained inhibitors.,J. Med. Chem.,2001,44,19,"Hanessian S, MacKay DB, Moitessier N",,106482,DTCT0024002,1200053,DTCC00273570,389552,16385
CHEMBL106016,P45452,,MMOBDSFVSOBMOV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11543675,IC50,=,1.1,NM,,,,,,,,,,,,,,In vitro inhibition of human matrix metalloprotease-13,,"N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: further probing of the S(1), S(1)', and S(2)' pockets.",J. Med. Chem.,2001,44,19,"Hanessian S, Moitessier N, Gauchet C, Viau M",,106474,DTCT0024002,1389492,DTCC00273742,335997,16392
CHEMBL10646,P45452,,PTRUGAYWWQMKAT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11297453,IC50,=,1660,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-13 in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,106481,DTCT0024002,956229,DTCC00138654,822791,16645
CHEMBL10646,P45452,,PTRUGAYWWQMKAT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12217355,IC50,=,1659.59,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant human matrix metalloprotease-13,,Analogue based design of MMP-13 (Collagenase-3) inhibitors.,Bioorg. Med. Chem. Lett.,2002,12,19,"Sarma JA, Rambabu G, Srikanth K, Raveendra D, Vithal M",,106465,DTCT0024002,810184,DTCC00138654,820416,5083
CHEMBL10655,P45452,,KMBQQDDLWIEVKL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11297453,IC50,=,24,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-13 in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,106481,DTCT0024002,947005,DTCC00138617,1949640,16645
CHEMBL10655,P45452,,KMBQQDDLWIEVKL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12217355,IC50,=,23.99,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant human matrix metalloprotease-13,,Analogue based design of MMP-13 (Collagenase-3) inhibitors.,Bioorg. Med. Chem. Lett.,2002,12,19,"Sarma JA, Rambabu G, Srikanth K, Raveendra D, Vithal M",,106465,DTCT0024002,805973,DTCC00138617,1947220,5083
CHEMBL10671,P45452,,UMBHCIONUFCHIP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11297453,IC50,=,16,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-13 in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,106481,DTCT0024002,952151,DTCC00138613,403685,16645
CHEMBL10671,P45452,,UMBHCIONUFCHIP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12217355,IC50,=,15.85,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant human matrix metalloprotease-13,,Analogue based design of MMP-13 (Collagenase-3) inhibitors.,Bioorg. Med. Chem. Lett.,2002,12,19,"Sarma JA, Rambabu G, Srikanth K, Raveendra D, Vithal M",,106465,DTCT0024002,775249,DTCC00138613,401219,5083
CHEMBL10672,P45452,,HSFOMBDSDMOJCP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11297453,IC50,=,33,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-13 in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,106481,DTCT0024002,957554,DTCC00138695,34638,16645
CHEMBL10672,P45452,,HSFOMBDSDMOJCP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12217355,IC50,=,33.11,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant human matrix metalloprotease-13,,Analogue based design of MMP-13 (Collagenase-3) inhibitors.,Bioorg. Med. Chem. Lett.,2002,12,19,"Sarma JA, Rambabu G, Srikanth K, Raveendra D, Vithal M",,106465,DTCT0024002,785215,DTCC00138695,30202,5083
CHEMBL10673,P45452,,ZCJYXMGAZICHPN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11297453,IC50,=,127,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-13 in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,106481,DTCT0024002,953642,DTCC00138696,1695956,16645
CHEMBL10673,P45452,,ZCJYXMGAZICHPN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12217355,IC50,=,125.89,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant human matrix metalloprotease-13,,Analogue based design of MMP-13 (Collagenase-3) inhibitors.,Bioorg. Med. Chem. Lett.,2002,12,19,"Sarma JA, Rambabu G, Srikanth K, Raveendra D, Vithal M",,106465,DTCT0024002,804586,DTCC00138696,1693628,5083
CHEMBL10674,P45452,,AXDNELHYOHIRLD-MIHMCVIASA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11297453,IC50,=,33,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-13 in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,106481,DTCT0024002,952155,DTCC00138552,822792,16645
CHEMBL10674,P45452,,AXDNELHYOHIRLD-MIHMCVIASA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12217355,IC50,=,33.11,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant human matrix metalloprotease-13,,Analogue based design of MMP-13 (Collagenase-3) inhibitors.,Bioorg. Med. Chem. Lett.,2002,12,19,"Sarma JA, Rambabu G, Srikanth K, Raveendra D, Vithal M",,106465,DTCT0024002,773942,DTCC00138552,820415,5083
CHEMBL10760,P45452,,XHIUPZBXQZTGTG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11297453,IC50,=,2146,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-13 in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,106481,DTCT0024002,975195,DTCC00138621,34636,16645
CHEMBL10760,P45452,,XHIUPZBXQZTGTG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12217355,IC50,=,2137.96,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant human matrix metalloprotease-13,,Analogue based design of MMP-13 (Collagenase-3) inhibitors.,Bioorg. Med. Chem. Lett.,2002,12,19,"Sarma JA, Rambabu G, Srikanth K, Raveendra D, Vithal M",,106465,DTCT0024002,783791,DTCC00138621,30203,5083
CHEMBL10761,P45452,,FFHXMPKAWWFPSX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11297453,IC50,=,270,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-13 in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,106481,DTCT0024002,964045,DTCC00138622,564527,16645
CHEMBL10761,P45452,,FFHXMPKAWWFPSX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12217355,IC50,=,269.15,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant human matrix metalloprotease-13,,Analogue based design of MMP-13 (Collagenase-3) inhibitors.,Bioorg. Med. Chem. Lett.,2002,12,19,"Sarma JA, Rambabu G, Srikanth K, Raveendra D, Vithal M",,106465,DTCT0024002,785213,DTCC00138622,562261,5083
CHEMBL1077203,P45452,,CNUCYIDHDPTDOD-SFHVURJKSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20172725,KI,>,40000,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Discovery and SAR of hydantoin TACE inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,6,"Yu W, Guo Z, Orth P, Madison V, Chen L, Dai C, Feltz RJ, Girijavallabhan VM, Kim SH, Kozlowski JA, Lavey BJ, Li D, Lundell D, Niu X, Piwinski JJ, Popovici-Muller J, Rizvi R, Rosner KE, Shankar BB, Shih NY, Siddiqui MA, Sun J, Tong L, Umland S, Wong MK, Yang DY, Zhou G",,615268,DTCT0024002,3227040,DTCC00631173,1104573,38167
CHEMBL1078281,P45452,,GRSFKJZRDUZQPW-ONUMYQOESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21417219,IC50,=,3.4,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 after 60 mins by fluorescence plate reader,,"Discovery of (1S,2R,3R)-2,3-Dimethyl-2-phenyl-1-sulfamidocyclopropanecarboxylates: Novel and Highly Selective Aggrecanase Inhibitors.",J. Med. Chem.,2011,54,8,"Shiozaki M, Maeda K, Miura T, Kotoku M, Yamasaki T, Matsuda I, Aoki K, Yasue K, Imai H, Ubukata M, Suma A, Yokota M, Hotta T, Tanaka M, Hase Y, Haas J, Fryer AM, Laird ER, Littmann NM, Andrews SW, Josey JA, Mimura T, Shinozaki Y, Yoshiuchi H, Inaba T",,743613,DTCT0024002,5927584,DTCC00632907,1007708,44276
CHEMBL1078396,P45452,,PIEMRKVLYXWKFP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20172725,KI,=,12860,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Discovery and SAR of hydantoin TACE inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,6,"Yu W, Guo Z, Orth P, Madison V, Chen L, Dai C, Feltz RJ, Girijavallabhan VM, Kim SH, Kozlowski JA, Lavey BJ, Li D, Lundell D, Niu X, Piwinski JJ, Popovici-Muller J, Rizvi R, Rosner KE, Shankar BB, Shih NY, Siddiqui MA, Sun J, Tong L, Umland S, Wong MK, Yang DY, Zhou G",,615268,DTCT0024002,3227039,DTCC00631942,1232705,38167
CHEMBL10792,P45452,,LQLNFJVHRIWFTO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11297453,IC50,=,303,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-13 in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,106481,DTCT0024002,939391,DTCC00138714,1308274,16645
CHEMBL10792,P45452,,LQLNFJVHRIWFTO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12217355,IC50,=,302,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant human matrix metalloprotease-13,,Analogue based design of MMP-13 (Collagenase-3) inhibitors.,Bioorg. Med. Chem. Lett.,2002,12,19,"Sarma JA, Rambabu G, Srikanth K, Raveendra D, Vithal M",,106465,DTCT0024002,786587,DTCC00138714,1305794,5083
CHEMBL10806,P45452,,DPNFTGXQMOIHKK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11297453,IC50,=,478,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-13 in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,106481,DTCT0024002,961571,DTCC00138724,1081840,16645
CHEMBL10806,P45452,,DPNFTGXQMOIHKK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12217355,IC50,=,478.63,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant human matrix metalloprotease-13,,Analogue based design of MMP-13 (Collagenase-3) inhibitors.,Bioorg. Med. Chem. Lett.,2002,12,19,"Sarma JA, Rambabu G, Srikanth K, Raveendra D, Vithal M",,106465,DTCT0024002,776573,DTCC00138724,1079437,5083
CHEMBL10809,P45452,,GCCFOYRWIAVTCA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11297453,IC50,=,147,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-13 in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,106481,DTCT0024002,962734,DTCC00138658,1755790,16645
CHEMBL10809,P45452,,GCCFOYRWIAVTCA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12217355,IC50,=,144.54,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant human matrix metalloprotease-13,,Analogue based design of MMP-13 (Collagenase-3) inhibitors.,Bioorg. Med. Chem. Lett.,2002,12,19,"Sarma JA, Rambabu G, Srikanth K, Raveendra D, Vithal M",,106465,DTCT0024002,800509,DTCC00138658,1753489,5083
CHEMBL10822,P45452,,HCOFTHTVAIHKKV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11297453,IC50,=,2150,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-13 in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,106481,DTCT0024002,936718,DTCC00138431,467502,16645
CHEMBL10822,P45452,,HCOFTHTVAIHKKV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12217355,IC50,=,2137.96,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant human matrix metalloprotease-13,,Analogue based design of MMP-13 (Collagenase-3) inhibitors.,Bioorg. Med. Chem. Lett.,2002,12,19,"Sarma JA, Rambabu G, Srikanth K, Raveendra D, Vithal M",,106465,DTCT0024002,792119,DTCC00138431,465000,5083
CHEMBL1082314,P45452,,QJQSFVGRKOULTN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20529685,IC50,=,25.1,NM,,,,,,,,,,,,,,Inhibition of MMP13,,MMP-13 selective isonipecotamide alpha-sulfone hydroxamates.,Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Stehle N, Swearingen C, Becker DP",,634118,DTCT0024002,3346167,DTCC00647778,230222,35540
CHEMBL1082317,P45452,,QOWJHUFMPPFELP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20529685,IC50,=,4,NM,,,,,,,,,,,,,,Inhibition of MMP13,,MMP-13 selective isonipecotamide alpha-sulfone hydroxamates.,Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Stehle N, Swearingen C, Becker DP",,634118,DTCT0024002,3346206,DTCC00647799,780673,35540
CHEMBL1082318,P45452,,HWZVYNMATDDRGV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20529685,IC50,=,27.7,NM,,,,,,,,,,,,,,Inhibition of MMP13,,MMP-13 selective isonipecotamide alpha-sulfone hydroxamates.,Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Stehle N, Swearingen C, Becker DP",,634118,DTCT0024002,3346207,DTCC00647800,2038151,35540
CHEMBL1082319,P45452,,TWUHFGMOEBVGGW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20529685,IC50,=,70,NM,,,,,,,,,,,,,,Inhibition of MMP13,,MMP-13 selective isonipecotamide alpha-sulfone hydroxamates.,Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Stehle N, Swearingen C, Becker DP",,634118,DTCT0024002,3346208,DTCC00647801,878385,35540
CHEMBL1082324,P45452,,ISXZSJVTKFNYSR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20529685,IC50,=,9,NM,,,,,,,,,,,,,,Inhibition of MMP13,,MMP-13 selective isonipecotamide alpha-sulfone hydroxamates.,Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Stehle N, Swearingen C, Becker DP",,634118,DTCT0024002,3346159,DTCC00647701,1330912,35540
CHEMBL1082325,P45452,,XFAVBLSYPFKCGW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20529685,IC50,=,4.4,NM,,,,,,,,,,,,,,Inhibition of MMP13,,MMP-13 selective isonipecotamide alpha-sulfone hydroxamates.,Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Stehle N, Swearingen C, Becker DP",,634118,DTCT0024002,3346161,DTCC00647703,1654393,35540
CHEMBL1082370,P45452,,XZDDXHHQKBWEQB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20529684,IC50,=,11.4,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634107,DTCT0024002,3346048,DTCC00647469,954160,35532
CHEMBL1082371,P45452,,PYJCXRBSZSSHDD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20529684,IC50,=,7,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634107,DTCT0024002,3346049,DTCC00647470,2049561,35532
CHEMBL1082381,P45452,SC-276,WXNWNNKHEJMQOM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16220987,KI,=,0.4,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024002,14742621,DTCC00031197,2108114,69259
CHEMBL1082381,P45452,SC-276,WXNWNNKHEJMQOM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20529684,IC50,=,0.4,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634107,DTCT0024002,3346105,DTCC00031197,792376,35532
CHEMBL1082381,P45452,SC-276,WXNWNNKHEJMQOM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20726512,IC50,=,0.4,NM,,,,,,,,,,,,,,Inhibition of human MMP13 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754464,DTCT0024002,6005778,DTCC00031197,781480,45214
CHEMBL1082381,P45452,SC-276,WXNWNNKHEJMQOM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21493063,IC50,<,1,NM,,,,,,,,,,,,,,Inhibition of human MMP13,,MMP-13 selective alpha-sulfone hydroxamates: Identification of selective P1' amides.,Bioorg. Med. Chem. Lett.,2011,21,10,"Fobian YM, Freskos JN, Barta TE, Bedell LJ, Heintz R, Kassab DJ, Kiefer JR, Mischke BV, Molyneaux JM, Mullins P, Munie GE, Becker DP",,744872,DTCT0024002,5936676,DTCC00031197,799452,44425
CHEMBL1082645,P45452,,LZVLSPCMSRJJKT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20529685,IC50,=,26.8,NM,,,,,,,,,,,,,,Inhibition of MMP13,,MMP-13 selective isonipecotamide alpha-sulfone hydroxamates.,Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Stehle N, Swearingen C, Becker DP",,634118,DTCT0024002,3346178,DTCC00647831,1622137,35540
CHEMBL1082657,P45452,,BBYYDINTRXZVIU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20529685,IC50,=,50,NM,,,,,,,,,,,,,,Inhibition of MMP13,,MMP-13 selective isonipecotamide alpha-sulfone hydroxamates.,Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Stehle N, Swearingen C, Becker DP",,634118,DTCT0024002,3346164,DTCC00647775,165828,35540
CHEMBL1082658,P45452,,SOPJLCCBZBCHFQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20529685,IC50,=,28,NM,,,,,,,,,,,,,,Inhibition of MMP13,,MMP-13 selective isonipecotamide alpha-sulfone hydroxamates.,Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Stehle N, Swearingen C, Becker DP",,634118,DTCT0024002,3346165,DTCC00647776,1298263,35540
CHEMBL1082789,P45452,,CWKUARBGJRTUFB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20529685,IC50,=,30,NM,,,,,,,,,,,,,,Inhibition of MMP13,,MMP-13 selective isonipecotamide alpha-sulfone hydroxamates.,Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Stehle N, Swearingen C, Becker DP",,634118,DTCT0024002,3346177,DTCC00646734,230213,35540
CHEMBL1082966,P45452,,NHBOIMAIUCLQKQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20529684,IC50,=,2.7,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634107,DTCT0024002,3345337,DTCC00647118,1051282,35532
CHEMBL1083007,P45452,,DDSDNLBIGCANQU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20529684,IC50,=,28.8,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634107,DTCT0024002,3346043,DTCC00647403,1822511,35532
CHEMBL1083030,P45452,,ZUERCGBCDFBAQX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20529685,IC50,=,35,NM,,,,,,,,,,,,,,Inhibition of MMP13,,MMP-13 selective isonipecotamide alpha-sulfone hydroxamates.,Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Stehle N, Swearingen C, Becker DP",,634118,DTCT0024002,3346156,DTCC00647616,1039529,35540
CHEMBL1083290,P45452,,IMRHHKFKEFFZON-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20529685,IC50,=,50,NM,,,,,,,,,,,,,,Inhibition of MMP13,,MMP-13 selective isonipecotamide alpha-sulfone hydroxamates.,Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Stehle N, Swearingen C, Becker DP",,634118,DTCT0024002,3346162,DTCC00647704,230221,35540
CHEMBL1083291,P45452,,BKCSZOHESJTBQU-HDICACEKSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20529685,IC50,=,18.1,NM,,,,,,,,,,,,,,Inhibition of MMP13,,MMP-13 selective isonipecotamide alpha-sulfone hydroxamates.,Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Stehle N, Swearingen C, Becker DP",,634118,DTCT0024002,3346163,DTCC00647705,619470,35540
CHEMBL1083321,P45452,,DNPNWGZXJBALIP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20529684,IC50,=,35,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634107,DTCT0024002,3346044,DTCC00647404,1951711,35532
CHEMBL1083322,P45452,,FSVPEOOPDJVOOW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20529684,IC50,=,11.3,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634107,DTCT0024002,3346046,DTCC00647405,112725,35532
CHEMBL1083336,P45452,,KURIXYQCCHLXJD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20529685,IC50,=,24.5,NM,,,,,,,,,,,,,,Inhibition of MMP13,,MMP-13 selective isonipecotamide alpha-sulfone hydroxamates.,Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Stehle N, Swearingen C, Becker DP",,634118,DTCT0024002,3346157,DTCC00647617,1810676,35540
CHEMBL1083337,P45452,,YOEUGEBWOYBNPP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20529685,IC50,=,20,NM,,,,,,,,,,,,,,Inhibition of MMP13,,MMP-13 selective isonipecotamide alpha-sulfone hydroxamates.,Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Stehle N, Swearingen C, Becker DP",,634118,DTCT0024002,3346158,DTCC00647618,1939510,35540
CHEMBL1083584,P45452,,XSEREZCRIQFANN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20529685,IC50,=,18,NM,,,,,,,,,,,,,,Inhibition of MMP13,,MMP-13 selective isonipecotamide alpha-sulfone hydroxamates.,Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Stehle N, Swearingen C, Becker DP",,634118,DTCT0024002,3346171,DTCC00646651,490568,35540
CHEMBL1083585,P45452,,DGNSDTQNQWONIY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20529685,IC50,=,6.7,NM,,,,,,,,,,,,,,Inhibition of MMP13,,MMP-13 selective isonipecotamide alpha-sulfone hydroxamates.,Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Stehle N, Swearingen C, Becker DP",,634118,DTCT0024002,3346173,DTCC00646653,1622116,35540
CHEMBL1083586,P45452,,FPRHOXXDKHGHSY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20529685,IC50,=,12.2,NM,,,,,,,,,,,,,,Inhibition of MMP13,,MMP-13 selective isonipecotamide alpha-sulfone hydroxamates.,Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Stehle N, Swearingen C, Becker DP",,634118,DTCT0024002,3346174,DTCC00646654,328385,35540
CHEMBL1083606,P45452,,BTDOGCFKKXBYKB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20529685,IC50,=,45,NM,,,,,,,,,,,,,,Inhibition of MMP13,,MMP-13 selective isonipecotamide alpha-sulfone hydroxamates.,Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Stehle N, Swearingen C, Becker DP",,634118,DTCT0024002,3346166,DTCC00647777,554962,35540
CHEMBL1083607,P45452,,PXTTXJDSBQDLQB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20529685,IC50,=,40,NM,,,,,,,,,,,,,,Inhibition of MMP13,,MMP-13 selective isonipecotamide alpha-sulfone hydroxamates.,Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Stehle N, Swearingen C, Becker DP",,634118,DTCT0024002,3346168,DTCC00647779,1939513,35540
CHEMBL1083625,P45452,,HQIAPHYTAVZNQW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20529684,IC50,=,42.5,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634107,DTCT0024002,3346041,DTCC00647325,566621,35532
CHEMBL1083626,P45452,,HCEJOINDKHKFPT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20529684,IC50,=,32.7,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634107,DTCT0024002,3346042,DTCC00647326,1790044,35532
CHEMBL1083906,P45452,,HYKTXCHYRXFJMV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20529684,IC50,=,7.7,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634107,DTCT0024002,3345338,DTCC00647119,1665937,35532
CHEMBL1083907,P45452,,XFCISDUWYSMJOU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20529684,IC50,=,9,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634107,DTCT0024002,3345339,DTCC00647120,534358,35532
CHEMBL1083908,P45452,,INGMGORXRMQEAG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20529684,IC50,=,130,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634107,DTCT0024002,3345340,DTCC00647121,2081682,35532
CHEMBL1083931,P45452,,VGQUGXBRZGFKOH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20529684,IC50,=,2.4,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634107,DTCT0024002,3346037,DTCC00647257,824921,35532
CHEMBL1083932,P45452,,BADHAWRYSSJDAG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20529684,IC50,=,6,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634107,DTCT0024002,3346038,DTCC00647258,1472207,35532
CHEMBL1084024,P45452,,RWVGBBDAACKFOR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20529685,IC50,=,10.7,NM,,,,,,,,,,,,,,Inhibition of MMP13,,MMP-13 selective isonipecotamide alpha-sulfone hydroxamates.,Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Stehle N, Swearingen C, Becker DP",,634118,DTCT0024002,3346175,DTCC00646732,1717798,35540
CHEMBL1084206,P45452,,RMMYIAVIROFVLC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20529684,IC50,=,8,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634107,DTCT0024002,3345341,DTCC00647201,1697970,35532
CHEMBL1084207,P45452,,REXXRRWHIZEEBC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20529684,IC50,=,20,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634107,DTCT0024002,3345343,DTCC00647202,824919,35532
CHEMBL1084208,P45452,,QQPOIMHFFPBDQM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20529684,IC50,=,0.63,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634107,DTCT0024002,3345344,DTCC00647203,1727327,35532
CHEMBL1084209,P45452,,HBPYDCJRDHWDAE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20529684,IC50,=,1.9,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634107,DTCT0024002,3345345,DTCC00647204,1018809,35532
CHEMBL1084217,P45452,,GWRXKVPUXYYCMA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20529684,IC50,=,28.6,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634107,DTCT0024002,3345346,DTCC00647255,340233,35532
CHEMBL1084218,P45452,,UWCWCXPWHSKCKX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20529684,IC50,=,3.3,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634107,DTCT0024002,3346036,DTCC00647256,1854573,35532
CHEMBL1084220,P45452,,DPDYQDPIBOABCX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20529684,IC50,=,17.5,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634107,DTCT0024002,3346039,DTCC00647323,1886832,35532
CHEMBL1084221,P45452,,FNEPKOHTWFANAW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20529684,IC50,=,0.7,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634107,DTCT0024002,3346040,DTCC00647324,598800,35532
CHEMBL1084238,P45452,,UFKFLDDRYBWLPH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20529684,IC50,=,0.6,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634107,DTCT0024002,3346102,DTCC00647546,80529,35532
CHEMBL1084298,P45452,,ITQUODOQSFVYAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20529685,IC50,=,6.4,NM,,,,,,,,,,,,,,Inhibition of MMP13,,MMP-13 selective isonipecotamide alpha-sulfone hydroxamates.,Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Stehle N, Swearingen C, Becker DP",,634118,DTCT0024002,3346176,DTCC00646733,490569,35540
CHEMBL1084509,P45452,,VCKIKUWRRCAZBI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20529684,IC50,=,1,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634107,DTCT0024002,3346103,DTCC00647547,1601315,35532
CHEMBL1084510,P45452,,HMVRHAWMVBUIKM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20529684,IC50,=,0.42,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634107,DTCT0024002,3346104,DTCC00647548,1375495,35532
CHEMBL10848,P45452,,QFUKIOJKDCKUGI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11297453,IC50,=,486,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-13 in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,106481,DTCT0024002,960228,DTCC00138628,1081839,16645
CHEMBL10848,P45452,,QFUKIOJKDCKUGI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12217355,IC50,=,478.63,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant human matrix metalloprotease-13,,Analogue based design of MMP-13 (Collagenase-3) inhibitors.,Bioorg. Med. Chem. Lett.,2002,12,19,"Sarma JA, Rambabu G, Srikanth K, Raveendra D, Vithal M",,106465,DTCT0024002,808807,DTCC00138628,1079438,5083
CHEMBL108494,P45452,,MBSMJAHZPVXQCK-HIGJEIRPSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11563922,KI,>,15000,NM,,,,,,,,,,,,,,In Vitro inhibitory activity against the catalytic domain of the matrix metalloprotease-13,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,106610,DTCT0024002,1704495,DTCC00282283,1196752,16424
CHEMBL108494,P45452,,MBSMJAHZPVXQCK-HIGJEIRPSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18790648,KI,>,15000,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497406,DTCT0024002,2457385,DTCC00282283,1210750,32556
CHEMBL10851,P45452,,GVUFJCREUUFMPP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11297453,IC50,=,774,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-13 in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,106481,DTCT0024002,936784,DTCC00138737,1146775,16645
CHEMBL10851,P45452,,GVUFJCREUUFMPP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12217355,IC50,=,758.58,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant human matrix metalloprotease-13,,Analogue based design of MMP-13 (Collagenase-3) inhibitors.,Bioorg. Med. Chem. Lett.,2002,12,19,"Sarma JA, Rambabu G, Srikanth K, Raveendra D, Vithal M",,106465,DTCT0024002,801794,DTCC00138737,1144414,5083
CHEMBL1085257,P45452,,WVNVANHURONWTG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20529685,IC50,=,9,NM,,,,,,,,,,,,,,Inhibition of MMP13,,MMP-13 selective isonipecotamide alpha-sulfone hydroxamates.,Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Stehle N, Swearingen C, Becker DP",,634118,DTCT0024002,3346221,DTCC00647802,262531,35540
CHEMBL1085263,P45452,,JOMDWNBZLUPPTA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20529684,IC50,=,11,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634107,DTCT0024002,3346050,DTCC00647471,1051285,35532
CHEMBL1085264,P45452,,ATIAZZHHFGJINP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20529684,IC50,=,11.4,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634107,DTCT0024002,3346051,DTCC00647472,80527,35532
CHEMBL1085562,P45452,,NJSDEGWKISRFRU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20529685,IC50,=,90,NM,,,,,,,,,,,,,,Inhibition of MMP13,,MMP-13 selective isonipecotamide alpha-sulfone hydroxamates.,Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Stehle N, Swearingen C, Becker DP",,634118,DTCT0024002,3346169,DTCC00646649,878376,35540
CHEMBL1085563,P45452,,FQMDDNHJAAIYKQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20529685,IC50,=,6.7,NM,,,,,,,,,,,,,,Inhibition of MMP13,,MMP-13 selective isonipecotamide alpha-sulfone hydroxamates.,Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Stehle N, Swearingen C, Becker DP",,634118,DTCT0024002,3346170,DTCC00646650,1622115,35540
CHEMBL1085602,P45452,,XFIZGIIZTOASLY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20529684,IC50,=,1.7,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634107,DTCT0024002,3345336,DTCC00647043,1568775,35532
CHEMBL1085748,P45452,,DNOKLXCRZPAPJH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20529684,IC50,=,70,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634107,DTCT0024002,3346052,DTCC00647545,112726,35532
CHEMBL1085787,P45452,,JKMQHCXIFJQOMJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20529685,IC50,=,6,NM,,,,,,,,,,,,,,Inhibition of MMP13,,MMP-13 selective isonipecotamide alpha-sulfone hydroxamates.,Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Stehle N, Swearingen C, Becker DP",,634118,DTCT0024002,3346172,DTCC00646652,716359,35540
CHEMBL1085988,P45452,,ODGSTGNVDAZIJX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20529684,IC50,=,33.7,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634107,DTCT0024002,3346047,DTCC00647406,1212002,35532
CHEMBL1086379,P45452,,SAXMIJMROZDLCS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20529685,IC50,=,6.2,NM,,,,,,,,,,,,,,Inhibition of MMP13,,MMP-13 selective isonipecotamide alpha-sulfone hydroxamates.,Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Stehle N, Swearingen C, Becker DP",,634118,DTCT0024002,3346160,DTCC00647702,911038,35540
CHEMBL10881,P45452,,WYTXTYOLYMMDCW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11297453,IC50,=,104,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-13 in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,106481,DTCT0024002,939395,DTCC00138674,403684,16645
CHEMBL10881,P45452,,WYTXTYOLYMMDCW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12217355,IC50,=,104.71,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant human matrix metalloprotease-13,,Analogue based design of MMP-13 (Collagenase-3) inhibitors.,Bioorg. Med. Chem. Lett.,2002,12,19,"Sarma JA, Rambabu G, Srikanth K, Raveendra D, Vithal M",,106465,DTCT0024002,801793,DTCC00138674,401218,5083
CHEMBL10885,P45452,,WUKUJFFVJZRRNH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11297453,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-13 in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,106481,DTCT0024002,943131,DTCC00138648,34637,16645
CHEMBL10908,P45452,,GLFZNNLEMNMSQE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11297453,IC50,=,154,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-13 in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,106481,DTCT0024002,957559,DTCC00138721,1373409,16645
CHEMBL10908,P45452,,GLFZNNLEMNMSQE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12217355,IC50,=,151.36,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant human matrix metalloprotease-13,,Analogue based design of MMP-13 (Collagenase-3) inhibitors.,Bioorg. Med. Chem. Lett.,2002,12,19,"Sarma JA, Rambabu G, Srikanth K, Raveendra D, Vithal M",,106465,DTCT0024002,793607,DTCC00138721,1371057,5083
CHEMBL109214,P45452,,PDKBAEDNMKVROV-CQSZACIVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11563922,KI,=,320,NM,,,,,,,,,,,,,,In Vitro inhibitory activity against the catalytic domain of the matrix metalloprotease-13,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,106610,DTCT0024002,1718168,DTCC00282259,422410,16424
CHEMBL109267,P45452,,FPHXOEUJYCDFQF-LAUBAEHRSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12951101,IC50,=,6,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-13.,,Synthesis and biological activity of piperazine-based dual MMP-13 and TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,19,"Letavic MA, Barberia JT, Carty TJ, Hardink JR, Liras J, Lopresti-Morrow LL, Mitchell PG, Noe MC, Reeves LM, Snow SL, Stam EJ, Sweeney FJ, Vaughn ML, Yu CH",,106625,DTCT0024002,667048,DTCC00282719,129471,5809
CHEMBL109326,P45452,,IINBMMZSLVIMTL-QMHKHESXSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12951101,IC50,=,17,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-13.,,Synthesis and biological activity of piperazine-based dual MMP-13 and TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,19,"Letavic MA, Barberia JT, Carty TJ, Hardink JR, Liras J, Lopresti-Morrow LL, Mitchell PG, Noe MC, Reeves LM, Snow SL, Stam EJ, Sweeney FJ, Vaughn ML, Yu CH",,106625,DTCT0024002,658562,DTCC00282505,1521302,5809
CHEMBL10935,P45452,,XFLXFAKGEAQTOI-MIHMCVIASA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11297453,IC50,=,81,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-13 in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,106481,DTCT0024002,949520,DTCC00138543,1242881,16645
CHEMBL10935,P45452,,XFLXFAKGEAQTOI-MIHMCVIASA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12217355,IC50,=,81.28,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant human matrix metalloprotease-13,,Analogue based design of MMP-13 (Collagenase-3) inhibitors.,Bioorg. Med. Chem. Lett.,2002,12,19,"Sarma JA, Rambabu G, Srikanth K, Raveendra D, Vithal M",,106465,DTCT0024002,786588,DTCC00138543,1240459,5083
CHEMBL109353,P45452,,JXHAGXRDZALSLG-GFCCVEGCSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11563922,KI,=,140,NM,,,,,,,,,,,,,,In Vitro inhibitory activity against the catalytic domain of the matrix metalloprotease-13,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,106610,DTCT0024002,1716618,DTCC00282683,357026,16424
CHEMBL10952,P45452,,MWPVYUMZDJJEOU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11297453,IC50,=,254,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-13 in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,106481,DTCT0024002,936780,DTCC00138640,1949638,16645
CHEMBL10952,P45452,,MWPVYUMZDJJEOU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12217355,IC50,=,251.19,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant human matrix metalloprotease-13,,Analogue based design of MMP-13 (Collagenase-3) inhibitors.,Bioorg. Med. Chem. Lett.,2002,12,19,"Sarma JA, Rambabu G, Srikanth K, Raveendra D, Vithal M",,106465,DTCT0024002,772581,DTCC00138640,1947219,5083
CHEMBL10953,P45452,,PMHIYNQSFXKIMZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11297453,IC50,=,22,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-13 in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,106481,DTCT0024002,941798,DTCC00138641,855708,16645
CHEMBL10953,P45452,,PMHIYNQSFXKIMZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12217355,IC50,=,21.88,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant human matrix metalloprotease-13,,Analogue based design of MMP-13 (Collagenase-3) inhibitors.,Bioorg. Med. Chem. Lett.,2002,12,19,"Sarma JA, Rambabu G, Srikanth K, Raveendra D, Vithal M",,106465,DTCT0024002,813142,DTCC00138641,853338,5083
CHEMBL109579,P45452,,LEDMBBYIVRLZAS-LBPRGKRZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11563922,KI,=,650,NM,,,,,,,,,,,,,,In Vitro inhibitory activity against the catalytic domain of the matrix metalloprotease-13,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,106610,DTCT0024002,1713954,DTCC00282314,258563,16424
CHEMBL109603,P45452,,JOKZNFFZUNYVMR-SFHVURJKSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11563922,KI,>,15000,NM,,,,,,,,,,,,,,In Vitro inhibitory activity against the catalytic domain of the matrix metalloprotease-13,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,106610,DTCT0024002,1693275,DTCC00281761,2034295,16424
CHEMBL109655,P45452,,PDKBAEDNMKVROV-AWEZNQCLSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11563922,KI,=,620,NM,,,,,,,,,,,,,,In Vitro inhibitory activity against the catalytic domain of the matrix metalloprotease-13,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,106610,DTCT0024002,1689451,DTCC00281762,2066041,16424
CHEMBL109770,P45452,,MYFWCGILTGDUAM-LBPRGKRZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11563922,KI,=,570,NM,,,,,,,,,,,,,,In Vitro inhibitory activity against the catalytic domain of the matrix metalloprotease-13,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,106610,DTCT0024002,1685583,DTCC00282704,1553370,16424
CHEMBL109775,P45452,,DODLQVHRMPIMNB-KSFYIVLOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12951101,IC50,=,40,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-13.,,Synthesis and biological activity of piperazine-based dual MMP-13 and TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,19,"Letavic MA, Barberia JT, Carty TJ, Hardink JR, Liras J, Lopresti-Morrow LL, Mitchell PG, Noe MC, Reeves LM, Snow SL, Stam EJ, Sweeney FJ, Vaughn ML, Yu CH",,106625,DTCT0024002,662179,DTCC00282969,809141,5809
CHEMBL109806,P45452,,JJTWETADXAELLS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11563922,KI,=,180,NM,,,,,,,,,,,,,,In Vitro inhibitory activity against the catalytic domain of the matrix metalloprotease-13,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,106610,DTCT0024002,1709912,DTCC00281760,1871211,16424
CHEMBL109833,P45452,,SHBOXSNAYNDDGN-KBXCAEBGSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12951101,IC50,=,11,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-13.,,Synthesis and biological activity of piperazine-based dual MMP-13 and TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,19,"Letavic MA, Barberia JT, Carty TJ, Hardink JR, Liras J, Lopresti-Morrow LL, Mitchell PG, Noe MC, Reeves LM, Snow SL, Stam EJ, Sweeney FJ, Vaughn ML, Yu CH",,106625,DTCT0024002,680835,DTCC00282570,97229,5809
CHEMBL109861,P45452,,BTMGFNYLYGWAKT-JTQLQIEISA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11563922,KI,=,3810,NM,,,,,,,,,,,,,,In Vitro inhibitory activity against the catalytic domain of the matrix metalloprotease-13,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,106610,DTCT0024002,1703226,DTCC00282336,1003340,16424
CHEMBL11005,P45452,,ILNPRELUGQHUMU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11297453,IC50,=,869,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-13 in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,106481,DTCT0024002,941802,DTCC00138731,1631580,16645
CHEMBL11005,P45452,,ILNPRELUGQHUMU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12217355,IC50,=,870.96,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant human matrix metalloprotease-13,,Analogue based design of MMP-13 (Collagenase-3) inhibitors.,Bioorg. Med. Chem. Lett.,2002,12,19,"Sarma JA, Rambabu G, Srikanth K, Raveendra D, Vithal M",,106465,DTCT0024002,783793,DTCC00138731,1629500,5083
CHEMBL110211,P45452,,HEJQAFMDGAOYSZ-MGPUTAFESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12951101,IC50,=,8,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-13.,,Synthesis and biological activity of piperazine-based dual MMP-13 and TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,19,"Letavic MA, Barberia JT, Carty TJ, Hardink JR, Liras J, Lopresti-Morrow LL, Mitchell PG, Noe MC, Reeves LM, Snow SL, Stam EJ, Sweeney FJ, Vaughn ML, Yu CH",,106625,DTCT0024002,685838,DTCC00282734,1100875,5809
CHEMBL110576,P45452,,SBPPAFQZTZUQSW-HRAATJIYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12951101,IC50,=,3,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-13.,,Synthesis and biological activity of piperazine-based dual MMP-13 and TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,19,"Letavic MA, Barberia JT, Carty TJ, Hardink JR, Liras J, Lopresti-Morrow LL, Mitchell PG, Noe MC, Reeves LM, Snow SL, Stam EJ, Sweeney FJ, Vaughn ML, Yu CH",,106625,DTCT0024002,690835,DTCC00282494,97230,5809
CHEMBL110591,P45452,,RSGVYIJLQVPSNJ-VBKZILBWSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12951101,IC50,=,3,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-13.,,Synthesis and biological activity of piperazine-based dual MMP-13 and TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,19,"Letavic MA, Barberia JT, Carty TJ, Hardink JR, Liras J, Lopresti-Morrow LL, Mitchell PG, Noe MC, Reeves LM, Snow SL, Stam EJ, Sweeney FJ, Vaughn ML, Yu CH",,106625,DTCT0024002,667044,DTCC00282925,2001374,5809
CHEMBL110750,P45452,,WOIMZSMDPIJLFO-LBPRGKRZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11563922,KI,=,370,NM,,,,,,,,,,,,,,In Vitro inhibitory activity against the catalytic domain of the matrix metalloprotease-13,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,106610,DTCT0024002,1683060,DTCC00281785,518969,16424
CHEMBL110901,P45452,,VSZRGCMKCYLOIV-OXJNMPFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12951101,IC50,=,4,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-13.,,Synthesis and biological activity of piperazine-based dual MMP-13 and TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,19,"Letavic MA, Barberia JT, Carty TJ, Hardink JR, Liras J, Lopresti-Morrow LL, Mitchell PG, Noe MC, Reeves LM, Snow SL, Stam EJ, Sweeney FJ, Vaughn ML, Yu CH",,106625,DTCT0024002,670687,DTCC00282529,1196754,5809
CHEMBL110970,P45452,,WOIMZSMDPIJLFO-GFCCVEGCSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11563922,KI,=,130,NM,,,,,,,,,,,,,,In Vitro inhibitory activity against the catalytic domain of the matrix metalloprotease-13,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,106610,DTCT0024002,1713946,DTCC00281754,1035753,16424
CHEMBL110994,P45452,,OVROAIFGKUSYAZ-NBGIEHNGSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12951101,IC50,,,,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13 (not determined),Not Determined,Synthesis and biological activity of piperazine-based dual MMP-13 and TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,19,"Letavic MA, Barberia JT, Carty TJ, Hardink JR, Liras J, Lopresti-Morrow LL, Mitchell PG, Noe MC, Reeves LM, Snow SL, Stam EJ, Sweeney FJ, Vaughn ML, Yu CH",,106626,DTCT0024002,673147,DTCC00283098,938720,5809
CHEMBL111068,P45452,,GCDCQOTVUSLXRJ-PGRDOPGGSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12951101,IC50,=,4,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-13.,,Synthesis and biological activity of piperazine-based dual MMP-13 and TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,19,"Letavic MA, Barberia JT, Carty TJ, Hardink JR, Liras J, Lopresti-Morrow LL, Mitchell PG, Noe MC, Reeves LM, Snow SL, Stam EJ, Sweeney FJ, Vaughn ML, Yu CH",,106625,DTCT0024002,669406,DTCC00282741,1392388,5809
CHEMBL111179,P45452,,GINBTQGVSPUJLE-ZDUSSCGKSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11563922,KI,=,120,NM,,,,,,,,,,,,,,In Vitro inhibitory activity against the catalytic domain of the matrix metalloprotease-13,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,106610,DTCT0024002,1715093,DTCC00282652,389663,16424
CHEMBL111257,P45452,,JXHAGXRDZALSLG-LBPRGKRZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11563922,KI,=,180,NM,,,,,,,,,,,,,,In Vitro inhibitory activity against the catalytic domain of the matrix metalloprotease-13,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,106610,DTCT0024002,1696861,DTCC00282583,809139,16424
CHEMBL111262,P45452,GW3333,SMZPWUUYPYYHIV-LYKJFQGKSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12951101,IC50,=,7,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-13.,,Synthesis and biological activity of piperazine-based dual MMP-13 and TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,19,"Letavic MA, Barberia JT, Carty TJ, Hardink JR, Liras J, Lopresti-Morrow LL, Mitchell PG, Noe MC, Reeves LM, Snow SL, Stam EJ, Sweeney FJ, Vaughn ML, Yu CH",,106625,DTCT0024002,682002,DTCC01742276,1132997,5809
CHEMBL111450,P45452,,IIABJCHWKFZJBK-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11563922,KI,=,210,NM,,,,,,,,,,,,,,In Vitro inhibitory activity against the catalytic domain of the matrix metalloprotease-13,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,106610,DTCT0024002,1701968,DTCC00282684,291838,16424
CHEMBL111460,P45452,,UTQLDSRMYUQUPD-HFZDXXHNSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12951101,IC50,,,,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13 (not determined),Not Determined,Synthesis and biological activity of piperazine-based dual MMP-13 and TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,19,"Letavic MA, Barberia JT, Carty TJ, Hardink JR, Liras J, Lopresti-Morrow LL, Mitchell PG, Noe MC, Reeves LM, Snow SL, Stam EJ, Sweeney FJ, Vaughn ML, Yu CH",,106626,DTCT0024002,670695,DTCC00283304,938721,5809
CHEMBL111475,P45452,,GIJWOCNEPGCMND-QMHKHESXSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12951101,IC50,=,98,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-13.,,Synthesis and biological activity of piperazine-based dual MMP-13 and TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,19,"Letavic MA, Barberia JT, Carty TJ, Hardink JR, Liras J, Lopresti-Morrow LL, Mitchell PG, Noe MC, Reeves LM, Snow SL, Stam EJ, Sweeney FJ, Vaughn ML, Yu CH",,106625,DTCT0024002,689565,DTCC00282752,907000,5809
CHEMBL111678,P45452,,WJWOJAKOSRCFKB-JTQLQIEISA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11563922,KI,=,470,NM,,,,,,,,,,,,,,In Vitro inhibitory activity against the catalytic domain of the matrix metalloprotease-13,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,106610,DTCT0024002,1688179,DTCC00282653,809140,16424
CHEMBL111856,P45452,,ZBRHTUMWSDPCMI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15177439,IC50,=,0.75,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP-13),,Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2004,14,13,"Reiter LA, Robinson RP, McClure KF, Jones CS, Reese MR, Mitchell PG, Otterness IG, Bliven ML, Liras J, Cortina SR, Donahue KM, Eskra JD, Griffiths RJ, Lame ME, Lopez-Anaya A, Martinelli GJ, McGahee SM, Yocum SA, Lopresti-Morrow LL, Tobiassen LM, Vaughn-Bowser ML",,106600,DTCT0024002,1496200,DTCC00287961,76527,6475
CHEMBL111856,P45452,,ZBRHTUMWSDPCMI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15177439,INHIBITION,=,68,%,,organism_based,,,,,,,,,,,,Inhibition of MMP-13 induced experimental arthritis in hamster knee by 30 mg/kg p.o.,,Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2004,14,13,"Reiter LA, Robinson RP, McClure KF, Jones CS, Reese MR, Mitchell PG, Otterness IG, Bliven ML, Liras J, Cortina SR, Donahue KM, Eskra JD, Griffiths RJ, Lame ME, Lopez-Anaya A, Martinelli GJ, McGahee SM, Yocum SA, Lopresti-Morrow LL, Tobiassen LM, Vaughn-Bowser ML",,82692,DTCT0024002,1496207,DTCC00287961,76527,6475
CHEMBL111862,P45452,,RCOBSDNFRJAUBV-RNODOKPDSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12951101,IC50,=,20,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-13.,,Synthesis and biological activity of piperazine-based dual MMP-13 and TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,19,"Letavic MA, Barberia JT, Carty TJ, Hardink JR, Liras J, Lopresti-Morrow LL, Mitchell PG, Noe MC, Reeves LM, Snow SL, Stam EJ, Sweeney FJ, Vaughn ML, Yu CH",,106625,DTCT0024002,671925,DTCC00282963,1871213,5809
CHEMBL11188,P45452,,NDCGWDYXJPEWRR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11297453,IC50,=,59,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-13 in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,106481,DTCT0024002,945724,DTCC00138717,1146774,16645
CHEMBL11188,P45452,,NDCGWDYXJPEWRR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12217355,IC50,=,58.88,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant human matrix metalloprotease-13,,Analogue based design of MMP-13 (Collagenase-3) inhibitors.,Bioorg. Med. Chem. Lett.,2002,12,19,"Sarma JA, Rambabu G, Srikanth K, Raveendra D, Vithal M",,106465,DTCT0024002,803240,DTCC00138717,1144415,5083
CHEMBL112232,P45452,,IJIWBJJLSPLOBZ-HNAYVOBHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12951101,IC50,=,19,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-13.,,Synthesis and biological activity of piperazine-based dual MMP-13 and TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,19,"Letavic MA, Barberia JT, Carty TJ, Hardink JR, Liras J, Lopresti-Morrow LL, Mitchell PG, Noe MC, Reeves LM, Snow SL, Stam EJ, Sweeney FJ, Vaughn ML, Yu CH",,106625,DTCT0024002,656136,DTCC00282964,680161,5809
CHEMBL112374,P45452,,ZXNZAWRNXJJQCL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15177439,IC50,=,4.6,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP-13),,Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2004,14,13,"Reiter LA, Robinson RP, McClure KF, Jones CS, Reese MR, Mitchell PG, Otterness IG, Bliven ML, Liras J, Cortina SR, Donahue KM, Eskra JD, Griffiths RJ, Lame ME, Lopez-Anaya A, Martinelli GJ, McGahee SM, Yocum SA, Lopresti-Morrow LL, Tobiassen LM, Vaughn-Bowser ML",,106600,DTCT0024002,1512591,DTCC00288066,659628,6475
CHEMBL112374,P45452,,ZXNZAWRNXJJQCL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15177439,INHIBITION,,31,%,,organism_based,,,,,,,,,,,,Inhibition of MMP-13 induced experimental arthritis in hamster knee by 30 mg/kg p.o.,,Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2004,14,13,"Reiter LA, Robinson RP, McClure KF, Jones CS, Reese MR, Mitchell PG, Otterness IG, Bliven ML, Liras J, Cortina SR, Donahue KM, Eskra JD, Griffiths RJ, Lame ME, Lopez-Anaya A, Martinelli GJ, McGahee SM, Yocum SA, Lopresti-Morrow LL, Tobiassen LM, Vaughn-Bowser ML",,82692,DTCT0024002,1512595,DTCC00288066,659628,6475
CHEMBL112470,P45452,,JSYMSOFUKLCCMS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15177439,IC50,=,1.5,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP-13),,Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2004,14,13,"Reiter LA, Robinson RP, McClure KF, Jones CS, Reese MR, Mitchell PG, Otterness IG, Bliven ML, Liras J, Cortina SR, Donahue KM, Eskra JD, Griffiths RJ, Lame ME, Lopez-Anaya A, Martinelli GJ, McGahee SM, Yocum SA, Lopresti-Morrow LL, Tobiassen LM, Vaughn-Bowser ML",,106600,DTCT0024002,1497296,DTCC00287998,1175921,6475
CHEMBL112470,P45452,,JSYMSOFUKLCCMS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15177439,INHIBITION,=,51,%,,organism_based,,,,,,,,,,,,Inhibition of MMP-13 induced experimental arthritis in hamster knee by 30 mg/kg p.o.,,Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2004,14,13,"Reiter LA, Robinson RP, McClure KF, Jones CS, Reese MR, Mitchell PG, Otterness IG, Bliven ML, Liras J, Cortina SR, Donahue KM, Eskra JD, Griffiths RJ, Lame ME, Lopez-Anaya A, Martinelli GJ, McGahee SM, Yocum SA, Lopresti-Morrow LL, Tobiassen LM, Vaughn-Bowser ML",,82692,DTCT0024002,1497301,DTCC00287998,1175921,6475
CHEMBL112609,P45452,,DUZIIVUARYJPTE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15177439,IC50,=,2,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP-13),,Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2004,14,13,"Reiter LA, Robinson RP, McClure KF, Jones CS, Reese MR, Mitchell PG, Otterness IG, Bliven ML, Liras J, Cortina SR, Donahue KM, Eskra JD, Griffiths RJ, Lame ME, Lopez-Anaya A, Martinelli GJ, McGahee SM, Yocum SA, Lopresti-Morrow LL, Tobiassen LM, Vaughn-Bowser ML",,106600,DTCT0024002,1495003,DTCC00287963,1500512,6475
CHEMBL112609,P45452,,DUZIIVUARYJPTE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15177439,INHIBITION,,6,%,,organism_based,,,,,,,,,,,,Inhibition of MMP-13 induced experimental arthritis in hamster knee by 30 mg/kg p.o.,,Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2004,14,13,"Reiter LA, Robinson RP, McClure KF, Jones CS, Reese MR, Mitchell PG, Otterness IG, Bliven ML, Liras J, Cortina SR, Donahue KM, Eskra JD, Griffiths RJ, Lame ME, Lopez-Anaya A, Martinelli GJ, McGahee SM, Yocum SA, Lopresti-Morrow LL, Tobiassen LM, Vaughn-Bowser ML",,82692,DTCT0024002,1495007,DTCC00287963,1500512,6475
CHEMBL113705,P45452,,AWPPALPLPMDYKF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15177439,IC50,=,14,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP-13),,Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2004,14,13,"Reiter LA, Robinson RP, McClure KF, Jones CS, Reese MR, Mitchell PG, Otterness IG, Bliven ML, Liras J, Cortina SR, Donahue KM, Eskra JD, Griffiths RJ, Lame ME, Lopez-Anaya A, Martinelli GJ, McGahee SM, Yocum SA, Lopresti-Morrow LL, Tobiassen LM, Vaughn-Bowser ML",,106600,DTCT0024002,1508160,DTCC00288088,820766,6475
CHEMBL113778,P45452,,FWJQSGAFJBBJTH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15177439,IC50,=,4.4,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP-13),,Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2004,14,13,"Reiter LA, Robinson RP, McClure KF, Jones CS, Reese MR, Mitchell PG, Otterness IG, Bliven ML, Liras J, Cortina SR, Donahue KM, Eskra JD, Griffiths RJ, Lame ME, Lopez-Anaya A, Martinelli GJ, McGahee SM, Yocum SA, Lopresti-Morrow LL, Tobiassen LM, Vaughn-Bowser ML",,106600,DTCT0024002,1491450,DTCC00288036,368817,6475
CHEMBL113778,P45452,,FWJQSGAFJBBJTH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15177439,INHIBITION,,26,%,,organism_based,,,,,,,,,,,,Inhibition of MMP-13 induced experimental arthritis in hamster knee by 30 mg/kg p.o.,,Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2004,14,13,"Reiter LA, Robinson RP, McClure KF, Jones CS, Reese MR, Mitchell PG, Otterness IG, Bliven ML, Liras J, Cortina SR, Donahue KM, Eskra JD, Griffiths RJ, Lame ME, Lopez-Anaya A, Martinelli GJ, McGahee SM, Yocum SA, Lopresti-Morrow LL, Tobiassen LM, Vaughn-Bowser ML",,82692,DTCT0024002,1491454,DTCC00288036,368817,6475
CHEMBL114148,P45452,,FTIYYJYCHWIXRZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15177439,IC50,=,1.5,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP-13),,Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2004,14,13,"Reiter LA, Robinson RP, McClure KF, Jones CS, Reese MR, Mitchell PG, Otterness IG, Bliven ML, Liras J, Cortina SR, Donahue KM, Eskra JD, Griffiths RJ, Lame ME, Lopez-Anaya A, Martinelli GJ, McGahee SM, Yocum SA, Lopresti-Morrow LL, Tobiassen LM, Vaughn-Bowser ML",,106600,DTCT0024002,1483184,DTCC00288114,30890,6475
CHEMBL114148,P45452,,FTIYYJYCHWIXRZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15177439,INHIBITION,,19,%,,organism_based,,,,,,,,,,,,Inhibition of MMP-13 induced experimental arthritis in hamster knee by 30 mg/kg p.o.,,Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2004,14,13,"Reiter LA, Robinson RP, McClure KF, Jones CS, Reese MR, Mitchell PG, Otterness IG, Bliven ML, Liras J, Cortina SR, Donahue KM, Eskra JD, Griffiths RJ, Lame ME, Lopez-Anaya A, Martinelli GJ, McGahee SM, Yocum SA, Lopresti-Morrow LL, Tobiassen LM, Vaughn-Bowser ML",,82692,DTCT0024002,1483188,DTCC00288114,30890,6475
CHEMBL114158,P45452,,GPKHOALPIBZPBS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15177439,IC50,=,5.7,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP-13),,Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2004,14,13,"Reiter LA, Robinson RP, McClure KF, Jones CS, Reese MR, Mitchell PG, Otterness IG, Bliven ML, Liras J, Cortina SR, Donahue KM, Eskra JD, Griffiths RJ, Lame ME, Lopez-Anaya A, Martinelli GJ, McGahee SM, Yocum SA, Lopresti-Morrow LL, Tobiassen LM, Vaughn-Bowser ML",,106600,DTCT0024002,1497293,DTCC00288089,1694008,6475
CHEMBL114158,P45452,,GPKHOALPIBZPBS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15177439,INHIBITION,=,50,%,,organism_based,,,,,,,,,,,,Inhibition of MMP-13 induced experimental arthritis in hamster knee by 30 mg/kg p.o.,,Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2004,14,13,"Reiter LA, Robinson RP, McClure KF, Jones CS, Reese MR, Mitchell PG, Otterness IG, Bliven ML, Liras J, Cortina SR, Donahue KM, Eskra JD, Griffiths RJ, Lame ME, Lopez-Anaya A, Martinelli GJ, McGahee SM, Yocum SA, Lopresti-Morrow LL, Tobiassen LM, Vaughn-Bowser ML",,82692,DTCT0024002,1497295,DTCC00288089,1694008,6475
CHEMBL114272,P45452,,SUEBJDNLBVTIQP-LLVKDONJSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15177439,IC50,=,1.7,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP-13),,Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2004,14,13,"Reiter LA, Robinson RP, McClure KF, Jones CS, Reese MR, Mitchell PG, Otterness IG, Bliven ML, Liras J, Cortina SR, Donahue KM, Eskra JD, Griffiths RJ, Lame ME, Lopez-Anaya A, Martinelli GJ, McGahee SM, Yocum SA, Lopresti-Morrow LL, Tobiassen LM, Vaughn-Bowser ML",,106600,DTCT0024002,1500625,DTCC00288482,562641,6475
CHEMBL114378,P45452,,LMSMOBVZXAUSAU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15177439,IC50,=,17,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP-13),,Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2004,14,13,"Reiter LA, Robinson RP, McClure KF, Jones CS, Reese MR, Mitchell PG, Otterness IG, Bliven ML, Liras J, Cortina SR, Donahue KM, Eskra JD, Griffiths RJ, Lame ME, Lopez-Anaya A, Martinelli GJ, McGahee SM, Yocum SA, Lopresti-Morrow LL, Tobiassen LM, Vaughn-Bowser ML",,106600,DTCT0024002,1493773,DTCC00288483,30891,6475
CHEMBL114528,P45452,,TWXMFJCBMYOHKC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15177439,IC50,=,11,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP-13),,Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2004,14,13,"Reiter LA, Robinson RP, McClure KF, Jones CS, Reese MR, Mitchell PG, Otterness IG, Bliven ML, Liras J, Cortina SR, Donahue KM, Eskra JD, Griffiths RJ, Lame ME, Lopez-Anaya A, Martinelli GJ, McGahee SM, Yocum SA, Lopresti-Morrow LL, Tobiassen LM, Vaughn-Bowser ML",,106600,DTCT0024002,1496222,DTCC00288367,917672,6475
CHEMBL114528,P45452,,TWXMFJCBMYOHKC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15177439,INHIBITION,=,0,%,,organism_based,,,,,,,,,,,,Inhibition of MMP-13 induced experimental arthritis in hamster knee by 30 mg/kg p.o.,,Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2004,14,13,"Reiter LA, Robinson RP, McClure KF, Jones CS, Reese MR, Mitchell PG, Otterness IG, Bliven ML, Liras J, Cortina SR, Donahue KM, Eskra JD, Griffiths RJ, Lame ME, Lopez-Anaya A, Martinelli GJ, McGahee SM, Yocum SA, Lopresti-Morrow LL, Tobiassen LM, Vaughn-Bowser ML",,82692,DTCT0024002,1496226,DTCC00288367,917672,6475
CHEMBL114706,P45452,,SOOSDOUTIZJYOW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15177439,IC50,=,0.65,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP-13),,Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2004,14,13,"Reiter LA, Robinson RP, McClure KF, Jones CS, Reese MR, Mitchell PG, Otterness IG, Bliven ML, Liras J, Cortina SR, Donahue KM, Eskra JD, Griffiths RJ, Lame ME, Lopez-Anaya A, Martinelli GJ, McGahee SM, Yocum SA, Lopresti-Morrow LL, Tobiassen LM, Vaughn-Bowser ML",,106600,DTCT0024002,1490205,DTCC00288496,336169,6475
CHEMBL114706,P45452,,SOOSDOUTIZJYOW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15177439,INHIBITION,=,71,%,,organism_based,,,,,,,,,,,,Inhibition of MMP-13 induced experimental arthritis in hamster knee by 30 mg/kg p.o.,,Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2004,14,13,"Reiter LA, Robinson RP, McClure KF, Jones CS, Reese MR, Mitchell PG, Otterness IG, Bliven ML, Liras J, Cortina SR, Donahue KM, Eskra JD, Griffiths RJ, Lame ME, Lopez-Anaya A, Martinelli GJ, McGahee SM, Yocum SA, Lopresti-Morrow LL, Tobiassen LM, Vaughn-Bowser ML",,82692,DTCT0024002,1490208,DTCC00288496,336169,6475
CHEMBL114815,P45452,,SQQHSADBIVCBBM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15177439,IC50,=,0.9,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP-13),,Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2004,14,13,"Reiter LA, Robinson RP, McClure KF, Jones CS, Reese MR, Mitchell PG, Otterness IG, Bliven ML, Liras J, Cortina SR, Donahue KM, Eskra JD, Griffiths RJ, Lame ME, Lopez-Anaya A, Martinelli GJ, McGahee SM, Yocum SA, Lopresti-Morrow LL, Tobiassen LM, Vaughn-Bowser ML",,106600,DTCT0024002,1509258,DTCC00288372,1597366,6475
CHEMBL114815,P45452,,SQQHSADBIVCBBM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15177439,INHIBITION,=,23,%,,organism_based,,,,,,,,,,,,Inhibition of MMP-13 induced experimental arthritis in hamster knee by 30 mg/kg p.o.,,Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2004,14,13,"Reiter LA, Robinson RP, McClure KF, Jones CS, Reese MR, Mitchell PG, Otterness IG, Bliven ML, Liras J, Cortina SR, Donahue KM, Eskra JD, Griffiths RJ, Lame ME, Lopez-Anaya A, Martinelli GJ, McGahee SM, Yocum SA, Lopresti-Morrow LL, Tobiassen LM, Vaughn-Bowser ML",,82692,DTCT0024002,1509265,DTCC00288372,1597366,6475
CHEMBL114815,P45452,,SQQHSADBIVCBBM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23287054,IC50,=,0.65,NM,,,,,,,,,,,,,,Inhibition of MMP13 (unknown origin),,Sulphonamides: Deserving class as MMP inhibitors?,Eur. J. Med. Chem.,2013,60,,"Jain P, Saravanan C, Singh SK",,944584,DTCT0024002,11835686,DTCC00288372,1612260,53820
CHEMBL114831,P45452,,YZIGEYGKVJNXSU-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15177439,IC50,=,1.3,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP-13),,Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2004,14,13,"Reiter LA, Robinson RP, McClure KF, Jones CS, Reese MR, Mitchell PG, Otterness IG, Bliven ML, Liras J, Cortina SR, Donahue KM, Eskra JD, Griffiths RJ, Lame ME, Lopez-Anaya A, Martinelli GJ, McGahee SM, Yocum SA, Lopresti-Morrow LL, Tobiassen LM, Vaughn-Bowser ML",,106600,DTCT0024002,1485656,DTCC00288491,1208055,6475
CHEMBL114878,P45452,,LCWWOMJWYGNKJF-IARZGTGTSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11585440,KI,>,2000,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,"Discovery of macrocyclic hydroxamic acids containing biphenylmethyl derivatives at P1', a series of selective TNF-alpha converting enzyme inhibitors with potent cellular activity in the inhibition of TNF-alpha release.",J. Med. Chem.,2001,44,21,"Xue CB, He X, Corbett RL, Roderick J, Wasserman ZR, Liu RQ, Jaffee BD, Covington MB, Qian M, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,106614,DTCT0024002,1322679,DTCC00286952,724080,16439
CHEMBL114884,P45452,,OCDVFODZPZVZMF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15177439,IC50,=,0.93,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP-13),,Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2004,14,13,"Reiter LA, Robinson RP, McClure KF, Jones CS, Reese MR, Mitchell PG, Otterness IG, Bliven ML, Liras J, Cortina SR, Donahue KM, Eskra JD, Griffiths RJ, Lame ME, Lopez-Anaya A, Martinelli GJ, McGahee SM, Yocum SA, Lopresti-Morrow LL, Tobiassen LM, Vaughn-Bowser ML",,106600,DTCT0024002,1488011,DTCC00288405,498329,6475
CHEMBL114884,P45452,,OCDVFODZPZVZMF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15177439,INHIBITION,=,56,%,,organism_based,,,,,,,,,,,,Inhibition of MMP-13 induced experimental arthritis in hamster knee by 30 mg/kg p.o.,,Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2004,14,13,"Reiter LA, Robinson RP, McClure KF, Jones CS, Reese MR, Mitchell PG, Otterness IG, Bliven ML, Liras J, Cortina SR, Donahue KM, Eskra JD, Griffiths RJ, Lame ME, Lopez-Anaya A, Martinelli GJ, McGahee SM, Yocum SA, Lopresti-Morrow LL, Tobiassen LM, Vaughn-Bowser ML",,82692,DTCT0024002,1488018,DTCC00288405,498329,6475
CHEMBL114906,P45452,,CIECVEXIXKIUIZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15177439,IC50,=,0.87,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP-13),,Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2004,14,13,"Reiter LA, Robinson RP, McClure KF, Jones CS, Reese MR, Mitchell PG, Otterness IG, Bliven ML, Liras J, Cortina SR, Donahue KM, Eskra JD, Griffiths RJ, Lame ME, Lopez-Anaya A, Martinelli GJ, McGahee SM, Yocum SA, Lopresti-Morrow LL, Tobiassen LM, Vaughn-Bowser ML",,106600,DTCT0024002,1509266,DTCC00288409,368819,6475
CHEMBL115168,P45452,,SJVJJZDVWOYTNM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15177439,IC50,=,9.7,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP-13),,Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2004,14,13,"Reiter LA, Robinson RP, McClure KF, Jones CS, Reese MR, Mitchell PG, Otterness IG, Bliven ML, Liras J, Cortina SR, Donahue KM, Eskra JD, Griffiths RJ, Lame ME, Lopez-Anaya A, Martinelli GJ, McGahee SM, Yocum SA, Lopresti-Morrow LL, Tobiassen LM, Vaughn-Bowser ML",,106600,DTCT0024002,1499586,DTCC00288395,950247,6475
CHEMBL115223,P45452,,KUNPRZXRPKRXHM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15177439,IC50,=,25,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP-13),,Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2004,14,13,"Reiter LA, Robinson RP, McClure KF, Jones CS, Reese MR, Mitchell PG, Otterness IG, Bliven ML, Liras J, Cortina SR, Donahue KM, Eskra JD, Griffiths RJ, Lame ME, Lopez-Anaya A, Martinelli GJ, McGahee SM, Yocum SA, Lopresti-Morrow LL, Tobiassen LM, Vaughn-Bowser ML",,106600,DTCT0024002,1502667,DTCC00288777,820767,6475
CHEMBL115263,P45452,,SOPDPCOBVSOXIM-ZDXQCDESSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11585440,KI,=,442,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,"Discovery of macrocyclic hydroxamic acids containing biphenylmethyl derivatives at P1', a series of selective TNF-alpha converting enzyme inhibitors with potent cellular activity in the inhibition of TNF-alpha release.",J. Med. Chem.,2001,44,21,"Xue CB, He X, Corbett RL, Roderick J, Wasserman ZR, Liu RQ, Jaffee BD, Covington MB, Qian M, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,106614,DTCT0024002,1309696,DTCC00287904,433861,16439
CHEMBL115283,P45452,,SHSBTGZNXOPCNV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15177439,IC50,=,0.53,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP-13),,Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2004,14,13,"Reiter LA, Robinson RP, McClure KF, Jones CS, Reese MR, Mitchell PG, Otterness IG, Bliven ML, Liras J, Cortina SR, Donahue KM, Eskra JD, Griffiths RJ, Lame ME, Lopez-Anaya A, Martinelli GJ, McGahee SM, Yocum SA, Lopresti-Morrow LL, Tobiassen LM, Vaughn-Bowser ML",,106600,DTCT0024002,1497285,DTCC00288758,756237,6475
CHEMBL115283,P45452,,SHSBTGZNXOPCNV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15177439,INHIBITION,=,51,%,,organism_based,,,,,,,,,,,,Inhibition of MMP-13 induced experimental arthritis in hamster knee by 30 mg/kg p.o.,,Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2004,14,13,"Reiter LA, Robinson RP, McClure KF, Jones CS, Reese MR, Mitchell PG, Otterness IG, Bliven ML, Liras J, Cortina SR, Donahue KM, Eskra JD, Griffiths RJ, Lame ME, Lopez-Anaya A, Martinelli GJ, McGahee SM, Yocum SA, Lopresti-Morrow LL, Tobiassen LM, Vaughn-Bowser ML",,82692,DTCT0024002,1497292,DTCC00288758,756237,6475
CHEMBL115460,P45452,,FOOIUOKCYUZPDW-YCLCTBJKSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12877590,IC50,=,2300,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,"A potent, selective inhibitor of matrix metalloproteinase-3 for the topical treatment of chronic dermal ulcers.",J. Med. Chem.,2003,46,16,"Fray MJ, Dickinson RP, Huggins JP, Occleston NL",,106471,DTCT0024002,1548444,DTCC00293174,1871336,17445
CHEMBL115653,P45452,CIPEMASTAT,GFUITADOEPNRML-SJORKVTESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10669559,KI,=,3,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13 (MMP-13).,,Protease inhibitors: current status and future prospects.,J. Med. Chem.,2000,43,3,"Leung D, Abbenante G, Fairlie DP",,106612,DTCT0024002,1065652,DTCC00288838,1839322,16063
CHEMBL115653,P45452,CIPEMASTAT,GFUITADOEPNRML-SJORKVTESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12930146,IC50,=,3.4,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP13),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,106606,DTCT0024002,527939,DTCC00288838,1850867,13726
CHEMBL115653,P45452,CIPEMASTAT,GFUITADOEPNRML-SJORKVTESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16516469,KI,=,1,NM,,,,,,,,,,,,,,Binding affinity to recombinant MMP13,,A cassette-dosing approach for improvement of oral bioavailability of dual TACE/MMP inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,10,"Janser P, Neumann U, Miltz W, Feifel R, Buhl T",,354053,DTCT0024002,1926047,DTCC00288838,1852176,20779
CHEMBL115653,P45452,CIPEMASTAT,GFUITADOEPNRML-SJORKVTESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,3.5,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500573,DTCT0024002,2844275,DTCC00288838,1841984,33635
CHEMBL115653,P45452,CIPEMASTAT,GFUITADOEPNRML-SJORKVTESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,4.7,NM,,,,,,,,,,,,,,Inhibition of MMP13 in presence of 1% bovine serum albumin,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500574,DTCT0024002,2844276,DTCC00288838,1841984,33635
CHEMBL115653,P45452,CIPEMASTAT,GFUITADOEPNRML-SJORKVTESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,KI,=,0.53,NM,,,,,,,,,,,,,,Inhibition of MMP13 assessed as dissociation constant,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500964,DTCT0024002,2824196,DTCC00288838,1841984,33635
CHEMBL115666,P45452,,ZBJPGEDYMPNAIZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15177439,IC50,=,13,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP-13),,Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2004,14,13,"Reiter LA, Robinson RP, McClure KF, Jones CS, Reese MR, Mitchell PG, Otterness IG, Bliven ML, Liras J, Cortina SR, Donahue KM, Eskra JD, Griffiths RJ, Lame ME, Lopez-Anaya A, Martinelli GJ, McGahee SM, Yocum SA, Lopresti-Morrow LL, Tobiassen LM, Vaughn-Bowser ML",,106600,DTCT0024002,1507019,DTCC00288365,1014894,6475
CHEMBL115727,P45452,,MCSWSPNUKWMZHM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22658537,IC50,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain incubated for 20 mins by fluorimetric assay,Not Determined,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827438,DTCT0024002,10535470,DTCC00288787,1591034,48665
CHEMBL115877,P45452,,SVDCGRYSXBTBBO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15177439,IC50,=,19,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP-13),,Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2004,14,13,"Reiter LA, Robinson RP, McClure KF, Jones CS, Reese MR, Mitchell PG, Otterness IG, Bliven ML, Liras J, Cortina SR, Donahue KM, Eskra JD, Griffiths RJ, Lame ME, Lopez-Anaya A, Martinelli GJ, McGahee SM, Yocum SA, Lopresti-Morrow LL, Tobiassen LM, Vaughn-Bowser ML",,106600,DTCT0024002,1492681,DTCC00288168,1629691,6475
CHEMBL116067,P45452,,BFMSCDGDXHTNEA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15177439,IC50,=,4.6,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP-13),,Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2004,14,13,"Reiter LA, Robinson RP, McClure KF, Jones CS, Reese MR, Mitchell PG, Otterness IG, Bliven ML, Liras J, Cortina SR, Donahue KM, Eskra JD, Griffiths RJ, Lame ME, Lopez-Anaya A, Martinelli GJ, McGahee SM, Yocum SA, Lopresti-Morrow LL, Tobiassen LM, Vaughn-Bowser ML",,106600,DTCT0024002,1489106,DTCC00288441,1564870,6475
CHEMBL116219,P45452,,YZIGEYGKVJNXSU-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15177439,IC50,=,0.77,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP-13),,Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2004,14,13,"Reiter LA, Robinson RP, McClure KF, Jones CS, Reese MR, Mitchell PG, Otterness IG, Bliven ML, Liras J, Cortina SR, Donahue KM, Eskra JD, Griffiths RJ, Lame ME, Lopez-Anaya A, Martinelli GJ, McGahee SM, Yocum SA, Lopresti-Morrow LL, Tobiassen LM, Vaughn-Bowser ML",,106600,DTCT0024002,1497302,DTCC00288336,76526,6475
CHEMBL116237,P45452,,ILDOICSWRSOHSV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15177439,IC50,=,1.5,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP-13),,Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2004,14,13,"Reiter LA, Robinson RP, McClure KF, Jones CS, Reese MR, Mitchell PG, Otterness IG, Bliven ML, Liras J, Cortina SR, Donahue KM, Eskra JD, Griffiths RJ, Lame ME, Lopez-Anaya A, Martinelli GJ, McGahee SM, Yocum SA, Lopresti-Morrow LL, Tobiassen LM, Vaughn-Bowser ML",,106600,DTCT0024002,1505997,DTCC00288603,368818,6475
CHEMBL116287,P45452,,CMENTMLKKMZGPM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15177439,IC50,=,0.97,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP-13),,Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2004,14,13,"Reiter LA, Robinson RP, McClure KF, Jones CS, Reese MR, Mitchell PG, Otterness IG, Bliven ML, Liras J, Cortina SR, Donahue KM, Eskra JD, Griffiths RJ, Lame ME, Lopez-Anaya A, Martinelli GJ, McGahee SM, Yocum SA, Lopresti-Morrow LL, Tobiassen LM, Vaughn-Bowser ML",,106600,DTCT0024002,1496192,DTCC00288106,1915034,6475
CHEMBL116287,P45452,,CMENTMLKKMZGPM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15177439,INHIBITION,,39,%,,organism_based,,,,,,,,,,,,Inhibition of MMP-13 induced experimental arthritis in hamster knee by 30 mg/kg p.o.,,Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2004,14,13,"Reiter LA, Robinson RP, McClure KF, Jones CS, Reese MR, Mitchell PG, Otterness IG, Bliven ML, Liras J, Cortina SR, Donahue KM, Eskra JD, Griffiths RJ, Lame ME, Lopez-Anaya A, Martinelli GJ, McGahee SM, Yocum SA, Lopresti-Morrow LL, Tobiassen LM, Vaughn-Bowser ML",,82692,DTCT0024002,1496199,DTCC00288106,1915034,6475
CHEMBL116348,P45452,,PDKYNJDOLOWNHI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15177439,IC50,=,50,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP-13),,Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2004,14,13,"Reiter LA, Robinson RP, McClure KF, Jones CS, Reese MR, Mitchell PG, Otterness IG, Bliven ML, Liras J, Cortina SR, Donahue KM, Eskra JD, Griffiths RJ, Lame ME, Lopez-Anaya A, Martinelli GJ, McGahee SM, Yocum SA, Lopresti-Morrow LL, Tobiassen LM, Vaughn-Bowser ML",,106600,DTCT0024002,1488007,DTCC00288446,108767,6475
CHEMBL116438,P45452,CURCUMIN,ZIUSSTSXXLLKKK-KOBPDPAPSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18358729,IC50,=,10300,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 expressed in Escherichia coli,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518658,DTCT0024002,2708823,DTCC00290109,35645,32215
CHEMBL116757,P45452,CL-82198,KUJQEQAVMNFFAO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15214773,IC50,=,10000,NM,,,,,,,,,,,,,,Inhibition of Matrix Metalloprotease-13 (MMP-13),,Fragment-based drug discovery.,J. Med. Chem.,2004,47,14,"Erlanson DA, McDowell RS, O'Brien T",,106644,DTCT0024002,634974,DTCC01742511,788458,17883
CHEMBL116757,P45452,CL-82198,KUJQEQAVMNFFAO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18790648,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of MMP13 at 10 ug/mL,Not Active,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497423,DTCT0024002,2457537,DTCC01742511,791159,32556
CHEMBL116904,P45452,,HFRJPVNBQJAJIX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15177439,IC50,=,49,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP-13),,Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2004,14,13,"Reiter LA, Robinson RP, McClure KF, Jones CS, Reese MR, Mitchell PG, Otterness IG, Bliven ML, Liras J, Cortina SR, Donahue KM, Eskra JD, Griffiths RJ, Lame ME, Lopez-Anaya A, Martinelli GJ, McGahee SM, Yocum SA, Lopresti-Morrow LL, Tobiassen LM, Vaughn-Bowser ML",,106600,DTCT0024002,1510446,DTCC00288432,1723543,6475
CHEMBL1169492,P45452,,BDCJZZXWIQJYLP-UXHICEINSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11206468,IC50,=,291,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,Heteroaryl and cycloalkyl sulfonamide hydroxamic acid inhibitors of matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2001,11,2,"Levin JI, Gu Y, Nelson FC, Zask A, DiJoseph JF, Sharr MA, Sung A, Jin G, Cowling R, Chanda P, Cosmi S, Hsiao CL, Edris W, Wilhelm J, Killar LM, Skotnicki JS",,106638,DTCT0024002,1294656,DTCC00656884,1014366,4516
CHEMBL117225,P45452,UK-356618,JJHRUUKMPWUYIB-HVOSOHGQSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11229774,IC50,=,73,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,Discovery of potent and selective succinyl hydroxamate inhibitors of matrix metalloprotease-3 (stromelysin-1).,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Dickinson RP",,106472,DTCT0024002,573966,DTCC01742560,174043,4692
CHEMBL117225,P45452,UK-356618,JJHRUUKMPWUYIB-HVOSOHGQSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12877590,IC50,=,73,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,"A potent, selective inhibitor of matrix metalloproteinase-3 for the topical treatment of chronic dermal ulcers.",J. Med. Chem.,2003,46,16,"Fray MJ, Dickinson RP, Huggins JP, Occleston NL",,106471,DTCT0024002,1551209,DTCC01742560,162203,17445
CHEMBL117225,P45452,UK-356618,JJHRUUKMPWUYIB-HVOSOHGQSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18790648,IC50,=,73,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497406,DTCT0024002,2457461,DTCC01742560,176034,32556
CHEMBL1172417,P45452,,NJNBOILPWXEYGR-GDNBJRDFSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,IC50,=,4700,NM,,,,,,,,,,,,,,Inhibition of MMP13 (unknown origin) using Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate after 3 mins by fluorimetric assay,,Evaluation of the anti-inflammatory/chondroprotective activity of aldose reductase inhibitors in human chondrocyte cultures,MedChemComm,2015,6,5,"Panico A, Maccari R, Cardile V, Avondo S, Crasci L, Ottana R",,1541340,DTCT0024002,11385,DTCC00655418,27470,65440
CHEMBL117375,P45452,,KWEXGQXQATXFLU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15177439,IC50,=,1.7,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP-13),,Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2004,14,13,"Reiter LA, Robinson RP, McClure KF, Jones CS, Reese MR, Mitchell PG, Otterness IG, Bliven ML, Liras J, Cortina SR, Donahue KM, Eskra JD, Griffiths RJ, Lame ME, Lopez-Anaya A, Martinelli GJ, McGahee SM, Yocum SA, Lopresti-Morrow LL, Tobiassen LM, Vaughn-Bowser ML",,106600,DTCT0024002,1513749,DTCC00288663,237874,6475
CHEMBL1221428,P45452,,YOFFGMSOURAUFV-HHHXNRCGSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20675133,IC50,=,140,NM,,,,,,,,,,,,,,Inhibition of MMP13,,SAR studies of non-zinc-chelating MMP-13 inhibitors: improving selectivity and metabolic stability.,Bioorg. Med. Chem. Lett.,2010,20,17,"Gao DA, Xiong Z, Heim-Riether A, Amodeo L, August EM, Cao X, Ciccarelli L, Collins BK, Harrington K, Haverty K, Hill-Drzewi M, Li X, Liang S, Margarit SM, Moss N, Nagaraja N, Proudfoot J, Roman R, Schlyer S, Keenan LS, Taylor S, Wellenzohn B, Wiedenmayer D, Li J, Farrow NA",,652122,DTCT0024002,3442657,DTCC00691802,954306,40392
CHEMBL1222867,P45452,,XMSHNXONZBWQTA-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20663669,INH,=,155,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Biaryl substituted hydantoin compounds as TACE inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,17,"Yu W, Tong L, Kim SH, Wong MK, Chen L, Yang DY, Shankar BB, Lavey BJ, Zhou G, Kosinski A, Rizvi R, Li D, Feltz RJ, Piwinski JJ, Rosner KE, Shih NY, Siddiqui MA, Guo Z, Orth P, Shah H, Sun J, Umland S, Lundell DJ, Niu X, Kozlowski JA",,651601,DTCT0024002,3456521,DTCC00691619,307666,40340
CHEMBL1222988,P45452,,QRMOUDIUZGKDLX-AREMUKBSSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20675133,IC50,=,100,NM,,,,,,,,,,,,,,Inhibition of MMP13,,SAR studies of non-zinc-chelating MMP-13 inhibitors: improving selectivity and metabolic stability.,Bioorg. Med. Chem. Lett.,2010,20,17,"Gao DA, Xiong Z, Heim-Riether A, Amodeo L, August EM, Cao X, Ciccarelli L, Collins BK, Harrington K, Haverty K, Hill-Drzewi M, Li X, Liang S, Margarit SM, Moss N, Nagaraja N, Proudfoot J, Roman R, Schlyer S, Keenan LS, Taylor S, Wellenzohn B, Wiedenmayer D, Li J, Farrow NA",,652122,DTCT0024002,3442660,DTCC00691737,1633807,40392
CHEMBL1222989,P45452,,CEVYCPKDAIYJCG-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20675133,IC50,=,3300,NM,,,,,,,,,,,,,,Inhibition of MMP13,,SAR studies of non-zinc-chelating MMP-13 inhibitors: improving selectivity and metabolic stability.,Bioorg. Med. Chem. Lett.,2010,20,17,"Gao DA, Xiong Z, Heim-Riether A, Amodeo L, August EM, Cao X, Ciccarelli L, Collins BK, Harrington K, Haverty K, Hill-Drzewi M, Li X, Liang S, Margarit SM, Moss N, Nagaraja N, Proudfoot J, Roman R, Schlyer S, Keenan LS, Taylor S, Wellenzohn B, Wiedenmayer D, Li J, Farrow NA",,652122,DTCT0024002,3442659,DTCC00691738,922023,40392
CHEMBL1223007,P45452,,JHADKVOWWKZBNS-QHCPKHFHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20663669,INH,=,202,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Biaryl substituted hydantoin compounds as TACE inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,17,"Yu W, Tong L, Kim SH, Wong MK, Chen L, Yang DY, Shankar BB, Lavey BJ, Zhou G, Kosinski A, Rizvi R, Li D, Feltz RJ, Piwinski JJ, Rosner KE, Shih NY, Siddiqui MA, Guo Z, Orth P, Shah H, Sun J, Umland S, Lundell DJ, Niu X, Kozlowski JA",,651601,DTCT0024002,3456547,DTCC00691756,1310511,40340
CHEMBL1223057,P45452,,KMPABSMQUVIRLC-AREMUKBSSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20675133,IC50,=,110,NM,,,,,,,,,,,,,,Inhibition of MMP13,,SAR studies of non-zinc-chelating MMP-13 inhibitors: improving selectivity and metabolic stability.,Bioorg. Med. Chem. Lett.,2010,20,17,"Gao DA, Xiong Z, Heim-Riether A, Amodeo L, August EM, Cao X, Ciccarelli L, Collins BK, Harrington K, Haverty K, Hill-Drzewi M, Li X, Liang S, Margarit SM, Moss N, Nagaraja N, Proudfoot J, Roman R, Schlyer S, Keenan LS, Taylor S, Wellenzohn B, Wiedenmayer D, Li J, Farrow NA",,652122,DTCT0024002,3442658,DTCC00691801,728217,40392
CHEMBL1223058,P45452,,SAQQFYPVHNLAFO-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20675133,IC50,=,75,NM,,,,,,,,,,,,,,Inhibition of MMP13,,SAR studies of non-zinc-chelating MMP-13 inhibitors: improving selectivity and metabolic stability.,Bioorg. Med. Chem. Lett.,2010,20,17,"Gao DA, Xiong Z, Heim-Riether A, Amodeo L, August EM, Cao X, Ciccarelli L, Collins BK, Harrington K, Haverty K, Hill-Drzewi M, Li X, Liang S, Margarit SM, Moss N, Nagaraja N, Proudfoot J, Roman R, Schlyer S, Keenan LS, Taylor S, Wellenzohn B, Wiedenmayer D, Li J, Farrow NA",,652122,DTCT0024002,3442656,DTCC00691803,1149013,40392
CHEMBL1223059,P45452,,VLGINQGZOTZBAC-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20675133,IC50,=,11,NM,,,,,,,,,,,,,,Inhibition of MMP13,,SAR studies of non-zinc-chelating MMP-13 inhibitors: improving selectivity and metabolic stability.,Bioorg. Med. Chem. Lett.,2010,20,17,"Gao DA, Xiong Z, Heim-Riether A, Amodeo L, August EM, Cao X, Ciccarelli L, Collins BK, Harrington K, Haverty K, Hill-Drzewi M, Li X, Liang S, Margarit SM, Moss N, Nagaraja N, Proudfoot J, Roman R, Schlyer S, Keenan LS, Taylor S, Wellenzohn B, Wiedenmayer D, Li J, Farrow NA",,652122,DTCT0024002,3442655,DTCC00691804,598964,40392
CHEMBL1223075,P45452,,HGPPYGXNQCWPLJ-VWLOTQADSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20663669,INH,=,194,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Biaryl substituted hydantoin compounds as TACE inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,17,"Yu W, Tong L, Kim SH, Wong MK, Chen L, Yang DY, Shankar BB, Lavey BJ, Zhou G, Kosinski A, Rizvi R, Li D, Feltz RJ, Piwinski JJ, Rosner KE, Shih NY, Siddiqui MA, Guo Z, Orth P, Shah H, Sun J, Umland S, Lundell DJ, Niu X, Kozlowski JA",,651601,DTCT0024002,3456564,DTCC00691820,922026,40340
CHEMBL1223132,P45452,,IGFLLZYTLLPXEH-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20675133,IC50,=,180,NM,,,,,,,,,,,,,,Inhibition of MMP13,,SAR studies of non-zinc-chelating MMP-13 inhibitors: improving selectivity and metabolic stability.,Bioorg. Med. Chem. Lett.,2010,20,17,"Gao DA, Xiong Z, Heim-Riether A, Amodeo L, August EM, Cao X, Ciccarelli L, Collins BK, Harrington K, Haverty K, Hill-Drzewi M, Li X, Liang S, Margarit SM, Moss N, Nagaraja N, Proudfoot J, Roman R, Schlyer S, Keenan LS, Taylor S, Wellenzohn B, Wiedenmayer D, Li J, Farrow NA",,652122,DTCT0024002,3442654,DTCC00691871,1951874,40392
CHEMBL1223133,P45452,,SQQPEZWYLVFNCS-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20675133,IC50,=,330,NM,,,,,,,,,,,,,,Inhibition of MMP13,,SAR studies of non-zinc-chelating MMP-13 inhibitors: improving selectivity and metabolic stability.,Bioorg. Med. Chem. Lett.,2010,20,17,"Gao DA, Xiong Z, Heim-Riether A, Amodeo L, August EM, Cao X, Ciccarelli L, Collins BK, Harrington K, Haverty K, Hill-Drzewi M, Li X, Liang S, Margarit SM, Moss N, Nagaraja N, Proudfoot J, Roman R, Schlyer S, Keenan LS, Taylor S, Wellenzohn B, Wiedenmayer D, Li J, Farrow NA",,652122,DTCT0024002,3442653,DTCC00691872,1472344,40392
CHEMBL1223134,P45452,,WDMHXNAXCIWRHN-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20675133,IC50,=,310,NM,,,,,,,,,,,,,,Inhibition of MMP13,,SAR studies of non-zinc-chelating MMP-13 inhibitors: improving selectivity and metabolic stability.,Bioorg. Med. Chem. Lett.,2010,20,17,"Gao DA, Xiong Z, Heim-Riether A, Amodeo L, August EM, Cao X, Ciccarelli L, Collins BK, Harrington K, Haverty K, Hill-Drzewi M, Li X, Liang S, Margarit SM, Moss N, Nagaraja N, Proudfoot J, Roman R, Schlyer S, Keenan LS, Taylor S, Wellenzohn B, Wiedenmayer D, Li J, Farrow NA",,652122,DTCT0024002,3442652,DTCC00691873,1666078,40392
CHEMBL1223135,P45452,,DZRVTYVYQGUGAM-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20675133,IC50,=,24,NM,,,,,,,,,,,,,,Inhibition of MMP13,,SAR studies of non-zinc-chelating MMP-13 inhibitors: improving selectivity and metabolic stability.,Bioorg. Med. Chem. Lett.,2010,20,17,"Gao DA, Xiong Z, Heim-Riether A, Amodeo L, August EM, Cao X, Ciccarelli L, Collins BK, Harrington K, Haverty K, Hill-Drzewi M, Li X, Liang S, Margarit SM, Moss N, Nagaraja N, Proudfoot J, Roman R, Schlyer S, Keenan LS, Taylor S, Wellenzohn B, Wiedenmayer D, Li J, Farrow NA",,652122,DTCT0024002,3442651,DTCC00691874,1790189,40392
CHEMBL1223199,P45452,,FAHQCMMNJMAMQH-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20675133,IC50,=,72,NM,,,,,,,,,,,,,,Inhibition of MMP13,,SAR studies of non-zinc-chelating MMP-13 inhibitors: improving selectivity and metabolic stability.,Bioorg. Med. Chem. Lett.,2010,20,17,"Gao DA, Xiong Z, Heim-Riether A, Amodeo L, August EM, Cao X, Ciccarelli L, Collins BK, Harrington K, Haverty K, Hill-Drzewi M, Li X, Liang S, Margarit SM, Moss N, Nagaraja N, Proudfoot J, Roman R, Schlyer S, Keenan LS, Taylor S, Wellenzohn B, Wiedenmayer D, Li J, Farrow NA",,652122,DTCT0024002,3442650,DTCC00691938,177398,40392
CHEMBL1223200,P45452,,DAIPKGZQWAUYKF-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20675133,IC50,=,140,NM,,,,,,,,,,,,,,Inhibition of MMP13,,SAR studies of non-zinc-chelating MMP-13 inhibitors: improving selectivity and metabolic stability.,Bioorg. Med. Chem. Lett.,2010,20,17,"Gao DA, Xiong Z, Heim-Riether A, Amodeo L, August EM, Cao X, Ciccarelli L, Collins BK, Harrington K, Haverty K, Hill-Drzewi M, Li X, Liang S, Margarit SM, Moss N, Nagaraja N, Proudfoot J, Roman R, Schlyer S, Keenan LS, Taylor S, Wellenzohn B, Wiedenmayer D, Li J, Farrow NA",,652122,DTCT0024002,3442649,DTCC00691939,760442,40392
CHEMBL1223201,P45452,,WCMRNSFGFNNKLJ-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20675133,IC50,=,8,NM,,,,,,,,,,,,,,Inhibition of MMP13,,SAR studies of non-zinc-chelating MMP-13 inhibitors: improving selectivity and metabolic stability.,Bioorg. Med. Chem. Lett.,2010,20,17,"Gao DA, Xiong Z, Heim-Riether A, Amodeo L, August EM, Cao X, Ciccarelli L, Collins BK, Harrington K, Haverty K, Hill-Drzewi M, Li X, Liang S, Margarit SM, Moss N, Nagaraja N, Proudfoot J, Roman R, Schlyer S, Keenan LS, Taylor S, Wellenzohn B, Wiedenmayer D, Li J, Farrow NA",,652122,DTCT0024002,3442648,DTCC00691940,825062,40392
CHEMBL1223202,P45452,,RNKZGNDTDUXUQW-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20675133,IC50,=,8,NM,,,,,,,,,,,,,,Inhibition of MMP13,,SAR studies of non-zinc-chelating MMP-13 inhibitors: improving selectivity and metabolic stability.,Bioorg. Med. Chem. Lett.,2010,20,17,"Gao DA, Xiong Z, Heim-Riether A, Amodeo L, August EM, Cao X, Ciccarelli L, Collins BK, Harrington K, Haverty K, Hill-Drzewi M, Li X, Liang S, Margarit SM, Moss N, Nagaraja N, Proudfoot J, Roman R, Schlyer S, Keenan LS, Taylor S, Wellenzohn B, Wiedenmayer D, Li J, Farrow NA",,652122,DTCT0024002,3442647,DTCC00691941,1084115,40392
CHEMBL1223282,P45452,,VFNUDCNRXNRCQE-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20675133,IC50,=,42,NM,,,,,,,,,,,,,,Inhibition of MMP13,,SAR studies of non-zinc-chelating MMP-13 inhibitors: improving selectivity and metabolic stability.,Bioorg. Med. Chem. Lett.,2010,20,17,"Gao DA, Xiong Z, Heim-Riether A, Amodeo L, August EM, Cao X, Ciccarelli L, Collins BK, Harrington K, Haverty K, Hill-Drzewi M, Li X, Liang S, Margarit SM, Moss N, Nagaraja N, Proudfoot J, Roman R, Schlyer S, Keenan LS, Taylor S, Wellenzohn B, Wiedenmayer D, Li J, Farrow NA",,652122,DTCT0024002,3442646,DTCC00692020,209607,40392
CHEMBL1223283,P45452,,WPLPIXLPJPHSQR-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20675133,IC50,=,31,NM,,,,,,,,,,,,,,Inhibition of MMP13,,SAR studies of non-zinc-chelating MMP-13 inhibitors: improving selectivity and metabolic stability.,Bioorg. Med. Chem. Lett.,2010,20,17,"Gao DA, Xiong Z, Heim-Riether A, Amodeo L, August EM, Cao X, Ciccarelli L, Collins BK, Harrington K, Haverty K, Hill-Drzewi M, Li X, Liang S, Margarit SM, Moss N, Nagaraja N, Proudfoot J, Roman R, Schlyer S, Keenan LS, Taylor S, Wellenzohn B, Wiedenmayer D, Li J, Farrow NA",,652122,DTCT0024002,3442645,DTCC00692021,890114,40392
CHEMBL1223284,P45452,,KCFVQFHCAXDOGF-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20675133,IC50,=,10,NM,,,,,,,,,,,,,,Inhibition of MMP13,,SAR studies of non-zinc-chelating MMP-13 inhibitors: improving selectivity and metabolic stability.,Bioorg. Med. Chem. Lett.,2010,20,17,"Gao DA, Xiong Z, Heim-Riether A, Amodeo L, August EM, Cao X, Ciccarelli L, Collins BK, Harrington K, Haverty K, Hill-Drzewi M, Li X, Liang S, Margarit SM, Moss N, Nagaraja N, Proudfoot J, Roman R, Schlyer S, Keenan LS, Taylor S, Wellenzohn B, Wiedenmayer D, Li J, Farrow NA",,652122,DTCT0024002,3442644,DTCC00692022,663647,40392
CHEMBL1223285,P45452,,KABNCEKFOYZBNB-RUZDIDTESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20675133,IC50,=,4,NM,,,,,,,,,,,,,,Inhibition of MMP13,,SAR studies of non-zinc-chelating MMP-13 inhibitors: improving selectivity and metabolic stability.,Bioorg. Med. Chem. Lett.,2010,20,17,"Gao DA, Xiong Z, Heim-Riether A, Amodeo L, August EM, Cao X, Ciccarelli L, Collins BK, Harrington K, Haverty K, Hill-Drzewi M, Li X, Liang S, Margarit SM, Moss N, Nagaraja N, Proudfoot J, Roman R, Schlyer S, Keenan LS, Taylor S, Wellenzohn B, Wiedenmayer D, Li J, Farrow NA",,652122,DTCT0024002,3442643,DTCC00692023,1757911,40392
CHEMBL1223351,P45452,,ZDZKYWBMWYAZMM-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20675133,IC50,=,9,NM,,,,,,,,,,,,,,Inhibition of MMP13,,SAR studies of non-zinc-chelating MMP-13 inhibitors: improving selectivity and metabolic stability.,Bioorg. Med. Chem. Lett.,2010,20,17,"Gao DA, Xiong Z, Heim-Riether A, Amodeo L, August EM, Cao X, Ciccarelli L, Collins BK, Harrington K, Haverty K, Hill-Drzewi M, Li X, Liang S, Margarit SM, Moss N, Nagaraja N, Proudfoot J, Roman R, Schlyer S, Keenan LS, Taylor S, Wellenzohn B, Wiedenmayer D, Li J, Farrow NA",,652122,DTCT0024002,3442642,DTCC00692088,1310515,40392
CHEMBL1223352,P45452,,OXUKYMIWWZCKSD-RUZDIDTESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20675133,IC50,=,100,NM,,,,,,,,,,,,,,Inhibition of MMP13,,SAR studies of non-zinc-chelating MMP-13 inhibitors: improving selectivity and metabolic stability.,Bioorg. Med. Chem. Lett.,2010,20,17,"Gao DA, Xiong Z, Heim-Riether A, Amodeo L, August EM, Cao X, Ciccarelli L, Collins BK, Harrington K, Haverty K, Hill-Drzewi M, Li X, Liang S, Margarit SM, Moss N, Nagaraja N, Proudfoot J, Roman R, Schlyer S, Keenan LS, Taylor S, Wellenzohn B, Wiedenmayer D, Li J, Farrow NA",,652122,DTCT0024002,3442641,DTCC00692089,631519,40392
CHEMBL1223353,P45452,,CSSYENOYWSXNTO-AREMUKBSSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20675133,IC50,=,29,NM,,,,,,,,,,,,,,Inhibition of MMP13,,SAR studies of non-zinc-chelating MMP-13 inhibitors: improving selectivity and metabolic stability.,Bioorg. Med. Chem. Lett.,2010,20,17,"Gao DA, Xiong Z, Heim-Riether A, Amodeo L, August EM, Cao X, Ciccarelli L, Collins BK, Harrington K, Haverty K, Hill-Drzewi M, Li X, Liang S, Margarit SM, Moss N, Nagaraja N, Proudfoot J, Roman R, Schlyer S, Keenan LS, Taylor S, Wellenzohn B, Wiedenmayer D, Li J, Farrow NA",,652122,DTCT0024002,3442640,DTCC00692090,2049708,40392
CHEMBL1223354,P45452,,YBMWZGDSDMFQPD-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20675133,IC50,=,27,NM,,,,,,,,,,,,,,Inhibition of MMP13,,SAR studies of non-zinc-chelating MMP-13 inhibitors: improving selectivity and metabolic stability.,Bioorg. Med. Chem. Lett.,2010,20,17,"Gao DA, Xiong Z, Heim-Riether A, Amodeo L, August EM, Cao X, Ciccarelli L, Collins BK, Harrington K, Haverty K, Hill-Drzewi M, Li X, Liang S, Margarit SM, Moss N, Nagaraja N, Proudfoot J, Roman R, Schlyer S, Keenan LS, Taylor S, Wellenzohn B, Wiedenmayer D, Li J, Farrow NA",,652122,DTCT0024002,3442639,DTCC00692091,1472347,40392
CHEMBL1223420,P45452,,YHYQKTVBLLJOLF-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20675133,IC50,=,3,NM,,,,,,,,,,,,,,Inhibition of MMP13,,SAR studies of non-zinc-chelating MMP-13 inhibitors: improving selectivity and metabolic stability.,Bioorg. Med. Chem. Lett.,2010,20,17,"Gao DA, Xiong Z, Heim-Riether A, Amodeo L, August EM, Cao X, Ciccarelli L, Collins BK, Harrington K, Haverty K, Hill-Drzewi M, Li X, Liang S, Margarit SM, Moss N, Nagaraja N, Proudfoot J, Roman R, Schlyer S, Keenan LS, Taylor S, Wellenzohn B, Wiedenmayer D, Li J, Farrow NA",,652122,DTCT0024002,3442638,DTCC00692158,1757912,40392
CHEMBL1223421,P45452,,KSDVJZGHORKLKZ-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20675133,IC50,=,7,NM,,,,,,,,,,,,,,Inhibition of MMP13,,SAR studies of non-zinc-chelating MMP-13 inhibitors: improving selectivity and metabolic stability.,Bioorg. Med. Chem. Lett.,2010,20,17,"Gao DA, Xiong Z, Heim-Riether A, Amodeo L, August EM, Cao X, Ciccarelli L, Collins BK, Harrington K, Haverty K, Hill-Drzewi M, Li X, Liang S, Margarit SM, Moss N, Nagaraja N, Proudfoot J, Roman R, Schlyer S, Keenan LS, Taylor S, Wellenzohn B, Wiedenmayer D, Li J, Farrow NA",,652122,DTCT0024002,3442637,DTCC00692159,1919019,40392
CHEMBL1223422,P45452,,HBDMNZVLMCFFFF-NRFANRHFSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20675133,IC50,=,6,NM,,,,,,,,,,,,,,Inhibition of MMP13,,SAR studies of non-zinc-chelating MMP-13 inhibitors: improving selectivity and metabolic stability.,Bioorg. Med. Chem. Lett.,2010,20,17,"Gao DA, Xiong Z, Heim-Riether A, Amodeo L, August EM, Cao X, Ciccarelli L, Collins BK, Harrington K, Haverty K, Hill-Drzewi M, Li X, Liang S, Margarit SM, Moss N, Nagaraja N, Proudfoot J, Roman R, Schlyer S, Keenan LS, Taylor S, Wellenzohn B, Wiedenmayer D, Li J, Farrow NA",,652122,DTCT0024002,3442636,DTCC00692160,80679,40392
CHEMBL1223423,P45452,,LNCWODREMUZEFC-NRFANRHFSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20675133,IC50,=,28,NM,,,,,,,,,,,,,,Inhibition of MMP13,,SAR studies of non-zinc-chelating MMP-13 inhibitors: improving selectivity and metabolic stability.,Bioorg. Med. Chem. Lett.,2010,20,17,"Gao DA, Xiong Z, Heim-Riether A, Amodeo L, August EM, Cao X, Ciccarelli L, Collins BK, Harrington K, Haverty K, Hill-Drzewi M, Li X, Liang S, Margarit SM, Moss N, Nagaraja N, Proudfoot J, Roman R, Schlyer S, Keenan LS, Taylor S, Wellenzohn B, Wiedenmayer D, Li J, Farrow NA",,652122,DTCT0024002,3442635,DTCC00692161,1984560,40392
CHEMBL1223490,P45452,,BAKKSMNSYICTIW-QHCPKHFHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20675133,IC50,=,2,NM,,,,,,,,,,,,,,Inhibition of MMP13,,SAR studies of non-zinc-chelating MMP-13 inhibitors: improving selectivity and metabolic stability.,Bioorg. Med. Chem. Lett.,2010,20,17,"Gao DA, Xiong Z, Heim-Riether A, Amodeo L, August EM, Cao X, Ciccarelli L, Collins BK, Harrington K, Haverty K, Hill-Drzewi M, Li X, Liang S, Margarit SM, Moss N, Nagaraja N, Proudfoot J, Roman R, Schlyer S, Keenan LS, Taylor S, Wellenzohn B, Wiedenmayer D, Li J, Farrow NA",,652122,DTCT0024002,3442634,DTCC00692229,857985,40392
CHEMBL1223491,P45452,,ZWZXMJHBQVILJV-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20675133,IC50,=,25,NM,,,,,,,,,,,,,,Inhibition of MMP13,,SAR studies of non-zinc-chelating MMP-13 inhibitors: improving selectivity and metabolic stability.,Bioorg. Med. Chem. Lett.,2010,20,17,"Gao DA, Xiong Z, Heim-Riether A, Amodeo L, August EM, Cao X, Ciccarelli L, Collins BK, Harrington K, Haverty K, Hill-Drzewi M, Li X, Liang S, Margarit SM, Moss N, Nagaraja N, Proudfoot J, Roman R, Schlyer S, Keenan LS, Taylor S, Wellenzohn B, Wiedenmayer D, Li J, Farrow NA",,652122,DTCT0024002,3442633,DTCC00692230,2017589,40392
CHEMBL1223492,P45452,,REIOURAGBASECY-IBGZPJMESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20675133,IC50,=,9,NM,,,,,,,,,,,,,,Inhibition of MMP13,,SAR studies of non-zinc-chelating MMP-13 inhibitors: improving selectivity and metabolic stability.,Bioorg. Med. Chem. Lett.,2010,20,17,"Gao DA, Xiong Z, Heim-Riether A, Amodeo L, August EM, Cao X, Ciccarelli L, Collins BK, Harrington K, Haverty K, Hill-Drzewi M, Li X, Liang S, Margarit SM, Moss N, Nagaraja N, Proudfoot J, Roman R, Schlyer S, Keenan LS, Taylor S, Wellenzohn B, Wiedenmayer D, Li J, Farrow NA",,652122,DTCT0024002,3442632,DTCC00692231,760445,40392
CHEMBL1223493,P45452,,FTHKKKKNTGUTPA-IBGZPJMESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20675133,IC50,=,36,NM,,,,,,,,,,,,,,Inhibition of MMP13,,SAR studies of non-zinc-chelating MMP-13 inhibitors: improving selectivity and metabolic stability.,Bioorg. Med. Chem. Lett.,2010,20,17,"Gao DA, Xiong Z, Heim-Riether A, Amodeo L, August EM, Cao X, Ciccarelli L, Collins BK, Harrington K, Haverty K, Hill-Drzewi M, Li X, Liang S, Margarit SM, Moss N, Nagaraja N, Proudfoot J, Roman R, Schlyer S, Keenan LS, Taylor S, Wellenzohn B, Wiedenmayer D, Li J, Farrow NA",,652122,DTCT0024002,3442631,DTCC00692232,2081855,40392
CHEMBL1223562,P45452,,FUTAWINRXHDAMN-NRFANRHFSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20675133,IC50,=,2,NM,,,,,,,,,,,,,,Inhibition of MMP13,,SAR studies of non-zinc-chelating MMP-13 inhibitors: improving selectivity and metabolic stability.,Bioorg. Med. Chem. Lett.,2010,20,17,"Gao DA, Xiong Z, Heim-Riether A, Amodeo L, August EM, Cao X, Ciccarelli L, Collins BK, Harrington K, Haverty K, Hill-Drzewi M, Li X, Liang S, Margarit SM, Moss N, Nagaraja N, Proudfoot J, Roman R, Schlyer S, Keenan LS, Taylor S, Wellenzohn B, Wiedenmayer D, Li J, Farrow NA",,652122,DTCT0024002,3442630,DTCC00692300,1343065,40392
CHEMBL1223563,P45452,,KXNXODOVFJBDPH-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20675133,IC50,=,5,NM,,,,,,,,,,,,,,Inhibition of MMP13,,SAR studies of non-zinc-chelating MMP-13 inhibitors: improving selectivity and metabolic stability.,Bioorg. Med. Chem. Lett.,2010,20,17,"Gao DA, Xiong Z, Heim-Riether A, Amodeo L, August EM, Cao X, Ciccarelli L, Collins BK, Harrington K, Haverty K, Hill-Drzewi M, Li X, Liang S, Margarit SM, Moss N, Nagaraja N, Proudfoot J, Roman R, Schlyer S, Keenan LS, Taylor S, Wellenzohn B, Wiedenmayer D, Li J, Farrow NA",,652122,DTCT0024002,3442629,DTCC00692301,1310517,40392
CHEMBL1229868,P45452,SC-77774,FOSWRYKPHVPIDJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20726512,IC50,=,0.4,NM,,,,,,,,,,,,,,Inhibition of human MMP13 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754464,DTCT0024002,6005815,DTCC00032045,781475,45214
CHEMBL1232074,P45452,,RBZQWZODGBMNHX-USACIQFYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20965620,KI,=,1.7,NM,,,,,,,,,,,,,,Inhibition of MMP13 by fluorimetric assay,,"Structure-based approach to nanomolar, water soluble matrix metalloproteinases inhibitors (MMPIs).",Eur. J. Med. Chem.,2010,45,12,"Attolino E, Calderone V, Dragoni E, Fragai M, Richichi B, Luchinat C, Nativi C",,694548,DTCT0024002,5018619,DTCC00126156,1654736,42241
CHEMBL1232487,P45452,,KOVQMCGGWATESY-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,40,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247985,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,184962,DTCC00694177,1422152,64498
CHEMBL1232489,P45452,,LIIRZRQVACDFBI-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247996,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,158712,DTCC00694178,484290,64498
CHEMBL1232492,P45452,,MMIHYNVQXYWTFM-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,684,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248076,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,185262,DTCC00694179,1680179,64498
CHEMBL1232492,P45452,,MMIHYNVQXYWTFM-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248077,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,168505,DTCC00694179,1680179,64498
CHEMBL123320,P45452,,CAPSVCHNNRHIDK-LOACHALJSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10669564,IC50,=,1,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13 (MMP-13),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,106473,DTCT0024002,1704456,DTCC00302421,1035964,16065
CHEMBL1233772,P45452,,QQDWEVONJRXVDB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20965620,KI,=,2.7,NM,,,,,,,,,,,,,,Inhibition of MMP13 by fluorimetric assay,,"Structure-based approach to nanomolar, water soluble matrix metalloproteinases inhibitors (MMPIs).",Eur. J. Med. Chem.,2010,45,12,"Attolino E, Calderone V, Dragoni E, Fragai M, Richichi B, Luchinat C, Nativi C",,694548,DTCT0024002,5018627,DTCC00694315,1939891,42241
CHEMBL1234370,P45452,,CYYCSKFJEOSZTF-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10579818,IC50,=,2330,NM,,,,,,,,,,,,,,In vitro inhibitory activity against collagenase-3 (matrix metalloprotease-13).,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,106469,DTCT0024002,1371841,DTCC00694384,1883251,15412
CHEMBL1234724,P45452,,IVGHGMHNUBCTDC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20965620,KI,=,1,NM,,,,,,,,,,,,,,Inhibition of MMP13 by fluorimetric assay,,"Structure-based approach to nanomolar, water soluble matrix metalloproteinases inhibitors (MMPIs).",Eur. J. Med. Chem.,2010,45,12,"Attolino E, Calderone V, Dragoni E, Fragai M, Richichi B, Luchinat C, Nativi C",,694548,DTCT0024002,5018620,DTCC00694419,1072323,42241
CHEMBL123499,P45452,,JCCRVIZMNYULMQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10669564,IC50,=,1.9,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13 (MMP-13),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,106473,DTCT0024002,1688101,DTCC00303217,486972,16065
CHEMBL123503,P45452,,DZFFLJXATZFATL-MZBJOSPHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12930146,IC50,=,248,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP13),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,106606,DTCT0024002,515826,DTCC00304831,1371678,13726
CHEMBL123563,P45452,,XVZWTHXPJUVJAU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10669564,IC50,=,1.3,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13 (MMP-13),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,106473,DTCT0024002,1711248,DTCC00302702,874710,16065
CHEMBL123615,P45452,,IAENNQHKVZEBQT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10669564,IC50,=,1.7,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13 (MMP-13),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,106473,DTCT0024002,1709799,DTCC00302858,1682780,16065
CHEMBL123615,P45452,,IAENNQHKVZEBQT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,IC50,=,1.7,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258783,DTCC00302858,1684869,24803
CHEMBL123627,P45452,,INSQINPAEQOIQL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10669564,IC50,=,2.5,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13 (MMP-13),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,106473,DTCT0024002,1704461,DTCC00302808,744987,16065
CHEMBL123627,P45452,,INSQINPAEQOIQL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,IC50,=,2.51,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258777,DTCC00302808,746933,24803
CHEMBL123967,P45452,,RYRSPABEKSPRKC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10669564,IC50,=,1,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13 (MMP-13),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,106473,DTCT0024002,1700454,DTCC00302821,777059,16065
CHEMBL124026,P45452,,GOLRDGXHDIYHCN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10669564,IC50,=,8,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13 (MMP-13),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,106473,DTCT0024002,1681647,DTCC00302820,1585795,16065
CHEMBL124100,P45452,,ZFYWVXBCKVCYOL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10669564,IC50,=,1.4,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13 (MMP-13),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,106473,DTCT0024002,1691929,DTCC00303263,1164479,16065
CHEMBL1241348,P45452,FALDAPREVIR,LLGDPTDZOVKFDU-XUHJSTDZSA-N,3,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20823284,INHIBITION,=,5,%,,,,,,,,,,,,,,Inhibition of human MMP-13 at 10 uM,,"Preclinical characterization of BI 201335, a C-terminal carboxylic acid inhibitor of the hepatitis C virus NS3-NS4A protease.",Antimicrob. Agents Chemother.,2010,54,11,"White PW, Llinàs-Brunet M, Amad M, Bethell RC, Bolger G, Cordingley MG, Duan J, Garneau M, Lagacé L, Thibeault D, Kukolj G",,724366,DTCT0024002,5125908,DTCC00126282,118904,43507
CHEMBL124265,P45452,,YWZUYEWFBPKKSJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10669564,IC50,=,4.2,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13 (MMP-13),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,106473,DTCT0024002,1712478,DTCC00303495,1521506,16065
CHEMBL124514,P45452,,QMHSEIOSCQWTPQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10669564,IC50,=,4.5,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13 (MMP-13),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,106473,DTCT0024002,1680211,DTCC00303304,97463,16065
CHEMBL124558,P45452,,VUANPBMJTLCNSC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10669564,IC50,=,1.3,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13 (MMP-13),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,106473,DTCT0024002,1707029,DTCC00302325,1262121,16065
CHEMBL124680,P45452,,NDGWYSJFTMSGNY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10579818,IC50,=,1.7,NM,,,,,,,,,,,,,,In vitro inhibitory activity against collagenase-3 (matrix metalloprotease-13).,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,106469,DTCT0024002,1379339,DTCC00303465,1662307,15412
CHEMBL124680,P45452,,NDGWYSJFTMSGNY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10669564,IC50,=,1.7,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13 (MMP-13),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,106473,DTCT0024002,1703161,DTCC00303465,1650647,16065
CHEMBL124681,P45452,,GTRBSPVJGOLISO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10669564,IC50,=,21,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13 (MMP-13),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,106473,DTCT0024002,1696749,DTCC00303466,1585794,16065
CHEMBL125068,P45452,,KEWGKOQZKWDXBX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10669564,IC50,=,3.6,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13 (MMP-13),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,106473,DTCT0024002,1712483,DTCC00303279,1489255,16065
CHEMBL125104,P45452,,BHBDAWJEKOCFGP-TUSQITKMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12930146,IC50,=,15,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP13),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,106606,DTCT0024002,541129,DTCC00304856,627570,13726
CHEMBL125138,P45452,,UROHLDAMBMAOKL-DPSWKAHMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12930146,IC50,=,417,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP13),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,106606,DTCT0024002,514823,DTCC00304556,1468365,13726
CHEMBL125281,P45452,,FGCFPKFVQOUMFJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10669564,IC50,=,57,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13 (MMP-13),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,106473,DTCT0024002,1720793,DTCC00302814,2001625,16065
CHEMBL125302,P45452,,KZZHUKUOPGQIRQ-YSSFQJQWSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12930146,IC50,>,100,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP13),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,106606,DTCT0024002,454818,DTCC00304565,917876,13726
CHEMBL125384,P45452,,PQRKDBIFJONDMB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10669564,IC50,=,54,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13 (MMP-13),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,106473,DTCT0024002,1694288,DTCC00302906,519185,16065
CHEMBL125598,P45452,,KXZZWRQJKQVMKR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10669564,IC50,=,0.9,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13 (MMP-13),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,106473,DTCT0024002,1689343,DTCC00303280,777060,16065
CHEMBL125598,P45452,,KXZZWRQJKQVMKR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,IC50,=,0.891,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258774,DTCC00303280,778992,24803
CHEMBL125601,P45452,,FKPCCEUCLYUJQA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10669564,IC50,=,3.2,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13 (MMP-13),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,106473,DTCT0024002,1703171,DTCC00302219,1164478,16065
CHEMBL125672,P45452,,PNVLBMRGQMDPBJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10669564,IC50,=,1.1,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13 (MMP-13),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,106473,DTCT0024002,1713851,DTCC00302951,258782,16065
CHEMBL125901,P45452,,LAXIFXUCVNKYRQ-TZYHBYERSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12930146,IC50,=,275,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP13),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,106606,DTCT0024002,513865,DTCC00304596,270760,13726
CHEMBL126004,P45452,,SJJAJPMVTRAZSX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10669564,IC50,=,1.8,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13 (MMP-13),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,106473,DTCT0024002,1716501,DTCC00302594,809381,16065
CHEMBL126044,P45452,,HWRVCRDVLWYPOY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10669564,IC50,=,2,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13 (MMP-13),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,106473,DTCT0024002,1713842,DTCC00302324,1262120,16065
CHEMBL126380,P45452,,QKYPFBUZQDJQHX-NWVWQQAFSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12930146,IC50,=,5,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP13),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,106606,DTCT0024002,518980,DTCC00304598,853892,13726
CHEMBL126380,P45452,,QKYPFBUZQDJQHX-NWVWQQAFSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12930146,IC50,=,28,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP13),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,106606,DTCT0024002,541124,DTCC00304598,853893,13726
CHEMBL126380,P45452,,QKYPFBUZQDJQHX-NWVWQQAFSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12930146,IC50,=,168,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP13),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,106606,DTCT0024002,536423,DTCC00304598,853891,13726
CHEMBL126461,P45452,,NOCFVGZKPITVEY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12930146,IC50,=,1.2,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP13),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,106606,DTCT0024002,533625,DTCC00304599,108960,13726
CHEMBL126711,P45452,,BOXAYSWQFMJSDX-OEOAZWSVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12930146,IC50,=,80,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP13),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,106606,DTCT0024002,514828,DTCC00304242,1500715,13726
CHEMBL126712,P45452,,DRINIAFHXKEERM-VDGAXYAQSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12930146,IC50,=,3.1,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP13),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,106606,DTCT0024002,516921,DTCC00304243,205585,13726
CHEMBL126923,P45452,,UVAFSUYDCCCUTO-HRNNMHKYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12930146,IC50,=,162,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP13),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,106606,DTCT0024002,530747,DTCC00304832,820979,13726
CHEMBL126977,P45452,,CXRYZROMBCZZFO-IGKWTDBASA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12930146,IC50,=,66,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP13),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,106606,DTCT0024002,537438,DTCC00304833,1241046,13726
CHEMBL127035,P45452,,IHWAKJKUYYZNCF-NDXORKPFSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12930146,IC50,=,133,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP13),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,106606,DTCT0024002,517915,DTCC00304827,595069,13726
CHEMBL127093,P45452,,DOIKBNWTWCOTKR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10669564,IC50,=,2.4,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13 (MMP-13),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,106473,DTCT0024002,1700459,DTCC00302970,2066273,16065
CHEMBL127138,P45452,,XJZZRJAENCZOAK-APTRMMRNSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12930146,IC50,=,5.1,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP13),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,106606,DTCT0024002,530752,DTCC00304826,1047499,13726
CHEMBL127168,P45452,,GQVFUZHQNCWOMM-SSPYTLHUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12930146,IC50,=,31,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP13),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,106606,DTCT0024002,538393,DTCC00304825,1565048,13726
CHEMBL127559,P45452,,AKWUAHDLDRSRDC-MZBJOSPHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12930146,IC50,=,808,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP13),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,106606,DTCT0024002,522124,DTCC00304754,724286,13726
CHEMBL127787,P45452,,IYWLZQLIFMUDCK-MZBJOSPHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12930146,IC50,=,2.8,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP13),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,106606,DTCT0024002,521083,DTCC00304726,498524,13726
CHEMBL127867,P45452,,SPHCUXPEUQITEV-HARLFGEKSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12930146,IC50,=,32,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP13),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,106606,DTCT0024002,539256,DTCC00304547,530612,13726
CHEMBL1287851,P45452,,FYZPCUXRTDXRBF-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21106451,IC50,=,2920,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Novel TNF-a converting enzyme (TACE) inhibitors as potential treatment for inflammatory diseases.,Bioorg. Med. Chem. Lett.,2010,20,24,"Girijavallabhan VM, Chen L, Dai C, Feltz RJ, Firmansjah L, Li D, Kim SH, Kozlowski JA, Lavey BJ, Kosinski A, Piwinski JJ, Popovici-Muller J, Rizvi R, Rosner KE, Shankar BB, Shih NY, Siddiqui MA, Tong L, Wong MK, Yang DY, Yang L, Yu W, Zhou G, Guo Z, Orth P, Madison V, Bian H, Lundell D, Niu X, Shah H, Sun J, Umland S",,686069,DTCT0024002,3618673,DTCC00707887,40801,42108
CHEMBL1305329,P45452,,GJPCWHPIEKIIRL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22018790,INHIBITION,=,36.6,%,,,,,,,,,,,,,,Inhibition of human full length recombinant MMP13 using triple-helical fTHP-15 as substrate at 40 uM after 4 hrs by FRET assay,,"Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds.",Bioorg. Med. Chem. Lett.,2011,21,23,"Roth J, Minond D, Darout E, Liu Q, Lauer J, Hodder P, Fields GB, Roush WR",,799259,DTCT0024002,7596077,DTCC00126810,1059490,47025
CHEMBL1346856,P45452,,NBYQRHXJDNHGJK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22018790,INHIBITION,=,37,%,,,,,,,,,,,,,,Inhibition of human full length recombinant MMP13 using triple-helical fTHP-15 as substrate at 40 uM after 4 hrs by FRET assay,,"Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds.",Bioorg. Med. Chem. Lett.,2011,21,23,"Roth J, Minond D, Darout E, Liu Q, Lauer J, Hodder P, Fields GB, Roush WR",,799259,DTCT0024002,7596073,DTCC00754903,1577169,47025
CHEMBL1352521,P45452,,PQLXBUALUZFSAJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22088955,IC50,=,177000,NM,,,,,,,,,,,,,,Inhibition of human MMP13 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate pre-incubated for 4 hrs before substrate addition measured every 15 secs for 15 mins by fluorimetry,,Identification of novel molecular scaffolds for the design of MMP-13 inhibitors: a first round of lead optimization.,Eur. J. Med. Chem.,2012,47,,"La Pietra V, Marinelli L, Cosconati S, Di Leva FS, Nuti E, Santamaria S, Pugliesi I, Morelli M, Casalini F, Rossello A, La Motta C, Taliani S, Visse R, Nagase H, da Settimo F, Novellino E",,791981,DTCT0024002,7555535,DTCC00760052,1253438,46745
CHEMBL1371684,P45452,,SEZPRMPVJMVCBV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22018790,ACTIVITY,=,38.6,%,,,,,,,,,,,,,,Inhibition of human full length recombinant MMP13 assessed as residual activity using Knight SSP as substrate at 100 uM after 1.5 to 4 hrs by spectrofluorometric analysis relative to control,,"Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds.",Bioorg. Med. Chem. Lett.,2011,21,23,"Roth J, Minond D, Darout E, Liu Q, Lauer J, Hodder P, Fields GB, Roush WR",,799334,DTCT0024002,7597018,DTCC00778134,283182,47025
CHEMBL1371684,P45452,,SEZPRMPVJMVCBV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22018790,INHIBITION,=,67,%,,,,,,,,,,,,,,Inhibition of human full length recombinant MMP13 using triple-helical fTHP-15 as substrate at 40 uM after 4 hrs by FRET assay,,"Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds.",Bioorg. Med. Chem. Lett.,2011,21,23,"Roth J, Minond D, Darout E, Liu Q, Lauer J, Hodder P, Fields GB, Roush WR",,799259,DTCT0024002,7596082,DTCC00778134,283182,47025
CHEMBL1371684,P45452,,SEZPRMPVJMVCBV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22018790,KI,=,824,NM,,,,,,,,,,,,,,Noncompetitive inhibition of human full length recombinant MMP13 using triple-helical fTHP-15 as substrate by Lineweaver-Burk plot analysis,,"Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds.",Bioorg. Med. Chem. Lett.,2011,21,23,"Roth J, Minond D, Darout E, Liu Q, Lauer J, Hodder P, Fields GB, Roush WR",,799260,DTCT0024002,7596100,DTCC00778134,283182,47025
CHEMBL1371684,P45452,,SEZPRMPVJMVCBV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25330343,IC50,=,400,NM,,,,,,,,,,,,,,Inhibition of full-length recombinant human MMP-13 assessed as bovine type-2 collagen hydrolysis after 18 hrs by ELISA,,Characterization of selective exosite-binding inhibitors of matrix metalloproteinase 13 that prevent articular cartilage degradation in vitro.,J. Med. Chem.,2014,57,22,"Spicer TP, Jiang J, Taylor AB, Choi JY, Hart PJ, Roush WR, Fields GB, Hodder PS, Minond D",,1435002,DTCT0024002,14018280,DTCC00778134,266421,60192
CHEMBL1371684,P45452,,SEZPRMPVJMVCBV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25330343,IC50,=,2400,NM,,,,,,,,,,,,,,Non-competitive inhibition of full-length recombinant human MMP-13 assessed as fTHP-15 substrate hydrolysis,,Characterization of selective exosite-binding inhibitors of matrix metalloproteinase 13 that prevent articular cartilage degradation in vitro.,J. Med. Chem.,2014,57,22,"Spicer TP, Jiang J, Taylor AB, Choi JY, Hart PJ, Roush WR, Fields GB, Hodder PS, Minond D",,1434999,DTCT0024002,14018308,DTCC00778134,266421,60192
CHEMBL1371684,P45452,,SEZPRMPVJMVCBV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25330343,INHIBITION,=,59,%,,,,,,,,,,,,,,Inhibition of full-length recombinant human MMP-13 assessed as prevention of bovine type-2 collagen degradation at 10 uM after 18 hrs by cartilage explant assay,,Characterization of selective exosite-binding inhibitors of matrix metalloproteinase 13 that prevent articular cartilage degradation in vitro.,J. Med. Chem.,2014,57,22,"Spicer TP, Jiang J, Taylor AB, Choi JY, Hart PJ, Roush WR, Fields GB, Hodder PS, Minond D",,1435003,DTCT0024002,14018305,DTCC00778134,266421,60192
CHEMBL1371684,P45452,,SEZPRMPVJMVCBV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25330343,INHIBITION,>,20,%,,,,,,,,,,,,,,Inhibition of recombinant human MMP-13 using GRIGFL substrate assessed as inhibition of enzyme activity up to 20 uM,,Characterization of selective exosite-binding inhibitors of matrix metalloproteinase 13 that prevent articular cartilage degradation in vitro.,J. Med. Chem.,2014,57,22,"Spicer TP, Jiang J, Taylor AB, Choi JY, Hart PJ, Roush WR, Fields GB, Hodder PS, Minond D",,1435010,DTCT0024002,14018299,DTCC00778134,266421,60192
CHEMBL1371684,P45452,,SEZPRMPVJMVCBV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25330343,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of full-length recombinant human MMP-13 assessed as bovine type-2 collagen hydrolysis after 18 hrs by ELISA,Dose-dependent effect,Characterization of selective exosite-binding inhibitors of matrix metalloproteinase 13 that prevent articular cartilage degradation in vitro.,J. Med. Chem.,2014,57,22,"Spicer TP, Jiang J, Taylor AB, Choi JY, Hart PJ, Roush WR, Fields GB, Hodder PS, Minond D",,1435002,DTCT0024002,14018306,DTCC00778134,266421,60192
CHEMBL1371684,P45452,,SEZPRMPVJMVCBV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25330343,KB,=,800,NM,,,,,,,,,,,,,,Non-competitive inhibition of full-length recombinant human MMP-13 assessed as fTHP-15 substrate hydrolysis by Lineweaver-Burke plot analysis,,Characterization of selective exosite-binding inhibitors of matrix metalloproteinase 13 that prevent articular cartilage degradation in vitro.,J. Med. Chem.,2014,57,22,"Spicer TP, Jiang J, Taylor AB, Choi JY, Hart PJ, Roush WR, Fields GB, Hodder PS, Minond D",,1435000,DTCT0024002,14018307,DTCC00778134,266421,60192
CHEMBL1371684,P45452,,SEZPRMPVJMVCBV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,IC50,=,2437,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Late stage results from the probe development efforts to identify inhibitors of Matrix Metalloprotease-13 (MMP-13). (Class of assay: screening) [Related pubchem assays (depositor defined):AID1931, AID570, AID734, AID735, AID769] Panel member name: MMP-13 [IC50 Assay]",Active,PUBCHEM BIOASSAY DATA SET,,,,,,,737461,DTCT0024002,5384335,DTCC00778134,280320,33038
CHEMBL1371684,P45452,,SEZPRMPVJMVCBV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,0.84,,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Late stage results from the probe development efforts to identify inhibitors of Matrix Metalloprotease-13 (MMP-13). (Class of assay: screening) [Related pubchem assays (depositor defined):AID1931, AID570, AID734, AID735, AID769] Panel member name: MMP-13 [Ki Assay]",Active,PUBCHEM BIOASSAY DATA SET,,,,,,,737462,DTCT0024002,5384340,DTCC00778134,280320,33038
CHEMBL139884,P45452,,JGHZXBJPZQXVAB-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10579818,IC50,=,2.3,NM,,,,,,,,,,,,,,In vitro inhibitory activity against collagenase-3 (matrix metalloprotease-13).,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,106469,DTCT0024002,1384564,DTCC00325370,1176354,15412
CHEMBL139886,P45452,,YTCCTPYUECNUFO-ZDUSSCGKSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10579818,IC50,=,9.2,NM,,,,,,,,,,,,,,In vitro inhibitory activity against collagenase-3 (matrix metalloprotease-13).,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,106469,DTCT0024002,1371834,DTCC00325371,821219,15412
CHEMBL140004,P45452,,GAQJSKIBXSLAJK-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10579818,IC50,<,0.4,NM,,,,,,,,,,,,,,In vitro inhibitory activity against collagenase-3 (matrix metalloprotease-13).,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,106469,DTCT0024002,1385764,DTCC00325534,1145228,15412
CHEMBL140152,P45452,,TVNINFNNQVBJHI-AWEZNQCLSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10579818,IC50,,,,,,,,,,,,,,,,,Inhibition of collagenase (Matrix metalloprotease-13) (Not determined),Not Determined,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,106470,DTCT0024002,1390650,DTCC00326357,1080274,15412
CHEMBL1404699,P45452,,CZCOIJUNGPPGLD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22018790,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of human full length recombinant MMP13 using triple-helical fTHP-15 as substrate at 40 uM after 4 hrs by FRET assay,Not Active,"Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds.",Bioorg. Med. Chem. Lett.,2011,21,23,"Roth J, Minond D, Darout E, Liu Q, Lauer J, Hodder P, Fields GB, Roush WR",,799259,DTCT0024002,7596079,DTCC00808748,736403,47025
CHEMBL140511,P45452,,XSWDEIOVOAQSMZ-LBPRGKRZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10579818,IC50,=,1.3,NM,,,,,,,,,,,,,,In vitro inhibitory activity against collagenase-3 (matrix metalloprotease-13).,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,106469,DTCT0024002,1383313,DTCC00325504,76971,15412
CHEMBL140568,P45452,,MRZSOAZZNSUPLS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10579818,IC50,=,1.9,NM,,,,,,,,,,,,,,In vitro inhibitory activity against collagenase-3 (matrix metalloprotease-13).,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,106469,DTCT0024002,1403038,DTCC00325326,1851096,15412
CHEMBL140569,P45452,,PZPOCZWOYXDPDG-SFHVURJKSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10579818,IC50,<,0.4,NM,,,,,,,,,,,,,,In vitro inhibitory activity against collagenase-3 (matrix metalloprotease-13).,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,106469,DTCT0024002,1381934,DTCC00325327,31638,15412
CHEMBL140575,P45452,,WFVYENBQHIIIQE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10579818,IC50,=,0.5,NM,,,,,,,,,,,,,,In vitro inhibitory activity against collagenase-3 (matrix metalloprotease-13).,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,106469,DTCT0024002,1393172,DTCC00325288,563042,15412
CHEMBL140720,P45452,,BPNDGQNQHSBNOE-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10579818,IC50,=,7.5,NM,,,,,,,,,,,,,,In vitro inhibitory activity against collagenase-3 (matrix metalloprotease-13).,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,106469,DTCT0024002,1378204,DTCC00325470,563043,15412
CHEMBL140788,P45452,,HXAROWWJPCDNRW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10579818,IC50,=,1.8,NM,,,,,,,,,,,,,,In vitro inhibitory activity against collagenase-3 (matrix metalloprotease-13).,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,106469,DTCT0024002,1394376,DTCC00326245,1786423,15412
CHEMBL140970,P45452,,CYYCSKFJEOSZTF-ZDUSSCGKSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10579818,IC50,=,0.9,NM,,,,,,,,,,,,,,In vitro inhibitory activity against collagenase-3 (matrix metalloprotease-13).,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,106469,DTCT0024002,1385758,DTCC00325595,692228,15412
CHEMBL141080,P45452,,ULILDPSFFUSXJH-LBPRGKRZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10579818,IC50,=,1,NM,,,,,,,,,,,,,,In vitro inhibitory activity against collagenase-3 (matrix metalloprotease-13).,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,106469,DTCT0024002,1401849,DTCC00108095,821220,15412
CHEMBL141451,P45452,,GFDLNQRSUGRRNQ-AWEZNQCLSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10579818,IC50,=,4,NM,,,,,,,,,,,,,,In vitro inhibitory activity against collagenase-3 (matrix metalloprotease-13).,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,106469,DTCT0024002,1386981,DTCC00325427,173833,15412
CHEMBL1427458,P45452,,KUELMQAVLKNHFA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21669521,IC50,=,10000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 substrate,,Selective non zinc binding inhibitors of MMP13.,Bioorg. Med. Chem. Lett.,2011,21,14,"De Savi C, Morley AD, Ting A, Nash I, Karabelas K, Wood CM, James M, Norris SJ, Karoutchi G, Rankine N, Hamlin G, Macfaul PA, Ryan D, Baker SV, Hargreaves D, Gerhardt S",,754229,DTCT0024002,5996205,DTCC00829882,605884,45042
CHEMBL1427458,P45452,,KUELMQAVLKNHFA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21669521,KD,<,10000,NM,,,,,,,,,,,,,,Binding affinity to MMP13 by by NMR time scale assay,,Selective non zinc binding inhibitors of MMP13.,Bioorg. Med. Chem. Lett.,2011,21,14,"De Savi C, Morley AD, Ting A, Nash I, Karabelas K, Wood CM, James M, Norris SJ, Karoutchi G, Rankine N, Hamlin G, Macfaul PA, Ryan D, Baker SV, Hargreaves D, Gerhardt S",,754266,DTCT0024002,5996238,DTCC00829882,605884,45042
CHEMBL1432095,P45452,,WSQAUALTIKYGJA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22018790,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of human full length recombinant MMP13 using triple-helical fTHP-15 as substrate at 40 uM after 4 hrs by FRET assay,Not Active,"Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds.",Bioorg. Med. Chem. Lett.,2011,21,23,"Roth J, Minond D, Darout E, Liu Q, Lauer J, Hodder P, Fields GB, Roush WR",,799259,DTCT0024002,7596071,DTCC00834129,2057787,47025
CHEMBL1433,P45452,DOXYCYCLINE,JBIWCJUYHHGXTC-AKNGSSGZSA-N,4,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17267227,IC50,=,40000,NM,,,,,,,,,,,,,,Inhibition of human MMP13,,Synthesis and in vitro evaluation of targeted tetracycline derivatives: effects on inhibition of matrix metalloproteinases.,Bioorg. Med. Chem.,2007,15,6,"Vidal A, Sabatini M, Rolland-Valognes G, Renard P, Madelmont JC, Mounetou E",,441981,DTCT0024002,2145000,DTCC00443319,370710,23207
CHEMBL1440,P45452,TETRACYCLINE,OFVLGDICTFRJMM-WESIUVDSSA-N,4,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17267227,IC50,=,180000,NM,,,,,,,,,,,,,,Inhibition of human MMP13,,Synthesis and in vitro evaluation of targeted tetracycline derivatives: effects on inhibition of matrix metalloproteinases.,Bioorg. Med. Chem.,2007,15,6,"Vidal A, Sabatini M, Rolland-Valognes G, Renard P, Madelmont JC, Mounetou E",,441981,DTCT0024002,2144987,DTCC00445351,34477,23207
CHEMBL144176,P45452,,HPIJZAVGIHKGTA-MAUKXSAKSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11150165,IC50,=,0.9,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13 (collagenase-3),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,106616,DTCT0024002,1635522,DTCC00332983,1586176,16049
CHEMBL144313,P45452,,IIDUBAKXXSWORH-OXJNMPFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11150165,IC50,<,0.4,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease-13 (collagenase-3),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,106477,DTCT0024002,1599913,DTCC00333379,130092,16049
CHEMBL144430,P45452,,KUEURUPTKRCKAQ-QFBILLFUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11150165,IC50,=,1,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease-13 (collagenase-3),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,106477,DTCT0024002,1624033,DTCC00333938,616106,16049
CHEMBL1448518,P45452,,LYTWDWCQUGSJLP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22018790,INHIBITION,=,55.8,%,,,,,,,,,,,,,,Inhibition of human full length recombinant MMP13 using triple-helical fTHP-15 as substrate at 40 uM after 4 hrs by FRET assay,,"Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds.",Bioorg. Med. Chem. Lett.,2011,21,23,"Roth J, Minond D, Darout E, Liu Q, Lauer J, Hodder P, Fields GB, Roush WR",,799259,DTCT0024002,7596098,DTCC00849624,1351285,47025
CHEMBL145175,P45452,,ZZEIPXVXVCUKGA-XJKSGUPXSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11150165,IC50,=,1,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease-13 (collagenase-3),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,106477,DTCT0024002,1607511,DTCC00333707,2034901,16049
CHEMBL1453397,P45452,,PUHZDFFPMMUTIV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22018790,INHIBITION,=,45.2,%,,,,,,,,,,,,,,Inhibition of human full length recombinant MMP13 using triple-helical fTHP-15 as substrate at 40 uM after 4 hrs by FRET assay,,"Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds.",Bioorg. Med. Chem. Lett.,2011,21,23,"Roth J, Minond D, Darout E, Liu Q, Lauer J, Hodder P, Fields GB, Roush WR",,799259,DTCT0024002,7596083,DTCC00854276,1895144,47025
CHEMBL145641,P45452,,VXVNMUQIRGITQV-WMLDXEAASA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11150165,IC50,<,0.4,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease-13 (collagenase-3),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,106477,DTCT0024002,1625358,DTCC00333647,875086,16049
CHEMBL145930,P45452,,ZEDSMYWEJHIELA-JOYOIKCWSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11150165,IC50,=,2,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease-13 (collagenase-3),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,106477,DTCT0024002,1606314,DTCC00333806,1257134,16049
CHEMBL146256,P45452,,OQWMKRBWGAJEGE-PKOBYXMFSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11150165,IC50,=,0.7,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease-13 (collagenase-3),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,106477,DTCT0024002,1610039,DTCC00333074,1262490,16049
CHEMBL146951,P45452,,NACPMNMCCDZXLH-AJAMINHISA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11150165,IC50,<,0.5,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease-13 (collagenase-3),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,106477,DTCT0024002,1621637,DTCC00333084,1553949,16049
CHEMBL147004,P45452,,VBPVZEMPZISXMF-WMLDXEAASA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11150165,IC50,=,1,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease-13 (collagenase-3),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,106477,DTCT0024002,1636631,DTCC00333211,1936150,16049
CHEMBL147005,P45452,,JRJPXBUCHQFJHU-MAUKXSAKSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11150165,IC50,=,0.3,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease-13 (collagenase-3),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,106477,DTCT0024002,1611281,DTCC00333055,1425118,16049
CHEMBL147107,P45452,,SESDSMKBCYCQSU-WMLDXEAASA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11150165,IC50,=,1,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease-13 (collagenase-3),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,106477,DTCT0024002,1612508,DTCC00333406,1425117,16049
CHEMBL1471486,P45452,,JLDONEFOBUEJOL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22018790,INHIBITION,=,31.2,%,,,,,,,,,,,,,,Inhibition of human full length recombinant MMP13 using triple-helical fTHP-15 as substrate at 40 uM after 4 hrs by FRET assay,,"Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds.",Bioorg. Med. Chem. Lett.,2011,21,23,"Roth J, Minond D, Darout E, Liu Q, Lauer J, Hodder P, Fields GB, Roush WR",,799259,DTCT0024002,7596074,DTCC00870846,1318622,47025
CHEMBL147261,P45452,,UJUNISWMIDZDSX-SWLSCSKDSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11150165,IC50,=,4.4,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13 (collagenase-3),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,106616,DTCT0024002,1617737,DTCC00333100,2066648,16049
CHEMBL147489,P45452,,YVJXBWDNNWDVMN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23287054,IC50,,,,,,,,,,,,,,,,,Inhibition of MMP13 (unknown origin),Not Determined,Sulphonamides: Deserving class as MMP inhibitors?,Eur. J. Med. Chem.,2013,60,,"Jain P, Saravanan C, Singh SK",,944584,DTCT0024002,11835682,DTCC00333722,900923,53820
CHEMBL147494,P45452,,HKQQBEWUPLWAAA-WMLDXEAASA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11150165,IC50,=,2,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease-13 (collagenase-3),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,106477,DTCT0024002,1603816,DTCC00333020,325018,16049
CHEMBL147561,P45452,,RZDQDYGREGZPAT-SLEUVZQESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11150165,IC50,=,1,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease-13 (collagenase-3),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,106477,DTCT0024002,1610035,DTCC00333933,97821,16049
CHEMBL147629,P45452,,CPBPQYOAJUZJNL-SWLSCSKDSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11150165,IC50,=,0.8,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease-13 (collagenase-3),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,106477,DTCT0024002,1608702,DTCC00333768,1457038,16049
CHEMBL147738,P45452,,FMYMFUHWQBEETO-IPELMVKDSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11150165,IC50,=,0.9,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease-13 (collagenase-3),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,106477,DTCT0024002,1629171,DTCC00333306,1586177,16049
CHEMBL147804,P45452,,PQPJWKCPMXIWMW-HEHGZKQESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11150165,IC50,=,1,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease-13 (collagenase-3),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,106477,DTCT0024002,1603797,DTCC00333935,5899,16049
CHEMBL147844,P45452,,UHNNTTJWQVSHSC-GZMMTYOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11150165,IC50,=,5,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease-13 (collagenase-3),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,106477,DTCT0024002,1603791,DTCC00333455,809739,16049
CHEMBL147903,P45452,,JAKYATQFPKVBNE-XJKSGUPXSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11150165,IC50,=,2.8,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease-13 (collagenase-3),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,106477,DTCT0024002,1626768,DTCC00333080,1714823,16049
CHEMBL147910,P45452,,LKSVLIAQUIGTTF-SCLBCKFNSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11150165,IC50,=,2,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease-13 (collagenase-3),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,106477,DTCT0024002,1617731,DTCC00333782,1489664,16049
CHEMBL148081,P45452,,YCKAPRALLQTAKS-WMLDXEAASA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11150165,IC50,=,0.4,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease-13 (collagenase-3),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,106477,DTCT0024002,1625364,DTCC00333857,1457037,16049
CHEMBL148120,P45452,,PTGMPWHDIULCAR-PMOQBDJRSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11150165,IC50,=,0.5,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13 (collagenase-3),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,106464,DTCT0024002,1621631,DTCC00333934,1714821,16049
CHEMBL148136,P45452,,YNSHKUPPIHHCNP-MAUKXSAKSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11150165,IC50,=,1,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease-13 (collagenase-3),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,106477,DTCT0024002,1605195,DTCC00333769,130093,16049
CHEMBL148169,P45452,IK-682,YDMIPBHQKFOFQW-NSYGIPOTSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12408705,KI,=,1417,NM,,,,,,,,,,,,,,Affinity for Matrix metalloprotease-13 (MMP-13),,"Discovery of gamma-lactam hydroxamic acids as selective inhibitors of tumor necrosis factor alpha converting enzyme: design, synthesis, and structure-activity relationships.",J. Med. Chem.,2002,45,23,"Duan JJ, Chen L, Wasserman ZR, Lu Z, Liu RQ, Covington MB, Qian M, Hardman KD, Magolda RL, Newton RC, Christ DD, Wexler RR, Decicco CP",,106608,DTCT0024002,697262,DTCC01743557,205947,17028
CHEMBL148169,P45452,IK-682,YDMIPBHQKFOFQW-NSYGIPOTSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17064892,IC50,=,1417,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440764,DTCT0024002,2153871,DTCC01743557,195837,23077
CHEMBL148169,P45452,IK-682,YDMIPBHQKFOFQW-NSYGIPOTSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17368021,KI,=,1417,NM,,,,,,,,,,,,,,Binding affinity to MMP13,,"Hydantoins, triazolones, and imidazolones as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).",Bioorg. Med. Chem. Lett.,2007,17,10,"Sheppeck JE, Gilmore JL, Tebben A, Xue CB, Liu RQ, Decicco CP, Duan JJ",,438532,DTCT0024002,2101546,DTCC01743557,207226,22885
CHEMBL148169,P45452,IK-682,YDMIPBHQKFOFQW-NSYGIPOTSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18790648,KI,=,1417,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497406,DTCT0024002,2457294,DTCC01743557,208203,32556
CHEMBL148178,P45452,,DZVJLUYVLJYLGY-BLLLJJGKSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11150165,IC50,=,0.8,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease-13 (collagenase-3),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,106477,DTCT0024002,1624044,DTCC00333407,583792,16049
CHEMBL148212,P45452,,BGWGORXFGYPUAF-SWLSCSKDSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11150165,IC50,=,3,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease-13 (collagenase-3),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,106477,DTCT0024002,1612503,DTCC00333583,1774954,16049
CHEMBL148213,P45452,,IWJCPVCPLCTWHT-XJKSGUPXSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11150165,IC50,<,0.4,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease-13 (collagenase-3),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,106477,DTCT0024002,1636657,DTCC00333584,1425116,16049
CHEMBL149977,P45452,,OCZKLINSAMKTBK-PWDRBQJJSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10639284,IC50,=,0.3,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant collagenase-3 (Matrix metalloprotease-13),,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,106475,DTCT0024002,504074,DTCC00340600,983146,15546
CHEMBL149983,P45452,,YUFOYANNKICWEX-XJKSGUPXSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11150165,IC50,=,0.7,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease-13 (collagenase-3),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,106477,DTCT0024002,1627969,DTCC00333972,842533,16049
CHEMBL150027,P45452,,GPLRECXXBJTJRJ-FFAHCDIZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10639284,IC50,=,0.4,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant collagenase-3 (Matrix metalloprotease-13),,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,106475,DTCT0024002,489266,DTCC00340723,918308,15546
CHEMBL150077,P45452,,BKIYUSXBJJEODV-VQCBNXJZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10639284,IC50,=,0.3,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant collagenase-3 (Matrix metalloprotease-13),,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,106475,DTCT0024002,491836,DTCC00340146,1662509,15546
CHEMBL150242,P45452,,USIBDKCJHKIPNX-VJOZSWGJSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10639284,IC50,<,0.4,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant collagenase-3 (Matrix metalloprotease-13),,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,106475,DTCT0024002,493103,DTCC00340535,1274218,15546
CHEMBL150342,P45452,,KUDBVBLUURDAMX-CTBJKRMSSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10639284,IC50,<,1,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant collagenase-3 (Matrix metalloprotease-13),,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,106475,DTCT0024002,504079,DTCC00340719,692420,15546
CHEMBL150483,P45452,,YVUNEHSVUBACDW-SDLDRHLBSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10639284,IC50,<,0.2,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant collagenase-3 (Matrix metalloprotease-13),,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,106475,DTCT0024002,483440,DTCC00340471,1694649,15546
CHEMBL150655,P45452,,SFESNYSPTLYJFZ-JYVXZMADSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10639284,IC50,=,0.2,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant collagenase-3 (Matrix metalloprotease-13),,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,106475,DTCT0024002,482258,DTCC00340890,1915624,15546
CHEMBL1506919,P45452,,CTYRBXFLKOAZKS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22018790,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of human full length recombinant MMP13 using triple-helical fTHP-15 as substrate at 40 uM after 4 hrs by FRET assay,Not Active,"Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds.",Bioorg. Med. Chem. Lett.,2011,21,23,"Roth J, Minond D, Darout E, Liu Q, Lauer J, Hodder P, Fields GB, Roush WR",,799259,DTCT0024002,7596097,DTCC00903922,639773,47025
CHEMBL150745,P45452,,MKKSGKUWQUXKAQ-CQSZACIVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10639284,IC50,=,1,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant collagenase-3 (Matrix metalloprotease-13),,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,106475,DTCT0024002,512681,DTCC00340182,304181,15546
CHEMBL151,P45452,LUTEOLIN,IQPNAANSBPBGFQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22658537,IC50,=,10050,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827438,DTCT0024002,10535459,DTCC00171064,458853,48665
CHEMBL151,P45452,LUTEOLIN,IQPNAANSBPBGFQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22658537,INHIBITION,>,30,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain at 10 uM incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827444,DTCT0024002,10535541,DTCC00171064,458853,48665
CHEMBL151024,P45452,,WGVFUINCAVSVGT-OAHLLOKOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10639284,IC50,=,0.7,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant collagenase-3 (Matrix metalloprotease-13),,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,106475,DTCT0024002,500255,DTCC00340793,1694648,15546
CHEMBL151133,P45452,,FIAWLFURFKPROF-RHTHQAGFSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10639284,IC50,=,0.4,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant collagenase-3 (Matrix metalloprotease-13),,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,106475,DTCT0024002,502896,DTCC00340745,466055,15546
CHEMBL151235,P45452,,JBWUJRFOXXRXHG-LRHAYUFXSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10639284,IC50,<,0.4,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant collagenase-3 (Matrix metalloprotease-13),,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,106475,DTCT0024002,500261,DTCC00340774,1948200,15546
CHEMBL151331,P45452,,AWPBSKGASHYAHG-AFDUHFSSSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10639284,IC50,<,1,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant collagenase-3 (Matrix metalloprotease-13),,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,106475,DTCT0024002,482263,DTCC00340688,206056,15546
CHEMBL151399,P45452,,CBDXJWSRGWXYPR-GFCCVEGCSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10639284,IC50,=,4,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant collagenase-3 (Matrix metalloprotease-13),,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,106475,DTCT0024002,494247,DTCC00340248,1662510,15546
CHEMBL151539,P45452,,NVNGYUBMJMOHQL-RQNDZEIBSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10639284,IC50,<,1,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant collagenase-3 (Matrix metalloprotease-13),,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,106475,DTCT0024002,475401,DTCC00340432,595467,15546
CHEMBL1515648,P45452,,XDOXZFXJIASILF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22018790,ACTIVITY,=,35.1,%,,,,,,,,,,,,,,Inhibition of human full length recombinant MMP13 assessed as residual activity using Knight SSP as substrate at 100 uM after 1.5 to 4 hrs by spectrofluorometric analysis relative to control,,"Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds.",Bioorg. Med. Chem. Lett.,2011,21,23,"Roth J, Minond D, Darout E, Liu Q, Lauer J, Hodder P, Fields GB, Roush WR",,799334,DTCT0024002,7597019,DTCC00912100,185710,47025
CHEMBL1515648,P45452,,XDOXZFXJIASILF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22018790,INHIBITION,=,61,%,,,,,,,,,,,,,,Inhibition of human full length recombinant MMP13 using triple-helical fTHP-15 as substrate at 40 uM after 4 hrs by FRET assay,,"Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds.",Bioorg. Med. Chem. Lett.,2011,21,23,"Roth J, Minond D, Darout E, Liu Q, Lauer J, Hodder P, Fields GB, Roush WR",,799259,DTCT0024002,7596086,DTCC00912100,185710,47025
CHEMBL1515648,P45452,,XDOXZFXJIASILF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22018790,KI,=,1526,NM,,,,,,,,,,,,,,Noncompetitive inhibition of human full length recombinant MMP13 using triple-helical fTHP-15 as substrate by Lineweaver-Burk plot analysis,,"Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds.",Bioorg. Med. Chem. Lett.,2011,21,23,"Roth J, Minond D, Darout E, Liu Q, Lauer J, Hodder P, Fields GB, Roush WR",,799260,DTCT0024002,7596101,DTCC00912100,185710,47025
CHEMBL1515648,P45452,,XDOXZFXJIASILF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25330343,IC50,=,2300,NM,,,,,,,,,,,,,,Inhibition of full-length recombinant human MMP-13 assessed as bovine type-2 collagen hydrolysis after 18 hrs by ELISA,,Characterization of selective exosite-binding inhibitors of matrix metalloproteinase 13 that prevent articular cartilage degradation in vitro.,J. Med. Chem.,2014,57,22,"Spicer TP, Jiang J, Taylor AB, Choi JY, Hart PJ, Roush WR, Fields GB, Hodder PS, Minond D",,1435002,DTCT0024002,14018279,DTCC00912100,169412,60192
CHEMBL1515648,P45452,,XDOXZFXJIASILF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25330343,IC50,=,2800,NM,,,,,,,,,,,,,,Non-competitive inhibition of full-length recombinant human MMP-13 assessed as fTHP-15 substrate hydrolysis,,Characterization of selective exosite-binding inhibitors of matrix metalloproteinase 13 that prevent articular cartilage degradation in vitro.,J. Med. Chem.,2014,57,22,"Spicer TP, Jiang J, Taylor AB, Choi JY, Hart PJ, Roush WR, Fields GB, Hodder PS, Minond D",,1434999,DTCT0024002,14018350,DTCC00912100,169412,60192
CHEMBL1515648,P45452,,XDOXZFXJIASILF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25330343,INHIBITION,=,38,%,,,,,,,,,,,,,,Inhibition of full-length recombinant human MMP-13 assessed as prevention of bovine type-2 collagen degradation at 10 uM after 18 hrs by cartilage explant assay,,Characterization of selective exosite-binding inhibitors of matrix metalloproteinase 13 that prevent articular cartilage degradation in vitro.,J. Med. Chem.,2014,57,22,"Spicer TP, Jiang J, Taylor AB, Choi JY, Hart PJ, Roush WR, Fields GB, Hodder PS, Minond D",,1435003,DTCT0024002,13947379,DTCC00912100,169412,60192
CHEMBL1515648,P45452,,XDOXZFXJIASILF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25330343,INHIBITION,>,20,%,,,,,,,,,,,,,,Inhibition of recombinant human MMP-13 using GRIGFL substrate assessed as inhibition of enzyme activity up to 20 uM,,Characterization of selective exosite-binding inhibitors of matrix metalloproteinase 13 that prevent articular cartilage degradation in vitro.,J. Med. Chem.,2014,57,22,"Spicer TP, Jiang J, Taylor AB, Choi JY, Hart PJ, Roush WR, Fields GB, Hodder PS, Minond D",,1435010,DTCT0024002,13947385,DTCC00912100,169412,60192
CHEMBL1515648,P45452,,XDOXZFXJIASILF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25330343,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of full-length recombinant human MMP-13 assessed as bovine type-2 collagen hydrolysis after 18 hrs by ELISA,Dose-dependent effect,Characterization of selective exosite-binding inhibitors of matrix metalloproteinase 13 that prevent articular cartilage degradation in vitro.,J. Med. Chem.,2014,57,22,"Spicer TP, Jiang J, Taylor AB, Choi JY, Hart PJ, Roush WR, Fields GB, Hodder PS, Minond D",,1435002,DTCT0024002,13947378,DTCC00912100,169412,60192
CHEMBL1515648,P45452,,XDOXZFXJIASILF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25330343,KB,=,1500,NM,,,,,,,,,,,,,,Non-competitive inhibition of full-length recombinant human MMP-13 assessed as fTHP-15 substrate hydrolysis by Lineweaver-Burke plot analysis,,Characterization of selective exosite-binding inhibitors of matrix metalloproteinase 13 that prevent articular cartilage degradation in vitro.,J. Med. Chem.,2014,57,22,"Spicer TP, Jiang J, Taylor AB, Choi JY, Hart PJ, Roush WR, Fields GB, Hodder PS, Minond D",,1435000,DTCT0024002,13947377,DTCC00912100,169412,60192
CHEMBL1515648,P45452,,XDOXZFXJIASILF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,IC50,=,2819,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Late stage results from the probe development efforts to identify inhibitors of Matrix Metalloprotease-13 (MMP-13). (Class of assay: screening) [Related pubchem assays (depositor defined):AID1931, AID570, AID734, AID735, AID769] Panel member name: MMP-13 [IC50 Assay]",Active,PUBCHEM BIOASSAY DATA SET,,,,,,,737461,DTCT0024002,5384332,DTCC00912100,184075,33038
CHEMBL1515648,P45452,,XDOXZFXJIASILF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,1.5,,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Late stage results from the probe development efforts to identify inhibitors of Matrix Metalloprotease-13 (MMP-13). (Class of assay: screening) [Related pubchem assays (depositor defined):AID1931, AID570, AID734, AID735, AID769] Panel member name: MMP-13 [Ki Assay]",Active,PUBCHEM BIOASSAY DATA SET,,,,,,,737462,DTCT0024002,5384339,DTCC00912100,184075,33038
CHEMBL151591,P45452,,OJLWCTMBGWSVFC-FFFFSGIJSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10639284,IC50,=,3,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant collagenase-3 (Matrix metalloprotease-13),,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,106475,DTCT0024002,478974,DTCC00340536,271200,15546
CHEMBL151718,P45452,,WXUQPWYPRTYWIR-JVVDOCDTSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10639284,IC50,<,0.5,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant collagenase-3 (Matrix metalloprotease-13),,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,106475,DTCT0024002,476526,DTCC00340145,692419,15546
CHEMBL1532097,P45452,DIHYDRODAPHNODORIN B,YXPCHLHMGOFXRA-DHGPJANISA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22658537,IC50,=,43550,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827438,DTCT0024002,10535461,DTCC00927565,717882,48665
CHEMBL1532097,P45452,DIHYDRODAPHNODORIN B,YXPCHLHMGOFXRA-DHGPJANISA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22658537,INHIBITION,>,30,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain at 10 uM incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827444,DTCT0024002,10535543,DTCC00927565,717882,48665
CHEMBL155862,P45452,,KJUQRHGKOLRTFD-HMEKMZBJSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11266157,IC50,=,176,NM,,,,,,,,,,,,,,Inhibition of Collagenase 3 (Matrix metalloprotease-13),,Chemoenzymatic synthesis of functionalized cyclohexylglycines and alpha-methylcyclohexylglycines via Kazmaier-Claisen rearrangement.,Bioorg. Med. Chem. Lett.,2001,11,5,"Hudlicky T, Oppong K, Duan C, Stanton C, Laufersweiler MJ, Natchus MG",,106602,DTCT0024002,640106,DTCC00349395,1489851,4704
CHEMBL1566001,P45452,,SDQFKDFGDPUANU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22018790,INHIBITION,=,17.1,%,,,,,,,,,,,,,,Inhibition of human full length recombinant MMP13 using triple-helical fTHP-15 as substrate at 40 uM after 4 hrs by FRET assay,,"Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds.",Bioorg. Med. Chem. Lett.,2011,21,23,"Roth J, Minond D, Darout E, Liu Q, Lauer J, Hodder P, Fields GB, Roush WR",,799259,DTCT0024002,7596092,DTCC00959006,1992985,47025
CHEMBL1566001,P45452,,SDQFKDFGDPUANU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,IC50,>,39840,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Late stage results from the probe development efforts to identify inhibitors of Matrix Metalloprotease-13 (MMP-13). (Class of assay: screening) [Related pubchem assays (depositor defined):AID1931, AID570, AID734, AID735, AID769] Panel member name: MMP-13 [IC50 Assay]",Active,PUBCHEM BIOASSAY DATA SET,,,,,,,737461,DTCT0024002,5384337,DTCC00959006,1991474,33038
CHEMBL158265,P45452,,ZXQRCQILIYTPOF-BEHPGTHXSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11266157,IC50,=,131,NM,,,,,,,,,,,,,,Inhibition of Collagenase 3 (Matrix metalloprotease-13),,Chemoenzymatic synthesis of functionalized cyclohexylglycines and alpha-methylcyclohexylglycines via Kazmaier-Claisen rearrangement.,Bioorg. Med. Chem. Lett.,2001,11,5,"Hudlicky T, Oppong K, Duan C, Stanton C, Laufersweiler MJ, Natchus MG",,106602,DTCT0024002,623452,DTCC00349425,1229760,4704
CHEMBL1607077,P45452,,GFGKJXGFRNRWOF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21669521,IC50,=,25118.86,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 substrate,,Selective non zinc binding inhibitors of MMP13.,Bioorg. Med. Chem. Lett.,2011,21,14,"De Savi C, Morley AD, Ting A, Nash I, Karabelas K, Wood CM, James M, Norris SJ, Karoutchi G, Rankine N, Hamlin G, Macfaul PA, Ryan D, Baker SV, Hargreaves D, Gerhardt S",,754229,DTCT0024002,5996207,DTCC00997290,735181,45042
CHEMBL1615186,P45452,,YSYXAGMNRKARQB-HJPURHCSSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21300546,IC50,=,430,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP13 assessed as substrate cleavage by measuring increase in fluorescence after 16 hrs,,The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,5,"De Savi C, Pape A, Cumming JG, Ting A, Smith PD, Burrows JN, Mills M, Davies C, Lamont S, Milne D, Cook C, Moore P, Sawyer Y, Gerhardt S",,728836,DTCT0024002,5145511,DTCC01003608,975118,43649
CHEMBL1615187,P45452,,UAGAABCJKYADIR-HJPURHCSSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21300546,IC50,>,8100,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP13 assessed as substrate cleavage by measuring increase in fluorescence after 16 hrs,,The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,5,"De Savi C, Pape A, Cumming JG, Ting A, Smith PD, Burrows JN, Mills M, Davies C, Lamont S, Milne D, Cook C, Moore P, Sawyer Y, Gerhardt S",,728836,DTCT0024002,5145586,DTCC01003609,1940035,43649
CHEMBL161669,P45452,,SKRSSNZOVQMETG-UVTDQMKNSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,IC50,=,55270,NM,,,,,,,,,,,,,,Inhibition of MMP13 (unknown origin) using Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate after 3 mins by fluorimetric assay,,Evaluation of the anti-inflammatory/chondroprotective activity of aldose reductase inhibitors in human chondrocyte cultures,MedChemComm,2015,6,5,"Panico A, Maccari R, Cardile V, Avondo S, Crasci L, Ottana R",,1541340,DTCT0024002,11389,DTCC00354612,786782,65440
CHEMBL1632637,P45452,,FAJZOFHZLDUFEM-VIFPVBQESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20965620,KI,=,3.6,NM,,,,,,,,,,,,,,Inhibition of MMP13 by fluorimetric assay,,"Structure-based approach to nanomolar, water soluble matrix metalloproteinases inhibitors (MMPIs).",Eur. J. Med. Chem.,2010,45,12,"Attolino E, Calderone V, Dragoni E, Fragai M, Richichi B, Luchinat C, Nativi C",,694548,DTCT0024002,5018621,DTCC01018413,1331294,42241
CHEMBL1632638,P45452,,VDUBALDTEGAJSW-JOYOIKCWSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20965620,KI,=,1.7,NM,,,,,,,,,,,,,,Inhibition of MMP13 by fluorimetric assay,,"Structure-based approach to nanomolar, water soluble matrix metalloproteinases inhibitors (MMPIs).",Eur. J. Med. Chem.,2010,45,12,"Attolino E, Calderone V, Dragoni E, Fragai M, Richichi B, Luchinat C, Nativi C",,694548,DTCT0024002,5018622,DTCC01018414,716738,42241
CHEMBL1632639,P45452,,PCRITYAGTCCZEK-SECBINFHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20965620,KI,=,2.2,NM,,,,,,,,,,,,,,Inhibition of MMP13 by fluorimetric assay,,"Structure-based approach to nanomolar, water soluble matrix metalloproteinases inhibitors (MMPIs).",Eur. J. Med. Chem.,2010,45,12,"Attolino E, Calderone V, Dragoni E, Fragai M, Richichi B, Luchinat C, Nativi C",,694548,DTCT0024002,5018624,DTCC01018415,426689,42241
CHEMBL1632640,P45452,,YNIHTMMJQXUNPE-GMSGAONNSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20965620,KI,=,2.9,NM,,,,,,,,,,,,,,Inhibition of MMP13 by fluorimetric assay,,"Structure-based approach to nanomolar, water soluble matrix metalloproteinases inhibitors (MMPIs).",Eur. J. Med. Chem.,2010,45,12,"Attolino E, Calderone V, Dragoni E, Fragai M, Richichi B, Luchinat C, Nativi C",,694548,DTCT0024002,5018625,DTCC01018416,1072324,42241
CHEMBL1632641,P45452,,KHCZZISCPQRODX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20965620,KI,=,46,NM,,,,,,,,,,,,,,Inhibition of MMP13 by fluorimetric assay,,"Structure-based approach to nanomolar, water soluble matrix metalloproteinases inhibitors (MMPIs).",Eur. J. Med. Chem.,2010,45,12,"Attolino E, Calderone V, Dragoni E, Fragai M, Richichi B, Luchinat C, Nativi C",,694548,DTCT0024002,5018626,DTCC01018417,69261,42241
CHEMBL1632642,P45452,,OEHVKBKRRIUTOR-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20965620,KI,=,18,NM,,,,,,,,,,,,,,Inhibition of MMP13 by fluorimetric assay,,"Structure-based approach to nanomolar, water soluble matrix metalloproteinases inhibitors (MMPIs).",Eur. J. Med. Chem.,2010,45,12,"Attolino E, Calderone V, Dragoni E, Fragai M, Richichi B, Luchinat C, Nativi C",,694548,DTCT0024002,5018628,DTCC01018418,1137369,42241
CHEMBL1645387,P45452,,TXGWLQVCPVHGKO-GDNBJRDFSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,IC50,=,3800,NM,,,,,,,,,,,,,,Inhibition of MMP13 (unknown origin) using Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate after 3 mins by fluorimetric assay,,Evaluation of the anti-inflammatory/chondroprotective activity of aldose reductase inhibitors in human chondrocyte cultures,MedChemComm,2015,6,5,"Panico A, Maccari R, Cardile V, Avondo S, Crasci L, Ottana R",,1541340,DTCT0024002,11384,DTCC01021953,1531249,65440
CHEMBL1645389,P45452,,DNXCXYIPCYQEBG-UVTDQMKNSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,IC50,=,3990,NM,,,,,,,,,,,,,,Inhibition of MMP13 (unknown origin) using Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate after 3 mins by fluorimetric assay,,Evaluation of the anti-inflammatory/chondroprotective activity of aldose reductase inhibitors in human chondrocyte cultures,MedChemComm,2015,6,5,"Panico A, Maccari R, Cardile V, Avondo S, Crasci L, Ottana R",,1541340,DTCT0024002,11388,DTCC01021955,107074,65440
CHEMBL1645390,P45452,,CPLDJHALZBPVNS-GDNBJRDFSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,IC50,=,5890,NM,,,,,,,,,,,,,,Inhibition of MMP13 (unknown origin) using Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate after 3 mins by fluorimetric assay,,Evaluation of the anti-inflammatory/chondroprotective activity of aldose reductase inhibitors in human chondrocyte cultures,MedChemComm,2015,6,5,"Panico A, Maccari R, Cardile V, Avondo S, Crasci L, Ottana R",,1541340,DTCT0024002,11391,DTCC01021956,1563125,65440
CHEMBL1645391,P45452,,LNPKMUHSBCXBNB-GDNBJRDFSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,IC50,=,640,NM,,,,,,,,,,,,,,Inhibition of MMP13 (unknown origin) using Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate after 3 mins by fluorimetric assay,,Evaluation of the anti-inflammatory/chondroprotective activity of aldose reductase inhibitors in human chondrocyte cultures,MedChemComm,2015,6,5,"Panico A, Maccari R, Cardile V, Avondo S, Crasci L, Ottana R",,1541340,DTCT0024002,11390,DTCC01021957,1945807,65440
CHEMBL1668626,P45452,,YGGOSFPNPAAKEW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23428964,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of MMP13 (unknown origin) up to 50 uM,Not Active,Selective aminopeptidase-N (CD13) inhibitors with relevance to cancer chemotherapy.,Bioorg. Med. Chem.,2013,21,7,"Schmitt C, Voegelin M, Marin A, Schmitt M, Schegg F, Hénon P, Guenot D, Tarnus C",,951224,DTCT0024002,11846952,DTCC01025454,330824,54192
CHEMBL1683443,P45452,,KLCHUAUMSZUJEX-KXBFYZLASA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21300546,IC50,=,11,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP13 assessed as substrate cleavage by measuring increase in fluorescence after 16 hrs,,The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,5,"De Savi C, Pape A, Cumming JG, Ting A, Smith PD, Burrows JN, Mills M, Davies C, Lamont S, Milne D, Cook C, Moore P, Sawyer Y, Gerhardt S",,728836,DTCT0024002,5145471,DTCC01029429,2038633,43649
CHEMBL1683444,P45452,,BGUXTVRZPYKBBN-KXBFYZLASA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21300546,IC50,=,180,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP13 assessed as substrate cleavage by measuring increase in fluorescence after 16 hrs,,The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,5,"De Savi C, Pape A, Cumming JG, Ting A, Smith PD, Burrows JN, Mills M, Davies C, Lamont S, Milne D, Cook C, Moore P, Sawyer Y, Gerhardt S",,728836,DTCT0024002,5145497,DTCC01029430,813528,43649
CHEMBL1683445,P45452,,MEGFCBVTRXVKDO-KKSFZXQISA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21300546,IC50,=,7.6,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP13 assessed as substrate cleavage by measuring increase in fluorescence after 16 hrs,,The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,5,"De Savi C, Pape A, Cumming JG, Ting A, Smith PD, Burrows JN, Mills M, Davies C, Lamont S, Milne D, Cook C, Moore P, Sawyer Y, Gerhardt S",,728836,DTCT0024002,5145465,DTCC01029431,943053,43649
CHEMBL1683449,P45452,,KFGJNQLPIZMSFB-XDHUDOTRSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21300546,IC50,=,260,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP13 assessed as substrate cleavage by measuring increase in fluorescence after 16 hrs,,The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,5,"De Savi C, Pape A, Cumming JG, Ting A, Smith PD, Burrows JN, Mills M, Davies C, Lamont S, Milne D, Cook C, Moore P, Sawyer Y, Gerhardt S",,728836,DTCT0024002,5145503,DTCC01029435,69400,43649
CHEMBL1683450,P45452,,UDTXDKDGZMYOBK-DFBJGRDBSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21300546,IC50,=,370,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP13 assessed as substrate cleavage by measuring increase in fluorescence after 16 hrs,,The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,5,"De Savi C, Pape A, Cumming JG, Ting A, Smith PD, Burrows JN, Mills M, Davies C, Lamont S, Milne D, Cook C, Moore P, Sawyer Y, Gerhardt S",,728836,DTCT0024002,5145508,DTCC01029436,1137499,43649
CHEMBL1683451,P45452,,AFXZHRNVMMQHOL-XDHUDOTRSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21300546,IC50,=,2300,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP13 assessed as substrate cleavage by measuring increase in fluorescence after 16 hrs,,The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,5,"De Savi C, Pape A, Cumming JG, Ting A, Smith PD, Burrows JN, Mills M, Davies C, Lamont S, Milne D, Cook C, Moore P, Sawyer Y, Gerhardt S",,728836,DTCT0024002,5145524,DTCC01029437,1233395,43649
CHEMBL1683452,P45452,,JAPLGNWCNXCEJT-XDHUDOTRSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21300546,IC50,=,570,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP13 assessed as substrate cleavage by measuring increase in fluorescence after 16 hrs,,The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,5,"De Savi C, Pape A, Cumming JG, Ting A, Smith PD, Burrows JN, Mills M, Davies C, Lamont S, Milne D, Cook C, Moore P, Sawyer Y, Gerhardt S",,728836,DTCT0024002,5145516,DTCC01029438,652502,43649
CHEMBL1683453,P45452,,JGAIDLBSMBNOAG-XDHUDOTRSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21300546,IC50,=,16000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP13 assessed as substrate cleavage by measuring increase in fluorescence after 16 hrs,,The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,5,"De Savi C, Pape A, Cumming JG, Ting A, Smith PD, Burrows JN, Mills M, Davies C, Lamont S, Milne D, Cook C, Moore P, Sawyer Y, Gerhardt S",,728836,DTCT0024002,5145547,DTCC01029439,619987,43649
CHEMBL1683454,P45452,,IXKRFERDVUXQLW-DFBJGRDBSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21300546,IC50,=,530,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP13 assessed as substrate cleavage by measuring increase in fluorescence after 16 hrs,,The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,5,"De Savi C, Pape A, Cumming JG, Ting A, Smith PD, Burrows JN, Mills M, Davies C, Lamont S, Milne D, Cook C, Moore P, Sawyer Y, Gerhardt S",,728836,DTCT0024002,5145514,DTCC01029440,1557705,43649
CHEMBL1683455,P45452,,AYZCFZMCYDMFMY-DFBJGRDBSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21300546,IC50,=,2300,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP13 assessed as substrate cleavage by measuring increase in fluorescence after 16 hrs,,The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,5,"De Savi C, Pape A, Cumming JG, Ting A, Smith PD, Burrows JN, Mills M, Davies C, Lamont S, Milne D, Cook C, Moore P, Sawyer Y, Gerhardt S",,728836,DTCT0024002,5145525,DTCC01029441,16131,43649
CHEMBL1683456,P45452,,HUWMGZNULSXXSW-PPHZAIPVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21300546,IC50,=,17000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP13 assessed as substrate cleavage by measuring increase in fluorescence after 16 hrs,,The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,5,"De Savi C, Pape A, Cumming JG, Ting A, Smith PD, Burrows JN, Mills M, Davies C, Lamont S, Milne D, Cook C, Moore P, Sawyer Y, Gerhardt S",,728836,DTCT0024002,5145548,DTCC01029442,846445,43649
CHEMBL1683457,P45452,,NYJKRUFCTNREQN-LVXARBLLSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21300546,IC50,=,23000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP13 assessed as substrate cleavage by measuring increase in fluorescence after 16 hrs,,The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,5,"De Savi C, Pape A, Cumming JG, Ting A, Smith PD, Burrows JN, Mills M, Davies C, Lamont S, Milne D, Cook C, Moore P, Sawyer Y, Gerhardt S",,728836,DTCT0024002,5145551,DTCC01029443,1525647,43649
CHEMBL1683458,P45452,,SOTNGZPOQMJOPI-BVZFJXPGSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21300546,IC50,=,14000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP13 assessed as substrate cleavage by measuring increase in fluorescence after 16 hrs,,The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,5,"De Savi C, Pape A, Cumming JG, Ting A, Smith PD, Burrows JN, Mills M, Davies C, Lamont S, Milne D, Cook C, Moore P, Sawyer Y, Gerhardt S",,728836,DTCT0024002,5145546,DTCC01029444,101600,43649
CHEMBL1683459,P45452,,PQEGPXRQOCZFEH-DFBJGRDBSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21300546,IC50,=,27000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP13 assessed as substrate cleavage by measuring increase in fluorescence after 16 hrs,,The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,5,"De Savi C, Pape A, Cumming JG, Ting A, Smith PD, Burrows JN, Mills M, Davies C, Lamont S, Milne D, Cook C, Moore P, Sawyer Y, Gerhardt S",,728836,DTCT0024002,5145554,DTCC01029445,1746789,43649
CHEMBL1683460,P45452,,YAQNYFRHXMKRGE-HJPURHCSSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21300546,IC50,=,4600,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP13 assessed as substrate cleavage by measuring increase in fluorescence after 16 hrs,,The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,5,"De Savi C, Pape A, Cumming JG, Ting A, Smith PD, Burrows JN, Mills M, Davies C, Lamont S, Milne D, Cook C, Moore P, Sawyer Y, Gerhardt S",,728836,DTCT0024002,5145538,DTCC01029446,684536,43649
CHEMBL1683461,P45452,,ICCQWMPCYVXIPA-DFBJGRDBSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21300546,IC50,>,4500,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP13 assessed as substrate cleavage by measuring increase in fluorescence after 16 hrs,,The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,5,"De Savi C, Pape A, Cumming JG, Ting A, Smith PD, Burrows JN, Mills M, Davies C, Lamont S, Milne D, Cook C, Moore P, Sawyer Y, Gerhardt S",,728836,DTCT0024002,5145577,DTCC01029447,328882,43649
CHEMBL1683462,P45452,,WTIUPHRWVGHPRH-HJPURHCSSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21300546,IC50,>,16000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP13 assessed as substrate cleavage by measuring increase in fluorescence after 16 hrs,,The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,5,"De Savi C, Pape A, Cumming JG, Ting A, Smith PD, Burrows JN, Mills M, Davies C, Lamont S, Milne D, Cook C, Moore P, Sawyer Y, Gerhardt S",,728836,DTCT0024002,5145572,DTCC01029448,491087,43649
CHEMBL1683463,P45452,,SVXOKXGEZUGFFS-UUOWRZLLSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21300546,IC50,=,6100,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP13 assessed as substrate cleavage by measuring increase in fluorescence after 16 hrs,,The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,5,"De Savi C, Pape A, Cumming JG, Ting A, Smith PD, Burrows JN, Mills M, Davies C, Lamont S, Milne D, Cook C, Moore P, Sawyer Y, Gerhardt S",,728836,DTCT0024002,5145541,DTCC01029449,69401,43649
CHEMBL1683464,P45452,,BWHNAQMOABQLDB-BVZFJXPGSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21300546,IC50,=,350,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP13 assessed as substrate cleavage by measuring increase in fluorescence after 16 hrs,,The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,5,"De Savi C, Pape A, Cumming JG, Ting A, Smith PD, Burrows JN, Mills M, Davies C, Lamont S, Milne D, Cook C, Moore P, Sawyer Y, Gerhardt S",,728836,DTCT0024002,5145505,DTCC01029450,911513,43649
CHEMBL1683465,P45452,,PDHFGTGPEOIGCF-SBUREZEXSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21300546,IC50,=,6700,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP13 assessed as substrate cleavage by measuring increase in fluorescence after 16 hrs,,The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,5,"De Savi C, Pape A, Cumming JG, Ting A, Smith PD, Burrows JN, Mills M, Davies C, Lamont S, Milne D, Cook C, Moore P, Sawyer Y, Gerhardt S",,728836,DTCT0024002,5145542,DTCC01029451,1718370,43649
CHEMBL1701338,P45452,,FIDGQGFKBKNAPE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22018790,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of human full length recombinant MMP13 using triple-helical fTHP-15 as substrate at 40 uM after 4 hrs by FRET assay,Not Active,"Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds.",Bioorg. Med. Chem. Lett.,2011,21,23,"Roth J, Minond D, Darout E, Liu Q, Lauer J, Hodder P, Fields GB, Roush WR",,799259,DTCT0024002,7596078,DTCC01036207,1253506,47025
CHEMBL1703321,P45452,,JCSJCPZXNFBGJR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22018790,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of human full length recombinant MMP13 using triple-helical fTHP-15 as substrate at 40 uM after 4 hrs by FRET assay,Not Active,"Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds.",Bioorg. Med. Chem. Lett.,2011,21,23,"Roth J, Minond D, Darout E, Liu Q, Lauer J, Hodder P, Fields GB, Roush WR",,799259,DTCT0024002,7596081,DTCC01038136,1253507,47025
CHEMBL1703805,P45452,,DDXUEYIKZYBVMC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21669521,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 substrate,,Selective non zinc binding inhibitors of MMP13.,Bioorg. Med. Chem. Lett.,2011,21,14,"De Savi C, Morley AD, Ting A, Nash I, Karabelas K, Wood CM, James M, Norris SJ, Karoutchi G, Rankine N, Hamlin G, Macfaul PA, Ryan D, Baker SV, Hargreaves D, Gerhardt S",,754229,DTCT0024002,5996216,DTCC01038606,1091248,45042
CHEMBL1708633,P45452,,HPKSJRQGNKXSTN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22018790,INHIBITION,=,7.7,%,,,,,,,,,,,,,,Inhibition of human full length recombinant MMP13 using triple-helical fTHP-15 as substrate at 40 uM after 4 hrs by FRET assay,,"Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds.",Bioorg. Med. Chem. Lett.,2011,21,23,"Roth J, Minond D, Darout E, Liu Q, Lauer J, Hodder P, Fields GB, Roush WR",,799259,DTCT0024002,7596089,DTCC01043279,478119,47025
CHEMBL1708633,P45452,,HPKSJRQGNKXSTN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,IC50,>,39840,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Late stage results from the probe development efforts to identify inhibitors of Matrix Metalloprotease-13 (MMP-13). (Class of assay: screening) [Related pubchem assays (depositor defined):AID1931, AID570, AID734, AID735, AID769] Panel member name: MMP-13 [IC50 Assay]",inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,737461,DTCT0024002,5384334,DTCC01043279,476446,33038
CHEMBL1717700,P45452,,GSRFVSAKODJJAU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22018790,INHIBITION,=,10.3,%,,,,,,,,,,,,,,Inhibition of human full length recombinant MMP13 using triple-helical fTHP-15 as substrate at 40 uM after 4 hrs by FRET assay,,"Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds.",Bioorg. Med. Chem. Lett.,2011,21,23,"Roth J, Minond D, Darout E, Liu Q, Lauer J, Hodder P, Fields GB, Roush WR",,799259,DTCT0024002,7596091,DTCC01052041,1286073,47025
CHEMBL1717700,P45452,,GSRFVSAKODJJAU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,IC50,>,39840,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Late stage results from the probe development efforts to identify inhibitors of Matrix Metalloprotease-13 (MMP-13). (Class of assay: screening) [Related pubchem assays (depositor defined):AID1931, AID570, AID734, AID735, AID769] Panel member name: MMP-13 [IC50 Assay]",inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,737461,DTCT0024002,5384336,DTCC01052041,1284452,33038
CHEMBL1720056,P45452,,RWAABDCMXWMEQF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22018790,INHIBITION,=,34.4,%,,,,,,,,,,,,,,Inhibition of human full length recombinant MMP13 using triple-helical fTHP-15 as substrate at 40 uM after 4 hrs by FRET assay,,"Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds.",Bioorg. Med. Chem. Lett.,2011,21,23,"Roth J, Minond D, Darout E, Liu Q, Lauer J, Hodder P, Fields GB, Roush WR",,799259,DTCT0024002,7596085,DTCC01054321,315845,47025
CHEMBL1720056,P45452,,RWAABDCMXWMEQF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,IC50,>,39840,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Late stage results from the probe development efforts to identify inhibitors of Matrix Metalloprotease-13 (MMP-13). (Class of assay: screening) [Related pubchem assays (depositor defined):AID1931, AID570, AID734, AID735, AID769] Panel member name: MMP-13 [IC50 Assay]",Active,PUBCHEM BIOASSAY DATA SET,,,,,,,737461,DTCT0024002,5384338,DTCC01054321,314376,33038
CHEMBL172588,P45452,,KMLHPTCEMLILLL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10230616,IC50,=,1,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 (MMP-13),,Discovery of a novel series of selective MMP inhibitors: identification of the gamma-sulfone-thiols.,Bioorg. Med. Chem. Lett.,1999,9,7,"Freskos JN, Mischke BV, DeCrescenzo GA, Heintz R, Getman DP, Howard SC, Kishore NN, McDonald JJ, Munie GE, Rangwala S, Swearingen CA, Voliva C, Welsch DJ",,106484,DTCT0024002,1690248,DTCC00373299,1715192,3610
CHEMBL172912,P45452,,UXTQFUKVODXBBJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10230616,IC50,=,32,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 (MMP-13),,Discovery of a novel series of selective MMP inhibitors: identification of the gamma-sulfone-thiols.,Bioorg. Med. Chem. Lett.,1999,9,7,"Freskos JN, Mischke BV, DeCrescenzo GA, Heintz R, Getman DP, Howard SC, Kishore NN, McDonald JJ, Munie GE, Rangwala S, Swearingen CA, Voliva C, Welsch DJ",,106484,DTCT0024002,1720296,DTCC00373213,1425571,3610
CHEMBL173539,P45452,,BBQIWKGIQNPWJU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10230616,IC50,=,18,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 (MMP-13),,Discovery of a novel series of selective MMP inhibitors: identification of the gamma-sulfone-thiols.,Bioorg. Med. Chem. Lett.,1999,9,7,"Freskos JN, Mischke BV, DeCrescenzo GA, Heintz R, Getman DP, Howard SC, Kishore NN, McDonald JJ, Munie GE, Rangwala S, Swearingen CA, Voliva C, Welsch DJ",,106484,DTCT0024002,1713385,DTCC00373214,194985,3610
CHEMBL1736529,P45452,,UFCNXRFIGHNKSK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22018790,INHIBITION,=,2.2,%,,,,,,,,,,,,,,Inhibition of human full length recombinant MMP13 using triple-helical fTHP-15 as substrate at 40 uM after 4 hrs by FRET assay,,"Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds.",Bioorg. Med. Chem. Lett.,2011,21,23,"Roth J, Minond D, Darout E, Liu Q, Lauer J, Hodder P, Fields GB, Roush WR",,799259,DTCT0024002,7596088,DTCC01070299,1706022,47025
CHEMBL1736529,P45452,,UFCNXRFIGHNKSK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,IC50,>,39840,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Late stage results from the probe development efforts to identify inhibitors of Matrix Metalloprotease-13 (MMP-13). (Class of assay: screening) [Related pubchem assays (depositor defined):AID1931, AID570, AID734, AID735, AID769] Panel member name: MMP-13 [IC50 Assay]",inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,737461,DTCT0024002,5384331,DTCC01070299,1704439,33038
CHEMBL1738748,P45452,,FEOIBPWKGPFSTB-NDEPHWFRSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21669521,IC50,=,79.43,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 substrate,,Selective non zinc binding inhibitors of MMP13.,Bioorg. Med. Chem. Lett.,2011,21,14,"De Savi C, Morley AD, Ting A, Nash I, Karabelas K, Wood CM, James M, Norris SJ, Karoutchi G, Rankine N, Hamlin G, Macfaul PA, Ryan D, Baker SV, Hargreaves D, Gerhardt S",,754229,DTCT0024002,5996195,DTCC01070791,799530,45042
CHEMBL1738748,P45452,,FEOIBPWKGPFSTB-NDEPHWFRSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22153941,IC50,=,79.43,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798828,DTCT0024002,7601206,DTCC01070791,800734,47049
CHEMBL175113,P45452,,SHMJSERYBLZGBT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10230616,IC50,=,6,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 (MMP-13),,Discovery of a novel series of selective MMP inhibitors: identification of the gamma-sulfone-thiols.,Bioorg. Med. Chem. Lett.,1999,9,7,"Freskos JN, Mischke BV, DeCrescenzo GA, Heintz R, Getman DP, Howard SC, Kishore NN, McDonald JJ, Munie GE, Rangwala S, Swearingen CA, Voliva C, Welsch DJ",,106484,DTCT0024002,1700054,DTCC00374974,130530,3610
CHEMBL175165,P45452,,VUWUUGVWGHAIEA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10230616,IC50,=,700,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 (MMP-13),,Discovery of a novel series of selective MMP inhibitors: identification of the gamma-sulfone-thiols.,Bioorg. Med. Chem. Lett.,1999,9,7,"Freskos JN, Mischke BV, DeCrescenzo GA, Heintz R, Getman DP, Howard SC, Kishore NN, McDonald JJ, Munie GE, Rangwala S, Swearingen CA, Voliva C, Welsch DJ",,106484,DTCT0024002,1705303,DTCC00374975,2035321,3610
CHEMBL176319,P45452,,XJUQEFFNMKAWSV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10230616,IC50,=,45,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 (MMP-13),,Discovery of a novel series of selective MMP inhibitors: identification of the gamma-sulfone-thiols.,Bioorg. Med. Chem. Lett.,1999,9,7,"Freskos JN, Mischke BV, DeCrescenzo GA, Heintz R, Getman DP, Howard SC, Kishore NN, McDonald JJ, Munie GE, Rangwala S, Swearingen CA, Voliva C, Welsch DJ",,106484,DTCT0024002,1712066,DTCC00373163,1393173,3610
CHEMBL176467,P45452,,RTBMLCLTYAPKIF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11327602,IC50,=,65,NM,,,,,,,,,,,,,,"Inhibition of collagenase-3, Matrix metalloprotease-13",,"Novel 5,5-disubstitutedpyrimidine-2,4,6-triones as selective MMP inhibitors.",Bioorg. Med. Chem. Lett.,2001,11,8,"Foley LH, Palermo R, Dunten P, Wang P",,106485,DTCT0024002,970233,DTCC00374112,1662912,4784
CHEMBL176467,P45452,,RTBMLCLTYAPKIF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15908214,KI,=,65,NM,,,,,,,,,,,,,,In vitro binding affinity against matrix metalloprotease 13,,"Non-hydroxamate 5-phenylpyrimidine-2,4,6-trione derivatives as selective inhibitors of tumor necrosis factor-alpha converting enzyme.",Bioorg. Med. Chem. Lett.,2005,15,12,"Duan JJ, Lu Z, Wasserman ZR, Liu RQ, Covington MB, Decicco CP",,302358,DTCT0024002,1800060,DTCC00374112,1651773,16433
CHEMBL176612,P45452,,QGVCPEQAAKTMNX-VIFPVBQESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10230616,IC50,=,250,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 (MMP-13),,Discovery of a novel series of selective MMP inhibitors: identification of the gamma-sulfone-thiols.,Bioorg. Med. Chem. Lett.,1999,9,7,"Freskos JN, Mischke BV, DeCrescenzo GA, Heintz R, Getman DP, Howard SC, Kishore NN, McDonald JJ, Munie GE, Rangwala S, Swearingen CA, Voliva C, Welsch DJ",,106484,DTCT0024002,1695217,DTCC00109228,65982,3610
CHEMBL1767014,P45452,,RDRCRROFSMSFED-KHIBUBOWSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21417219,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 after 60 mins by fluorescence plate reader,,"Discovery of (1S,2R,3R)-2,3-Dimethyl-2-phenyl-1-sulfamidocyclopropanecarboxylates: Novel and Highly Selective Aggrecanase Inhibitors.",J. Med. Chem.,2011,54,8,"Shiozaki M, Maeda K, Miura T, Kotoku M, Yamasaki T, Matsuda I, Aoki K, Yasue K, Imai H, Ubukata M, Suma A, Yokota M, Hotta T, Tanaka M, Hase Y, Haas J, Fryer AM, Laird ER, Littmann NM, Andrews SW, Josey JA, Mimura T, Shinozaki Y, Yoshiuchi H, Inaba T",,743613,DTCT0024002,5927585,DTCC01079536,2005992,44276
CHEMBL176832,P45452,,CQGUKDZSAPDCJL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11327602,IC50,=,78,NM,,,,,,,,,,,,,,"Inhibition of collagenase-3, Matrix metalloprotease-13",,"Novel 5,5-disubstitutedpyrimidine-2,4,6-triones as selective MMP inhibitors.",Bioorg. Med. Chem. Lett.,2001,11,8,"Foley LH, Palermo R, Dunten P, Wang P",,106485,DTCT0024002,959845,DTCC00374111,1209081,4784
CHEMBL176911,P45452,,YDQUJRRZUVGVRH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10230616,IC50,=,1500,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 (MMP-13),,Discovery of a novel series of selective MMP inhibitors: identification of the gamma-sulfone-thiols.,Bioorg. Med. Chem. Lett.,1999,9,7,"Freskos JN, Mischke BV, DeCrescenzo GA, Heintz R, Getman DP, Howard SC, Kishore NN, McDonald JJ, Munie GE, Rangwala S, Swearingen CA, Voliva C, Welsch DJ",,106484,DTCT0024002,1720294,DTCC00372863,1069157,3610
CHEMBL1770157,P45452,,STMMWXRQAOVQNP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21493063,IC50,=,0.3,NM,,,,,,,,,,,,,,Inhibition of human MMP13,,MMP-13 selective alpha-sulfone hydroxamates: Identification of selective P1' amides.,Bioorg. Med. Chem. Lett.,2011,21,10,"Fobian YM, Freskos JN, Barta TE, Bedell LJ, Heintz R, Kassab DJ, Kiefer JR, Mischke BV, Molyneaux JM, Mullins P, Munie GE, Becker DP",,744872,DTCT0024002,5936688,DTCC01080448,961249,44425
CHEMBL1770629,P45452,,IIBLNMYMPDUKOQ-HKDUHGGJSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20638281,KI,=,3300,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Structure and activity relationships of tartrate-based TACE inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,16,"Li D, Popovici-Muller J, Belanger DB, Caldwell J, Dai C, David M, Girijavallabhan VM, Lavey BJ, Lee JF, Liu Z, Mazzola R, Rizvi R, Rosner KE, Shankar B, Spitler J, Ting PC, Vaccaro H, Yu W, Zhou G, Zhu Z, Niu X, Sun J, Guo Z, Orth P, Chen S, Kozlowski JA, Lundell DJ, Madison V, McKittrick B, Piwinski JJ, Shih NY, Shipps GW, Siddiqui MA, Strickland CO",,748392,DTCT0024002,5959020,DTCC01080384,652661,44590
CHEMBL1770629,P45452,,IIBLNMYMPDUKOQ-HKDUHGGJSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21458257,KI,=,3300,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"2-(2-Aminothiazol-4-yl)pyrrolidine-based tartrate diamides as potent, selective and orally bioavailable TACE inhibitors.",Bioorg. Med. Chem. Lett.,2011,21,10,"Dai C, Li D, Popovici-Muller J, Zhao L, Girijavallabhan VM, Rosner KE, Lavey BJ, Rizvi R, Shankar BB, Wong MK, Guo Z, Orth P, Strickland CO, Sun J, Niu X, Chen S, Kozlowski JA, Lundell DJ, Piwinski JJ, Shih NY, Siddiqui MA",,744288,DTCT0024002,5930523,DTCC01080384,652615,44403
CHEMBL1770649,P45452,,PRUCBZGVKSTGBL-FPHUIIFBSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21458257,KI,>,40000,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"2-(2-Aminothiazol-4-yl)pyrrolidine-based tartrate diamides as potent, selective and orally bioavailable TACE inhibitors.",Bioorg. Med. Chem. Lett.,2011,21,10,"Dai C, Li D, Popovici-Muller J, Zhao L, Girijavallabhan VM, Rosner KE, Lavey BJ, Rizvi R, Shankar BB, Wong MK, Guo Z, Orth P, Strickland CO, Sun J, Niu X, Chen S, Kozlowski JA, Lundell DJ, Piwinski JJ, Shih NY, Siddiqui MA",,744288,DTCT0024002,5930524,DTCC01080402,1266399,44403
CHEMBL1770697,P45452,,CLXRDURJLYSMHZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21493063,IC50,=,3.3,NM,,,,,,,,,,,,,,Inhibition of human MMP13,,MMP-13 selective alpha-sulfone hydroxamates: Identification of selective P1' amides.,Bioorg. Med. Chem. Lett.,2011,21,10,"Fobian YM, Freskos JN, Barta TE, Bedell LJ, Heintz R, Kassab DJ, Kiefer JR, Mischke BV, Molyneaux JM, Mullins P, Munie GE, Becker DP",,744872,DTCT0024002,5936690,DTCC01080449,799451,44425
CHEMBL1770698,P45452,,RCSWIFOOANTXTQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21493063,IC50,=,8,NM,,,,,,,,,,,,,,Inhibition of human MMP13,,MMP-13 selective alpha-sulfone hydroxamates: Identification of selective P1' amides.,Bioorg. Med. Chem. Lett.,2011,21,10,"Fobian YM, Freskos JN, Barta TE, Bedell LJ, Heintz R, Kassab DJ, Kiefer JR, Mischke BV, Molyneaux JM, Mullins P, Munie GE, Becker DP",,744872,DTCT0024002,5936677,DTCC01080450,49638,44425
CHEMBL1770699,P45452,,WBIKMXRYXWFRCE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21493063,IC50,=,0.4,NM,,,,,,,,,,,,,,Inhibition of human MMP13,,MMP-13 selective alpha-sulfone hydroxamates: Identification of selective P1' amides.,Bioorg. Med. Chem. Lett.,2011,21,10,"Fobian YM, Freskos JN, Barta TE, Bedell LJ, Heintz R, Kassab DJ, Kiefer JR, Mischke BV, Molyneaux JM, Mullins P, Munie GE, Becker DP",,744872,DTCT0024002,5936678,DTCC01080451,831943,44425
CHEMBL1770700,P45452,,MASDJPGVHCTFLM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21493063,IC50,=,1.6,NM,,,,,,,,,,,,,,Inhibition of human MMP13,,MMP-13 selective alpha-sulfone hydroxamates: Identification of selective P1' amides.,Bioorg. Med. Chem. Lett.,2011,21,10,"Fobian YM, Freskos JN, Barta TE, Bedell LJ, Heintz R, Kassab DJ, Kiefer JR, Mischke BV, Molyneaux JM, Mullins P, Munie GE, Becker DP",,744872,DTCT0024002,5936679,DTCC01080452,1058218,44425
CHEMBL1770700,P45452,,MASDJPGVHCTFLM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21507637,KI,=,1.6,NM,,,,,,,,,,,,,,Inhibition of human MMP-13,,MMP-13 selective a-sulfone hydroxamates: A survey of P1' heterocyclic amide isosteres.,Bioorg. Med. Chem. Lett.,2011,21,10,"Barta TE, Becker DP, Bedell LJ, Easton AM, Hockerman SL, Kiefer J, Munie GE, Mathis KJ, Li MH, Rico JG, Villamil CI, Williams JM",,744955,DTCT0024002,5930592,DTCC01080452,1040141,44430
CHEMBL1770701,P45452,,OICBVOJTVMMIHN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21493063,IC50,=,1.6,NM,,,,,,,,,,,,,,Inhibition of human MMP13,,MMP-13 selective alpha-sulfone hydroxamates: Identification of selective P1' amides.,Bioorg. Med. Chem. Lett.,2011,21,10,"Fobian YM, Freskos JN, Barta TE, Bedell LJ, Heintz R, Kassab DJ, Kiefer JR, Mischke BV, Molyneaux JM, Mullins P, Munie GE, Becker DP",,744872,DTCT0024002,5936680,DTCC01080453,314520,44425
CHEMBL1770702,P45452,,JNMYIRAUFFFDQS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21493063,IC50,=,0.66,NM,,,,,,,,,,,,,,Inhibition of human MMP13,,MMP-13 selective alpha-sulfone hydroxamates: Identification of selective P1' amides.,Bioorg. Med. Chem. Lett.,2011,21,10,"Fobian YM, Freskos JN, Barta TE, Bedell LJ, Heintz R, Kassab DJ, Kiefer JR, Mischke BV, Molyneaux JM, Mullins P, Munie GE, Becker DP",,744872,DTCT0024002,5936681,DTCC01080454,1025844,44425
CHEMBL1770703,P45452,,KLRCKSDGEDNMNL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21493063,IC50,=,8,NM,,,,,,,,,,,,,,Inhibition of human MMP13,,MMP-13 selective alpha-sulfone hydroxamates: Identification of selective P1' amides.,Bioorg. Med. Chem. Lett.,2011,21,10,"Fobian YM, Freskos JN, Barta TE, Bedell LJ, Heintz R, Kassab DJ, Kiefer JR, Mischke BV, Molyneaux JM, Mullins P, Munie GE, Becker DP",,744872,DTCT0024002,5936682,DTCC01080455,1186873,44425
CHEMBL1770704,P45452,,UKBSDNIYHDAZDN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21493063,IC50,=,8.2,NM,,,,,,,,,,,,,,Inhibition of human MMP13,,MMP-13 selective alpha-sulfone hydroxamates: Identification of selective P1' amides.,Bioorg. Med. Chem. Lett.,2011,21,10,"Fobian YM, Freskos JN, Barta TE, Bedell LJ, Heintz R, Kassab DJ, Kiefer JR, Mischke BV, Molyneaux JM, Mullins P, Munie GE, Becker DP",,744872,DTCT0024002,5936683,DTCC01080456,767291,44425
CHEMBL1770705,P45452,,NVZOQOOLHGCJGV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21493063,IC50,=,8.2,NM,,,,,,,,,,,,,,Inhibition of human MMP13,,MMP-13 selective alpha-sulfone hydroxamates: Identification of selective P1' amides.,Bioorg. Med. Chem. Lett.,2011,21,10,"Fobian YM, Freskos JN, Barta TE, Bedell LJ, Heintz R, Kassab DJ, Kiefer JR, Mischke BV, Molyneaux JM, Mullins P, Munie GE, Becker DP",,744872,DTCT0024002,5936684,DTCC01080457,638469,44425
CHEMBL1770706,P45452,,SJTWWQWUAQAYAB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21493063,IC50,=,0.9,NM,,,,,,,,,,,,,,Inhibition of human MMP13,,MMP-13 selective alpha-sulfone hydroxamates: Identification of selective P1' amides.,Bioorg. Med. Chem. Lett.,2011,21,10,"Fobian YM, Freskos JN, Barta TE, Bedell LJ, Heintz R, Kassab DJ, Kiefer JR, Mischke BV, Molyneaux JM, Mullins P, Munie GE, Becker DP",,744872,DTCT0024002,5936685,DTCC01080458,87486,44425
CHEMBL1770707,P45452,,CADOQGNFDXDEHI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21493063,IC50,=,0.2,NM,,,,,,,,,,,,,,Inhibition of human MMP13,,MMP-13 selective alpha-sulfone hydroxamates: Identification of selective P1' amides.,Bioorg. Med. Chem. Lett.,2011,21,10,"Fobian YM, Freskos JN, Barta TE, Bedell LJ, Heintz R, Kassab DJ, Kiefer JR, Mischke BV, Molyneaux JM, Mullins P, Munie GE, Becker DP",,744872,DTCT0024002,5936686,DTCC01080459,1829540,44425
CHEMBL1770708,P45452,,WWVWMBFCEZHXFR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21493063,IC50,=,1.7,NM,,,,,,,,,,,,,,Inhibition of human MMP13,,MMP-13 selective alpha-sulfone hydroxamates: Identification of selective P1' amides.,Bioorg. Med. Chem. Lett.,2011,21,10,"Fobian YM, Freskos JN, Barta TE, Bedell LJ, Heintz R, Kassab DJ, Kiefer JR, Mischke BV, Molyneaux JM, Mullins P, Munie GE, Becker DP",,744872,DTCT0024002,5936687,DTCC01080460,1349992,44425
CHEMBL1770709,P45452,,PCOMQZCYLOTKTN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21493063,IC50,=,0.2,NM,,,,,,,,,,,,,,Inhibition of human MMP13,,MMP-13 selective alpha-sulfone hydroxamates: Identification of selective P1' amides.,Bioorg. Med. Chem. Lett.,2011,21,10,"Fobian YM, Freskos JN, Barta TE, Bedell LJ, Heintz R, Kassab DJ, Kiefer JR, Mischke BV, Molyneaux JM, Mullins P, Munie GE, Becker DP",,744872,DTCT0024002,5936689,DTCC01080461,1349993,44425
CHEMBL1770710,P45452,,DZVDZJSJBKHJOK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21493063,IC50,=,1.2,NM,,,,,,,,,,,,,,Inhibition of human MMP13,,MMP-13 selective alpha-sulfone hydroxamates: Identification of selective P1' amides.,Bioorg. Med. Chem. Lett.,2011,21,10,"Fobian YM, Freskos JN, Barta TE, Bedell LJ, Heintz R, Kassab DJ, Kiefer JR, Mischke BV, Molyneaux JM, Mullins P, Munie GE, Becker DP",,744872,DTCT0024002,5936691,DTCC01080462,1446682,44425
CHEMBL1770711,P45452,,WNBNYVCTXXPOJB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21493063,IC50,=,1.8,NM,,,,,,,,,,,,,,Inhibition of human MMP13,,MMP-13 selective alpha-sulfone hydroxamates: Identification of selective P1' amides.,Bioorg. Med. Chem. Lett.,2011,21,10,"Fobian YM, Freskos JN, Barta TE, Bedell LJ, Heintz R, Kassab DJ, Kiefer JR, Mischke BV, Molyneaux JM, Mullins P, Munie GE, Becker DP",,744872,DTCT0024002,5936692,DTCC01080463,1414913,44425
CHEMBL1770712,P45452,,DLMROZSTEBHAOO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21493063,IC50,=,0.9,NM,,,,,,,,,,,,,,Inhibition of human MMP13,,MMP-13 selective alpha-sulfone hydroxamates: Identification of selective P1' amides.,Bioorg. Med. Chem. Lett.,2011,21,10,"Fobian YM, Freskos JN, Barta TE, Bedell LJ, Heintz R, Kassab DJ, Kiefer JR, Mischke BV, Molyneaux JM, Mullins P, Munie GE, Becker DP",,744872,DTCT0024002,5936693,DTCC01080464,1349994,44425
CHEMBL1770826,P45452,,LOTUNSOIIWVNBG-JUJUEEDWSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21458257,KI,=,14100,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"2-(2-Aminothiazol-4-yl)pyrrolidine-based tartrate diamides as potent, selective and orally bioavailable TACE inhibitors.",Bioorg. Med. Chem. Lett.,2011,21,10,"Dai C, Li D, Popovici-Muller J, Zhao L, Girijavallabhan VM, Rosner KE, Lavey BJ, Rizvi R, Shankar BB, Wong MK, Guo Z, Orth P, Strickland CO, Sun J, Niu X, Chen S, Kozlowski JA, Lundell DJ, Piwinski JJ, Shih NY, Siddiqui MA",,744288,DTCT0024002,5930525,DTCC01080561,749314,44403
CHEMBL1771212,P45452,SD-2590,NXUHVWMBPOFLMA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20726512,IC50,<,0.1,NM,,,,,,,,,,,,,,Inhibition of human MMP13 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754464,DTCT0024002,6005788,DTCC00033985,1557982,45214
CHEMBL1771212,P45452,SD-2590,NXUHVWMBPOFLMA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21507637,IC50,<,0.1,NM,,,,,,,,,,,,,,Inhibition of human MMP-13,,MMP-13 selective a-sulfone hydroxamates: A survey of P1' heterocyclic amide isosteres.,Bioorg. Med. Chem. Lett.,2011,21,10,"Barta TE, Becker DP, Bedell LJ, Easton AM, Hockerman SL, Kiefer J, Munie GE, Mathis KJ, Li MH, Rico JG, Villamil CI, Williams JM",,744955,DTCT0024002,5930590,DTCC00033985,1557806,44430
CHEMBL1771213,P45452,,QCRPOQONCVCBFI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21507637,IC50,=,0.7,NM,,,,,,,,,,,,,,Inhibition of human MMP-13,,MMP-13 selective a-sulfone hydroxamates: A survey of P1' heterocyclic amide isosteres.,Bioorg. Med. Chem. Lett.,2011,21,10,"Barta TE, Becker DP, Bedell LJ, Easton AM, Hockerman SL, Kiefer J, Munie GE, Mathis KJ, Li MH, Rico JG, Villamil CI, Williams JM",,744955,DTCT0024002,5930591,DTCC01080938,1040140,44430
CHEMBL1771214,P45452,,UIGGXLFLAQCMAY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21507637,IC50,=,0.2,NM,,,,,,,,,,,,,,Inhibition of human MMP-13,,MMP-13 selective a-sulfone hydroxamates: A survey of P1' heterocyclic amide isosteres.,Bioorg. Med. Chem. Lett.,2011,21,10,"Barta TE, Becker DP, Bedell LJ, Easton AM, Hockerman SL, Kiefer J, Munie GE, Mathis KJ, Li MH, Rico JG, Villamil CI, Williams JM",,744955,DTCT0024002,5930593,DTCC01080939,134084,44430
CHEMBL1771215,P45452,,BNPWNBBKUMLEJM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21507637,KI,=,0.66,NM,,,,,,,,,,,,,,Inhibition of human MMP-13,,MMP-13 selective a-sulfone hydroxamates: A survey of P1' heterocyclic amide isosteres.,Bioorg. Med. Chem. Lett.,2011,21,10,"Barta TE, Becker DP, Bedell LJ, Easton AM, Hockerman SL, Kiefer J, Munie GE, Mathis KJ, Li MH, Rico JG, Villamil CI, Williams JM",,744955,DTCT0024002,5930594,DTCC01080940,361645,44430
CHEMBL1771216,P45452,,MTRATHZFTCSGDT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21507637,KI,=,0.13,NM,,,,,,,,,,,,,,Inhibition of human MMP-13,,MMP-13 selective a-sulfone hydroxamates: A survey of P1' heterocyclic amide isosteres.,Bioorg. Med. Chem. Lett.,2011,21,10,"Barta TE, Becker DP, Bedell LJ, Easton AM, Hockerman SL, Kiefer J, Munie GE, Mathis KJ, Li MH, Rico JG, Villamil CI, Williams JM",,744955,DTCT0024002,5930595,DTCC01080941,1233526,44430
CHEMBL1771217,P45452,,MMCUCOOPEAHRPL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21507637,KI,=,0.66,NM,,,,,,,,,,,,,,Inhibition of human MMP-13,,MMP-13 selective a-sulfone hydroxamates: A survey of P1' heterocyclic amide isosteres.,Bioorg. Med. Chem. Lett.,2011,21,10,"Barta TE, Becker DP, Bedell LJ, Easton AM, Hockerman SL, Kiefer J, Munie GE, Mathis KJ, Li MH, Rico JG, Villamil CI, Williams JM",,744955,DTCT0024002,5930596,DTCC01080942,1040142,44430
CHEMBL1771218,P45452,,LIQFLIXIOKMDTJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21507637,KI,=,0.6,NM,,,,,,,,,,,,,,Inhibition of human MMP-13,,MMP-13 selective a-sulfone hydroxamates: A survey of P1' heterocyclic amide isosteres.,Bioorg. Med. Chem. Lett.,2011,21,10,"Barta TE, Becker DP, Bedell LJ, Easton AM, Hockerman SL, Kiefer J, Munie GE, Mathis KJ, Li MH, Rico JG, Villamil CI, Williams JM",,744955,DTCT0024002,5930597,DTCC01080943,1908020,44430
CHEMBL1771219,P45452,,VCIBNYPUVKINDS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21507637,KI,=,1.5,NM,,,,,,,,,,,,,,Inhibition of human MMP-13,,MMP-13 selective a-sulfone hydroxamates: A survey of P1' heterocyclic amide isosteres.,Bioorg. Med. Chem. Lett.,2011,21,10,"Barta TE, Becker DP, Bedell LJ, Easton AM, Hockerman SL, Kiefer J, Munie GE, Mathis KJ, Li MH, Rico JG, Villamil CI, Williams JM",,744955,DTCT0024002,5930598,DTCC01080944,975250,44430
CHEMBL1771220,P45452,,NVQGQIYFJRAZLX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21507637,KI,=,2,NM,,,,,,,,,,,,,,Inhibition of human MMP-13,,MMP-13 selective a-sulfone hydroxamates: A survey of P1' heterocyclic amide isosteres.,Bioorg. Med. Chem. Lett.,2011,21,10,"Barta TE, Becker DP, Bedell LJ, Easton AM, Hockerman SL, Kiefer J, Munie GE, Mathis KJ, Li MH, Rico JG, Villamil CI, Williams JM",,744955,DTCT0024002,5930599,DTCC01080945,1590129,44430
CHEMBL1771221,P45452,,JRPLACGAMSWTCU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21507637,KI,=,1.7,NM,,,,,,,,,,,,,,Inhibition of human MMP-13,,MMP-13 selective a-sulfone hydroxamates: A survey of P1' heterocyclic amide isosteres.,Bioorg. Med. Chem. Lett.,2011,21,10,"Barta TE, Becker DP, Bedell LJ, Easton AM, Hockerman SL, Kiefer J, Munie GE, Mathis KJ, Li MH, Rico JG, Villamil CI, Williams JM",,744955,DTCT0024002,5930600,DTCC01080946,230822,44430
CHEMBL1771222,P45452,,FVPQYGSYGOKFLW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21507637,KI,=,3.7,NM,,,,,,,,,,,,,,Inhibition of human MMP-13,,MMP-13 selective a-sulfone hydroxamates: A survey of P1' heterocyclic amide isosteres.,Bioorg. Med. Chem. Lett.,2011,21,10,"Barta TE, Becker DP, Bedell LJ, Easton AM, Hockerman SL, Kiefer J, Munie GE, Mathis KJ, Li MH, Rico JG, Villamil CI, Williams JM",,744955,DTCT0024002,5930601,DTCC01080947,1105335,44430
CHEMBL1771223,P45452,,UAFRGDNTZQMZFA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21507637,KI,=,1.2,NM,,,,,,,,,,,,,,Inhibition of human MMP-13,,MMP-13 selective a-sulfone hydroxamates: A survey of P1' heterocyclic amide isosteres.,Bioorg. Med. Chem. Lett.,2011,21,10,"Barta TE, Becker DP, Bedell LJ, Easton AM, Hockerman SL, Kiefer J, Munie GE, Mathis KJ, Li MH, Rico JG, Villamil CI, Williams JM",,744955,DTCT0024002,5930602,DTCC01080948,587727,44430
CHEMBL1779630,P45452,,BXLWVAKSQMYQKF-HRUVVLKGSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20638281,KI,=,3500,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Structure and activity relationships of tartrate-based TACE inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,16,"Li D, Popovici-Muller J, Belanger DB, Caldwell J, Dai C, David M, Girijavallabhan VM, Lavey BJ, Lee JF, Liu Z, Mazzola R, Rizvi R, Rosner KE, Shankar B, Spitler J, Ting PC, Vaccaro H, Yu W, Zhou G, Zhu Z, Niu X, Sun J, Guo Z, Orth P, Chen S, Kozlowski JA, Lundell DJ, Madison V, McKittrick B, Piwinski JJ, Shih NY, Shipps GW, Siddiqui MA, Strickland CO",,748392,DTCT0024002,5959057,DTCC01085211,1875737,44590
CHEMBL178163,P45452,,WKXRIMLOWDOHMN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15686921,KI,=,0.33,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,Structure-based design of potent and selective inhibitors of collagenase-3 (MMP-13).,Bioorg. Med. Chem. Lett.,2005,15,4,"Kim SH, Pudzianowski AT, Leavitt KJ, Barbosa J, McDonnell PA, Metzler WJ, Rankin BM, Liu R, Vaccaro W, Pitts W",,302508,DTCT0024002,1744902,DTCC00381624,130640,18787
CHEMBL178163,P45452,,WKXRIMLOWDOHMN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,KI,=,0.331,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258729,DTCC00381624,131667,24803
CHEMBL1784338,P45452,,FUEVUWZQRYWTIH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21536437,IC50,=,46000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-13 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751102,DTCT0024002,5969327,DTCC01087874,1991668,44768
CHEMBL1784339,P45452,,NYSZVCQWENKRKM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21536437,IC50,=,940,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-13 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751102,DTCT0024002,5969328,DTCC01087875,1219147,44768
CHEMBL1784340,P45452,,ISHINUUQDKDNHQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21536437,IC50,>,31000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-13 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751102,DTCT0024002,5969329,DTCC01087876,314584,44768
CHEMBL1784341,P45452,,DDRRRYMVRWYNKI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21536437,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-13 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751102,DTCT0024002,5970324,DTCC01087877,248843,44768
CHEMBL1784342,P45452,,OGDMRINQXHOSNB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21536437,IC50,=,4600,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-13 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751102,DTCT0024002,5970325,DTCC01087878,1991670,44768
CHEMBL1784343,P45452,,XRFARLVFDBABAU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21536437,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-13 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751102,DTCT0024002,5970326,DTCC01087879,767362,44768
CHEMBL1784344,P45452,,DTSDNCVLJXFMRH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21536437,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-13 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751102,DTCT0024002,5970327,DTCC01087880,1732985,44768
CHEMBL1784345,P45452,,IIJIMCYNCLMHHL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21536437,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-13 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751102,DTCT0024002,5970328,DTCC01087881,184445,44768
CHEMBL1784346,P45452,,OUTUIYKUSHWASL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21536437,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-13 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751102,DTCT0024002,5970329,DTCC01087882,1252217,44768
CHEMBL1784347,P45452,,IWRJDNKXMJBFEA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21536437,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-13 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751102,DTCT0024002,5970330,DTCC01087883,897249,44768
CHEMBL1784348,P45452,,JHWOJEJVRYYQFM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21536437,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-13 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751102,DTCT0024002,5970331,DTCC01087884,541502,44768
CHEMBL1784349,P45452,,CCTJPVSDIZDFJW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21536437,IC50,=,2000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-13 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751102,DTCT0024002,5969323,DTCC01087885,1284804,44768
CHEMBL1784350,P45452,,PSAIRTKPKUWNNP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21536437,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-13 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751102,DTCT0024002,5970332,DTCC01087886,1284805,44768
CHEMBL1784351,P45452,,IHEWXNWFNBGUFE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21536437,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-13 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751102,DTCT0024002,5970333,DTCC01087887,1350068,44768
CHEMBL1784352,P45452,,YIKZSHOVCXXIBY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21536437,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-13 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751102,DTCT0024002,5970334,DTCC01087888,1704803,44768
CHEMBL1784353,P45452,,CAFLLFZUWQCIHM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21536437,IC50,>,4100,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-13 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751102,DTCT0024002,5970335,DTCC01087889,735158,44768
CHEMBL1784354,P45452,,JKTGELXOMXEKJI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21536437,IC50,=,1400,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-13 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751102,DTCT0024002,5970413,DTCC01087890,1058279,44768
CHEMBL1784355,P45452,,OGLLJVIOQHNPQC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21536437,INHIBITION,=,81,%,,,,,,,,,,,,,,Inhibition of recombinant human MMP-13 assessed as substrate cleavage at 15 uM after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751106,DTCT0024002,5970431,DTCC01087891,1284806,44768
CHEMBL1784356,P45452,,HECFJRXDSZZJLW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21536437,IC50,=,570,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-13 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751102,DTCT0024002,5970422,DTCC01087892,443570,44768
CHEMBL1784357,P45452,,XAXGZPUPBCYAIE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21536437,INHIBITION,=,97,%,,,,,,,,,,,,,,Inhibition of recombinant human MMP-13 assessed as substrate cleavage at 15 uM after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751106,DTCT0024002,5970430,DTCC01087893,1575892,44768
CHEMBL1784358,P45452,,VLNVWKDSFQRXHZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21536437,IC50,=,780,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-13 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751102,DTCT0024002,5969316,DTCC01087894,1543800,44768
CHEMBL1784359,P45452,,BZUGNOPIQMYMFU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21536437,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-13 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751102,DTCT0024002,5969317,DTCC01087895,184446,44768
CHEMBL1784360,P45452,,VYEJHVQIVKCLHC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21536437,IC50,=,1700,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-13 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751102,DTCT0024002,5969318,DTCC01087896,509332,44768
CHEMBL1784361,P45452,,STVUCRKRBAWCPC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21536437,IC50,=,5900,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-13 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751102,DTCT0024002,5969319,DTCC01087897,1186951,44768
CHEMBL1784362,P45452,,AWLKOGZBGNQOBA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21536437,IC50,=,260,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-13 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751102,DTCT0024002,5969320,DTCC01087898,1025922,44768
CHEMBL1784363,P45452,,DVWZDEQXQWWQOU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21536437,IC50,>,600,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-13 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751102,DTCT0024002,5969321,DTCC01087899,184447,44768
CHEMBL1784364,P45452,,IBSGSCYXBWXQDW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21536437,IC50,=,1100,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-13 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751102,DTCT0024002,5969322,DTCC01087900,2024514,44768
CHEMBL1784365,P45452,,OFQBKLDPHHFEPJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21536437,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-13 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751102,DTCT0024002,5969324,DTCC01087901,1861581,44768
CHEMBL1784366,P45452,,BTKROMQYNIJXLC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21536437,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-13 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751102,DTCT0024002,5969325,DTCC01087902,1317331,44768
CHEMBL1784367,P45452,,QVHFARCMIMVLSZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21536437,IC50,=,8400,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-13 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751102,DTCT0024002,5969326,DTCC01087903,1446758,44768
CHEMBL1784368,P45452,,MESQXIKYNYUZRV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21536437,IC50,=,154,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-13 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751102,DTCT0024002,5970408,DTCC01087904,928980,44768
CHEMBL178509,P45452,,TVKGACNFKXXAEF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15686921,KI,=,4.7,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,Structure-based design of potent and selective inhibitors of collagenase-3 (MMP-13).,Bioorg. Med. Chem. Lett.,2005,15,4,"Kim SH, Pudzianowski AT, Leavitt KJ, Barbosa J, McDonnell PA, Metzler WJ, Rankin BM, Liu R, Vaccaro W, Pitts W",,302508,DTCT0024002,1744231,DTCC00381771,227480,18787
CHEMBL178509,P45452,,TVKGACNFKXXAEF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,KI,=,4.68,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258723,DTCC00381771,228502,24803
CHEMBL178625,P45452,,NVXCZQCEAPQVLT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15686921,KI,=,110,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,Structure-based design of potent and selective inhibitors of collagenase-3 (MMP-13).,Bioorg. Med. Chem. Lett.,2005,15,4,"Kim SH, Pudzianowski AT, Leavitt KJ, Barbosa J, McDonnell PA, Metzler WJ, Rankin BM, Liu R, Vaccaro W, Pitts W",,302508,DTCT0024002,1744787,DTCC00381719,1969973,18787
CHEMBL178651,P45452,,XVIHAKHSIOBKFG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15686921,KI,=,2200,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,Structure-based design of potent and selective inhibitors of collagenase-3 (MMP-13).,Bioorg. Med. Chem. Lett.,2005,15,4,"Kim SH, Pudzianowski AT, Leavitt KJ, Barbosa J, McDonnell PA, Metzler WJ, Rankin BM, Liu R, Vaccaro W, Pitts W",,302508,DTCT0024002,1744229,DTCC00381748,6888,18787
CHEMBL178652,P45452,,QSXWMSOERGLVDJ-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16002291,IC50,=,2200,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,Structure-based design and synthesis of novel non-zinc chelating MMP-12 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,16,"Dublanchet AC, Ducrot P, Andrianjara C, O'Gara M, Morales R, Compère D, Denis A, Blais S, Cluzeau P, Courté K, Hamon J, Moreau F, Prunet ML, Tertre A",,305159,DTCT0024002,1743219,DTCC00381419,109852,9478
CHEMBL178732,P45452,,ROWNCZWVCCMTQI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15745814,IC50,=,20,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-13 at 1 uM,,Synthesis and SAR of diazepine and thiazepine TACE and MMP inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,6,"Zask A, Kaplan J, Du X, MacEwan G, Sandanayaka V, Eudy N, Levin J, Jin G, Xu J, Cummons T, Barone D, Ayral-Kaloustian S, Skotnicki J",,305328,DTCT0024002,1749397,DTCC00382944,1241982,18895
CHEMBL178732,P45452,,ROWNCZWVCCMTQI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,IC50,=,19.95,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258772,DTCC00382944,1231169,24803
CHEMBL178749,P45452,,DMWFWKLZKONSAG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15686921,KI,=,5.8,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,Structure-based design of potent and selective inhibitors of collagenase-3 (MMP-13).,Bioorg. Med. Chem. Lett.,2005,15,4,"Kim SH, Pudzianowski AT, Leavitt KJ, Barbosa J, McDonnell PA, Metzler WJ, Rankin BM, Liu R, Vaccaro W, Pitts W",,302508,DTCT0024002,1744788,DTCC00381739,616682,18787
CHEMBL1788203,P45452,3-BENZENESULFONYL-HEPTANOIC ACID HYDROXYAMIDE,TUUMURVUDGZZQZ-GFCCVEGCSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10882358,IC50,=,79,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,Hydroxamic acid derivatives as potent peptide deformylase inhibitors and antibacterial agents.,J. Med. Chem.,2000,43,12,"Apfel C, Banner DW, Bur D, Dietz M, Hirata T, Hubschwerlen C, Locher H, Page MG, Pirson W, Rossé G, Specklin JL",,104572,DTCT0024002,559026,DTCC00034233,1338257,15751
CHEMBL178929,P45452,,VAMKUUUJVOOTKN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15745814,IC50,=,31,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-13 at 1 uM,,Synthesis and SAR of diazepine and thiazepine TACE and MMP inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,6,"Zask A, Kaplan J, Du X, MacEwan G, Sandanayaka V, Eudy N, Levin J, Jin G, Xu J, Cummons T, Barone D, Ayral-Kaloustian S, Skotnicki J",,305328,DTCT0024002,1749504,DTCC00382968,1241983,18895
CHEMBL178929,P45452,,VAMKUUUJVOOTKN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,IC50,=,30.9,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258770,DTCC00382968,1231170,24803
CHEMBL179177,P45452,,LYWORXBHRXQZHC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16002291,IC50,>,1200,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,Structure-based design and synthesis of novel non-zinc chelating MMP-12 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,16,"Dublanchet AC, Ducrot P, Andrianjara C, O'Gara M, Morales R, Compère D, Denis A, Blais S, Cluzeau P, Courté K, Hamon J, Moreau F, Prunet ML, Tertre A",,305159,DTCT0024002,1742675,DTCC00381378,466542,9478
CHEMBL179285,P45452,,IZRGHLXXFQNRMD-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16002291,IC50,=,270,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,Structure-based design and synthesis of novel non-zinc chelating MMP-12 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,16,"Dublanchet AC, Ducrot P, Andrianjara C, O'Gara M, Morales R, Compère D, Denis A, Blais S, Cluzeau P, Courté K, Hamon J, Moreau F, Prunet ML, Tertre A",,305159,DTCT0024002,1742164,DTCC00381438,1436893,9478
CHEMBL179288,P45452,,DGZZVIWCMGVHGV-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19775099,IC50,=,4.1,NM,,,,,,,,,,,,,,Inhibition of para-aminophenylmercuric acetate-activated human pro-MMP13 after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591604,DTCT0024002,3044917,DTCC00381940,1071500,35647
CHEMBL179552,P45452,,GBGAKFWYCGVPHY-BEFAXECRSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15911259,IC50,=,3,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-13 (MMP-13),,"Discovery of 3,3-dimethyl-5-hydroxypipecolic hydroxamate-based inhibitors of aggrecanase and MMP-13.",Bioorg. Med. Chem. Lett.,2005,15,11,"Noe MC, Natarajan V, Snow SL, Mitchell PG, Lopresti-Morrow L, Reeves LM, Yocum SA, Carty TJ, Barberia JA, Sweeney FJ, Liras JL, Vaughn M, Hardink JR, Hawkins JM, Tokar C",,304865,DTCT0024002,1812896,DTCC00381529,66278,18491
CHEMBL1796279,P45452,,TXFFTKJHXJZMGV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21669521,IC50,=,25118.86,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 substrate,,Selective non zinc binding inhibitors of MMP13.,Bioorg. Med. Chem. Lett.,2011,21,14,"De Savi C, Morley AD, Ting A, Nash I, Karabelas K, Wood CM, James M, Norris SJ, Karoutchi G, Rankine N, Hamlin G, Macfaul PA, Ryan D, Baker SV, Hargreaves D, Gerhardt S",,754229,DTCT0024002,5996210,DTCC01092113,1219164,45042
CHEMBL1796280,P45452,,XJLATCOVZSRIIF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21669521,IC50,>,398107.17,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 substrate,,Selective non zinc binding inhibitors of MMP13.,Bioorg. Med. Chem. Lett.,2011,21,14,"De Savi C, Morley AD, Ting A, Nash I, Karabelas K, Wood CM, James M, Norris SJ, Karoutchi G, Rankine N, Hamlin G, Macfaul PA, Ryan D, Baker SV, Hargreaves D, Gerhardt S",,754229,DTCT0024002,5996221,DTCC01092114,1764931,45042
CHEMBL1796281,P45452,,GPGZQMJRLDYJCL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21669521,IC50,=,25118.86,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 substrate,,Selective non zinc binding inhibitors of MMP13.,Bioorg. Med. Chem. Lett.,2011,21,14,"De Savi C, Morley AD, Ting A, Nash I, Karabelas K, Wood CM, James M, Norris SJ, Karoutchi G, Rankine N, Hamlin G, Macfaul PA, Ryan D, Baker SV, Hargreaves D, Gerhardt S",,754229,DTCT0024002,5996209,DTCC01092115,347313,45042
CHEMBL1796282,P45452,,AKTILUJYCBOTIS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21669521,IC50,=,50118.72,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 substrate,,Selective non zinc binding inhibitors of MMP13.,Bioorg. Med. Chem. Lett.,2011,21,14,"De Savi C, Morley AD, Ting A, Nash I, Karabelas K, Wood CM, James M, Norris SJ, Karoutchi G, Rankine N, Hamlin G, Macfaul PA, Ryan D, Baker SV, Hargreaves D, Gerhardt S",,754229,DTCT0024002,5996214,DTCC01092116,897267,45042
CHEMBL1796283,P45452,,JHBQYMKKDZQMTH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21669521,IC50,>,398107.17,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 substrate,,Selective non zinc binding inhibitors of MMP13.,Bioorg. Med. Chem. Lett.,2011,21,14,"De Savi C, Morley AD, Ting A, Nash I, Karabelas K, Wood CM, James M, Norris SJ, Karoutchi G, Rankine N, Hamlin G, Macfaul PA, Ryan D, Baker SV, Hargreaves D, Gerhardt S",,754229,DTCT0024002,5996220,DTCC01092117,702914,45042
CHEMBL1796284,P45452,,PGSDUFVZNHBEOJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21669521,IC50,=,50118.72,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 substrate,,Selective non zinc binding inhibitors of MMP13.,Bioorg. Med. Chem. Lett.,2011,21,14,"De Savi C, Morley AD, Ting A, Nash I, Karabelas K, Wood CM, James M, Norris SJ, Karoutchi G, Rankine N, Hamlin G, Macfaul PA, Ryan D, Baker SV, Hargreaves D, Gerhardt S",,754229,DTCT0024002,5996213,DTCC01092118,1829634,45042
CHEMBL1796285,P45452,,YXUNJHYIDPCDAK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21669521,IC50,=,31622.78,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 substrate,,Selective non zinc binding inhibitors of MMP13.,Bioorg. Med. Chem. Lett.,2011,21,14,"De Savi C, Morley AD, Ting A, Nash I, Karabelas K, Wood CM, James M, Norris SJ, Karoutchi G, Rankine N, Hamlin G, Macfaul PA, Ryan D, Baker SV, Hargreaves D, Gerhardt S",,754229,DTCT0024002,5996211,DTCC01092119,87561,45042
CHEMBL1796286,P45452,,IJNJIIUAAAJNQQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21669521,IC50,>,398107.17,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 substrate,,Selective non zinc binding inhibitors of MMP13.,Bioorg. Med. Chem. Lett.,2011,21,14,"De Savi C, Morley AD, Ting A, Nash I, Karabelas K, Wood CM, James M, Norris SJ, Karoutchi G, Rankine N, Hamlin G, Macfaul PA, Ryan D, Baker SV, Hargreaves D, Gerhardt S",,754229,DTCT0024002,5996219,DTCC01092120,1733006,45042
CHEMBL1796287,P45452,,YHLDIJWGGHAGJK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21669521,IC50,=,25118.86,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 substrate,,Selective non zinc binding inhibitors of MMP13.,Bioorg. Med. Chem. Lett.,2011,21,14,"De Savi C, Morley AD, Ting A, Nash I, Karabelas K, Wood CM, James M, Norris SJ, Karoutchi G, Rankine N, Hamlin G, Macfaul PA, Ryan D, Baker SV, Hargreaves D, Gerhardt S",,754229,DTCT0024002,5996208,DTCC01092121,443597,45042
CHEMBL1796288,P45452,,PLTMSQOTVPPEEH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21669521,IC50,>,1000000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 substrate,,Selective non zinc binding inhibitors of MMP13.,Bioorg. Med. Chem. Lett.,2011,21,14,"De Savi C, Morley AD, Ting A, Nash I, Karabelas K, Wood CM, James M, Norris SJ, Karoutchi G, Rankine N, Hamlin G, Macfaul PA, Ryan D, Baker SV, Hargreaves D, Gerhardt S",,754229,DTCT0024002,5996222,DTCC01092122,1382664,45042
CHEMBL1796289,P45452,,JBXPVMOIWQIHRH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21669521,IC50,=,39810.72,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 substrate,,Selective non zinc binding inhibitors of MMP13.,Bioorg. Med. Chem. Lett.,2011,21,14,"De Savi C, Morley AD, Ting A, Nash I, Karabelas K, Wood CM, James M, Norris SJ, Karoutchi G, Rankine N, Hamlin G, Macfaul PA, Ryan D, Baker SV, Hargreaves D, Gerhardt S",,754229,DTCT0024002,5996212,DTCC01092123,1511762,45042
CHEMBL1796290,P45452,,KVCYVMNMWHRDFJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21669521,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 substrate,,Selective non zinc binding inhibitors of MMP13.,Bioorg. Med. Chem. Lett.,2011,21,14,"De Savi C, Morley AD, Ting A, Nash I, Karabelas K, Wood CM, James M, Norris SJ, Karoutchi G, Rankine N, Hamlin G, Macfaul PA, Ryan D, Baker SV, Hargreaves D, Gerhardt S",,754229,DTCT0024002,5996215,DTCC01092124,1673080,45042
CHEMBL1796291,P45452,,VMLFXCWYXVKOOC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21669521,IC50,=,19952.62,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 substrate,,Selective non zinc binding inhibitors of MMP13.,Bioorg. Med. Chem. Lett.,2011,21,14,"De Savi C, Morley AD, Ting A, Nash I, Karabelas K, Wood CM, James M, Norris SJ, Karoutchi G, Rankine N, Hamlin G, Macfaul PA, Ryan D, Baker SV, Hargreaves D, Gerhardt S",,754229,DTCT0024002,5996206,DTCC01092125,184469,45042
CHEMBL1796292,P45452,,NUZSDRZTHGSDTA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21669521,IC50,>,398107.17,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 substrate,,Selective non zinc binding inhibitors of MMP13.,Bioorg. Med. Chem. Lett.,2011,21,14,"De Savi C, Morley AD, Ting A, Nash I, Karabelas K, Wood CM, James M, Norris SJ, Karoutchi G, Rankine N, Hamlin G, Macfaul PA, Ryan D, Baker SV, Hargreaves D, Gerhardt S",,754229,DTCT0024002,5996218,DTCC01092126,412911,45042
CHEMBL1796293,P45452,,SPHCZZBTYLIKMU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21669521,IC50,>,398107.17,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 substrate,,Selective non zinc binding inhibitors of MMP13.,Bioorg. Med. Chem. Lett.,2011,21,14,"De Savi C, Morley AD, Ting A, Nash I, Karabelas K, Wood CM, James M, Norris SJ, Karoutchi G, Rankine N, Hamlin G, Macfaul PA, Ryan D, Baker SV, Hargreaves D, Gerhardt S",,754229,DTCT0024002,5996217,DTCC01092127,573575,45042
CHEMBL1796294,P45452,,XTVLVDRHAKESLV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21669521,IC50,=,5011.87,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 substrate,,Selective non zinc binding inhibitors of MMP13.,Bioorg. Med. Chem. Lett.,2011,21,14,"De Savi C, Morley AD, Ting A, Nash I, Karabelas K, Wood CM, James M, Norris SJ, Karoutchi G, Rankine N, Hamlin G, Macfaul PA, Ryan D, Baker SV, Hargreaves D, Gerhardt S",,754229,DTCT0024002,5996204,DTCC01092128,961358,45042
CHEMBL1796295,P45452,,LBPOXRSIRBVFGX-DAFODLJHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21669521,IC50,=,63.1,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 substrate,,Selective non zinc binding inhibitors of MMP13.,Bioorg. Med. Chem. Lett.,2011,21,14,"De Savi C, Morley AD, Ting A, Nash I, Karabelas K, Wood CM, James M, Norris SJ, Karoutchi G, Rankine N, Hamlin G, Macfaul PA, Ryan D, Baker SV, Hargreaves D, Gerhardt S",,754229,DTCT0024002,5996194,DTCC01092129,1382665,45042
CHEMBL1796296,P45452,,FEOIBPWKGPFSTB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21669521,IC50,=,125.89,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 substrate,,Selective non zinc binding inhibitors of MMP13.,Bioorg. Med. Chem. Lett.,2011,21,14,"De Savi C, Morley AD, Ting A, Nash I, Karabelas K, Wood CM, James M, Norris SJ, Karoutchi G, Rankine N, Hamlin G, Macfaul PA, Ryan D, Baker SV, Hargreaves D, Gerhardt S",,754229,DTCT0024002,5996197,DTCC01092130,929001,45042
CHEMBL1796297,P45452,,FEOIBPWKGPFSTB-MUUNZHRXSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21669521,IC50,=,316.23,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 substrate,,Selective non zinc binding inhibitors of MMP13.,Bioorg. Med. Chem. Lett.,2011,21,14,"De Savi C, Morley AD, Ting A, Nash I, Karabelas K, Wood CM, James M, Norris SJ, Karoutchi G, Rankine N, Hamlin G, Macfaul PA, Ryan D, Baker SV, Hargreaves D, Gerhardt S",,754229,DTCT0024002,5996199,DTCC01092131,864928,45042
CHEMBL1796298,P45452,,YNSKBMXZDCLQIV-MHZLTWQESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21669521,IC50,=,100,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 substrate,,Selective non zinc binding inhibitors of MMP13.,Bioorg. Med. Chem. Lett.,2011,21,14,"De Savi C, Morley AD, Ting A, Nash I, Karabelas K, Wood CM, James M, Norris SJ, Karoutchi G, Rankine N, Hamlin G, Macfaul PA, Ryan D, Baker SV, Hargreaves D, Gerhardt S",,754229,DTCT0024002,5996196,DTCC01092132,1925915,45042
CHEMBL1796298,P45452,,YNSKBMXZDCLQIV-MHZLTWQESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22153941,IC50,=,100,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798828,DTCT0024002,7601163,DTCC01092132,1927204,47049
CHEMBL1796299,P45452,,YNSKBMXZDCLQIV-HHHXNRCGSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21669521,IC50,=,398.11,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 substrate,,Selective non zinc binding inhibitors of MMP13.,Bioorg. Med. Chem. Lett.,2011,21,14,"De Savi C, Morley AD, Ting A, Nash I, Karabelas K, Wood CM, James M, Norris SJ, Karoutchi G, Rankine N, Hamlin G, Macfaul PA, Ryan D, Baker SV, Hargreaves D, Gerhardt S",,754229,DTCT0024002,5996200,DTCC01092133,1640799,45042
CHEMBL1796300,P45452,,YROZMGJALTWTLQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21669521,IC50,=,2511.89,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 substrate,,Selective non zinc binding inhibitors of MMP13.,Bioorg. Med. Chem. Lett.,2011,21,14,"De Savi C, Morley AD, Ting A, Nash I, Karabelas K, Wood CM, James M, Norris SJ, Karoutchi G, Rankine N, Hamlin G, Macfaul PA, Ryan D, Baker SV, Hargreaves D, Gerhardt S",,754229,DTCT0024002,5996202,DTCC01092134,1704820,45042
CHEMBL1796301,P45452,,UENRBBCWNNBMTO-UKTHLTGXSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21669521,IC50,=,251.19,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 substrate,,Selective non zinc binding inhibitors of MMP13.,Bioorg. Med. Chem. Lett.,2011,21,14,"De Savi C, Morley AD, Ting A, Nash I, Karabelas K, Wood CM, James M, Norris SJ, Karoutchi G, Rankine N, Hamlin G, Macfaul PA, Ryan D, Baker SV, Hargreaves D, Gerhardt S",,754229,DTCT0024002,5996198,DTCC01092135,314600,45042
CHEMBL1796302,P45452,,DRQQFCRAPMKEIO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21669521,IC50,=,3162.28,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 substrate,,Selective non zinc binding inhibitors of MMP13.,Bioorg. Med. Chem. Lett.,2011,21,14,"De Savi C, Morley AD, Ting A, Nash I, Karabelas K, Wood CM, James M, Norris SJ, Karoutchi G, Rankine N, Hamlin G, Macfaul PA, Ryan D, Baker SV, Hargreaves D, Gerhardt S",,754229,DTCT0024002,5996203,DTCC01092136,702915,45042
CHEMBL1796303,P45452,,BOXFLOBECAYEME-DAFODLJHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21669521,IC50,=,501.19,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 substrate,,Selective non zinc binding inhibitors of MMP13.,Bioorg. Med. Chem. Lett.,2011,21,14,"De Savi C, Morley AD, Ting A, Nash I, Karabelas K, Wood CM, James M, Norris SJ, Karoutchi G, Rankine N, Hamlin G, Macfaul PA, Ryan D, Baker SV, Hargreaves D, Gerhardt S",,754229,DTCT0024002,5996201,DTCC01092137,897268,45042
CHEMBL179984,P45452,,RDCLFTKMELYUEI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15780611,IC50,=,190,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 13,,Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.,Bioorg. Med. Chem. Lett.,2005,15,7,"Blagg JA, Noe MC, Wolf-Gouveia LA, Reiter LA, Laird ER, Chang SP, Danley DE, Downs JT, Elliott NC, Eskra JD, Griffiths RJ, Hardink JR, Haugeto AI, Jones CS, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robinson RP, Subramanyam C, Vaughn-Bowser ML, Yocum SA",,305127,DTCT0024002,1753718,DTCC00384592,1307385,18917
CHEMBL1800089,P45452,,VMWGPLRCSWOQJR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20726512,IC50,=,0.35,NM,,,,,,,,,,,,,,Inhibition of human MMP13 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754464,DTCT0024002,6005793,DTCC01095116,1622971,45214
CHEMBL180047,P45452,,KEEWWGMUNANVLU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15745814,IC50,=,311,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-13 at 1 uM,,Synthesis and SAR of diazepine and thiazepine TACE and MMP inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,6,"Zask A, Kaplan J, Du X, MacEwan G, Sandanayaka V, Eudy N, Levin J, Jin G, Xu J, Cummons T, Barone D, Ayral-Kaloustian S, Skotnicki J",,305328,DTCT0024002,1749386,DTCC00383020,1981639,18895
CHEMBL1801044,P45452,,XQXSQQVRMVVPJW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20726512,IC50,=,0.1,NM,,,,,,,,,,,,,,Inhibition of human MMP13 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754464,DTCT0024002,6005823,DTCC01094745,1557976,45214
CHEMBL1801045,P45452,,KOPIIXVBCHXDHO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20726512,IC50,=,0.45,NM,,,,,,,,,,,,,,Inhibition of human MMP13 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754464,DTCT0024002,6005822,DTCC01094746,1747121,45214
CHEMBL1801046,P45452,,HBYRXCFAHCMHAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16220987,KI,=,0.15,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024002,14743565,DTCC01094747,2108425,69259
CHEMBL1801046,P45452,,HBYRXCFAHCMHAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20726512,IC50,=,0.15,NM,,,,,,,,,,,,,,Inhibition of human MMP13 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754464,DTCT0024002,6005821,DTCC01094747,1364426,45214
CHEMBL1801047,P45452,,RDFQXFRQTOWZEQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20726512,IC50,=,0.8,NM,,,,,,,,,,,,,,Inhibition of human MMP13 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754464,DTCT0024002,6005820,DTCC01094748,1525962,45214
CHEMBL1801048,P45452,,PKAAOTCIUWGSDS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20726512,IC50,=,0.3,NM,,,,,,,,,,,,,,Inhibition of human MMP13 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754464,DTCT0024002,6005819,DTCC01094749,1590328,45214
CHEMBL1801049,P45452,,NUTUARVYQWFZAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20726512,IC50,=,0.1,NM,,,,,,,,,,,,,,Inhibition of human MMP13 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754464,DTCT0024002,6005818,DTCC01094750,1429088,45214
CHEMBL1801050,P45452,,SPEYRVQKGFNUCY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20726512,IC50,=,0.25,NM,,,,,,,,,,,,,,Inhibition of human MMP13 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754464,DTCT0024002,6005817,DTCC01094751,2070708,45214
CHEMBL1801051,P45452,,VFDSDRZNXLFCFF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20726512,IC50,=,0.8,NM,,,,,,,,,,,,,,Inhibition of human MMP13 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754464,DTCT0024002,6005816,DTCC01094752,1811467,45214
CHEMBL1801052,P45452,,QLTNWLFWQKKDEO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20726512,IC50,<,0.1,NM,,,,,,,,,,,,,,Inhibition of human MMP13 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754464,DTCT0024002,6005814,DTCC01094753,1105534,45214
CHEMBL1801053,P45452,,UZMULMICABXSNQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20726512,IC50,<,0.1,NM,,,,,,,,,,,,,,Inhibition of human MMP13 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754464,DTCT0024002,6005813,DTCC01094754,1779150,45214
CHEMBL1801054,P45452,,PGEMRSCSFPLCBF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20726512,IC50,=,0.25,NM,,,,,,,,,,,,,,Inhibition of human MMP13 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754464,DTCT0024002,6005812,DTCC01094755,1940371,45214
CHEMBL1801055,P45452,,BIHFHTLMZBLJAX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20726512,IC50,=,1,NM,,,,,,,,,,,,,,Inhibition of human MMP13 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754464,DTCT0024002,6005811,DTCC01094756,1525963,45214
CHEMBL1801056,P45452,,GXZSIAVJNPWNMR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20726512,IC50,=,0.4,NM,,,,,,,,,,,,,,Inhibition of human MMP13 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754464,DTCT0024002,6005810,DTCC01094757,1811468,45214
CHEMBL1801057,P45452,,QJNGNVJSSUXWBO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20726512,IC50,=,0.3,NM,,,,,,,,,,,,,,Inhibition of human MMP13 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754464,DTCT0024002,6005809,DTCC01094758,1687244,45214
CHEMBL180130,P45452,,UNINFAIJOLFFHN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15745814,IC50,=,21,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-13 at 1 uM,,Synthesis and SAR of diazepine and thiazepine TACE and MMP inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,6,"Zask A, Kaplan J, Du X, MacEwan G, Sandanayaka V, Eudy N, Levin J, Jin G, Xu J, Cummons T, Barone D, Ayral-Kaloustian S, Skotnicki J",,305328,DTCT0024002,1749947,DTCC00383021,1469284,18895
CHEMBL180130,P45452,,UNINFAIJOLFFHN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,IC50,=,20.89,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258766,DTCC00383021,1458612,24803
CHEMBL1801393,P45452,,JATUSZYMCBLDQS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20726512,IC50,=,0.2,NM,,,,,,,,,,,,,,Inhibition of human MMP13 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754464,DTCT0024002,6005785,DTCC01095085,1622970,45214
CHEMBL1801394,P45452,,OTKHAYOLIGHFRB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20726512,IC50,<,0.1,NM,,,,,,,,,,,,,,Inhibition of human MMP13 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754464,DTCT0024002,6005784,DTCC01095086,1557980,45214
CHEMBL1801395,P45452,,OMFMQXSBXJDRCB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20726512,IC50,<,0.1,NM,,,,,,,,,,,,,,Inhibition of human MMP13 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754464,DTCT0024002,6005783,DTCC01095087,749526,45214
CHEMBL1801396,P45452,,QDGVTWBFTFHWOG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20726512,IC50,=,0.2,NM,,,,,,,,,,,,,,Inhibition of human MMP13 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754464,DTCT0024002,6005782,DTCC01095088,1072789,45214
CHEMBL1801397,P45452,,WVUXCTUJEGJKKV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20726512,IC50,=,0.2,NM,,,,,,,,,,,,,,Inhibition of human MMP13 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754464,DTCT0024002,6005781,DTCC01095089,1299069,45214
CHEMBL1801398,P45452,,QURZZKPWFKUXBF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20726512,IC50,=,0.6,NM,,,,,,,,,,,,,,Inhibition of human MMP13 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754464,DTCT0024002,6005780,DTCC01095090,555801,45214
CHEMBL1801399,P45452,,HYIVZTPHVNIXFU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20726512,IC50,<,0.1,NM,,,,,,,,,,,,,,Inhibition of human MMP13 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754464,DTCT0024002,6005779,DTCC01095091,1266628,45214
CHEMBL1801412,P45452,,ASZIRMQBBYBMMU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20726512,IC50,=,0.25,NM,,,,,,,,,,,,,,Inhibition of human MMP13 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754464,DTCT0024002,6005808,DTCC01095102,523654,45214
CHEMBL1801413,P45452,,SIEIWCDBNIGNIG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20726512,IC50,=,0.25,NM,,,,,,,,,,,,,,Inhibition of human MMP13 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754464,DTCT0024002,6005807,DTCC01095103,846766,45214
CHEMBL1801414,P45452,,YPRABBTWBDZWGP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20726512,IC50,=,0.2,NM,,,,,,,,,,,,,,Inhibition of human MMP13 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754464,DTCT0024002,6005806,DTCC01095104,587925,45214
CHEMBL1801415,P45452,,SXSIQUOYBXOPSS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20726512,IC50,=,2.7,NM,,,,,,,,,,,,,,Inhibition of human MMP13 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754464,DTCT0024002,6005804,DTCC01095105,1396864,45214
CHEMBL1801416,P45452,,PFIVDCYVKKFLEU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20726512,IC50,=,0.5,NM,,,,,,,,,,,,,,Inhibition of human MMP13 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754464,DTCT0024002,6005803,DTCC01095106,394582,45214
CHEMBL1801417,P45452,,SFEPJGMZSMIONR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20726512,IC50,=,0.1,NM,,,,,,,,,,,,,,Inhibition of human MMP13 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754464,DTCT0024002,6005802,DTCC01095107,263382,45214
CHEMBL1801418,P45452,,JNCKLKQBIMZPBF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20726512,IC50,=,2.9,NM,,,,,,,,,,,,,,Inhibition of human MMP13 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754464,DTCT0024002,6005801,DTCC01095108,1525968,45214
CHEMBL1801419,P45452,,SYYRIPAKWJBIOW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20726512,IC50,=,1.9,NM,,,,,,,,,,,,,,Inhibition of human MMP13 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754464,DTCT0024002,6005800,DTCC01095109,1072790,45214
CHEMBL1801420,P45452,,LMIHEFSBOIGKDH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20726512,IC50,=,0.6,NM,,,,,,,,,,,,,,Inhibition of human MMP13 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754464,DTCT0024002,6005799,DTCC01095110,879231,45214
CHEMBL1801421,P45452,,BDONYXHHXNTUSW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20726512,IC50,=,0.2,NM,,,,,,,,,,,,,,Inhibition of human MMP13 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754464,DTCT0024002,6005798,DTCC01095111,1557981,45214
CHEMBL1801422,P45452,,ZHIRJJYNGRGHQQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20726512,IC50,=,0.3,NM,,,,,,,,,,,,,,Inhibition of human MMP13 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754464,DTCT0024002,6005797,DTCC01095112,1718593,45214
CHEMBL1801423,P45452,,XFBRPTYLOIFAQR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20726512,IC50,=,0.5,NM,,,,,,,,,,,,,,Inhibition of human MMP13 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754464,DTCT0024002,6005796,DTCC01095113,1429093,45214
CHEMBL1801424,P45452,,AOPZFYOXZYZEAC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20726512,IC50,=,0.2,NM,,,,,,,,,,,,,,Inhibition of human MMP13 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754464,DTCT0024002,6005795,DTCC01095114,101933,45214
CHEMBL1801425,P45452,,DZCGIZPIPKWUIX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20726512,IC50,=,1.2,NM,,,,,,,,,,,,,,Inhibition of human MMP13 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754464,DTCT0024002,6005794,DTCC01095115,1779153,45214
CHEMBL1801426,P45452,,LTCNKRUYOJZZJO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20726512,IC50,=,5.5,NM,,,,,,,,,,,,,,Inhibition of human MMP13 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754464,DTCT0024002,6005792,DTCC01095117,1843781,45214
CHEMBL1801427,P45452,,JKRVXAWKSWVVCV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20726512,IC50,=,0.6,NM,,,,,,,,,,,,,,Inhibition of human MMP13 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754464,DTCT0024002,6005791,DTCC01095118,1169008,45214
CHEMBL1801428,P45452,,ORSWNUGKUNQTLF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20726512,IC50,=,0.2,NM,,,,,,,,,,,,,,Inhibition of human MMP13 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754464,DTCT0024002,6005790,DTCC01095119,1687248,45214
CHEMBL1801429,P45452,,LCYYUMHWMVOGPC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20726512,IC50,=,0.1,NM,,,,,,,,,,,,,,Inhibition of human MMP13 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754464,DTCT0024002,6005789,DTCC01095120,717206,45214
CHEMBL1801430,P45452,SC-77964,NBRBWZJMBITNBC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20726512,IC50,=,0.1,NM,,,,,,,,,,,,,,Inhibition of human MMP13 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754464,DTCT0024002,6005787,DTCC00034383,620315,45214
CHEMBL1801431,P45452,,IXVDOEAUVAJHER-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20726512,IC50,<,0.1,NM,,,,,,,,,,,,,,Inhibition of human MMP13 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754464,DTCT0024002,6005786,DTCC01095121,263383,45214
CHEMBL180181,P45452,,KRUUUOUZTDKUCF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15745814,IC50,=,11,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-13 at 1 uM,,Synthesis and SAR of diazepine and thiazepine TACE and MMP inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,6,"Zask A, Kaplan J, Du X, MacEwan G, Sandanayaka V, Eudy N, Levin J, Jin G, Xu J, Cummons T, Barone D, Ayral-Kaloustian S, Skotnicki J",,305328,DTCT0024002,1750062,DTCC00382930,238992,18895
CHEMBL180197,P45452,,YNTZVOSILJPSFZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15745814,IC50,=,88,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-13 at 1 uM,,Synthesis and SAR of diazepine and thiazepine TACE and MMP inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,6,"Zask A, Kaplan J, Du X, MacEwan G, Sandanayaka V, Eudy N, Levin J, Jin G, Xu J, Cummons T, Barone D, Ayral-Kaloustian S, Skotnicki J",,305328,DTCT0024002,1748951,DTCC00382951,271720,18895
CHEMBL180245,P45452,,DKBDATWDEJHFQS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15745814,IC50,=,363,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-13 at 1 uM,,Synthesis and SAR of diazepine and thiazepine TACE and MMP inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,6,"Zask A, Kaplan J, Du X, MacEwan G, Sandanayaka V, Eudy N, Levin J, Jin G, Xu J, Cummons T, Barone D, Ayral-Kaloustian S, Skotnicki J",,305328,DTCT0024002,1748308,DTCC00382912,1533997,18895
CHEMBL180275,P45452,,JGGFVHVZVBWBKF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15686921,KI,=,2.7,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,Structure-based design of potent and selective inhibitors of collagenase-3 (MMP-13).,Bioorg. Med. Chem. Lett.,2005,15,4,"Kim SH, Pudzianowski AT, Leavitt KJ, Barbosa J, McDonnell PA, Metzler WJ, Rankin BM, Liu R, Vaccaro W, Pitts W",,302508,DTCT0024002,1744796,DTCC00381599,1360845,18787
CHEMBL180275,P45452,,JGGFVHVZVBWBKF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,KI,=,2.69,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258730,DTCC00381599,1361905,24803
CHEMBL180333,P45452,,BLVHWPCGFOTRGU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15745814,IC50,=,52,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-13 at 1 uM,,Synthesis and SAR of diazepine and thiazepine TACE and MMP inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,6,"Zask A, Kaplan J, Du X, MacEwan G, Sandanayaka V, Eudy N, Levin J, Jin G, Xu J, Cummons T, Barone D, Ayral-Kaloustian S, Skotnicki J",,305328,DTCT0024002,1748960,DTCC00382974,854832,18895
CHEMBL180410,P45452,,MCUUTMPQGFSADF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15745814,IC50,=,1063,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-13 at 1 uM,,Synthesis and SAR of diazepine and thiazepine TACE and MMP inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,6,"Zask A, Kaplan J, Du X, MacEwan G, Sandanayaka V, Eudy N, Levin J, Jin G, Xu J, Cummons T, Barone D, Ayral-Kaloustian S, Skotnicki J",,305328,DTCT0024002,1748835,DTCC00382977,1851780,18895
CHEMBL180484,P45452,,SMRKDKVRUIEVHG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15745814,IC50,=,65,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-13 at 1 uM,,Synthesis and SAR of diazepine and thiazepine TACE and MMP inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,6,"Zask A, Kaplan J, Du X, MacEwan G, Sandanayaka V, Eudy N, Levin J, Jin G, Xu J, Cummons T, Barone D, Ayral-Kaloustian S, Skotnicki J",,305328,DTCT0024002,1748414,DTCC00382934,1080990,18895
CHEMBL180616,P45452,,FKICHBNUXJBKPB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15686921,KI,=,0.95,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,Structure-based design of potent and selective inhibitors of collagenase-3 (MMP-13).,Bioorg. Med. Chem. Lett.,2005,15,4,"Kim SH, Pudzianowski AT, Leavitt KJ, Barbosa J, McDonnell PA, Metzler WJ, Rankin BM, Liu R, Vaccaro W, Pitts W",,302508,DTCT0024002,1744360,DTCC00381808,713599,18787
CHEMBL180616,P45452,,FKICHBNUXJBKPB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,KI,=,0.955,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258732,DTCC00381808,714627,24803
CHEMBL180616,P45452,,FKICHBNUXJBKPB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18083558,KI,=,1,NM,,,,,,,,,,,,,,Inhibition of MMP13,,beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 2. Optimization of alpha-amino substituents.,Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Huang Z, Karnachi P, Wilson LJ, Rhodes KJ, Lagu B, Murray WV",,461909,DTCT0024002,2278528,DTCC00381808,730979,25112
CHEMBL180627,P45452,,PBCSMBZCRUWUMR-FNORWQNLSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15745814,IC50,=,307,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-13 at 1 uM,,Synthesis and SAR of diazepine and thiazepine TACE and MMP inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,6,"Zask A, Kaplan J, Du X, MacEwan G, Sandanayaka V, Eudy N, Levin J, Jin G, Xu J, Cummons T, Barone D, Ayral-Kaloustian S, Skotnicki J",,305328,DTCT0024002,1750073,DTCC00382891,466563,18895
CHEMBL180762,P45452,,ZRYWWVOWAKCPRO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16002291,IC50,=,2500,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,Structure-based design and synthesis of novel non-zinc chelating MMP-12 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,16,"Dublanchet AC, Ducrot P, Andrianjara C, O'Gara M, Morales R, Compère D, Denis A, Blais S, Cluzeau P, Courté K, Hamon J, Moreau F, Prunet ML, Tertre A",,305159,DTCT0024002,1742815,DTCC00381335,142261,9478
CHEMBL180891,P45452,,VMMAOHBHWSKMLW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15745814,IC50,=,305,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-13 at 1 uM,,Synthesis and SAR of diazepine and thiazepine TACE and MMP inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,6,"Zask A, Kaplan J, Du X, MacEwan G, Sandanayaka V, Eudy N, Levin J, Jin G, Xu J, Cummons T, Barone D, Ayral-Kaloustian S, Skotnicki J",,305328,DTCT0024002,1748424,DTCC00382947,1662992,18895
CHEMBL180900,P45452,,LZYKHUZBVFGWCA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15780611,IC50,=,3.8,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 13,,Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.,Bioorg. Med. Chem. Lett.,2005,15,7,"Blagg JA, Noe MC, Wolf-Gouveia LA, Reiter LA, Laird ER, Chang SP, Danley DE, Downs JT, Elliott NC, Eskra JD, Griffiths RJ, Hardink JR, Haugeto AI, Jones CS, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robinson RP, Subramanyam C, Vaughn-Bowser ML, Yocum SA",,305127,DTCT0024002,1752536,DTCC00384556,1436929,18917
CHEMBL180925,P45452,,YQOQYXIGUJZYGD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15780611,IC50,=,390,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 13,,Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.,Bioorg. Med. Chem. Lett.,2005,15,7,"Blagg JA, Noe MC, Wolf-Gouveia LA, Reiter LA, Laird ER, Chang SP, Danley DE, Downs JT, Elliott NC, Eskra JD, Griffiths RJ, Hardink JR, Haugeto AI, Jones CS, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robinson RP, Subramanyam C, Vaughn-Bowser ML, Yocum SA",,305127,DTCT0024002,1752660,DTCC00384477,1274723,18917
CHEMBL181022,P45452,,QFZKHPPJLAADLC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15686921,KI,=,934,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,Structure-based design of potent and selective inhibitors of collagenase-3 (MMP-13).,Bioorg. Med. Chem. Lett.,2005,15,4,"Kim SH, Pudzianowski AT, Leavitt KJ, Barbosa J, McDonnell PA, Metzler WJ, Rankin BM, Liu R, Vaccaro W, Pitts W",,302508,DTCT0024002,1744348,DTCC00381789,1102029,18787
CHEMBL181094,P45452,,MCYLJYADJGYSSU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15745814,IC50,=,180,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-13 at 1 uM,,Synthesis and SAR of diazepine and thiazepine TACE and MMP inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,6,"Zask A, Kaplan J, Du X, MacEwan G, Sandanayaka V, Eudy N, Levin J, Jin G, Xu J, Cummons T, Barone D, Ayral-Kaloustian S, Skotnicki J",,305328,DTCT0024002,1748956,DTCC00382973,1048413,18895
CHEMBL181110,P45452,,OTDAXJIWZBAIMD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15745814,IC50,=,395,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-13 at 1 uM,,Synthesis and SAR of diazepine and thiazepine TACE and MMP inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,6,"Zask A, Kaplan J, Du X, MacEwan G, Sandanayaka V, Eudy N, Levin J, Jin G, Xu J, Cummons T, Barone D, Ayral-Kaloustian S, Skotnicki J",,305328,DTCT0024002,1748839,DTCC00383000,1113597,18895
CHEMBL181208,P45452,,KJFHTZIVTSKATM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15745814,IC50,=,17,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-13 at 1 uM,,Synthesis and SAR of diazepine and thiazepine TACE and MMP inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,6,"Zask A, Kaplan J, Du X, MacEwan G, Sandanayaka V, Eudy N, Levin J, Jin G, Xu J, Cummons T, Barone D, Ayral-Kaloustian S, Skotnicki J",,305328,DTCT0024002,1749953,DTCC00383022,918841,18895
CHEMBL181208,P45452,,KJFHTZIVTSKATM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,IC50,=,16.98,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258765,DTCC00383022,909287,24803
CHEMBL181244,P45452,,PHGLPDURIUEELR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19606871,IC50,=,25,NM,,,,,,,,,,,,,,Inhibition of MMP13-mediated collagen degradation by SDS-PAGE,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571091,DTCT0024002,2859529,DTCC00381891,1588877,34421
CHEMBL181244,P45452,,PHGLPDURIUEELR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19606871,IC50,=,45,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571086,DTCT0024002,2859489,DTCC00381891,1588877,34421
CHEMBL181244,P45452,,PHGLPDURIUEELR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19606871,KI,=,20,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571086,DTCT0024002,2859546,DTCC00381891,1588877,34421
CHEMBL181244,P45452,,PHGLPDURIUEELR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23287054,IC50,,,,,,,,,,,,,,,,,Inhibition of MMP13 (unknown origin),Not Determined,Sulphonamides: Deserving class as MMP inhibitors?,Eur. J. Med. Chem.,2013,60,,"Jain P, Saravanan C, Singh SK",,944584,DTCT0024002,11835694,DTCC00381891,1612259,53820
CHEMBL181317,P45452,,RXYVRCSDLULANF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15745814,IC50,=,128,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-13 at 1 uM,,Synthesis and SAR of diazepine and thiazepine TACE and MMP inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,6,"Zask A, Kaplan J, Du X, MacEwan G, Sandanayaka V, Eudy N, Levin J, Jin G, Xu J, Cummons T, Barone D, Ayral-Kaloustian S, Skotnicki J",,305328,DTCT0024002,1748843,DTCC00383016,725224,18895
CHEMBL181328,P45452,,JKWHUKMFJPDCMY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15745814,IC50,=,8,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-13 at 1 uM,,Synthesis and SAR of diazepine and thiazepine TACE and MMP inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,6,"Zask A, Kaplan J, Du X, MacEwan G, Sandanayaka V, Eudy N, Levin J, Jin G, Xu J, Cummons T, Barone D, Ayral-Kaloustian S, Skotnicki J",,305328,DTCT0024002,1750068,DTCC00382872,1436908,18895
CHEMBL181365,P45452,,LVVFBDASYOIWFN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15745814,IC50,=,140,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-13 at 1 uM,,Synthesis and SAR of diazepine and thiazepine TACE and MMP inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,6,"Zask A, Kaplan J, Du X, MacEwan G, Sandanayaka V, Eudy N, Levin J, Jin G, Xu J, Cummons T, Barone D, Ayral-Kaloustian S, Skotnicki J",,305328,DTCT0024002,1748849,DTCC00383017,1372518,18895
CHEMBL181372,P45452,,QBHJWCOJUICREF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15686921,KI,=,130,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,Structure-based design of potent and selective inhibitors of collagenase-3 (MMP-13).,Bioorg. Med. Chem. Lett.,2005,15,4,"Kim SH, Pudzianowski AT, Leavitt KJ, Barbosa J, McDonnell PA, Metzler WJ, Rankin BM, Liu R, Vaccaro W, Pitts W",,302508,DTCT0024002,1744230,DTCC00381766,195082,18787
CHEMBL181391,P45452,,AXEVJOXFWBOXDW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15686921,KI,=,1100,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,Structure-based design of potent and selective inhibitors of collagenase-3 (MMP-13).,Bioorg. Med. Chem. Lett.,2005,15,4,"Kim SH, Pudzianowski AT, Leavitt KJ, Barbosa J, McDonnell PA, Metzler WJ, Rankin BM, Liu R, Vaccaro W, Pitts W",,302508,DTCT0024002,1744359,DTCC00381807,1651599,18787
CHEMBL181562,P45452,,VLYKOMJYRYYWFW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15686921,KI,=,1.9,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,Structure-based design of potent and selective inhibitors of collagenase-3 (MMP-13).,Bioorg. Med. Chem. Lett.,2005,15,4,"Kim SH, Pudzianowski AT, Leavitt KJ, Barbosa J, McDonnell PA, Metzler WJ, Rankin BM, Liu R, Vaccaro W, Pitts W",,302508,DTCT0024002,1744786,DTCC00381706,1102030,18787
CHEMBL181682,P45452,,VWGKXDUPRHRCAO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16002291,IC50,=,24000,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,Structure-based design and synthesis of novel non-zinc chelating MMP-12 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,16,"Dublanchet AC, Ducrot P, Andrianjara C, O'Gara M, Morales R, Compère D, Denis A, Blais S, Cluzeau P, Courté K, Hamon J, Moreau F, Prunet ML, Tertre A",,305019,DTCT0024002,1742477,DTCC00381375,142259,9478
CHEMBL181807,P45452,,RLQDDFZTFKMONF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15357971,KI,>,5000,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 (MMP-13),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302721,DTCT0024002,1766886,DTCC00387593,2046737,18194
CHEMBL181819,P45452,,FSSPDFKSDKXWQO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15780611,IC50,=,3.1,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 13,,Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.,Bioorg. Med. Chem. Lett.,2005,15,7,"Blagg JA, Noe MC, Wolf-Gouveia LA, Reiter LA, Laird ER, Chang SP, Danley DE, Downs JT, Elliott NC, Eskra JD, Griffiths RJ, Hardink JR, Haugeto AI, Jones CS, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robinson RP, Subramanyam C, Vaughn-Bowser ML, Yocum SA",,305127,DTCT0024002,1754265,DTCC00384593,2014497,18917
CHEMBL181905,P45452,,OJGIWNSVHKBBDS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15780611,IC50,=,9.2,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 13,,Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.,Bioorg. Med. Chem. Lett.,2005,15,7,"Blagg JA, Noe MC, Wolf-Gouveia LA, Reiter LA, Laird ER, Chang SP, Danley DE, Downs JT, Elliott NC, Eskra JD, Griffiths RJ, Hardink JR, Haugeto AI, Jones CS, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robinson RP, Subramanyam C, Vaughn-Bowser ML, Yocum SA",,305127,DTCT0024002,1753191,DTCC00384547,2046716,18917
CHEMBL1821978,P45452,,QDLPFXRBZXAZRL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23428964,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of MMP13 (unknown origin) up to 50 uM,Not Active,Selective aminopeptidase-N (CD13) inhibitors with relevance to cancer chemotherapy.,Bioorg. Med. Chem.,2013,21,7,"Schmitt C, Voegelin M, Marin A, Schmitt M, Schegg F, Hénon P, Guenot D, Tarnus C",,951224,DTCT0024002,11846951,DTCC01103969,1107149,54192
CHEMBL182273,P45452,,FNCXJJHZBHAVJZ-IEBWSBKVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15324896,IC50,=,28,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 13,,3-Hydroxy-4-arylsulfonyltetrahydropyranyl-3-hydroxamic acids are novel inhibitors of MMP-13 and aggrecanase.,Bioorg. Med. Chem. Lett.,2004,14,18,"Noe MC, Snow SL, Wolf-Gouveia LA, Mitchell PG, Lopresti-Morrow L, Reeves LM, Yocum SA, Liras JL, Vaughn M",,305094,DTCT0024002,1768924,DTCC00388226,1307417,18227
CHEMBL182344,P45452,,HYDHEJPXRHGPLP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15780611,IC50,=,53,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 13,,Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.,Bioorg. Med. Chem. Lett.,2005,15,7,"Blagg JA, Noe MC, Wolf-Gouveia LA, Reiter LA, Laird ER, Chang SP, Danley DE, Downs JT, Elliott NC, Eskra JD, Griffiths RJ, Hardink JR, Haugeto AI, Jones CS, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robinson RP, Subramanyam C, Vaughn-Bowser ML, Yocum SA",,305127,DTCT0024002,1753598,DTCC00384445,1630746,18917
CHEMBL182534,P45452,,HMJIPPQTLJLPNE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15780611,IC50,=,19,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 13,,Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.,Bioorg. Med. Chem. Lett.,2005,15,7,"Blagg JA, Noe MC, Wolf-Gouveia LA, Reiter LA, Laird ER, Chang SP, Danley DE, Downs JT, Elliott NC, Eskra JD, Griffiths RJ, Hardink JR, Haugeto AI, Jones CS, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robinson RP, Subramanyam C, Vaughn-Bowser ML, Yocum SA",,305127,DTCT0024002,1754130,DTCC00384409,337345,18917
CHEMBL182582,P45452,,RBXJTRGTMYPRKK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15780611,IC50,=,1.7,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 13,,Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.,Bioorg. Med. Chem. Lett.,2005,15,7,"Blagg JA, Noe MC, Wolf-Gouveia LA, Reiter LA, Laird ER, Chang SP, Danley DE, Downs JT, Elliott NC, Eskra JD, Griffiths RJ, Hardink JR, Haugeto AI, Jones CS, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robinson RP, Subramanyam C, Vaughn-Bowser ML, Yocum SA",,305127,DTCT0024002,1753721,DTCC00384615,1981650,18917
CHEMBL182730,P45452,,VMEQJHZAHNCRQC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15357971,KI,=,3266,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 (MMP-13),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302721,DTCT0024002,1768286,DTCC00387769,337382,18194
CHEMBL182841,P45452,,WBRQJRYOZZQHQI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15780611,IC50,=,28,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 13,,Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.,Bioorg. Med. Chem. Lett.,2005,15,7,"Blagg JA, Noe MC, Wolf-Gouveia LA, Reiter LA, Laird ER, Chang SP, Danley DE, Downs JT, Elliott NC, Eskra JD, Griffiths RJ, Hardink JR, Haugeto AI, Jones CS, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robinson RP, Subramanyam C, Vaughn-Bowser ML, Yocum SA",,305127,DTCT0024002,1753724,DTCC00384630,304710,18917
CHEMBL182880,P45452,,NXFDHNJDXVCAMS-TZIWHRDSSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15324896,IC50,=,300,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 13,,3-Hydroxy-4-arylsulfonyltetrahydropyranyl-3-hydroxamic acids are novel inhibitors of MMP-13 and aggrecanase.,Bioorg. Med. Chem. Lett.,2004,14,18,"Noe MC, Snow SL, Wolf-Gouveia LA, Mitchell PG, Lopresti-Morrow L, Reeves LM, Yocum SA, Liras JL, Vaughn M",,305094,DTCT0024002,1768951,DTCC00388353,596010,18227
CHEMBL182894,P45452,,PLCRCZGBQOTIFV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15780611,IC50,=,0.87,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 13,,Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.,Bioorg. Med. Chem. Lett.,2005,15,7,"Blagg JA, Noe MC, Wolf-Gouveia LA, Reiter LA, Laird ER, Chang SP, Danley DE, Downs JT, Elliott NC, Eskra JD, Griffiths RJ, Hardink JR, Haugeto AI, Jones CS, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robinson RP, Subramanyam C, Vaughn-Bowser ML, Yocum SA",,305127,DTCT0024002,1753617,DTCC00384562,1340027,18917
CHEMBL183132,P45452,,CLTINYAXRIROMY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15745814,IC50,=,7,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-13 at 1 uM,,Synthesis and SAR of diazepine and thiazepine TACE and MMP inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,6,"Zask A, Kaplan J, Du X, MacEwan G, Sandanayaka V, Eudy N, Levin J, Jin G, Xu J, Cummons T, Barone D, Ayral-Kaloustian S, Skotnicki J",,305328,DTCT0024002,1749508,DTCC00382982,1819667,18895
CHEMBL183132,P45452,,CLTINYAXRIROMY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,IC50,=,7.08,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258769,DTCC00382982,1808957,24803
CHEMBL183146,P45452,,ICCZTDHQUXGJEO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15780611,IC50,=,3.1,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 13,,Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.,Bioorg. Med. Chem. Lett.,2005,15,7,"Blagg JA, Noe MC, Wolf-Gouveia LA, Reiter LA, Laird ER, Chang SP, Danley DE, Downs JT, Elliott NC, Eskra JD, Griffiths RJ, Hardink JR, Haugeto AI, Jones CS, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robinson RP, Subramanyam C, Vaughn-Bowser ML, Yocum SA",,305127,DTCT0024002,1753194,DTCC00384417,1916102,18917
CHEMBL183216,P45452,,BGEFVHSKSARWDE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15780611,IC50,=,1.4,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 13,,Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.,Bioorg. Med. Chem. Lett.,2005,15,7,"Blagg JA, Noe MC, Wolf-Gouveia LA, Reiter LA, Laird ER, Chang SP, Danley DE, Downs JT, Elliott NC, Eskra JD, Griffiths RJ, Hardink JR, Haugeto AI, Jones CS, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robinson RP, Subramanyam C, Vaughn-Bowser ML, Yocum SA",,305127,DTCT0024002,1753197,DTCC00384431,660719,18917
CHEMBL183228,P45452,,XMKAMECIIHUBSZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15261259,IC50,=,67,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13,,Benzodiazepine inhibitors of the MMPs and TACE. Part 2.,Bioorg. Med. Chem. Lett.,2004,14,16,"Levin JI, Nelson FC, Delos Santos E, Du MT, MacEwan G, Chen JM, Ayral-Kaloustian S, Xu J, Jin G, Cummons T, Barone D",,305704,DTCT0024002,1764993,DTCC00387337,1113640,13193
CHEMBL183273,P45452,,QDUBONLFDSIPOU-UYAOXDASSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15324896,IC50,=,46,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 13,,3-Hydroxy-4-arylsulfonyltetrahydropyranyl-3-hydroxamic acids are novel inhibitors of MMP-13 and aggrecanase.,Bioorg. Med. Chem. Lett.,2004,14,18,"Noe MC, Snow SL, Wolf-Gouveia LA, Mitchell PG, Lopresti-Morrow L, Reeves LM, Yocum SA, Liras JL, Vaughn M",,305094,DTCT0024002,1769514,DTCC00388232,369973,18227
CHEMBL183404,P45452,,VVCQPDVATXLSSI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15261259,IC50,=,97,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13,,Benzodiazepine inhibitors of the MMPs and TACE. Part 2.,Bioorg. Med. Chem. Lett.,2004,14,16,"Levin JI, Nelson FC, Delos Santos E, Du MT, MacEwan G, Chen JM, Ayral-Kaloustian S, Xu J, Jin G, Cummons T, Barone D",,305704,DTCT0024002,1763995,DTCC00387504,692988,13193
CHEMBL183410,P45452,,ZTJUBPXNBSLSGL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15780611,IC50,=,1,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 13,,Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.,Bioorg. Med. Chem. Lett.,2005,15,7,"Blagg JA, Noe MC, Wolf-Gouveia LA, Reiter LA, Laird ER, Chang SP, Danley DE, Downs JT, Elliott NC, Eskra JD, Griffiths RJ, Hardink JR, Haugeto AI, Jones CS, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robinson RP, Subramanyam C, Vaughn-Bowser ML, Yocum SA",,305127,DTCT0024002,1754251,DTCC00384419,1113613,18917
CHEMBL183431,P45452,,VTKKCTKODCNOOX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15357971,KI,>,5000,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 (MMP-13),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302721,DTCT0024002,1767152,DTCC00387678,109915,18194
CHEMBL183697,P45452,,UIODHSBHBXTRBO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15780611,IC50,=,19,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 13,,Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.,Bioorg. Med. Chem. Lett.,2005,15,7,"Blagg JA, Noe MC, Wolf-Gouveia LA, Reiter LA, Laird ER, Chang SP, Danley DE, Downs JT, Elliott NC, Eskra JD, Griffiths RJ, Hardink JR, Haugeto AI, Jones CS, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robinson RP, Subramanyam C, Vaughn-Bowser ML, Yocum SA",,305127,DTCT0024002,1753611,DTCC00384397,1015951,18917
CHEMBL183713,P45452,,FRIYTZJGYCAFHL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15780611,IC50,=,0.95,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 13,,Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.,Bioorg. Med. Chem. Lett.,2005,15,7,"Blagg JA, Noe MC, Wolf-Gouveia LA, Reiter LA, Laird ER, Chang SP, Danley DE, Downs JT, Elliott NC, Eskra JD, Griffiths RJ, Hardink JR, Haugeto AI, Jones CS, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robinson RP, Subramanyam C, Vaughn-Bowser ML, Yocum SA",,305127,DTCT0024002,1752533,DTCC00384536,821901,18917
CHEMBL183732,P45452,,YXMRNZNQTDDTSA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15261259,IC50,=,12,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13,,Benzodiazepine inhibitors of the MMPs and TACE. Part 2.,Bioorg. Med. Chem. Lett.,2004,14,16,"Levin JI, Nelson FC, Delos Santos E, Du MT, MacEwan G, Chen JM, Ayral-Kaloustian S, Xu J, Jin G, Cummons T, Barone D",,305704,DTCT0024002,1765001,DTCC00387409,1307409,13193
CHEMBL183735,P45452,,BWBHMVGDPUEYMT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15261259,IC50,=,21,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13,,Benzodiazepine inhibitors of the MMPs and TACE. Part 2.,Bioorg. Med. Chem. Lett.,2004,14,16,"Levin JI, Nelson FC, Delos Santos E, Du MT, MacEwan G, Chen JM, Ayral-Kaloustian S, Xu J, Jin G, Cummons T, Barone D",,305704,DTCT0024002,1764428,DTCC00387224,1145966,13193
CHEMBL183783,P45452,,RQCXYESMODRPPY-IEBWSBKVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15324896,IC50,=,0.88,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 13,,3-Hydroxy-4-arylsulfonyltetrahydropyranyl-3-hydroxamic acids are novel inhibitors of MMP-13 and aggrecanase.,Bioorg. Med. Chem. Lett.,2004,14,18,"Noe MC, Snow SL, Wolf-Gouveia LA, Mitchell PG, Lopresti-Morrow L, Reeves LM, Yocum SA, Liras JL, Vaughn M",,305094,DTCT0024002,1768921,DTCC00388276,1145978,18227
CHEMBL183828,P45452,,GZPFSVVEOIXUBD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15357971,KI,>,5000,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 (MMP-13),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302721,DTCT0024002,1769766,DTCC00387598,1113642,18194
CHEMBL183848,P45452,,TUUOOTOFTLPOMW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15780611,IC50,=,0.61,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 13,,Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.,Bioorg. Med. Chem. Lett.,2005,15,7,"Blagg JA, Noe MC, Wolf-Gouveia LA, Reiter LA, Laird ER, Chang SP, Danley DE, Downs JT, Elliott NC, Eskra JD, Griffiths RJ, Hardink JR, Haugeto AI, Jones CS, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robinson RP, Subramanyam C, Vaughn-Bowser ML, Yocum SA",,305127,DTCT0024002,1752542,DTCC00384424,271737,18917
CHEMBL183868,P45452,,LCIIHDPWZSSNGB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15357971,KI,>,5000,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 (MMP-13),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302721,DTCT0024002,1768682,DTCC00387868,1663052,18194
CHEMBL183886,P45452,,SPZLSWDAZSYJAK-VQIMIIECSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15324896,IC50,=,15,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 13,,3-Hydroxy-4-arylsulfonyltetrahydropyranyl-3-hydroxamic acids are novel inhibitors of MMP-13 and aggrecanase.,Bioorg. Med. Chem. Lett.,2004,14,18,"Noe MC, Snow SL, Wolf-Gouveia LA, Mitchell PG, Lopresti-Morrow L, Reeves LM, Yocum SA, Liras JL, Vaughn M",,305094,DTCT0024002,1768927,DTCC00388455,1274771,18227
CHEMBL183924,P45452,,JQGYJNKTRDAQCV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15261259,IC50,=,20,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13,,Benzodiazepine inhibitors of the MMPs and TACE. Part 2.,Bioorg. Med. Chem. Lett.,2004,14,16,"Levin JI, Nelson FC, Delos Santos E, Du MT, MacEwan G, Chen JM, Ayral-Kaloustian S, Xu J, Jin G, Cummons T, Barone D",,305704,DTCT0024002,1764543,DTCC00387305,206585,13193
CHEMBL183924,P45452,,JQGYJNKTRDAQCV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19095454,IC50,=,20,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Current perspective of TACE inhibitors: a review.,Bioorg. Med. Chem.,2009,17,2,"DasGupta S, Murumkar PR, Giridhar R, Yadav MR",,495051,DTCT0024002,2595394,DTCC00387305,207843,32093
CHEMBL183935,P45452,,XWNLDJDYIDRBJI-UYAOXDASSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15324896,IC50,=,21,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 13,,3-Hydroxy-4-arylsulfonyltetrahydropyranyl-3-hydroxamic acids are novel inhibitors of MMP-13 and aggrecanase.,Bioorg. Med. Chem. Lett.,2004,14,18,"Noe MC, Snow SL, Wolf-Gouveia LA, Mitchell PG, Lopresti-Morrow L, Reeves LM, Yocum SA, Liras JL, Vaughn M",,305094,DTCT0024002,1768404,DTCC00388271,1754941,18227
CHEMBL183936,P45452,,UWLVDBFIOGAENY-UYAOXDASSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15324896,IC50,=,38,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 13,,3-Hydroxy-4-arylsulfonyltetrahydropyranyl-3-hydroxamic acids are novel inhibitors of MMP-13 and aggrecanase.,Bioorg. Med. Chem. Lett.,2004,14,18,"Noe MC, Snow SL, Wolf-Gouveia LA, Mitchell PG, Lopresti-Morrow L, Reeves LM, Yocum SA, Liras JL, Vaughn M",,305094,DTCT0024002,1769512,DTCC00388272,142331,18227
CHEMBL184007,P45452,,BNLNSLPPTDOCGX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15261259,IC50,=,17,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13,,Benzodiazepine inhibitors of the MMPs and TACE. Part 2.,Bioorg. Med. Chem. Lett.,2004,14,16,"Levin JI, Nelson FC, Delos Santos E, Du MT, MacEwan G, Chen JM, Ayral-Kaloustian S, Xu J, Jin G, Cummons T, Barone D",,305704,DTCT0024002,1764419,DTCC00387298,563744,13193
CHEMBL184062,P45452,,QDMJDGKLXWJUSU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15357971,KI,=,754,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 (MMP-13),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302721,DTCT0024002,1766615,DTCC00387550,1948766,18194
CHEMBL184064,P45452,,OTYJRWAMIOUIHN-IEBWSBKVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15324896,IC50,=,2.7,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 13,,3-Hydroxy-4-arylsulfonyltetrahydropyranyl-3-hydroxamic acids are novel inhibitors of MMP-13 and aggrecanase.,Bioorg. Med. Chem. Lett.,2004,14,18,"Noe MC, Snow SL, Wolf-Gouveia LA, Mitchell PG, Lopresti-Morrow L, Reeves LM, Yocum SA, Liras JL, Vaughn M",,305094,DTCT0024002,1768804,DTCC00388331,821946,18227
CHEMBL184065,P45452,,OUHOPXMPDCBZLB-IEBWSBKVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15324896,IC50,=,2.4,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 13,,3-Hydroxy-4-arylsulfonyltetrahydropyranyl-3-hydroxamic acids are novel inhibitors of MMP-13 and aggrecanase.,Bioorg. Med. Chem. Lett.,2004,14,18,"Noe MC, Snow SL, Wolf-Gouveia LA, Mitchell PG, Lopresti-Morrow L, Reeves LM, Yocum SA, Liras JL, Vaughn M",,305094,DTCT0024002,1768918,DTCC00388332,1048463,18227
CHEMBL184119,P45452,,FSJPBIIVCZKHRS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15261259,IC50,=,28,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13,,Benzodiazepine inhibitors of the MMPs and TACE. Part 2.,Bioorg. Med. Chem. Lett.,2004,14,16,"Levin JI, Nelson FC, Delos Santos E, Du MT, MacEwan G, Chen JM, Ayral-Kaloustian S, Xu J, Jin G, Cummons T, Barone D",,305704,DTCT0024002,1764539,DTCC00387344,692983,13193
CHEMBL184168,P45452,,ISBRGXFRKARDDV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15261259,IC50,=,32,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13,,Benzodiazepine inhibitors of the MMPs and TACE. Part 2.,Bioorg. Med. Chem. Lett.,2004,14,16,"Levin JI, Nelson FC, Delos Santos E, Du MT, MacEwan G, Chen JM, Ayral-Kaloustian S, Xu J, Jin G, Cummons T, Barone D",,305704,DTCT0024002,1764547,DTCC00387377,1598530,13193
CHEMBL184190,P45452,,JITKRVBMGWVILD-IEBWSBKVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15324896,IC50,>,300,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 13,,3-Hydroxy-4-arylsulfonyltetrahydropyranyl-3-hydroxamic acids are novel inhibitors of MMP-13 and aggrecanase.,Bioorg. Med. Chem. Lett.,2004,14,18,"Noe MC, Snow SL, Wolf-Gouveia LA, Mitchell PG, Lopresti-Morrow L, Reeves LM, Yocum SA, Liras JL, Vaughn M",,305094,DTCT0024002,1768944,DTCC00388434,789562,18227
CHEMBL184200,P45452,,OOVNTYFKKPGWIY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15357971,KI,>,5000,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 (MMP-13),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302721,DTCT0024002,1769206,DTCC00387611,2014535,18194
CHEMBL184265,P45452,,ZLXSMXRIMOZSHG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15357971,KI,>,5000,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 (MMP-13),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302721,DTCT0024002,1766769,DTCC00387522,174524,18194
CHEMBL184266,P45452,,SUTQJRNQIINAFC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15357971,KI,>,5000,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 (MMP-13),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302721,DTCT0024002,1769664,DTCC00387523,951382,18194
CHEMBL184302,P45452,,KVMYRTIGLLQRFY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15357971,KI,=,804,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 (MMP-13),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302721,DTCT0024002,1769259,DTCC00387529,1787170,18194
CHEMBL184501,P45452,,OUPAYUKAUNZSER-IEBWSBKVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15324896,IC50,=,1,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 13,,3-Hydroxy-4-arylsulfonyltetrahydropyranyl-3-hydroxamic acids are novel inhibitors of MMP-13 and aggrecanase.,Bioorg. Med. Chem. Lett.,2004,14,18,"Noe MC, Snow SL, Wolf-Gouveia LA, Mitchell PG, Lopresti-Morrow L, Reeves LM, Yocum SA, Liras JL, Vaughn M",,305094,DTCT0024002,1769500,DTCC00388061,660751,18227
CHEMBL184522,P45452,,YPTZORUBNMNKDA-TZIWHRDSSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15324896,IC50,=,17,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 13,,3-Hydroxy-4-arylsulfonyltetrahydropyranyl-3-hydroxamic acids are novel inhibitors of MMP-13 and aggrecanase.,Bioorg. Med. Chem. Lett.,2004,14,18,"Noe MC, Snow SL, Wolf-Gouveia LA, Mitchell PG, Lopresti-Morrow L, Reeves LM, Yocum SA, Liras JL, Vaughn M",,305094,DTCT0024002,1768948,DTCC00388392,1405073,18227
CHEMBL184553,P45452,,AENHIDVKFOYIJJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15357971,KI,=,653,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 (MMP-13),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302721,DTCT0024002,1768816,DTCC00387561,854875,18194
CHEMBL184745,P45452,,MJYIMHGWKZRGTK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15261259,IC50,=,47,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13,,Benzodiazepine inhibitors of the MMPs and TACE. Part 2.,Bioorg. Med. Chem. Lett.,2004,14,16,"Levin JI, Nelson FC, Delos Santos E, Du MT, MacEwan G, Chen JM, Ayral-Kaloustian S, Xu J, Jin G, Cummons T, Barone D",,305704,DTCT0024002,1764535,DTCC00387289,1469334,13193
CHEMBL184768,P45452,,DHUZZZSRYGMFNN-YBEGLDIGSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,IC50,=,1590,NM,,,,,,,,,,,,,,Inhibition of MMP13 (unknown origin) using Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate after 3 mins by fluorimetric assay,,Evaluation of the anti-inflammatory/chondroprotective activity of aldose reductase inhibitors in human chondrocyte cultures,MedChemComm,2015,6,5,"Panico A, Maccari R, Cardile V, Avondo S, Crasci L, Ottana R",,1541340,DTCT0024002,11387,DTCC00386608,301939,65440
CHEMBL184782,P45452,,QKSLJJWUWAALHK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15357971,KI,=,3266,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 (MMP-13),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302721,DTCT0024002,1768690,DTCC00387435,1209204,18194
CHEMBL184885,P45452,,QPQUYVHWOXJEPM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15357971,KI,=,1708,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 (MMP-13),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302721,DTCT0024002,1769092,DTCC00387860,563749,18194
CHEMBL184889,P45452,,JCNKARFKCMFPMK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15357971,KI,>,5000,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 (MMP-13),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302721,DTCT0024002,1768292,DTCC00387709,466623,18194
CHEMBL184942,P45452,,XDBJJTDYSZNDQT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15357971,KI,>,5000,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 (MMP-13),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302721,DTCT0024002,1767052,DTCC00387754,271779,18194
CHEMBL184943,P45452,,OUIRYNJKZCTIHG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15261259,IC50,=,42,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13,,Benzodiazepine inhibitors of the MMPs and TACE. Part 2.,Bioorg. Med. Chem. Lett.,2004,14,16,"Levin JI, Nelson FC, Delos Santos E, Du MT, MacEwan G, Chen JM, Ayral-Kaloustian S, Xu J, Jin G, Cummons T, Barone D",,305704,DTCT0024002,1765005,DTCC00387476,983705,13193
CHEMBL184975,P45452,,ZYBZWGUZKUJPEX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15357971,KI,>,5000,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 (MMP-13),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302721,DTCT0024002,1769218,DTCC00387627,1340070,18194
CHEMBL185158,P45452,,UBFOQDMFNBRRSY-UYAOXDASSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15324896,IC50,=,5,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 13,,3-Hydroxy-4-arylsulfonyltetrahydropyranyl-3-hydroxamic acids are novel inhibitors of MMP-13 and aggrecanase.,Bioorg. Med. Chem. Lett.,2004,14,18,"Noe MC, Snow SL, Wolf-Gouveia LA, Mitchell PG, Lopresti-Morrow L, Reeves LM, Yocum SA, Liras JL, Vaughn M",,305094,DTCT0024002,1768797,DTCC00388221,1209210,18227
CHEMBL185159,P45452,,PGTJOSSSBWAALE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15357971,KI,=,503,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 (MMP-13),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302721,DTCT0024002,1766893,DTCC00387543,1534047,18194
CHEMBL185160,P45452,,PVWTVPDAGBLFIJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15357971,KI,>,5000,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 (MMP-13),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302721,DTCT0024002,1769773,DTCC00387544,1015993,18194
CHEMBL1852660,P45452,,XFZZDIHCNHYESF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23428964,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of MMP13 (unknown origin) up to 50 uM,Not Active,Selective aminopeptidase-N (CD13) inhibitors with relevance to cancer chemotherapy.,Bioorg. Med. Chem.,2013,21,7,"Schmitt C, Voegelin M, Marin A, Schmitt M, Schegg F, Hénon P, Guenot D, Tarnus C",,951224,DTCT0024002,11846950,DTCC01113468,1877558,54192
CHEMBL185279,P45452,,NWEMVUGYMZFTLT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15357971,KI,=,955,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 (MMP-13),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302721,DTCT0024002,1767173,DTCC00387634,32985,18194
CHEMBL185321,P45452,,MBVFAXQWLSRZPW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15357971,KI,=,753,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 (MMP-13),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302721,DTCT0024002,1769193,DTCC00387430,1724709,18194
CHEMBL185375,P45452,,KUDDIXBNWHQPDJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15261259,IC50,=,20,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13,,Benzodiazepine inhibitors of the MMPs and TACE. Part 2.,Bioorg. Med. Chem. Lett.,2004,14,16,"Levin JI, Nelson FC, Delos Santos E, Du MT, MacEwan G, Chen JM, Ayral-Kaloustian S, Xu J, Jin G, Cummons T, Barone D",,305704,DTCT0024002,1764008,DTCC00387221,628510,13193
CHEMBL185397,P45452,,KCWUMRBDUUZPAL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15357971,KI,>,5000,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 (MMP-13),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302721,DTCT0024002,1768158,DTCC00387675,1663050,18194
CHEMBL185521,P45452,,IFZNBBFLMYGGPO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15357971,KI,>,5000,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 (MMP-13),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302721,DTCT0024002,1767166,DTCC00387708,1630785,18194
CHEMBL185587,P45452,,GQEXSMDDEGSZJA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15357971,KI,=,2613,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 (MMP-13),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302721,DTCT0024002,1769781,DTCC00387743,109914,18194
CHEMBL185623,P45452,,KDHQPBOMSXIRRL-YBEGLDIGSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,IC50,=,6970,NM,,,,,,,,,,,,,,Inhibition of MMP13 (unknown origin) using Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate after 3 mins by fluorimetric assay,,Evaluation of the anti-inflammatory/chondroprotective activity of aldose reductase inhibitors in human chondrocyte cultures,MedChemComm,2015,6,5,"Panico A, Maccari R, Cardile V, Avondo S, Crasci L, Ottana R",,1541340,DTCT0024002,11386,DTCC00386607,1271920,65440
CHEMBL18614,P45452,,JXCARHJPSZBVFH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11934587,IC50,=,21,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,Anthranilate sulfonamide hydroxamate TACE inhibitors. Part 1: Structure-based design of novel acetylenic P1' groups.,Bioorg. Med. Chem. Lett.,2002,12,8,"Chen JM, Jin G, Sung A, Levin JI",,106633,DTCT0024002,1121128,DTCC00149659,1049355,5358
CHEMBL18614,P45452,,JXCARHJPSZBVFH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11934588,IC50,=,21,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 activity,,Anthranilate sulfonamide hydroxamate TACE inhibitors. Part 2: SAR of the acetylenic P1' group.,Bioorg. Med. Chem. Lett.,2002,12,8,"Levin JI, Chen JM, Du MT, Nelson FC, Killar LM, Skala S, Sung A, Jin G, Cowling R, Barone D, March CJ, Mohler KM, Black RA, Skotnicki JS",,106622,DTCT0024002,780854,DTCC00149659,1034297,5465
CHEMBL18614,P45452,,JXCARHJPSZBVFH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19095454,IC50,=,11,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Current perspective of TACE inhibitors: a review.,Bioorg. Med. Chem.,2009,17,2,"DasGupta S, Murumkar PR, Giridhar R, Yadav MR",,495051,DTCT0024002,2594710,DTCC00149659,1049712,32093
CHEMBL18649,P45452,,MDOGBVLWCBWUMC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11934588,IC50,=,358,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 activity,,Anthranilate sulfonamide hydroxamate TACE inhibitors. Part 2: SAR of the acetylenic P1' group.,Bioorg. Med. Chem. Lett.,2002,12,8,"Levin JI, Chen JM, Du MT, Nelson FC, Killar LM, Skala S, Sung A, Jin G, Cowling R, Barone D, March CJ, Mohler KM, Black RA, Skotnicki JS",,106622,DTCT0024002,777960,DTCC00150397,1681122,5465
CHEMBL18667,P45452,,JNFDCDGQVIEXPD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11934588,IC50,=,252,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 at 10 uM,,Anthranilate sulfonamide hydroxamate TACE inhibitors. Part 2: SAR of the acetylenic P1' group.,Bioorg. Med. Chem. Lett.,2002,12,8,"Levin JI, Chen JM, Du MT, Nelson FC, Killar LM, Skala S, Sung A, Jin G, Cowling R, Barone D, March CJ, Mohler KM, Black RA, Skotnicki JS",,106623,DTCT0024002,786547,DTCC00150436,355581,5465
CHEMBL187092,P45452,,LTVIJEFEZVFIST-AZUAARDMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22891645,IC50,=,0.9,NM,,,,,,,,,,,,,,Inhibition of MMP-13 using 5-FAM-TPGPLGL[Dap- (DNP)]ARRK(5-TAMRA)-amide as substrate after 45 mins,,Discovery of highly potent and selective small molecule ADAMTS-5 inhibitors that inhibit human cartilage degradation via encoded library technology (ELT).,J. Med. Chem.,2012,55,16,"Deng H, O'Keefe H, Davie CP, Lind KE, Acharya RA, Franklin GJ, Larkin J, Matico R, Neeb M, Thompson MM, Lohr T, Gross JW, Centrella PA, O'Donovan GK, Bedard KL, van Vloten K, Mataruse S, Skinner SR, Belyanskaya SL, Carpenter TY, Shearer TW, Clark MA, Cuozzo JW, Arico-Muendel CC, Morgan BA",,860058,DTCT0024002,11399446,DTCC00390625,705702,51288
CHEMBL187092,P45452,,LTVIJEFEZVFIST-AZUAARDMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25415648,IC50,=,1,NM,,,,,,,,,,,,,,Inhibition of human MMP13 using Mca-PQG1 peptide substrate assessed as substrate cleavage after 2 to 4 hrs,,Identification of potent and selective hydantoin inhibitors of aggrecanase-1 and aggrecanase-2 that are efficacious in both chemical and surgical models of osteoarthritis.,J. Med. Chem.,2014,57,24,"Durham TB, Klimkowski VJ, Rito CJ, Marimuthu J, Toth JL, Liu C, Durbin JD, Stout SL, Adams L, Swearingen C, Lin C, Chambers MG, Thirunavukkarasu K, Wiley MR",,1435763,DTCT0024002,14000078,DTCC00390625,708051,60298
CHEMBL187265,P45452,"1,3,6,7-TETRAHYDROXYXANTONE",ZHTQCPCDXKMMLU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22658537,IC50,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain incubated for 20 mins by fluorimetric assay,Not Determined,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827438,DTCT0024002,10535464,DTCC00000833,1779807,48665
CHEMBL18742,P45452,,IUPDLWWZWJCNBN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11934588,IC50,=,416,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 activity,,Anthranilate sulfonamide hydroxamate TACE inhibitors. Part 2: SAR of the acetylenic P1' group.,Bioorg. Med. Chem. Lett.,2002,12,8,"Levin JI, Chen JM, Du MT, Nelson FC, Killar LM, Skala S, Sung A, Jin G, Cowling R, Barone D, March CJ, Mohler KM, Black RA, Skotnicki JS",,106622,DTCT0024002,772526,DTCC00150112,807759,5465
CHEMBL187523,P45452,,HJFONKSERLWIGE-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16153831,IC50,=,2.4,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-13,,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321194,DTCT0024002,1860316,DTCC00394634,435259,19837
CHEMBL187523,P45452,,HJFONKSERLWIGE-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19278250,IC50,=,1.3,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 expressed in Escherichia coli,,"A selective matrix metalloprotease 12 inhibitor for potential treatment of chronic obstructive pulmonary disease (COPD): discovery of (S)-2-(8-(methoxycarbonylamino)dibenzo[b,d]furan-3-sulfonamido)-3-methylbutanoic acid (MMP408).",J. Med. Chem.,2009,52,7,"Li W, Li J, Wu Y, Wu J, Hotchandani R, Cunningham K, McFadyen I, Bard J, Morgan P, Schlerman F, Xu X, Tam S, Goldman SJ, Williams C, Sypek J, Mansour TS",,566183,DTCT0024002,2482734,DTCC00394634,425237,33018
CHEMBL187523,P45452,,HJFONKSERLWIGE-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19625186,IC50,=,2.4,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"3,4-Disubstituted benzofuran P1' MMP-13 inhibitors: optimization of selectivity and reduction of protein binding.",Bioorg. Med. Chem. Lett.,2009,19,16,"Li W, Hu Y, Li J, Thomason JR, DeVincentis D, Du X, Wu J, Hotchandani R, Rush TS, Skotnicki JS, Tam S, Chockalingam PS, Morris EA, Levin JI",,581466,DTCT0024002,2904529,DTCC00394634,425792,35265
CHEMBL187523,P45452,,HJFONKSERLWIGE-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19725580,IC50,=,1.3,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthma.,J. Med. Chem.,2009,52,17,"Li W, Li J, Wu Y, Rancati F, Vallese S, Raveglia L, Wu J, Hotchandani R, Fuller N, Cunningham K, Morgan P, Fish S, Krykbaev R, Xu X, Tam S, Goldman SJ, Abraham W, Williams C, Sypek J, Mansour TS",,579100,DTCT0024002,2894814,DTCC00394634,425760,34869
CHEMBL18895,P45452,,FODLAGUBVKDEIZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11934588,IC50,=,233,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 activity,,Anthranilate sulfonamide hydroxamate TACE inhibitors. Part 2: SAR of the acetylenic P1' group.,Bioorg. Med. Chem. Lett.,2002,12,8,"Levin JI, Chen JM, Du MT, Nelson FC, Killar LM, Skala S, Sung A, Jin G, Cowling R, Barone D, March CJ, Mohler KM, Black RA, Skotnicki JS",,106622,DTCT0024002,777965,DTCC00150803,743367,5465
CHEMBL189052,P45452,,MVPVFNYLHBJBHV-XLIONFOSSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15911259,IC50,=,6.5,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-13 (MMP-13),,"Discovery of 3,3-dimethyl-5-hydroxypipecolic hydroxamate-based inhibitors of aggrecanase and MMP-13.",Bioorg. Med. Chem. Lett.,2005,15,11,"Noe MC, Natarajan V, Snow SL, Mitchell PG, Lopresti-Morrow L, Reeves LM, Yocum SA, Carty TJ, Barberia JA, Sweeney FJ, Liras JL, Vaughn M, Hardink JR, Hawkins JM, Tokar C",,304865,DTCT0024002,1814645,DTCC00398595,1457819,18491
CHEMBL189107,P45452,,MPWKVKMEMCVIDI-DYVFJYSZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15911259,IC50,,,,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-13 (MMP-13); ND=not determined,Not Determined,"Discovery of 3,3-dimethyl-5-hydroxypipecolic hydroxamate-based inhibitors of aggrecanase and MMP-13.",Bioorg. Med. Chem. Lett.,2005,15,11,"Noe MC, Natarajan V, Snow SL, Mitchell PG, Lopresti-Morrow L, Reeves LM, Yocum SA, Carty TJ, Barberia JA, Sweeney FJ, Liras JL, Vaughn M, Hardink JR, Hawkins JM, Tokar C",,305480,DTCT0024002,1815358,DTCC00398414,681488,18491
CHEMBL189156,P45452,,ZMDMPUVIZFSSCM-NQIIRXRSSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15911259,IC50,=,36,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-13 (MMP-13),,"Discovery of 3,3-dimethyl-5-hydroxypipecolic hydroxamate-based inhibitors of aggrecanase and MMP-13.",Bioorg. Med. Chem. Lett.,2005,15,11,"Noe MC, Natarajan V, Snow SL, Mitchell PG, Lopresti-Morrow L, Reeves LM, Yocum SA, Carty TJ, Barberia JA, Sweeney FJ, Liras JL, Vaughn M, Hardink JR, Hawkins JM, Tokar C",,304865,DTCT0024002,1813720,DTCC00398817,325767,18491
CHEMBL189216,P45452,,QEWCDBOSGBDOOY-UZLBHIALSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15911259,IC50,=,4.3,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-13 (MMP-13),,"Discovery of 3,3-dimethyl-5-hydroxypipecolic hydroxamate-based inhibitors of aggrecanase and MMP-13.",Bioorg. Med. Chem. Lett.,2005,15,11,"Noe MC, Natarajan V, Snow SL, Mitchell PG, Lopresti-Morrow L, Reeves LM, Yocum SA, Carty TJ, Barberia JA, Sweeney FJ, Liras JL, Vaughn M, Hardink JR, Hawkins JM, Tokar C",,304865,DTCT0024002,1813736,DTCC00398846,1393476,18491
CHEMBL18943,P45452,,ZEZNNQDUSMNIDE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11934588,IC50,=,83,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 activity,,Anthranilate sulfonamide hydroxamate TACE inhibitors. Part 2: SAR of the acetylenic P1' group.,Bioorg. Med. Chem. Lett.,2002,12,8,"Levin JI, Chen JM, Du MT, Nelson FC, Killar LM, Skala S, Sung A, Jin G, Cowling R, Barone D, March CJ, Mohler KM, Black RA, Skotnicki JS",,106622,DTCT0024002,785159,DTCC00150790,1455020,5465
CHEMBL189591,P45452,,BKBMJVASMYYCKO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15908214,KI,>,5020,NM,,,,,,,,,,,,,,In vitro binding affinity against matrix metalloprotease 13,,"Non-hydroxamate 5-phenylpyrimidine-2,4,6-trione derivatives as selective inhibitors of tumor necrosis factor-alpha converting enzyme.",Bioorg. Med. Chem. Lett.,2005,15,12,"Duan JJ, Lu Z, Wasserman ZR, Liu RQ, Covington MB, Decicco CP",,302358,DTCT0024002,1800090,DTCC00398075,584553,16433
CHEMBL189975,P45452,,XVBKVNVPXQZYQF-VGSWGCGISA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15911259,IC50,=,53,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-13 (MMP-13),,"Discovery of 3,3-dimethyl-5-hydroxypipecolic hydroxamate-based inhibitors of aggrecanase and MMP-13.",Bioorg. Med. Chem. Lett.,2005,15,11,"Noe MC, Natarajan V, Snow SL, Mitchell PG, Lopresti-Morrow L, Reeves LM, Yocum SA, Carty TJ, Barberia JA, Sweeney FJ, Liras JL, Vaughn M, Hardink JR, Hawkins JM, Tokar C",,304865,DTCT0024002,1815027,DTCC00398703,1683964,18491
CHEMBL19005,P45452,,PDBHRMUGMOPNOC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11934587,IC50,=,154,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,Anthranilate sulfonamide hydroxamate TACE inhibitors. Part 1: Structure-based design of novel acetylenic P1' groups.,Bioorg. Med. Chem. Lett.,2002,12,8,"Chen JM, Jin G, Sung A, Levin JI",,106633,DTCT0024002,1095548,DTCC00150235,1949738,5358
CHEMBL19005,P45452,,PDBHRMUGMOPNOC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11934588,IC50,=,154,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 activity,,Anthranilate sulfonamide hydroxamate TACE inhibitors. Part 2: SAR of the acetylenic P1' group.,Bioorg. Med. Chem. Lett.,2002,12,8,"Levin JI, Chen JM, Du MT, Nelson FC, Killar LM, Skala S, Sung A, Jin G, Cowling R, Barone D, March CJ, Mohler KM, Black RA, Skotnicki JS",,106622,DTCT0024002,790614,DTCC00150235,1934079,5465
CHEMBL190215,P45452,,CEGUOXMMRKISPK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15908214,KI,=,356,NM,,,,,,,,,,,,,,In vitro binding affinity against matrix metalloprotease 13,,"Non-hydroxamate 5-phenylpyrimidine-2,4,6-trione derivatives as selective inhibitors of tumor necrosis factor-alpha converting enzyme.",Bioorg. Med. Chem. Lett.,2005,15,12,"Duan JJ, Lu Z, Wasserman ZR, Liu RQ, Covington MB, Decicco CP",,302358,DTCT0024002,1800244,DTCC00398109,1457816,16433
CHEMBL190415,P45452,,LOMOBWUKCBVLNJ-XLIONFOSSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15911259,IC50,=,3.5,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-13 (MMP-13),,"Discovery of 3,3-dimethyl-5-hydroxypipecolic hydroxamate-based inhibitors of aggrecanase and MMP-13.",Bioorg. Med. Chem. Lett.,2005,15,11,"Noe MC, Natarajan V, Snow SL, Mitchell PG, Lopresti-Morrow L, Reeves LM, Yocum SA, Carty TJ, Barberia JA, Sweeney FJ, Liras JL, Vaughn M, Hardink JR, Hawkins JM, Tokar C",,304865,DTCT0024002,1814263,DTCC00398065,1936875,18491
CHEMBL190441,P45452,,DNUKGGCABDLAEO-GCJKJVERSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15911259,IC50,=,188,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-13 (MMP-13),,"Discovery of 3,3-dimethyl-5-hydroxypipecolic hydroxamate-based inhibitors of aggrecanase and MMP-13.",Bioorg. Med. Chem. Lett.,2005,15,11,"Noe MC, Natarajan V, Snow SL, Mitchell PG, Lopresti-Morrow L, Reeves LM, Yocum SA, Carty TJ, Barberia JA, Sweeney FJ, Liras JL, Vaughn M, Hardink JR, Hawkins JM, Tokar C",,304865,DTCT0024002,1812737,DTCC00398240,1457818,18491
CHEMBL190506,P45452,,YSLNEVXKZVORTK-VGSWGCGISA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15911259,IC50,=,7.8,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-13 (MMP-13),,"Discovery of 3,3-dimethyl-5-hydroxypipecolic hydroxamate-based inhibitors of aggrecanase and MMP-13.",Bioorg. Med. Chem. Lett.,2005,15,11,"Noe MC, Natarajan V, Snow SL, Mitchell PG, Lopresti-Morrow L, Reeves LM, Yocum SA, Carty TJ, Barberia JA, Sweeney FJ, Liras JL, Vaughn M, Hardink JR, Hawkins JM, Tokar C",,304865,DTCT0024002,1816215,DTCC00398152,1651777,18491
CHEMBL190563,P45452,,BHRJTBRTTVQRNI-XLIONFOSSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15911259,IC50,=,14,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-13 (MMP-13),,"Discovery of 3,3-dimethyl-5-hydroxypipecolic hydroxamate-based inhibitors of aggrecanase and MMP-13.",Bioorg. Med. Chem. Lett.,2005,15,11,"Noe MC, Natarajan V, Snow SL, Mitchell PG, Lopresti-Morrow L, Reeves LM, Yocum SA, Carty TJ, Barberia JA, Sweeney FJ, Liras JL, Vaughn M, Hardink JR, Hawkins JM, Tokar C",,304865,DTCT0024002,1809968,DTCC00397932,875789,18491
CHEMBL190686,P45452,,NAUAIDYHJRWZDQ-KDOFPFPSSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15911259,IC50,=,19,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-13 (MMP-13),,"Discovery of 3,3-dimethyl-5-hydroxypipecolic hydroxamate-based inhibitors of aggrecanase and MMP-13.",Bioorg. Med. Chem. Lett.,2005,15,11,"Noe MC, Natarajan V, Snow SL, Mitchell PG, Lopresti-Morrow L, Reeves LM, Yocum SA, Carty TJ, Barberia JA, Sweeney FJ, Liras JL, Vaughn M, Hardink JR, Hawkins JM, Tokar C",,304865,DTCT0024002,1817350,DTCC00398598,713763,18491
CHEMBL190936,P45452,,INGVNDTUNOZHOP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15908214,KI,>,5020,NM,,,,,,,,,,,,,,In vitro binding affinity against matrix metalloprotease 13,,"Non-hydroxamate 5-phenylpyrimidine-2,4,6-trione derivatives as selective inhibitors of tumor necrosis factor-alpha converting enzyme.",Bioorg. Med. Chem. Lett.,2005,15,12,"Duan JJ, Lu Z, Wasserman ZR, Liu RQ, Covington MB, Decicco CP",,302358,DTCT0024002,1800214,DTCC00398012,7206,16433
CHEMBL191030,P45452,,XQUSEXYSIGIEBX-VQIMIIECSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15911259,IC50,=,2.1,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-13 (MMP-13),,"Discovery of 3,3-dimethyl-5-hydroxypipecolic hydroxamate-based inhibitors of aggrecanase and MMP-13.",Bioorg. Med. Chem. Lett.,2005,15,11,"Noe MC, Natarajan V, Snow SL, Mitchell PG, Lopresti-Morrow L, Reeves LM, Yocum SA, Carty TJ, Barberia JA, Sweeney FJ, Liras JL, Vaughn M, Hardink JR, Hawkins JM, Tokar C",,304865,DTCT0024002,1809092,DTCC00109677,1004669,18491
CHEMBL1910438,P45452,,PPCHUKYNNDWTFT-AREMUKBSSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21982494,IC50,=,4,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Continued exploration of biphenylsulfonamide scaffold as a platform for aggrecanase-1 inhibition.,Bioorg. Med. Chem. Lett.,2011,21,22,"Hu Y, Xing L, Thomason JR, Xiang J, Ipek M, Guler S, Li H, Sabatini J, Chockalingam P, Reifenberg E, Sheldon R, Morris EA, Georgiadis KE, Tam S",,774908,DTCT0024002,7503531,DTCC01157924,866049,45376
CHEMBL1910449,P45452,,WFKAOUORBBLUOE-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21982494,IC50,=,450,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Continued exploration of biphenylsulfonamide scaffold as a platform for aggrecanase-1 inhibition.,Bioorg. Med. Chem. Lett.,2011,21,22,"Hu Y, Xing L, Thomason JR, Xiang J, Ipek M, Guler S, Li H, Sabatini J, Chockalingam P, Reifenberg E, Sheldon R, Morris EA, Georgiadis KE, Tam S",,774908,DTCT0024002,7503532,DTCC01157935,1059360,45376
CHEMBL1910453,P45452,,BQWMHBWBEWWNOR-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21982494,IC50,=,5.6,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Continued exploration of biphenylsulfonamide scaffold as a platform for aggrecanase-1 inhibition.,Bioorg. Med. Chem. Lett.,2011,21,22,"Hu Y, Xing L, Thomason JR, Xiang J, Ipek M, Guler S, Li H, Sabatini J, Chockalingam P, Reifenberg E, Sheldon R, Morris EA, Georgiadis KE, Tam S",,774908,DTCT0024002,7503495,DTCC01157939,249968,45376
CHEMBL1910458,P45452,,RWAXNHQEXFCSDK-HHHXNRCGSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21982494,IC50,=,7.1,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Continued exploration of biphenylsulfonamide scaffold as a platform for aggrecanase-1 inhibition.,Bioorg. Med. Chem. Lett.,2011,21,22,"Hu Y, Xing L, Thomason JR, Xiang J, Ipek M, Guler S, Li H, Sabatini J, Chockalingam P, Reifenberg E, Sheldon R, Morris EA, Georgiadis KE, Tam S",,774908,DTCT0024002,7503496,DTCC01157944,1992840,45376
CHEMBL1910459,P45452,,RIJMYCAFDDBRHW-HHHXNRCGSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21982494,IC50,=,1.4,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Continued exploration of biphenylsulfonamide scaffold as a platform for aggrecanase-1 inhibition.,Bioorg. Med. Chem. Lett.,2011,21,22,"Hu Y, Xing L, Thomason JR, Xiang J, Ipek M, Guler S, Li H, Sabatini J, Chockalingam P, Reifenberg E, Sheldon R, Morris EA, Georgiadis KE, Tam S",,774908,DTCT0024002,7503497,DTCC01157945,606992,45376
CHEMBL1910460,P45452,,SRNVCZIFDUXAJE-AREMUKBSSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21982494,IC50,=,5.2,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Continued exploration of biphenylsulfonamide scaffold as a platform for aggrecanase-1 inhibition.,Bioorg. Med. Chem. Lett.,2011,21,22,"Hu Y, Xing L, Thomason JR, Xiang J, Ipek M, Guler S, Li H, Sabatini J, Chockalingam P, Reifenberg E, Sheldon R, Morris EA, Georgiadis KE, Tam S",,774908,DTCT0024002,7503498,DTCC01157946,704011,45376
CHEMBL1910461,P45452,,OYJHJMVVIQMCQV-HHHXNRCGSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21982494,IC50,=,9.6,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Continued exploration of biphenylsulfonamide scaffold as a platform for aggrecanase-1 inhibition.,Bioorg. Med. Chem. Lett.,2011,21,22,"Hu Y, Xing L, Thomason JR, Xiang J, Ipek M, Guler S, Li H, Sabatini J, Chockalingam P, Reifenberg E, Sheldon R, Morris EA, Georgiadis KE, Tam S",,774908,DTCT0024002,7503499,DTCC01157947,704012,45376
CHEMBL1910465,P45452,,QVVGWBKEGGOLSP-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21982494,IC50,=,1.1,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Continued exploration of biphenylsulfonamide scaffold as a platform for aggrecanase-1 inhibition.,Bioorg. Med. Chem. Lett.,2011,21,22,"Hu Y, Xing L, Thomason JR, Xiang J, Ipek M, Guler S, Li H, Sabatini J, Chockalingam P, Reifenberg E, Sheldon R, Morris EA, Georgiadis KE, Tam S",,774908,DTCT0024002,7503500,DTCC01157951,283027,45376
CHEMBL1910466,P45452,,CPBYLQSCRDREEZ-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21982494,IC50,=,0.7,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Continued exploration of biphenylsulfonamide scaffold as a platform for aggrecanase-1 inhibition.,Bioorg. Med. Chem. Lett.,2011,21,22,"Hu Y, Xing L, Thomason JR, Xiang J, Ipek M, Guler S, Li H, Sabatini J, Chockalingam P, Reifenberg E, Sheldon R, Morris EA, Georgiadis KE, Tam S",,774908,DTCT0024002,7503501,DTCC01157952,1480374,45376
CHEMBL1910467,P45452,,IQSOHDSWWDGCBY-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21982494,IC50,=,1,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Continued exploration of biphenylsulfonamide scaffold as a platform for aggrecanase-1 inhibition.,Bioorg. Med. Chem. Lett.,2011,21,22,"Hu Y, Xing L, Thomason JR, Xiang J, Ipek M, Guler S, Li H, Sabatini J, Chockalingam P, Reifenberg E, Sheldon R, Morris EA, Georgiadis KE, Tam S",,774908,DTCT0024002,7503502,DTCC01157953,1830726,45376
CHEMBL1910468,P45452,,CCJMOEFMUUDIQM-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21982494,IC50,=,4300,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Continued exploration of biphenylsulfonamide scaffold as a platform for aggrecanase-1 inhibition.,Bioorg. Med. Chem. Lett.,2011,21,22,"Hu Y, Xing L, Thomason JR, Xiang J, Ipek M, Guler S, Li H, Sabatini J, Chockalingam P, Reifenberg E, Sheldon R, Morris EA, Georgiadis KE, Tam S",,774908,DTCT0024002,7503503,DTCC01157954,1092384,45376
CHEMBL1910469,P45452,,BKXKRQGSEIULQV-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21982494,IC50,=,24700,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Continued exploration of biphenylsulfonamide scaffold as a platform for aggrecanase-1 inhibition.,Bioorg. Med. Chem. Lett.,2011,21,22,"Hu Y, Xing L, Thomason JR, Xiang J, Ipek M, Guler S, Li H, Sabatini J, Chockalingam P, Reifenberg E, Sheldon R, Morris EA, Georgiadis KE, Tam S",,774908,DTCT0024002,7503504,DTCC01157955,1862745,45376
CHEMBL1910470,P45452,,UBJGIPIZMMCOJX-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21982494,IC50,=,4.6,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Continued exploration of biphenylsulfonamide scaffold as a platform for aggrecanase-1 inhibition.,Bioorg. Med. Chem. Lett.,2011,21,22,"Hu Y, Xing L, Thomason JR, Xiang J, Ipek M, Guler S, Li H, Sabatini J, Chockalingam P, Reifenberg E, Sheldon R, Morris EA, Georgiadis KE, Tam S",,774908,DTCT0024002,7503505,DTCC01157956,574652,45376
CHEMBL1910471,P45452,,DJEDDHGTONHFQL-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21982494,IC50,=,0.1,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Continued exploration of biphenylsulfonamide scaffold as a platform for aggrecanase-1 inhibition.,Bioorg. Med. Chem. Lett.,2011,21,22,"Hu Y, Xing L, Thomason JR, Xiang J, Ipek M, Guler S, Li H, Sabatini J, Chockalingam P, Reifenberg E, Sheldon R, Morris EA, Georgiadis KE, Tam S",,774908,DTCT0024002,7503506,DTCC01157957,1155715,45376
CHEMBL1910472,P45452,,ODOUKZOJMQSYME-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21982494,IC50,=,3.5,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Continued exploration of biphenylsulfonamide scaffold as a platform for aggrecanase-1 inhibition.,Bioorg. Med. Chem. Lett.,2011,21,22,"Hu Y, Xing L, Thomason JR, Xiang J, Ipek M, Guler S, Li H, Sabatini J, Chockalingam P, Reifenberg E, Sheldon R, Morris EA, Georgiadis KE, Tam S",,774908,DTCT0024002,7503507,DTCC01157958,381042,45376
CHEMBL1910473,P45452,,XAQIEDHHALLLRN-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21982494,IC50,=,0.1,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Continued exploration of biphenylsulfonamide scaffold as a platform for aggrecanase-1 inhibition.,Bioorg. Med. Chem. Lett.,2011,21,22,"Hu Y, Xing L, Thomason JR, Xiang J, Ipek M, Guler S, Li H, Sabatini J, Chockalingam P, Reifenberg E, Sheldon R, Morris EA, Georgiadis KE, Tam S",,774908,DTCT0024002,7503508,DTCC01157959,153466,45376
CHEMBL1910474,P45452,,QEVUKTOHTYCKMA-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21982494,IC50,=,2,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Continued exploration of biphenylsulfonamide scaffold as a platform for aggrecanase-1 inhibition.,Bioorg. Med. Chem. Lett.,2011,21,22,"Hu Y, Xing L, Thomason JR, Xiang J, Ipek M, Guler S, Li H, Sabatini J, Chockalingam P, Reifenberg E, Sheldon R, Morris EA, Georgiadis KE, Tam S",,774908,DTCT0024002,7503509,DTCC01157960,639607,45376
CHEMBL1910475,P45452,,HDZRQSNVDCCUNF-FZYLFJGDSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21982494,IC50,=,12,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Continued exploration of biphenylsulfonamide scaffold as a platform for aggrecanase-1 inhibition.,Bioorg. Med. Chem. Lett.,2011,21,22,"Hu Y, Xing L, Thomason JR, Xiang J, Ipek M, Guler S, Li H, Sabatini J, Chockalingam P, Reifenberg E, Sheldon R, Morris EA, Georgiadis KE, Tam S",,774908,DTCT0024002,7503510,DTCC01157961,414006,45376
CHEMBL1910476,P45452,,CRWSSUTUNYHTON-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21982494,IC50,=,1.4,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Continued exploration of biphenylsulfonamide scaffold as a platform for aggrecanase-1 inhibition.,Bioorg. Med. Chem. Lett.,2011,21,22,"Hu Y, Xing L, Thomason JR, Xiang J, Ipek M, Guler S, Li H, Sabatini J, Chockalingam P, Reifenberg E, Sheldon R, Morris EA, Georgiadis KE, Tam S",,774908,DTCT0024002,7503511,DTCC01157962,2089770,45376
CHEMBL1910647,P45452,,KQIHNYZYABCSQP-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21982494,IC50,=,2.2,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Continued exploration of biphenylsulfonamide scaffold as a platform for aggrecanase-1 inhibition.,Bioorg. Med. Chem. Lett.,2011,21,22,"Hu Y, Xing L, Thomason JR, Xiang J, Ipek M, Guler S, Li H, Sabatini J, Chockalingam P, Reifenberg E, Sheldon R, Morris EA, Georgiadis KE, Tam S",,774908,DTCT0024002,7503515,DTCC00128979,1480378,45376
CHEMBL1910648,P45452,,HKBXBBXQCDCNLR-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21982494,IC50,=,1.4,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Continued exploration of biphenylsulfonamide scaffold as a platform for aggrecanase-1 inhibition.,Bioorg. Med. Chem. Lett.,2011,21,22,"Hu Y, Xing L, Thomason JR, Xiang J, Ipek M, Guler S, Li H, Sabatini J, Chockalingam P, Reifenberg E, Sheldon R, Morris EA, Georgiadis KE, Tam S",,774908,DTCT0024002,7503516,DTCC00128980,1798456,45376
CHEMBL1910649,P45452,,HOSYCMQDQLQXLY-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21982494,IC50,=,2.6,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Continued exploration of biphenylsulfonamide scaffold as a platform for aggrecanase-1 inhibition.,Bioorg. Med. Chem. Lett.,2011,21,22,"Hu Y, Xing L, Thomason JR, Xiang J, Ipek M, Guler S, Li H, Sabatini J, Chockalingam P, Reifenberg E, Sheldon R, Morris EA, Georgiadis KE, Tam S",,774908,DTCT0024002,7503512,DTCC00128981,414009,45376
CHEMBL1910650,P45452,,YJLOTVAYMPXEFZ-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21982494,IC50,=,2.7,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Continued exploration of biphenylsulfonamide scaffold as a platform for aggrecanase-1 inhibition.,Bioorg. Med. Chem. Lett.,2011,21,22,"Hu Y, Xing L, Thomason JR, Xiang J, Ipek M, Guler S, Li H, Sabatini J, Chockalingam P, Reifenberg E, Sheldon R, Morris EA, Georgiadis KE, Tam S",,774908,DTCT0024002,7503514,DTCC00128982,1895002,45376
CHEMBL1910651,P45452,,HVCJZDOPEFRPED-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21982494,IC50,=,1600,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Continued exploration of biphenylsulfonamide scaffold as a platform for aggrecanase-1 inhibition.,Bioorg. Med. Chem. Lett.,2011,21,22,"Hu Y, Xing L, Thomason JR, Xiang J, Ipek M, Guler S, Li H, Sabatini J, Chockalingam P, Reifenberg E, Sheldon R, Morris EA, Georgiadis KE, Tam S",,774908,DTCT0024002,7503517,DTCC00128983,217613,45376
CHEMBL1910652,P45452,,XIMVXQYMBNKLRP-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21982494,IC50,=,4000,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Continued exploration of biphenylsulfonamide scaffold as a platform for aggrecanase-1 inhibition.,Bioorg. Med. Chem. Lett.,2011,21,22,"Hu Y, Xing L, Thomason JR, Xiang J, Ipek M, Guler S, Li H, Sabatini J, Chockalingam P, Reifenberg E, Sheldon R, Morris EA, Georgiadis KE, Tam S",,774908,DTCT0024002,7503518,DTCC00128984,639609,45376
CHEMBL191076,P45452,,XTJZQNUILYKCRX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15908214,KI,>,5020,NM,,,,,,,,,,,,,,In vitro binding affinity against matrix metalloprotease 13,,"Non-hydroxamate 5-phenylpyrimidine-2,4,6-trione derivatives as selective inhibitors of tumor necrosis factor-alpha converting enzyme.",Bioorg. Med. Chem. Lett.,2005,15,12,"Duan JJ, Lu Z, Wasserman ZR, Liu RQ, Covington MB, Decicco CP",,302358,DTCT0024002,1800066,DTCC00398004,1361039,16433
CHEMBL191359,P45452,,ZXORTEVXPYNWIB-XLIONFOSSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15911259,IC50,=,1.2,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-13 (MMP-13),,"Discovery of 3,3-dimethyl-5-hydroxypipecolic hydroxamate-based inhibitors of aggrecanase and MMP-13.",Bioorg. Med. Chem. Lett.,2005,15,11,"Noe MC, Natarajan V, Snow SL, Mitchell PG, Lopresti-Morrow L, Reeves LM, Yocum SA, Carty TJ, Barberia JA, Sweeney FJ, Liras JL, Vaughn M, Hardink JR, Hawkins JM, Tokar C",,304865,DTCT0024002,1813308,DTCC00398211,293165,18491
CHEMBL191360,P45452,,HEICZDBUMBAABJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15908214,KI,>,5020,NM,,,,,,,,,,,,,,In vitro binding affinity against matrix metalloprotease 13,,"Non-hydroxamate 5-phenylpyrimidine-2,4,6-trione derivatives as selective inhibitors of tumor necrosis factor-alpha converting enzyme.",Bioorg. Med. Chem. Lett.,2005,15,12,"Duan JJ, Lu Z, Wasserman ZR, Liu RQ, Covington MB, Decicco CP",,302358,DTCT0024002,1800401,DTCC00398432,1328331,16433
CHEMBL1914481,P45452,,ABWKZZSKNBCWLN-CQSZACIVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21937229,IC50,=,33,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788431,DTCT0024002,7527146,DTCC01161442,381077,46372
CHEMBL1914483,P45452,,ZTWMNQMJFNKJFV-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21937229,IC50,=,0.05,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788431,DTCT0024002,7527182,DTCC01161638,1027126,46372
CHEMBL1916050,P45452,,GETDIWSMCUZGCD-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21925881,IC50,=,0.4,NM,,,,,,,,,,,,,,Inhibition of human MMP13 catalytic domain (amino acids 103 to 268) using acetyl-Cys(Eu)-Pro-Leu-Gly-Leu-Lys-(QSY7)-Ala-Arg-amide as substrate preincubated for 1 hrs before substrate addition measured after 15 mins by fluorimetry,,Discovery of novel Cobactin-T based matrix metalloproteinase inhibitors via a ring closing metathesis strategy.,Bioorg. Med. Chem. Lett.,2011,21,21,"Wilson LJ, Wang B, Yang SM, Scannevin RH, Burke SL, Karnachi P, Rhodes KJ, Murray WV",,787974,DTCT0024002,7525364,DTCC01160859,685161,46368
CHEMBL1916054,P45452,,XAOJSOMIBKILNZ-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21925881,IC50,=,0.2,NM,,,,,,,,,,,,,,Inhibition of human MMP13 catalytic domain (amino acids 103 to 268) using acetyl-Cys(Eu)-Pro-Leu-Gly-Leu-Lys-(QSY7)-Ala-Arg-amide as substrate preincubated for 1 hrs before substrate addition measured after 15 mins by fluorimetry,,Discovery of novel Cobactin-T based matrix metalloproteinase inhibitors via a ring closing metathesis strategy.,Bioorg. Med. Chem. Lett.,2011,21,21,"Wilson LJ, Wang B, Yang SM, Scannevin RH, Burke SL, Karnachi P, Rhodes KJ, Murray WV",,787974,DTCT0024002,7525365,DTCC01160863,749845,46368
CHEMBL1916207,P45452,,AFHDVSQBDWGAQU-CQSZACIVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21925881,IC50,=,3,NM,,,,,,,,,,,,,,Inhibition of human MMP13 catalytic domain (amino acids 103 to 268) using acetyl-Cys(Eu)-Pro-Leu-Gly-Leu-Lys-(QSY7)-Ala-Arg-amide as substrate preincubated for 1 hrs before substrate addition measured after 15 mins by fluorimetry,,Discovery of novel Cobactin-T based matrix metalloproteinase inhibitors via a ring closing metathesis strategy.,Bioorg. Med. Chem. Lett.,2011,21,21,"Wilson LJ, Wang B, Yang SM, Scannevin RH, Burke SL, Karnachi P, Rhodes KJ, Murray WV",,787974,DTCT0024002,7525366,DTCC01161004,1397221,46368
CHEMBL1916210,P45452,,YBTXAIOMVIXCOD-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21925881,IC50,=,0.7,NM,,,,,,,,,,,,,,Inhibition of human MMP13 catalytic domain (amino acids 103 to 268) using acetyl-Cys(Eu)-Pro-Leu-Gly-Leu-Lys-(QSY7)-Ala-Arg-amide as substrate preincubated for 1 hrs before substrate addition measured after 15 mins by fluorimetry,,Discovery of novel Cobactin-T based matrix metalloproteinase inhibitors via a ring closing metathesis strategy.,Bioorg. Med. Chem. Lett.,2011,21,21,"Wilson LJ, Wang B, Yang SM, Scannevin RH, Burke SL, Karnachi P, Rhodes KJ, Murray WV",,787974,DTCT0024002,7525367,DTCC01161007,1655475,46368
CHEMBL1916640,P45452,,IOQOIXCSRBBCDP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21937229,IC50,=,8,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788431,DTCT0024002,7527144,DTCC01161440,930145,46372
CHEMBL1916641,P45452,,NAMZXOAZPHMVHE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21937229,IC50,=,180,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788431,DTCT0024002,7527145,DTCC01161441,1609616,46372
CHEMBL1916642,P45452,,JOOOUNMUHMUOJH-OAHLLOKOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21937229,IC50,=,2.9,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788431,DTCT0024002,7527147,DTCC01161443,1641910,46372
CHEMBL1916643,P45452,,NNUQGANTDABHBL-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21937229,IC50,=,7,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788431,DTCT0024002,7527148,DTCC01161444,51704,46372
CHEMBL1916644,P45452,,MRJCPNBIHXIUFQ-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21937229,IC50,=,3,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788431,DTCT0024002,7527149,DTCC01161445,1544977,46372
CHEMBL1916645,P45452,,BHCRZOUPEFVWHZ-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21937229,IC50,=,28,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788431,DTCT0024002,7527150,DTCC01161446,121036,46372
CHEMBL1916646,P45452,,ZHMDSAFJPANUBJ-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21937229,IC50,=,2,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788431,DTCT0024002,7527151,DTCC01161447,1609617,46372
CHEMBL1916647,P45452,,BRECBJOQRORDAF-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21937229,IC50,=,24,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788431,DTCT0024002,7527152,DTCC01161448,2057692,46372
CHEMBL1916648,P45452,,ICSWIBNMQZLUKX-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21937229,IC50,=,7,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788431,DTCT0024002,7527153,DTCC01161449,381078,46372
CHEMBL1916649,P45452,,YTELTZFLAYFFDQ-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21937229,IC50,=,15,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788431,DTCT0024002,7527154,DTCC01161450,1480418,46372
CHEMBL1916650,P45452,,ZHHIFOMQPDSUIP-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21937229,IC50,=,2.2,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788431,DTCT0024002,7527155,DTCC01161451,1188130,46372
CHEMBL1916651,P45452,,IVBBTZQIKSRCPC-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21937229,IC50,=,32,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788431,DTCT0024002,7527156,DTCC01161452,1674210,46372
CHEMBL1916652,P45452,,WHSJFJHSWYAKDM-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21937229,IC50,=,18,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788431,DTCT0024002,7527157,DTCC01161453,1155744,46372
CHEMBL1916653,P45452,,OXLIYFANWBIKMH-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21937229,IC50,=,0.6,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788431,DTCT0024002,7527158,DTCC01161454,1318507,46372
CHEMBL1916654,P45452,,FUOOTOLTPDFGCS-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21937229,IC50,=,1.3,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788431,DTCT0024002,7527159,DTCC01161455,866077,46372
CHEMBL1916655,P45452,,PSLXIIKDHBIITK-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21937229,IC50,=,12,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788431,DTCT0024002,7527160,DTCC01161456,51705,46372
CHEMBL1916656,P45452,,QGGLZVYZDFRHHX-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21937229,IC50,=,26,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788431,DTCT0024002,7527161,DTCC01161457,153514,46372
CHEMBL1916657,P45452,,IMCGJWBSANDEHB-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21937229,IC50,=,28,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788431,DTCT0024002,7527162,DTCC01161458,962508,46372
CHEMBL1916658,P45452,,PHVICSOQJHYLEW-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21937229,IC50,=,2.2,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788431,DTCT0024002,7527163,DTCC01161459,607032,46372
CHEMBL1916659,P45452,,TXFWBKCCZLIBMU-IBGZPJMESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21937229,IC50,=,34,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788431,DTCT0024002,7527164,DTCC01161460,704057,46372
CHEMBL1916660,P45452,,BCNQQPWDHJUQFQ-XPKAQORNSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21937229,IC50,=,3.2,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788431,DTCT0024002,7527165,DTCC01161461,930146,46372
CHEMBL1916661,P45452,,DHCMKRCHROJJHB-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21937229,IC50,=,1,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788431,DTCT0024002,7527166,DTCC01161462,768524,46372
CHEMBL1916662,P45452,,MDDFFAOYZXGICC-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21937229,IC50,=,242,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788431,DTCT0024002,7527167,DTCC01161463,1092420,46372
CHEMBL1916663,P45452,,URNPXFKEVDQWTO-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21937229,IC50,=,1.3,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788431,DTCT0024002,7527168,DTCC01161464,1609618,46372
CHEMBL1916664,P45452,,UUTDMYYQOAVOHN-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21937229,IC50,=,480,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788431,DTCT0024002,7527169,DTCC01161465,1577070,46372
CHEMBL1916665,P45452,,NYACXZAKXKSUHM-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21937229,IC50,=,3.6,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788431,DTCT0024002,7527170,DTCC01161466,1059387,46372
CHEMBL1916666,P45452,,GXINZIOTECAGST-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21937229,IC50,=,603,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788431,DTCT0024002,7527171,DTCC01161467,1188131,46372
CHEMBL1916830,P45452,,PEDLXNUHJRCVGF-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21937229,IC50,=,10,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788431,DTCT0024002,7527172,DTCC01161628,898351,46372
CHEMBL1916831,P45452,,VIWOHIOPIHELRI-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21937229,IC50,=,13,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788431,DTCT0024002,7527173,DTCC01161629,671853,46372
CHEMBL1916832,P45452,,JWGZOXAEXNYYHO-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21937229,IC50,=,176,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788431,DTCT0024002,7527174,DTCC01161630,962509,46372
CHEMBL1916833,P45452,,ZHMXASGBGYZMST-AREMUKBSSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21937229,IC50,=,165,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788431,DTCT0024002,7527175,DTCC01161631,704059,46372
CHEMBL1916834,P45452,,UXOSVQFKXFZCKF-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21937229,IC50,=,0.3,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788431,DTCT0024002,7527176,DTCC01161632,1220339,46372
CHEMBL1916835,P45452,,QGCFRSYWGLGDTC-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21937229,IC50,=,100,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788431,DTCT0024002,7527177,DTCC01161633,1188132,46372
CHEMBL1916836,P45452,,MFBQXIJAOSFCJR-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21937229,IC50,=,361,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788431,DTCT0024002,7527178,DTCC01161634,1830760,46372
CHEMBL1916837,P45452,,XUBGKCSUKRWGIB-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21937229,IC50,=,12,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788431,DTCT0024002,7527179,DTCC01161635,1960131,46372
CHEMBL1916838,P45452,,LSURBVCXYPJWOW-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21937229,IC50,=,1.8,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788431,DTCT0024002,7527180,DTCC01161636,510370,46372
CHEMBL1916839,P45452,,OOUAVDQEGOBVOR-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21937229,IC50,=,0.6,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788431,DTCT0024002,7527181,DTCC01161637,1734123,46372
CHEMBL1916840,P45452,,RNYCOGRIXBDHFK-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21937229,IC50,=,3892,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788431,DTCT0024002,7527183,DTCC01161639,1577071,46372
CHEMBL19179,P45452,,YASPRBVZHKHORZ-JKSUJKDBSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10882354,IC50,=,946,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,Structure-based design and synthesis of a potent matrix metalloproteinase-13 inhibitor based on a pyrrolidinone scaffold.,J. Med. Chem.,2000,43,12,"Robinson RP, Laird ER, Blake JF, Bordner J, Donahue KM, Lopresti-Morrow LL, Mitchell PG, Reese MR, Reeves LM, Stam EJ, Yocum SA",,106624,DTCT0024002,1121534,DTCC00151841,1785350,15747
CHEMBL19179,P45452,,YASPRBVZHKHORZ-JKSUJKDBSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11354379,IC50,=,946,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,Design and synthesis of 2-oxo-imidazolidine-4-carboxylic acid hydroxyamides as potent matrix metalloproteinase-13 inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,9,"Robinson RP, Laird ER, Donahue KM, Lopresti-Morrow LL, Mitchell PG, Reese MR, Reeves LM, Rouch AI, Stam EJ, Yocum SA",,106643,DTCT0024002,708589,DTCC00151841,1772879,4814
CHEMBL192204,P45452,,JXUDAYOKNXBKHH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15908214,KI,>,5020,NM,,,,,,,,,,,,,,In vitro binding affinity against matrix metalloprotease 13,,"Non-hydroxamate 5-phenylpyrimidine-2,4,6-trione derivatives as selective inhibitors of tumor necrosis factor-alpha converting enzyme.",Bioorg. Med. Chem. Lett.,2005,15,12,"Duan JJ, Lu Z, Wasserman ZR, Liu RQ, Covington MB, Decicco CP",,302358,DTCT0024002,1800389,DTCC00398406,7207,16433
CHEMBL192309,P45452,,AFKFHHGAXGELQR-APWZRJJASA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15911259,IC50,,,,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-13 (MMP-13); ND=not determined,Not Determined,"Discovery of 3,3-dimethyl-5-hydroxypipecolic hydroxamate-based inhibitors of aggrecanase and MMP-13.",Bioorg. Med. Chem. Lett.,2005,15,11,"Noe MC, Natarajan V, Snow SL, Mitchell PG, Lopresti-Morrow L, Reeves LM, Yocum SA, Carty TJ, Barberia JA, Sweeney FJ, Liras JL, Vaughn M, Hardink JR, Hawkins JM, Tokar C",,305480,DTCT0024002,1817364,DTCC00398684,423810,18491
CHEMBL19269,P45452,,LNMKFTOPZCDAED-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11934588,IC50,=,255,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 activity,,Anthranilate sulfonamide hydroxamate TACE inhibitors. Part 2: SAR of the acetylenic P1' group.,Bioorg. Med. Chem. Lett.,2002,12,8,"Levin JI, Chen JM, Du MT, Nelson FC, Killar LM, Skala S, Sung A, Jin G, Cowling R, Barone D, March CJ, Mohler KM, Black RA, Skotnicki JS",,106622,DTCT0024002,776521,DTCC00150802,421007,5465
CHEMBL1927183,P45452,,URQNIKFTQMJDKH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22088955,IC50,=,14000,NM,,,,,,,,,,,,,,Inhibition of human MMP13 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate pre-incubated for 4 hrs before substrate addition measured every 15 secs for 15 mins by fluorimetry,,Identification of novel molecular scaffolds for the design of MMP-13 inhibitors: a first round of lead optimization.,Eur. J. Med. Chem.,2012,47,,"La Pietra V, Marinelli L, Cosconati S, Di Leva FS, Nuti E, Santamaria S, Pugliesi I, Morelli M, Casalini F, Rossello A, La Motta C, Taliani S, Visse R, Nagase H, da Settimo F, Novellino E",,791981,DTCT0024002,7555530,DTCC01165287,2025754,46745
CHEMBL1927184,P45452,,MXDNHABTSLQECK-VEJZVKIUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22088955,IC50,=,22000,NM,,,,,,,,,,,,,,Inhibition of human MMP13 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate pre-incubated for 4 hrs before substrate addition measured every 15 secs for 15 mins by fluorimetry,,Identification of novel molecular scaffolds for the design of MMP-13 inhibitors: a first round of lead optimization.,Eur. J. Med. Chem.,2012,47,,"La Pietra V, Marinelli L, Cosconati S, Di Leva FS, Nuti E, Santamaria S, Pugliesi I, Morelli M, Casalini F, Rossello A, La Motta C, Taliani S, Visse R, Nagase H, da Settimo F, Novellino E",,791981,DTCT0024002,7555531,DTCC01165288,1480457,46745
CHEMBL1927185,P45452,,KKYDQVAGMODEPF-VMPITWQZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22088955,IC50,=,67000,NM,,,,,,,,,,,,,,Inhibition of human MMP13 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate pre-incubated for 4 hrs before substrate addition measured every 15 secs for 15 mins by fluorimetry,,Identification of novel molecular scaffolds for the design of MMP-13 inhibitors: a first round of lead optimization.,Eur. J. Med. Chem.,2012,47,,"La Pietra V, Marinelli L, Cosconati S, Di Leva FS, Nuti E, Santamaria S, Pugliesi I, Morelli M, Casalini F, Rossello A, La Motta C, Taliani S, Visse R, Nagase H, da Settimo F, Novellino E",,791981,DTCT0024002,7555532,DTCC01165289,671878,46745
CHEMBL1927186,P45452,,RMYNLYNJRHVJNU-RIYZIHGNSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22088955,IC50,=,120000,NM,,,,,,,,,,,,,,Inhibition of human MMP13 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate pre-incubated for 4 hrs before substrate addition measured every 15 secs for 15 mins by fluorimetry,,Identification of novel molecular scaffolds for the design of MMP-13 inhibitors: a first round of lead optimization.,Eur. J. Med. Chem.,2012,47,,"La Pietra V, Marinelli L, Cosconati S, Di Leva FS, Nuti E, Santamaria S, Pugliesi I, Morelli M, Casalini F, Rossello A, La Motta C, Taliani S, Visse R, Nagase H, da Settimo F, Novellino E",,791981,DTCT0024002,7555533,DTCC01165290,898397,46745
CHEMBL1927187,P45452,,UEOIUIPMEKCWHI-YJBIHYNGSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22088955,IC50,=,140000,NM,,,,,,,,,,,,,,Inhibition of human MMP13 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate pre-incubated for 4 hrs before substrate addition measured every 15 secs for 15 mins by fluorimetry,,Identification of novel molecular scaffolds for the design of MMP-13 inhibitors: a first round of lead optimization.,Eur. J. Med. Chem.,2012,47,,"La Pietra V, Marinelli L, Cosconati S, Di Leva FS, Nuti E, Santamaria S, Pugliesi I, Morelli M, Casalini F, Rossello A, La Motta C, Taliani S, Visse R, Nagase H, da Settimo F, Novellino E",,791981,DTCT0024002,7555534,DTCC01165291,1351218,46745
CHEMBL1927188,P45452,,CLAIXOTVTWDIMV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22088955,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of human MMP13 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate at 100 uM pre-incubated for 4 hrs before substrate addition measured every 15 secs for 15 mins by fluorimetry,Not Active,Identification of novel molecular scaffolds for the design of MMP-13 inhibitors: a first round of lead optimization.,Eur. J. Med. Chem.,2012,47,,"La Pietra V, Marinelli L, Cosconati S, Di Leva FS, Nuti E, Santamaria S, Pugliesi I, Morelli M, Casalini F, Rossello A, La Motta C, Taliani S, Visse R, Nagase H, da Settimo F, Novellino E",,791983,DTCT0024002,7555548,DTCC01165292,185656,46745
CHEMBL1927189,P45452,,ZMIRBLYNPOSRPX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22088955,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of human MMP13 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate at 100 uM pre-incubated for 4 hrs before substrate addition measured every 15 secs for 15 mins by fluorimetry,Not Active,Identification of novel molecular scaffolds for the design of MMP-13 inhibitors: a first round of lead optimization.,Eur. J. Med. Chem.,2012,47,,"La Pietra V, Marinelli L, Cosconati S, Di Leva FS, Nuti E, Santamaria S, Pugliesi I, Morelli M, Casalini F, Rossello A, La Motta C, Taliani S, Visse R, Nagase H, da Settimo F, Novellino E",,791983,DTCT0024002,7555549,DTCC01165293,315779,46745
CHEMBL1927190,P45452,,JWWLKAGPOHICPO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22088955,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of human MMP13 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate at 100 uM pre-incubated for 4 hrs before substrate addition measured every 15 secs for 15 mins by fluorimetry,Not Active,Identification of novel molecular scaffolds for the design of MMP-13 inhibitors: a first round of lead optimization.,Eur. J. Med. Chem.,2012,47,,"La Pietra V, Marinelli L, Cosconati S, Di Leva FS, Nuti E, Santamaria S, Pugliesi I, Morelli M, Casalini F, Rossello A, La Motta C, Taliani S, Visse R, Nagase H, da Settimo F, Novellino E",,791983,DTCT0024002,7555550,DTCC01165294,1862814,46745
CHEMBL1927191,P45452,,OHXQEZHOXRQQFE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22088955,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of human MMP13 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate at 100 uM pre-incubated for 4 hrs before substrate addition measured every 15 secs for 15 mins by fluorimetry,Not Active,Identification of novel molecular scaffolds for the design of MMP-13 inhibitors: a first round of lead optimization.,Eur. J. Med. Chem.,2012,47,,"La Pietra V, Marinelli L, Cosconati S, Di Leva FS, Nuti E, Santamaria S, Pugliesi I, Morelli M, Casalini F, Rossello A, La Motta C, Taliani S, Visse R, Nagase H, da Settimo F, Novellino E",,791983,DTCT0024002,7555551,DTCC01165295,1253436,46745
CHEMBL1927192,P45452,,JARKGTQUOUWEGI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22088955,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of human MMP13 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate at 100 uM pre-incubated for 4 hrs before substrate addition measured every 15 secs for 15 mins by fluorimetry,Not Active,Identification of novel molecular scaffolds for the design of MMP-13 inhibitors: a first round of lead optimization.,Eur. J. Med. Chem.,2012,47,,"La Pietra V, Marinelli L, Cosconati S, Di Leva FS, Nuti E, Santamaria S, Pugliesi I, Morelli M, Casalini F, Rossello A, La Motta C, Taliani S, Visse R, Nagase H, da Settimo F, Novellino E",,791983,DTCT0024002,7555552,DTCC01165296,1480458,46745
CHEMBL1927193,P45452,,XSHDFSVVLUVNJI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22088955,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of human MMP13 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate at 100 uM pre-incubated for 4 hrs before substrate addition measured every 15 secs for 15 mins by fluorimetry,Not Active,Identification of novel molecular scaffolds for the design of MMP-13 inhibitors: a first round of lead optimization.,Eur. J. Med. Chem.,2012,47,,"La Pietra V, Marinelli L, Cosconati S, Di Leva FS, Nuti E, Santamaria S, Pugliesi I, Morelli M, Casalini F, Rossello A, La Motta C, Taliani S, Visse R, Nagase H, da Settimo F, Novellino E",,791983,DTCT0024002,7555553,DTCC01165297,1351219,46745
CHEMBL1927194,P45452,,BAIKYEOFHMISHA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22088955,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of human MMP13 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate at 100 uM pre-incubated for 4 hrs before substrate addition measured every 15 secs for 15 mins by fluorimetry,Not Active,Identification of novel molecular scaffolds for the design of MMP-13 inhibitors: a first round of lead optimization.,Eur. J. Med. Chem.,2012,47,,"La Pietra V, Marinelli L, Cosconati S, Di Leva FS, Nuti E, Santamaria S, Pugliesi I, Morelli M, Casalini F, Rossello A, La Motta C, Taliani S, Visse R, Nagase H, da Settimo F, Novellino E",,791983,DTCT0024002,7555554,DTCC01165298,1545022,46745
CHEMBL1927195,P45452,,VBEUHQGJOSFXBT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22088955,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of human MMP13 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate at 100 uM pre-incubated for 4 hrs before substrate addition measured every 15 secs for 15 mins by fluorimetry,Not Active,Identification of novel molecular scaffolds for the design of MMP-13 inhibitors: a first round of lead optimization.,Eur. J. Med. Chem.,2012,47,,"La Pietra V, Marinelli L, Cosconati S, Di Leva FS, Nuti E, Santamaria S, Pugliesi I, Morelli M, Casalini F, Rossello A, La Motta C, Taliani S, Visse R, Nagase H, da Settimo F, Novellino E",,791983,DTCT0024002,7555555,DTCC01165299,1447998,46745
CHEMBL1927196,P45452,,CPSWJHBUUGMXAB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22088955,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of human MMP13 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate at 100 uM pre-incubated for 4 hrs before substrate addition measured every 15 secs for 15 mins by fluorimetry,Not Active,Identification of novel molecular scaffolds for the design of MMP-13 inhibitors: a first round of lead optimization.,Eur. J. Med. Chem.,2012,47,,"La Pietra V, Marinelli L, Cosconati S, Di Leva FS, Nuti E, Santamaria S, Pugliesi I, Morelli M, Casalini F, Rossello A, La Motta C, Taliani S, Visse R, Nagase H, da Settimo F, Novellino E",,791983,DTCT0024002,7555556,DTCC01165300,1960173,46745
CHEMBL1927197,P45452,,DJAZZQJULYRVMH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22088955,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of human MMP13 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate at 100 uM pre-incubated for 4 hrs before substrate addition measured every 15 secs for 15 mins by fluorimetry,Not Active,Identification of novel molecular scaffolds for the design of MMP-13 inhibitors: a first round of lead optimization.,Eur. J. Med. Chem.,2012,47,,"La Pietra V, Marinelli L, Cosconati S, Di Leva FS, Nuti E, Santamaria S, Pugliesi I, Morelli M, Casalini F, Rossello A, La Motta C, Taliani S, Visse R, Nagase H, da Settimo F, Novellino E",,791983,DTCT0024002,7555557,DTCC01165301,1253437,46745
CHEMBL1927198,P45452,,DYBFYEOABYDNRA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22088955,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of human MMP13 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate at 100 uM pre-incubated for 4 hrs before substrate addition measured every 15 secs for 15 mins by fluorimetry,Not Active,Identification of novel molecular scaffolds for the design of MMP-13 inhibitors: a first round of lead optimization.,Eur. J. Med. Chem.,2012,47,,"La Pietra V, Marinelli L, Cosconati S, Di Leva FS, Nuti E, Santamaria S, Pugliesi I, Morelli M, Casalini F, Rossello A, La Motta C, Taliani S, Visse R, Nagase H, da Settimo F, Novellino E",,791983,DTCT0024002,7555558,DTCC01165302,607078,46745
CHEMBL1927199,P45452,,JVAIYFASDWZOSF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22088955,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of human MMP13 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate at 100 uM pre-incubated for 4 hrs before substrate addition measured every 15 secs for 15 mins by fluorimetry,Not Active,Identification of novel molecular scaffolds for the design of MMP-13 inhibitors: a first round of lead optimization.,Eur. J. Med. Chem.,2012,47,,"La Pietra V, Marinelli L, Cosconati S, Di Leva FS, Nuti E, Santamaria S, Pugliesi I, Morelli M, Casalini F, Rossello A, La Motta C, Taliani S, Visse R, Nagase H, da Settimo F, Novellino E",,791983,DTCT0024002,7555559,DTCC01165303,1027174,46745
CHEMBL1927200,P45452,,DZILGYLWRFMPOA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22088955,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of human MMP13 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate at 100 uM pre-incubated for 4 hrs before substrate addition measured every 15 secs for 15 mins by fluorimetry,Not Active,Identification of novel molecular scaffolds for the design of MMP-13 inhibitors: a first round of lead optimization.,Eur. J. Med. Chem.,2012,47,,"La Pietra V, Marinelli L, Cosconati S, Di Leva FS, Nuti E, Santamaria S, Pugliesi I, Morelli M, Casalini F, Rossello A, La Motta C, Taliani S, Visse R, Nagase H, da Settimo F, Novellino E",,791983,DTCT0024002,7555560,DTCC01165304,607079,46745
CHEMBL1927201,P45452,,BVULSQXCOXUJCA-XYOKQWHBSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22088955,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of human MMP13 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate at 100 uM pre-incubated for 4 hrs before substrate addition measured every 15 secs for 15 mins by fluorimetry,Not Active,Identification of novel molecular scaffolds for the design of MMP-13 inhibitors: a first round of lead optimization.,Eur. J. Med. Chem.,2012,47,,"La Pietra V, Marinelli L, Cosconati S, Di Leva FS, Nuti E, Santamaria S, Pugliesi I, Morelli M, Casalini F, Rossello A, La Motta C, Taliani S, Visse R, Nagase H, da Settimo F, Novellino E",,791983,DTCT0024002,7555561,DTCC01165305,1960174,46745
CHEMBL1927202,P45452,,BDGVYJAWWIKKBN-AQHRCUNFSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22088955,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of human MMP13 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate at 100 uM pre-incubated for 4 hrs before substrate addition measured every 15 secs for 15 mins by fluorimetry,Not Active,Identification of novel molecular scaffolds for the design of MMP-13 inhibitors: a first round of lead optimization.,Eur. J. Med. Chem.,2012,47,,"La Pietra V, Marinelli L, Cosconati S, Di Leva FS, Nuti E, Santamaria S, Pugliesi I, Morelli M, Casalini F, Rossello A, La Motta C, Taliani S, Visse R, Nagase H, da Settimo F, Novellino E",,791983,DTCT0024002,7555562,DTCC01165306,510427,46745
CHEMBL1927203,P45452,,DYILTSUXJXXNBE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22088955,IC50,>,300000,NM,,,,,,,,,,,,,,Inhibition of human MMP13 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate pre-incubated for 4 hrs before substrate addition measured every 15 secs for 15 mins by fluorimetry,,Identification of novel molecular scaffolds for the design of MMP-13 inhibitors: a first round of lead optimization.,Eur. J. Med. Chem.,2012,47,,"La Pietra V, Marinelli L, Cosconati S, Di Leva FS, Nuti E, Santamaria S, Pugliesi I, Morelli M, Casalini F, Rossello A, La Motta C, Taliani S, Visse R, Nagase H, da Settimo F, Novellino E",,791981,DTCT0024002,7555536,DTCC01165307,800673,46745
CHEMBL1927204,P45452,,NKOOQEXUIIOFNF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22088955,IC50,=,5200,NM,,,,,,,,,,,,,,Inhibition of human MMP13 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate pre-incubated for 4 hrs before substrate addition measured every 15 secs for 15 mins by fluorimetry,,Identification of novel molecular scaffolds for the design of MMP-13 inhibitors: a first round of lead optimization.,Eur. J. Med. Chem.,2012,47,,"La Pietra V, Marinelli L, Cosconati S, Di Leva FS, Nuti E, Santamaria S, Pugliesi I, Morelli M, Casalini F, Rossello A, La Motta C, Taliani S, Visse R, Nagase H, da Settimo F, Novellino E",,791981,DTCT0024002,7555537,DTCC01165308,930201,46745
CHEMBL1927205,P45452,,SAFXYJWXQPZDKB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22088955,IC50,=,3200,NM,,,,,,,,,,,,,,Inhibition of human MMP13 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate pre-incubated for 4 hrs before substrate addition measured every 15 secs for 15 mins by fluorimetry,,Identification of novel molecular scaffolds for the design of MMP-13 inhibitors: a first round of lead optimization.,Eur. J. Med. Chem.,2012,47,,"La Pietra V, Marinelli L, Cosconati S, Di Leva FS, Nuti E, Santamaria S, Pugliesi I, Morelli M, Casalini F, Rossello A, La Motta C, Taliani S, Visse R, Nagase H, da Settimo F, Novellino E",,791981,DTCT0024002,7555538,DTCC01165309,1318556,46745
CHEMBL1927206,P45452,,AAXDSXQOIOVALR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22088955,IC50,=,5500,NM,,,,,,,,,,,,,,Inhibition of human MMP13 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate pre-incubated for 4 hrs before substrate addition measured every 15 secs for 15 mins by fluorimetry,,Identification of novel molecular scaffolds for the design of MMP-13 inhibitors: a first round of lead optimization.,Eur. J. Med. Chem.,2012,47,,"La Pietra V, Marinelli L, Cosconati S, Di Leva FS, Nuti E, Santamaria S, Pugliesi I, Morelli M, Casalini F, Rossello A, La Motta C, Taliani S, Visse R, Nagase H, da Settimo F, Novellino E",,791981,DTCT0024002,7555539,DTCC01165310,444742,46745
CHEMBL1927207,P45452,,GLUKBIYRQDQIFQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22088955,IC50,=,2600,NM,,,,,,,,,,,,,,Inhibition of human MMP13 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate pre-incubated for 4 hrs before substrate addition measured every 15 secs for 15 mins by fluorimetry,,Identification of novel molecular scaffolds for the design of MMP-13 inhibitors: a first round of lead optimization.,Eur. J. Med. Chem.,2012,47,,"La Pietra V, Marinelli L, Cosconati S, Di Leva FS, Nuti E, Santamaria S, Pugliesi I, Morelli M, Casalini F, Rossello A, La Motta C, Taliani S, Visse R, Nagase H, da Settimo F, Novellino E",,791981,DTCT0024002,7555540,DTCC01165311,2089862,46745
CHEMBL1927208,P45452,,HJKTUFXPVSDGCO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22088955,IC50,=,4900,NM,,,,,,,,,,,,,,Inhibition of human MMP13 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate pre-incubated for 4 hrs before substrate addition measured every 15 secs for 15 mins by fluorimetry,,Identification of novel molecular scaffolds for the design of MMP-13 inhibitors: a first round of lead optimization.,Eur. J. Med. Chem.,2012,47,,"La Pietra V, Marinelli L, Cosconati S, Di Leva FS, Nuti E, Santamaria S, Pugliesi I, Morelli M, Casalini F, Rossello A, La Motta C, Taliani S, Visse R, Nagase H, da Settimo F, Novellino E",,791981,DTCT0024002,7555541,DTCC01165312,833275,46745
CHEMBL1927209,P45452,,UKBNGSYHDLSJFI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22088955,IC50,=,4900,NM,,,,,,,,,,,,,,Inhibition of human MMP13 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate pre-incubated for 4 hrs before substrate addition measured every 15 secs for 15 mins by fluorimetry,,Identification of novel molecular scaffolds for the design of MMP-13 inhibitors: a first round of lead optimization.,Eur. J. Med. Chem.,2012,47,,"La Pietra V, Marinelli L, Cosconati S, Di Leva FS, Nuti E, Santamaria S, Pugliesi I, Morelli M, Casalini F, Rossello A, La Motta C, Taliani S, Visse R, Nagase H, da Settimo F, Novellino E",,791981,DTCT0024002,7555542,DTCC01165313,1609666,46745
CHEMBL192773,P45452,,LQRPHHDGTPYXHT-XLIONFOSSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15911259,IC50,=,2.8,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-13 (MMP-13),,"Discovery of 3,3-dimethyl-5-hydroxypipecolic hydroxamate-based inhibitors of aggrecanase and MMP-13.",Bioorg. Med. Chem. Lett.,2005,15,11,"Noe MC, Natarajan V, Snow SL, Mitchell PG, Lopresti-Morrow L, Reeves LM, Yocum SA, Carty TJ, Barberia JA, Sweeney FJ, Liras JL, Vaughn M, Hardink JR, Hawkins JM, Tokar C",,304865,DTCT0024002,1810971,DTCC00397626,1683959,18491
CHEMBL19278,P45452,,WGPIMMRNIAYWBT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11934588,IC50,=,47,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 activity,,Anthranilate sulfonamide hydroxamate TACE inhibitors. Part 2: SAR of the acetylenic P1' group.,Bioorg. Med. Chem. Lett.,2002,12,8,"Levin JI, Chen JM, Du MT, Nelson FC, Killar LM, Skala S, Sung A, Jin G, Cowling R, Barone D, March CJ, Mohler KM, Black RA, Skotnicki JS",,106622,DTCT0024002,801754,DTCC00150852,1034298,5465
CHEMBL19279,P45452,,CSVWGAZPMRHMHB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11934588,IC50,=,433,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 activity,,Anthranilate sulfonamide hydroxamate TACE inhibitors. Part 2: SAR of the acetylenic P1' group.,Bioorg. Med. Chem. Lett.,2002,12,8,"Levin JI, Chen JM, Du MT, Nelson FC, Killar LM, Skala S, Sung A, Jin G, Cowling R, Barone D, March CJ, Mohler KM, Black RA, Skotnicki JS",,106622,DTCT0024002,811560,DTCC00150553,127998,5465
CHEMBL193084,P45452,,HNINPFHHNYDBSH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15908214,KI,>,5020,NM,,,,,,,,,,,,,,In vitro binding affinity against matrix metalloprotease 13,,"Non-hydroxamate 5-phenylpyrimidine-2,4,6-trione derivatives as selective inhibitors of tumor necrosis factor-alpha converting enzyme.",Bioorg. Med. Chem. Lett.,2005,15,12,"Duan JJ, Lu Z, Wasserman ZR, Liu RQ, Covington MB, Decicco CP",,302358,DTCT0024002,1800208,DTCC00398196,227645,16433
CHEMBL19320,P45452,,VXXLUYPODYWRKE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11934588,INHIBITION,=,42,%,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 at 10 uM,,Anthranilate sulfonamide hydroxamate TACE inhibitors. Part 2: SAR of the acetylenic P1' group.,Bioorg. Med. Chem. Lett.,2002,12,8,"Levin JI, Chen JM, Du MT, Nelson FC, Killar LM, Skala S, Sung A, Jin G, Cowling R, Barone D, March CJ, Mohler KM, Black RA, Skotnicki JS",,106772,DTCT0024002,783719,DTCC00150440,2064635,5465
CHEMBL193316,P45452,,QKXIBRKQCXPSEK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15908214,KI,=,5020,NM,,,,,,,,,,,,,,In vitro binding affinity against matrix metalloprotease 13,,"Non-hydroxamate 5-phenylpyrimidine-2,4,6-trione derivatives as selective inhibitors of tumor necrosis factor-alpha converting enzyme.",Bioorg. Med. Chem. Lett.,2005,15,12,"Duan JJ, Lu Z, Wasserman ZR, Liu RQ, Covington MB, Decicco CP",,302358,DTCT0024002,1802361,DTCC00398156,1619558,16433
CHEMBL1935291,P45452,,MUMVNZHARHFSLP-SFHVURJKSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22153340,IC50,=,1980,NM,,,,,,,,,,,,,,Inhibition of human MMP-13,,Discovery of potent and selective matrix metalloprotease 12 inhibitors for the potential treatment of chronic obstructive pulmonary disease (COPD).,Bioorg. Med. Chem. Lett.,2012,22,1,"Wu Y, Li J, Wu J, Morgan P, Xu X, Rancati F, Vallese S, Raveglia L, Hotchandani R, Fuller N, Bard J, Cunningham K, Fish S, Krykbaev R, Tam S, Goldman SJ, Williams C, Mansour TS, Saiah E, Sypek J, Li W",,796151,DTCT0024002,7576413,DTCC01169633,51895,46933
CHEMBL19371,P45452,,BRHXKZALFBLRIF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11934588,IC50,=,289,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 activity,,Anthranilate sulfonamide hydroxamate TACE inhibitors. Part 2: SAR of the acetylenic P1' group.,Bioorg. Med. Chem. Lett.,2002,12,8,"Levin JI, Chen JM, Du MT, Nelson FC, Killar LM, Skala S, Sung A, Jin G, Cowling R, Barone D, March CJ, Mohler KM, Black RA, Skotnicki JS",,106622,DTCT0024002,780859,DTCC00150615,1034299,5465
CHEMBL193945,P45452,,OCBYWAVDKLDIDI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15908214,KI,=,95,NM,,,,,,,,,,,,,,In vitro binding affinity against matrix metalloprotease 13,,"Non-hydroxamate 5-phenylpyrimidine-2,4,6-trione derivatives as selective inhibitors of tumor necrosis factor-alpha converting enzyme.",Bioorg. Med. Chem. Lett.,2005,15,12,"Duan JJ, Lu Z, Wasserman ZR, Liu RQ, Covington MB, Decicco CP",,302358,DTCT0024002,1800232,DTCC00398285,875794,16433
CHEMBL1939844,P45452,,FTRCUXMVUJZMHT-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22017477,IC50,=,300,NM,,,,,,,,,,,,,,Inhibition of MMP13 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate preincubated for 4 hrs measured every 15 secs for 20 mins by fluorescence analysis,,"Novel 1-hydroxypiperazine-2,6-diones as new leads in the inhibition of metalloproteinases.",J. Med. Chem.,2011,54,24,"Marques SM, Tuccinardi T, Nuti E, Santamaria S, André V, Rossello A, Martinelli A, Santos MA",,799127,DTCT0024002,7595889,DTCC01171473,2071098,47023
CHEMBL1939845,P45452,,JVBFGGAYMSJQBZ-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22017477,IC50,=,52,NM,,,,,,,,,,,,,,Inhibition of MMP13 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate preincubated for 4 hrs measured every 15 secs for 20 mins by fluorescence analysis,,"Novel 1-hydroxypiperazine-2,6-diones as new leads in the inhibition of metalloproteinases.",J. Med. Chem.,2011,54,24,"Marques SM, Tuccinardi T, Nuti E, Santamaria S, André V, Rossello A, Martinelli A, Santos MA",,799127,DTCT0024002,7595890,DTCC01171474,1811871,47023
CHEMBL1939846,P45452,,RQCBSNJRFVZHOS-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22017477,IC50,=,9.5,NM,,,,,,,,,,,,,,Inhibition of MMP13 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate preincubated for 4 hrs measured every 15 secs for 20 mins by fluorescence analysis,,"Novel 1-hydroxypiperazine-2,6-diones as new leads in the inhibition of metalloproteinases.",J. Med. Chem.,2011,54,24,"Marques SM, Tuccinardi T, Nuti E, Santamaria S, André V, Rossello A, Martinelli A, Santos MA",,799127,DTCT0024002,7595891,DTCC01171475,1461560,47023
CHEMBL1939861,P45452,,JIKNCQOTMSZCCM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22017539,IC50,=,97000,NM,,,,,,,,,,,,,,Inhibition of human MMP13 expressed in Escherichia coli after 30 mins by fluorimetry,,Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.,J. Med. Chem.,2011,54,23,"Taylor SJ, Abeywardane A, Liang S, Muegge I, Padyana AK, Xiong Z, Hill-Drzewi M, Farmer B, Li X, Collins B, Li JX, Heim-Riether A, Proudfoot J, Zhang Q, Goldberg D, Zuvela-Jelaska L, Zaher H, Li J, Farrow NA",,799144,DTCT0024002,7595962,DTCC01171489,1448052,47024
CHEMBL1939861,P45452,,JIKNCQOTMSZCCM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22017539,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of MMP13 at 500 uM after 30 mins by fluorimetry in the presence of 1.25% human serum albumin,Active,Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.,J. Med. Chem.,2011,54,23,"Taylor SJ, Abeywardane A, Liang S, Muegge I, Padyana AK, Xiong Z, Hill-Drzewi M, Farmer B, Li X, Collins B, Li JX, Heim-Riether A, Proudfoot J, Zhang Q, Goldberg D, Zuvela-Jelaska L, Zaher H, Li J, Farrow NA",,799143,DTCT0024002,7595965,DTCC01171489,1448052,47024
CHEMBL1939862,P45452,,HNSDWMLOQWSYEZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22017539,IC50,=,39000,NM,,,,,,,,,,,,,,Inhibition of human MMP13 expressed in Escherichia coli after 30 mins by fluorimetry,,Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.,J. Med. Chem.,2011,54,23,"Taylor SJ, Abeywardane A, Liang S, Muegge I, Padyana AK, Xiong Z, Hill-Drzewi M, Farmer B, Li X, Collins B, Li JX, Heim-Riether A, Proudfoot J, Zhang Q, Goldberg D, Zuvela-Jelaska L, Zaher H, Li J, Farrow NA",,799144,DTCT0024002,7595967,DTCC01171490,1027241,47024
CHEMBL1939862,P45452,,HNSDWMLOQWSYEZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22017539,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of MMP13 at 500 uM after 30 mins by fluorimetry in the presence of 1.25% human serum albumin,Active,Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.,J. Med. Chem.,2011,54,23,"Taylor SJ, Abeywardane A, Liang S, Muegge I, Padyana AK, Xiong Z, Hill-Drzewi M, Farmer B, Li X, Collins B, Li JX, Heim-Riether A, Proudfoot J, Zhang Q, Goldberg D, Zuvela-Jelaska L, Zaher H, Li J, Farrow NA",,799143,DTCT0024002,7595966,DTCC01171490,1027241,47024
CHEMBL1939863,P45452,,NSMIRZBXLNLXDX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22017539,IC50,>,500000,NM,,,,,,,,,,,,,,Inhibition of human MMP13 expressed in Escherichia coli after 30 mins by fluorimetry,,Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.,J. Med. Chem.,2011,54,23,"Taylor SJ, Abeywardane A, Liang S, Muegge I, Padyana AK, Xiong Z, Hill-Drzewi M, Farmer B, Li X, Collins B, Li JX, Heim-Riether A, Proudfoot J, Zhang Q, Goldberg D, Zuvela-Jelaska L, Zaher H, Li J, Farrow NA",,799144,DTCT0024002,7595968,DTCC01171491,1766143,47024
CHEMBL1939864,P45452,,DUIOAVKMTLORSS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22017539,IC50,>,500000,NM,,,,,,,,,,,,,,Inhibition of human MMP13 expressed in Escherichia coli after 30 mins by fluorimetry,,Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.,J. Med. Chem.,2011,54,23,"Taylor SJ, Abeywardane A, Liang S, Muegge I, Padyana AK, Xiong Z, Hill-Drzewi M, Farmer B, Li X, Collins B, Li JX, Heim-Riether A, Proudfoot J, Zhang Q, Goldberg D, Zuvela-Jelaska L, Zaher H, Li J, Farrow NA",,799144,DTCT0024002,7595969,DTCC01171492,994770,47024
CHEMBL1939865,P45452,,NPIPEGMWIPYGFS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22017539,IC50,=,31000,NM,,,,,,,,,,,,,,Inhibition of human MMP13 expressed in Escherichia coli after 30 mins by fluorimetry,,Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.,J. Med. Chem.,2011,54,23,"Taylor SJ, Abeywardane A, Liang S, Muegge I, Padyana AK, Xiong Z, Hill-Drzewi M, Farmer B, Li X, Collins B, Li JX, Heim-Riether A, Proudfoot J, Zhang Q, Goldberg D, Zuvela-Jelaska L, Zaher H, Li J, Farrow NA",,799144,DTCT0024002,7595970,DTCC01171493,1480531,47024
CHEMBL1939866,P45452,,BPAGZGRJYMKXTM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22017539,IC50,=,220000,NM,,,,,,,,,,,,,,Inhibition of human MMP13 expressed in Escherichia coli after 30 mins by fluorimetry,,Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.,J. Med. Chem.,2011,54,23,"Taylor SJ, Abeywardane A, Liang S, Muegge I, Padyana AK, Xiong Z, Hill-Drzewi M, Farmer B, Li X, Collins B, Li JX, Heim-Riether A, Proudfoot J, Zhang Q, Goldberg D, Zuvela-Jelaska L, Zaher H, Li J, Farrow NA",,799144,DTCT0024002,7595971,DTCC01171494,1155846,47024
CHEMBL1939867,P45452,,LGCJHSHDRDEELV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22017539,IC50,>,500000,NM,,,,,,,,,,,,,,Inhibition of human MMP13 expressed in Escherichia coli after 30 mins by fluorimetry,,Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.,J. Med. Chem.,2011,54,23,"Taylor SJ, Abeywardane A, Liang S, Muegge I, Padyana AK, Xiong Z, Hill-Drzewi M, Farmer B, Li X, Collins B, Li JX, Heim-Riether A, Proudfoot J, Zhang Q, Goldberg D, Zuvela-Jelaska L, Zaher H, Li J, Farrow NA",,799144,DTCT0024002,7595972,DTCC01171495,1577168,47024
CHEMBL1939868,P45452,,YCALHTWCQXREQN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22017539,IC50,>,500000,NM,,,,,,,,,,,,,,Inhibition of human MMP13 expressed in Escherichia coli after 30 mins by fluorimetry,,Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.,J. Med. Chem.,2011,54,23,"Taylor SJ, Abeywardane A, Liang S, Muegge I, Padyana AK, Xiong Z, Hill-Drzewi M, Farmer B, Li X, Collins B, Li JX, Heim-Riether A, Proudfoot J, Zhang Q, Goldberg D, Zuvela-Jelaska L, Zaher H, Li J, Farrow NA",,799144,DTCT0024002,7595973,DTCC01171496,1383924,47024
CHEMBL1939869,P45452,,LOJFRPMFTHNIRX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22017539,IC50,=,15000,NM,,,,,,,,,,,,,,Inhibition of human MMP13 expressed in Escherichia coli after 30 mins by fluorimetry,,Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.,J. Med. Chem.,2011,54,23,"Taylor SJ, Abeywardane A, Liang S, Muegge I, Padyana AK, Xiong Z, Hill-Drzewi M, Farmer B, Li X, Collins B, Li JX, Heim-Riether A, Proudfoot J, Zhang Q, Goldberg D, Zuvela-Jelaska L, Zaher H, Li J, Farrow NA",,799144,DTCT0024002,7595974,DTCC01171497,348592,47024
CHEMBL1939870,P45452,,HESNUJSXTQZPIZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22017539,IC50,=,82000,NM,,,,,,,,,,,,,,Inhibition of human MMP13 expressed in Escherichia coli after 30 mins by fluorimetry,,Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.,J. Med. Chem.,2011,54,23,"Taylor SJ, Abeywardane A, Liang S, Muegge I, Padyana AK, Xiong Z, Hill-Drzewi M, Farmer B, Li X, Collins B, Li JX, Heim-Riether A, Proudfoot J, Zhang Q, Goldberg D, Zuvela-Jelaska L, Zaher H, Li J, Farrow NA",,799144,DTCT0024002,7595975,DTCC01171498,1286070,47024
CHEMBL1939871,P45452,,BPFTZTNLEWSFNX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22017539,IC50,=,9600,NM,,,,,,,,,,,,,,Inhibition of human MMP13 expressed in Escherichia coli after 30 mins by fluorimetry,,Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.,J. Med. Chem.,2011,54,23,"Taylor SJ, Abeywardane A, Liang S, Muegge I, Padyana AK, Xiong Z, Hill-Drzewi M, Farmer B, Li X, Collins B, Li JX, Heim-Riether A, Proudfoot J, Zhang Q, Goldberg D, Zuvela-Jelaska L, Zaher H, Li J, Farrow NA",,799144,DTCT0024002,7595976,DTCC01171499,1092535,47024
CHEMBL1939872,P45452,,FOLNSFQIWULSJC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22017539,IC50,=,2500,NM,,,,,,,,,,,,,,Inhibition of human MMP13 expressed in Escherichia coli after 30 mins by fluorimetry,,Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.,J. Med. Chem.,2011,54,23,"Taylor SJ, Abeywardane A, Liang S, Muegge I, Padyana AK, Xiong Z, Hill-Drzewi M, Farmer B, Li X, Collins B, Li JX, Heim-Riether A, Proudfoot J, Zhang Q, Goldberg D, Zuvela-Jelaska L, Zaher H, Li J, Farrow NA",,799144,DTCT0024002,7595977,DTCC01171500,1027242,47024
CHEMBL1939873,P45452,,BUDKKUJVRGJAJW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22017539,IC50,=,2400,NM,,,,,,,,,,,,,,Inhibition of human MMP13 expressed in Escherichia coli after 30 mins by fluorimetry,,Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.,J. Med. Chem.,2011,54,23,"Taylor SJ, Abeywardane A, Liang S, Muegge I, Padyana AK, Xiong Z, Hill-Drzewi M, Farmer B, Li X, Collins B, Li JX, Heim-Riether A, Proudfoot J, Zhang Q, Goldberg D, Zuvela-Jelaska L, Zaher H, Li J, Farrow NA",,799144,DTCT0024002,7595978,DTCC01171501,51933,47024
CHEMBL1939874,P45452,,XYAPTVNWZXNGOT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22017539,IC50,=,90,NM,,,,,,,,,,,,,,Inhibition of human MMP13 expressed in Escherichia coli after 30 mins by fluorimetry,,Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.,J. Med. Chem.,2011,54,23,"Taylor SJ, Abeywardane A, Liang S, Muegge I, Padyana AK, Xiong Z, Hill-Drzewi M, Farmer B, Li X, Collins B, Li JX, Heim-Riether A, Proudfoot J, Zhang Q, Goldberg D, Zuvela-Jelaska L, Zaher H, Li J, Farrow NA",,799144,DTCT0024002,7595979,DTCC01171502,121152,47024
CHEMBL1939874,P45452,,XYAPTVNWZXNGOT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22017539,IC50,=,360,NM,,,,,,,,,,,,,,Inhibition of MMP13 after 30 mins by fluorimetry in the presence of 1.25% human serum albumin,,Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.,J. Med. Chem.,2011,54,23,"Taylor SJ, Abeywardane A, Liang S, Muegge I, Padyana AK, Xiong Z, Hill-Drzewi M, Farmer B, Li X, Collins B, Li JX, Heim-Riether A, Proudfoot J, Zhang Q, Goldberg D, Zuvela-Jelaska L, Zaher H, Li J, Farrow NA",,799149,DTCT0024002,7596029,DTCC01171502,121152,47024
CHEMBL1939875,P45452,,REANBRVQFZEMPZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22017539,IC50,=,120,NM,,,,,,,,,,,,,,Inhibition of human MMP13 expressed in Escherichia coli after 30 mins by fluorimetry,,Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.,J. Med. Chem.,2011,54,23,"Taylor SJ, Abeywardane A, Liang S, Muegge I, Padyana AK, Xiong Z, Hill-Drzewi M, Farmer B, Li X, Collins B, Li JX, Heim-Riether A, Proudfoot J, Zhang Q, Goldberg D, Zuvela-Jelaska L, Zaher H, Li J, Farrow NA",,799144,DTCT0024002,7595980,DTCC01171503,994771,47024
CHEMBL1939875,P45452,,REANBRVQFZEMPZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22017539,IC50,=,280,NM,,,,,,,,,,,,,,Inhibition of MMP13 after 30 mins by fluorimetry in the presence of 1.25% human serum albumin,,Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.,J. Med. Chem.,2011,54,23,"Taylor SJ, Abeywardane A, Liang S, Muegge I, Padyana AK, Xiong Z, Hill-Drzewi M, Farmer B, Li X, Collins B, Li JX, Heim-Riether A, Proudfoot J, Zhang Q, Goldberg D, Zuvela-Jelaska L, Zaher H, Li J, Farrow NA",,799149,DTCT0024002,7596030,DTCC01171503,994771,47024
CHEMBL1939876,P45452,,MMJPVSDTLGFIQW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22017539,IC50,=,1,NM,,,,,,,,,,,,,,Inhibition of human MMP13 expressed in Escherichia coli after 30 mins by fluorimetry,,Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.,J. Med. Chem.,2011,54,23,"Taylor SJ, Abeywardane A, Liang S, Muegge I, Padyana AK, Xiong Z, Hill-Drzewi M, Farmer B, Li X, Collins B, Li JX, Heim-Riether A, Proudfoot J, Zhang Q, Goldberg D, Zuvela-Jelaska L, Zaher H, Li J, Farrow NA",,799144,DTCT0024002,7595981,DTCC01171504,1734238,47024
CHEMBL1939876,P45452,,MMJPVSDTLGFIQW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22017539,IC50,=,4,NM,,,,,,,,,,,,,,Inhibition of MMP13 after 30 mins by fluorimetry in the presence of 1.25% human serum albumin,,Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.,J. Med. Chem.,2011,54,23,"Taylor SJ, Abeywardane A, Liang S, Muegge I, Padyana AK, Xiong Z, Hill-Drzewi M, Farmer B, Li X, Collins B, Li JX, Heim-Riether A, Proudfoot J, Zhang Q, Goldberg D, Zuvela-Jelaska L, Zaher H, Li J, Farrow NA",,799149,DTCT0024002,7596031,DTCC01171504,1734238,47024
CHEMBL1939876,P45452,,MMJPVSDTLGFIQW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22017539,IC50,=,11,NM,,,,,,,,,,,,,,Inhibition of AMPA-activated MMP13-mediated degradation of FITC-labeled type2 collagen after 1.5 hrs by fluorimetry,,Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.,J. Med. Chem.,2011,54,23,"Taylor SJ, Abeywardane A, Liang S, Muegge I, Padyana AK, Xiong Z, Hill-Drzewi M, Farmer B, Li X, Collins B, Li JX, Heim-Riether A, Proudfoot J, Zhang Q, Goldberg D, Zuvela-Jelaska L, Zaher H, Li J, Farrow NA",,799236,DTCT0024002,7596045,DTCC01171504,1734238,47024
CHEMBL1939876,P45452,,MMJPVSDTLGFIQW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22017539,IC50,=,31,NM,,,,,,,,,,,,,,Inhibition of human MMP13-mediated degradation of bovine nasal cartilage after 2 hrs by ELISA in the presence of 10% human serum,,Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.,J. Med. Chem.,2011,54,23,"Taylor SJ, Abeywardane A, Liang S, Muegge I, Padyana AK, Xiong Z, Hill-Drzewi M, Farmer B, Li X, Collins B, Li JX, Heim-Riether A, Proudfoot J, Zhang Q, Goldberg D, Zuvela-Jelaska L, Zaher H, Li J, Farrow NA",,799237,DTCT0024002,7596046,DTCC01171504,1734238,47024
CHEMBL1939877,P45452,,UHHFYGOUQISNPH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22017539,IC50,=,3,NM,,,,,,,,,,,,,,Inhibition of human MMP13 expressed in Escherichia coli after 30 mins by fluorimetry,,Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.,J. Med. Chem.,2011,54,23,"Taylor SJ, Abeywardane A, Liang S, Muegge I, Padyana AK, Xiong Z, Hill-Drzewi M, Farmer B, Li X, Collins B, Li JX, Heim-Riether A, Proudfoot J, Zhang Q, Goldberg D, Zuvela-Jelaska L, Zaher H, Li J, Farrow NA",,799144,DTCT0024002,7595982,DTCC01171505,283179,47024
CHEMBL1939877,P45452,,UHHFYGOUQISNPH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22017539,IC50,=,14,NM,,,,,,,,,,,,,,Inhibition of MMP13 after 30 mins by fluorimetry in the presence of 1.25% human serum albumin,,Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.,J. Med. Chem.,2011,54,23,"Taylor SJ, Abeywardane A, Liang S, Muegge I, Padyana AK, Xiong Z, Hill-Drzewi M, Farmer B, Li X, Collins B, Li JX, Heim-Riether A, Proudfoot J, Zhang Q, Goldberg D, Zuvela-Jelaska L, Zaher H, Li J, Farrow NA",,799149,DTCT0024002,7596032,DTCC01171505,283179,47024
CHEMBL1939878,P45452,,DMKUTALHEIQGEX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22017539,IC50,=,150,NM,,,,,,,,,,,,,,Inhibition of human MMP13 expressed in Escherichia coli after 30 mins by fluorimetry,,Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.,J. Med. Chem.,2011,54,23,"Taylor SJ, Abeywardane A, Liang S, Muegge I, Padyana AK, Xiong Z, Hill-Drzewi M, Farmer B, Li X, Collins B, Li JX, Heim-Riether A, Proudfoot J, Zhang Q, Goldberg D, Zuvela-Jelaska L, Zaher H, Li J, Farrow NA",,799144,DTCT0024002,7595983,DTCC01171506,1124652,47024
CHEMBL1939878,P45452,,DMKUTALHEIQGEX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22017539,IC50,=,640,NM,,,,,,,,,,,,,,Inhibition of MMP13 after 30 mins by fluorimetry in the presence of 1.25% human serum albumin,,Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.,J. Med. Chem.,2011,54,23,"Taylor SJ, Abeywardane A, Liang S, Muegge I, Padyana AK, Xiong Z, Hill-Drzewi M, Farmer B, Li X, Collins B, Li JX, Heim-Riether A, Proudfoot J, Zhang Q, Goldberg D, Zuvela-Jelaska L, Zaher H, Li J, Farrow NA",,799149,DTCT0024002,7596033,DTCC01171506,1124652,47024
CHEMBL1939879,P45452,,CNAVZNPDBKLQMF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22017539,IC50,=,25000,NM,,,,,,,,,,,,,,Inhibition of human MMP13 expressed in Escherichia coli after 30 mins by fluorimetry,,Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.,J. Med. Chem.,2011,54,23,"Taylor SJ, Abeywardane A, Liang S, Muegge I, Padyana AK, Xiong Z, Hill-Drzewi M, Farmer B, Li X, Collins B, Li JX, Heim-Riether A, Proudfoot J, Zhang Q, Goldberg D, Zuvela-Jelaska L, Zaher H, Li J, Farrow NA",,799144,DTCT0024002,7595984,DTCC01171507,898461,47024
CHEMBL1939879,P45452,,CNAVZNPDBKLQMF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22017539,IC50,=,56000,NM,,,,,,,,,,,,,,Inhibition of MMP13 after 30 mins by fluorimetry in the presence of 1.25% human serum albumin,,Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.,J. Med. Chem.,2011,54,23,"Taylor SJ, Abeywardane A, Liang S, Muegge I, Padyana AK, Xiong Z, Hill-Drzewi M, Farmer B, Li X, Collins B, Li JX, Heim-Riether A, Proudfoot J, Zhang Q, Goldberg D, Zuvela-Jelaska L, Zaher H, Li J, Farrow NA",,799149,DTCT0024002,7596034,DTCC01171507,898461,47024
CHEMBL1939880,P45452,,FOIUQQUDMFDDDC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22017539,IC50,>,26000,NM,,,,,,,,,,,,,,Inhibition of human MMP13 expressed in Escherichia coli after 30 mins by fluorimetry,,Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.,J. Med. Chem.,2011,54,23,"Taylor SJ, Abeywardane A, Liang S, Muegge I, Padyana AK, Xiong Z, Hill-Drzewi M, Farmer B, Li X, Collins B, Li JX, Heim-Riether A, Proudfoot J, Zhang Q, Goldberg D, Zuvela-Jelaska L, Zaher H, Li J, Farrow NA",,799144,DTCT0024002,7595985,DTCC01171508,866192,47024
CHEMBL1939881,P45452,,MPAWABYIQDNGTF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22017539,IC50,=,250,NM,,,,,,,,,,,,,,Inhibition of human MMP13 expressed in Escherichia coli after 30 mins by fluorimetry,,Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.,J. Med. Chem.,2011,54,23,"Taylor SJ, Abeywardane A, Liang S, Muegge I, Padyana AK, Xiong Z, Hill-Drzewi M, Farmer B, Li X, Collins B, Li JX, Heim-Riether A, Proudfoot J, Zhang Q, Goldberg D, Zuvela-Jelaska L, Zaher H, Li J, Farrow NA",,799144,DTCT0024002,7595986,DTCC01171509,1480532,47024
CHEMBL1939881,P45452,,MPAWABYIQDNGTF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22017539,IC50,=,1900,NM,,,,,,,,,,,,,,Inhibition of MMP13 after 30 mins by fluorimetry in the presence of 1.25% human serum albumin,,Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.,J. Med. Chem.,2011,54,23,"Taylor SJ, Abeywardane A, Liang S, Muegge I, Padyana AK, Xiong Z, Hill-Drzewi M, Farmer B, Li X, Collins B, Li JX, Heim-Riether A, Proudfoot J, Zhang Q, Goldberg D, Zuvela-Jelaska L, Zaher H, Li J, Farrow NA",,799149,DTCT0024002,7596035,DTCC01171509,1480532,47024
CHEMBL1939882,P45452,,KAYFBYGQLVMKBS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22018790,INHIBITION,=,32.9,%,,,,,,,,,,,,,,Inhibition of human full length recombinant MMP13 using triple-helical fTHP-15 as substrate at 40 uM after 4 hrs by FRET assay,,"Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds.",Bioorg. Med. Chem. Lett.,2011,21,23,"Roth J, Minond D, Darout E, Liu Q, Lauer J, Hodder P, Fields GB, Roush WR",,799259,DTCT0024002,7596072,DTCC01171510,898462,47025
CHEMBL1940017,P45452,,SYJJEQWZPIPHRJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22018790,INHIBITION,=,30.5,%,,,,,,,,,,,,,,Inhibition of human full length recombinant MMP13 using triple-helical fTHP-15 as substrate at 40 uM after 4 hrs by FRET assay,,"Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds.",Bioorg. Med. Chem. Lett.,2011,21,23,"Roth J, Minond D, Darout E, Liu Q, Lauer J, Hodder P, Fields GB, Roush WR",,799259,DTCT0024002,7596075,DTCC01171643,1092536,47025
CHEMBL1940018,P45452,,SCPZKKACZBRJQN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22018790,INHIBITION,=,37.7,%,,,,,,,,,,,,,,Inhibition of human full length recombinant MMP13 using triple-helical fTHP-15 as substrate at 40 uM after 4 hrs by FRET assay,,"Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds.",Bioorg. Med. Chem. Lett.,2011,21,23,"Roth J, Minond D, Darout E, Liu Q, Lauer J, Hodder P, Fields GB, Roush WR",,799259,DTCT0024002,7596076,DTCC01171644,898464,47025
CHEMBL1940019,P45452,,QLCOPJMEIRNGIU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22018790,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of human full length recombinant MMP13 using triple-helical fTHP-15 as substrate at 40 uM after 4 hrs by FRET assay,Not Active,"Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds.",Bioorg. Med. Chem. Lett.,2011,21,23,"Roth J, Minond D, Darout E, Liu Q, Lauer J, Hodder P, Fields GB, Roush WR",,799259,DTCT0024002,7596080,DTCC01171645,1059491,47025
CHEMBL1940020,P45452,,NTFJZROMMPMZHM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22018790,INHIBITION,=,46.7,%,,,,,,,,,,,,,,Inhibition of human full length recombinant MMP13 using triple-helical fTHP-15 as substrate at 40 uM after 4 hrs by FRET assay,,"Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds.",Bioorg. Med. Chem. Lett.,2011,21,23,"Roth J, Minond D, Darout E, Liu Q, Lauer J, Hodder P, Fields GB, Roush WR",,799259,DTCT0024002,7596084,DTCC01171646,833347,47025
CHEMBL1940021,P45452,,CBTFKNWTIFEQIG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22018790,INHIBITION,=,7.2,%,,,,,,,,,,,,,,Inhibition of human full length recombinant MMP13 using triple-helical fTHP-15 as substrate at 40 uM after 4 hrs by FRET assay,,"Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds.",Bioorg. Med. Chem. Lett.,2011,21,23,"Roth J, Minond D, Darout E, Liu Q, Lauer J, Hodder P, Fields GB, Roush WR",,799259,DTCT0024002,7596090,DTCC01171647,444801,47025
CHEMBL1940022,P45452,,MCYRWNXWNIRIDF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22018790,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of human full length recombinant MMP13 using triple-helical fTHP-15 as substrate at 40 uM after 4 hrs by FRET assay,Not Active,"Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds.",Bioorg. Med. Chem. Lett.,2011,21,23,"Roth J, Minond D, Darout E, Liu Q, Lauer J, Hodder P, Fields GB, Roush WR",,799259,DTCT0024002,7596093,DTCC01171648,1642035,47025
CHEMBL1940023,P45452,,BDCBSAPZGIOAFN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22018790,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of human full length recombinant MMP13 using triple-helical fTHP-15 as substrate at 40 uM after 4 hrs by FRET assay,Not Active,"Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds.",Bioorg. Med. Chem. Lett.,2011,21,23,"Roth J, Minond D, Darout E, Liu Q, Lauer J, Hodder P, Fields GB, Roush WR",,799259,DTCT0024002,7596094,DTCC01171649,1318623,47025
CHEMBL1940024,P45452,,FBZUTQDZLGLHTE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22018790,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of human full length recombinant MMP13 using triple-helical fTHP-15 as substrate at 40 uM after 4 hrs by FRET assay,Not Active,"Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds.",Bioorg. Med. Chem. Lett.,2011,21,23,"Roth J, Minond D, Darout E, Liu Q, Lauer J, Hodder P, Fields GB, Roush WR",,799259,DTCT0024002,7596095,DTCC01171650,478120,47025
CHEMBL1940025,P45452,,JHBHSNDSMKOPRX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22018790,INHIBITION,=,16,%,,,,,,,,,,,,,,Inhibition of human full length recombinant MMP13 using triple-helical fTHP-15 as substrate at 40 uM after 4 hrs by FRET assay,,"Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds.",Bioorg. Med. Chem. Lett.,2011,21,23,"Roth J, Minond D, Darout E, Liu Q, Lauer J, Hodder P, Fields GB, Roush WR",,799259,DTCT0024002,7596096,DTCC01171651,1059492,47025
CHEMBL1940277,P45452,,RNUQVLPAAPSKGH-LJAQVGFWSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22153941,IC50,=,251.19,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798828,DTCT0024002,7601205,DTCC01171896,1642036,47049
CHEMBL1940278,P45452,,SYUFFODKYFQNKR-PBBNMVCDSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22153941,IC50,=,12.59,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798828,DTCT0024002,7601202,DTCC01171897,1706025,47049
CHEMBL1940279,P45452,,BLVTYAOGMSRRPZ-YTTGMZPUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22153941,IC50,=,19.95,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798828,DTCT0024002,7601201,DTCC01171898,542752,47049
CHEMBL1940280,P45452,,IUJKVSRFVDSMJK-MHZLTWQESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22153941,IC50,=,316.23,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798828,DTCT0024002,7601204,DTCC01171899,1059493,47049
CHEMBL1940281,P45452,,FJMHXOYGOGYKAU-LJAQVGFWSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22153941,IC50,=,63.1,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798828,DTCT0024002,7601200,DTCC01171900,510519,47049
CHEMBL1940282,P45452,,IPGBSWJQXVYQBT-PMERELPUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22153941,IC50,=,31.62,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798828,DTCT0024002,7601199,DTCC01171901,1512992,47049
CHEMBL1940283,P45452,,GQZCCXOGTHJTFK-PMERELPUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22153941,IC50,=,79.43,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798828,DTCT0024002,7601198,DTCC01171902,1642037,47049
CHEMBL1940284,P45452,,IFVVAVDCKGJFSK-PMERELPUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22153941,IC50,=,63.1,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798828,DTCT0024002,7601197,DTCC01171903,1383927,47049
CHEMBL1940285,P45452,,BJMJYODXDWMFDH-PMERELPUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22153941,IC50,=,63.1,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798828,DTCT0024002,7601196,DTCC01171904,542753,47049
CHEMBL1940286,P45452,,YQMHKWPHLMVWLN-LJAQVGFWSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22153941,IC50,=,31.62,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798828,DTCT0024002,7601195,DTCC01171905,444802,47049
CHEMBL1940287,P45452,,BDWCIDSXORGMEX-HKBQPEDESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22153941,IC50,=,10,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798828,DTCT0024002,7601194,DTCC01171906,1927205,47049
CHEMBL1940288,P45452,,DBVCMEXOYUZQJM-HKBQPEDESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22153941,IC50,=,50.12,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798828,DTCT0024002,7601193,DTCC01171907,51937,47049
CHEMBL1940289,P45452,,WBHJOSGWNQHLCM-HKBQPEDESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22153941,IC50,=,39.81,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798828,DTCT0024002,7601192,DTCC01171908,833354,47049
CHEMBL1940290,P45452,,DCRZEJJUPRPPOS-LJAQVGFWSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22153941,IC50,=,100,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798828,DTCT0024002,7601191,DTCC01171909,1480536,47049
CHEMBL1940291,P45452,,HVWVSAVLGKOEBY-NDEPHWFRSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22153941,IC50,=,79.43,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798828,DTCT0024002,7601203,DTCC01171910,2057793,47049
CHEMBL1940292,P45452,,PLYGOFXFDNGSQZ-LJAQVGFWSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22153941,IC50,=,100,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798828,DTCT0024002,7601190,DTCC01171911,704138,47049
CHEMBL1940293,P45452,,OINRDKHSDNWICI-NDEPHWFRSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22153941,IC50,=,25.12,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798828,DTCT0024002,7601189,DTCC01171912,1927206,47049
CHEMBL1940294,P45452,,OPHMVUHOAQVGHE-VWLOTQADSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22153941,IC50,=,100,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798828,DTCT0024002,7601188,DTCC01171913,833355,47049
CHEMBL1940295,P45452,,CFEBEGNWVYAYDX-BCHFMIIMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22153941,IC50,=,50.12,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798828,DTCT0024002,7601187,DTCC01171914,1798571,47049
CHEMBL1940296,P45452,,CWFNNQMBLVACQD-QHCPKHFHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22153941,IC50,=,199.53,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798828,DTCT0024002,7601186,DTCC01171915,1124659,47049
CHEMBL1940297,P45452,,QYNYVCREJAXCIU-QFIPXVFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22153941,IC50,=,5011.87,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798828,DTCT0024002,7601185,DTCC01171916,639775,47049
CHEMBL1940298,P45452,,QAQSNNOKIPKADY-QFIPXVFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22153941,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798828,DTCT0024002,7601184,DTCC01171917,381190,47049
CHEMBL1940299,P45452,,QOKVSISTOJSNTA-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22153941,IC50,=,1000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798828,DTCT0024002,7601183,DTCC01171918,1862885,47049
CHEMBL1940300,P45452,,JKWGAOMOBSWCRX-QFIPXVFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22153941,IC50,=,630.96,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798828,DTCT0024002,7601182,DTCC01171919,768634,47049
CHEMBL1940301,P45452,,ACFGWGVCEQHPKH-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22153941,IC50,=,1584.89,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798828,DTCT0024002,7601181,DTCC00129335,1027247,47049
CHEMBL1940302,P45452,,HPKSKDNLXCDEMU-QHCPKHFHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22153941,IC50,=,2511.89,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798828,DTCT0024002,7601180,DTCC00129336,736405,47049
CHEMBL1940303,P45452,,ROSHPMUADVBKAX-QHCPKHFHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22153941,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798828,DTCT0024002,7601179,DTCC00129337,1642038,47049
CHEMBL1940304,P45452,,MLCYWTZZAGWMNW-QFIPXVFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22153941,IC50,=,2511.89,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798828,DTCT0024002,7601178,DTCC00129338,639777,47049
CHEMBL1940305,P45452,,BWRWARXRSYCARL-YMQLSTQVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22153941,IC50,=,398.11,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798828,DTCT0024002,7601177,DTCC01171920,1545092,47049
CHEMBL1940306,P45452,,SBZWCADMWCTYJD-QFIPXVFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22153941,IC50,=,316.23,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798828,DTCT0024002,7601176,DTCC01171921,348595,47049
CHEMBL1940307,P45452,,LBUIUPMSHUKSPO-QFIPXVFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22153941,IC50,=,100,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798828,DTCT0024002,7601175,DTCC01171922,51938,47049
CHEMBL1940308,P45452,,RMPYEISUTHEMLW-NDEPHWFRSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22153941,IC50,=,74,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798828,DTCT0024002,7601162,DTCC01171923,574793,47049
CHEMBL1940308,P45452,,RMPYEISUTHEMLW-NDEPHWFRSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22153941,IC50,=,79.43,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798828,DTCT0024002,7601174,DTCC01171923,574793,47049
CHEMBL1940309,P45452,,WHUKRVZMYYJSJL-NDEPHWFRSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22153941,IC50,=,50.12,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798828,DTCT0024002,7601173,DTCC01171924,1448056,47049
CHEMBL1940310,P45452,,IERBLZLEQYZHMU-LJAQVGFWSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22153941,IC50,=,39.81,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798828,DTCT0024002,7601172,DTCC01171925,1674314,47049
CHEMBL1940311,P45452,,LIYRHLZYJZBQCM-HKBQPEDESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22153941,IC50,=,25.12,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798828,DTCT0024002,7601171,DTCC01171926,1416228,47049
CHEMBL1940312,P45452,,QAOWEZMLHINPHR-LJAQVGFWSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22153941,IC50,=,50.12,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798828,DTCT0024002,7601169,DTCC01171927,1830857,47049
CHEMBL1940313,P45452,,BVTIVQKMMMOOTF-PMERELPUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22153941,IC50,=,79.43,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798828,DTCT0024002,7601168,DTCC01171928,1318627,47049
CHEMBL1940314,P45452,,OMQWCWIEQOEJBD-MHZLTWQESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22153941,IC50,=,100,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798828,DTCT0024002,7601167,DTCC01171929,1286076,47049
CHEMBL1940315,P45452,,IOEYWFCDGXVEFG-JVHFYALYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22153941,IC50,=,10,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798828,DTCT0024002,7601165,DTCC01171930,1734241,47049
CHEMBL1940315,P45452,,IOEYWFCDGXVEFG-JVHFYALYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22153941,IC50,=,37,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798828,DTCT0024002,7601161,DTCC01171930,1734240,47049
CHEMBL1940315,P45452,,IOEYWFCDGXVEFG-JVHFYALYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22153941,IC50,=,39.81,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798828,DTCT0024002,7601166,DTCC01171930,1734240,47049
CHEMBL1940316,P45452,,NMPAJDNRYQXHBH-XGCAABAXSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22153941,IC50,=,79.43,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798828,DTCT0024002,7601164,DTCC01171931,1830858,47049
CHEMBL194237,P45452,,VRUQYJXYEALKCT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16084720,IC50,=,6,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metallopeptidase 13,,Acetylenic TACE inhibitors. Part 2: SAR of six-membered cyclic sulfonamide hydroxamates.,Bioorg. Med. Chem. Lett.,2005,15,19,"Levin JI, Chen JM, Laakso LM, Du M, Du X, Venkatesan AM, Sandanayaka V, Zask A, Xu J, Xu W, Zhang Y, Skotnicki JS",,321254,DTCT0024002,1861785,DTCC00408064,2002834,19752
CHEMBL194237,P45452,,VRUQYJXYEALKCT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16084720,IC50,=,6,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metallopeptidase 13,,Acetylenic TACE inhibitors. Part 2: SAR of six-membered cyclic sulfonamide hydroxamates.,Bioorg. Med. Chem. Lett.,2005,15,19,"Levin JI, Chen JM, Laakso LM, Du M, Du X, Venkatesan AM, Sandanayaka V, Zask A, Xu J, Xu W, Zhang Y, Skotnicki JS",,321254,DTCT0024002,1862305,DTCC00408064,2002835,19752
CHEMBL194377,P45452,,LRMGKWDRORXPRE-SANMLTNESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16153831,IC50,=,3.8,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-13,,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321194,DTCT0024002,1860390,DTCC00407675,110120,19837
CHEMBL194430,P45452,,FXZROVPZUUATHR-SANMLTNESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16153831,IC50,=,11,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-13,,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321194,DTCT0024002,1860438,DTCC00407681,596206,19837
CHEMBL1946141,P45452,,BRXGWWVUCIZYMM-VNRZBHCFSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22118188,IC50,=,645,NM,,,,,,,,,,,,,,"Inhibition of MMP13 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins measured after 10 mins by fluorescence analysis",,"A new generation of radiofluorinated pyrimidine-2,4,6-triones as MMP-targeted radiotracers for positron emission tomography.",J. Med. Chem.,2012,55,1,"Schrigten D, Breyholz HJ, Wagner S, Hermann S, Schober O, Schäfers M, Haufe G, Kopka K",,800776,DTCT0024002,7619097,DTCC01174040,736427,47195
CHEMBL1946142,P45452,,HSQOMGXZKXTHEM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22118188,IC50,=,48,NM,,,,,,,,,,,,,,"Inhibition of MMP13 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins measured after 10 mins by fluorescence analysis",,"A new generation of radiofluorinated pyrimidine-2,4,6-triones as MMP-targeted radiotracers for positron emission tomography.",J. Med. Chem.,2012,55,1,"Schrigten D, Breyholz HJ, Wagner S, Hermann S, Schober O, Schäfers M, Haufe G, Kopka K",,800776,DTCT0024002,7619098,DTCC01174041,866229,47195
CHEMBL1946143,P45452,,BCOFTFDFNHXYGF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22118188,IC50,=,16,NM,,,,,,,,,,,,,,"Inhibition of MMP13 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins measured after 10 mins by fluorescence analysis",,"A new generation of radiofluorinated pyrimidine-2,4,6-triones as MMP-targeted radiotracers for positron emission tomography.",J. Med. Chem.,2012,55,1,"Schrigten D, Breyholz HJ, Wagner S, Hermann S, Schober O, Schäfers M, Haufe G, Kopka K",,800776,DTCT0024002,7619099,DTCC01174042,1766168,47195
CHEMBL1946144,P45452,,APJIPTNFOKEMIQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22118188,IC50,=,87,NM,,,,,,,,,,,,,,"Inhibition of MMP13 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins measured after 10 mins by fluorescence analysis",,"A new generation of radiofluorinated pyrimidine-2,4,6-triones as MMP-targeted radiotracers for positron emission tomography.",J. Med. Chem.,2012,55,1,"Schrigten D, Breyholz HJ, Wagner S, Hermann S, Schober O, Schäfers M, Haufe G, Kopka K",,800776,DTCT0024002,7619100,DTCC01174043,1124683,47195
CHEMBL1946145,P45452,,LEIFVUOVYOUZFH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22118188,IC50,=,9,NM,,,,,,,,,,,,,,"Inhibition of MMP13 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins measured after 10 mins by fluorescence analysis",,"A new generation of radiofluorinated pyrimidine-2,4,6-triones as MMP-targeted radiotracers for positron emission tomography.",J. Med. Chem.,2012,55,1,"Schrigten D, Breyholz HJ, Wagner S, Hermann S, Schober O, Schäfers M, Haufe G, Kopka K",,800776,DTCT0024002,7619101,DTCC01174044,866230,47195
CHEMBL1946146,P45452,,HSWKOBISGMUSTR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22118188,IC50,=,51,NM,,,,,,,,,,,,,,"Inhibition of MMP13 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins measured after 10 mins by fluorescence analysis",,"A new generation of radiofluorinated pyrimidine-2,4,6-triones as MMP-targeted radiotracers for positron emission tomography.",J. Med. Chem.,2012,55,1,"Schrigten D, Breyholz HJ, Wagner S, Hermann S, Schober O, Schäfers M, Haufe G, Kopka K",,800776,DTCT0024002,7619102,DTCC01174045,704155,47195
CHEMBL1946147,P45452,,GGMOCOYDYRCVAH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22118188,IC50,=,94,NM,,,,,,,,,,,,,,"Inhibition of MMP13 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins measured after 10 mins by fluorescence analysis",,"A new generation of radiofluorinated pyrimidine-2,4,6-triones as MMP-targeted radiotracers for positron emission tomography.",J. Med. Chem.,2012,55,1,"Schrigten D, Breyholz HJ, Wagner S, Hermann S, Schober O, Schäfers M, Haufe G, Kopka K",,800776,DTCT0024002,7619103,DTCC01174046,185744,47195
CHEMBL1946148,P45452,,LWNWGJXWKYGLPU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22118188,IC50,=,605,NM,,,,,,,,,,,,,,"Inhibition of MMP13 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins measured after 10 mins by fluorescence analysis",,"A new generation of radiofluorinated pyrimidine-2,4,6-triones as MMP-targeted radiotracers for positron emission tomography.",J. Med. Chem.,2012,55,1,"Schrigten D, Breyholz HJ, Wagner S, Hermann S, Schober O, Schäfers M, Haufe G, Kopka K",,800776,DTCT0024002,7619104,DTCC01174047,1706054,47195
CHEMBL1946149,P45452,,SVUOUTRIPGSFHF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22118188,IC50,=,7,NM,,,,,,,,,,,,,,"Inhibition of MMP13 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins measured after 10 mins by fluorescence analysis",,"A new generation of radiofluorinated pyrimidine-2,4,6-triones as MMP-targeted radiotracers for positron emission tomography.",J. Med. Chem.,2012,55,1,"Schrigten D, Breyholz HJ, Wagner S, Hermann S, Schober O, Schäfers M, Haufe G, Kopka K",,800776,DTCT0024002,7619105,DTCC01174048,1513025,47195
CHEMBL194627,P45452,,YCIYENASUWAOBH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16084720,IC50,=,49,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metallopeptidase 13,,Acetylenic TACE inhibitors. Part 2: SAR of six-membered cyclic sulfonamide hydroxamates.,Bioorg. Med. Chem. Lett.,2005,15,19,"Levin JI, Chen JM, Laakso LM, Du M, Du X, Venkatesan AM, Sandanayaka V, Zask A, Xu J, Xu W, Zhang Y, Skotnicki JS",,321254,DTCT0024002,1861765,DTCC00408048,1198212,19752
CHEMBL194627,P45452,,YCIYENASUWAOBH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16084720,IC50,=,49,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metallopeptidase 13,,Acetylenic TACE inhibitors. Part 2: SAR of six-membered cyclic sulfonamide hydroxamates.,Bioorg. Med. Chem. Lett.,2005,15,19,"Levin JI, Chen JM, Laakso LM, Du M, Du X, Venkatesan AM, Sandanayaka V, Zask A, Xu J, Xu W, Zhang Y, Skotnicki JS",,321254,DTCT0024002,1862284,DTCC00408048,1198214,19752
CHEMBL1946275,P45452,,RWOLXJOULAGHOB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22118188,IC50,=,23,NM,,,,,,,,,,,,,,"Inhibition of MMP13 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins measured after 10 mins by fluorescence analysis",,"A new generation of radiofluorinated pyrimidine-2,4,6-triones as MMP-targeted radiotracers for positron emission tomography.",J. Med. Chem.,2012,55,1,"Schrigten D, Breyholz HJ, Wagner S, Hermann S, Schober O, Schäfers M, Haufe G, Kopka K",,800776,DTCT0024002,7619106,DTCC01174168,542782,47195
CHEMBL1946276,P45452,,JZIODDCGNMBMLB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22118188,IC50,=,21,NM,,,,,,,,,,,,,,"Inhibition of MMP13 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins measured after 10 mins by fluorescence analysis",,"A new generation of radiofluorinated pyrimidine-2,4,6-triones as MMP-targeted radiotracers for positron emission tomography.",J. Med. Chem.,2012,55,1,"Schrigten D, Breyholz HJ, Wagner S, Hermann S, Schober O, Schäfers M, Haufe G, Kopka K",,800776,DTCT0024002,7619107,DTCC01174169,1830895,47195
CHEMBL1946277,P45452,,PTJXSKQZLWNDNB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22118188,IC50,=,40,NM,,,,,,,,,,,,,,"Inhibition of MMP13 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins measured after 10 mins by fluorescence analysis",,"A new generation of radiofluorinated pyrimidine-2,4,6-triones as MMP-targeted radiotracers for positron emission tomography.",J. Med. Chem.,2012,55,1,"Schrigten D, Breyholz HJ, Wagner S, Hermann S, Schober O, Schäfers M, Haufe G, Kopka K",,800776,DTCT0024002,7619108,DTCC01174170,833388,47195
CHEMBL1956115,P45452,,GDYIQUFNICPYHF-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22175825,KI,=,7730,NM,,,,,,,,,,,,,,Inhibition of human MMP13,,Potent inhibitors of LpxC for the treatment of Gram-negative infections.,J. Med. Chem.,2012,55,2,"Brown MF, Reilly U, Abramite JA, Arcari JT, Oliver R, Barham RA, Che Y, Chen JM, Collantes EM, Chung SW, Desbonnet C, Doty J, Doroski M, Engtrakul JJ, Harris TM, Huband M, Knafels JD, Leach KL, Liu S, Marfat A, Marra A, McElroy E, Melnick M, Menard CA, Montgomery JI, Mullins L, Noe MC, O'Donnell J, Penzien J, Plummer MS, Price LM, Shanmugasundaram V, Thoma C, Uccello DP, Warmus JS, Wishka DG",,806646,DTCT0024002,7652743,DTCC01177834,866270,47510
CHEMBL19583,P45452,,VKJGUUNWURODIB-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11354379,IC50,=,123,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,Design and synthesis of 2-oxo-imidazolidine-4-carboxylic acid hydroxyamides as potent matrix metalloproteinase-13 inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,9,"Robinson RP, Laird ER, Donahue KM, Lopresti-Morrow LL, Mitchell PG, Reese MR, Reeves LM, Rouch AI, Stam EJ, Yocum SA",,106643,DTCT0024002,703848,DTCC00151368,581756,4814
CHEMBL195948,P45452,,VJCSPSPTFYXXJB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16084720,IC50,=,22,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metallopeptidase 13,,Acetylenic TACE inhibitors. Part 2: SAR of six-membered cyclic sulfonamide hydroxamates.,Bioorg. Med. Chem. Lett.,2005,15,19,"Levin JI, Chen JM, Laakso LM, Du M, Du X, Venkatesan AM, Sandanayaka V, Zask A, Xu J, Xu W, Zhang Y, Skotnicki JS",,321254,DTCT0024002,1861770,DTCC00408054,7385,19752
CHEMBL195948,P45452,,VJCSPSPTFYXXJB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16084720,IC50,=,22,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metallopeptidase 13,,Acetylenic TACE inhibitors. Part 2: SAR of six-membered cyclic sulfonamide hydroxamates.,Bioorg. Med. Chem. Lett.,2005,15,19,"Levin JI, Chen JM, Laakso LM, Du M, Du X, Venkatesan AM, Sandanayaka V, Zask A, Xu J, Xu W, Zhang Y, Skotnicki JS",,321254,DTCT0024002,1862290,DTCC00408054,7386,19752
CHEMBL196092,P45452,,SEOIKBYFTLCBTF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16084720,IC50,=,26,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metallopeptidase 13,,Acetylenic TACE inhibitors. Part 2: SAR of six-membered cyclic sulfonamide hydroxamates.,Bioorg. Med. Chem. Lett.,2005,15,19,"Levin JI, Chen JM, Laakso LM, Du M, Du X, Venkatesan AM, Sandanayaka V, Zask A, Xu J, Xu W, Zhang Y, Skotnicki JS",,321254,DTCT0024002,1861750,DTCC00408040,423945,19752
CHEMBL196092,P45452,,SEOIKBYFTLCBTF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16084720,IC50,=,26,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metallopeptidase 13,,Acetylenic TACE inhibitors. Part 2: SAR of six-membered cyclic sulfonamide hydroxamates.,Bioorg. Med. Chem. Lett.,2005,15,19,"Levin JI, Chen JM, Laakso LM, Du M, Du X, Venkatesan AM, Sandanayaka V, Zask A, Xu J, Xu W, Zhang Y, Skotnicki JS",,321254,DTCT0024002,1862267,DTCC00408040,423947,19752
CHEMBL19611,P45452,ILOMASTAT,NITYDPDXAAFEIT-DYVFJYSZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17623656,IC50,=,5.2,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain,,Discovery and characterization of a novel inhibitor of matrix metalloprotease-13 that reduces cartilage damage in vivo without joint fibroplasia side effects.,J. Biol. Chem.,2007,282,38,"Johnson AR, Pavlovsky AG, Ortwine DF, Prior F, Man CF, Bornemeier DA, Banotai CA, Mueller WT, McConnell P, Yan C, Baragi V, Lesch C, Roark WH, Wilson M, Datta K, Guzman R, Han HK, Dyer RD",,507870,DTCT0024002,2388616,DTCC00151638,1885151,29282
CHEMBL19611,P45452,ILOMASTAT,NITYDPDXAAFEIT-DYVFJYSZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23376997,IC50,=,5.2,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Mca-Lys-Pro- Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 2 hrs prior to substrate addition measured every 15 secs for 15 mins by fluorometric analysis,,Arylsulfonamide inhibitors of aggrecanases as potential therapeutic agents for osteoarthritis: Synthesis and biological evaluation.,Eur. J. Med. Chem.,2013,62,,"Nuti E, Santamaria S, Casalini F, Yamamoto K, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Marini AM, Salerno S, Taliani S, Da Settimo F, Nagase H, Rossello A",,948652,DTCT0024002,11842589,DTCC00151638,1877524,53978
CHEMBL197587,P45452,,DCSURGDKZBMZEV-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16153831,IC50,=,0.4,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-13,,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321194,DTCT0024002,1860295,DTCC00407623,2014748,19837
CHEMBL197809,P45452,,SKYVAYDFIWVHPU-LJAQVGFWSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16153831,IC50,=,220,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-13,,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321194,DTCT0024002,1860322,DTCC00407651,983915,19837
CHEMBL197842,P45452,,WHHAEBOHMHRZGW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23376997,IC50,=,7,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Mca-Lys-Pro- Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 2 hrs prior to substrate addition measured every 15 secs for 15 mins by fluorometric analysis,,Arylsulfonamide inhibitors of aggrecanases as potential therapeutic agents for osteoarthritis: Synthesis and biological evaluation.,Eur. J. Med. Chem.,2013,62,,"Nuti E, Santamaria S, Casalini F, Yamamoto K, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Marini AM, Salerno S, Taliani S, Da Settimo F, Nagase H, Rossello A",,948652,DTCT0024002,11842591,DTCC00407684,1656720,53978
CHEMBL197877,P45452,,URNZIKDWYXXADG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15566296,INHIBITION,=,56,%,,,,,,,,,,,,,,Inhibition of MMP13,,"Synthesis and structure-activity relationships of 4-alkynyloxy phenyl sulfanyl, sulfinyl, and sulfonyl alkyl hydroxamates as tumor necrosis factor-alpha converting enzyme and matrix metalloproteinase inhibitors.",J. Med. Chem.,2004,47,25,"Venkatesan AM, Davis JM, Grosu GT, Baker J, Zask A, Levin JI, Ellingboe J, Skotnicki JS, Dijoseph JF, Sung A, Jin G, Xu W, McCarthy DJ, Barone D",,429672,DTCT0024002,2041991,DTCC00408175,110472,22157
CHEMBL198039,P45452,,IRPQGYYABIPNQJ-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16153831,IC50,=,1.9,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-13,,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321194,DTCT0024002,1860346,DTCC00407671,1048682,19837
CHEMBL198100,P45452,,CYIOQNVVHKTYRH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16084720,IC50,=,83,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metallopeptidase 13,,Acetylenic TACE inhibitors. Part 2: SAR of six-membered cyclic sulfonamide hydroxamates.,Bioorg. Med. Chem. Lett.,2005,15,19,"Levin JI, Chen JM, Laakso LM, Du M, Du X, Venkatesan AM, Sandanayaka V, Zask A, Xu J, Xu W, Zhang Y, Skotnicki JS",,321254,DTCT0024002,1861797,DTCC00408079,1198213,19752
CHEMBL198100,P45452,,CYIOQNVVHKTYRH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16084720,IC50,=,83,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metallopeptidase 13,,Acetylenic TACE inhibitors. Part 2: SAR of six-membered cyclic sulfonamide hydroxamates.,Bioorg. Med. Chem. Lett.,2005,15,19,"Levin JI, Chen JM, Laakso LM, Du M, Du X, Venkatesan AM, Sandanayaka V, Zask A, Xu J, Xu W, Zhang Y, Skotnicki JS",,321254,DTCT0024002,1862315,DTCC00408079,1198215,19752
CHEMBL198254,P45452,,QMJIUHKQZQSTQO-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16153831,IC50,=,17,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-13,,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321194,DTCT0024002,1860329,DTCC00407668,563938,19837
CHEMBL198262,P45452,,HHHAELOQIYTSIY-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16153831,IC50,=,2.3,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-13,,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321194,DTCT0024002,1860300,DTCC00407624,1405256,19837
CHEMBL198262,P45452,,HHHAELOQIYTSIY-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19625186,IC50,=,2.3,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"3,4-Disubstituted benzofuran P1' MMP-13 inhibitors: optimization of selectivity and reduction of protein binding.",Bioorg. Med. Chem. Lett.,2009,19,16,"Li W, Hu Y, Li J, Thomason JR, DeVincentis D, Du X, Wu J, Hotchandani R, Rush TS, Skotnicki JS, Tam S, Chockalingam PS, Morris EA, Levin JI",,581466,DTCT0024002,2904532,DTCC00407624,1395426,35265
CHEMBL198389,P45452,,HAWUDCIVXQTNAF-VWLOTQADSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16153831,IC50,=,7.8,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-13,,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321194,DTCT0024002,1860357,DTCC00407672,304937,19837
CHEMBL19855,P45452,,RUZDCFCMYATJSO-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11354379,IC50,=,4,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,Design and synthesis of 2-oxo-imidazolidine-4-carboxylic acid hydroxyamides as potent matrix metalloproteinase-13 inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,9,"Robinson RP, Laird ER, Donahue KM, Lopresti-Morrow LL, Mitchell PG, Reese MR, Reeves LM, Rouch AI, Stam EJ, Yocum SA",,106643,DTCT0024002,711888,DTCC00151144,581757,4814
CHEMBL19870,P45452,,BCBPGVLRMIXMDN-SNVBAGLBSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11354379,IC50,=,281,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,Design and synthesis of 2-oxo-imidazolidine-4-carboxylic acid hydroxyamides as potent matrix metalloproteinase-13 inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,9,"Robinson RP, Laird ER, Donahue KM, Lopresti-Morrow LL, Mitchell PG, Reese MR, Reeves LM, Rouch AI, Stam EJ, Yocum SA",,106643,DTCT0024002,694595,DTCC00151497,2032902,4814
CHEMBL19876,P45452,,XYJDYCVPZSFGLI-OAHLLOKOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11354379,IC50,=,214,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,Design and synthesis of 2-oxo-imidazolidine-4-carboxylic acid hydroxyamides as potent matrix metalloproteinase-13 inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,9,"Robinson RP, Laird ER, Donahue KM, Lopresti-Morrow LL, Mitchell PG, Reese MR, Reeves LM, Rouch AI, Stam EJ, Yocum SA",,106643,DTCT0024002,698103,DTCC00151499,1869755,4814
CHEMBL198778,P45452,,YJRJYIQWWPZSTM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23376997,IC50,=,0.1,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Mca-Lys-Pro- Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 2 hrs prior to substrate addition measured every 15 secs for 15 mins by fluorometric analysis,,Arylsulfonamide inhibitors of aggrecanases as potential therapeutic agents for osteoarthritis: Synthesis and biological evaluation.,Eur. J. Med. Chem.,2013,62,,"Nuti E, Santamaria S, Casalini F, Yamamoto K, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Marini AM, Salerno S, Taliani S, Da Settimo F, Nagase H, Rossello A",,948652,DTCT0024002,11842594,DTCC00407760,913494,53978
CHEMBL199018,P45452,,XTRLBSLKNQZDBD-VWLOTQADSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16153831,IC50,=,3.2,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-13,,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321194,DTCT0024002,1860401,DTCC00407676,822181,19837
CHEMBL199158,P45452,,HHHAELOQIYTSIY-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16153831,IC50,=,3.4,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-13,,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321194,DTCT0024002,1860332,DTCC00407669,1916337,19837
CHEMBL199227,P45452,,YHEMJEYZYLVDRO-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16153831,IC50,=,0.61,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-13,,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321194,DTCT0024002,1860292,DTCC00407618,1566230,19837
CHEMBL199241,P45452,,LSKSBHBGNRQEFN-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16153831,IC50,=,2.1,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-13,,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321194,DTCT0024002,1860335,DTCC00407670,1787390,19837
CHEMBL20159,P45452,,SAEHHNLETPZCLQ-VHSXEESVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10882354,IC50,=,1480,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,Structure-based design and synthesis of a potent matrix metalloproteinase-13 inhibitor based on a pyrrolidinone scaffold.,J. Med. Chem.,2000,43,12,"Robinson RP, Laird ER, Blake JF, Bordner J, Donahue KM, Lopresti-Morrow LL, Mitchell PG, Reese MR, Reeves LM, Stam EJ, Yocum SA",,106624,DTCT0024002,1110747,DTCC00151949,1946930,15747
CHEMBL20159,P45452,,SAEHHNLETPZCLQ-VHSXEESVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11354379,IC50,=,1480,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,Design and synthesis of 2-oxo-imidazolidine-4-carboxylic acid hydroxyamides as potent matrix metalloproteinase-13 inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,9,"Robinson RP, Laird ER, Donahue KM, Lopresti-Morrow LL, Mitchell PG, Reese MR, Reeves LM, Rouch AI, Stam EJ, Yocum SA",,106643,DTCT0024002,702851,DTCC00151949,1934086,4814
CHEMBL20160,P45452,,CGAZROFVKJRMSR-LSDHHAIUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10882354,IC50,=,182,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,Structure-based design and synthesis of a potent matrix metalloproteinase-13 inhibitor based on a pyrrolidinone scaffold.,J. Med. Chem.,2000,43,12,"Robinson RP, Laird ER, Blake JF, Bordner J, Donahue KM, Lopresti-Morrow LL, Mitchell PG, Reese MR, Reeves LM, Stam EJ, Yocum SA",,106624,DTCT0024002,1110749,DTCC00151900,1403188,15747
CHEMBL20160,P45452,,CGAZROFVKJRMSR-LSDHHAIUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11354379,IC50,=,182,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,Design and synthesis of 2-oxo-imidazolidine-4-carboxylic acid hydroxyamides as potent matrix metalloproteinase-13 inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,9,"Robinson RP, Laird ER, Donahue KM, Lopresti-Morrow LL, Mitchell PG, Reese MR, Reeves LM, Rouch AI, Stam EJ, Yocum SA",,106643,DTCT0024002,722250,DTCC00151900,1390932,4814
CHEMBL202806,P45452,,MLHIPHSANXGLHI-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16426848,IC50,=,14,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Acetylenic TACE inhibitors. Part 3: Thiomorpholine sulfonamide hydroxamates.,Bioorg. Med. Chem. Lett.,2006,16,6,"Levin JI, Chen JM, Laakso LM, Du M, Schmid J, Xu W, Cummons T, Xu J, Jin G, Barone D, Skotnicki JS",,339181,DTCT0024002,1909216,DTCC00417689,628834,14616
CHEMBL202839,P45452,,AANXPIMDONQTQF-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16426848,IC50,=,8,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Acetylenic TACE inhibitors. Part 3: Thiomorpholine sulfonamide hydroxamates.,Bioorg. Med. Chem. Lett.,2006,16,6,"Levin JI, Chen JM, Laakso LM, Du M, Schmid J, Xu W, Cummons T, Xu J, Jin G, Barone D, Skotnicki JS",,339181,DTCT0024002,1909209,DTCC00417951,370268,14616
CHEMBL20287,P45452,,RGNRNPIPRYODKL-QWHCGFSZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10882354,IC50,=,3450,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,Structure-based design and synthesis of a potent matrix metalloproteinase-13 inhibitor based on a pyrrolidinone scaffold.,J. Med. Chem.,2000,43,12,"Robinson RP, Laird ER, Blake JF, Bordner J, Donahue KM, Lopresti-Morrow LL, Mitchell PG, Reese MR, Reeves LM, Stam EJ, Yocum SA",,106624,DTCT0024002,1122755,DTCC00151894,1914347,15747
CHEMBL20287,P45452,,RGNRNPIPRYODKL-QWHCGFSZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11354379,IC50,=,3450,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,Design and synthesis of 2-oxo-imidazolidine-4-carboxylic acid hydroxyamides as potent matrix metalloproteinase-13 inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,9,"Robinson RP, Laird ER, Donahue KM, Lopresti-Morrow LL, Mitchell PG, Reese MR, Reeves LM, Rouch AI, Stam EJ, Yocum SA",,106643,DTCT0024002,696881,DTCC00151894,1902122,4814
CHEMBL202899,P45452,,DOPZAFIJEYWGQT-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16426848,IC50,=,27,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Acetylenic TACE inhibitors. Part 3: Thiomorpholine sulfonamide hydroxamates.,Bioorg. Med. Chem. Lett.,2006,16,6,"Levin JI, Chen JM, Laakso LM, Du M, Schmid J, Xu W, Cummons T, Xu J, Jin G, Barone D, Skotnicki JS",,339181,DTCT0024002,1909208,DTCC00418003,110210,14616
CHEMBL202932,P45452,,BZVYQWLRCHLAGK-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17088065,IC50,=,2.6,NM,,,,,,,,,,,,,,Inhibition of MMP13,,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432508,DTCT0024002,2061864,DTCC00413183,1263648,22402
CHEMBL203160,P45452,,XVLVIDNHSWHJBN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16289878,KI,>,5025,NM,,,,,,,,,,,,,,Binding affinity to MMP13,,Conversion of potent MMP inhibitors into selective TACE inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,4,"Cherney RJ, King BW, Gilmore JL, Liu RQ, Covington MB, Duan JJ, Decicco CP",,334537,DTCT0024002,1895740,DTCC00415520,855174,20373
CHEMBL203886,P45452,,LHUIUEQQDGBKCU-SFHVURJKSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16426848,IC50,=,7,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Acetylenic TACE inhibitors. Part 3: Thiomorpholine sulfonamide hydroxamates.,Bioorg. Med. Chem. Lett.,2006,16,6,"Levin JI, Chen JM, Laakso LM, Du M, Schmid J, Xu W, Cummons T, Xu J, Jin G, Barone D, Skotnicki JS",,339181,DTCT0024002,1909206,DTCC00417779,693286,14616
CHEMBL203972,P45452,,BZIUKEPVFXHVPZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16289878,KI,>,5025,NM,,,,,,,,,,,,,,Binding affinity to MMP13,,Conversion of potent MMP inhibitors into selective TACE inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,4,"Cherney RJ, King BW, Gilmore JL, Liu RQ, Covington MB, Duan JJ, Decicco CP",,334537,DTCT0024002,1895738,DTCC00415441,1113898,20373
CHEMBL204048,P45452,,CNJHNAILYAGVJU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16289878,KI,>,5025,NM,,,,,,,,,,,,,,Binding affinity to MMP13,,Conversion of potent MMP inhibitors into selective TACE inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,4,"Cherney RJ, King BW, Gilmore JL, Liu RQ, Covington MB, Duan JJ, Decicco CP",,334537,DTCT0024002,1895742,DTCC00415512,1981982,20373
CHEMBL204100,P45452,,XNLVNQQMTWGGIM-HOCLYGCPSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16426848,IC50,=,24,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Acetylenic TACE inhibitors. Part 3: Thiomorpholine sulfonamide hydroxamates.,Bioorg. Med. Chem. Lett.,2006,16,6,"Levin JI, Chen JM, Laakso LM, Du M, Schmid J, Xu W, Cummons T, Xu J, Jin G, Barone D, Skotnicki JS",,339181,DTCT0024002,1909203,DTCC00418391,466954,14616
CHEMBL204357,P45452,SR-973,WICQDDCNCVTFDX-VJGNERBWSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16473009,KI,=,10,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Synthesis and evaluation of succinoyl-caprolactam gamma-secretase inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,9,"Thompson LA, Liauw AY, Ramanjulu MM, Kasireddy-Polam P, Mercer SE, Maduskuie TP, Glicksman M, Roach AH, Meredith JE, Liu RQ, Combs AP, Higaki JN, Cordell B, Seiffert D, Zaczek RC, Robertson DW, Olson RE",,350095,DTCT0024002,1920769,DTCC00001675,1949133,20704
CHEMBL204495,P45452,,JHHLVVDASBMHIL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16289878,KI,>,5025,NM,,,,,,,,,,,,,,Binding affinity to MMP13,,Conversion of potent MMP inhibitors into selective TACE inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,4,"Cherney RJ, King BW, Gilmore JL, Liu RQ, Covington MB, Duan JJ, Decicco CP",,334537,DTCT0024002,469060,DTCC00415490,1695445,20373
CHEMBL204549,P45452,,OZLFXWYCUHTSQI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16289878,KI,>,5025,NM,,,,,,,,,,,,,,Binding affinity to MMP13,,Conversion of potent MMP inhibitors into selective TACE inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,4,"Cherney RJ, King BW, Gilmore JL, Liu RQ, Covington MB, Duan JJ, Decicco CP",,334537,DTCT0024002,1895741,DTCC00415513,855173,20373
CHEMBL2047536,P45452,,DACARRUBIAXSBX-IBGZPJMESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22175799,IC50,=,0.03,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using MCA-Pro-Cha-Gly-Nva-His-Ala-Dpa-NH2 as substrate preincubated for 10 mins measured by fluorescence analysis,,"Discovery and evaluation of a non-Zn chelating, selective matrix metalloproteinase 13 (MMP-13) inhibitor for potential intra-articular treatment of osteoarthritis.",J. Med. Chem.,2012,55,2,"Gege C, Bao B, Bluhm H, Boer J, Gallagher BM, Korniski B, Powers TS, Steeneck C, Taveras AG, Baragi VM",,827027,DTCT0024002,10526942,DTCC01242723,653432,48586
CHEMBL2047537,P45452,,CZRLAOXITNZAJA-FQEVSTJZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22175799,IC50,=,1.3,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using MCA-Pro-Cha-Gly-Nva-His-Ala-Dpa-NH2 as substrate preincubated for 10 mins measured by fluorescence analysis,,"Discovery and evaluation of a non-Zn chelating, selective matrix metalloproteinase 13 (MMP-13) inhibitor for potential intra-articular treatment of osteoarthritis.",J. Med. Chem.,2012,55,2,"Gege C, Bao B, Bluhm H, Boer J, Gallagher BM, Korniski B, Powers TS, Steeneck C, Taveras AG, Baragi VM",,827027,DTCT0024002,10526943,DTCC01242724,1655819,48586
CHEMBL2048502,P45452,MACRATHOIN F,VEBNYMXKXIIGFX-KBXRYBNXSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22658537,IC50,=,7620,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827438,DTCT0024002,10535451,DTCC01243472,1844458,48665
CHEMBL2048502,P45452,MACRATHOIN F,VEBNYMXKXIIGFX-KBXRYBNXSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22658537,INHIBITION,>,30,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain at 10 uM incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827444,DTCT0024002,10535536,DTCC01243472,1844458,48665
CHEMBL2048503,P45452,,MZNIJRAPCCELQX-HWKANZROSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22658537,IC50,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain incubated for 20 mins by fluorimetric assay,Not Determined,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827438,DTCT0024002,10535452,DTCC01243473,492092,48665
CHEMBL2048504,P45452,,FLOHNUCSNZDDJO-DUXPYHPUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22658537,IC50,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain incubated for 20 mins by fluorimetric assay,Not Determined,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827438,DTCT0024002,10535453,DTCC01243474,427800,48665
CHEMBL2048505,P45452,DIMETHYL LITHOSPERMATE,YAXTXMBBIHBGPZ-ZBBBDWFHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22658537,IC50,=,18520,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827438,DTCT0024002,10535454,DTCC01243475,1494333,48665
CHEMBL2048505,P45452,DIMETHYL LITHOSPERMATE,YAXTXMBBIHBGPZ-ZBBBDWFHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22658537,INHIBITION,>,30,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain at 10 uM incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827444,DTCT0024002,10535537,DTCC01243475,1494333,48665
CHEMBL2048506,P45452,,QWHMMEKTFNJGTI-GNBMGSNXSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22658537,IC50,=,24490,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827438,DTCT0024002,10535456,DTCC01243476,1041021,48665
CHEMBL2048506,P45452,,QWHMMEKTFNJGTI-GNBMGSNXSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22658537,INHIBITION,>,30,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain at 10 uM incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827444,DTCT0024002,10535538,DTCC01243476,1041021,48665
CHEMBL2048507,P45452,DAPHNODORIN F,KVPJDVHJFGPPAB-XOHQIPOJSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22658537,IC50,=,13170,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827438,DTCT0024002,10535460,DTCC01243477,2071373,48665
CHEMBL2048507,P45452,DAPHNODORIN F,KVPJDVHJFGPPAB-XOHQIPOJSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22658537,INHIBITION,>,30,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain at 10 uM incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827444,DTCT0024002,10535542,DTCC01243477,2071373,48665
CHEMBL2048508,P45452,"(2R,3S)-DIHYDROMYRICETIN",KJXSIXMJHKAJOD-HUUCEWRRSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22658537,IC50,=,9330,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827438,DTCT0024002,10535462,DTCC00042059,362498,48665
CHEMBL2048508,P45452,"(2R,3S)-DIHYDROMYRICETIN",KJXSIXMJHKAJOD-HUUCEWRRSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22658537,INHIBITION,>,30,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain at 10 uM incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827444,DTCT0024002,10535544,DTCC00042059,362498,48665
CHEMBL2048509,P45452,,FYEZJIXULOZDRT-ARJAWSKDSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22658537,IC50,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain incubated for 20 mins by fluorimetric assay,Not Determined,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827438,DTCT0024002,10535466,DTCC01243478,717883,48665
CHEMBL2048510,P45452,,DXXGHDAWCPTRPU-XOSAIJSUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22658537,IC50,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain incubated for 20 mins by fluorimetric assay,Not Determined,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827438,DTCT0024002,10535467,DTCC01243479,556512,48665
CHEMBL2048511,P45452,ALPHA-ISOVALEROXYISOVALERIC ACID,SOJFCTIYHPWXGZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22658537,IC50,=,42520,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827438,DTCT0024002,10535469,DTCC00042060,264062,48665
CHEMBL2048511,P45452,ALPHA-ISOVALEROXYISOVALERIC ACID,SOJFCTIYHPWXGZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22658537,INHIBITION,>,30,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain at 10 uM incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827444,DTCT0024002,10535546,DTCC00042060,264062,48665
CHEMBL2048512,P45452,,FQRZOEBSTPAQBJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22658537,IC50,=,6.4,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827438,DTCT0024002,10535471,DTCC01243480,1812174,48665
CHEMBL2048512,P45452,,FQRZOEBSTPAQBJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22658537,INHIBITION,>,30,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain at 10 uM incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827444,DTCT0024002,10535547,DTCC01243480,1812174,48665
CHEMBL205290,P45452,,VRUYZVHIDJWWTM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16516466,KI,>,5025,NM,,,,,,,,,,,,,,Binding affinity to MMP13,,"Synthesis and structure-activity relationship of a novel, achiral series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2006,16,10,"Gilmore JL, King BW, Harris C, Maduskuie T, Mercer SE, Liu RQ, Covington MB, Qian M, Ribadeneria MD, Vaddi K, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,354462,DTCT0024002,1926526,DTCC00421634,617113,20786
CHEMBL205523,P45452,,HBYOIHRPSQTDLO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16516466,KI,>,5025,NM,,,,,,,,,,,,,,Binding affinity to MMP13,,"Synthesis and structure-activity relationship of a novel, achiral series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2006,16,10,"Gilmore JL, King BW, Harris C, Maduskuie T, Mercer SE, Liu RQ, Covington MB, Qian M, Ribadeneria MD, Vaddi K, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,354462,DTCT0024002,1926547,DTCC00422036,1361292,20786
CHEMBL205900,P45452,,XNQVZVNWVMQCPC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16516466,KI,>,5025,NM,,,,,,,,,,,,,,Binding affinity to MMP13,,"Synthesis and structure-activity relationship of a novel, achiral series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2006,16,10,"Gilmore JL, King BW, Harris C, Maduskuie T, Mercer SE, Liu RQ, Covington MB, Qian M, Ribadeneria MD, Vaddi K, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,354462,DTCT0024002,1926540,DTCC00422242,778397,20786
CHEMBL205998,P45452,,BUSXTPHZLBAFDD-FPOVZHCZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16426848,IC50,=,48,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Acetylenic TACE inhibitors. Part 3: Thiomorpholine sulfonamide hydroxamates.,Bioorg. Med. Chem. Lett.,2006,16,6,"Levin JI, Chen JM, Laakso LM, Du M, Schmid J, Xu W, Cummons T, Xu J, Jin G, Barone D, Skotnicki JS",,339181,DTCT0024002,1909200,DTCC00418446,596310,14616
CHEMBL206144,P45452,,GHZXWVPNZMUKBT-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16426848,IC50,=,86,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Acetylenic TACE inhibitors. Part 3: Thiomorpholine sulfonamide hydroxamates.,Bioorg. Med. Chem. Lett.,2006,16,6,"Levin JI, Chen JM, Laakso LM, Du M, Schmid J, Xu W, Cummons T, Xu J, Jin G, Barone D, Skotnicki JS",,339181,DTCT0024002,1909215,DTCC00417690,174826,14616
CHEMBL206155,P45452,,TZYCKWCFYXFTIR-FQEVSTJZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16426848,IC50,=,2,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Acetylenic TACE inhibitors. Part 3: Thiomorpholine sulfonamide hydroxamates.,Bioorg. Med. Chem. Lett.,2006,16,6,"Levin JI, Chen JM, Laakso LM, Du M, Schmid J, Xu W, Cummons T, Xu J, Jin G, Barone D, Skotnicki JS",,339181,DTCT0024002,1909211,DTCC00417944,499762,14616
CHEMBL206254,P45452,,DJBJEUJDVZJUDS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16516466,KI,>,5025,NM,,,,,,,,,,,,,,Binding affinity to MMP13,,"Synthesis and structure-activity relationship of a novel, achiral series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2006,16,10,"Gilmore JL, King BW, Harris C, Maduskuie T, Mercer SE, Liu RQ, Covington MB, Qian M, Ribadeneria MD, Vaddi K, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,354462,DTCT0024002,1926529,DTCC00422256,1652037,20786
CHEMBL206298,P45452,,ZMAYDSCNOCAOHA-SFHVURJKSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16426848,IC50,=,7,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Acetylenic TACE inhibitors. Part 3: Thiomorpholine sulfonamide hydroxamates.,Bioorg. Med. Chem. Lett.,2006,16,6,"Levin JI, Chen JM, Laakso LM, Du M, Schmid J, Xu W, Cummons T, Xu J, Jin G, Barone D, Skotnicki JS",,339181,DTCT0024002,1909219,DTCC00418095,628833,14616
CHEMBL2064540,P45452,,GKLOCXVNLLEZMX-DIPNUNPCSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22540974,IC50,=,4,NM,,,,,,,,,,,,,,"Inhibition of MMP13 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured for 10 mins by fluorometry",,A new class of highly potent matrix metalloproteinase inhibitors based on triazole-substituted hydroxamates: (radio)synthesis and in vitro and first in vivo evaluation.,J. Med. Chem.,2012,55,10,"Hugenberg V, Breyholz HJ, Riemann B, Hermann S, Schober O, Schäfers M, Gangadharmath U, Mocharla V, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,832928,DTCT0024002,10563960,DTCC01248689,284246,48958
CHEMBL2064541,P45452,,GDXZUNJRYLVZAT-WJOKGBTCSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22540974,IC50,=,6,NM,,,,,,,,,,,,,,"Inhibition of MMP13 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured for 10 mins by fluorometry",,A new class of highly potent matrix metalloproteinase inhibitors based on triazole-substituted hydroxamates: (radio)synthesis and in vitro and first in vivo evaluation.,J. Med. Chem.,2012,55,10,"Hugenberg V, Breyholz HJ, Riemann B, Hermann S, Schober O, Schäfers M, Gangadharmath U, Mocharla V, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,832928,DTCT0024002,10563959,DTCC01248690,1254587,48958
CHEMBL2064542,P45452,,YDSGUUACYYBPLW-GDLZYMKVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22540974,IC50,=,0.09,NM,,,,,,,,,,,,,,"Inhibition of MMP13 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured for 10 mins by fluorometry",,A new class of highly potent matrix metalloproteinase inhibitors based on triazole-substituted hydroxamates: (radio)synthesis and in vitro and first in vivo evaluation.,J. Med. Chem.,2012,55,10,"Hugenberg V, Breyholz HJ, Riemann B, Hermann S, Schober O, Schäfers M, Gangadharmath U, Mocharla V, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,832928,DTCT0024002,10563958,DTCC01248691,1028287,48958
CHEMBL2064543,P45452,,HBDUXNUNXGZOCK-VLIRCAPWSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22540974,IC50,=,18,NM,,,,,,,,,,,,,,"Inhibition of MMP13 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured for 10 mins by fluorometry",,A new class of highly potent matrix metalloproteinase inhibitors based on triazole-substituted hydroxamates: (radio)synthesis and in vitro and first in vivo evaluation.,J. Med. Chem.,2012,55,10,"Hugenberg V, Breyholz HJ, Riemann B, Hermann S, Schober O, Schäfers M, Gangadharmath U, Mocharla V, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,832928,DTCT0024002,10563961,DTCC01248692,316917,48958
CHEMBL2064544,P45452,,JZHHNBACJYFNCE-LDLOPFEMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22540974,IC50,=,1,NM,,,,,,,,,,,,,,"Inhibition of MMP13 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured for 10 mins by fluorometry",,A new class of highly potent matrix metalloproteinase inhibitors based on triazole-substituted hydroxamates: (radio)synthesis and in vitro and first in vivo evaluation.,J. Med. Chem.,2012,55,10,"Hugenberg V, Breyholz HJ, Riemann B, Hermann S, Schober O, Schäfers M, Gangadharmath U, Mocharla V, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,832928,DTCT0024002,10563962,DTCC01248693,543756,48958
CHEMBL2064545,P45452,,JLXRKMSJFVPFIG-CQSZACIVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22540974,IC50,=,10,NM,,,,,,,,,,,,,,"Inhibition of MMP13 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured for 10 mins by fluorometry",,A new class of highly potent matrix metalloproteinase inhibitors based on triazole-substituted hydroxamates: (radio)synthesis and in vitro and first in vivo evaluation.,J. Med. Chem.,2012,55,10,"Hugenberg V, Breyholz HJ, Riemann B, Hermann S, Schober O, Schäfers M, Gangadharmath U, Mocharla V, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,832928,DTCT0024002,10563963,DTCC01248694,1707024,48958
CHEMBL2064546,P45452,,ANZWBBMLNAIBAB-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22540974,IC50,=,5,NM,,,,,,,,,,,,,,"Inhibition of MMP13 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured for 10 mins by fluorometry",,A new class of highly potent matrix metalloproteinase inhibitors based on triazole-substituted hydroxamates: (radio)synthesis and in vitro and first in vivo evaluation.,J. Med. Chem.,2012,55,10,"Hugenberg V, Breyholz HJ, Riemann B, Hermann S, Schober O, Schäfers M, Gangadharmath U, Mocharla V, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,832928,DTCT0024002,10563964,DTCC01248695,186735,48958
CHEMBL2064547,P45452,,LOPZANGJCBIBLO-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22540974,IC50,=,0.006,NM,,,,,,,,,,,,,,"Inhibition of MMP13 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured for 10 mins by fluorometry",,A new class of highly potent matrix metalloproteinase inhibitors based on triazole-substituted hydroxamates: (radio)synthesis and in vitro and first in vivo evaluation.,J. Med. Chem.,2012,55,10,"Hugenberg V, Breyholz HJ, Riemann B, Hermann S, Schober O, Schäfers M, Gangadharmath U, Mocharla V, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,832928,DTCT0024002,10563965,DTCC01248696,382253,48958
CHEMBL2064548,P45452,,FGQWFLDBWZDRJJ-GDLZYMKVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22540974,IC50,=,0.02,NM,,,,,,,,,,,,,,"Inhibition of MMP13 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured for 10 mins by fluorometry",,A new class of highly potent matrix metalloproteinase inhibitors based on triazole-substituted hydroxamates: (radio)synthesis and in vitro and first in vivo evaluation.,J. Med. Chem.,2012,55,10,"Hugenberg V, Breyholz HJ, Riemann B, Hermann S, Schober O, Schäfers M, Gangadharmath U, Mocharla V, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,832928,DTCT0024002,10563966,DTCC01248697,1319659,48958
CHEMBL2064549,P45452,,NRRIJAHIBBGLNH-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22540974,IC50,=,0.04,NM,,,,,,,,,,,,,,"Inhibition of MMP13 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured for 10 mins by fluorometry",,A new class of highly potent matrix metalloproteinase inhibitors based on triazole-substituted hydroxamates: (radio)synthesis and in vitro and first in vivo evaluation.,J. Med. Chem.,2012,55,10,"Hugenberg V, Breyholz HJ, Riemann B, Hermann S, Schober O, Schäfers M, Gangadharmath U, Mocharla V, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,832928,DTCT0024002,10563967,DTCC01248698,1767171,48958
CHEMBL2064550,P45452,,UMBBJTOZRJURJL-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22540974,IC50,=,6,NM,,,,,,,,,,,,,,"Inhibition of MMP13 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured for 10 mins by fluorometry",,A new class of highly potent matrix metalloproteinase inhibitors based on triazole-substituted hydroxamates: (radio)synthesis and in vitro and first in vivo evaluation.,J. Med. Chem.,2012,55,10,"Hugenberg V, Breyholz HJ, Riemann B, Hermann S, Schober O, Schäfers M, Gangadharmath U, Mocharla V, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,832928,DTCT0024002,10563968,DTCC01248699,1449098,48958
CHEMBL2064551,P45452,,JXMJSOSLBMBYGM-AREMUKBSSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22540974,IC50,=,1,NM,,,,,,,,,,,,,,"Inhibition of MMP13 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured for 10 mins by fluorometry",,A new class of highly potent matrix metalloproteinase inhibitors based on triazole-substituted hydroxamates: (radio)synthesis and in vitro and first in vivo evaluation.,J. Med. Chem.,2012,55,10,"Hugenberg V, Breyholz HJ, Riemann B, Hermann S, Schober O, Schäfers M, Gangadharmath U, Mocharla V, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,832928,DTCT0024002,10563969,DTCC01248700,316918,48958
CHEMBL2064552,P45452,,TUYLXABAVZEOSZ-WGVHSKNFSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22540974,IC50,=,0.5,NM,,,,,,,,,,,,,,"Inhibition of MMP13 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured for 10 mins by fluorometry",,A new class of highly potent matrix metalloproteinase inhibitors based on triazole-substituted hydroxamates: (radio)synthesis and in vitro and first in vivo evaluation.,J. Med. Chem.,2012,55,10,"Hugenberg V, Breyholz HJ, Riemann B, Hermann S, Schober O, Schäfers M, Gangadharmath U, Mocharla V, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,832928,DTCT0024002,10563970,DTCC01248701,769661,48958
CHEMBL2064553,P45452,,YWHKQQSHVPCBRN-LQFQNGICSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22540974,IC50,>,100000,NM,,,,,,,,,,,,,,"Inhibition of MMP13 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured for 10 mins by fluorometry",,A new class of highly potent matrix metalloproteinase inhibitors based on triazole-substituted hydroxamates: (radio)synthesis and in vitro and first in vivo evaluation.,J. Med. Chem.,2012,55,10,"Hugenberg V, Breyholz HJ, Riemann B, Hermann S, Schober O, Schäfers M, Gangadharmath U, Mocharla V, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,832928,DTCT0024002,10563971,DTCC01248702,1319660,48958
CHEMBL206481,P45452,,NUDMVYOFBGJGMN-RDJZCZTQSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16426848,IC50,=,14,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Acetylenic TACE inhibitors. Part 3: Thiomorpholine sulfonamide hydroxamates.,Bioorg. Med. Chem. Lett.,2006,16,6,"Levin JI, Chen JM, Laakso LM, Du M, Schmid J, Xu W, Cummons T, Xu J, Jin G, Barone D, Skotnicki JS",,339181,DTCT0024002,1909202,DTCC00418427,887380,14616
CHEMBL206688,P45452,,ZWHGUGYVAMXPJZ-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16426848,IC50,=,1,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Acetylenic TACE inhibitors. Part 3: Thiomorpholine sulfonamide hydroxamates.,Bioorg. Med. Chem. Lett.,2006,16,6,"Levin JI, Chen JM, Laakso LM, Du M, Schmid J, Xu W, Cummons T, Xu J, Jin G, Barone D, Skotnicki JS",,339181,DTCT0024002,1909223,DTCC00418170,305032,14616
CHEMBL206739,P45452,,AVQCFDJVRXAPJO-YOEHRIQHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16426848,IC50,=,29,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Acetylenic TACE inhibitors. Part 3: Thiomorpholine sulfonamide hydroxamates.,Bioorg. Med. Chem. Lett.,2006,16,6,"Levin JI, Chen JM, Laakso LM, Du M, Schmid J, Xu W, Cummons T, Xu J, Jin G, Barone D, Skotnicki JS",,339181,DTCT0024002,1909204,DTCC00418385,1631082,14616
CHEMBL206815,P45452,APRATASTAT,MAVDNGWEBZTACC-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16426848,IC50,=,8,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Acetylenic TACE inhibitors. Part 3: Thiomorpholine sulfonamide hydroxamates.,Bioorg. Med. Chem. Lett.,2006,16,6,"Levin JI, Chen JM, Laakso LM, Du M, Schmid J, Xu W, Cummons T, Xu J, Jin G, Barone D, Skotnicki JS",,339181,DTCT0024002,1909217,DTCC00417680,337667,14616
CHEMBL206875,P45452,,ZFXFRRPQPVEFAM-LSDHHAIUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16516469,KI,=,55,NM,,,,,,,,,,,,,,Binding affinity to recombinant MMP13,,A cassette-dosing approach for improvement of oral bioavailability of dual TACE/MMP inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,10,"Janser P, Neumann U, Miltz W, Feifel R, Buhl T",,354053,DTCT0024002,1926044,DTCC00422586,2047092,20779
CHEMBL206993,P45452,,OVSGONSKJHXDJO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16516466,KI,>,5025,NM,,,,,,,,,,,,,,Binding affinity to MMP13,,"Synthesis and structure-activity relationship of a novel, achiral series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2006,16,10,"Gilmore JL, King BW, Harris C, Maduskuie T, Mercer SE, Liu RQ, Covington MB, Qian M, Ribadeneria MD, Vaddi K, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,354462,DTCT0024002,1926532,DTCC00422065,940295,20786
CHEMBL207018,P45452,,MCNQDQIVWJTIBW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16516466,KI,=,3136,NM,,,,,,,,,,,,,,Binding affinity to MMP13,,"Synthesis and structure-activity relationship of a novel, achiral series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2006,16,10,"Gilmore JL, King BW, Harris C, Maduskuie T, Mercer SE, Liu RQ, Covington MB, Qian M, Ribadeneria MD, Vaddi K, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,354462,DTCT0024002,1926537,DTCC00421714,260143,20786
CHEMBL207075,P45452,,FAKDVMIECOUVIL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16516466,KI,>,5025,NM,,,,,,,,,,,,,,Binding affinity to MMP13,,"Synthesis and structure-activity relationship of a novel, achiral series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2006,16,10,"Gilmore JL, King BW, Harris C, Maduskuie T, Mercer SE, Liu RQ, Covington MB, Qian M, Ribadeneria MD, Vaddi K, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,354462,DTCT0024002,1926544,DTCC00422051,1840834,20786
CHEMBL207180,P45452,,MIUWEXKKKWGHOC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16516466,KI,>,5025,NM,,,,,,,,,,,,,,Binding affinity to MMP13,,"Synthesis and structure-activity relationship of a novel, achiral series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2006,16,10,"Gilmore JL, King BW, Harris C, Maduskuie T, Mercer SE, Liu RQ, Covington MB, Qian M, Ribadeneria MD, Vaddi K, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,354462,DTCT0024002,1926546,DTCC00422044,972339,20786
CHEMBL207305,P45452,,NUVSGXIVCJBRBF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16516466,KI,>,5025,NM,,,,,,,,,,,,,,Binding affinity to MMP13,,"Synthesis and structure-activity relationship of a novel, achiral series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2006,16,10,"Gilmore JL, King BW, Harris C, Maduskuie T, Mercer SE, Liu RQ, Covington MB, Qian M, Ribadeneria MD, Vaddi K, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,354462,DTCT0024002,1926527,DTCC00421580,552632,20786
CHEMBL207305,P45452,,NUVSGXIVCJBRBF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18790648,KI,>,5025,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497406,DTCT0024002,2457278,DTCC00421580,565360,32556
CHEMBL207415,P45452,,ZTSCXJSYCOZWKZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16516466,KI,>,5025,NM,,,,,,,,,,,,,,Binding affinity to MMP13,,"Synthesis and structure-activity relationship of a novel, achiral series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2006,16,10,"Gilmore JL, King BW, Harris C, Maduskuie T, Mercer SE, Liu RQ, Covington MB, Qian M, Ribadeneria MD, Vaddi K, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,354462,DTCT0024002,1926528,DTCC00422266,876063,20786
CHEMBL207468,P45452,,RBUVXLALMRWKQA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16516466,KI,>,5025,NM,,,,,,,,,,,,,,Binding affinity to MMP13,,"Synthesis and structure-activity relationship of a novel, achiral series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2006,16,10,"Gilmore JL, King BW, Harris C, Maduskuie T, Mercer SE, Liu RQ, Covington MB, Qian M, Ribadeneria MD, Vaddi K, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,354462,DTCT0024002,1926549,DTCC00110329,227887,20786
CHEMBL207683,P45452,,NHMWZOLCOOIQJX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16516466,KI,>,5025,NM,,,,,,,,,,,,,,Binding affinity to MMP13,,"Synthesis and structure-activity relationship of a novel, achiral series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2006,16,10,"Gilmore JL, King BW, Harris C, Maduskuie T, Mercer SE, Liu RQ, Covington MB, Qian M, Ribadeneria MD, Vaddi K, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,354462,DTCT0024002,1926530,DTCC00422250,1165868,20786
CHEMBL207709,P45452,,ALAICNBWAOLDPL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16516466,KI,>,5025,NM,,,,,,,,,,,,,,Binding affinity to MMP13,,"Synthesis and structure-activity relationship of a novel, achiral series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2006,16,10,"Gilmore JL, King BW, Harris C, Maduskuie T, Mercer SE, Liu RQ, Covington MB, Qian M, Ribadeneria MD, Vaddi K, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,354462,DTCT0024002,1926545,DTCC00422046,1295959,20786
CHEMBL207726,P45452,,CBKSKDVWCOUHEC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16516466,KI,>,5025,NM,,,,,,,,,,,,,,Binding affinity to MMP13,,"Synthesis and structure-activity relationship of a novel, achiral series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2006,16,10,"Gilmore JL, King BW, Harris C, Maduskuie T, Mercer SE, Liu RQ, Covington MB, Qian M, Ribadeneria MD, Vaddi K, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,354462,DTCT0024002,1926533,DTCC00421740,2035826,20786
CHEMBL207729,P45452,,CVZIHNYAZLXRRS-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,14718605,IC50,=,3,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024002,14717451,DTCC00110220,2101028,69108
CHEMBL207729,P45452,,CVZIHNYAZLXRRS-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16426848,IC50,=,3,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Acetylenic TACE inhibitors. Part 3: Thiomorpholine sulfonamide hydroxamates.,Bioorg. Med. Chem. Lett.,2006,16,6,"Levin JI, Chen JM, Laakso LM, Du M, Schmid J, Xu W, Cummons T, Xu J, Jin G, Barone D, Skotnicki JS",,339181,DTCT0024002,1909149,DTCC00110220,855191,14616
CHEMBL207729,P45452,,CVZIHNYAZLXRRS-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17606376,IC50,=,2.4,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,Structure-based design of TACE selective inhibitors: manipulations in the S1'-S3' pocket.,Bioorg. Med. Chem.,2007,15,18,"Huang A, Joseph-McCarthy D, Lovering F, Sun L, Wang W, Xu W, Zhu Y, Cui J, Zhang Y, Levin JI",,448560,DTCT0024002,2180874,DTCC00110220,844026,23780
CHEMBL207729,P45452,,CVZIHNYAZLXRRS-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19095454,IC50,=,3,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Current perspective of TACE inhibitors: a review.,Bioorg. Med. Chem.,2009,17,2,"DasGupta S, Murumkar PR, Giridhar R, Yadav MR",,495051,DTCT0024002,2594720,DTCC00110220,856184,32093
CHEMBL207756,P45452,,ZQORGANDVNQVJF-YESZJQIVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16516469,KI,=,7,NM,,,,,,,,,,,,,,Binding affinity to recombinant MMP13,,A cassette-dosing approach for improvement of oral bioavailability of dual TACE/MMP inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,10,"Janser P, Neumann U, Miltz W, Feifel R, Buhl T",,354053,DTCT0024002,1926042,DTCC00422639,919235,20779
CHEMBL207776,P45452,,KLSLMSQYLRDFGN-AWEZNQCLSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16426848,IC50,=,1,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Acetylenic TACE inhibitors. Part 3: Thiomorpholine sulfonamide hydroxamates.,Bioorg. Med. Chem. Lett.,2006,16,6,"Levin JI, Chen JM, Laakso LM, Du M, Schmid J, Xu W, Cummons T, Xu J, Jin G, Barone D, Skotnicki JS",,339181,DTCT0024002,1909224,DTCC00110221,370267,14616
CHEMBL207999,P45452,,FQARNXJHFBTHOY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16516466,KI,>,5025,NM,,,,,,,,,,,,,,Binding affinity to MMP13,,"Synthesis and structure-activity relationship of a novel, achiral series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2006,16,10,"Gilmore JL, King BW, Harris C, Maduskuie T, Mercer SE, Liu RQ, Covington MB, Qian M, Ribadeneria MD, Vaddi K, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,354462,DTCT0024002,1926531,DTCC00422073,1004906,20786
CHEMBL208009,P45452,,BODLESUVCQEUII-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16516466,KI,>,5025,NM,,,,,,,,,,,,,,Binding affinity to MMP13,,"Synthesis and structure-activity relationship of a novel, achiral series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2006,16,10,"Gilmore JL, King BW, Harris C, Maduskuie T, Mercer SE, Liu RQ, Covington MB, Qian M, Ribadeneria MD, Vaddi K, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,354462,DTCT0024002,1926551,DTCC00421655,1037257,20786
CHEMBL208022,P45452,,ADROOOBIKREWPX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16516466,KI,>,5025,NM,,,,,,,,,,,,,,Binding affinity to MMP13,,"Synthesis and structure-activity relationship of a novel, achiral series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2006,16,10,"Gilmore JL, King BW, Harris C, Maduskuie T, Mercer SE, Liu RQ, Covington MB, Qian M, Ribadeneria MD, Vaddi K, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,354462,DTCT0024002,1926548,DTCC00421838,260142,20786
CHEMBL208172,P45452,,CTANAKVMPKAIQD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16516466,KI,>,5025,NM,,,,,,,,,,,,,,Binding affinity to MMP13,,"Synthesis and structure-activity relationship of a novel, achiral series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2006,16,10,"Gilmore JL, King BW, Harris C, Maduskuie T, Mercer SE, Liu RQ, Covington MB, Qian M, Ribadeneria MD, Vaddi K, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,354462,DTCT0024002,1926538,DTCC00421845,552631,20786
CHEMBL208181,P45452,,MWYSQPGMUZLIHV-RCCFBDPRSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16516469,KI,=,3,NM,,,,,,,,,,,,,,Binding affinity to recombinant MMP13,,A cassette-dosing approach for improvement of oral bioavailability of dual TACE/MMP inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,10,"Janser P, Neumann U, Miltz W, Feifel R, Buhl T",,354053,DTCT0024002,1926046,DTCC00422272,1695509,20779
CHEMBL208841,P45452,,BNKOGVVBAYMLMZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16723229,IC50,=,69,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Design and synthesis of butynyloxyphenyl beta-sulfone piperidine hydroxamates as TACE inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,15,"Park K, Aplasca A, Du MT, Sun L, Zhu Y, Zhang Y, Levin JI",,377988,DTCT0024002,1969685,DTCC00428615,2067649,21111
CHEMBL2092878,P45452,3-BENZENESULFONYL-HEPTANOIC ACID HYDROXYAMIDE,TUUMURVUDGZZQZ-LBPRGKRZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10882358,IC50,=,18,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,Hydroxamic acid derivatives as potent peptide deformylase inhibitors and antibacterial agents.,J. Med. Chem.,2000,43,12,"Apfel C, Banner DW, Bur D, Dietz M, Hirata T, Hubschwerlen C, Locher H, Page MG, Pirson W, Rossé G, Specklin JL",,104572,DTCT0024002,562572,DTCC00043357,140611,15751
CHEMBL209490,P45452,,YLPGDDBCDVVMDA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16723229,IC50,=,327,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Design and synthesis of butynyloxyphenyl beta-sulfone piperidine hydroxamates as TACE inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,15,"Park K, Aplasca A, Du MT, Sun L, Zhu Y, Zhang Y, Levin JI",,377988,DTCT0024002,1969723,DTCC00428567,1684282,21111
CHEMBL2096738,P45452,,FROMXYGXLCSILK-LHSJRXKWSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15566296,IC50,=,72,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Synthesis and structure-activity relationships of 4-alkynyloxy phenyl sulfanyl, sulfinyl, and sulfonyl alkyl hydroxamates as tumor necrosis factor-alpha converting enzyme and matrix metalloproteinase inhibitors.",J. Med. Chem.,2004,47,25,"Venkatesan AM, Davis JM, Grosu GT, Baker J, Zask A, Levin JI, Ellingboe J, Skotnicki JS, Dijoseph JF, Sung A, Jin G, Xu W, McCarthy DJ, Barone D",,429672,DTCT0024002,2041949,DTCC01256900,1405627,22157
CHEMBL2096739,P45452,,LMLJZJGMFKPKNY-BPNWFJGMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15566296,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Synthesis and structure-activity relationships of 4-alkynyloxy phenyl sulfanyl, sulfinyl, and sulfonyl alkyl hydroxamates as tumor necrosis factor-alpha converting enzyme and matrix metalloproteinase inhibitors.",J. Med. Chem.,2004,47,25,"Venkatesan AM, Davis JM, Grosu GT, Baker J, Zask A, Levin JI, Ellingboe J, Skotnicki JS, Dijoseph JF, Sung A, Jin G, Xu W, McCarthy DJ, Barone D",,429672,DTCT0024002,2041970,DTCC01256901,1081613,22157
CHEMBL2096740,P45452,,PCASIOOVBSODBH-QOBPCVTDSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15566296,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Synthesis and structure-activity relationships of 4-alkynyloxy phenyl sulfanyl, sulfinyl, and sulfonyl alkyl hydroxamates as tumor necrosis factor-alpha converting enzyme and matrix metalloproteinase inhibitors.",J. Med. Chem.,2004,47,25,"Venkatesan AM, Davis JM, Grosu GT, Baker J, Zask A, Levin JI, Ellingboe J, Skotnicki JS, Dijoseph JF, Sung A, Jin G, Xu W, McCarthy DJ, Barone D",,429672,DTCT0024002,2041966,DTCC01256903,1631355,22157
CHEMBL2096775,P45452,,FBLGEUMPZQFQFF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15780611,IC50,=,3.9,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 13,,Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.,Bioorg. Med. Chem. Lett.,2005,15,7,"Blagg JA, Noe MC, Wolf-Gouveia LA, Reiter LA, Laird ER, Chang SP, Danley DE, Downs JT, Elliott NC, Eskra JD, Griffiths RJ, Hardink JR, Haugeto AI, Jones CS, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robinson RP, Subramanyam C, Vaughn-Bowser ML, Yocum SA",,305127,DTCT0024002,1752545,DTCC01256933,1436928,18917
CHEMBL2096852,P45452,,FROMXYGXLCSILK-QKKBWIMNSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15566296,IC50,=,18,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Synthesis and structure-activity relationships of 4-alkynyloxy phenyl sulfanyl, sulfinyl, and sulfonyl alkyl hydroxamates as tumor necrosis factor-alpha converting enzyme and matrix metalloproteinase inhibitors.",J. Med. Chem.,2004,47,25,"Venkatesan AM, Davis JM, Grosu GT, Baker J, Zask A, Levin JI, Ellingboe J, Skotnicki JS, Dijoseph JF, Sung A, Jin G, Xu W, McCarthy DJ, Barone D",,429672,DTCT0024002,2041980,DTCC01257002,1209739,22157
CHEMBL2096854,P45452,,LMLJZJGMFKPKNY-KEJDIYNNSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15566296,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Synthesis and structure-activity relationships of 4-alkynyloxy phenyl sulfanyl, sulfinyl, and sulfonyl alkyl hydroxamates as tumor necrosis factor-alpha converting enzyme and matrix metalloproteinase inhibitors.",J. Med. Chem.,2004,47,25,"Venkatesan AM, Davis JM, Grosu GT, Baker J, Zask A, Levin JI, Ellingboe J, Skotnicki JS, Dijoseph JF, Sung A, Jin G, Xu W, McCarthy DJ, Barone D",,429672,DTCT0024002,2041969,DTCC01257003,855452,22157
CHEMBL2096855,P45452,,PCASIOOVBSODBH-MDYZWHIJSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15566296,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Synthesis and structure-activity relationships of 4-alkynyloxy phenyl sulfanyl, sulfinyl, and sulfonyl alkyl hydroxamates as tumor necrosis factor-alpha converting enzyme and matrix metalloproteinase inhibitors.",J. Med. Chem.,2004,47,25,"Venkatesan AM, Davis JM, Grosu GT, Baker J, Zask A, Levin JI, Ellingboe J, Skotnicki JS, Dijoseph JF, Sung A, Jin G, Xu W, McCarthy DJ, Barone D",,429672,DTCT0024002,2041965,DTCC01257004,370549,22157
CHEMBL209970,P45452,,CEVLUPQNDFOYSI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16723229,IC50,=,230,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Design and synthesis of butynyloxyphenyl beta-sulfone piperidine hydroxamates as TACE inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,15,"Park K, Aplasca A, Du MT, Sun L, Zhu Y, Zhang Y, Levin JI",,377988,DTCT0024002,1969603,DTCC00428551,1426125,21111
CHEMBL209970,P45452,,CEVLUPQNDFOYSI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17064892,IC50,=,230,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440764,DTCT0024002,2153872,DTCC00428551,1426378,23077
CHEMBL209970,P45452,,CEVLUPQNDFOYSI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17606376,IC50,=,157,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,Structure-based design of TACE selective inhibitors: manipulations in the S1'-S3' pocket.,Bioorg. Med. Chem.,2007,15,18,"Huang A, Joseph-McCarthy D, Lovering F, Sun L, Wang W, Xu W, Zhu Y, Cui J, Zhang Y, Levin JI",,448560,DTCT0024002,2180830,DTCC00428551,1426485,23780
CHEMBL209970,P45452,,CEVLUPQNDFOYSI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18790648,IC50,=,230,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497406,DTCT0024002,2456490,DTCC00428551,1438568,32556
CHEMBL210441,P45452,,LOZYBBRAEOAORI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16632358,IC50,=,0.8,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Synthesis and SAR of alpha-sulfonylcarboxylic acids as potent matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,12,"Zhang YM, Fan X, Xiang B, Chakravarty D, Scannevin R, Burke S, Karnachi P, Rhodes K, Jackson P",,361730,DTCT0024002,1937053,DTCC00423321,778415,20885
CHEMBL210517,P45452,,OIBWGGKYJHWGPB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16632358,IC50,=,1.4,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Synthesis and SAR of alpha-sulfonylcarboxylic acids as potent matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,12,"Zhang YM, Fan X, Xiang B, Chakravarty D, Scannevin R, Burke S, Karnachi P, Rhodes K, Jackson P",,361730,DTCT0024002,1937052,DTCC00422956,1872825,20885
CHEMBL2111753,P45452,,JJSAEDOMTCNEQL-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15177439,IC50,=,0.35,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP-13),,Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2004,14,13,"Reiter LA, Robinson RP, McClure KF, Jones CS, Reese MR, Mitchell PG, Otterness IG, Bliven ML, Liras J, Cortina SR, Donahue KM, Eskra JD, Griffiths RJ, Lame ME, Lopez-Anaya A, Martinelli GJ, McGahee SM, Yocum SA, Lopresti-Morrow LL, Tobiassen LM, Vaughn-Bowser ML",,106600,DTCT0024002,1491455,DTCC01264140,1112510,6475
CHEMBL2111753,P45452,,JJSAEDOMTCNEQL-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15177439,IC50,=,1,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP-13),,Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2004,14,13,"Reiter LA, Robinson RP, McClure KF, Jones CS, Reese MR, Mitchell PG, Otterness IG, Bliven ML, Liras J, Cortina SR, Donahue KM, Eskra JD, Griffiths RJ, Lame ME, Lopez-Anaya A, Martinelli GJ, McGahee SM, Yocum SA, Lopresti-Morrow LL, Tobiassen LM, Vaughn-Bowser ML",,106600,DTCT0024002,1500629,DTCC01264140,1112511,6475
CHEMBL2111753,P45452,,JJSAEDOMTCNEQL-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15177439,INHIBITION,=,50,%,,organism_based,,,,,,,,,,,,Inhibition of MMP-13 induced experimental arthritis in hamster knee by 30 mg/kg p.o.,,Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2004,14,13,"Reiter LA, Robinson RP, McClure KF, Jones CS, Reese MR, Mitchell PG, Otterness IG, Bliven ML, Liras J, Cortina SR, Donahue KM, Eskra JD, Griffiths RJ, Lame ME, Lopez-Anaya A, Martinelli GJ, McGahee SM, Yocum SA, Lopresti-Morrow LL, Tobiassen LM, Vaughn-Bowser ML",,82692,DTCT0024002,1500636,DTCC01264140,1112511,6475
CHEMBL2111754,P45452,,MRSUSKBPRPSZTK-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15177439,IC50,=,1.2,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP-13),,Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2004,14,13,"Reiter LA, Robinson RP, McClure KF, Jones CS, Reese MR, Mitchell PG, Otterness IG, Bliven ML, Liras J, Cortina SR, Donahue KM, Eskra JD, Griffiths RJ, Lame ME, Lopez-Anaya A, Martinelli GJ, McGahee SM, Yocum SA, Lopresti-Morrow LL, Tobiassen LM, Vaughn-Bowser ML",,106600,DTCT0024002,1495008,DTCC01264141,562640,6475
CHEMBL2111965,P45452,,KMLOBHZAEFITDB-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10579818,IC50,=,137,NM,,,,,,,,,,,,,,In vitro inhibitory activity against collagenase-3 (matrix metalloprotease-13).,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,106469,DTCT0024002,1366557,DTCC01264342,1208504,15412
CHEMBL211274,P45452,,NILIMKWDWHKQOZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16723229,IC50,=,54,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Design and synthesis of butynyloxyphenyl beta-sulfone piperidine hydroxamates as TACE inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,15,"Park K, Aplasca A, Du MT, Sun L, Zhu Y, Zhang Y, Levin JI",,377988,DTCT0024002,1969669,DTCC00428620,227939,21111
CHEMBL2112796,P45452,,KMLOBHZAEFITDB-MOPGFXCFSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10579818,IC50,=,2.5,NM,,,,,,,,,,,,,,In vitro inhibitory activity against collagenase-3 (matrix metalloprotease-13).,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,106469,DTCT0024002,1401854,DTCC01265121,1241293,15412
CHEMBL2114153,P45452,,FLIOXLIZONFFSH-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773041,IC50,=,4,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-13,,"Synthesis and structure-activity relationship of alpha-sulfonylhydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Grosu GT, Davis JM, Hu B, Ellingboe J, Baker JL, Skotnicki JS, Zask A, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R",,106627,DTCT0024002,791169,DTCC01266127,808586,17339
CHEMBL2114153,P45452,,FLIOXLIZONFFSH-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773041,IC50,=,86,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-13,,"Synthesis and structure-activity relationship of alpha-sulfonylhydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Grosu GT, Davis JM, Hu B, Ellingboe J, Baker JL, Skotnicki JS, Zask A, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R",,106627,DTCT0024002,774272,DTCC01266127,808585,17339
CHEMBL2114153,P45452,,FLIOXLIZONFFSH-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,6,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260765,DTCC01266127,811357,24831
CHEMBL211487,P45452,,MTSOZTJGECJILJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16723229,IC50,=,24,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Design and synthesis of butynyloxyphenyl beta-sulfone piperidine hydroxamates as TACE inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,15,"Park K, Aplasca A, Du MT, Sun L, Zhu Y, Zhang Y, Levin JI",,377988,DTCT0024002,1969709,DTCC00428518,520596,21111
CHEMBL2115084,P45452,,KVNBSMBKXVJFRN-RXVVDRJESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11454461,IC50,=,17,NM,,,,,,,,,,,,,,In vitro inhibitory concentration against Matrix metalloprotease-13,,The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold.,Bioorg. Med. Chem. Lett.,2001,11,15,"Tullis JS, Laufersweiler MJ, VanRens JC, Natchus MG, Bookland RG, Almstead NG, Pikul S, De B, Hsieh LC, Janusz MJ, Branch TM, Peng SX, Jin YY, Hudlicky T, Oppong K",,106479,DTCT0024002,1533985,DTCC01266559,2076820,4358
CHEMBL2115165,P45452,ABT-518,IVPPTWCRAFCOFJ-RTBURBONSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11754593,IC50,=,3.3,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 (MMP-13) in fluorimetric assay,,"Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitors.",J. Med. Chem.,2002,45,1,"Wada CK, Holms JH, Curtin ML, Dai Y, Florjancic AS, Garland RB, Guo Y, Heyman HR, Stacey JR, Steinman DH, Albert DH, Bouska JJ, Elmore IN, Goodfellow CL, Marcotte PA, Tapang P, Morgan DW, Michaelides MR, Davidsen SK",,106639,DTCT0024002,1572605,DTCC00045007,550427,16699
CHEMBL211726,P45452,,LWFCUEQJXZSHMP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16723229,IC50,=,14,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Design and synthesis of butynyloxyphenyl beta-sulfone piperidine hydroxamates as TACE inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,15,"Park K, Aplasca A, Du MT, Sun L, Zhu Y, Zhang Y, Levin JI",,377988,DTCT0024002,1969653,DTCC00428523,326079,21111
CHEMBL211770,P45452,,WPYFTDWGMAINBU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16723229,IC50,=,10,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Design and synthesis of butynyloxyphenyl beta-sulfone piperidine hydroxamates as TACE inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,15,"Park K, Aplasca A, Du MT, Sun L, Zhu Y, Zhang Y, Levin JI",,377988,DTCT0024002,1969623,DTCC00428541,163652,21111
CHEMBL212411,P45452,,LNPBBURQSUEIHO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16723229,IC50,=,39,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Design and synthesis of butynyloxyphenyl beta-sulfone piperidine hydroxamates as TACE inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,15,"Park K, Aplasca A, Du MT, Sun L, Zhu Y, Zhang Y, Levin JI",,377988,DTCT0024002,1969639,DTCC00428532,1652105,21111
CHEMBL212481,P45452,,HNEDFPGSHTUVKZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16723229,IC50,=,69,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Design and synthesis of butynyloxyphenyl beta-sulfone piperidine hydroxamates as TACE inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,15,"Park K, Aplasca A, Du MT, Sun L, Zhu Y, Zhang Y, Levin JI",,377988,DTCT0024002,1969661,DTCC00428522,1872868,21111
CHEMBL212481,P45452,,HNEDFPGSHTUVKZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19464885,IC50,=,59,NM,,,,,,,,,,,,,,inhibition of human recombinant MMP13 catalytic domain,,Synthesis and activity of quinolinylmethyl P1' alpha-sulfone piperidine hydroxamate inhibitors of TACE.,Bioorg. Med. Chem. Lett.,2009,19,13,"Zhang C, Lovering F, Behnke M, Zask A, Sandanayaka V, Sun L, Zhu Y, Xu W, Zhang Y, Levin JI",,523796,DTCT0024002,2832609,DTCC00428522,1885648,33699
CHEMBL2153738,P45452,,CGPJRIXIBMANTN-PHCUSUGSSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21780776,KI,>,200000,NM,,,,,,,,,,,,,,Inhibition of MMP-13,,Remarkable potential of the a-aminophosphonate/phosphinate structural motif in medicinal chemistry.,J. Med. Chem.,2011,54,17,"Mucha A, Kafarski P, Berlicki L",,850712,DTCT0024002,11357662,DTCC01286635,705682,50957
CHEMBL2153739,P45452,,SGHHKDAEMQQYOU-CEURZZNXSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21780776,KI,=,28,NM,,,,,,,,,,,,,,Inhibition of MMP-13,,Remarkable potential of the a-aminophosphonate/phosphinate structural motif in medicinal chemistry.,J. Med. Chem.,2011,54,17,"Mucha A, Kafarski P, Berlicki L",,850712,DTCT0024002,11357605,DTCC01286636,512150,50957
CHEMBL2164094,P45452,,RNVLUWRPULKASN-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22891645,IC50,=,25000,NM,,,,,,,,,,,,,,Inhibition of MMP-13 using 5-FAM-TPGPLGL[Dap- (DNP)]ARRK(5-TAMRA)-amide as substrate after 45 mins,,Discovery of highly potent and selective small molecule ADAMTS-5 inhibitors that inhibit human cartilage degradation via encoded library technology (ELT).,J. Med. Chem.,2012,55,16,"Deng H, O'Keefe H, Davie CP, Lind KE, Acharya RA, Franklin GJ, Larkin J, Matico R, Neeb M, Thompson MM, Lohr T, Gross JW, Centrella PA, O'Donovan GK, Bedard KL, van Vloten K, Mataruse S, Skinner SR, Belyanskaya SL, Carpenter TY, Shearer TW, Clark MA, Cuozzo JW, Arico-Muendel CC, Morgan BA",,860058,DTCT0024002,11400358,DTCC01289599,187284,51288
CHEMBL2164111,P45452,,URLQNGAYIHTGNE-RUZDIDTESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22891645,IC50,=,7900,NM,,,,,,,,,,,,,,Inhibition of MMP-13 using 5-FAM-TPGPLGL[Dap- (DNP)]ARRK(5-TAMRA)-amide as substrate after 45 mins,,Discovery of highly potent and selective small molecule ADAMTS-5 inhibitors that inhibit human cartilage degradation via encoded library technology (ELT).,J. Med. Chem.,2012,55,16,"Deng H, O'Keefe H, Davie CP, Lind KE, Acharya RA, Franklin GJ, Larkin J, Matico R, Neeb M, Thompson MM, Lohr T, Gross JW, Centrella PA, O'Donovan GK, Bedard KL, van Vloten K, Mataruse S, Skinner SR, Belyanskaya SL, Carpenter TY, Shearer TW, Clark MA, Cuozzo JW, Arico-Muendel CC, Morgan BA",,860058,DTCT0024002,11400360,DTCC01289616,1417885,51288
CHEMBL2164113,P45452,,LBWXQSGZOWXNEF-RUZDIDTESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22891645,IC50,=,7900,NM,,,,,,,,,,,,,,Inhibition of MMP-13 using 5-FAM-TPGPLGL[Dap- (DNP)]ARRK(5-TAMRA)-amide as substrate after 45 mins,,Discovery of highly potent and selective small molecule ADAMTS-5 inhibitors that inhibit human cartilage degradation via encoded library technology (ELT).,J. Med. Chem.,2012,55,16,"Deng H, O'Keefe H, Davie CP, Lind KE, Acharya RA, Franklin GJ, Larkin J, Matico R, Neeb M, Thompson MM, Lohr T, Gross JW, Centrella PA, O'Donovan GK, Bedard KL, van Vloten K, Mataruse S, Skinner SR, Belyanskaya SL, Carpenter TY, Shearer TW, Clark MA, Cuozzo JW, Arico-Muendel CC, Morgan BA",,860058,DTCT0024002,11400359,DTCC01289618,835045,51288
CHEMBL2164120,P45452,,ZDDSIQGYVHATQX-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22891645,IC50,>,50000,NM,,,,,,,,,,,,,,Inhibition of MMP-13 using 5-FAM-TPGPLGL[Dap- (DNP)]ARRK(5-TAMRA)-amide as substrate after 45 mins,,Discovery of highly potent and selective small molecule ADAMTS-5 inhibitors that inhibit human cartilage degradation via encoded library technology (ELT).,J. Med. Chem.,2012,55,16,"Deng H, O'Keefe H, Davie CP, Lind KE, Acharya RA, Franklin GJ, Larkin J, Matico R, Neeb M, Thompson MM, Lohr T, Gross JW, Centrella PA, O'Donovan GK, Bedard KL, van Vloten K, Mataruse S, Skinner SR, Belyanskaya SL, Carpenter TY, Shearer TW, Clark MA, Cuozzo JW, Arico-Muendel CC, Morgan BA",,860058,DTCT0024002,11400363,DTCC01289625,1928836,51288
CHEMBL2164121,P45452,,IIXODPXDUIIVAF-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22891645,IC50,>,25000,NM,,,,,,,,,,,,,,Inhibition of MMP-13 using 5-FAM-TPGPLGL[Dap- (DNP)]ARRK(5-TAMRA)-amide as substrate after 45 mins,,Discovery of highly potent and selective small molecule ADAMTS-5 inhibitors that inhibit human cartilage degradation via encoded library technology (ELT).,J. Med. Chem.,2012,55,16,"Deng H, O'Keefe H, Davie CP, Lind KE, Acharya RA, Franklin GJ, Larkin J, Matico R, Neeb M, Thompson MM, Lohr T, Gross JW, Centrella PA, O'Donovan GK, Bedard KL, van Vloten K, Mataruse S, Skinner SR, Belyanskaya SL, Carpenter TY, Shearer TW, Clark MA, Cuozzo JW, Arico-Muendel CC, Morgan BA",,860058,DTCT0024002,11400362,DTCC01289626,2027549,51288
CHEMBL2164122,P45452,,MZFVSYXTBIQFNO-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22891645,IC50,>,25000,NM,,,,,,,,,,,,,,Inhibition of MMP-13 using 5-FAM-TPGPLGL[Dap- (DNP)]ARRK(5-TAMRA)-amide as substrate after 45 mins,,Discovery of highly potent and selective small molecule ADAMTS-5 inhibitors that inhibit human cartilage degradation via encoded library technology (ELT).,J. Med. Chem.,2012,55,16,"Deng H, O'Keefe H, Davie CP, Lind KE, Acharya RA, Franklin GJ, Larkin J, Matico R, Neeb M, Thompson MM, Lohr T, Gross JW, Centrella PA, O'Donovan GK, Bedard KL, van Vloten K, Mataruse S, Skinner SR, Belyanskaya SL, Carpenter TY, Shearer TW, Clark MA, Cuozzo JW, Arico-Muendel CC, Morgan BA",,860058,DTCT0024002,11400361,DTCC01289627,544348,51288
CHEMBL218118,P45452,,HXWAXUQSZMRTTE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16942871,IC50,=,3.4,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Potent, selective pyrimidinetrione-based inhibitors of MMP-13.",Bioorg. Med. Chem. Lett.,2006,16,22,"Reiter LA, Freeman-Cook KD, Jones CS, Martinelli GJ, Antipas AS, Berliner MA, Datta K, Downs JT, Eskra JD, Forman MD, Greer EM, Guzman R, Hardink JR, Janat F, Keene NF, Laird ER, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robertson D, Sperger D, Vaughn-Bowser ML, Waller DM, Yocum SA",,424283,DTCT0024002,2011692,DTCC00440821,596519,21753
CHEMBL220522,P45452,,ZCXHOQKYVQEPQH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16942871,IC50,=,0.4,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Potent, selective pyrimidinetrione-based inhibitors of MMP-13.",Bioorg. Med. Chem. Lett.,2006,16,22,"Reiter LA, Freeman-Cook KD, Jones CS, Martinelli GJ, Antipas AS, Berliner MA, Datta K, Downs JT, Eskra JD, Forman MD, Greer EM, Guzman R, Hardink JR, Janat F, Keene NF, Laird ER, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robertson D, Sperger D, Vaughn-Bowser ML, Waller DM, Yocum SA",,424283,DTCT0024002,2011660,DTCC00440955,175015,21753
CHEMBL220644,P45452,,UZAMKIKZKYPSEU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16942871,IC50,=,6.1,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Potent, selective pyrimidinetrione-based inhibitors of MMP-13.",Bioorg. Med. Chem. Lett.,2006,16,22,"Reiter LA, Freeman-Cook KD, Jones CS, Martinelli GJ, Antipas AS, Berliner MA, Datta K, Downs JT, Eskra JD, Forman MD, Greer EM, Guzman R, Hardink JR, Janat F, Keene NF, Laird ER, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robertson D, Sperger D, Vaughn-Bowser ML, Waller DM, Yocum SA",,424283,DTCT0024002,2011689,DTCC00440842,78185,21753
CHEMBL220904,P45452,,FGEWPRGSHIGWTP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16942871,IC50,=,0.36,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Potent, selective pyrimidinetrione-based inhibitors of MMP-13.",Bioorg. Med. Chem. Lett.,2006,16,22,"Reiter LA, Freeman-Cook KD, Jones CS, Martinelli GJ, Antipas AS, Berliner MA, Datta K, Downs JT, Eskra JD, Forman MD, Greer EM, Guzman R, Hardink JR, Janat F, Keene NF, Laird ER, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robertson D, Sperger D, Vaughn-Bowser ML, Waller DM, Yocum SA",,424283,DTCT0024002,2011671,DTCC00440882,435565,21753
CHEMBL220904,P45452,,FGEWPRGSHIGWTP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17935984,IC50,=,0.35,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Potent, selective spiropyrrolidine pyrimidinetrione inhibitors of MMP-13.",Bioorg. Med. Chem. Lett.,2007,17,23,"Freeman-Cook KD, Reiter LA, Noe MC, Antipas AS, Danley DE, Datta K, Downs JT, Eisenbeis S, Eskra JD, Garmene DJ, Greer EM, Griffiths RJ, Guzman R, Hardink JR, Janat F, Jones CS, Martinelli GJ, Mitchell PG, Laird ER, Liras JL, Lopresti-Morrow LL, Pandit J, Reilly UD, Robertson D, Vaughn-Bowser ML, Wolf-Gouviea LA, Yocum SA",,458357,DTCT0024002,2254802,DTCC00440882,424685,24756
CHEMBL220911,P45452,,AGWKHVSTJXNYET-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16942871,IC50,=,3.4,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Potent, selective pyrimidinetrione-based inhibitors of MMP-13.",Bioorg. Med. Chem. Lett.,2006,16,22,"Reiter LA, Freeman-Cook KD, Jones CS, Martinelli GJ, Antipas AS, Berliner MA, Datta K, Downs JT, Eskra JD, Forman MD, Greer EM, Guzman R, Hardink JR, Janat F, Keene NF, Laird ER, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robertson D, Sperger D, Vaughn-Bowser ML, Waller DM, Yocum SA",,424283,DTCT0024002,2011685,DTCC00440896,1663594,21753
CHEMBL220957,P45452,,DJUDJCFUDCLJSQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16942871,IC50,=,0.68,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Potent, selective pyrimidinetrione-based inhibitors of MMP-13.",Bioorg. Med. Chem. Lett.,2006,16,22,"Reiter LA, Freeman-Cook KD, Jones CS, Martinelli GJ, Antipas AS, Berliner MA, Datta K, Downs JT, Eskra JD, Forman MD, Greer EM, Guzman R, Hardink JR, Janat F, Keene NF, Laird ER, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robertson D, Sperger D, Vaughn-Bowser ML, Waller DM, Yocum SA",,424283,DTCT0024002,2011669,DTCC00440897,142861,21753
CHEMBL220957,P45452,,DJUDJCFUDCLJSQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17935984,IC50,=,0.68,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Potent, selective spiropyrrolidine pyrimidinetrione inhibitors of MMP-13.",Bioorg. Med. Chem. Lett.,2007,17,23,"Freeman-Cook KD, Reiter LA, Noe MC, Antipas AS, Danley DE, Datta K, Downs JT, Eisenbeis S, Eskra JD, Garmene DJ, Greer EM, Griffiths RJ, Guzman R, Hardink JR, Janat F, Jones CS, Martinelli GJ, Mitchell PG, Laird ER, Liras JL, Lopresti-Morrow LL, Pandit J, Reilly UD, Robertson D, Vaughn-Bowser ML, Wolf-Gouviea LA, Yocum SA",,458357,DTCT0024002,2254806,DTCC00440897,131652,24756
CHEMBL220964,P45452,,SDPYWOXUCQVWHK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16942871,IC50,=,1.6,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Potent, selective pyrimidinetrione-based inhibitors of MMP-13.",Bioorg. Med. Chem. Lett.,2006,16,22,"Reiter LA, Freeman-Cook KD, Jones CS, Martinelli GJ, Antipas AS, Berliner MA, Datta K, Downs JT, Eskra JD, Forman MD, Greer EM, Guzman R, Hardink JR, Janat F, Keene NF, Laird ER, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robertson D, Sperger D, Vaughn-Bowser ML, Waller DM, Yocum SA",,424283,DTCT0024002,2011684,DTCC00110911,919420,21753
CHEMBL220965,P45452,,FRDQLMYGRCNAES-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16942871,IC50,=,7.5,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Potent, selective pyrimidinetrione-based inhibitors of MMP-13.",Bioorg. Med. Chem. Lett.,2006,16,22,"Reiter LA, Freeman-Cook KD, Jones CS, Martinelli GJ, Antipas AS, Berliner MA, Datta K, Downs JT, Eskra JD, Forman MD, Greer EM, Guzman R, Hardink JR, Janat F, Keene NF, Laird ER, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robertson D, Sperger D, Vaughn-Bowser ML, Waller DM, Yocum SA",,424283,DTCT0024002,2011683,DTCC00440907,33842,21753
CHEMBL221267,P45452,,RBKFSOLEBKDLKQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16942871,IC50,=,0.73,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Potent, selective pyrimidinetrione-based inhibitors of MMP-13.",Bioorg. Med. Chem. Lett.,2006,16,22,"Reiter LA, Freeman-Cook KD, Jones CS, Martinelli GJ, Antipas AS, Berliner MA, Datta K, Downs JT, Eskra JD, Forman MD, Greer EM, Guzman R, Hardink JR, Janat F, Keene NF, Laird ER, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robertson D, Sperger D, Vaughn-Bowser ML, Waller DM, Yocum SA",,424283,DTCT0024002,2011668,DTCC00441012,1405572,21753
CHEMBL221379,P45452,,GVQBOJQAYUWFEZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16942871,IC50,=,3.3,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Potent, selective pyrimidinetrione-based inhibitors of MMP-13.",Bioorg. Med. Chem. Lett.,2006,16,22,"Reiter LA, Freeman-Cook KD, Jones CS, Martinelli GJ, Antipas AS, Berliner MA, Datta K, Downs JT, Eskra JD, Forman MD, Greer EM, Guzman R, Hardink JR, Janat F, Keene NF, Laird ER, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robertson D, Sperger D, Vaughn-Bowser ML, Waller DM, Yocum SA",,424283,DTCT0024002,2011680,DTCC00440815,984231,21753
CHEMBL221449,P45452,,SUMNMUSMCVCNRE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16942871,IC50,=,6.1,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Potent, selective pyrimidinetrione-based inhibitors of MMP-13.",Bioorg. Med. Chem. Lett.,2006,16,22,"Reiter LA, Freeman-Cook KD, Jones CS, Martinelli GJ, Antipas AS, Berliner MA, Datta K, Downs JT, Eskra JD, Forman MD, Greer EM, Guzman R, Hardink JR, Janat F, Keene NF, Laird ER, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robertson D, Sperger D, Vaughn-Bowser ML, Waller DM, Yocum SA",,424283,DTCT0024002,2011678,DTCC00440829,1146453,21753
CHEMBL221480,P45452,,YGXCAQDYOSTOFA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16942871,IC50,=,0.34,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Potent, selective pyrimidinetrione-based inhibitors of MMP-13.",Bioorg. Med. Chem. Lett.,2006,16,22,"Reiter LA, Freeman-Cook KD, Jones CS, Martinelli GJ, Antipas AS, Berliner MA, Datta K, Downs JT, Eskra JD, Forman MD, Greer EM, Guzman R, Hardink JR, Janat F, Keene NF, Laird ER, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robertson D, Sperger D, Vaughn-Bowser ML, Waller DM, Yocum SA",,424283,DTCT0024002,2011661,DTCC00440948,1916637,21753
CHEMBL221497,P45452,,FUUSOAVBYCIIOJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16942871,IC50,=,1,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Potent, selective pyrimidinetrione-based inhibitors of MMP-13.",Bioorg. Med. Chem. Lett.,2006,16,22,"Reiter LA, Freeman-Cook KD, Jones CS, Martinelli GJ, Antipas AS, Berliner MA, Datta K, Downs JT, Eskra JD, Forman MD, Greer EM, Guzman R, Hardink JR, Janat F, Keene NF, Laird ER, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robertson D, Sperger D, Vaughn-Bowser ML, Waller DM, Yocum SA",,424283,DTCT0024002,2011677,DTCC00440837,1787699,21753
CHEMBL221552,P45452,,DGAMJHDFRZBGST-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16942871,IC50,=,2.6,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Potent, selective pyrimidinetrione-based inhibitors of MMP-13.",Bioorg. Med. Chem. Lett.,2006,16,22,"Reiter LA, Freeman-Cook KD, Jones CS, Martinelli GJ, Antipas AS, Berliner MA, Datta K, Downs JT, Eskra JD, Forman MD, Greer EM, Guzman R, Hardink JR, Janat F, Keene NF, Laird ER, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robertson D, Sperger D, Vaughn-Bowser ML, Waller DM, Yocum SA",,424283,DTCT0024002,2011688,DTCC00440851,1177527,21753
CHEMBL221627,P45452,,DNSZKZUFQIXHCV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15566296,INHIBITION,=,24,%,,,,,,,,,,,,,,Inhibition of MMP13,,"Synthesis and structure-activity relationships of 4-alkynyloxy phenyl sulfanyl, sulfinyl, and sulfonyl alkyl hydroxamates as tumor necrosis factor-alpha converting enzyme and matrix metalloproteinase inhibitors.",J. Med. Chem.,2004,47,25,"Venkatesan AM, Davis JM, Grosu GT, Baker J, Zask A, Levin JI, Ellingboe J, Skotnicki JS, Dijoseph JF, Sung A, Jin G, Xu W, McCarthy DJ, Barone D",,429672,DTCT0024002,2041990,DTCC00444519,1437534,22157
CHEMBL221632,P45452,,BRQJYFLUVAGTOK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16942871,IC50,=,0.53,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Potent, selective pyrimidinetrione-based inhibitors of MMP-13.",Bioorg. Med. Chem. Lett.,2006,16,22,"Reiter LA, Freeman-Cook KD, Jones CS, Martinelli GJ, Antipas AS, Berliner MA, Datta K, Downs JT, Eskra JD, Forman MD, Greer EM, Guzman R, Hardink JR, Janat F, Keene NF, Laird ER, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robertson D, Sperger D, Vaughn-Bowser ML, Waller DM, Yocum SA",,424283,DTCT0024002,2011665,DTCC00440923,693495,21753
CHEMBL221632,P45452,,BRQJYFLUVAGTOK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17935984,IC50,=,0.52,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Potent, selective spiropyrrolidine pyrimidinetrione inhibitors of MMP-13.",Bioorg. Med. Chem. Lett.,2007,17,23,"Freeman-Cook KD, Reiter LA, Noe MC, Antipas AS, Danley DE, Datta K, Downs JT, Eisenbeis S, Eskra JD, Garmene DJ, Greer EM, Griffiths RJ, Guzman R, Hardink JR, Janat F, Jones CS, Martinelli GJ, Mitchell PG, Laird ER, Liras JL, Lopresti-Morrow LL, Pandit J, Reilly UD, Robertson D, Vaughn-Bowser ML, Wolf-Gouviea LA, Yocum SA",,458357,DTCT0024002,2254798,DTCC00440923,682302,24756
CHEMBL221634,P45452,,WWTUVSFMSLUEKT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16942871,IC50,=,0.45,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Potent, selective pyrimidinetrione-based inhibitors of MMP-13.",Bioorg. Med. Chem. Lett.,2006,16,22,"Reiter LA, Freeman-Cook KD, Jones CS, Martinelli GJ, Antipas AS, Berliner MA, Datta K, Downs JT, Eskra JD, Forman MD, Greer EM, Guzman R, Hardink JR, Janat F, Keene NF, Laird ER, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robertson D, Sperger D, Vaughn-Bowser ML, Waller DM, Yocum SA",,424283,DTCT0024002,2011663,DTCC00440935,337871,21753
CHEMBL221634,P45452,,WWTUVSFMSLUEKT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17935984,IC50,=,0.43,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Potent, selective spiropyrrolidine pyrimidinetrione inhibitors of MMP-13.",Bioorg. Med. Chem. Lett.,2007,17,23,"Freeman-Cook KD, Reiter LA, Noe MC, Antipas AS, Danley DE, Datta K, Downs JT, Eisenbeis S, Eskra JD, Garmene DJ, Greer EM, Griffiths RJ, Guzman R, Hardink JR, Janat F, Jones CS, Martinelli GJ, Mitchell PG, Laird ER, Liras JL, Lopresti-Morrow LL, Pandit J, Reilly UD, Robertson D, Vaughn-Bowser ML, Wolf-Gouviea LA, Yocum SA",,458357,DTCT0024002,2254800,DTCC00440935,326629,24756
CHEMBL221677,P45452,,VAQBMYMELLMZQZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15566296,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Synthesis and structure-activity relationships of 4-alkynyloxy phenyl sulfanyl, sulfinyl, and sulfonyl alkyl hydroxamates as tumor necrosis factor-alpha converting enzyme and matrix metalloproteinase inhibitors.",J. Med. Chem.,2004,47,25,"Venkatesan AM, Davis JM, Grosu GT, Baker J, Zask A, Levin JI, Ellingboe J, Skotnicki JS, Dijoseph JF, Sung A, Jin G, Xu W, McCarthy DJ, Barone D",,429672,DTCT0024002,2041957,DTCC00111041,1884529,22157
CHEMBL221685,P45452,,FMEAQXZJDJBJJP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16942871,IC50,=,1,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Potent, selective pyrimidinetrione-based inhibitors of MMP-13.",Bioorg. Med. Chem. Lett.,2006,16,22,"Reiter LA, Freeman-Cook KD, Jones CS, Martinelli GJ, Antipas AS, Berliner MA, Datta K, Downs JT, Eskra JD, Forman MD, Greer EM, Guzman R, Hardink JR, Janat F, Keene NF, Laird ER, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robertson D, Sperger D, Vaughn-Bowser ML, Waller DM, Yocum SA",,424283,DTCT0024002,2011662,DTCC00440941,2079322,21753
CHEMBL221717,P45452,,SEFCVQRMTNTWJO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15566296,IC50,=,3,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Synthesis and structure-activity relationships of 4-alkynyloxy phenyl sulfanyl, sulfinyl, and sulfonyl alkyl hydroxamates as tumor necrosis factor-alpha converting enzyme and matrix metalloproteinase inhibitors.",J. Med. Chem.,2004,47,25,"Venkatesan AM, Davis JM, Grosu GT, Baker J, Zask A, Levin JI, Ellingboe J, Skotnicki JS, Dijoseph JF, Sung A, Jin G, Xu W, McCarthy DJ, Barone D",,429672,DTCT0024002,2041951,DTCC00444488,532172,22157
CHEMBL221751,P45452,,FWIRQPTYAFFUNS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16942871,IC50,=,1.1,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Potent, selective pyrimidinetrione-based inhibitors of MMP-13.",Bioorg. Med. Chem. Lett.,2006,16,22,"Reiter LA, Freeman-Cook KD, Jones CS, Martinelli GJ, Antipas AS, Berliner MA, Datta K, Downs JT, Eskra JD, Forman MD, Greer EM, Guzman R, Hardink JR, Janat F, Keene NF, Laird ER, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robertson D, Sperger D, Vaughn-Bowser ML, Waller DM, Yocum SA",,424283,DTCT0024002,2011694,DTCC00440805,1016471,21753
CHEMBL221806,P45452,,CACMQTZSAXPCFI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16942871,IC50,=,0.85,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Potent, selective pyrimidinetrione-based inhibitors of MMP-13.",Bioorg. Med. Chem. Lett.,2006,16,22,"Reiter LA, Freeman-Cook KD, Jones CS, Martinelli GJ, Antipas AS, Berliner MA, Datta K, Downs JT, Eskra JD, Forman MD, Greer EM, Guzman R, Hardink JR, Janat F, Keene NF, Laird ER, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robertson D, Sperger D, Vaughn-Bowser ML, Waller DM, Yocum SA",,424283,DTCT0024002,2011693,DTCC00440813,1663593,21753
CHEMBL221808,P45452,,PBXGGFUTOUWSQP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16942871,IC50,=,7.8,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Potent, selective pyrimidinetrione-based inhibitors of MMP-13.",Bioorg. Med. Chem. Lett.,2006,16,22,"Reiter LA, Freeman-Cook KD, Jones CS, Martinelli GJ, Antipas AS, Berliner MA, Datta K, Downs JT, Eskra JD, Forman MD, Greer EM, Guzman R, Hardink JR, Janat F, Keene NF, Laird ER, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robertson D, Sperger D, Vaughn-Bowser ML, Waller DM, Yocum SA",,424283,DTCT0024002,2011679,DTCC00440823,142860,21753
CHEMBL222002,P45452,,XRSYNYGEEYTXJV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17935984,IC50,=,0.6,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Potent, selective spiropyrrolidine pyrimidinetrione inhibitors of MMP-13.",Bioorg. Med. Chem. Lett.,2007,17,23,"Freeman-Cook KD, Reiter LA, Noe MC, Antipas AS, Danley DE, Datta K, Downs JT, Eisenbeis S, Eskra JD, Garmene DJ, Greer EM, Griffiths RJ, Guzman R, Hardink JR, Janat F, Jones CS, Martinelli GJ, Mitchell PG, Laird ER, Liras JL, Lopresti-Morrow LL, Pandit J, Reilly UD, Robertson D, Vaughn-Bowser ML, Wolf-Gouviea LA, Yocum SA",,458357,DTCT0024002,2254750,DTCC00440858,1620384,24756
CHEMBL222007,P45452,,VZODRLLXYBAWGB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16942871,IC50,=,0.46,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Potent, selective pyrimidinetrione-based inhibitors of MMP-13.",Bioorg. Med. Chem. Lett.,2006,16,22,"Reiter LA, Freeman-Cook KD, Jones CS, Martinelli GJ, Antipas AS, Berliner MA, Datta K, Downs JT, Eskra JD, Forman MD, Greer EM, Guzman R, Hardink JR, Janat F, Keene NF, Laird ER, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robertson D, Sperger D, Vaughn-Bowser ML, Waller DM, Yocum SA",,424283,DTCT0024002,2011672,DTCC00440875,272286,21753
CHEMBL222060,P45452,,OSPKZTFBTJTJIO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16942871,IC50,=,2.4,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Potent, selective pyrimidinetrione-based inhibitors of MMP-13.",Bioorg. Med. Chem. Lett.,2006,16,22,"Reiter LA, Freeman-Cook KD, Jones CS, Martinelli GJ, Antipas AS, Berliner MA, Datta K, Downs JT, Eskra JD, Forman MD, Greer EM, Guzman R, Hardink JR, Janat F, Keene NF, Laird ER, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robertson D, Sperger D, Vaughn-Bowser ML, Waller DM, Yocum SA",,424283,DTCT0024002,2011686,DTCC00440880,142859,21753
CHEMBL222077,P45452,,YDTQINPZBUBYRX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16942871,ED50,=,1,MG.KG-1,,,,,,,,,,,,,,Inhibition of MMP13 in hamster synovial fluid,,"Potent, selective pyrimidinetrione-based inhibitors of MMP-13.",Bioorg. Med. Chem. Lett.,2006,16,22,"Reiter LA, Freeman-Cook KD, Jones CS, Martinelli GJ, Antipas AS, Berliner MA, Datta K, Downs JT, Eskra JD, Forman MD, Greer EM, Guzman R, Hardink JR, Janat F, Keene NF, Laird ER, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robertson D, Sperger D, Vaughn-Bowser ML, Waller DM, Yocum SA",,424287,DTCT0024002,2011804,DTCC00440929,435566,21753
CHEMBL222077,P45452,,YDTQINPZBUBYRX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16942871,IC50,=,0.84,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Potent, selective pyrimidinetrione-based inhibitors of MMP-13.",Bioorg. Med. Chem. Lett.,2006,16,22,"Reiter LA, Freeman-Cook KD, Jones CS, Martinelli GJ, Antipas AS, Berliner MA, Datta K, Downs JT, Eskra JD, Forman MD, Greer EM, Guzman R, Hardink JR, Janat F, Keene NF, Laird ER, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robertson D, Sperger D, Vaughn-Bowser ML, Waller DM, Yocum SA",,424283,DTCT0024002,2011664,DTCC00440929,435566,21753
CHEMBL222077,P45452,,YDTQINPZBUBYRX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18790648,IC50,=,0.36,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497406,DTCT0024002,2457414,DTCC00440929,436646,32556
CHEMBL222282,P45452,,MKEVHBFZBURDHJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15566296,IC50,=,708,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Synthesis and structure-activity relationships of 4-alkynyloxy phenyl sulfanyl, sulfinyl, and sulfonyl alkyl hydroxamates as tumor necrosis factor-alpha converting enzyme and matrix metalloproteinase inhibitors.",J. Med. Chem.,2004,47,25,"Venkatesan AM, Davis JM, Grosu GT, Baker J, Zask A, Levin JI, Ellingboe J, Skotnicki JS, Dijoseph JF, Sung A, Jin G, Xu W, McCarthy DJ, Barone D",,429672,DTCT0024002,2041962,DTCC00444529,1566560,22157
CHEMBL222303,P45452,,NPIXRIRDKCZNLD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15566296,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Synthesis and structure-activity relationships of 4-alkynyloxy phenyl sulfanyl, sulfinyl, and sulfonyl alkyl hydroxamates as tumor necrosis factor-alpha converting enzyme and matrix metalloproteinase inhibitors.",J. Med. Chem.,2004,47,25,"Venkatesan AM, Davis JM, Grosu GT, Baker J, Zask A, Levin JI, Ellingboe J, Skotnicki JS, Dijoseph JF, Sung A, Jin G, Xu W, McCarthy DJ, Barone D",,429672,DTCT0024002,2041959,DTCC00444432,1049040,22157
CHEMBL222309,P45452,,XWQYRXPGPDOWAJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15566296,IC50,=,68,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Synthesis and structure-activity relationships of 4-alkynyloxy phenyl sulfanyl, sulfinyl, and sulfonyl alkyl hydroxamates as tumor necrosis factor-alpha converting enzyme and matrix metalloproteinase inhibitors.",J. Med. Chem.,2004,47,25,"Venkatesan AM, Davis JM, Grosu GT, Baker J, Zask A, Levin JI, Ellingboe J, Skotnicki JS, Dijoseph JF, Sung A, Jin G, Xu W, McCarthy DJ, Barone D",,429672,DTCT0024002,2041968,DTCC00444512,1373173,22157
CHEMBL222397,P45452,,WGANCLOVDGTTMN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15566296,INHIBITION,=,60,%,,,,,,,,,,,,,,Inhibition of MMP13 at 10 uM,,"Synthesis and structure-activity relationships of 4-alkynyloxy phenyl sulfanyl, sulfinyl, and sulfonyl alkyl hydroxamates as tumor necrosis factor-alpha converting enzyme and matrix metalloproteinase inhibitors.",J. Med. Chem.,2004,47,25,"Venkatesan AM, Davis JM, Grosu GT, Baker J, Zask A, Levin JI, Ellingboe J, Skotnicki JS, Dijoseph JF, Sung A, Jin G, Xu W, McCarthy DJ, Barone D",,429673,DTCT0024002,2041983,DTCC00444517,305301,22157
CHEMBL222594,P45452,,KTMMYBDZBIJPLY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15566296,IC50,=,107,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Synthesis and structure-activity relationships of 4-alkynyloxy phenyl sulfanyl, sulfinyl, and sulfonyl alkyl hydroxamates as tumor necrosis factor-alpha converting enzyme and matrix metalloproteinase inhibitors.",J. Med. Chem.,2004,47,25,"Venkatesan AM, Davis JM, Grosu GT, Baker J, Zask A, Levin JI, Ellingboe J, Skotnicki JS, Dijoseph JF, Sung A, Jin G, Xu W, McCarthy DJ, Barone D",,429672,DTCT0024002,2041972,DTCC00444499,1340649,22157
CHEMBL222714,P45452,,QFAMXNMLWJDJPV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15566296,IC50,=,40,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Synthesis and structure-activity relationships of 4-alkynyloxy phenyl sulfanyl, sulfinyl, and sulfonyl alkyl hydroxamates as tumor necrosis factor-alpha converting enzyme and matrix metalloproteinase inhibitors.",J. Med. Chem.,2004,47,25,"Venkatesan AM, Davis JM, Grosu GT, Baker J, Zask A, Levin JI, Ellingboe J, Skotnicki JS, Dijoseph JF, Sung A, Jin G, Xu W, McCarthy DJ, Barone D",,429672,DTCT0024002,2041987,DTCC00444503,1755545,22157
CHEMBL222854,P45452,,MNQFMKHWJNOSIX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15566296,IC50,=,155,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Synthesis and structure-activity relationships of 4-alkynyloxy phenyl sulfanyl, sulfinyl, and sulfonyl alkyl hydroxamates as tumor necrosis factor-alpha converting enzyme and matrix metalloproteinase inhibitors.",J. Med. Chem.,2004,47,25,"Venkatesan AM, Davis JM, Grosu GT, Baker J, Zask A, Levin JI, Ellingboe J, Skotnicki JS, Dijoseph JF, Sung A, Jin G, Xu W, McCarthy DJ, Barone D",,429672,DTCT0024002,2041950,DTCC00444496,239576,22157
CHEMBL222934,P45452,,YJZSNVXLDDRADS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15566296,IC50,=,5,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Synthesis and structure-activity relationships of 4-alkynyloxy phenyl sulfanyl, sulfinyl, and sulfonyl alkyl hydroxamates as tumor necrosis factor-alpha converting enzyme and matrix metalloproteinase inhibitors.",J. Med. Chem.,2004,47,25,"Venkatesan AM, Davis JM, Grosu GT, Baker J, Zask A, Levin JI, Ellingboe J, Skotnicki JS, Dijoseph JF, Sung A, Jin G, Xu W, McCarthy DJ, Barone D",,429672,DTCT0024002,2041952,DTCC00444468,2015109,22157
CHEMBL222935,P45452,,JUKIJVGLFPZICB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15566296,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Synthesis and structure-activity relationships of 4-alkynyloxy phenyl sulfanyl, sulfinyl, and sulfonyl alkyl hydroxamates as tumor necrosis factor-alpha converting enzyme and matrix metalloproteinase inhibitors.",J. Med. Chem.,2004,47,25,"Venkatesan AM, Davis JM, Grosu GT, Baker J, Zask A, Levin JI, Ellingboe J, Skotnicki JS, Dijoseph JF, Sung A, Jin G, Xu W, McCarthy DJ, Barone D",,429672,DTCT0024002,2041974,DTCC00444494,757981,22157
CHEMBL222936,P45452,,NOIOOWNKXMUESY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15566296,IC50,=,3687,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Synthesis and structure-activity relationships of 4-alkynyloxy phenyl sulfanyl, sulfinyl, and sulfonyl alkyl hydroxamates as tumor necrosis factor-alpha converting enzyme and matrix metalloproteinase inhibitors.",J. Med. Chem.,2004,47,25,"Venkatesan AM, Davis JM, Grosu GT, Baker J, Zask A, Levin JI, Ellingboe J, Skotnicki JS, Dijoseph JF, Sung A, Jin G, Xu W, McCarthy DJ, Barone D",,429672,DTCT0024002,2041964,DTCC00444521,110471,22157
CHEMBL222992,P45452,,ILUVAAMGYFXXGD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15566296,IC50,=,2000,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Synthesis and structure-activity relationships of 4-alkynyloxy phenyl sulfanyl, sulfinyl, and sulfonyl alkyl hydroxamates as tumor necrosis factor-alpha converting enzyme and matrix metalloproteinase inhibitors.",J. Med. Chem.,2004,47,25,"Venkatesan AM, Davis JM, Grosu GT, Baker J, Zask A, Levin JI, Ellingboe J, Skotnicki JS, Dijoseph JF, Sung A, Jin G, Xu W, McCarthy DJ, Barone D",,429672,DTCT0024002,2041963,DTCC00444522,1820288,22157
CHEMBL223418,P45452,,CWTPXHBVRVZHBV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15566296,INHIBITION,=,32,%,,,,,,,,,,,,,,Inhibition of MMP13 at 10 uM,,"Synthesis and structure-activity relationships of 4-alkynyloxy phenyl sulfanyl, sulfinyl, and sulfonyl alkyl hydroxamates as tumor necrosis factor-alpha converting enzyme and matrix metalloproteinase inhibitors.",J. Med. Chem.,2004,47,25,"Venkatesan AM, Davis JM, Grosu GT, Baker J, Zask A, Levin JI, Ellingboe J, Skotnicki JS, Dijoseph JF, Sung A, Jin G, Xu W, McCarthy DJ, Barone D",,429673,DTCT0024002,2041989,DTCC00444515,435624,22157
CHEMBL223831,P45452,,LJPYOTNMYOBJHB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15566296,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Synthesis and structure-activity relationships of 4-alkynyloxy phenyl sulfanyl, sulfinyl, and sulfonyl alkyl hydroxamates as tumor necrosis factor-alpha converting enzyme and matrix metalloproteinase inhibitors.",J. Med. Chem.,2004,47,25,"Venkatesan AM, Davis JM, Grosu GT, Baker J, Zask A, Levin JI, Ellingboe J, Skotnicki JS, Dijoseph JF, Sung A, Jin G, Xu W, McCarthy DJ, Barone D",,429672,DTCT0024002,2041954,DTCC00444454,1949369,22157
CHEMBL223888,P45452,,HIBWRSXXRMHOLM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15566296,IC50,=,2000,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Synthesis and structure-activity relationships of 4-alkynyloxy phenyl sulfanyl, sulfinyl, and sulfonyl alkyl hydroxamates as tumor necrosis factor-alpha converting enzyme and matrix metalloproteinase inhibitors.",J. Med. Chem.,2004,47,25,"Venkatesan AM, Davis JM, Grosu GT, Baker J, Zask A, Levin JI, Ellingboe J, Skotnicki JS, Dijoseph JF, Sung A, Jin G, Xu W, McCarthy DJ, Barone D",,429672,DTCT0024002,2041978,DTCC00444486,370548,22157
CHEMBL224845,P45452,,MWQQOCVRFAKHSC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15566296,INHIBITION,=,56,%,,,,,,,,,,,,,,Inhibition of MMP13 at 10 uM,,"Synthesis and structure-activity relationships of 4-alkynyloxy phenyl sulfanyl, sulfinyl, and sulfonyl alkyl hydroxamates as tumor necrosis factor-alpha converting enzyme and matrix metalloproteinase inhibitors.",J. Med. Chem.,2004,47,25,"Venkatesan AM, Davis JM, Grosu GT, Baker J, Zask A, Levin JI, Ellingboe J, Skotnicki JS, Dijoseph JF, Sung A, Jin G, Xu W, McCarthy DJ, Barone D",,429673,DTCT0024002,2041988,DTCC00444509,1114162,22157
CHEMBL225331,P45452,,XMAZUULAIZPAJR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15566296,INHIBITION,=,40,%,,,,,,,,,,,,,,Inhibition of MMP13 at 10 uM,,"Synthesis and structure-activity relationships of 4-alkynyloxy phenyl sulfanyl, sulfinyl, and sulfonyl alkyl hydroxamates as tumor necrosis factor-alpha converting enzyme and matrix metalloproteinase inhibitors.",J. Med. Chem.,2004,47,25,"Venkatesan AM, Davis JM, Grosu GT, Baker J, Zask A, Levin JI, Ellingboe J, Skotnicki JS, Dijoseph JF, Sung A, Jin G, Xu W, McCarthy DJ, Barone D",,429673,DTCT0024002,2041982,DTCC00444508,337937,22157
CHEMBL226439,P45452,,ICISPHGVMHWYTI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23287054,IC50,,,,,,,,,,,,,,,,,Inhibition of MMP13 (unknown origin),Not Determined,Sulphonamides: Deserving class as MMP inhibitors?,Eur. J. Med. Chem.,2013,60,,"Jain P, Saravanan C, Singh SK",,944584,DTCT0024002,11835693,DTCC00449741,447228,53820
CHEMBL226852,P45452,,SWOIHXOGQYPPNC-GFCCVEGCSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17591762,IC50,=,49600,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440142,DTCT0024002,2113803,DTCC00452681,1361615,23023
CHEMBL226852,P45452,,SWOIHXOGQYPPNC-GFCCVEGCSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17591762,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of MMP13 at 10 uM,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440148,DTCT0024002,2113831,DTCC00452681,1361615,23023
CHEMBL226852,P45452,,SWOIHXOGQYPPNC-GFCCVEGCSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17591762,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of MMP13 at 100 uM,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440154,DTCT0024002,2113863,DTCC00452681,1361615,23023
CHEMBL226852,P45452,,SWOIHXOGQYPPNC-GFCCVEGCSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17591762,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of MMP13 at 30 uM,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440160,DTCT0024002,2113888,DTCC00452681,1361615,23023
CHEMBL227484,P45452,,CJTUBZULFXKTAT-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17088065,IC50,=,3.3,NM,,,,,,,,,,,,,,Inhibition of MMP13,,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432508,DTCT0024002,2061870,DTCC00447716,326283,22402
CHEMBL227484,P45452,,CJTUBZULFXKTAT-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17088065,IC50,=,3.3,NM,,,,,,,,,,,,,,Inhibition of MMP13,,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432508,DTCT0024002,2062004,DTCC00447716,326284,22402
CHEMBL227501,P45452,,WNLZTTHHHYZJMB-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17088065,IC50,=,15,NM,,,,,,,,,,,,,,Inhibition of MMP13,,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432508,DTCT0024002,2061867,DTCC00447830,1426294,22402
CHEMBL227553,P45452,,FHZGYMLWCVBBPM-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17088065,IC50,=,820,NM,,,,,,,,,,,,,,Inhibition of MMP13,,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432508,DTCT0024002,2061866,DTCC00447831,1166105,22402
CHEMBL227598,P45452,,VKFNDAOTTJONML-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17088065,IC50,=,4.2,NM,,,,,,,,,,,,,,Inhibition of MMP13,,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432508,DTCT0024002,2061873,DTCC00447803,972589,22402
CHEMBL227824,P45452,,RVKPGECPCLBLDB-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17088065,IC50,=,1.1,NM,,,,,,,,,,,,,,Inhibition of MMP13,,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432508,DTCT0024002,2061874,DTCC00447798,940549,22402
CHEMBL228141,P45452,,AGSXHHFUSDGSSO-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17088065,IC50,=,480,NM,,,,,,,,,,,,,,Inhibition of MMP13,,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432508,DTCT0024002,2061865,DTCC00447839,520801,22402
CHEMBL228187,P45452,,NZKKRYAESABOSS-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17088065,IC50,=,63,NM,,,,,,,,,,,,,,Inhibition of MMP13,,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432508,DTCT0024002,2061869,DTCC00447819,1684493,22402
CHEMBL228188,P45452,,BGBWSADVPWNBME-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17088065,IC50,=,24,NM,,,,,,,,,,,,,,Inhibition of MMP13,,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432508,DTCT0024002,2061868,DTCC00447820,1102691,22402
CHEMBL228268,P45452,,GQLPTZZPKXZFQR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17368021,KI,>,5025,NM,,,,,,,,,,,,,,Binding affinity to MMP13,,"Hydantoins, triazolones, and imidazolones as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).",Bioorg. Med. Chem. Lett.,2007,17,10,"Sheppeck JE, Gilmore JL, Tebben A, Xue CB, Liu RQ, Decicco CP, Duan JJ",,438532,DTCT0024002,2101578,DTCC00455487,143032,22885
CHEMBL228318,P45452,,BSAORORNNRENRI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17368021,KI,=,4314,NM,,,,,,,,,,,,,,Binding affinity to MMP13,,"Hydantoins, triazolones, and imidazolones as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).",Bioorg. Med. Chem. Lett.,2007,17,10,"Sheppeck JE, Gilmore JL, Tebben A, Xue CB, Liu RQ, Decicco CP, Duan JJ",,438532,DTCT0024002,2101577,DTCC00455489,1884640,22885
CHEMBL228319,P45452,,CLYVYZOSMYXOBC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17368021,KI,>,5025,NM,,,,,,,,,,,,,,Binding affinity to MMP13,,"Hydantoins, triazolones, and imidazolones as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).",Bioorg. Med. Chem. Lett.,2007,17,10,"Sheppeck JE, Gilmore JL, Tebben A, Xue CB, Liu RQ, Decicco CP, Duan JJ",,438532,DTCT0024002,2101576,DTCC00455490,984390,22885
CHEMBL228320,P45452,,HVVGLHPJPUUJHI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17368021,KI,=,4314,NM,,,,,,,,,,,,,,Binding affinity to MMP13,,"Hydantoins, triazolones, and imidazolones as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).",Bioorg. Med. Chem. Lett.,2007,17,10,"Sheppeck JE, Gilmore JL, Tebben A, Xue CB, Liu RQ, Decicco CP, Duan JJ",,438532,DTCT0024002,2101575,DTCC00455491,467364,22885
CHEMBL228320,P45452,,HVVGLHPJPUUJHI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18790648,KI,=,4314,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497406,DTCT0024002,2456512,DTCC00455491,468361,32556
CHEMBL229070,P45452,,BDTGEWQPSASMAZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17188863,KI,>,5025,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Discovery of novel hydantoins as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,5,"Sheppeck JE, Gilmore JL, Yang A, Chen XT, Xue CB, Roderick J, Liu RQ, Covington MB, Decicco CP, Duan JJ",,453872,DTCT0024002,2221473,DTCC00455480,391848,24252
CHEMBL229072,P45452,,IKRKDUGQVRSGJX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17368021,KI,>,5025,NM,,,,,,,,,,,,,,Binding affinity to MMP13,,"Hydantoins, triazolones, and imidazolones as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).",Bioorg. Med. Chem. Lett.,2007,17,10,"Sheppeck JE, Gilmore JL, Tebben A, Xue CB, Liu RQ, Decicco CP, Duan JJ",,438532,DTCT0024002,2101579,DTCC00455483,1373275,22885
CHEMBL230806,P45452,AGELADINE A,QAKGJAQGTQLMFN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21413800,IC50,=,0.47,UG.ML-1,,,,,,,,,,,,,,Inhibition of MMP13,,A one-pot synthesis and biological activity of ageladine A and analogues.,J. Med. Chem.,2011,54,7,"Shengule SR, Loa-Kum-Cheung WL, Parish CR, Blairvacq M, Meijer L, Nakao Y, Karuso P",,853828,DTCT0024002,11368659,DTCC00454296,1189861,50935
CHEMBL2311765,P45452,,WPGRSZLFNFYSPR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23246356,IC50,=,44,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-13 after 45 mins by fluorogenic assay,,MMP inhibition by barbiturate homodimers.,Bioorg. Med. Chem. Lett.,2013,23,2,"Wang J, Radomski MW, Medina C, Gilmer JF",,935676,DTCT0024002,11750443,DTCC01335238,770711,53282
CHEMBL2311766,P45452,,XLNFBXKUCFOQRQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23246356,IC50,=,106,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-13 after 45 mins by fluorogenic assay,,MMP inhibition by barbiturate homodimers.,Bioorg. Med. Chem. Lett.,2013,23,2,"Wang J, Radomski MW, Medina C, Gilmer JF",,935676,DTCT0024002,11750442,DTCC01335239,1897286,53282
CHEMBL2311767,P45452,,DRCOOMXUPYOBBW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23246356,IC50,=,104,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-13 after 45 mins by fluorogenic assay,,MMP inhibition by barbiturate homodimers.,Bioorg. Med. Chem. Lett.,2013,23,2,"Wang J, Radomski MW, Medina C, Gilmer JF",,935676,DTCT0024002,11750441,DTCC01335240,900591,53282
CHEMBL2311768,P45452,,BZTZPJQXNWROKR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23246356,IC50,=,70,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-13 after 45 mins by fluorogenic assay,,MMP inhibition by barbiturate homodimers.,Bioorg. Med. Chem. Lett.,2013,23,2,"Wang J, Radomski MW, Medina C, Gilmer JF",,935676,DTCT0024002,11750440,DTCC01335241,674087,53282
CHEMBL2311769,P45452,,BUELAJMDFCPTAV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23246356,IC50,=,134,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-13 after 45 mins by fluorogenic assay,,MMP inhibition by barbiturate homodimers.,Bioorg. Med. Chem. Lett.,2013,23,2,"Wang J, Radomski MW, Medina C, Gilmer JF",,935676,DTCT0024002,11750439,DTCC01335242,1995132,53282
CHEMBL2311770,P45452,,FHCIUVTYGHWJQR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23246356,IC50,=,225,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-13 after 45 mins by fluorogenic assay,,MMP inhibition by barbiturate homodimers.,Bioorg. Med. Chem. Lett.,2013,23,2,"Wang J, Radomski MW, Medina C, Gilmer JF",,935676,DTCT0024002,11750438,DTCC01335243,996895,53282
CHEMBL2311771,P45452,,UKASSNVNXOWYDK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23246356,IC50,=,23,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-13 after 45 mins by fluorogenic assay,,MMP inhibition by barbiturate homodimers.,Bioorg. Med. Chem. Lett.,2013,23,2,"Wang J, Radomski MW, Medina C, Gilmer JF",,935676,DTCT0024002,11750437,DTCC01335244,416242,53282
CHEMBL2311774,P45452,,PHKLGXHLOXCURO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23246356,IC50,=,11,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-13 after 45 mins by fluorogenic assay,,MMP inhibition by barbiturate homodimers.,Bioorg. Med. Chem. Lett.,2013,23,2,"Wang J, Radomski MW, Medina C, Gilmer JF",,935676,DTCT0024002,11750448,DTCC01335247,1800637,53282
CHEMBL2311775,P45452,,XATUMTIXUAJCSA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23246356,IC50,=,164,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-13 after 45 mins by fluorogenic assay,,MMP inhibition by barbiturate homodimers.,Bioorg. Med. Chem. Lett.,2013,23,2,"Wang J, Radomski MW, Medina C, Gilmer JF",,935676,DTCT0024002,11750447,DTCC01335248,383300,53282
CHEMBL2311776,P45452,,HTUSESRFPXTJLY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23246356,IC50,=,23,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-13 after 45 mins by fluorogenic assay,,MMP inhibition by barbiturate homodimers.,Bioorg. Med. Chem. Lett.,2013,23,2,"Wang J, Radomski MW, Medina C, Gilmer JF",,935676,DTCT0024002,11750446,DTCC01335249,1768162,53282
CHEMBL2311777,P45452,,LYRSIRCJLISGFP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23246356,IC50,=,648,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-13 after 45 mins by fluorogenic assay,,MMP inhibition by barbiturate homodimers.,Bioorg. Med. Chem. Lett.,2013,23,2,"Wang J, Radomski MW, Medina C, Gilmer JF",,935676,DTCT0024002,11750445,DTCC01335250,2027994,53282
CHEMBL2311778,P45452,,WDDBBBHPBMFFCX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23246356,IC50,=,155,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-13 after 45 mins by fluorogenic assay,,MMP inhibition by barbiturate homodimers.,Bioorg. Med. Chem. Lett.,2013,23,2,"Wang J, Radomski MW, Medina C, Gilmer JF",,935676,DTCT0024002,11750444,DTCC01335251,446880,53282
CHEMBL2316256,P45452,,RXBMEHOLQJITJI-LEOXJPRUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23343195,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of human MMP13 prodomain (20 to 272) using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate by spectrophotometry,Active,Molecular determinants of a selective matrix metalloprotease-12 inhibitor: insights from crystallography and thermodynamic studies.,J. Med. Chem.,2013,56,3,"Czarny B, Stura EA, Devel L, Vera L, Cassar-Lajeunesse E, Beau F, Calderone V, Fragai M, Luchinat C, Dive V",,935211,DTCT0024002,11751199,DTCC01339596,71045,53441
CHEMBL2316257,P45452,,LIUMDGLYGBIKBM-SFYKDHMMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23343195,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of human MMP13 prodomain (20 to 272) using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate by spectrophotometry,Not Active,Molecular determinants of a selective matrix metalloprotease-12 inhibitor: insights from crystallography and thermodynamic studies.,J. Med. Chem.,2013,56,3,"Czarny B, Stura EA, Devel L, Vera L, Cassar-Lajeunesse E, Beau F, Calderone V, Fragai M, Luchinat C, Dive V",,935211,DTCT0024002,11751198,DTCC01339597,589403,53441
CHEMBL231665,P45452,,MGIMQKIBRRRYRM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17064892,IC50,=,229,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440764,DTCT0024002,2153960,DTCC00461920,778733,23077
CHEMBL231666,P45452,,DUPLEMOAJXTDKP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17064892,IC50,=,195,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440764,DTCT0024002,2153959,DTCC00461921,1070027,23077
CHEMBL231667,P45452,,UFEAOVWYWYBIFX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17064892,IC50,=,144,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440764,DTCT0024002,2153958,DTCC00461922,1684599,23077
CHEMBL231877,P45452,,WUVJCBZUUQXYIT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17064892,IC50,=,104,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440764,DTCT0024002,2153956,DTCC00461924,358923,23077
CHEMBL231878,P45452,,IASRCCATUJITDX-IBGZPJMESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17064892,IC50,=,190,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440764,DTCT0024002,2153955,DTCC00461925,260453,23077
CHEMBL231879,P45452,,LOOGWNWWNBNMRC-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17064892,IC50,=,354,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440764,DTCT0024002,2153954,DTCC00461926,1587506,23077
CHEMBL232086,P45452,,FGPWEPZCTGVLNA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17064892,IC50,=,259,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440764,DTCT0024002,2154034,DTCC00461927,1037560,23077
CHEMBL2326363,P45452,,UIVFNXLDHQCJRY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23458498,IC50,=,22,NM,,,,,,,,,,,,,,Inhibition of MMP-13 (unknown origin) using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate after 4 hrs by fluorometric assay,,Synthesis and preliminary evaluation in tumor bearing mice of new (18)f-labeled arylsulfone matrix metalloproteinase inhibitors as tracers for positron emission tomography.,J. Med. Chem.,2013,56,6,"Casalini F, Fugazza L, Esposito G, Cabella C, Brioschi C, Cordaro A, D'Angeli L, Bartoli A, Filannino AM, Gringeri CV, Longo DL, Muzio V, Nuti E, Orlandini E, Figlia G, Quattrini A, Tei L, Digilio G, Rossello A, Maiocchi A",,940799,DTCT0024002,11795556,DTCC01344669,199799,53669
CHEMBL2326364,P45452,,XXBXRJDBCMCGGD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23458498,IC50,=,386,NM,,,,,,,,,,,,,,Inhibition of MMP-13 (unknown origin) using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate after 4 hrs by fluorometric assay,,Synthesis and preliminary evaluation in tumor bearing mice of new (18)f-labeled arylsulfone matrix metalloproteinase inhibitors as tracers for positron emission tomography.,J. Med. Chem.,2013,56,6,"Casalini F, Fugazza L, Esposito G, Cabella C, Brioschi C, Cordaro A, D'Angeli L, Bartoli A, Filannino AM, Gringeri CV, Longo DL, Muzio V, Nuti E, Orlandini E, Figlia G, Quattrini A, Tei L, Digilio G, Rossello A, Maiocchi A",,940799,DTCT0024002,11795555,DTCC01344670,2040368,53669
CHEMBL2326365,P45452,,CREFCFAJHQSGNR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23458498,IC50,=,220,NM,,,,,,,,,,,,,,Inhibition of MMP-13 (unknown origin) using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate after 4 hrs by fluorometric assay,,Synthesis and preliminary evaluation in tumor bearing mice of new (18)f-labeled arylsulfone matrix metalloproteinase inhibitors as tracers for positron emission tomography.,J. Med. Chem.,2013,56,6,"Casalini F, Fugazza L, Esposito G, Cabella C, Brioschi C, Cordaro A, D'Angeli L, Bartoli A, Filannino AM, Gringeri CV, Longo DL, Muzio V, Nuti E, Orlandini E, Figlia G, Quattrini A, Tei L, Digilio G, Rossello A, Maiocchi A",,940799,DTCT0024002,11795554,DTCC01344671,913412,53669
CHEMBL2333287,P45452,,HTYCVVAAKRVDGM-LKCJCFKCSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23353736,IC50,=,4500,NM,,,,,,,,,,,,,,Inhibition of MMP13 (unknown origin),,Synthesis of derivatives of methyl rosmarinate and their inhibitory activities against matrix metalloproteinase-1 (MMP-1).,Eur. J. Med. Chem.,2013,62,,"Yuan H, Lu W, Wang L, Shan L, Li H, Huang J, Sun Q, Zhang W",,946626,DTCT0024002,11806932,DTCC01346826,868646,53896
CHEMBL2333288,P45452,,HTYCVVAAKRVDGM-IPXXLZSSSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23353736,IC50,=,5400,NM,,,,,,,,,,,,,,Inhibition of MMP13 (unknown origin),,Synthesis of derivatives of methyl rosmarinate and their inhibitory activities against matrix metalloproteinase-1 (MMP-1).,Eur. J. Med. Chem.,2013,62,,"Yuan H, Lu W, Wang L, Shan L, Li H, Huang J, Sun Q, Zhang W",,946626,DTCT0024002,11806931,DTCC01346827,447178,53896
CHEMBL233629,P45452,,YIIFUMKWGPMPET-LADGPHEKSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17276676,IC50,>,5000,NM,,,,,,,,,,,,,,Inhibition of MMP13,,A new 4-(2-methylquinolin-4-ylmethyl)phenyl P1' group for the beta-amino hydroxamic acid derived TACE inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,7,"Chen XT, Ghavimi B, Corbett RL, Xue CB, Liu RQ, Covington MB, Qian M, Vaddi KG, Christ DD, Hartman KD, Ribadeneira MD, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,447089,DTCT0024002,2169370,DTCC00464768,1070100,23623
CHEMBL2337129,P45452,,HJFONKSERLWIGE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23287054,IC50,=,1.3,NM,,,,,,,,,,,,,,Inhibition of MMP13 (unknown origin),,Sulphonamides: Deserving class as MMP inhibitors?,Eur. J. Med. Chem.,2013,60,,"Jain P, Saravanan C, Singh SK",,944584,DTCT0024002,11835679,DTCC01350531,1865246,53820
CHEMBL2337130,P45452,,BEZJPBNIFWANDL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23287054,IC50,=,12.2,NM,,,,,,,,,,,,,,Inhibition of MMP13 (unknown origin),,Sulphonamides: Deserving class as MMP inhibitors?,Eur. J. Med. Chem.,2013,60,,"Jain P, Saravanan C, Singh SK",,944584,DTCT0024002,11835683,DTCC01350532,56348,53820
CHEMBL2337131,P45452,,AJAHTKZXCRUIAR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23287054,IC50,,,,,,,,,,,,,,,,,Inhibition of MMP13 (unknown origin),Not Determined,Sulphonamides: Deserving class as MMP inhibitors?,Eur. J. Med. Chem.,2013,60,,"Jain P, Saravanan C, Singh SK",,944584,DTCT0024002,11835681,DTCC01350533,1061928,53820
CHEMBL2337690,P45452,,FGQTUBBIXYISNM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23376997,IC50,=,1.5,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Mca-Lys-Pro- Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 2 hrs prior to substrate addition measured every 15 secs for 15 mins by fluorometric analysis,,Arylsulfonamide inhibitors of aggrecanases as potential therapeutic agents for osteoarthritis: Synthesis and biological evaluation.,Eur. J. Med. Chem.,2013,62,,"Nuti E, Santamaria S, Casalini F, Yamamoto K, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Marini AM, Salerno S, Taliani S, Da Settimo F, Nagase H, Rossello A",,948652,DTCT0024002,11842596,DTCC01351073,1527535,53978
CHEMBL2337691,P45452,,ZVJILQAAQQNBOP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23376997,IC50,=,19,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Mca-Lys-Pro- Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 2 hrs prior to substrate addition measured every 15 secs for 15 mins by fluorometric analysis,,Arylsulfonamide inhibitors of aggrecanases as potential therapeutic agents for osteoarthritis: Synthesis and biological evaluation.,Eur. J. Med. Chem.,2013,62,,"Nuti E, Santamaria S, Casalini F, Yamamoto K, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Marini AM, Salerno S, Taliani S, Da Settimo F, Nagase H, Rossello A",,948652,DTCT0024002,11842595,DTCC01351074,848343,53978
CHEMBL2337696,P45452,,UGRPRGWEEBXORM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23376997,IC50,=,18,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Mca-Lys-Pro- Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 2 hrs prior to substrate addition measured every 15 secs for 15 mins by fluorometric analysis,,Arylsulfonamide inhibitors of aggrecanases as potential therapeutic agents for osteoarthritis: Synthesis and biological evaluation.,Eur. J. Med. Chem.,2013,62,,"Nuti E, Santamaria S, Casalini F, Yamamoto K, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Marini AM, Salerno S, Taliani S, Da Settimo F, Nagase H, Rossello A",,948652,DTCT0024002,11842593,DTCC01351079,1462678,53978
CHEMBL2337697,P45452,,BTMSEVQRJBBBAY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23376997,IC50,=,0.65,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Mca-Lys-Pro- Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 2 hrs prior to substrate addition measured every 15 secs for 15 mins by fluorometric analysis,,Arylsulfonamide inhibitors of aggrecanases as potential therapeutic agents for osteoarthritis: Synthesis and biological evaluation.,Eur. J. Med. Chem.,2013,62,,"Nuti E, Santamaria S, Casalini F, Yamamoto K, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Marini AM, Salerno S, Taliani S, Da Settimo F, Nagase H, Rossello A",,948652,DTCT0024002,11842592,DTCC01351080,1559589,53978
CHEMBL2337698,P45452,,CHTZMALPRVCUIK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23376997,IC50,=,62,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Mca-Lys-Pro- Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 2 hrs prior to substrate addition measured every 15 secs for 15 mins by fluorometric analysis,,Arylsulfonamide inhibitors of aggrecanases as potential therapeutic agents for osteoarthritis: Synthesis and biological evaluation.,Eur. J. Med. Chem.,2013,62,,"Nuti E, Santamaria S, Casalini F, Yamamoto K, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Marini AM, Salerno S, Taliani S, Da Settimo F, Nagase H, Rossello A",,948652,DTCT0024002,11842590,DTCC01351081,492967,53978
CHEMBL233842,P45452,,LBHPINDOHXBHHL-UKILVPOCSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17276676,IC50,>,5000,NM,,,,,,,,,,,,,,Inhibition of MMP13,,A new 4-(2-methylquinolin-4-ylmethyl)phenyl P1' group for the beta-amino hydroxamic acid derived TACE inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,7,"Chen XT, Ghavimi B, Corbett RL, Xue CB, Liu RQ, Covington MB, Qian M, Vaddi KG, Christ DD, Hartman KD, Ribadeneira MD, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,447089,DTCT0024002,2169369,DTCC00464769,1135027,23623
CHEMBL233843,P45452,,XDSDBWPXGOPPFL-UKILVPOCSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17276676,IC50,>,5000,NM,,,,,,,,,,,,,,Inhibition of MMP13,,A new 4-(2-methylquinolin-4-ylmethyl)phenyl P1' group for the beta-amino hydroxamic acid derived TACE inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,7,"Chen XT, Ghavimi B, Corbett RL, Xue CB, Liu RQ, Covington MB, Qian M, Vaddi KG, Christ DD, Hartman KD, Ribadeneira MD, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,447089,DTCT0024002,2169367,DTCC00464771,326448,23623
CHEMBL233844,P45452,,ZASAXMMLZWOHBG-RBBKRZOGSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17276676,IC50,>,5000,NM,,,,,,,,,,,,,,Inhibition of MMP13,,A new 4-(2-methylquinolin-4-ylmethyl)phenyl P1' group for the beta-amino hydroxamic acid derived TACE inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,7,"Chen XT, Ghavimi B, Corbett RL, Xue CB, Liu RQ, Covington MB, Qian M, Vaddi KG, Christ DD, Hartman KD, Ribadeneira MD, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,447089,DTCT0024002,2169366,DTCC00464772,1970813,23623
CHEMBL2338554,P45452,SYMPLOSTATIN 5,KPKJQINJXGFAPS-NBGICTFWSA-M,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23350733,ACTIVITY,=,100,%,,,,,,,,,,,,,,Inhibition of MMP13 (unknown origin) using (5-FAM/QXLTM) FRET peptide substrate assessed as residual activity at 10 uM incubated for 15 mins prior to substrate addition measured for 2 hrs,,Potent elastase inhibitors from cyanobacteria: structural basis and mechanisms mediating cytoprotective and anti-inflammatory effects in bronchial epithelial cells.,J. Med. Chem.,2013,56,3,"Salvador LA, Taori K, Biggs JS, Jakoncic J, Ostrov DA, Paul VJ, Luesch H",,944681,DTCT0024002,11803592,DTCC01351885,686495,53882
CHEMBL233932,P45452,,ZYKVSIDVBIFMGD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17064892,IC50,=,238,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440764,DTCT0024002,2153953,DTCC00461901,1490934,23077
CHEMBL234032,P45452,,IBWSLBQVCNZYSS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17276676,IC50,>,5000,NM,,,,,,,,,,,,,,Inhibition of MMP13,,A new 4-(2-methylquinolin-4-ylmethyl)phenyl P1' group for the beta-amino hydroxamic acid derived TACE inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,7,"Chen XT, Ghavimi B, Corbett RL, Xue CB, Liu RQ, Covington MB, Qian M, Vaddi KG, Christ DD, Hartman KD, Ribadeneira MD, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,447089,DTCT0024002,2169365,DTCC00464773,260537,23623
CHEMBL234033,P45452,,UNCGRKPTWVECFJ-PZJWPPBQSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17276676,IC50,>,5000,NM,,,,,,,,,,,,,,Inhibition of MMP13,,A new 4-(2-methylquinolin-4-ylmethyl)phenyl P1' group for the beta-amino hydroxamic acid derived TACE inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,7,"Chen XT, Ghavimi B, Corbett RL, Xue CB, Liu RQ, Covington MB, Qian M, Vaddi KG, Christ DD, Hartman KD, Ribadeneira MD, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,447089,DTCT0024002,2169364,DTCC00464774,1684679,23623
CHEMBL234034,P45452,,NMHJSIJTDAPUMQ-RBBKRZOGSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17276676,IC50,>,5000,NM,,,,,,,,,,,,,,Inhibition of MMP13,,A new 4-(2-methylquinolin-4-ylmethyl)phenyl P1' group for the beta-amino hydroxamic acid derived TACE inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,7,"Chen XT, Ghavimi B, Corbett RL, Xue CB, Liu RQ, Covington MB, Qian M, Vaddi KG, Christ DD, Hartman KD, Ribadeneira MD, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,447089,DTCT0024002,2169363,DTCC00464775,876465,23623
CHEMBL234143,P45452,,DKLKUPISRVEUAG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17064892,IC50,=,72,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440764,DTCT0024002,2153975,DTCC00461904,1426379,23077
CHEMBL234144,P45452,,KAWCOVYOZMDLKQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17064892,IC50,=,43,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440764,DTCT0024002,2153974,DTCC00461905,1166190,23077
CHEMBL234145,P45452,,IYSKDTAJMOMROJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17064892,IC50,=,130,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440764,DTCT0024002,2153973,DTCC00461906,778732,23077
CHEMBL234199,P45452,,KEGZCMGJDRKBBL-UKILVPOCSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17276676,IC50,>,5000,NM,,,,,,,,,,,,,,Inhibition of MMP13,,A new 4-(2-methylquinolin-4-ylmethyl)phenyl P1' group for the beta-amino hydroxamic acid derived TACE inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,7,"Chen XT, Ghavimi B, Corbett RL, Xue CB, Liu RQ, Covington MB, Qian M, Vaddi KG, Christ DD, Hartman KD, Ribadeneira MD, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,447089,DTCT0024002,2169371,DTCC00464767,260536,23623
CHEMBL234350,P45452,,PUHDBKGWNNZTBP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16220987,KI,=,1.1,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024002,14759283,DTCC00461900,2111482,69259
CHEMBL234350,P45452,,PUHDBKGWNNZTBP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16220987,KI,=,1.1,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024002,14759932,DTCC00461900,2111482,69259
CHEMBL234350,P45452,,PUHDBKGWNNZTBP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17064892,IC50,=,1.1,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440764,DTCT0024002,2153873,DTCC00461900,650170,23077
CHEMBL234351,P45452,,VGMJDHAFWAQDDY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17064892,IC50,=,155,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440764,DTCT0024002,2153971,DTCC00461908,1198666,23077
CHEMBL234352,P45452,,KVLYVSHQXNTARE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17064892,IC50,=,24.4,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440764,DTCT0024002,2153970,DTCC00461909,1296297,23077
CHEMBL234353,P45452,,WHUGMPJJQOVPAC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17064892,IC50,=,205,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440764,DTCT0024002,2153969,DTCC00461910,1296298,23077
CHEMBL234565,P45452,,VRQPNJFSKYEBCN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17064892,IC50,=,2040,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440764,DTCT0024002,2153968,DTCC00461911,228220,23077
CHEMBL234566,P45452,,GFRCZBUEHADXTC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17064892,IC50,=,166,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440764,DTCT0024002,2153966,DTCC00461913,326357,23077
CHEMBL234567,P45452,,BIGQJQKSDHOEOM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17064892,IC50,=,2277,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440764,DTCT0024002,2153965,DTCC00461914,1808694,23077
CHEMBL234774,P45452,,XAISFEMYYICOMZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17064892,IC50,=,147,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440764,DTCT0024002,2153963,DTCC00461916,876379,23077
CHEMBL234776,P45452,,PRHFUFABVIQNBK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17064892,IC50,=,23,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440764,DTCT0024002,2153962,DTCC00461918,714342,23077
CHEMBL235095,P45452,,BUEVFADAMKTXGD-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17956082,IC50,=,0.9,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET.,J. Med. Chem.,2007,50,23,"Wagner S, Breyholz HJ, Law MP, Faust A, Höltke C, Schröer S, Haufe G, Levkau B, Schober O, Schäfers M, Kopka K",,451368,DTCT0024002,2204613,DTCC00471862,195973,24059
CHEMBL235318,P45452,,JOIDQCSRISGBOH-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17956082,IC50,=,30000,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET.,J. Med. Chem.,2007,50,23,"Wagner S, Breyholz HJ, Law MP, Faust A, Höltke C, Schröer S, Haufe G, Levkau B, Schober O, Schäfers M, Kopka K",,451368,DTCT0024002,2204632,DTCC00471863,67005,24059
CHEMBL235559,P45452,,DYUKSKSACQYNBM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17606376,IC50,=,3199,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,Structure-based design of TACE selective inhibitors: manipulations in the S1'-S3' pocket.,Bioorg. Med. Chem.,2007,15,18,"Huang A, Joseph-McCarthy D, Lovering F, Sun L, Wang W, Xu W, Zhu Y, Cui J, Zhang Y, Levin JI",,448560,DTCT0024002,2180833,DTCC00470412,1744477,23780
CHEMBL235916,P45452,,WGTWQHQAJDQPEW-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17956082,IC50,=,10,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET.,J. Med. Chem.,2007,50,23,"Wagner S, Breyholz HJ, Law MP, Faust A, Höltke C, Schröer S, Haufe G, Levkau B, Schober O, Schäfers M, Kopka K",,451368,DTCT0024002,2204628,DTCC00471841,228357,24059
CHEMBL236130,P45452,,VUFJIPWRAIIGQA-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17956082,IC50,=,14000,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET.,J. Med. Chem.,2007,50,23,"Wagner S, Breyholz HJ, Law MP, Faust A, Höltke C, Schröer S, Haufe G, Levkau B, Schober O, Schäfers M, Kopka K",,451368,DTCT0024002,2204627,DTCC00471848,1491086,24059
CHEMBL236400,P45452,,IHSDOJRAORURAS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17606376,IC50,=,584,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,Structure-based design of TACE selective inhibitors: manipulations in the S1'-S3' pocket.,Bioorg. Med. Chem.,2007,15,18,"Huang A, Joseph-McCarthy D, Lovering F, Sun L, Wang W, Xu W, Zhu Y, Cui J, Zhang Y, Levin JI",,448560,DTCT0024002,2180835,DTCC00470410,1005301,23780
CHEMBL236446,P45452,,QROXNPLBULDOSL-QGRTWZNFSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17512742,IC50,=,122,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Simultaneous presence of unsaturation and long alkyl chain at P'1 of Ilomastat confers selectivity for gelatinase A (MMP-2) over gelatinase B (MMP-9) inhibition as shown by molecular modelling studies.,Bioorg. Med. Chem.,2007,15,14,"Moroy G, Denhez C, El Mourabit H, Toribio A, Dassonville A, Decarme M, Renault JH, Mirand C, Bellon G, Sapi J, Alix AJ, Hornebeck W, Bourguet E",,447910,DTCT0024002,2176054,DTCC00468601,163984,23716
CHEMBL236523,P45452,,HBXVEQHRTCDTPV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17804234,IC50,>,22000,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"5'-Phenyl-3'H-spiro[indoline-3,2'-[1,3,4]thiadiazol]-2-one inhibitors of ADAMTS-5 (aggrecanase-2).",Bioorg. Med. Chem. Lett.,2007,17,20,"Bursavich MG, Gilbert AM, Lombardi S, Georgiadis KE, Reifenberg E, Flannery CR, Morris EA",,449411,DTCT0024002,2188833,DTCC00467567,1410631,23878
CHEMBL236565,P45452,,REIYGWGAFRRHED-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17956082,IC50,,,,,,,,,,,,,,,,,Inhibition of MMP13,Not Determined,Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET.,J. Med. Chem.,2007,50,23,"Wagner S, Breyholz HJ, Law MP, Faust A, Höltke C, Schröer S, Haufe G, Levkau B, Schober O, Schäfers M, Kopka K",,451368,DTCT0024002,2204619,DTCC00471856,326506,24059
CHEMBL236572,P45452,,XOBSNYRLSVUYKY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17606376,IC50,=,135,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,Structure-based design of TACE selective inhibitors: manipulations in the S1'-S3' pocket.,Bioorg. Med. Chem.,2007,15,18,"Huang A, Joseph-McCarthy D, Lovering F, Sun L, Wang W, Xu W, Zhu Y, Cui J, Zhang Y, Levin JI",,448560,DTCT0024002,2180843,DTCC00470402,2003455,23780
CHEMBL236572,P45452,,XOBSNYRLSVUYKY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19464885,IC50,=,135,NM,,,,,,,,,,,,,,inhibition of human recombinant MMP13 catalytic domain,,Synthesis and activity of quinolinylmethyl P1' alpha-sulfone piperidine hydroxamate inhibitors of TACE.,Bioorg. Med. Chem. Lett.,2009,19,13,"Zhang C, Lovering F, Behnke M, Zask A, Sandanayaka V, Sun L, Zhu Y, Xu W, Zhang Y, Levin JI",,523796,DTCT0024002,2832613,DTCC00470402,2016242,33699
CHEMBL236573,P45452,,RXFCFGLSOUOCEA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17606376,IC50,=,860,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,Structure-based design of TACE selective inhibitors: manipulations in the S1'-S3' pocket.,Bioorg. Med. Chem.,2007,15,18,"Huang A, Joseph-McCarthy D, Lovering F, Sun L, Wang W, Xu W, Zhu Y, Cui J, Zhang Y, Levin JI",,448560,DTCT0024002,2180842,DTCC00470403,909129,23780
CHEMBL236574,P45452,,VYJYRILYFYRPCK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17606376,IC50,=,1600,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,Structure-based design of TACE selective inhibitors: manipulations in the S1'-S3' pocket.,Bioorg. Med. Chem.,2007,15,18,"Huang A, Joseph-McCarthy D, Lovering F, Sun L, Wang W, Xu W, Zhu Y, Cui J, Zhang Y, Levin JI",,448560,DTCT0024002,2180841,DTCC00470404,876482,23780
CHEMBL236770,P45452,,YVCXCHMORKNFGU-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17956082,IC50,=,50,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET.,J. Med. Chem.,2007,50,23,"Wagner S, Breyholz HJ, Law MP, Faust A, Höltke C, Schröer S, Haufe G, Levkau B, Schober O, Schäfers M, Kopka K",,451368,DTCT0024002,2204617,DTCC00471858,1716115,24059
CHEMBL236806,P45452,,UFOCAFMHHPCHKN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17606376,IC50,=,2912,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,Structure-based design of TACE selective inhibitors: manipulations in the S1'-S3' pocket.,Bioorg. Med. Chem.,2007,15,18,"Huang A, Joseph-McCarthy D, Lovering F, Sun L, Wang W, Xu W, Zhu Y, Cui J, Zhang Y, Levin JI",,448560,DTCT0024002,2180832,DTCC00470413,131505,23780
CHEMBL236974,P45452,,YJBLORWBSQLNFW-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17956082,IC50,=,10,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET.,J. Med. Chem.,2007,50,23,"Wagner S, Breyholz HJ, Law MP, Faust A, Höltke C, Schröer S, Haufe G, Levkau B, Schober O, Schäfers M, Kopka K",,451368,DTCT0024002,2204623,DTCC00471852,1841312,24059
CHEMBL237149,P45452,,ABCUGGKORKLYBH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17804234,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"5'-Phenyl-3'H-spiro[indoline-3,2'-[1,3,4]thiadiazol]-2-one inhibitors of ADAMTS-5 (aggrecanase-2).",Bioorg. Med. Chem. Lett.,2007,17,20,"Bursavich MG, Gilbert AM, Lombardi S, Georgiadis KE, Reifenberg E, Flannery CR, Morris EA",,449411,DTCT0024002,2188834,DTCC00467582,1086666,23878
CHEMBL237177,P45452,,GYLCNFGXAVLQBI-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17956082,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET.,J. Med. Chem.,2007,50,23,"Wagner S, Breyholz HJ, Law MP, Faust A, Höltke C, Schröer S, Haufe G, Levkau B, Schober O, Schäfers M, Kopka K",,451368,DTCT0024002,2204621,DTCC00471854,1905591,24059
CHEMBL237366,P45452,,DPMMJDFRISXTPA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17804234,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"5'-Phenyl-3'H-spiro[indoline-3,2'-[1,3,4]thiadiazol]-2-one inhibitors of ADAMTS-5 (aggrecanase-2).",Bioorg. Med. Chem. Lett.,2007,17,20,"Bursavich MG, Gilbert AM, Lombardi S, Georgiadis KE, Reifenberg E, Flannery CR, Morris EA",,449411,DTCT0024002,2188835,DTCC00467586,1954415,23878
CHEMBL237384,P45452,,PMSJHLLBCDOJAE-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17956082,IC50,=,527,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET.,J. Med. Chem.,2007,50,23,"Wagner S, Breyholz HJ, Law MP, Faust A, Höltke C, Schröer S, Haufe G, Levkau B, Schober O, Schäfers M, Kopka K",,451368,DTCT0024002,2204626,DTCC00471849,521031,24059
CHEMBL237466,P45452,,CEVWXUVNZJTNNB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17606376,IC50,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,Not Determined,Structure-based design of TACE selective inhibitors: manipulations in the S1'-S3' pocket.,Bioorg. Med. Chem.,2007,15,18,"Huang A, Joseph-McCarthy D, Lovering F, Sun L, Wang W, Xu W, Zhu Y, Cui J, Zhang Y, Levin JI",,448560,DTCT0024002,2180839,DTCC00470406,131504,23780
CHEMBL237467,P45452,,CIPRRERRNXDHQR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17606376,IC50,=,2075,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,Structure-based design of TACE selective inhibitors: manipulations in the S1'-S3' pocket.,Bioorg. Med. Chem.,2007,15,18,"Huang A, Joseph-McCarthy D, Lovering F, Sun L, Wang W, Xu W, Zhu Y, Cui J, Zhang Y, Levin JI",,448560,DTCT0024002,2180838,DTCC00470407,1135053,23780
CHEMBL237468,P45452,,CLSBMSGIRGYRMI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17606376,IC50,=,6882,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,Structure-based design of TACE selective inhibitors: manipulations in the S1'-S3' pocket.,Bioorg. Med. Chem.,2007,15,18,"Huang A, Joseph-McCarthy D, Lovering F, Sun L, Wang W, Xu W, Zhu Y, Cui J, Zhang Y, Levin JI",,448560,DTCT0024002,2180837,DTCC00470408,228328,23780
CHEMBL2380314,P45452,,ZXVWNUSVQOQAIY-ZEQRLZLVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23631440,KI,=,27,NM,,,,,,,,,,,,,,Inhibition of MMP-13 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959633,DTCT0024002,12429877,DTCC01373961,1256045,54589
CHEMBL2380391,P45452,,YTQYMJLEQVXIPD-SJORKVTESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23631440,KI,=,200,NM,,,,,,,,,,,,,,Inhibition of MMP-13 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959633,DTCT0024002,12429890,DTCC01373950,1995520,54589
CHEMBL2380391,P45452,,YTQYMJLEQVXIPD-SJORKVTESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23631440,KI,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP-13 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959633,DTCT0024002,12429889,DTCC01373950,1995521,54589
CHEMBL2380392,P45452,,YTQYMJLEQVXIPD-DLBZAZTESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23631440,KI,=,160,NM,,,,,,,,,,,,,,Inhibition of MMP-13 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959633,DTCT0024002,12429888,DTCC01373951,1929711,54589
CHEMBL2380393,P45452,,IVYZHWRIIPQLOI-QWRGUYRKSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23631440,KI,=,3400,NM,,,,,,,,,,,,,,Inhibition of MMP-13 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959633,DTCT0024002,12429887,DTCC01373952,1929712,54589
CHEMBL2380394,P45452,,XBPHJVRPJAQGKS-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23631440,KI,=,230,NM,,,,,,,,,,,,,,Inhibition of MMP-13 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959633,DTCT0024002,12429885,DTCC01373953,706586,54589
CHEMBL2380395,P45452,,YTQYMJLEQVXIPD-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23631440,KI,=,15,NM,,,,,,,,,,,,,,Inhibition of MMP-13 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959633,DTCT0024002,12429884,DTCC01373954,1962829,54589
CHEMBL2380395,P45452,,YTQYMJLEQVXIPD-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23631440,KI,=,17,NM,,,,,,,,,,,,,,Inhibition of MMP-13 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959633,DTCT0024002,12429883,DTCC01373954,1962830,54589
CHEMBL2380396,P45452,,YTQYMJLEQVXIPD-IAGOWNOFSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23631440,KI,=,10,NM,,,,,,,,,,,,,,Inhibition of MMP-13 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959633,DTCT0024002,12429882,DTCC01373955,156243,54589
CHEMBL2380397,P45452,,GPFVSBBSRCFVPP-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23631440,KI,=,100000,NM,,,,,,,,,,,,,,Inhibition of MMP-13 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959633,DTCT0024002,12429881,DTCC01373956,738899,54589
CHEMBL2380398,P45452,,WOUSJKQGCHWOAQ-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23631440,KI,=,28000,NM,,,,,,,,,,,,,,Inhibition of MMP-13 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959633,DTCT0024002,12429880,DTCC01373957,480801,54589
CHEMBL2380400,P45452,,UJWXVGWYDPXCST-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23631440,KI,=,50,NM,,,,,,,,,,,,,,Inhibition of MMP-13 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959633,DTCT0024002,12429879,DTCC01373959,1579765,54589
CHEMBL2380401,P45452,,BTCYLUBBXQARQV-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23631440,KI,=,28,NM,,,,,,,,,,,,,,Inhibition of MMP-13 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959633,DTCT0024002,12429878,DTCC01373960,706587,54589
CHEMBL2380402,P45452,,MUWDEQLPHWVPPA-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23631440,KI,=,1.7,NM,,,,,,,,,,,,,,Inhibition of MMP-13 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959633,DTCT0024002,12429876,DTCC01373962,156244,54589
CHEMBL2380403,P45452,,FHORSTUZHMJGTR-GUTACTQSSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23631440,KI,=,2,NM,,,,,,,,,,,,,,Inhibition of MMP-13 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959633,DTCT0024002,12429875,DTCC01373963,318346,54589
CHEMBL2380404,P45452,,NCMGDRDFDQYIHA-GUTACTQSSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23631440,KI,>,200000,NM,,,,,,,,,,,,,,Inhibition of MMP-13 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959633,DTCT0024002,12429874,DTCC01373964,1962831,54589
CHEMBL238081,P45452,,YLRFPZVTHHHQAF-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17606376,IC50,=,30,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,Structure-based design of TACE selective inhibitors: manipulations in the S1'-S3' pocket.,Bioorg. Med. Chem.,2007,15,18,"Huang A, Joseph-McCarthy D, Lovering F, Sun L, Wang W, Xu W, Zhu Y, Cui J, Zhang Y, Levin JI",,448560,DTCT0024002,2180878,DTCC00470415,1620239,23780
CHEMBL2385479,P45452,,QTUCHEGSWFEUBW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,42,NM,,,,,,,,,,,,,,Inhibition of MMP13 (unknown origin)-mediated Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorimetric assay,,,ACS Med. Chem. Lett.,2013,4,6,,,960928,DTCT0024002,12452611,DTCC01376381,771114,54626
CHEMBL2385480,P45452,,CWDYQHCEZVYJNX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,49,NM,,,,,,,,,,,,,,Inhibition of MMP13 (unknown origin)-mediated Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorimetric assay,,,ACS Med. Chem. Lett.,2013,4,6,,,960928,DTCT0024002,12452610,DTCC01376382,1223051,54626
CHEMBL2385481,P45452,,FTQOZDRDOVWSBK-GFCCVEGCSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,14,NM,,,,,,,,,,,,,,Inhibition of MMP13 (unknown origin)-mediated Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorimetric assay,,,ACS Med. Chem. Lett.,2013,4,6,,,960928,DTCT0024002,12452609,DTCC01376383,1515521,54626
CHEMBL2385482,P45452,,LMKSZZKXCRCXFM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,12,NM,,,,,,,,,,,,,,Inhibition of MMP13 (unknown origin)-mediated Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorimetric assay,,,ACS Med. Chem. Lett.,2013,4,6,,,960928,DTCT0024002,12452607,DTCC01376384,1450589,54626
CHEMBL2385483,P45452,,BLXHYKZAZZIQOC-ZDUSSCGKSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,1,NM,,,,,,,,,,,,,,Inhibition of MMP13 (unknown origin)-mediated Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorimetric assay,,,ACS Med. Chem. Lett.,2013,4,6,,,960928,DTCT0024002,12452606,DTCC01376385,2092444,54626
CHEMBL2385484,P45452,,JXZUMXBHWMKALL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,19,NM,,,,,,,,,,,,,,Inhibition of MMP13 (unknown origin)-mediated Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorimetric assay,,,ACS Med. Chem. Lett.,2013,4,6,,,960928,DTCT0024002,12452605,DTCC01376386,1962854,54626
CHEMBL2385485,P45452,,PLJKONSYASWBHO-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,10,NM,,,,,,,,,,,,,,Inhibition of MMP13 (unknown origin)-mediated Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorimetric assay,,,ACS Med. Chem. Lett.,2013,4,6,,,960928,DTCT0024002,12452604,DTCC01376387,1190853,54626
CHEMBL2385486,P45452,,AMHJUVNJSCPYSD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,5,NM,,,,,,,,,,,,,,Inhibition of MMP13 (unknown origin)-mediated Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorimetric assay,,,ACS Med. Chem. Lett.,2013,4,6,,,960928,DTCT0024002,12452602,DTCC01376388,416675,54626
CHEMBL2385487,P45452,,UIMOJSHBVUUXAE-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,1,NM,,,,,,,,,,,,,,Inhibition of MMP13 (unknown origin)-mediated Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorimetric assay,,,ACS Med. Chem. Lett.,2013,4,6,,,960928,DTCT0024002,12452601,DTCC01376389,1353845,54626
CHEMBL2385488,P45452,,AQWIHDVVCANJLS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,35,NM,,,,,,,,,,,,,,Inhibition of MMP13 (unknown origin)-mediated Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorimetric assay,,,ACS Med. Chem. Lett.,2013,4,6,,,960928,DTCT0024002,12452600,DTCC01376390,188159,54626
CHEMBL2385489,P45452,,XYXRFODFDUOQKS-NSHDSACASA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,10,NM,,,,,,,,,,,,,,Inhibition of MMP13 (unknown origin)-mediated Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorimetric assay,,,ACS Med. Chem. Lett.,2013,4,6,,,960928,DTCT0024002,12452599,DTCC01376391,1223052,54626
CHEMBL2385490,P45452,,DOZFSSIRRROWRF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,6,NM,,,,,,,,,,,,,,Inhibition of MMP13 (unknown origin)-mediated Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorimetric assay,,,ACS Med. Chem. Lett.,2013,4,6,,,960928,DTCT0024002,12452598,DTCC01376392,1768575,54626
CHEMBL2385491,P45452,,OEXQBZKLEMTXMU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,323,NM,,,,,,,,,,,,,,Inhibition of MMP13 (unknown origin)-mediated Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorimetric assay,,,ACS Med. Chem. Lett.,2013,4,6,,,960928,DTCT0024002,12452597,DTCC01376393,220369,54626
CHEMBL2385492,P45452,,YJKZJSXUMXIJNB-VIFPVBQESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,3,NM,,,,,,,,,,,,,,Inhibition of MMP13 (unknown origin)-mediated Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorimetric assay,,,ACS Med. Chem. Lett.,2013,4,6,,,960928,DTCT0024002,12452595,DTCC01376394,1418784,54626
CHEMBL2385493,P45452,,UYVXUYVAIIWBSW-LURJTMIESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,175,NM,,,,,,,,,,,,,,Inhibition of MMP13 (unknown origin)-mediated Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorimetric assay,,,ACS Med. Chem. Lett.,2013,4,6,,,960928,DTCT0024002,12452594,DTCC01376395,416676,54626
CHEMBL2407117,P45452,,PVVGPDUDEJOIAA-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23810497,IC50,=,2.8,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-13 using Mca-Pro-beta-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973501,DTCT0024002,12514613,DTCC01388072,1062170,55294
CHEMBL2409667,P45452,,SEFFUKHXSNXXNA-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23810497,IC50,=,0.8,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-13 using Mca-Pro-beta-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973501,DTCT0024002,12514590,DTCC01388064,351316,55294
CHEMBL2409669,P45452,,WLLMTUVXMNKZIA-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23810497,IC50,=,544.6,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-13 using Mca-Pro-beta-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973501,DTCT0024002,12514619,DTCC01388066,1515660,55294
CHEMBL2409670,P45452,,VMNLEVMQHUBVEO-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23810497,IC50,=,1080,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-13 using Mca-Pro-beta-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973501,DTCT0024002,12514618,DTCC01388067,642527,55294
CHEMBL2409671,P45452,,GINDPAMPKCUTHT-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23810497,IC50,=,7329,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-13 using Mca-Pro-beta-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973501,DTCT0024002,12514617,DTCC01388068,1547687,55294
CHEMBL2409672,P45452,,DABAWURVVHVUIM-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23810497,IC50,=,47.3,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-13 using Mca-Pro-beta-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973501,DTCT0024002,12514616,DTCC01388069,1612496,55294
CHEMBL2409673,P45452,,WBJISRGJJFIEKT-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23810497,IC50,=,31.5,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-13 using Mca-Pro-beta-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973501,DTCT0024002,12514615,DTCC01388070,642528,55294
CHEMBL2409674,P45452,,IKFFESJLELVFMG-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23810497,IC50,=,17.7,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-13 using Mca-Pro-beta-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973501,DTCT0024002,12514614,DTCC01388071,1897835,55294
CHEMBL2409675,P45452,,QEDQJMCQDYBMTN-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23810497,IC50,=,3.8,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-13 using Mca-Pro-beta-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973501,DTCT0024002,12514612,DTCC01388073,513182,55294
CHEMBL2409676,P45452,,VUNVHTRIAQAVIJ-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23810497,IC50,=,5.1,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-13 using Mca-Pro-beta-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973501,DTCT0024002,12514611,DTCC01388074,1547688,55294
CHEMBL2409677,P45452,,INEQIZHJKBPXON-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23810497,IC50,=,8.3,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-13 using Mca-Pro-beta-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973501,DTCT0024002,12514610,DTCC01388075,480932,55294
CHEMBL2409678,P45452,,PUMWDRFJNKAWSM-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23810497,IC50,=,71.2,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-13 using Mca-Pro-beta-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973501,DTCT0024002,12515747,DTCC01388076,447452,55294
CHEMBL2409679,P45452,,NAPHACRGTVNBFT-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23810497,IC50,=,178,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-13 using Mca-Pro-beta-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973501,DTCT0024002,12515746,DTCC01388077,1321204,55294
CHEMBL2409680,P45452,,KMFGLQOYVHYJNC-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23810497,IC50,=,1051,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-13 using Mca-Pro-beta-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973501,DTCT0024002,12515744,DTCC01388078,2028560,55294
CHEMBL2409681,P45452,,ZTYORZXGFQCDTH-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23810497,IC50,=,8445,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-13 using Mca-Pro-beta-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973501,DTCT0024002,12515743,DTCC01388079,1579913,55294
CHEMBL2409682,P45452,,HEKVSVDHQDDIEK-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23810497,IC50,=,1.4,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-13 using Mca-Pro-beta-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973501,DTCT0024002,12515742,DTCC01388080,91482,55294
CHEMBL2409683,P45452,,SYNSXJHFJAEBFU-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23810497,IC50,=,1.4,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-13 using Mca-Pro-beta-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973501,DTCT0024002,12515741,DTCC01388081,1515661,55294
CHEMBL2409684,P45452,,PSLRKUXEVFQKIV-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23810497,IC50,=,0.69,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-13 using Mca-Pro-beta-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973501,DTCT0024002,12515740,DTCC01388082,1676919,55294
CHEMBL2409685,P45452,,UUVAUHUMINHXNV-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23810497,IC50,=,1.8,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-13 using Mca-Pro-beta-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973501,DTCT0024002,12515739,DTCC01388083,706731,55294
CHEMBL2409686,P45452,,KOMMTFBIYYINQN-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23810497,IC50,=,2.7,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-13 using Mca-Pro-beta-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973501,DTCT0024002,12515738,DTCC01388084,1676920,55294
CHEMBL2409687,P45452,,QTGLBCRCOSPUMG-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23810497,IC50,=,3.6,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-13 using Mca-Pro-beta-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973501,DTCT0024002,12515737,DTCC01388085,901138,55294
CHEMBL2409688,P45452,,BIHFFXMAAJBXAB-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23810497,IC50,=,0.88,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-13 using Mca-Pro-beta-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973501,DTCT0024002,12515736,DTCC01388086,91483,55294
CHEMBL2409689,P45452,,JZZAWBZYLOHRQP-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23810497,IC50,=,1.9,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-13 using Mca-Pro-beta-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973501,DTCT0024002,12515735,DTCC01388087,901139,55294
CHEMBL2409690,P45452,,IDSFPGOHXLYSBI-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23810497,IC50,=,2.9,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-13 using Mca-Pro-beta-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973501,DTCT0024002,12515734,DTCC01388088,642529,55294
CHEMBL2409691,P45452,,JHHVLAYNAWPINK-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23810497,IC50,=,4.7,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-13 using Mca-Pro-beta-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973501,DTCT0024002,12515733,DTCC01388089,383856,55294
CHEMBL2409692,P45452,,SXPZZTMIBGJPCR-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23810497,IC50,=,5.3,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-13 using Mca-Pro-beta-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973501,DTCT0024002,12515732,DTCC01388090,156365,55294
CHEMBL2409693,P45452,,HGHQBSHHIZJUCO-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23810497,IC50,=,1.6,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-13 using Mca-Pro-beta-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973501,DTCT0024002,12515731,DTCC01388091,2028561,55294
CHEMBL2409694,P45452,,PUGYNRMGOHDNQM-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23810497,IC50,=,0.82,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-13 using Mca-Pro-beta-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973501,DTCT0024002,12515730,DTCC01388092,1801225,55294
CHEMBL2409695,P45452,,QJVAYGYFNIIDHO-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23810497,IC50,=,14,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-13 using Mca-Pro-beta-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973501,DTCT0024002,12515729,DTCC01388093,1801226,55294
CHEMBL2409696,P45452,,PKCWEIUDUFDFAG-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23810497,IC50,=,3.3,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-13 using Mca-Pro-beta-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973501,DTCT0024002,12515728,DTCC01388094,56838,55294
CHEMBL2409697,P45452,,VSJFQUSZEQOOSY-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23810497,IC50,=,13.8,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-13 using Mca-Pro-beta-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973501,DTCT0024002,12515726,DTCC01388095,351317,55294
CHEMBL2409698,P45452,,NCROEDXPKVIJMH-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23810497,IC50,=,28.9,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-13 using Mca-Pro-beta-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973501,DTCT0024002,12515758,DTCC01388096,803416,55294
CHEMBL2409699,P45452,,AYZMSYVMXDNCPT-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23810497,IC50,=,18.2,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-13 using Mca-Pro-beta-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973501,DTCT0024002,12515757,DTCC01388097,2060484,55294
CHEMBL2409700,P45452,,DJXZXNHJKPAVOT-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23810497,IC50,=,59.1,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-13 using Mca-Pro-beta-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973501,DTCT0024002,12515756,DTCC01388098,156366,55294
CHEMBL2409701,P45452,,KPZCYIMLUUEAGX-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23810497,IC50,=,53.8,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-13 using Mca-Pro-beta-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973501,DTCT0024002,12515755,DTCC01388099,1483192,55294
CHEMBL2409702,P45452,,YSUBCUHCVFDMIT-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23810497,IC50,=,8.5,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-13 using Mca-Pro-beta-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973501,DTCT0024002,12515754,DTCC01388100,771224,55294
CHEMBL2409703,P45452,,BVLWMZKKLQDSIB-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23810497,IC50,=,1617,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-13 using Mca-Pro-beta-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973501,DTCT0024002,12515753,DTCC01388101,1029892,55294
CHEMBL2409704,P45452,,ZVFKJDDERIYYSN-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23810497,IC50,=,5.4,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-13 using Mca-Pro-beta-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973501,DTCT0024002,12515752,DTCC01388102,123817,55294
CHEMBL2409705,P45452,,FZWJDQVSTLXMHL-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23810497,IC50,=,2.6,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-13 using Mca-Pro-beta-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973501,DTCT0024002,12515751,DTCC01388103,1418900,55294
CHEMBL2409706,P45452,,NWYAUZLEGMZWIR-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23810497,IC50,=,1.2,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-13 using Mca-Pro-beta-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973501,DTCT0024002,12515750,DTCC01388104,739055,55294
CHEMBL2409707,P45452,,SBVAXUGOISPYPX-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23810497,IC50,=,4.7,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-13 using Mca-Pro-beta-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973501,DTCT0024002,12515749,DTCC01388105,351318,55294
CHEMBL2409708,P45452,,PIMSLVWUPZQPML-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23810497,IC50,=,9.8,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-13 using Mca-Pro-beta-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973501,DTCT0024002,12515748,DTCC01388106,252837,55294
CHEMBL2409709,P45452,,UUVJATOETXKOAS-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23810497,IC50,=,6980,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-13 using Mca-Pro-beta-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973501,DTCT0024002,12515759,DTCC01388107,513183,55294
CHEMBL2409710,P45452,,NZWCKNGEMCPIOP-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23810497,IC50,=,21,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-13 using Mca-Pro-beta-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973501,DTCT0024002,12515761,DTCC01388108,577487,55294
CHEMBL2409711,P45452,,ZUGWYJYJZWGIPG-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23810497,IC50,=,11.5,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-13 using Mca-Pro-beta-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973501,DTCT0024002,12515760,DTCC01388109,1515662,55294
CHEMBL241048,P45452,,RYFSQVRNVFCETF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17027261,KI,>,5020,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,1,"Duan JJ, Chen L, Lu Z, Jiang B, Asakawa N, Sheppeck JE, Liu RQ, Covington MB, Pitts W, Kim SH, Decicco CP",,452976,DTCT0024002,2215320,DTCC00477159,83180,24158
CHEMBL241405,P45452,METHYL ROSMARINATE,XHALVRQBZGZHFE-BBOMDTFKSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22658537,IC50,=,29030,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827438,DTCT0024002,10535450,DTCC00474227,1267308,48665
CHEMBL241405,P45452,METHYL ROSMARINATE,XHALVRQBZGZHFE-BBOMDTFKSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22658537,INHIBITION,>,30,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain at 10 uM incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827444,DTCT0024002,10535535,DTCC00474227,1267308,48665
CHEMBL242073,P45452,,HOAKXOLFZXBTCB-UEUJIKQLSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17267227,IC50,=,120000,NM,,,,,,,,,,,,,,Inhibition of human MMP13,,Synthesis and in vitro evaluation of targeted tetracycline derivatives: effects on inhibition of matrix metalloproteinases.,Bioorg. Med. Chem.,2007,15,6,"Vidal A, Sabatini M, Rolland-Valognes G, Renard P, Madelmont JC, Mounetou E",,441981,DTCT0024002,2144999,DTCC00460316,2079532,23207
CHEMBL242074,P45452,,PAWMGXIJYPYCIU-WQMPYENHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17267227,IC50,=,4900,NM,,,,,,,,,,,,,,Inhibition of human MMP13,,Synthesis and in vitro evaluation of targeted tetracycline derivatives: effects on inhibition of matrix metalloproteinases.,Bioorg. Med. Chem.,2007,15,6,"Vidal A, Sabatini M, Rolland-Valognes G, Renard P, Madelmont JC, Mounetou E",,441981,DTCT0024002,2144998,DTCC00460317,661441,23207
CHEMBL2425930,P45452,,PECBDMOWKLTTSB-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23899323,IC50,=,1,NM,,,,,,,,,,,,,,"Inhibition of MMP-13 (unknown origin) using 7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by fluorescence assay",,"Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (radio)synthesis, in vitro and first in vivo evaluation.",J. Med. Chem.,2013,56,17,"Hugenberg V, Riemann B, Hermann S, Schober O, Schäfers M, Szardenings K, Lebedev A, Gangadharmath U, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,983461,DTCT0024002,12577895,DTCC01394954,1780885,55760
CHEMBL2425931,P45452,,ZTOBNNQGIRZHDO-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23899323,IC50,=,1,NM,,,,,,,,,,,,,,"Inhibition of MMP-13 (unknown origin) using 7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by fluorescence assay",,"Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (radio)synthesis, in vitro and first in vivo evaluation.",J. Med. Chem.,2013,56,17,"Hugenberg V, Riemann B, Hermann S, Schober O, Schäfers M, Szardenings K, Lebedev A, Gangadharmath U, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,983461,DTCT0024002,12577894,DTCC01394955,396398,55760
CHEMBL2425932,P45452,,XMVQXBAGOTVZDD-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23899323,IC50,=,0.3,NM,,,,,,,,,,,,,,"Inhibition of MMP-13 (unknown origin) using 7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by fluorescence assay",,"Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (radio)synthesis, in vitro and first in vivo evaluation.",J. Med. Chem.,2013,56,17,"Hugenberg V, Riemann B, Hermann S, Schober O, Schäfers M, Szardenings K, Lebedev A, Gangadharmath U, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,983461,DTCT0024002,12577893,DTCC01394956,977332,55760
CHEMBL2425933,P45452,,UCWSKTMFEWSSSI-AREMUKBSSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23899323,IC50,=,0.1,NM,,,,,,,,,,,,,,"Inhibition of MMP-13 (unknown origin) using 7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by fluorescence assay",,"Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (radio)synthesis, in vitro and first in vivo evaluation.",J. Med. Chem.,2013,56,17,"Hugenberg V, Riemann B, Hermann S, Schober O, Schäfers M, Szardenings K, Lebedev A, Gangadharmath U, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,983461,DTCT0024002,12577892,DTCC01394957,589788,55760
CHEMBL2425934,P45452,,BDPAGEAOFNRCNJ-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23899323,IC50,=,3,NM,,,,,,,,,,,,,,"Inhibition of MMP-13 (unknown origin) using 7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by fluorescence assay",,"Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (radio)synthesis, in vitro and first in vivo evaluation.",J. Med. Chem.,2013,56,17,"Hugenberg V, Riemann B, Hermann S, Schober O, Schäfers M, Szardenings K, Lebedev A, Gangadharmath U, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,983461,DTCT0024002,12577891,DTCC01394958,1720338,55760
CHEMBL2425935,P45452,,WCHOGKFWHQMHQW-CQSZACIVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23899323,IC50,=,1,NM,,,,,,,,,,,,,,"Inhibition of MMP-13 (unknown origin) using 7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by fluorescence assay",,"Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (radio)synthesis, in vitro and first in vivo evaluation.",J. Med. Chem.,2013,56,17,"Hugenberg V, Riemann B, Hermann S, Schober O, Schäfers M, Szardenings K, Lebedev A, Gangadharmath U, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,983461,DTCT0024002,12577890,DTCC01394959,945221,55760
CHEMBL2425936,P45452,,WTEZGXPTIFMTCH-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23899323,IC50,=,0.07,NM,,,,,,,,,,,,,,"Inhibition of MMP-13 (unknown origin) using 7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by fluorescence assay",,"Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (radio)synthesis, in vitro and first in vivo evaluation.",J. Med. Chem.,2013,56,17,"Hugenberg V, Riemann B, Hermann S, Schober O, Schäfers M, Szardenings K, Lebedev A, Gangadharmath U, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,983461,DTCT0024002,12577889,DTCC01394960,200173,55760
CHEMBL2425937,P45452,,MIKGRMSWGTVOSA-HHHXNRCGSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23899323,IC50,=,7,NM,,,,,,,,,,,,,,"Inhibition of MMP-13 (unknown origin) using 7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by fluorescence assay",,"Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (radio)synthesis, in vitro and first in vivo evaluation.",J. Med. Chem.,2013,56,17,"Hugenberg V, Riemann B, Hermann S, Schober O, Schäfers M, Szardenings K, Lebedev A, Gangadharmath U, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,983461,DTCT0024002,12577888,DTCC01394961,1720339,55760
CHEMBL2425938,P45452,,XJNFMEAYBQFDAS-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23899323,IC50,=,0.07,NM,,,,,,,,,,,,,,"Inhibition of MMP-13 (unknown origin) using 7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by fluorescence assay",,"Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (radio)synthesis, in vitro and first in vivo evaluation.",J. Med. Chem.,2013,56,17,"Hugenberg V, Riemann B, Hermann S, Schober O, Schäfers M, Szardenings K, Lebedev A, Gangadharmath U, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,983461,DTCT0024002,12577887,DTCC01394962,686766,55760
CHEMBL2425939,P45452,,CMKYCYOBCXIZPF-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23899323,IC50,=,0.1,NM,,,,,,,,,,,,,,"Inhibition of MMP-13 (unknown origin) using 7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by fluorescence assay",,"Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (radio)synthesis, in vitro and first in vivo evaluation.",J. Med. Chem.,2013,56,17,"Hugenberg V, Riemann B, Hermann S, Schober O, Schäfers M, Szardenings K, Lebedev A, Gangadharmath U, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,983461,DTCT0024002,12577886,DTCC01394963,493235,55760
CHEMBL2425940,P45452,,NXCSXUBVRRHHLE-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23899323,IC50,=,1,NM,,,,,,,,,,,,,,"Inhibition of MMP-13 (unknown origin) using 7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by fluorescence assay",,"Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (radio)synthesis, in vitro and first in vivo evaluation.",J. Med. Chem.,2013,56,17,"Hugenberg V, Riemann B, Hermann S, Schober O, Schäfers M, Szardenings K, Lebedev A, Gangadharmath U, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,983461,DTCT0024002,12577885,DTCC01394964,622205,55760
CHEMBL2425941,P45452,,NTDGKPHATDVYNT-CQSZACIVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23899323,IC50,=,0.04,NM,,,,,,,,,,,,,,"Inhibition of MMP-13 (unknown origin) using 7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by fluorescence assay",,"Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (radio)synthesis, in vitro and first in vivo evaluation.",J. Med. Chem.,2013,56,17,"Hugenberg V, Riemann B, Hermann S, Schober O, Schäfers M, Szardenings K, Lebedev A, Gangadharmath U, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,983461,DTCT0024002,12577884,DTCC01394965,913758,55760
CHEMBL2425942,P45452,,VPDOXKSDXTZFIX-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23899323,IC50,=,0.7,NM,,,,,,,,,,,,,,"Inhibition of MMP-13 (unknown origin) using 7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by fluorescence assay",,"Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (radio)synthesis, in vitro and first in vivo evaluation.",J. Med. Chem.,2013,56,17,"Hugenberg V, Riemann B, Hermann S, Schober O, Schäfers M, Szardenings K, Lebedev A, Gangadharmath U, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,983461,DTCT0024002,12577883,DTCC01394966,428918,55760
CHEMBL2425943,P45452,,ADDYZQRMSCIHFH-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23899323,IC50,=,0.6,NM,,,,,,,,,,,,,,"Inhibition of MMP-13 (unknown origin) using 7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by fluorescence assay",,"Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (radio)synthesis, in vitro and first in vivo evaluation.",J. Med. Chem.,2013,56,17,"Hugenberg V, Riemann B, Hermann S, Schober O, Schäfers M, Szardenings K, Lebedev A, Gangadharmath U, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,983461,DTCT0024002,12577882,DTCC01394967,1748898,55760
CHEMBL2425944,P45452,,WUGYYDAXBPEKAI-HHHXNRCGSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23899323,IC50,=,0.3,NM,,,,,,,,,,,,,,"Inhibition of MMP-13 (unknown origin) using 7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by fluorescence assay",,"Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (radio)synthesis, in vitro and first in vivo evaluation.",J. Med. Chem.,2013,56,17,"Hugenberg V, Riemann B, Hermann S, Schober O, Schäfers M, Szardenings K, Lebedev A, Gangadharmath U, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,983461,DTCT0024002,12577881,DTCC01394968,686767,55760
CHEMBL2425946,P45452,,OPJBQWSZZMIIHX-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23899323,IC50,=,9,NM,,,,,,,,,,,,,,"Inhibition of MMP-13 (unknown origin) using 7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by fluorescence assay",,"Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (radio)synthesis, in vitro and first in vivo evaluation.",J. Med. Chem.,2013,56,17,"Hugenberg V, Riemann B, Hermann S, Schober O, Schäfers M, Szardenings K, Lebedev A, Gangadharmath U, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,983461,DTCT0024002,12577900,DTCC01394970,21657,55760
CHEMBL2425947,P45452,,MFOJAATVHNHXKB-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23899323,IC50,=,0.05,NM,,,,,,,,,,,,,,"Inhibition of MMP-13 (unknown origin) using 7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by fluorescence assay",,"Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (radio)synthesis, in vitro and first in vivo evaluation.",J. Med. Chem.,2013,56,17,"Hugenberg V, Riemann B, Hermann S, Schober O, Schäfers M, Szardenings K, Lebedev A, Gangadharmath U, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,983461,DTCT0024002,12577899,DTCC01394971,331061,55760
CHEMBL2425948,P45452,,LTTRJMCJTUBEGF-AREMUKBSSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23899323,IC50,=,6,NM,,,,,,,,,,,,,,"Inhibition of MMP-13 (unknown origin) using 7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by fluorescence assay",,"Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (radio)synthesis, in vitro and first in vivo evaluation.",J. Med. Chem.,2013,56,17,"Hugenberg V, Riemann B, Hermann S, Schober O, Schäfers M, Szardenings K, Lebedev A, Gangadharmath U, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,983461,DTCT0024002,12577898,DTCC01394972,1430830,55760
CHEMBL2425949,P45452,,ZXGBSFAKYZEOPJ-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23899323,IC50,=,0.04,NM,,,,,,,,,,,,,,"Inhibition of MMP-13 (unknown origin) using 7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by fluorescence assay",,"Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (radio)synthesis, in vitro and first in vivo evaluation.",J. Med. Chem.,2013,56,17,"Hugenberg V, Riemann B, Hermann S, Schober O, Schäfers M, Szardenings K, Lebedev A, Gangadharmath U, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,983461,DTCT0024002,12577897,DTCC01394973,525520,55760
CHEMBL2425950,P45452,,SMKRBNFEFJZHAI-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23899323,IC50,=,0.09,NM,,,,,,,,,,,,,,"Inhibition of MMP-13 (unknown origin) using 7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by fluorescence assay",,"Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (radio)synthesis, in vitro and first in vivo evaluation.",J. Med. Chem.,2013,56,17,"Hugenberg V, Riemann B, Hermann S, Schober O, Schäfers M, Szardenings K, Lebedev A, Gangadharmath U, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,983461,DTCT0024002,12577896,DTCC01394974,1909986,55760
CHEMBL243236,P45452,,NVJUVGMOOGFJLZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17289381,KI,=,700,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Novel thiol-based TACE inhibitors: rational design, synthesis, and SAR of thiol-containing aryl sulfonamides.",Bioorg. Med. Chem. Lett.,2007,17,8,"Govinda Rao B, Bandarage UK, Wang T, Come JH, Perola E, Wei Y, Tian SK, Saunders JO",,442207,DTCT0024002,2162220,DTCC00463665,110626,23225
CHEMBL2437163,P45452,,JRAYHZWPXHIVJI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,24044937,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of human MMP-13 after 10 mins,,Aggrecanase-2 inhibitors based on the acylthiosemicarbazide zinc-binding group.,Eur. J. Med. Chem.,2013,69,,"Maingot L, Elbakali J, Dumont J, Bosc D, Cousaert N, Urban A, Deglane G, Villoutreix B, Nagase H, Sperandio O, Leroux F, Deprez B, Deprez-Poulain R",,986689,DTCT0024002,12607871,DTCC01400189,751355,56087
CHEMBL243874,P45452,,IEFFRLNSCQIVBY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17289381,KI,=,2000,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Novel thiol-based TACE inhibitors: rational design, synthesis, and SAR of thiol-containing aryl sulfonamides.",Bioorg. Med. Chem. Lett.,2007,17,8,"Govinda Rao B, Bandarage UK, Wang T, Come JH, Perola E, Wei Y, Tian SK, Saunders JO",,442207,DTCT0024002,2162339,DTCC00463738,2047468,23225
CHEMBL245382,P45452,,FXJADKGLMYYRPW-AJTFRIOCSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17188863,KI,>,5025,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Discovery of novel hydantoins as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,5,"Sheppeck JE, Gilmore JL, Yang A, Chen XT, Xue CB, Roderick J, Liu RQ, Covington MB, Decicco CP, Duan JJ",,453872,DTCT0024002,2221466,DTCC00478075,359103,24252
CHEMBL245383,P45452,,SXQXJOREJVFQQR-ATIYNZHBSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17188863,KI,>,5025,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Discovery of novel hydantoins as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,5,"Sheppeck JE, Gilmore JL, Yang A, Chen XT, Xue CB, Roderick J, Liu RQ, Covington MB, Decicco CP, Duan JJ",,453872,DTCT0024002,2221465,DTCC00478076,326532,24252
CHEMBL245384,P45452,,UTQFFMUHRGYGFM-YIXXDRMTSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17188863,KI,>,5025,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Discovery of novel hydantoins as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,5,"Sheppeck JE, Gilmore JL, Yang A, Chen XT, Xue CB, Roderick J, Liu RQ, Covington MB, Decicco CP, Duan JJ",,453872,DTCT0024002,2221463,DTCC00478078,1744537,24252
CHEMBL245581,P45452,,BNMNXPAFKBDIBX-WIZGVZBGSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17188863,KI,>,5025,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Discovery of novel hydantoins as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,5,"Sheppeck JE, Gilmore JL, Yang A, Chen XT, Xue CB, Roderick J, Liu RQ, Covington MB, Decicco CP, Duan JJ",,453872,DTCT0024002,2221462,DTCC00478079,131576,24252
CHEMBL245582,P45452,,CVQRCKDPFUCDTJ-CGHJUBPDSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17188863,KI,>,5025,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Discovery of novel hydantoins as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,5,"Sheppeck JE, Gilmore JL, Yang A, Chen XT, Xue CB, Roderick J, Liu RQ, Covington MB, Decicco CP, Duan JJ",,453872,DTCT0024002,2221461,DTCC00478080,811250,24252
CHEMBL24573,P45452,,IHXYDMMVEDLUPK-WCSIJFPASA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10021913,IC50,=,1600,NM,,,,,,,,,,,,,,Inhibition of recombinant Matrix metalloprotease-13 (MMP-13),,Inhibition of MMP-1 and MMP-13 with phosphinic acids that exploit binding in the S2 pocket.,Bioorg. Med. Chem. Lett.,1999,9,2,"Reiter LA, Rizzi JP, Pandit J, Lasut MJ, McGahee SM, Parikh VD, Blake JF, Danley DE, Laird ER, Lopez-Anaya A, Lopresti-Morrow LL, Mansour MN, Martinelli GJ, Mitchell PG, Owens BS, Pauly TA, Reeves LM, Schulte GK, Yocum SA",,106601,DTCT0024002,683369,DTCC00160423,485416,3377
CHEMBL245774,P45452,,GHIFQOQBENAQBR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17188863,KI,>,5025,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Discovery of novel hydantoins as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,5,"Sheppeck JE, Gilmore JL, Yang A, Chen XT, Xue CB, Roderick J, Liu RQ, Covington MB, Decicco CP, Duan JJ",,453872,DTCT0024002,2221480,DTCC00478054,228402,24252
CHEMBL245776,P45452,,GHIFQOQBENAQBR-IBGZPJMESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17188863,KI,>,5025,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Discovery of novel hydantoins as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,5,"Sheppeck JE, Gilmore JL, Yang A, Chen XT, Xue CB, Roderick J, Liu RQ, Covington MB, Decicco CP, Duan JJ",,453872,DTCT0024002,2221479,DTCC00478057,228403,24252
CHEMBL245974,P45452,,XTOUSIOCVVYRQR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17188863,KI,>,5025,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Discovery of novel hydantoins as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,5,"Sheppeck JE, Gilmore JL, Yang A, Chen XT, Xue CB, Roderick J, Liu RQ, Covington MB, Decicco CP, Duan JJ",,453872,DTCT0024002,2221476,DTCC00478061,1620304,24252
CHEMBL246171,P45452,,LGAMIUMXRWOVGN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17188863,KI,>,5025,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Discovery of novel hydantoins as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,5,"Sheppeck JE, Gilmore JL, Yang A, Chen XT, Xue CB, Roderick J, Liu RQ, Covington MB, Decicco CP, Duan JJ",,453872,DTCT0024002,2221475,DTCC00478062,1263918,24252
CHEMBL246376,P45452,,UEOYACNTKVVWRI-QFQXNSOFSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17188863,KI,>,5025,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Discovery of novel hydantoins as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,5,"Sheppeck JE, Gilmore JL, Yang A, Chen XT, Xue CB, Roderick J, Liu RQ, Covington MB, Decicco CP, Duan JJ",,453872,DTCT0024002,2221471,DTCC00478069,8772,24252
CHEMBL246563,P45452,,GHIFQOQBENAQBR-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17188863,KI,=,4120,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Discovery of novel hydantoins as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,5,"Sheppeck JE, Gilmore JL, Yang A, Chen XT, Xue CB, Roderick J, Liu RQ, Covington MB, Decicco CP, Duan JJ",,453872,DTCT0024002,2221478,DTCC00477929,1231073,24252
CHEMBL246576,P45452,,SSOHCNKODIJGFS-XHCCPWGMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17188863,KI,>,5025,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Discovery of novel hydantoins as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,5,"Sheppeck JE, Gilmore JL, Yang A, Chen XT, Xue CB, Roderick J, Liu RQ, Covington MB, Decicco CP, Duan JJ",,453872,DTCT0024002,2221470,DTCC00478071,1776382,24252
CHEMBL246577,P45452,,SSOHCNKODIJGFS-UZTOHYMASA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17188863,KI,>,5025,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Discovery of novel hydantoins as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,5,"Sheppeck JE, Gilmore JL, Yang A, Chen XT, Xue CB, Roderick J, Liu RQ, Covington MB, Decicco CP, Duan JJ",,453872,DTCT0024002,2221468,DTCC00478072,1361794,24252
CHEMBL246577,P45452,,SSOHCNKODIJGFS-UZTOHYMASA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17188863,KI,>,5025,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Discovery of novel hydantoins as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,5,"Sheppeck JE, Gilmore JL, Yang A, Chen XT, Xue CB, Roderick J, Liu RQ, Covington MB, Decicco CP, Duan JJ",,453872,DTCT0024002,2221469,DTCC00478072,1361793,24252
CHEMBL247140,P45452,,BYQIIKCYPGKHOY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17576061,KI,=,753,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Synthesis and structure-activity relationship of a novel, non-hydroxamate series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,16,"Gilmore JL, King BW, Asakawa N, Harrison K, Tebben A, Sheppeck JE, Liu RQ, Covington M, Duan JJ",,456579,DTCT0024002,2240703,DTCC00479011,1987234,24538
CHEMBL247141,P45452,,WUGZBWFREMAISJ-LADGPHEKSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17576061,KI,>,5025,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Synthesis and structure-activity relationship of a novel, non-hydroxamate series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,16,"Gilmore JL, King BW, Asakawa N, Harrison K, Tebben A, Sheppeck JE, Liu RQ, Covington M, Duan JJ",,456579,DTCT0024002,2240700,DTCC00479014,1442482,24538
CHEMBL247346,P45452,,CXRXRCFYUZTJSR-JTHBVZDNSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17576061,KI,>,5025,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Synthesis and structure-activity relationship of a novel, non-hydroxamate series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,16,"Gilmore JL, King BW, Asakawa N, Harrison K, Tebben A, Sheppeck JE, Liu RQ, Covington M, Duan JJ",,456579,DTCT0024002,2240698,DTCC00479016,634208,24538
CHEMBL247347,P45452,,XZCDAPHMYWQDPY-RBBKRZOGSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17576061,KI,>,5025,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Synthesis and structure-activity relationship of a novel, non-hydroxamate series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,16,"Gilmore JL, King BW, Asakawa N, Harrison K, Tebben A, Sheppeck JE, Liu RQ, Covington M, Duan JJ",,456579,DTCT0024002,2240696,DTCC00479018,439330,24538
CHEMBL247348,P45452,,MOMCZJRIDPUOBK-RBBKRZOGSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17576061,KI,>,5025,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Synthesis and structure-activity relationship of a novel, non-hydroxamate series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,16,"Gilmore JL, King BW, Asakawa N, Harrison K, Tebben A, Sheppeck JE, Liu RQ, Covington M, Duan JJ",,456579,DTCT0024002,2240695,DTCC00479019,1954523,24538
CHEMBL247545,P45452,,IMAXZHZQJLQAFI-UKILVPOCSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17576061,KI,>,5025,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Synthesis and structure-activity relationship of a novel, non-hydroxamate series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,16,"Gilmore JL, King BW, Asakawa N, Harrison K, Tebben A, Sheppeck JE, Liu RQ, Covington M, Duan JJ",,456579,DTCT0024002,2240694,DTCC00479020,1280403,24538
CHEMBL247546,P45452,,DAUHEXDIKFZUFM-LADGPHEKSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17576061,KI,=,3136,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Synthesis and structure-activity relationship of a novel, non-hydroxamate series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,16,"Gilmore JL, King BW, Asakawa N, Harrison K, Tebben A, Sheppeck JE, Liu RQ, Covington M, Duan JJ",,456579,DTCT0024002,2240692,DTCC00479022,1313114,24538
CHEMBL247742,P45452,,HUKXOIMLTBNTPV-UKILVPOCSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17576061,KI,>,5025,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Synthesis and structure-activity relationship of a novel, non-hydroxamate series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,16,"Gilmore JL, King BW, Asakawa N, Harrison K, Tebben A, Sheppeck JE, Liu RQ, Covington M, Duan JJ",,456579,DTCT0024002,2240691,DTCC00479023,1280404,24538
CHEMBL247743,P45452,,QOMQSCJPJZHYPI-JTHBVZDNSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17576061,KI,>,5025,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Synthesis and structure-activity relationship of a novel, non-hydroxamate series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,16,"Gilmore JL, King BW, Asakawa N, Harrison K, Tebben A, Sheppeck JE, Liu RQ, Covington M, Duan JJ",,456579,DTCT0024002,2240690,DTCC00479024,892829,24538
CHEMBL247946,P45452,,NBEQYTSXQZAREJ-UKILVPOCSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17576061,KI,>,5025,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Synthesis and structure-activity relationship of a novel, non-hydroxamate series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,16,"Gilmore JL, King BW, Asakawa N, Harrison K, Tebben A, Sheppeck JE, Liu RQ, Covington M, Duan JJ",,456579,DTCT0024002,2240688,DTCC00479026,1442483,24538
CHEMBL247947,P45452,,GQPOMTPZRNEORO-UKILVPOCSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17576061,KI,>,5025,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Synthesis and structure-activity relationship of a novel, non-hydroxamate series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,16,"Gilmore JL, King BW, Asakawa N, Harrison K, Tebben A, Sheppeck JE, Liu RQ, Covington M, Duan JJ",,456579,DTCT0024002,2240687,DTCC00479027,1507443,24538
CHEMBL247967,P45452,,YYHXOYNNTNFXCS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17027261,KI,,,,,,,,,,,,,,,,,Inhibition of MMP13,Not Determined,Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,1,"Duan JJ, Chen L, Lu Z, Jiang B, Asakawa N, Sheppeck JE, Liu RQ, Covington MB, Pitts W, Kim SH, Decicco CP",,452976,DTCT0024002,2215488,DTCC00477190,634148,24158
CHEMBL248148,P45452,,DXSANODVHPAKSB-UFHPHHKVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17576061,KI,>,5025,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Synthesis and structure-activity relationship of a novel, non-hydroxamate series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,16,"Gilmore JL, King BW, Asakawa N, Harrison K, Tebben A, Sheppeck JE, Liu RQ, Covington M, Duan JJ",,456579,DTCT0024002,2240686,DTCC00479028,698565,24538
CHEMBL248172,P45452,,CNPXAHGTJQERBN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17027261,KI,=,3530,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,1,"Duan JJ, Chen L, Lu Z, Jiang B, Asakawa N, Sheppeck JE, Liu RQ, Covington MB, Pitts W, Kim SH, Decicco CP",,452976,DTCT0024002,2215487,DTCC00477191,244564,24158
CHEMBL248173,P45452,,VXTLHKJGOCNUSX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17027261,KI,=,3950,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,1,"Duan JJ, Chen L, Lu Z, Jiang B, Asakawa N, Sheppeck JE, Liu RQ, Covington MB, Pitts W, Kim SH, Decicco CP",,452976,DTCT0024002,2215489,DTCC00477192,1086718,24158
CHEMBL248323,P45452,,MEWQGNPVNKWBSS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17576061,KI,>,5025,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Synthesis and structure-activity relationship of a novel, non-hydroxamate series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,16,"Gilmore JL, King BW, Asakawa N, Harrison K, Tebben A, Sheppeck JE, Liu RQ, Covington M, Duan JJ",,456579,DTCT0024002,2240706,DTCC00479008,1119298,24538
CHEMBL248523,P45452,,AZDMTLYFRFXZGD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17576061,KI,>,5025,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Synthesis and structure-activity relationship of a novel, non-hydroxamate series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,16,"Gilmore JL, King BW, Asakawa N, Harrison K, Tebben A, Sheppeck JE, Liu RQ, Covington M, Duan JJ",,456579,DTCT0024002,2240705,DTCC00479009,634207,24538
CHEMBL248524,P45452,,FRIRYAGACGIOFP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17576061,KI,>,5025,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Synthesis and structure-activity relationship of a novel, non-hydroxamate series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,16,"Gilmore JL, King BW, Asakawa N, Harrison K, Tebben A, Sheppeck JE, Liu RQ, Covington M, Duan JJ",,456579,DTCT0024002,2240704,DTCC00479010,342991,24538
CHEMBL248543,P45452,,NJLYIWVYOOAOGD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17935984,IC50,=,0.49,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Potent, selective spiropyrrolidine pyrimidinetrione inhibitors of MMP-13.",Bioorg. Med. Chem. Lett.,2007,17,23,"Freeman-Cook KD, Reiter LA, Noe MC, Antipas AS, Danley DE, Datta K, Downs JT, Eisenbeis S, Eskra JD, Garmene DJ, Greer EM, Griffiths RJ, Guzman R, Hardink JR, Janat F, Jones CS, Martinelli GJ, Mitchell PG, Laird ER, Liras JL, Lopresti-Morrow LL, Pandit J, Reilly UD, Robertson D, Vaughn-Bowser ML, Wolf-Gouviea LA, Yocum SA",,458357,DTCT0024002,2254796,DTCC00484203,1937737,24756
CHEMBL248916,P45452,,GTZIJWRUYJNVLH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17935984,IC50,=,11.7,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Potent, selective spiropyrrolidine pyrimidinetrione inhibitors of MMP-13.",Bioorg. Med. Chem. Lett.,2007,17,23,"Freeman-Cook KD, Reiter LA, Noe MC, Antipas AS, Danley DE, Datta K, Downs JT, Eisenbeis S, Eskra JD, Garmene DJ, Greer EM, Griffiths RJ, Guzman R, Hardink JR, Janat F, Jones CS, Martinelli GJ, Mitchell PG, Laird ER, Liras JL, Lopresti-Morrow LL, Pandit J, Reilly UD, Robertson D, Vaughn-Bowser ML, Wolf-Gouviea LA, Yocum SA",,458357,DTCT0024002,2254812,DTCC00484135,1296576,24756
CHEMBL248918,P45452,,DJCAIEAYZGFFDA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17935984,IC50,=,15.1,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Potent, selective spiropyrrolidine pyrimidinetrione inhibitors of MMP-13.",Bioorg. Med. Chem. Lett.,2007,17,23,"Freeman-Cook KD, Reiter LA, Noe MC, Antipas AS, Danley DE, Datta K, Downs JT, Eisenbeis S, Eskra JD, Garmene DJ, Greer EM, Griffiths RJ, Guzman R, Hardink JR, Janat F, Jones CS, Martinelli GJ, Mitchell PG, Laird ER, Liras JL, Lopresti-Morrow LL, Pandit J, Reilly UD, Robertson D, Vaughn-Bowser ML, Wolf-Gouviea LA, Yocum SA",,458357,DTCT0024002,2254811,DTCC00484138,1970978,24756
CHEMBL248939,P45452,,APBWJXHEFGHMDV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17935984,IC50,=,0.96,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Potent, selective spiropyrrolidine pyrimidinetrione inhibitors of MMP-13.",Bioorg. Med. Chem. Lett.,2007,17,23,"Freeman-Cook KD, Reiter LA, Noe MC, Antipas AS, Danley DE, Datta K, Downs JT, Eisenbeis S, Eskra JD, Garmene DJ, Greer EM, Griffiths RJ, Guzman R, Hardink JR, Janat F, Jones CS, Martinelli GJ, Mitchell PG, Laird ER, Liras JL, Lopresti-Morrow LL, Pandit J, Reilly UD, Robertson D, Vaughn-Bowser ML, Wolf-Gouviea LA, Yocum SA",,458357,DTCT0024002,2254794,DTCC00484209,488929,24756
CHEMBL248941,P45452,,MYWFODDQTUULHX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17935984,IC50,=,0.1,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Potent, selective spiropyrrolidine pyrimidinetrione inhibitors of MMP-13.",Bioorg. Med. Chem. Lett.,2007,17,23,"Freeman-Cook KD, Reiter LA, Noe MC, Antipas AS, Danley DE, Datta K, Downs JT, Eisenbeis S, Eskra JD, Garmene DJ, Greer EM, Griffiths RJ, Guzman R, Hardink JR, Janat F, Jones CS, Martinelli GJ, Mitchell PG, Laird ER, Liras JL, Lopresti-Morrow LL, Pandit J, Reilly UD, Robertson D, Vaughn-Bowser ML, Wolf-Gouviea LA, Yocum SA",,458357,DTCT0024002,2254793,DTCC00484210,294008,24756
CHEMBL249122,P45452,,QZZFSRYCXAPMRI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17935984,IC50,=,12,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Potent, selective spiropyrrolidine pyrimidinetrione inhibitors of MMP-13.",Bioorg. Med. Chem. Lett.,2007,17,23,"Freeman-Cook KD, Reiter LA, Noe MC, Antipas AS, Danley DE, Datta K, Downs JT, Eisenbeis S, Eskra JD, Garmene DJ, Greer EM, Griffiths RJ, Guzman R, Hardink JR, Janat F, Jones CS, Martinelli GJ, Mitchell PG, Laird ER, Liras JL, Lopresti-Morrow LL, Pandit J, Reilly UD, Robertson D, Vaughn-Bowser ML, Wolf-Gouviea LA, Yocum SA",,458357,DTCT0024002,2254810,DTCC00484141,1135218,24756
CHEMBL249988,P45452,,XTGSXSLCZLEGOR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17935984,IC50,=,3.49,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Potent, selective spiropyrrolidine pyrimidinetrione inhibitors of MMP-13.",Bioorg. Med. Chem. Lett.,2007,17,23,"Freeman-Cook KD, Reiter LA, Noe MC, Antipas AS, Danley DE, Datta K, Downs JT, Eisenbeis S, Eskra JD, Garmene DJ, Greer EM, Griffiths RJ, Guzman R, Hardink JR, Janat F, Jones CS, Martinelli GJ, Mitchell PG, Laird ER, Liras JL, Lopresti-Morrow LL, Pandit J, Reilly UD, Robertson D, Vaughn-Bowser ML, Wolf-Gouviea LA, Yocum SA",,458357,DTCT0024002,2254815,DTCC00484122,1937736,24756
CHEMBL250093,P45452,,RZISBFWRHNXABZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17531482,IC50,=,1200,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Design and synthesis of 3,3-piperidine hydroxamate analogs as selective TACE inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,15,"Lombart HG, Feyfant E, Joseph-McCarthy D, Huang A, Lovering F, Sun L, Zhu Y, Zeng C, Zhang Y, Levin J",,456210,DTCT0024002,2237269,DTCC00480948,1716176,24495
CHEMBL250094,P45452,,PPNXUTAPILQZQN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17531482,IC50,=,1100,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Design and synthesis of 3,3-piperidine hydroxamate analogs as selective TACE inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,15,"Lombart HG, Feyfant E, Joseph-McCarthy D, Huang A, Lovering F, Sun L, Zhu Y, Zeng C, Zhang Y, Levin J",,456210,DTCT0024002,2237285,DTCC00480949,1684812,24495
CHEMBL250189,P45452,,GCZMDMHHGVIXIT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17935984,IC50,=,138,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Potent, selective spiropyrrolidine pyrimidinetrione inhibitors of MMP-13.",Bioorg. Med. Chem. Lett.,2007,17,23,"Freeman-Cook KD, Reiter LA, Noe MC, Antipas AS, Danley DE, Datta K, Downs JT, Eisenbeis S, Eskra JD, Garmene DJ, Greer EM, Griffiths RJ, Guzman R, Hardink JR, Janat F, Jones CS, Martinelli GJ, Mitchell PG, Laird ER, Liras JL, Lopresti-Morrow LL, Pandit J, Reilly UD, Robertson D, Vaughn-Bowser ML, Wolf-Gouviea LA, Yocum SA",,458357,DTCT0024002,2254814,DTCC00484127,164148,24756
CHEMBL250266,P45452,UK-370106,NSMABJUGSNPHMN-BHYWQNONSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18029177,IC50,=,2300,NM,,,,,,,,,,,,,,Inhibition of MMP13,,A novel series of highly selective inhibitors of MMP-3.,Bioorg. Med. Chem. Lett.,2007,17,24,"Whitlock GA, Dack KN, Dickinson RP, Lewis ML",,459995,DTCT0024002,2266851,DTCC00003798,779009,24951
CHEMBL250266,P45452,UK-370106,NSMABJUGSNPHMN-BHYWQNONSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18790648,IC50,=,2300,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497406,DTCT0024002,2457456,DTCC00003798,791164,32556
CHEMBL250297,P45452,,NYRVSWKULSLJMD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17531482,IC50,=,2860,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Design and synthesis of 3,3-piperidine hydroxamate analogs as selective TACE inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,15,"Lombart HG, Feyfant E, Joseph-McCarthy D, Huang A, Lovering F, Sun L, Zhu Y, Zeng C, Zhang Y, Levin J",,456210,DTCT0024002,2237283,DTCC00480951,1426591,24495
CHEMBL250298,P45452,,UVFPNZAMZZIJLE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17531482,IC50,=,1200,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Design and synthesis of 3,3-piperidine hydroxamate analogs as selective TACE inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,15,"Lombart HG, Feyfant E, Joseph-McCarthy D, Huang A, Lovering F, Sun L, Zhu Y, Zeng C, Zhang Y, Levin J",,456210,DTCT0024002,2237282,DTCC00480952,196054,24495
CHEMBL250299,P45452,,GRFJGGIFOFQTRL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17531482,IC50,=,1110,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Design and synthesis of 3,3-piperidine hydroxamate analogs as selective TACE inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,15,"Lombart HG, Feyfant E, Joseph-McCarthy D, Huang A, Lovering F, Sun L, Zhu Y, Zeng C, Zhang Y, Levin J",,456210,DTCT0024002,2237281,DTCC00480953,1361831,24495
CHEMBL250363,P45452,,FJXIFRHJZMAZKQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17935984,IC50,=,0.16,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Potent, selective spiropyrrolidine pyrimidinetrione inhibitors of MMP-13.",Bioorg. Med. Chem. Lett.,2007,17,23,"Freeman-Cook KD, Reiter LA, Noe MC, Antipas AS, Danley DE, Datta K, Downs JT, Eisenbeis S, Eskra JD, Garmene DJ, Greer EM, Griffiths RJ, Guzman R, Hardink JR, Janat F, Jones CS, Martinelli GJ, Mitchell PG, Laird ER, Liras JL, Lopresti-Morrow LL, Pandit J, Reilly UD, Robertson D, Vaughn-Bowser ML, Wolf-Gouviea LA, Yocum SA",,458357,DTCT0024002,2254803,DTCC00484178,1458599,24756
CHEMBL250503,P45452,,RYUNWXPVOIGBCD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17531482,IC50,=,1010,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Design and synthesis of 3,3-piperidine hydroxamate analogs as selective TACE inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,15,"Lombart HG, Feyfant E, Joseph-McCarthy D, Huang A, Lovering F, Sun L, Zhu Y, Zeng C, Zhang Y, Levin J",,456210,DTCT0024002,2237279,DTCC00480956,1620344,24495
CHEMBL250504,P45452,,OAXXNDPRBWJXOJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17531482,IC50,=,470,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Design and synthesis of 3,3-piperidine hydroxamate analogs as selective TACE inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,15,"Lombart HG, Feyfant E, Joseph-McCarthy D, Huang A, Lovering F, Sun L, Zhu Y, Zeng C, Zhang Y, Levin J",,456210,DTCT0024002,2237277,DTCC00480958,8867,24495
CHEMBL250554,P45452,,AYNZBUDTDWVQJH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17935984,IC50,=,0.4,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Potent, selective spiropyrrolidine pyrimidinetrione inhibitors of MMP-13.",Bioorg. Med. Chem. Lett.,2007,17,23,"Freeman-Cook KD, Reiter LA, Noe MC, Antipas AS, Danley DE, Datta K, Downs JT, Eisenbeis S, Eskra JD, Garmene DJ, Greer EM, Griffiths RJ, Guzman R, Hardink JR, Janat F, Jones CS, Martinelli GJ, Mitchell PG, Laird ER, Liras JL, Lopresti-Morrow LL, Pandit J, Reilly UD, Robertson D, Vaughn-Bowser ML, Wolf-Gouviea LA, Yocum SA",,458357,DTCT0024002,2254792,DTCC00484212,1426629,24756
CHEMBL250570,P45452,,ZCQYOSQRMKVFJH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17935984,IC50,=,0.09,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Potent, selective spiropyrrolidine pyrimidinetrione inhibitors of MMP-13.",Bioorg. Med. Chem. Lett.,2007,17,23,"Freeman-Cook KD, Reiter LA, Noe MC, Antipas AS, Danley DE, Datta K, Downs JT, Eisenbeis S, Eskra JD, Garmene DJ, Greer EM, Griffiths RJ, Guzman R, Hardink JR, Janat F, Jones CS, Martinelli GJ, Mitchell PG, Laird ER, Liras JL, Lopresti-Morrow LL, Pandit J, Reilly UD, Robertson D, Vaughn-Bowser ML, Wolf-Gouviea LA, Yocum SA",,458357,DTCT0024002,2254801,DTCC00484181,67141,24756
CHEMBL250708,P45452,,YFKTVOCECCSHLJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17531482,IC50,=,1190,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Design and synthesis of 3,3-piperidine hydroxamate analogs as selective TACE inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,15,"Lombart HG, Feyfant E, Joseph-McCarthy D, Huang A, Lovering F, Sun L, Zhu Y, Zeng C, Zhang Y, Levin J",,456210,DTCT0024002,2237276,DTCC00480959,714559,24495
CHEMBL250710,P45452,,KLUBFNJJJWONQA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17531482,IC50,=,950,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Design and synthesis of 3,3-piperidine hydroxamate analogs as selective TACE inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,15,"Lombart HG, Feyfant E, Joseph-McCarthy D, Huang A, Lovering F, Sun L, Zhu Y, Zeng C, Zhang Y, Levin J",,456210,DTCT0024002,2237275,DTCC00480961,1231111,24495
CHEMBL250758,P45452,,VQQQRTMSDPVBAF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17935984,IC50,=,0.08,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Potent, selective spiropyrrolidine pyrimidinetrione inhibitors of MMP-13.",Bioorg. Med. Chem. Lett.,2007,17,23,"Freeman-Cook KD, Reiter LA, Noe MC, Antipas AS, Danley DE, Datta K, Downs JT, Eisenbeis S, Eskra JD, Garmene DJ, Greer EM, Griffiths RJ, Guzman R, Hardink JR, Janat F, Jones CS, Martinelli GJ, Mitchell PG, Laird ER, Liras JL, Lopresti-Morrow LL, Pandit J, Reilly UD, Robertson D, Vaughn-Bowser ML, Wolf-Gouviea LA, Yocum SA",,458357,DTCT0024002,2254791,DTCC00484216,1684852,24756
CHEMBL250776,P45452,,AVCSBRLWHLUWMX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17935984,IC50,=,0.05,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Potent, selective spiropyrrolidine pyrimidinetrione inhibitors of MMP-13.",Bioorg. Med. Chem. Lett.,2007,17,23,"Freeman-Cook KD, Reiter LA, Noe MC, Antipas AS, Danley DE, Datta K, Downs JT, Eisenbeis S, Eskra JD, Garmene DJ, Greer EM, Griffiths RJ, Guzman R, Hardink JR, Janat F, Jones CS, Martinelli GJ, Mitchell PG, Laird ER, Liras JL, Lopresti-Morrow LL, Pandit J, Reilly UD, Robertson D, Vaughn-Bowser ML, Wolf-Gouviea LA, Yocum SA",,458357,DTCT0024002,2254799,DTCC00484188,1652626,24756
CHEMBL250906,P45452,,ZUAUVLUKHSXGGD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17531482,IC50,>,16666,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Design and synthesis of 3,3-piperidine hydroxamate analogs as selective TACE inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,15,"Lombart HG, Feyfant E, Joseph-McCarthy D, Huang A, Lovering F, Sun L, Zhu Y, Zeng C, Zhang Y, Levin J",,456210,DTCT0024002,2237271,DTCC00480965,326576,24495
CHEMBL250907,P45452,,RZAVXBHMHDOVTM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17531482,IC50,>,16666,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Design and synthesis of 3,3-piperidine hydroxamate analogs as selective TACE inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,15,"Lombart HG, Feyfant E, Joseph-McCarthy D, Huang A, Lovering F, Sun L, Zhu Y, Zeng C, Zhang Y, Levin J",,456210,DTCT0024002,2237270,DTCC00480966,1905673,24495
CHEMBL250972,P45452,,BIPRBNGRDMIZHW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17935984,IC50,=,0.11,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Potent, selective spiropyrrolidine pyrimidinetrione inhibitors of MMP-13.",Bioorg. Med. Chem. Lett.,2007,17,23,"Freeman-Cook KD, Reiter LA, Noe MC, Antipas AS, Danley DE, Datta K, Downs JT, Eisenbeis S, Eskra JD, Garmene DJ, Greer EM, Griffiths RJ, Guzman R, Hardink JR, Janat F, Jones CS, Martinelli GJ, Mitchell PG, Laird ER, Liras JL, Lopresti-Morrow LL, Pandit J, Reilly UD, Robertson D, Vaughn-Bowser ML, Wolf-Gouviea LA, Yocum SA",,458357,DTCT0024002,2254797,DTCC00484189,1361890,24756
CHEMBL251276,P45452,,DBLSRXLCLISVHT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,4.85,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260782,DTCC00486021,1103044,24831
CHEMBL251277,P45452,,RBBJRRIKUGFUNE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,6.4,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260781,DTCC00486023,585418,24831
CHEMBL251278,P45452,,YNYCJXFJTBMLCP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,5.52,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260771,DTCC00486026,1873445,24831
CHEMBL251583,P45452,,VPVGVAGTYSVBFL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17935984,IC50,=,8.9,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Potent, selective spiropyrrolidine pyrimidinetrione inhibitors of MMP-13.",Bioorg. Med. Chem. Lett.,2007,17,23,"Freeman-Cook KD, Reiter LA, Noe MC, Antipas AS, Danley DE, Datta K, Downs JT, Eisenbeis S, Eskra JD, Garmene DJ, Greer EM, Griffiths RJ, Guzman R, Hardink JR, Janat F, Jones CS, Martinelli GJ, Mitchell PG, Laird ER, Liras JL, Lopresti-Morrow LL, Pandit J, Reilly UD, Robertson D, Vaughn-Bowser ML, Wolf-Gouviea LA, Yocum SA",,458357,DTCT0024002,2254752,DTCC00484089,1652625,24756
CHEMBL251584,P45452,,OVQQZYABPYQSFZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17935984,IC50,=,2.9,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Potent, selective spiropyrrolidine pyrimidinetrione inhibitors of MMP-13.",Bioorg. Med. Chem. Lett.,2007,17,23,"Freeman-Cook KD, Reiter LA, Noe MC, Antipas AS, Danley DE, Datta K, Downs JT, Eisenbeis S, Eskra JD, Garmene DJ, Greer EM, Griffiths RJ, Guzman R, Hardink JR, Janat F, Jones CS, Martinelli GJ, Mitchell PG, Laird ER, Liras JL, Lopresti-Morrow LL, Pandit J, Reilly UD, Robertson D, Vaughn-Bowser ML, Wolf-Gouviea LA, Yocum SA",,458357,DTCT0024002,2254751,DTCC00484091,714614,24756
CHEMBL252266,P45452,,IVDMXEGLZLKBRS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,IC50,=,45.71,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258759,DTCC00487212,2068208,24803
CHEMBL252461,P45452,,LFIBBNGLBKGWGV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,IC50,=,5.13,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258756,DTCC00487213,1620402,24803
CHEMBL252462,P45452,,CAPSVCHNNRHIDK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,IC50,=,1,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258781,DTCC00487214,1776499,24803
CHEMBL252463,P45452,,DDVSTKQJONYTTE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,IC50,=,20.89,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258776,DTCC00487215,1329169,24803
CHEMBL252713,P45452,,KFLMLACIMFJTMO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,4.96,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260836,DTCC00486079,1905744,24831
CHEMBL252917,P45452,,YWDVOYCLYDORQI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,5.22,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260835,DTCC00486080,228506,24831
CHEMBL253261,P45452,,APXZBXMVEOBZDS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,IC50,=,3.02,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258644,DTCC00487206,972940,24803
CHEMBL253275,P45452,BMS-566394,PGVYYPZKXKGBLD-JKSUJKDBSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18242982,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.",Bioorg. Med. Chem. Lett.,2008,18,5,"Ott GR, Asakawa N, Lu Z, Anand R, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Trzaskos JM, Duan JJ",,462370,DTCT0024002,2282468,DTCC00003908,392011,25163
CHEMBL253275,P45452,BMS-566394,PGVYYPZKXKGBLD-JKSUJKDBSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18790648,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497406,DTCT0024002,2457234,DTCC00003908,404569,32556
CHEMBL253337,P45452,,VAMOVZICEXQQGW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,5.3,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260802,DTCC00486085,424722,24831
CHEMBL253680,P45452,,LFOGEPKUSWRLCL-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11472202,IC50,=,0.4,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,106478,DTCT0024002,1312044,DTCC00487204,1035283,16328
CHEMBL253680,P45452,,LFOGEPKUSWRLCL-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,IC50,=,0.398,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258654,DTCC00487204,1037850,24803
CHEMBL253680,P45452,,LFOGEPKUSWRLCL-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,0.5,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500573,DTCT0024002,2844318,DTCC00487204,1038436,33635
CHEMBL253680,P45452,,LFOGEPKUSWRLCL-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,11,NM,,,,,,,,,,,,,,Inhibition of MMP13 in presence of 1% bovine serum albumin,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500574,DTCT0024002,2844319,DTCC00487204,1038436,33635
CHEMBL253904,P45452,,MODHAVAUWHEELR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,IC50,=,15.85,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258760,DTCC00487211,2036416,24803
CHEMBL256157,P45452,,PRJCFROAJDAXAD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16220987,KI,=,0.55,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024002,14744860,DTCC00490063,2108850,69259
CHEMBL257088,P45452,,HAPYOOOJPQOLHH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17981034,IC50,=,2.5,NM,,,,,,,,,,,,,,Inhibition of MMP13,,1-Hydroxy-2-pyridinone-based MMP inhibitors: synthesis and biological evaluation for the treatment of ischemic stroke.,Bioorg. Med. Chem. Lett.,2008,18,1,"Zhang YM, Fan X, Chakaravarty D, Xiang B, Scannevin RH, Huang Z, Ma J, Burke SL, Karnachi P, Rhodes KJ, Jackson PF",,469434,DTCT0024002,2289321,DTCC00501372,2068358,25715
CHEMBL257480,P45452,,ISONEAYXNYSTJQ-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17980583,IC50,=,11,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Syntheses and in vitro evaluation of arylsulfone-based MMP inhibitors with heterocycle-derived zinc-binding groups (ZBGs).,Bioorg. Med. Chem. Lett.,2008,18,1,"Zhang YM, Fan X, Yang SM, Scannevin RH, Burke SL, Rhodes KJ, Jackson PF",,469153,DTCT0024002,2289025,DTCC00501865,1873601,25686
CHEMBL260091,P45452,CHIR-090,FQYBTYFKOHPWQT-VGSWGCGISA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25408833,INHIBITION,=,30,%,,,,,,,,,,,,,,Inhibition of MMP13 (unknown origin) at 30 uM,,"Synthesis, Structure, and SAR of Tetrahydropyran-Based LpxC Inhibitors.",ACS Med. Chem. Lett.,2014,5,11,"Murphy-Benenato KE, Olivier N, Choy A, Ross PL, Miller MD, Thresher J, Gao N, Hale MR",,1432688,DTCT0024002,13976529,DTCC00004087,902363,60283
CHEMBL260125,P45452,,DHOGINMHWHECDJ-ZROIWOOFSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25725607,IC50,=,158,NM,,,,,,,,,,,,,,Inhibition of MMP13 catalytic domain (unknown origin) assessed as reduction in hydrolysis of Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 substrate measured for 3 mins after substrate addition by fluorescence assay,,2-Benzisothiazolylimino-5-benzylidene-4-thiazolidinones as protective agents against cartilage destruction.,Bioorg. Med. Chem.,2015,23,7,"Crascì L, Vicini P, Incerti M, Cardile V, Avondo S, Panico A",,1463481,DTCT0024002,14035842,DTCC00495940,1464129,61492
CHEMBL260886,P45452,,MVMPYCDFQNONAY-DHDCSXOGSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25725607,IC50,>=,100000,NM,,,,,,,,,,,,,,Inhibition of MMP13 catalytic domain (unknown origin) assessed as reduction in hydrolysis of Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 substrate measured for 3 mins after substrate addition by fluorescence assay,,2-Benzisothiazolylimino-5-benzylidene-4-thiazolidinones as protective agents against cartilage destruction.,Bioorg. Med. Chem.,2015,23,7,"Crascì L, Vicini P, Incerti M, Cardile V, Avondo S, Panico A",,1463481,DTCT0024002,14035841,DTCC00495908,1431957,61492
CHEMBL261267,P45452,,JWLRMBKRMUREIB-ZROIWOOFSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25725607,IC50,=,55880,NM,,,,,,,,,,,,,,Inhibition of MMP13 catalytic domain (unknown origin) assessed as reduction in hydrolysis of Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 substrate measured for 3 mins after substrate addition by fluorescence assay,,2-Benzisothiazolylimino-5-benzylidene-4-thiazolidinones as protective agents against cartilage destruction.,Bioorg. Med. Chem.,2015,23,7,"Crascì L, Vicini P, Incerti M, Cardile V, Avondo S, Panico A",,1463481,DTCT0024002,14035840,DTCC00495875,1171911,61492
CHEMBL261932,P45452,TANOMASTAT,JXAGDPXECXQWBC-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10669559,KI,=,1470,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13 (MMP-13).,,Protease inhibitors: current status and future prospects.,J. Med. Chem.,2000,43,3,"Leung D, Abbenante G, Fairlie DP",,106612,DTCT0024002,1077308,DTCC00288849,1035816,16063
CHEMBL263054,P45452,,FTFANCIOHXJKDG-YCRPNKLZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12951101,IC50,=,7,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-13.,,Synthesis and biological activity of piperazine-based dual MMP-13 and TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,19,"Letavic MA, Barberia JT, Carty TJ, Hardink JR, Liras J, Lopresti-Morrow LL, Mitchell PG, Noe MC, Reeves LM, Snow SL, Stam EJ, Sweeney FJ, Vaughn ML, Yu CH",,106625,DTCT0024002,663473,DTCC00282962,1392389,5809
CHEMBL263501,P45452,3-BENZENESULFONYL-HEPTANOIC ACID HYDROXYAMIDE,TUUMURVUDGZZQZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10882358,IC50,=,22,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,Hydroxamic acid derivatives as potent peptide deformylase inhibitors and antibacterial agents.,J. Med. Chem.,2000,43,12,"Apfel C, Banner DW, Bur D, Dietz M, Hirata T, Hubschwerlen C, Locher H, Page MG, Pirson W, Rossé G, Specklin JL",,104572,DTCT0024002,560164,DTCC01741124,885373,15751
CHEMBL263909,P45452,,PUFLXTPEEIWEIM-ZROIWOOFSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25725607,IC50,=,25000,NM,,,,,,,,,,,,,,Inhibition of MMP13 catalytic domain (unknown origin) assessed as reduction in hydrolysis of Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 substrate measured for 3 mins after substrate addition by fluorescence assay,,2-Benzisothiazolylimino-5-benzylidene-4-thiazolidinones as protective agents against cartilage destruction.,Bioorg. Med. Chem.,2015,23,7,"Crascì L, Vicini P, Incerti M, Cardile V, Avondo S, Panico A",,1463481,DTCT0024002,14035843,DTCC00495838,1204202,61492
CHEMBL264067,P45452,,HJFONKSERLWIGE-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16153831,IC50,=,2.6,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-13,,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321194,DTCT0024002,1860325,DTCC00407659,855096,19837
CHEMBL264164,P45452,,WFCYAEPJWPWCIM-ZROIWOOFSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25725607,IC50,=,89430,NM,,,,,,,,,,,,,,Inhibition of MMP13 catalytic domain (unknown origin) assessed as reduction in hydrolysis of Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 substrate measured for 3 mins after substrate addition by fluorescence assay,,2-Benzisothiazolylimino-5-benzylidene-4-thiazolidinones as protective agents against cartilage destruction.,Bioorg. Med. Chem.,2015,23,7,"Crascì L, Vicini P, Incerti M, Cardile V, Avondo S, Panico A",,1463481,DTCT0024002,14035837,DTCC00495840,1108532,61492
CHEMBL268050,P45452,,SBJYHMQPQSBUBA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11297453,IC50,=,16900,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-13 in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,106481,DTCT0024002,938138,DTCC00138716,1177786,16645
CHEMBL268050,P45452,,SBJYHMQPQSBUBA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12217355,IC50,=,16982.44,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant human matrix metalloprotease-13,,Analogue based design of MMP-13 (Collagenase-3) inhibitors.,Bioorg. Med. Chem. Lett.,2002,12,19,"Sarma JA, Rambabu G, Srikanth K, Raveendra D, Vithal M",,106465,DTCT0024002,797619,DTCC00138716,1175548,5083
CHEMBL26824,P45452,,XSVPQCFQSHEEQW-BBMPLOMVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10021913,IC50,=,1100,NM,,,,,,,,,,,,,,Inhibition of recombinant Matrix metalloprotease-13 (MMP-13),,Inhibition of MMP-1 and MMP-13 with phosphinic acids that exploit binding in the S2 pocket.,Bioorg. Med. Chem. Lett.,1999,9,2,"Reiter LA, Rizzi JP, Pandit J, Lasut MJ, McGahee SM, Parikh VD, Blake JF, Danley DE, Laird ER, Lopez-Anaya A, Lopresti-Morrow LL, Mansour MN, Martinelli GJ, Mitchell PG, Owens BS, Pauly TA, Reeves LM, Schulte GK, Yocum SA",,106601,DTCT0024002,667010,DTCC00160831,614197,3377
CHEMBL270050,P45452,,YOFJHCFIKFPSLE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18251495,IC50,=,6.72,NM,,,,,,,,,,,,,,Inhibition of human MMP13 catalytic domain,,"Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2008,51,4,"Li JJ, Nahra J, Johnson AR, Bunker A, O'Brien P, Yue WS, Ortwine DF, Man CF, Baragi V, Kilgore K, Dyer RD, Han HK",,465537,DTCT0024002,2311326,DTCC00503704,1636500,25409
CHEMBL270050,P45452,,YOFJHCFIKFPSLE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18251495,IC50,=,30.5,NM,,,,,,,,,,,,,,Inhibition of human MMP13,,"Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2008,51,4,"Li JJ, Nahra J, Johnson AR, Bunker A, O'Brien P, Yue WS, Ortwine DF, Man CF, Baragi V, Kilgore K, Dyer RD, Han HK",,465538,DTCT0024002,2311358,DTCC00503704,1636500,25409
CHEMBL270050,P45452,,YOFJHCFIKFPSLE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18790648,IC50,=,6.72,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497406,DTCT0024002,2457322,DTCC00503704,1632393,32556
CHEMBL270083,P45452,CIS-2-AMINOCYCLOHEXYLCARBAMOYLPHOSPHONIC ACID,XHCXISPZIHYKQD-NTSWFWBYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18257543,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,"Carbamoylphosphonate matrix metalloproteinase inhibitors 6: cis-2-aminocyclohexylcarbamoylphosphonic acid, a novel orally active antimetastatic matrix metalloproteinase-2 selective inhibitor--synthesis and pharmacodynamic and pharmacokinetic analysis.",J. Med. Chem.,2008,51,5,"Hoffman A, Qadri B, Frant J, Katz Y, Bhusare SR, Breuer E, Hadar R, Reich R",,465800,DTCT0024002,2311842,DTCC00004596,2020286,25428
CHEMBL270083,P45452,CIS-2-AMINOCYCLOHEXYLCARBAMOYLPHOSPHONIC ACID,XHCXISPZIHYKQD-NTSWFWBYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18790648,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497406,DTCT0024002,2457399,DTCC00004596,2016157,32556
CHEMBL270296,P45452,TRANS-2-AMINOCYCLOHEXYLCARBAMOYLPHOSPHONIC ACID,XHCXISPZIHYKQD-PHDIDXHHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18257543,IC50,=,55000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,"Carbamoylphosphonate matrix metalloproteinase inhibitors 6: cis-2-aminocyclohexylcarbamoylphosphonic acid, a novel orally active antimetastatic matrix metalloproteinase-2 selective inhibitor--synthesis and pharmacodynamic and pharmacokinetic analysis.",J. Med. Chem.,2008,51,5,"Hoffman A, Qadri B, Frant J, Katz Y, Bhusare SR, Breuer E, Hadar R, Reich R",,465800,DTCT0024002,2311850,DTCC00004597,1151799,25428
CHEMBL270480,P45452,,DOADCMDDDNIBIH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18251495,IC50,=,365,NM,,,,,,,,,,,,,,Inhibition of human MMP13 catalytic domain,,"Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2008,51,4,"Li JJ, Nahra J, Johnson AR, Bunker A, O'Brien P, Yue WS, Ortwine DF, Man CF, Baragi V, Kilgore K, Dyer RD, Han HK",,465537,DTCT0024002,2311329,DTCC00503780,2020281,25409
CHEMBL270480,P45452,,DOADCMDDDNIBIH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18251495,IC50,=,6000,NM,,,,,,,,,,,,,,Inhibition of human MMP13,,"Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2008,51,4,"Li JJ, Nahra J, Johnson AR, Bunker A, O'Brien P, Yue WS, Ortwine DF, Man CF, Baragi V, Kilgore K, Dyer RD, Han HK",,465538,DTCT0024002,2311361,DTCC00503780,2020281,25409
CHEMBL270481,P45452,,ZQVGPQMOIOLUQX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18251495,IC50,=,237,NM,,,,,,,,,,,,,,Inhibition of human MMP13 catalytic domain,,"Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2008,51,4,"Li JJ, Nahra J, Johnson AR, Bunker A, O'Brien P, Yue WS, Ortwine DF, Man CF, Baragi V, Kilgore K, Dyer RD, Han HK",,465537,DTCT0024002,2311328,DTCC00503781,1636499,25409
CHEMBL270481,P45452,,ZQVGPQMOIOLUQX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18251495,IC50,=,3000,NM,,,,,,,,,,,,,,Inhibition of human MMP13,,"Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2008,51,4,"Li JJ, Nahra J, Johnson AR, Bunker A, O'Brien P, Yue WS, Ortwine DF, Man CF, Baragi V, Kilgore K, Dyer RD, Han HK",,465538,DTCT0024002,2311360,DTCC00503781,1636499,25409
CHEMBL270502,P45452,,WMRPTLRLGQOISA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18251495,IC50,=,1.61,NM,,,,,,,,,,,,,,Inhibition of human MMP13 catalytic domain,,"Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2008,51,4,"Li JJ, Nahra J, Johnson AR, Bunker A, O'Brien P, Yue WS, Ortwine DF, Man CF, Baragi V, Kilgore K, Dyer RD, Han HK",,465537,DTCT0024002,2311330,DTCC00503782,1410885,25409
CHEMBL270502,P45452,,WMRPTLRLGQOISA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18251495,IC50,=,11,NM,,,,,,,,,,,,,,Inhibition of human MMP13,,"Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2008,51,4,"Li JJ, Nahra J, Johnson AR, Bunker A, O'Brien P, Yue WS, Ortwine DF, Man CF, Baragi V, Kilgore K, Dyer RD, Han HK",,465538,DTCT0024002,2311362,DTCC00503782,1410885,25409
CHEMBL271148,P45452,,AOWUKXFBPGVBDW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18251495,IC50,=,13.9,NM,,,,,,,,,,,,,,Inhibition of human MMP13 catalytic domain,,"Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2008,51,4,"Li JJ, Nahra J, Johnson AR, Bunker A, O'Brien P, Yue WS, Ortwine DF, Man CF, Baragi V, Kilgore K, Dyer RD, Han HK",,465537,DTCT0024002,2311341,DTCC00503708,1119438,25409
CHEMBL271148,P45452,,AOWUKXFBPGVBDW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18251495,IC50,=,79,NM,,,,,,,,,,,,,,Inhibition of human MMP13,,"Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2008,51,4,"Li JJ, Nahra J, Johnson AR, Bunker A, O'Brien P, Yue WS, Ortwine DF, Man CF, Baragi V, Kilgore K, Dyer RD, Han HK",,465538,DTCT0024002,2311371,DTCC00503708,1119438,25409
CHEMBL271235,P45452,,SIICAQVADMFEDB-LADGPHEKSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18061445,KI,=,490,NM,,,,,,,,,,,,,,Binding affinity to MMP13,,"Alpha,beta-cyclic-beta-benzamido hydroxamic acids: novel templates for the design, synthesis, and evaluation of selective inhibitors of TNF-alpha converting enzyme (TACE).",Bioorg. Med. Chem. Lett.,2008,18,2,"Ott GR, Asakawa N, Lu Z, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Traskos JM, Decicco CP, Duan JJ",,463243,DTCT0024002,2296562,DTCC00502102,1776559,25233
CHEMBL271535,P45452,,BMNQZQLFLYGSKQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18251495,IC50,=,25.3,NM,,,,,,,,,,,,,,Inhibition of human MMP13 catalytic domain,,"Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2008,51,4,"Li JJ, Nahra J, Johnson AR, Bunker A, O'Brien P, Yue WS, Ortwine DF, Man CF, Baragi V, Kilgore K, Dyer RD, Han HK",,465537,DTCT0024002,2311315,DTCC00504011,115644,25409
CHEMBL271535,P45452,,BMNQZQLFLYGSKQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18251495,IC50,=,184,NM,,,,,,,,,,,,,,Inhibition of human MMP13,,"Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2008,51,4,"Li JJ, Nahra J, Johnson AR, Bunker A, O'Brien P, Yue WS, Ortwine DF, Man CF, Baragi V, Kilgore K, Dyer RD, Han HK",,465538,DTCT0024002,2311346,DTCC00504011,115644,25409
CHEMBL271616,P45452,,SDWNOOWGHHPVLB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18251495,IC50,=,75000,NM,,,,,,,,,,,,,,Inhibition of human MMP13 catalytic domain,,"Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2008,51,4,"Li JJ, Nahra J, Johnson AR, Bunker A, O'Brien P, Yue WS, Ortwine DF, Man CF, Baragi V, Kilgore K, Dyer RD, Han HK",,465537,DTCT0024002,2311332,DTCC00503570,957118,25409
CHEMBL271616,P45452,,SDWNOOWGHHPVLB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18251495,IC50,=,100000,NM,,,,,,,,,,,,,,Inhibition of human MMP13,,"Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2008,51,4,"Li JJ, Nahra J, Johnson AR, Bunker A, O'Brien P, Yue WS, Ortwine DF, Man CF, Baragi V, Kilgore K, Dyer RD, Han HK",,465538,DTCT0024002,2311364,DTCC00503570,957118,25409
CHEMBL271866,P45452,,CDYLCTGLLNQEQF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17980583,IC50,=,7.3,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Syntheses and in vitro evaluation of arylsulfone-based MMP inhibitors with heterocycle-derived zinc-binding groups (ZBGs).,Bioorg. Med. Chem. Lett.,2008,18,1,"Zhang YM, Fan X, Yang SM, Scannevin RH, Burke SL, Rhodes KJ, Jackson PF",,469153,DTCT0024002,2289023,DTCC00502114,1103192,25686
CHEMBL271867,P45452,,WKRVNRRBAKSSCD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17980583,IC50,=,13.4,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Syntheses and in vitro evaluation of arylsulfone-based MMP inhibitors with heterocycle-derived zinc-binding groups (ZBGs).,Bioorg. Med. Chem. Lett.,2008,18,1,"Zhang YM, Fan X, Yang SM, Scannevin RH, Burke SL, Rhodes KJ, Jackson PF",,469153,DTCT0024002,2289024,DTCC00502115,1555685,25686
CHEMBL271997,P45452,,ZGZIVDBMQNROFU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18251495,IC50,=,4.24,NM,,,,,,,,,,,,,,Inhibition of human MMP13 catalytic domain,,"Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2008,51,4,"Li JJ, Nahra J, Johnson AR, Bunker A, O'Brien P, Yue WS, Ortwine DF, Man CF, Baragi V, Kilgore K, Dyer RD, Han HK",,465537,DTCT0024002,2311320,DTCC00503569,43807,25409
CHEMBL271997,P45452,,ZGZIVDBMQNROFU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18251495,IC50,=,37,NM,,,,,,,,,,,,,,Inhibition of human MMP13,,"Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2008,51,4,"Li JJ, Nahra J, Johnson AR, Bunker A, O'Brien P, Yue WS, Ortwine DF, Man CF, Baragi V, Kilgore K, Dyer RD, Han HK",,465538,DTCT0024002,2311351,DTCC00503569,43807,25409
CHEMBL272007,P45452,,HQHAWMIMHSUVQD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18251495,IC50,=,2.69,NM,,,,,,,,,,,,,,Inhibition of human MMP13 catalytic domain,,"Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2008,51,4,"Li JJ, Nahra J, Johnson AR, Bunker A, O'Brien P, Yue WS, Ortwine DF, Man CF, Baragi V, Kilgore K, Dyer RD, Han HK",,465537,DTCT0024002,2311318,DTCC00504038,1378442,25409
CHEMBL272007,P45452,,HQHAWMIMHSUVQD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18251495,IC50,=,21.2,NM,,,,,,,,,,,,,,Inhibition of human MMP13,,"Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2008,51,4,"Li JJ, Nahra J, Johnson AR, Bunker A, O'Brien P, Yue WS, Ortwine DF, Man CF, Baragi V, Kilgore K, Dyer RD, Han HK",,465538,DTCT0024002,2311349,DTCC00504038,1378442,25409
CHEMBL272008,P45452,,IEQLIMOSLUGHGD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18251495,IC50,=,16.4,NM,,,,,,,,,,,,,,Inhibition of human MMP13 catalytic domain,,"Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2008,51,4,"Li JJ, Nahra J, Johnson AR, Bunker A, O'Brien P, Yue WS, Ortwine DF, Man CF, Baragi V, Kilgore K, Dyer RD, Han HK",,465537,DTCT0024002,2311317,DTCC00504039,795345,25409
CHEMBL272008,P45452,,IEQLIMOSLUGHGD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18251495,IC50,=,46,NM,,,,,,,,,,,,,,Inhibition of human MMP13,,"Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2008,51,4,"Li JJ, Nahra J, Johnson AR, Bunker A, O'Brien P, Yue WS, Ortwine DF, Man CF, Baragi V, Kilgore K, Dyer RD, Han HK",,465538,DTCT0024002,2311348,DTCC00504039,795345,25409
CHEMBL27213,P45452,,PNXGQJYPAQEZOP-XIJSCUBXSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10021913,IC50,=,2000,NM,,,,,,,,,,,,,,Inhibition of recombinant Matrix metalloprotease-13 (MMP-13),,Inhibition of MMP-1 and MMP-13 with phosphinic acids that exploit binding in the S2 pocket.,Bioorg. Med. Chem. Lett.,1999,9,2,"Reiter LA, Rizzi JP, Pandit J, Lasut MJ, McGahee SM, Parikh VD, Blake JF, Danley DE, Laird ER, Lopez-Anaya A, Lopresti-Morrow LL, Mansour MN, Martinelli GJ, Mitchell PG, Owens BS, Pauly TA, Reeves LM, Schulte GK, Yocum SA",,106601,DTCT0024002,659800,DTCC00160772,743486,3377
CHEMBL272188,P45452,,WGABLHIJVWTAKI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18251495,IC50,=,194,NM,,,,,,,,,,,,,,Inhibition of human MMP13 catalytic domain,,"Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2008,51,4,"Li JJ, Nahra J, Johnson AR, Bunker A, O'Brien P, Yue WS, Ortwine DF, Man CF, Baragi V, Kilgore K, Dyer RD, Han HK",,465537,DTCT0024002,2311335,DTCC00113094,83347,25409
CHEMBL272188,P45452,,WGABLHIJVWTAKI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18251495,IC50,=,100000,NM,,,,,,,,,,,,,,Inhibition of human MMP13,,"Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2008,51,4,"Li JJ, Nahra J, Johnson AR, Bunker A, O'Brien P, Yue WS, Ortwine DF, Man CF, Baragi V, Kilgore K, Dyer RD, Han HK",,465538,DTCT0024002,2311366,DTCC00113094,83347,25409
CHEMBL272245,P45452,,HVWRJWLBELGFOQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18251495,IC50,=,6.12,NM,,,,,,,,,,,,,,Inhibition of human MMP13 catalytic domain,,"Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2008,51,4,"Li JJ, Nahra J, Johnson AR, Bunker A, O'Brien P, Yue WS, Ortwine DF, Man CF, Baragi V, Kilgore K, Dyer RD, Han HK",,465537,DTCT0024002,2311343,DTCC00503747,989478,25409
CHEMBL272245,P45452,,HVWRJWLBELGFOQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18251495,IC50,=,18,NM,,,,,,,,,,,,,,Inhibition of human MMP13,,"Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2008,51,4,"Li JJ, Nahra J, Johnson AR, Bunker A, O'Brien P, Yue WS, Ortwine DF, Man CF, Baragi V, Kilgore K, Dyer RD, Han HK",,465538,DTCT0024002,2311373,DTCC00503747,989478,25409
CHEMBL272246,P45452,,IHAOAKQKZVQAQJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18251495,IC50,=,13.5,NM,,,,,,,,,,,,,,Inhibition of human MMP13 catalytic domain,,"Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2008,51,4,"Li JJ, Nahra J, Johnson AR, Bunker A, O'Brien P, Yue WS, Ortwine DF, Man CF, Baragi V, Kilgore K, Dyer RD, Han HK",,465537,DTCT0024002,2311342,DTCC00503748,1345941,25409
CHEMBL272246,P45452,,IHAOAKQKZVQAQJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18251495,IC50,=,140,NM,,,,,,,,,,,,,,Inhibition of human MMP13,,"Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2008,51,4,"Li JJ, Nahra J, Johnson AR, Bunker A, O'Brien P, Yue WS, Ortwine DF, Man CF, Baragi V, Kilgore K, Dyer RD, Han HK",,465538,DTCT0024002,2311372,DTCC00503748,1345941,25409
CHEMBL272261,P45452,,UHZUYRNSOCKOAW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18251495,IC50,=,31.1,NM,,,,,,,,,,,,,,Inhibition of human MMP13 catalytic domain,,"Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2008,51,4,"Li JJ, Nahra J, Johnson AR, Bunker A, O'Brien P, Yue WS, Ortwine DF, Man CF, Baragi V, Kilgore K, Dyer RD, Han HK",,465537,DTCT0024002,2311314,DTCC00503980,43808,25409
CHEMBL272261,P45452,,UHZUYRNSOCKOAW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18251495,IC50,=,1710,NM,,,,,,,,,,,,,,Inhibition of human MMP13,,"Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2008,51,4,"Li JJ, Nahra J, Johnson AR, Bunker A, O'Brien P, Yue WS, Ortwine DF, Man CF, Baragi V, Kilgore K, Dyer RD, Han HK",,465538,DTCT0024002,2311345,DTCC00503980,43808,25409
CHEMBL272866,P45452,,RHWQBDCMIUUGLN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18251495,IC50,=,63.2,NM,,,,,,,,,,,,,,Inhibition of human MMP13 catalytic domain,,"Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2008,51,4,"Li JJ, Nahra J, Johnson AR, Bunker A, O'Brien P, Yue WS, Ortwine DF, Man CF, Baragi V, Kilgore K, Dyer RD, Han HK",,465537,DTCT0024002,2311338,DTCC00503665,763193,25409
CHEMBL272866,P45452,,RHWQBDCMIUUGLN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18251495,IC50,=,244,NM,,,,,,,,,,,,,,Inhibition of human MMP13,,"Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2008,51,4,"Li JJ, Nahra J, Johnson AR, Bunker A, O'Brien P, Yue WS, Ortwine DF, Man CF, Baragi V, Kilgore K, Dyer RD, Han HK",,465538,DTCT0024002,2311368,DTCC00503665,763193,25409
CHEMBL273054,P45452,,ICGYHHIJQXSEQH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18251495,IC50,=,1.54,NM,,,,,,,,,,,,,,Inhibition of human MMP13 catalytic domain,,"Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2008,51,4,"Li JJ, Nahra J, Johnson AR, Bunker A, O'Brien P, Yue WS, Ortwine DF, Man CF, Baragi V, Kilgore K, Dyer RD, Han HK",,465537,DTCT0024002,2311344,DTCC00503750,731016,25409
CHEMBL273054,P45452,,ICGYHHIJQXSEQH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18251495,IC50,=,9.8,NM,,,,,,,,,,,,,,Inhibition of human MMP13,,"Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2008,51,4,"Li JJ, Nahra J, Johnson AR, Bunker A, O'Brien P, Yue WS, Ortwine DF, Man CF, Baragi V, Kilgore K, Dyer RD, Han HK",,465538,DTCT0024002,2311374,DTCC00503750,731016,25409
CHEMBL273113,P45452,,BKBGPDRYXCHWSD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18251495,IC50,=,3.46,NM,,,,,,,,,,,,,,Inhibition of human MMP13 catalytic domain,,"Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2008,51,4,"Li JJ, Nahra J, Johnson AR, Bunker A, O'Brien P, Yue WS, Ortwine DF, Man CF, Baragi V, Kilgore K, Dyer RD, Han HK",,465537,DTCT0024002,2311322,DTCC00503593,343136,25409
CHEMBL273113,P45452,,BKBGPDRYXCHWSD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18251495,IC50,=,18,NM,,,,,,,,,,,,,,Inhibition of human MMP13,,"Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2008,51,4,"Li JJ, Nahra J, Johnson AR, Bunker A, O'Brien P, Yue WS, Ortwine DF, Man CF, Baragi V, Kilgore K, Dyer RD, Han HK",,465538,DTCT0024002,2311354,DTCC00503593,343136,25409
CHEMBL273114,P45452,,FPXQZXTYXVGUID-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18251495,IC50,=,65000,NM,,,,,,,,,,,,,,Inhibition of human MMP13 catalytic domain,,"Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2008,51,4,"Li JJ, Nahra J, Johnson AR, Bunker A, O'Brien P, Yue WS, Ortwine DF, Man CF, Baragi V, Kilgore K, Dyer RD, Han HK",,465537,DTCT0024002,2311334,DTCC00503595,1021718,25409
CHEMBL273114,P45452,,FPXQZXTYXVGUID-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18251495,IC50,=,100000,NM,,,,,,,,,,,,,,Inhibition of human MMP13,,"Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2008,51,4,"Li JJ, Nahra J, Johnson AR, Bunker A, O'Brien P, Yue WS, Ortwine DF, Man CF, Baragi V, Kilgore K, Dyer RD, Han HK",,465538,DTCT0024002,2311365,DTCC00503595,1021718,25409
CHEMBL273764,P45452,,IHKCSGLIRGMLDE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11934587,IC50,=,68,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,Anthranilate sulfonamide hydroxamate TACE inhibitors. Part 1: Structure-based design of novel acetylenic P1' groups.,Bioorg. Med. Chem. Lett.,2002,12,8,"Chen JM, Jin G, Sung A, Levin JI",,106633,DTCT0024002,1100881,DTCC00149694,1405954,5358
CHEMBL273764,P45452,,IHKCSGLIRGMLDE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11934588,IC50,=,68,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 activity,,Anthranilate sulfonamide hydroxamate TACE inhibitors. Part 2: SAR of the acetylenic P1' group.,Bioorg. Med. Chem. Lett.,2002,12,8,"Levin JI, Chen JM, Du MT, Nelson FC, Killar LM, Skala S, Sung A, Jin G, Cowling R, Barone D, March CJ, Mohler KM, Black RA, Skotnicki JS",,106622,DTCT0024002,811554,DTCC00149694,1390919,5465
CHEMBL274174,P45452,,LFQCQDFQXKNBRD-OCOZRVBESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11297453,IC50,=,498,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-13 at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,106463,DTCT0024002,954773,DTCC00138502,952175,16645
CHEMBL274174,P45452,,LFQCQDFQXKNBRD-OCOZRVBESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12217355,IC50,=,489.78,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant human matrix metalloprotease-13,,Analogue based design of MMP-13 (Collagenase-3) inhibitors.,Bioorg. Med. Chem. Lett.,2002,12,19,"Sarma JA, Rambabu G, Srikanth K, Raveendra D, Vithal M",,106465,DTCT0024002,776571,DTCC00138502,949836,5083
CHEMBL27439,P45452,,JSOUFOXMENBKFM-AMVUTOCUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10021913,IC50,=,110,NM,,,,,,,,,,,,,,Inhibition of recombinant Matrix metalloprotease-13 (MMP-13),,Inhibition of MMP-1 and MMP-13 with phosphinic acids that exploit binding in the S2 pocket.,Bioorg. Med. Chem. Lett.,1999,9,2,"Reiter LA, Rizzi JP, Pandit J, Lasut MJ, McGahee SM, Parikh VD, Blake JF, Danley DE, Laird ER, Lopez-Anaya A, Lopresti-Morrow LL, Mansour MN, Martinelli GJ, Mitchell PG, Owens BS, Pauly TA, Reeves LM, Schulte GK, Yocum SA",,106601,DTCT0024002,675664,DTCC00160799,873243,3377
CHEMBL274881,P45452,,QJKGJGURDPRKGW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11297453,IC50,=,76,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-13 in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,106481,DTCT0024002,948299,DTCC00138736,855707,16645
CHEMBL274881,P45452,,QJKGJGURDPRKGW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12217355,IC50,=,75.86,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant human matrix metalloprotease-13,,Analogue based design of MMP-13 (Collagenase-3) inhibitors.,Bioorg. Med. Chem. Lett.,2002,12,19,"Sarma JA, Rambabu G, Srikanth K, Raveendra D, Vithal M",,106465,DTCT0024002,786586,DTCC00138736,853339,5083
CHEMBL274997,P45452,,PSKXAYSNQRZKIG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11297453,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-13 in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,106481,DTCT0024002,965336,DTCC00138499,1949639,16645
CHEMBL275053,P45452,,ZIMPTCJSUZVWEK-IEBWSBKVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15324896,IC50,=,0.43,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 13,,3-Hydroxy-4-arylsulfonyltetrahydropyranyl-3-hydroxamic acids are novel inhibitors of MMP-13 and aggrecanase.,Bioorg. Med. Chem. Lett.,2004,14,18,"Noe MC, Snow SL, Wolf-Gouveia LA, Mitchell PG, Lopresti-Morrow L, Reeves LM, Yocum SA, Liras JL, Vaughn M",,305094,DTCT0024002,1769506,DTCC00388321,304750,18227
CHEMBL275130,P45452,,NJHUORLPMNSFLB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11297453,IC50,=,50,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-13 in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,106481,DTCT0024002,949524,DTCC00138690,305534,16645
CHEMBL275130,P45452,,NJHUORLPMNSFLB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12217355,IC50,=,48.98,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant human matrix metalloprotease-13,,Analogue based design of MMP-13 (Collagenase-3) inhibitors.,Bioorg. Med. Chem. Lett.,2002,12,19,"Sarma JA, Rambabu G, Srikanth K, Raveendra D, Vithal M",,106465,DTCT0024002,797618,DTCC00138690,303187,5083
CHEMBL275345,P45452,,LRNHIFFROICLCJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11297453,IC50,=,2780,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-13 in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,106481,DTCT0024002,975199,DTCC00138682,1502499,16645
CHEMBL275345,P45452,,LRNHIFFROICLCJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12217355,IC50,=,2754.23,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant human matrix metalloprotease-13,,Analogue based design of MMP-13 (Collagenase-3) inhibitors.,Bioorg. Med. Chem. Lett.,2002,12,19,"Sarma JA, Rambabu G, Srikanth K, Raveendra D, Vithal M",,106465,DTCT0024002,783794,DTCC00138682,1500103,5083
CHEMBL275700,P45452,,ZZBMCFITYYSQSJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11297453,IC50,=,226,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-13 in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,106481,DTCT0024002,939400,DTCC00138634,1437792,16645
CHEMBL275700,P45452,,ZZBMCFITYYSQSJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12217355,IC50,=,223.87,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant human matrix metalloprotease-13,,Analogue based design of MMP-13 (Collagenase-3) inhibitors.,Bioorg. Med. Chem. Lett.,2002,12,19,"Sarma JA, Rambabu G, Srikanth K, Raveendra D, Vithal M",,106465,DTCT0024002,785216,DTCC00138634,1435423,5083
CHEMBL275754,P45452,,ZJBLIILJIFWDHP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11297453,IC50,=,3050,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-13 in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,106481,DTCT0024002,953646,DTCC00138683,596814,16645
CHEMBL275754,P45452,,ZJBLIILJIFWDHP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12217355,IC50,=,3019.95,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant human matrix metalloprotease-13,,Analogue based design of MMP-13 (Collagenase-3) inhibitors.,Bioorg. Med. Chem. Lett.,2002,12,19,"Sarma JA, Rambabu G, Srikanth K, Raveendra D, Vithal M",,106465,DTCT0024002,780891,DTCC00138683,594451,5083
CHEMBL276016,P45452,,TYFXGYABSVUPRB-IDCGIGBZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11297453,IC50,=,14,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-13 in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,106481,DTCT0024002,969198,DTCC00138586,1437793,16645
CHEMBL276016,P45452,,TYFXGYABSVUPRB-IDCGIGBZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12217355,IC50,=,14.13,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant human matrix metalloprotease-13,,Analogue based design of MMP-13 (Collagenase-3) inhibitors.,Bioorg. Med. Chem. Lett.,2002,12,19,"Sarma JA, Rambabu G, Srikanth K, Raveendra D, Vithal M",,106465,DTCT0024002,785214,DTCC00138586,1435422,5083
CHEMBL276086,P45452,,IVMSMXBRUPDONM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11934588,INHIBITION,=,48,%,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 at 1 uM,,Anthranilate sulfonamide hydroxamate TACE inhibitors. Part 2: SAR of the acetylenic P1' group.,Bioorg. Med. Chem. Lett.,2002,12,8,"Levin JI, Chen JM, Du MT, Nelson FC, Killar LM, Skala S, Sung A, Jin G, Cowling R, Barone D, March CJ, Mohler KM, Black RA, Skotnicki JS",,106765,DTCT0024002,790609,DTCC00150697,1902110,5465
CHEMBL276119,P45452,,LCQNQVIUMDNDJS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773042,IC50,=,2,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13.,,"Synthesis and structure-activity relationship of N-substituted 4-arylsulfonylpiperidine-4-hydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Davis JM, Grosu GT, Baker J, Ellingboe J, Zask A, Levin JI, Sandanayaka VP, Du M, Skotnicki JS, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R, Tillett J, Zhao W, McDevitt J, Xu ZB",,106632,DTCT0024002,477845,DTCC00235150,368245,17340
CHEMBL276119,P45452,,LCQNQVIUMDNDJS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,5.7,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260833,DTCC00235150,359219,24831
CHEMBL276275,P45452,,XDKNQAWYSUZUDU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11934588,IC50,=,908,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 activity,,Anthranilate sulfonamide hydroxamate TACE inhibitors. Part 2: SAR of the acetylenic P1' group.,Bioorg. Med. Chem. Lett.,2002,12,8,"Levin JI, Chen JM, Du MT, Nelson FC, Killar LM, Skala S, Sung A, Jin G, Cowling R, Barone D, March CJ, Mohler KM, Black RA, Skotnicki JS",,106622,DTCT0024002,779302,DTCC00150731,1741081,5465
CHEMBL27647,P45452,,ROFAQOFULLWONA-KEKNWZKVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10021913,IC50,=,300,NM,,,,,,,,,,,,,,Inhibition of recombinant Matrix metalloprotease-13 (MMP-13),,Inhibition of MMP-1 and MMP-13 with phosphinic acids that exploit binding in the S2 pocket.,Bioorg. Med. Chem. Lett.,1999,9,2,"Reiter LA, Rizzi JP, Pandit J, Lasut MJ, McGahee SM, Parikh VD, Blake JF, Danley DE, Laird ER, Lopez-Anaya A, Lopresti-Morrow LL, Mansour MN, Martinelli GJ, Mitchell PG, Owens BS, Pauly TA, Reeves LM, Schulte GK, Yocum SA",,106601,DTCT0024002,656096,DTCC00160735,2000042,3377
CHEMBL277206,P45452,,WZCXPYXIESDPBM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11934588,IC50,=,2377,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 activity,,Anthranilate sulfonamide hydroxamate TACE inhibitors. Part 2: SAR of the acetylenic P1' group.,Bioorg. Med. Chem. Lett.,2002,12,8,"Levin JI, Chen JM, Du MT, Nelson FC, Killar LM, Skala S, Sung A, Jin G, Cowling R, Barone D, March CJ, Mohler KM, Black RA, Skotnicki JS",,106622,DTCT0024002,792070,DTCC00150705,63360,5465
CHEMBL278060,P45452,,JMJKKHVSMQBPSU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11934587,IC50,=,52,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,Anthranilate sulfonamide hydroxamate TACE inhibitors. Part 1: Structure-based design of novel acetylenic P1' groups.,Bioorg. Med. Chem. Lett.,2002,12,8,"Chen JM, Jin G, Sung A, Levin JI",,106633,DTCT0024002,1115326,DTCC00150237,919845,5358
CHEMBL278060,P45452,,JMJKKHVSMQBPSU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11934588,IC50,=,52,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 activity,,Anthranilate sulfonamide hydroxamate TACE inhibitors. Part 2: SAR of the acetylenic P1' group.,Bioorg. Med. Chem. Lett.,2002,12,8,"Levin JI, Chen JM, Du MT, Nelson FC, Killar LM, Skala S, Sung A, Jin G, Cowling R, Barone D, March CJ, Mohler KM, Black RA, Skotnicki JS",,106622,DTCT0024002,788939,DTCC00150237,905437,5465
CHEMBL278060,P45452,,JMJKKHVSMQBPSU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12951101,IC50,=,113,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-13.,,Synthesis and biological activity of piperazine-based dual MMP-13 and TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,19,"Letavic MA, Barberia JT, Carty TJ, Hardink JR, Liras J, Lopresti-Morrow LL, Mitchell PG, Noe MC, Reeves LM, Snow SL, Stam EJ, Sweeney FJ, Vaughn ML, Yu CH",,106625,DTCT0024002,668197,DTCC00150237,906999,5809
CHEMBL278366,P45452,,XHQJYOVRCNEYKT-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11354379,IC50,=,1590,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,Design and synthesis of 2-oxo-imidazolidine-4-carboxylic acid hydroxyamides as potent matrix metalloproteinase-13 inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,9,"Robinson RP, Laird ER, Donahue KM, Lopresti-Morrow LL, Mitchell PG, Reese MR, Reeves LM, Rouch AI, Stam EJ, Yocum SA",,106643,DTCT0024002,717515,DTCC00152003,711034,4814
CHEMBL278368,P45452,,CNFIFPZUBUFKIB-LSDHHAIUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10882354,IC50,=,4760,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,Structure-based design and synthesis of a potent matrix metalloproteinase-13 inhibitor based on a pyrrolidinone scaffold.,J. Med. Chem.,2000,43,12,"Robinson RP, Laird ER, Blake JF, Bordner J, Donahue KM, Lopresti-Morrow LL, Mitchell PG, Reese MR, Reeves LM, Stam EJ, Yocum SA",,106624,DTCT0024002,1130313,DTCC00152005,1785351,15747
CHEMBL278368,P45452,,CNFIFPZUBUFKIB-LSDHHAIUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11354379,IC50,=,4760,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,Design and synthesis of 2-oxo-imidazolidine-4-carboxylic acid hydroxyamides as potent matrix metalloproteinase-13 inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,9,"Robinson RP, Laird ER, Donahue KM, Lopresti-Morrow LL, Mitchell PG, Reese MR, Reeves LM, Rouch AI, Stam EJ, Yocum SA",,106643,DTCT0024002,715157,DTCC00152005,1772878,4814
CHEMBL278872,P45452,,ZLSOXSXSNCNKSX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11934588,IC50,=,5,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 activity,,Anthranilate sulfonamide hydroxamate TACE inhibitors. Part 2: SAR of the acetylenic P1' group.,Bioorg. Med. Chem. Lett.,2002,12,8,"Levin JI, Chen JM, Du MT, Nelson FC, Killar LM, Skala S, Sung A, Jin G, Cowling R, Barone D, March CJ, Mohler KM, Black RA, Skotnicki JS",,106622,DTCT0024002,777955,DTCC00150719,1934080,5465
CHEMBL279176,P45452,,XGSYUAINDUGIHK-OAHLLOKOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11354379,IC50,=,331,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,Design and synthesis of 2-oxo-imidazolidine-4-carboxylic acid hydroxyamides as potent matrix metalloproteinase-13 inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,9,"Robinson RP, Laird ER, Donahue KM, Lopresti-Morrow LL, Mitchell PG, Reese MR, Reeves LM, Rouch AI, Stam EJ, Yocum SA",,106643,DTCT0024002,694598,DTCC00151397,1902123,4814
CHEMBL279482,P45452,,TUIHSDQRXNNCLL-LSDHHAIUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10882354,IC50,=,7,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,Structure-based design and synthesis of a potent matrix metalloproteinase-13 inhibitor based on a pyrrolidinone scaffold.,J. Med. Chem.,2000,43,12,"Robinson RP, Laird ER, Blake JF, Bordner J, Donahue KM, Lopresti-Morrow LL, Mitchell PG, Reese MR, Reeves LM, Stam EJ, Yocum SA",,106624,DTCT0024002,1106730,DTCC00152021,140588,15747
CHEMBL279482,P45452,,TUIHSDQRXNNCLL-LSDHHAIUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11354379,IC50,=,7,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,Design and synthesis of 2-oxo-imidazolidine-4-carboxylic acid hydroxyamides as potent matrix metalloproteinase-13 inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,9,"Robinson RP, Laird ER, Donahue KM, Lopresti-Morrow LL, Mitchell PG, Reese MR, Reeves LM, Rouch AI, Stam EJ, Yocum SA",,106643,DTCT0024002,703846,DTCC00152021,128005,4814
CHEMBL279785,P45452,MARIMASTAT,OCSMOTCMPXTDND-OUAUKWLOSA-N,3,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10397503,IC50,=,3.5,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,"Picking the S1, S1' and S2' pockets of matrix metalloproteinases. A niche for potent acyclic sulfonamide inhibitors.",Bioorg. Med. Chem. Lett.,1999,9,12,"Hanessian S, Bouzbouz S, Boudon A, Tucker GC, Peyroulan D",,101903,DTCT0024002,513409,DTCC00151612,905843,3181
CHEMBL279785,P45452,MARIMASTAT,OCSMOTCMPXTDND-OUAUKWLOSA-N,3,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10522712,IC50,=,2,NM,,,,,,,,,,,,,,Inhibition of Coll-3 MMP-13,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,101904,DTCT0024002,1478662,DTCC00151612,917406,3373
CHEMBL279785,P45452,MARIMASTAT,OCSMOTCMPXTDND-OUAUKWLOSA-N,3,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11133099,IC50,=,2,NM,,,,,,,,,,,,,,50 percent inhibition of human Matrix metalloprotease-13 by the cleavage of fluorogenic peptide MCA-Pro-Leu-Gly-Leu-Dpa-ala-Arg-NH2,,Synthesis and activity of selective MMP inhibitors with an aryl backbone.,Bioorg. Med. Chem. Lett.,2000,10,24,"Barta TE, Becker DP, Bedell LJ, De Crescenzo GA, McDonald JJ, Munie GE, Rao S, Shieh HS, Stegeman R, Stevens AM, Villamil CI",,106604,DTCT0024002,723514,DTCC00151612,906713,3985
CHEMBL279785,P45452,MARIMASTAT,OCSMOTCMPXTDND-OUAUKWLOSA-N,3,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11212095,IC50,=,3.4,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,General synthesis of alpha-substituted 3-bisaryloxy propionic acid derivatives as specific MMP inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,3,"Chollet AM, Le Diguarher T, Murray L, Bertrand M, Tucker GC, Sabatini M, Pierré A, Atassi G, Bonnet J, Casara P",,106483,DTCT0024002,627894,DTCC00151612,906831,4635
CHEMBL279785,P45452,MARIMASTAT,OCSMOTCMPXTDND-OUAUKWLOSA-N,3,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11549451,ACTIVITY,=,2,NM,,,,,,,,,,,,,,Inhibitory activity against human Matrix metalloprotease-13,,"Selective, orally active MMP inhibitors with an aryl backbone.",Bioorg. Med. Chem. Lett.,2001,11,18,"Barta TE, Becker DP, Bedell LJ, De Crescenzo GA, McDonald JJ, Mehta P, Munie GE, Villamil CI",,106466,DTCT0024002,1673844,DTCC00151612,917130,4449
CHEMBL279785,P45452,MARIMASTAT,OCSMOTCMPXTDND-OUAUKWLOSA-N,3,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11591510,IC50,=,2,NM,,,,,,,,,,,,,,Inhibitory activity against human Matrix metalloprotease-13,,alpha-Alkyl-alpha-amino-beta-sulphone hydroxamates as potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2001,11,20,"Becker DP, DeCrescenzo G, Freskos J, Getman DP, Hockerman SL, Li M, Mehta P, Munie GE, Swearingen C",,106599,DTCT0024002,1080729,DTCC00151612,917285,4541
CHEMBL279785,P45452,MARIMASTAT,OCSMOTCMPXTDND-OUAUKWLOSA-N,3,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11754593,IC50,=,1.2,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 (MMP-13) in fluorimetric assay,,"Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitors.",J. Med. Chem.,2002,45,1,"Wada CK, Holms JH, Curtin ML, Dai Y, Florjancic AS, Garland RB, Guo Y, Heyman HR, Stacey JR, Steinman DH, Albert DH, Bouska JJ, Elmore IN, Goodfellow CL, Marcotte PA, Tapang P, Morgan DW, Michaelides MR, Davidsen SK",,106639,DTCT0024002,1580595,DTCC00151612,906350,16699
CHEMBL279785,P45452,MARIMASTAT,OCSMOTCMPXTDND-OUAUKWLOSA-N,3,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12930146,IC50,=,3.4,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP13),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,106606,DTCT0024002,516915,DTCC00151612,917874,13726
CHEMBL279786,P45452,BATIMASTAT,XFILPEOLDIKJHX-QYZOEREBSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12877590,IC50,=,5,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,"A potent, selective inhibitor of matrix metalloproteinase-3 for the topical treatment of chronic dermal ulcers.",J. Med. Chem.,2003,46,16,"Fray MJ, Dickinson RP, Huggins JP, Occleston NL",,106471,DTCT0024002,1526048,DTCC00151611,970901,17445
CHEMBL28170,P45452,,KATBPZLMXQIZLF-BBMPLOMVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10021913,IC50,=,180,NM,,,,,,,,,,,,,,Inhibition of recombinant Matrix metalloprotease-13 (MMP-13),,Inhibition of MMP-1 and MMP-13 with phosphinic acids that exploit binding in the S2 pocket.,Bioorg. Med. Chem. Lett.,1999,9,2,"Reiter LA, Rizzi JP, Pandit J, Lasut MJ, McGahee SM, Parikh VD, Blake JF, Danley DE, Laird ER, Lopez-Anaya A, Lopresti-Morrow LL, Mansour MN, Martinelli GJ, Mitchell PG, Owens BS, Pauly TA, Reeves LM, Schulte GK, Yocum SA",,106601,DTCT0024002,681968,DTCC00160737,517604,3377
CHEMBL282004,P45452,,JFRAGUOIAHJTOM-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11354379,IC50,=,825,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,Design and synthesis of 2-oxo-imidazolidine-4-carboxylic acid hydroxyamides as potent matrix metalloproteinase-13 inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,9,"Robinson RP, Laird ER, Donahue KM, Lopresti-Morrow LL, Mitchell PG, Reese MR, Reeves LM, Rouch AI, Stam EJ, Yocum SA",,106643,DTCT0024002,729571,DTCC00151395,290351,4814
CHEMBL282466,P45452,,WNJWSNXIZOSCTK-RDFOUATCSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10021913,IC50,=,30,NM,,,,,,,,,,,,,,Inhibition of recombinant Matrix metalloprotease-13 (MMP-13),,Inhibition of MMP-1 and MMP-13 with phosphinic acids that exploit binding in the S2 pocket.,Bioorg. Med. Chem. Lett.,1999,9,2,"Reiter LA, Rizzi JP, Pandit J, Lasut MJ, McGahee SM, Parikh VD, Blake JF, Danley DE, Laird ER, Lopez-Anaya A, Lopresti-Morrow LL, Mansour MN, Martinelli GJ, Mitchell PG, Owens BS, Pauly TA, Reeves LM, Schulte GK, Yocum SA",,106601,DTCT0024002,678099,DTCC00161044,451896,3377
CHEMBL283064,P45452,,SMXPIECMTBWEDK-AMVUTOCUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10021913,IC50,>,3000,NM,,,,,,,,,,,,,,Inhibition of recombinant Matrix metalloprotease-13 (MMP-13),,Inhibition of MMP-1 and MMP-13 with phosphinic acids that exploit binding in the S2 pocket.,Bioorg. Med. Chem. Lett.,1999,9,2,"Reiter LA, Rizzi JP, Pandit J, Lasut MJ, McGahee SM, Parikh VD, Blake JF, Danley DE, Laird ER, Lopez-Anaya A, Lopresti-Morrow LL, Mansour MN, Martinelli GJ, Mitchell PG, Owens BS, Pauly TA, Reeves LM, Schulte GK, Yocum SA",,106601,DTCT0024002,681970,DTCC00161424,1162876,3377
CHEMBL283580,P45452,,NBBPYGNNDFCNNP-OAHLLOKOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11354379,IC50,=,3,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,Design and synthesis of 2-oxo-imidazolidine-4-carboxylic acid hydroxyamides as potent matrix metalloproteinase-13 inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,9,"Robinson RP, Laird ER, Donahue KM, Lopresti-Morrow LL, Mitchell PG, Reese MR, Reeves LM, Rouch AI, Stam EJ, Yocum SA",,106643,DTCT0024002,696879,DTCC00151925,1066552,4814
CHEMBL28389,P45452,,UTSFQPTVPZNJJH-XIJSCUBXSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10021913,IC50,=,14,NM,,,,,,,,,,,,,,Inhibition of recombinant Matrix metalloprotease-13 (MMP-13),,Inhibition of MMP-1 and MMP-13 with phosphinic acids that exploit binding in the S2 pocket.,Bioorg. Med. Chem. Lett.,1999,9,2,"Reiter LA, Rizzi JP, Pandit J, Lasut MJ, McGahee SM, Parikh VD, Blake JF, Danley DE, Laird ER, Lopez-Anaya A, Lopresti-Morrow LL, Mansour MN, Martinelli GJ, Mitchell PG, Owens BS, Pauly TA, Reeves LM, Schulte GK, Yocum SA",,106601,DTCT0024002,668161,DTCC00160701,2210,3377
CHEMBL283912,P45452,,LQDHQVJPGDBOJR-CPRJBALCSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10021913,IC50,=,1600,NM,,,,,,,,,,,,,,Inhibition of recombinant Matrix metalloprotease-13 (MMP-13),,Inhibition of MMP-1 and MMP-13 with phosphinic acids that exploit binding in the S2 pocket.,Bioorg. Med. Chem. Lett.,1999,9,2,"Reiter LA, Rizzi JP, Pandit J, Lasut MJ, McGahee SM, Parikh VD, Blake JF, Danley DE, Laird ER, Lopez-Anaya A, Lopresti-Morrow LL, Mansour MN, Martinelli GJ, Mitchell PG, Owens BS, Pauly TA, Reeves LM, Schulte GK, Yocum SA",,106601,DTCT0024002,670650,DTCC00160773,1713010,3377
CHEMBL285546,P45452,,ZYBCZOFEUHHWME-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12668018,IC50,=,3,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease 13 (MMP-13).,,Synthesis and SAR of bicyclic heteroaryl hydroxamic acid MMP and TACE inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,8,"Zask A, Gu Y, Albright JD, Du X, Hogan M, Levin JI, Chen JM, Killar LM, Sung A, DiJoseph JF, Sharr MA, Roth CE, Skala S, Jin G, Cowling R, Mohler KM, Barone D, Black R, March C, Skotnicki JS",,106642,DTCT0024002,1283659,DTCC00174861,529217,6276
CHEMBL28646,P45452,,RIYWMJMELHHCTR-KBXCAEBGSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15324896,IC50,=,12,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 13,,3-Hydroxy-4-arylsulfonyltetrahydropyranyl-3-hydroxamic acids are novel inhibitors of MMP-13 and aggrecanase.,Bioorg. Med. Chem. Lett.,2004,14,18,"Noe MC, Snow SL, Wolf-Gouveia LA, Mitchell PG, Lopresti-Morrow L, Reeves LM, Yocum SA, Liras JL, Vaughn M",,305094,DTCT0024002,1768401,DTCC00165671,1274770,18227
CHEMBL286848,P45452,,YMQBLRHAACUVFH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12668018,IC50,=,1,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease 13 (MMP-13).,,Synthesis and SAR of bicyclic heteroaryl hydroxamic acid MMP and TACE inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,8,"Zask A, Gu Y, Albright JD, Du X, Hogan M, Levin JI, Chen JM, Killar LM, Sung A, DiJoseph JF, Sharr MA, Roth CE, Skala S, Jin G, Cowling R, Mohler KM, Barone D, Black R, March C, Skotnicki JS",,106642,DTCT0024002,1268996,DTCC00173911,884761,6276
CHEMBL287820,P45452,,NVQUYHFBHXGQLL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12668018,IC50,=,1,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease 13 (MMP-13).,,Synthesis and SAR of bicyclic heteroaryl hydroxamic acid MMP and TACE inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,8,"Zask A, Gu Y, Albright JD, Du X, Hogan M, Levin JI, Chen JM, Killar LM, Sung A, DiJoseph JF, Sharr MA, Roth CE, Skala S, Jin G, Cowling R, Mohler KM, Barone D, Black R, March C, Skotnicki JS",,106642,DTCT0024002,1273423,DTCC00174306,1143540,6276
CHEMBL287823,P45452,,RPOHBDSRTDJNFN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12668018,IC50,=,7,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease 13 (MMP-13).,,Synthesis and SAR of bicyclic heteroaryl hydroxamic acid MMP and TACE inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,8,"Zask A, Gu Y, Albright JD, Du X, Hogan M, Levin JI, Chen JM, Killar LM, Sung A, DiJoseph JF, Sharr MA, Roth CE, Skala S, Jin G, Cowling R, Mohler KM, Barone D, Black R, March C, Skotnicki JS",,106642,DTCT0024002,1265564,DTCC00174719,626110,6276
CHEMBL287871,P45452,,RAOAFDPXSFVLJD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12668018,IC50,=,1,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease 13 (MMP-13).,,Synthesis and SAR of bicyclic heteroaryl hydroxamic acid MMP and TACE inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,8,"Zask A, Gu Y, Albright JD, Du X, Hogan M, Levin JI, Chen JM, Killar LM, Sung A, DiJoseph JF, Sharr MA, Roth CE, Skala S, Jin G, Cowling R, Mohler KM, Barone D, Black R, March C, Skotnicki JS",,106642,DTCT0024002,1272315,DTCC00173934,1304975,6276
CHEMBL287885,P45452,,FBPORLJZYBBNBL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10915056,IC50,=,5100,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,Difluoroketones as inhibitors of matrix metalloprotease-13.,Bioorg. Med. Chem. Lett.,2000,10,14,"Reiter LA, Martinelli GJ, Reeves LA, Mitchell PG",,106764,DTCT0024002,1504098,DTCC00181445,497195,3800
CHEMBL288670,P45452,,TVRLHUWRJSTBAB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12668018,IC50,=,2,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease 13 (MMP-13).,,Synthesis and SAR of bicyclic heteroaryl hydroxamic acid MMP and TACE inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,8,"Zask A, Gu Y, Albright JD, Du X, Hogan M, Levin JI, Chen JM, Killar LM, Sung A, DiJoseph JF, Sharr MA, Roth CE, Skala S, Jin G, Cowling R, Mohler KM, Barone D, Black R, March C, Skotnicki JS",,106642,DTCT0024002,1251300,DTCC00174680,948997,6276
CHEMBL288671,P45452,,DWBZTKJXPJGGSU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12668018,IC50,=,9,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease 13 (MMP-13).,,Synthesis and SAR of bicyclic heteroaryl hydroxamic acid MMP and TACE inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,8,"Zask A, Gu Y, Albright JD, Du X, Hogan M, Levin JI, Chen JM, Killar LM, Sung A, DiJoseph JF, Sharr MA, Roth CE, Skala S, Jin G, Cowling R, Mohler KM, Barone D, Black R, March C, Skotnicki JS",,106642,DTCT0024002,1258314,DTCC00174681,1563605,6276
CHEMBL289222,P45452,,UICCGUSKKDLVIN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12668018,IC50,=,100,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease 13 (MMP-13).,,Synthesis and SAR of bicyclic heteroaryl hydroxamic acid MMP and TACE inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,8,"Zask A, Gu Y, Albright JD, Du X, Hogan M, Levin JI, Chen JM, Killar LM, Sung A, DiJoseph JF, Sharr MA, Roth CE, Skala S, Jin G, Cowling R, Mohler KM, Barone D, Black R, March C, Skotnicki JS",,106642,DTCT0024002,1283667,DTCC00174370,1402621,6276
CHEMBL289411,P45452,,JFQFSHSHMHJPSW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12668018,IC50,=,26,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease 13 (MMP-13).,,Synthesis and SAR of bicyclic heteroaryl hydroxamic acid MMP and TACE inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,8,"Zask A, Gu Y, Albright JD, Du X, Hogan M, Levin JI, Chen JM, Killar LM, Sung A, DiJoseph JF, Sharr MA, Roth CE, Skala S, Jin G, Cowling R, Mohler KM, Barone D, Black R, March C, Skotnicki JS",,106642,DTCT0024002,1260702,DTCC00174594,464135,6276
CHEMBL289604,P45452,,DCZIFTAWIUHEEC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12668018,IC50,=,50,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease 13 (MMP-13).,,Synthesis and SAR of bicyclic heteroaryl hydroxamic acid MMP and TACE inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,8,"Zask A, Gu Y, Albright JD, Du X, Hogan M, Levin JI, Chen JM, Killar LM, Sung A, DiJoseph JF, Sharr MA, Roth CE, Skala S, Jin G, Cowling R, Mohler KM, Barone D, Black R, March C, Skotnicki JS",,106642,DTCT0024002,1283663,DTCC00174383,107527,6276
CHEMBL289619,P45452,,JETKDBIGPHPOQN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10915056,IC50,>>,30000,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,Difluoroketones as inhibitors of matrix metalloprotease-13.,Bioorg. Med. Chem. Lett.,2000,10,14,"Reiter LA, Martinelli GJ, Reeves LA, Mitchell PG",,106764,DTCT0024002,1488369,DTCC00181443,658521,3800
CHEMBL290377,P45452,,UTSFQPTVPZNJJH-YPJJGMIRSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10915056,IC50,=,14,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,Difluoroketones as inhibitors of matrix metalloprotease-13.,Bioorg. Med. Chem. Lett.,2000,10,14,"Reiter LA, Martinelli GJ, Reeves LA, Mitchell PG",,106764,DTCT0024002,1487339,DTCC00181446,852563,3800
CHEMBL290377,P45452,,UTSFQPTVPZNJJH-YPJJGMIRSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12824028,IC50,=,21,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13,,Phosphinic acid-based MMP-13 inhibitors that spare MMP-1 and MMP-3.,Bioorg. Med. Chem. Lett.,2003,13,14,"Reiter LA, Mitchell PG, Martinelli GJ, Lopresti-Morrow LL, Yocum SA, Eskra JD",,106640,DTCT0024002,1488307,DTCC00181446,853101,5648
CHEMBL290948,P45452,,OMMFNEZCURCLPN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12668018,IC50,=,4,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease 13 (MMP-13).,,Synthesis and SAR of bicyclic heteroaryl hydroxamic acid MMP and TACE inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,8,"Zask A, Gu Y, Albright JD, Du X, Hogan M, Levin JI, Chen JM, Killar LM, Sung A, DiJoseph JF, Sharr MA, Roth CE, Skala S, Jin G, Cowling R, Mohler KM, Barone D, Black R, March C, Skotnicki JS",,106642,DTCT0024002,1282471,DTCC00174557,172191,6276
CHEMBL290952,P45452,,JRKVJTDYMGJJAK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12668018,IC50,=,4,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease 13 (MMP-13).,,Synthesis and SAR of bicyclic heteroaryl hydroxamic acid MMP and TACE inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,8,"Zask A, Gu Y, Albright JD, Du X, Hogan M, Levin JI, Chen JM, Killar LM, Sung A, DiJoseph JF, Sharr MA, Roth CE, Skala S, Jin G, Cowling R, Mohler KM, Barone D, Black R, March C, Skotnicki JS",,106642,DTCT0024002,1276618,DTCC00174833,2076465,6276
CHEMBL290952,P45452,,JRKVJTDYMGJJAK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19095454,IC50,=,4,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Current perspective of TACE inhibitors: a review.,Bioorg. Med. Chem.,2009,17,2,"DasGupta S, Murumkar PR, Giridhar R, Yadav MR",,495051,DTCT0024002,2594724,DTCC00174833,2080105,32093
CHEMBL291133,P45452,,UAFDRTNAZWZUDR-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10649971,IC50,=,13,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant matrix metalloprotease-13 (MMP-13),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,106476,DTCT0024002,903637,DTCC00185834,1046252,15892
CHEMBL293019,P45452,,NPZDPBHMFYXBRP-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11454461,IC50,=,43,NM,,,,,,,,,,,,,,In vitro inhibitory concentration against Matrix metalloprotease-13,,The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold.,Bioorg. Med. Chem. Lett.,2001,11,15,"Tullis JS, Laufersweiler MJ, VanRens JC, Natchus MG, Bookland RG, Almstead NG, Pikul S, De B, Hsieh LC, Janusz MJ, Branch TM, Peng SX, Jin YY, Hudlicky T, Oppong K",,106479,DTCT0024002,1528043,DTCC00209001,1046465,4358
CHEMBL293411,P45452,,XXCBSIYZQACPFC-OBFZPWGMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11454461,IC50,=,1,NM,,,,,,,,,,,,,,In vitro inhibitory concentration against Matrix metalloprotease-13,,The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold.,Bioorg. Med. Chem. Lett.,2001,11,15,"Tullis JS, Laufersweiler MJ, VanRens JC, Natchus MG, Bookland RG, Almstead NG, Pikul S, De B, Hsieh LC, Janusz MJ, Branch TM, Peng SX, Jin YY, Hudlicky T, Oppong K",,106479,DTCT0024002,1555879,DTCC00208643,497500,4358
CHEMBL293854,P45452,,LYAHBKLKJSTSGZ-TZBSWOFLSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11454461,IC50,=,21,NM,,,,,,,,,,,,,,In vitro inhibitory concentration against Matrix metalloprotease-13,,The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold.,Bioorg. Med. Chem. Lett.,2001,11,15,"Tullis JS, Laufersweiler MJ, VanRens JC, Natchus MG, Bookland RG, Almstead NG, Pikul S, De B, Hsieh LC, Janusz MJ, Branch TM, Peng SX, Jin YY, Hudlicky T, Oppong K",,106479,DTCT0024002,1550758,DTCC00209221,1564033,4358
CHEMBL294405,P45452,,RUILUWMFIHGOHD-NKFKGCMQSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11454461,IC50,=,21,NM,,,,,,,,,,,,,,In vitro inhibitory concentration against Matrix metalloprotease-13,,The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold.,Bioorg. Med. Chem. Lett.,2001,11,15,"Tullis JS, Laufersweiler MJ, VanRens JC, Natchus MG, Bookland RG, Almstead NG, Pikul S, De B, Hsieh LC, Janusz MJ, Branch TM, Peng SX, Jin YY, Hudlicky T, Oppong K",,106479,DTCT0024002,1529268,DTCC00208195,1046467,4358
CHEMBL295066,P45452,,CTONTIQKTODDRQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10406637,IC50,=,22,NM,,,,,,,,,,,,,,Inhibition of human recombinant matrix metalloprotease-13 (hMMP-13),,Synthesis and identification of conformationally constrained selective MMP inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,13,"Freskos JN, McDonald JJ, Mischke BV, Mullins PB, Shieh HS, Stegeman RA, Stevens AM",,101902,DTCT0024002,1448230,DTCC00193515,1838262,3192
CHEMBL295871,P45452,,JUPHQCOZPHPYPF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10649971,IC50,=,36,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant matrix metalloprotease-13 (MMP-13),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,106476,DTCT0024002,927046,DTCC00186639,1402750,15892
CHEMBL296196,P45452,,PTONAIKVYGVBIS-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10649971,IC50,=,48,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant matrix metalloprotease-13 (MMP-13),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,106476,DTCT0024002,909628,DTCC00186419,236755,15892
CHEMBL296196,P45452,,PTONAIKVYGVBIS-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17088065,IC50,=,48,NM,,,,,,,,,,,,,,Inhibition of MMP13,,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432508,DTCT0024002,2061890,DTCC00186419,228138,22402
CHEMBL296911,P45452,,TWQZYQBXMVVVCY-NRFANRHFSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10397503,IC50,=,12,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,"Picking the S1, S1' and S2' pockets of matrix metalloproteinases. A niche for potent acyclic sulfonamide inhibitors.",Bioorg. Med. Chem. Lett.,1999,9,12,"Hanessian S, Bouzbouz S, Boudon A, Tucker GC, Peyroulan D",,101903,DTCT0024002,526387,DTCC00188240,2796,3181
CHEMBL297749,P45452,,GZQRNXJPJXICJZ-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10649971,IC50,=,7,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant matrix metalloprotease-13 (MMP-13),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,106476,DTCT0024002,918815,DTCC00186610,658584,15892
CHEMBL298647,P45452,,OMZKWXAFDODBPH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11384231,IC50,=,460,NM,,,,,,,,,,,,,,"Inhibition of Collagenase-3, matrix metalloprotease-13 (MMP-13).",,"2-(2-Oxo-1,4-dihydro-2H-quinazolin-3-yl)- and 2-(2,2-dioxo-1,4-dihydro-2H-2lambda6-benzo[1,2,6]thiadiazin-3-yl)-N-hydroxy-acetamides as potent and selective peptide deformylase inhibitors.",J. Med. Chem.,2001,44,12,"Apfel C, Banner DW, Bur D, Dietz M, Hubschwerlen C, Locher H, Marlin F, Masciadri R, Pirson W, Stalder H",,106480,DTCT0024002,1580403,DTCC00199650,1752934,16260
CHEMBL299946,P45452,,MNAUWMOCDLCGGF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11384231,IC50,=,500,NM,,,,,,,,,,,,,,"Inhibition of Collagenase-3, matrix metalloprotease-13 (MMP-13).",,"2-(2-Oxo-1,4-dihydro-2H-quinazolin-3-yl)- and 2-(2,2-dioxo-1,4-dihydro-2H-2lambda6-benzo[1,2,6]thiadiazin-3-yl)-N-hydroxy-acetamides as potent and selective peptide deformylase inhibitors.",J. Med. Chem.,2001,44,12,"Apfel C, Banner DW, Bur D, Dietz M, Hubschwerlen C, Locher H, Marlin F, Masciadri R, Pirson W, Stalder H",,106480,DTCT0024002,1585612,DTCC00199863,1849653,16260
CHEMBL300375,P45452,,YHTDLXCRQOJRHH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11454461,IC50,=,16,NM,,,,,,,,,,,,,,In vitro inhibitory concentration against Matrix metalloprotease-13,,The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold.,Bioorg. Med. Chem. Lett.,2001,11,15,"Tullis JS, Laufersweiler MJ, VanRens JC, Natchus MG, Bookland RG, Almstead NG, Pikul S, De B, Hsieh LC, Janusz MJ, Branch TM, Peng SX, Jin YY, Hudlicky T, Oppong K",,106479,DTCT0024002,1538619,DTCC00209051,367960,4358
CHEMBL300697,P45452,,XUDODBAIOYVRJQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10406637,IC50,=,0.4,NM,,,,,,,,,,,,,,Inhibition of human recombinant matrix metalloprotease-13 (hMMP-13),,Synthesis and identification of conformationally constrained selective MMP inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,13,"Freskos JN, McDonald JJ, Mischke BV, Mullins PB, Shieh HS, Stegeman RA, Stevens AM",,101902,DTCT0024002,1465326,DTCC00194150,549968,3192
CHEMBL300771,P45452,,BTZXQMHZPVTFBL-YITPRAEKSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11454461,IC50,=,0.8,NM,,,,,,,,,,,,,,In vitro inhibitory concentration against Matrix metalloprotease-13,,The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold.,Bioorg. Med. Chem. Lett.,2001,11,15,"Tullis JS, Laufersweiler MJ, VanRens JC, Natchus MG, Bookland RG, Almstead NG, Pikul S, De B, Hsieh LC, Janusz MJ, Branch TM, Peng SX, Jin YY, Hudlicky T, Oppong K",,106479,DTCT0024002,1526922,DTCC00209002,819930,4358
CHEMBL301565,P45452,,CTVWOVYWOFCAMW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10230616,IC50,=,0.5,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 (MMP-13),,Discovery of a novel series of selective MMP inhibitors: identification of the gamma-sulfone-thiols.,Bioorg. Med. Chem. Lett.,1999,9,7,"Freskos JN, Mischke BV, DeCrescenzo GA, Heintz R, Getman DP, Howard SC, Kishore NN, McDonald JJ, Munie GE, Rangwala S, Swearingen CA, Voliva C, Welsch DJ",,106484,DTCT0024002,1696308,DTCC00194174,939779,3610
CHEMBL301565,P45452,,CTVWOVYWOFCAMW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10406637,IC50,=,0.5,NM,,,,,,,,,,,,,,Inhibition of human recombinant matrix metalloprotease-13 (hMMP-13),,Synthesis and identification of conformationally constrained selective MMP inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,13,"Freskos JN, McDonald JJ, Mischke BV, Mullins PB, Shieh HS, Stegeman RA, Stevens AM",,101902,DTCT0024002,1477358,DTCC00194174,937726,3192
CHEMBL302592,P45452,,UVIHZDFNAMLPGD-SFHVURJKSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12798337,INHIBITION EFFECT,=,0.942,,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-13 at 20 nM,,Synthesis of radiolabeled biphenylsulfonamide matrix metalloproteinase inhibitors as new potential PET cancer imaging agents.,Bioorg. Med. Chem. Lett.,2003,13,13,"Fei X, Zheng QH, Liu X, Wang JQ, Sun HB, Mock BH, Stone KL, Miller KD, Sledge GW, Hutchins GD",,106607,DTCT0024002,1386575,DTCC00224128,1693316,5629
CHEMBL303286,P45452,,ZYWQCDFNGKDOSB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11454461,IC50,=,67,NM,,,,,,,,,,,,,,In vitro inhibitory concentration against Matrix metalloprotease-13,,The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold.,Bioorg. Med. Chem. Lett.,2001,11,15,"Tullis JS, Laufersweiler MJ, VanRens JC, Natchus MG, Bookland RG, Almstead NG, Pikul S, De B, Hsieh LC, Janusz MJ, Branch TM, Peng SX, Jin YY, Hudlicky T, Oppong K",,106479,DTCT0024002,1530488,DTCC00209007,529586,4358
CHEMBL303666,P45452,,MWNWUYJAANVQLN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11514167,IC50,=,4,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,The discovery of anthranilic acid-based MMP inhibitors. Part 2: SAR of the 5-position and P1(1) groups.,Bioorg. Med. Chem. Lett.,2001,11,16,"Levin JI, Chen J, Du M, Hogan M, Kincaid S, Nelson FC, Venkatesan AM, Wehr T, Zask A, DiJoseph J, Killar LM, Skala S, Sung A, Sharr M, Roth C, Jin G, Cowling R, Mohler KM, Black RA, March CJ, Skotnicki JS",,106636,DTCT0024002,979606,DTCC00222357,1488327,4353
CHEMBL304730,P45452,,RMZUAMXVNUZHBB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11514167,IC50,=,2,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,The discovery of anthranilic acid-based MMP inhibitors. Part 2: SAR of the 5-position and P1(1) groups.,Bioorg. Med. Chem. Lett.,2001,11,16,"Levin JI, Chen J, Du M, Hogan M, Kincaid S, Nelson FC, Venkatesan AM, Wehr T, Zask A, DiJoseph J, Killar LM, Skala S, Sung A, Sharr M, Roth C, Jin G, Cowling R, Mohler KM, Black RA, March CJ, Skotnicki JS",,106636,DTCT0024002,997534,DTCC00222106,1293653,4353
CHEMBL305160,P45452,,CPDXTLZUFAYJLD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11454461,IC50,=,29,NM,,,,,,,,,,,,,,In vitro inhibitory concentration against Matrix metalloprotease-13,,The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold.,Bioorg. Med. Chem. Lett.,2001,11,15,"Tullis JS, Laufersweiler MJ, VanRens JC, Natchus MG, Bookland RG, Almstead NG, Pikul S, De B, Hsieh LC, Janusz MJ, Branch TM, Peng SX, Jin YY, Hudlicky T, Oppong K",,106479,DTCT0024002,1524590,DTCC00208701,140369,4358
CHEMBL305499,P45452,,AQCACFZZOGNMPR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11514167,INHIBITION,=,48,%,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,The discovery of anthranilic acid-based MMP inhibitors. Part 2: SAR of the 5-position and P1(1) groups.,Bioorg. Med. Chem. Lett.,2001,11,16,"Levin JI, Chen J, Du M, Hogan M, Kincaid S, Nelson FC, Venkatesan AM, Wehr T, Zask A, DiJoseph J, Killar LM, Skala S, Sung A, Sharr M, Roth C, Jin G, Cowling R, Mohler KM, Black RA, March CJ, Skotnicki JS",,106769,DTCT0024002,1008419,DTCC00222632,1552689,4353
CHEMBL305722,P45452,,ZBIYSEFCPUXCRC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773041,IC50,=,9,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-13,,"Synthesis and structure-activity relationship of alpha-sulfonylhydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Grosu GT, Davis JM, Hu B, Ellingboe J, Baker JL, Skotnicki JS, Zask A, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R",,106627,DTCT0024002,785558,DTCC00234512,1228326,17339
CHEMBL306158,P45452,,AUCTYKZCPSWUEL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773041,IC50,=,12,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-13,,"Synthesis and structure-activity relationship of alpha-sulfonylhydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Grosu GT, Davis JM, Hu B, Ellingboe J, Baker JL, Skotnicki JS, Zask A, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R",,106627,DTCT0024002,806435,DTCC00235153,1326329,17339
CHEMBL306158,P45452,,AUCTYKZCPSWUEL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,4.92,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260773,DTCC00235153,1329172,24831
CHEMBL306577,P45452,,YZCLZWVHSZUTMP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773041,IC50,=,4,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-13,,"Synthesis and structure-activity relationship of alpha-sulfonylhydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Grosu GT, Davis JM, Hu B, Ellingboe J, Baker JL, Skotnicki JS, Zask A, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R",,106627,DTCT0024002,809319,DTCC00234582,1773789,17339
CHEMBL306617,P45452,,GMRJGTBNERTZIB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773042,IC50,=,2,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13.,,"Synthesis and structure-activity relationship of N-substituted 4-arylsulfonylpiperidine-4-hydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Davis JM, Grosu GT, Baker J, Ellingboe J, Zask A, Levin JI, Sandanayaka VP, Du M, Skotnicki JS, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R, Tillett J, Zhao W, McDevitt J, Xu ZB",,106632,DTCT0024002,482342,DTCC00236306,1850069,17340
CHEMBL306617,P45452,,GMRJGTBNERTZIB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,5.7,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260816,DTCC00236306,1841452,24831
CHEMBL306635,P45452,,VKCIBOBTIOCYLR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773041,IC50,=,12,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,"Synthesis and structure-activity relationship of alpha-sulfonylhydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Grosu GT, Davis JM, Hu B, Ellingboe J, Baker JL, Skotnicki JS, Zask A, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R",,106630,DTCT0024002,775680,DTCC00233622,225734,17339
CHEMBL306723,P45452,,IOUQKHPLPLPITI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773041,IC50,=,2,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-13,,"Synthesis and structure-activity relationship of alpha-sulfonylhydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Grosu GT, Davis JM, Hu B, Ellingboe J, Baker JL, Skotnicki JS, Zask A, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R",,106627,DTCT0024002,793978,DTCC00233944,647728,17339
CHEMBL307079,P45452,,CBLOGBROLDHLEE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11514167,IC50,=,11,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,The discovery of anthranilic acid-based MMP inhibitors. Part 2: SAR of the 5-position and P1(1) groups.,Bioorg. Med. Chem. Lett.,2001,11,16,"Levin JI, Chen J, Du M, Hogan M, Kincaid S, Nelson FC, Venkatesan AM, Wehr T, Zask A, DiJoseph J, Killar LM, Skala S, Sung A, Sharr M, Roth C, Jin G, Cowling R, Mohler KM, Black RA, March CJ, Skotnicki JS",,106636,DTCT0024002,1004654,DTCC00221921,421716,4353
CHEMBL307168,P45452,,WNJWSNXIZOSCTK-ZGVDRVBQSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12824028,IC50,=,30,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13,,Phosphinic acid-based MMP-13 inhibitors that spare MMP-1 and MMP-3.,Bioorg. Med. Chem. Lett.,2003,13,14,"Reiter LA, Mitchell PG, Martinelli GJ, Lopresti-Morrow LL, Yocum SA, Eskra JD",,106640,DTCT0024002,1496539,DTCC00232502,755641,5648
CHEMBL307182,P45452,,MJUMZXKGECTNMD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11206467,IC50,,,,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 (Not tested),Not Determined,The discovery of anthranilic acid-based MMP inhibitors. Part 1: SAR of the 3-position.,Bioorg. Med. Chem. Lett.,2001,11,2,"Levin JI, Du MT, DiJoseph JF, Killar LM, Sung A, Walter T, Sharr MA, Roth CE, Moy FJ, Powers R, Jin G, Cowling R, Skotnicki JS",,106468,DTCT0024002,599887,DTCC00234900,323784,4515
CHEMBL307252,P45452,,JRBJMWFZOMECPK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773041,IC50,=,14,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-13,,"Synthesis and structure-activity relationship of alpha-sulfonylhydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Grosu GT, Davis JM, Hu B, Ellingboe J, Baker JL, Skotnicki JS, Zask A, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R",,106627,DTCT0024002,800916,DTCC00234779,421871,17339
CHEMBL307252,P45452,,JRBJMWFZOMECPK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,4.85,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260785,DTCC00234779,424721,24831
CHEMBL307494,P45452,,ZSRPSCNAFVEYRR-ZBAATNBSSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12824028,IC50,=,17,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13,,Phosphinic acid-based MMP-13 inhibitors that spare MMP-1 and MMP-3.,Bioorg. Med. Chem. Lett.,2003,13,14,"Reiter LA, Mitchell PG, Martinelli GJ, Lopresti-Morrow LL, Yocum SA, Eskra JD",,106640,DTCT0024002,1518633,DTCC00231963,1207482,5648
CHEMBL307990,P45452,,VZKDMHBTNFCZIW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11514167,IC50,=,137,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,The discovery of anthranilic acid-based MMP inhibitors. Part 2: SAR of the 5-position and P1(1) groups.,Bioorg. Med. Chem. Lett.,2001,11,16,"Levin JI, Chen J, Du M, Hogan M, Kincaid S, Nelson FC, Venkatesan AM, Wehr T, Zask A, DiJoseph J, Killar LM, Skala S, Sung A, Sharr M, Roth C, Jin G, Cowling R, Mohler KM, Black RA, March CJ, Skotnicki JS",,106636,DTCT0024002,985338,DTCC00222701,64166,4353
CHEMBL308014,P45452,,XUACSMCLVIHIAC-SFHVURJKSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12798337,INHIBITION EFFECT,=,0.935,,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-13 at 20 nM,,Synthesis of radiolabeled biphenylsulfonamide matrix metalloproteinase inhibitors as new potential PET cancer imaging agents.,Bioorg. Med. Chem. Lett.,2003,13,13,"Fei X, Zheng QH, Liu X, Wang JQ, Sun HB, Mock BH, Stone KL, Miller KD, Sledge GW, Hutchins GD",,106607,DTCT0024002,1384223,DTCC00224287,1661205,5629
CHEMBL308084,P45452,,XRIJPQABKMSHIA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11206467,IC50,=,136,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-13,,The discovery of anthranilic acid-based MMP inhibitors. Part 1: SAR of the 3-position.,Bioorg. Med. Chem. Lett.,2001,11,2,"Levin JI, Du MT, DiJoseph JF, Killar LM, Sung A, Walter T, Sharr MA, Roth CE, Moy FJ, Powers R, Jin G, Cowling R, Skotnicki JS",,106467,DTCT0024002,598903,DTCC00234892,1520762,4515
CHEMBL308084,P45452,,XRIJPQABKMSHIA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,IC50,=,134.9,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258703,DTCC00234892,1523433,24803
CHEMBL308277,P45452,,VGXYGECPCDQSNI-DINWUYGQSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12824028,IC50,=,4.5,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13,,Phosphinic acid-based MMP-13 inhibitors that spare MMP-1 and MMP-3.,Bioorg. Med. Chem. Lett.,2003,13,14,"Reiter LA, Mitchell PG, Martinelli GJ, Lopresti-Morrow LL, Yocum SA, Eskra JD",,106640,DTCT0024002,1510773,DTCC00232492,1532289,5648
CHEMBL308305,P45452,,QRWJUWNAJTZLAE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11206467,IC50,=,555,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-13,,The discovery of anthranilic acid-based MMP inhibitors. Part 1: SAR of the 3-position.,Bioorg. Med. Chem. Lett.,2001,11,2,"Levin JI, Du MT, DiJoseph JF, Killar LM, Sung A, Walter T, Sharr MA, Roth CE, Moy FJ, Powers R, Jin G, Cowling R, Skotnicki JS",,106467,DTCT0024002,610339,DTCC00234733,1391810,4515
CHEMBL308305,P45452,,QRWJUWNAJTZLAE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11206468,IC50,=,555,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,Heteroaryl and cycloalkyl sulfonamide hydroxamic acid inhibitors of matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2001,11,2,"Levin JI, Gu Y, Nelson FC, Zask A, DiJoseph JF, Sharr MA, Sung A, Jin G, Cowling R, Chanda P, Cosmi S, Hsiao CL, Edris W, Wilhelm J, Killar LM, Skotnicki JS",,106638,DTCT0024002,1294657,DTCC00234733,1403267,4516
CHEMBL308305,P45452,,QRWJUWNAJTZLAE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,IC50,=,549.54,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258689,DTCC00234733,1394252,24803
CHEMBL3084281,P45452,,FVYBFRCALRJYHO-SFHVURJKSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,4.49,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260766,DTCC01407258,67166,24831
CHEMBL3084282,P45452,,VKCIBOBTIOCYLR-RUZDIDTESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,4.92,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260764,DTCC01407259,746936,24831
CHEMBL3084283,P45452,,KDJZFDKCOPXERM-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,4.51,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260760,DTCC01407260,1005468,24831
CHEMBL3084284,P45452,,OQOVBCVMAHMMFY-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,4.89,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260770,DTCC01407261,2036425,24831
CHEMBL3084285,P45452,,IOUQKHPLPLPITI-HHHXNRCGSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,5.7,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260794,DTCC01407262,359218,24831
CHEMBL3084287,P45452,,JQVXQUOPUHBHAD-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,4.8,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260759,DTCC01407264,675554,24831
CHEMBL3084288,P45452,,JGDVFBCMNUSQQW-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,4.05,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260769,DTCC01407265,1841451,24831
CHEMBL3084289,P45452,,XBLZKAPRZBJHCZ-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,4.96,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260786,DTCC01407266,661779,24831
CHEMBL3084290,P45452,,ZBIYSEFCPUXCRC-NRFANRHFSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,5.05,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260784,DTCC01407267,99404,24831
CHEMBL3084291,P45452,,CEYDMEZCBBKZBI-QHCPKHFHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,4.82,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260762,DTCC01407268,1971008,24831
CHEMBL3084292,P45452,,YZCLZWVHSZUTMP-SSEXGKCCSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,5.4,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260761,DTCC01407269,779001,24831
CHEMBL3084293,P45452,,BCVFMUCILNFXOC-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,4.66,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260772,DTCC01407270,359217,24831
CHEMBL3084294,P45452,,UNQHIMAGAUGZGX-RUZDIDTESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,4.72,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260763,DTCC01407271,553261,24831
CHEMBL3084295,P45452,,VEUYFZWVWBJLBT-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,4.62,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260775,DTCC01407272,1873444,24831
CHEMBL308451,P45452,,NPGSXLDVSQYWEV-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12798337,INHIBITION EFFECT,=,0.919,,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-13 at 20 nM,,Synthesis of radiolabeled biphenylsulfonamide matrix metalloproteinase inhibitors as new potential PET cancer imaging agents.,Bioorg. Med. Chem. Lett.,2003,13,13,"Fei X, Zheng QH, Liu X, Wang JQ, Sun HB, Mock BH, Stone KL, Miller KD, Sledge GW, Hutchins GD",,106607,DTCT0024002,1372716,DTCC00224318,529750,5629
CHEMBL3084965,P45452,,FWZHHLOLYIUTJO-LBXVMSDZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11266157,IC50,=,30,NM,,,,,,,,,,,,,,Inhibition of Collagenase 3 (Matrix metalloprotease-13),,Chemoenzymatic synthesis of functionalized cyclohexylglycines and alpha-methylcyclohexylglycines via Kazmaier-Claisen rearrangement.,Bioorg. Med. Chem. Lett.,2001,11,5,"Hudlicky T, Oppong K, Duan C, Stanton C, Laufersweiler MJ, Natchus MG",,106602,DTCT0024002,646733,DTCC01407937,487523,4704
CHEMBL3084966,P45452,,RMJFXTVVOBTABN-RWWKDMOOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11266157,IC50,=,338,NM,,,,,,,,,,,,,,Inhibition of Collagenase 3 (Matrix metalloprotease-13),,Chemoenzymatic synthesis of functionalized cyclohexylglycines and alpha-methylcyclohexylglycines via Kazmaier-Claisen rearrangement.,Bioorg. Med. Chem. Lett.,2001,11,5,"Hudlicky T, Oppong K, Duan C, Stanton C, Laufersweiler MJ, Natchus MG",,106602,DTCT0024002,618643,DTCC01407938,1165043,4704
CHEMBL3085155,P45452,,IQNGGJYKFADFHE-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773041,IC50,=,43,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-13,,"Synthesis and structure-activity relationship of alpha-sulfonylhydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Grosu GT, Davis JM, Hu B, Ellingboe J, Baker JL, Skotnicki JS, Zask A, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R",,106627,DTCT0024002,785565,DTCC01408122,808584,17339
CHEMBL3085155,P45452,,IQNGGJYKFADFHE-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,4.37,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260767,DTCC01408122,811356,24831
CHEMBL3085156,P45452,,KDSNJNDUIRTNNR-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773041,IC50,=,127,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-13,,"Synthesis and structure-activity relationship of alpha-sulfonylhydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Grosu GT, Davis JM, Hu B, Ellingboe J, Baker JL, Skotnicki JS, Zask A, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R",,106627,DTCT0024002,807787,DTCC01408123,1293773,17339
CHEMBL3085156,P45452,,KDSNJNDUIRTNNR-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,3.9,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260768,DTCC01408123,1296599,24831
CHEMBL308523,P45452,,VKSDFADIGYDZCS-BDCODIICSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12824028,IC50,=,37,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13,,Phosphinic acid-based MMP-13 inhibitors that spare MMP-1 and MMP-3.,Bioorg. Med. Chem. Lett.,2003,13,14,"Reiter LA, Mitchell PG, Martinelli GJ, Lopresti-Morrow LL, Yocum SA, Eskra JD",,106640,DTCT0024002,1498799,DTCC00232455,981998,5648
CHEMBL3085322,P45452,,YYOVZJXOBZVIQK-LHSJRXKWSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15566296,IC50,=,216,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Synthesis and structure-activity relationships of 4-alkynyloxy phenyl sulfanyl, sulfinyl, and sulfonyl alkyl hydroxamates as tumor necrosis factor-alpha converting enzyme and matrix metalloproteinase inhibitors.",J. Med. Chem.,2004,47,25,"Venkatesan AM, Davis JM, Grosu GT, Baker J, Zask A, Levin JI, Ellingboe J, Skotnicki JS, Dijoseph JF, Sung A, Jin G, Xu W, McCarthy DJ, Barone D",,429672,DTCT0024002,2041973,DTCC01408281,1146517,22157
CHEMBL309105,P45452,,ZAMIBNJCPAMMPI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11514167,IC50,=,38,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,The discovery of anthranilic acid-based MMP inhibitors. Part 2: SAR of the 5-position and P1(1) groups.,Bioorg. Med. Chem. Lett.,2001,11,16,"Levin JI, Chen J, Du M, Hogan M, Kincaid S, Nelson FC, Venkatesan AM, Wehr T, Zask A, DiJoseph J, Killar LM, Skala S, Sung A, Sharr M, Roth C, Jin G, Cowling R, Mohler KM, Black RA, March CJ, Skotnicki JS",,106636,DTCT0024002,986596,DTCC00222545,1132336,4353
CHEMBL309311,P45452,,ZBDXZEGIXHCDMC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773042,IC50,=,1,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13.,,"Synthesis and structure-activity relationship of N-substituted 4-arylsulfonylpiperidine-4-hydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Davis JM, Grosu GT, Baker J, Ellingboe J, Zask A, Levin JI, Sandanayaka VP, Du M, Skotnicki JS, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R, Tillett J, Zhao W, McDevitt J, Xu ZB",,106632,DTCT0024002,493177,DTCC00236109,853157,17340
CHEMBL309311,P45452,,ZBDXZEGIXHCDMC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,6,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260801,DTCC00236109,844228,24831
CHEMBL309416,P45452,,HYZDHISHDZBYBQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773042,IC50,=,2,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13.,,"Synthesis and structure-activity relationship of N-substituted 4-arylsulfonylpiperidine-4-hydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Davis JM, Grosu GT, Baker J, Ellingboe J, Zask A, Levin JI, Sandanayaka VP, Du M, Skotnicki JS, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R, Tillett J, Zhao W, McDevitt J, Xu ZB",,106632,DTCT0024002,505398,DTCC00235722,1305618,17340
CHEMBL309416,P45452,,HYZDHISHDZBYBQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,5.7,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260825,DTCC00235722,1296600,24831
CHEMBL309465,P45452,,SMUHFCXUZGSRMF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11133099,IC50,=,12.2,NM,,,,,,,,,,,,,,50 percent inhibition of human Matrix metalloprotease-13 by the cleavage of fluorogenic peptide MCA-Pro-Leu-Gly-Leu-Dpa-ala-Arg-NH2,,Synthesis and activity of selective MMP inhibitors with an aryl backbone.,Bioorg. Med. Chem. Lett.,2000,10,24,"Barta TE, Becker DP, Bedell LJ, De Crescenzo GA, McDonald JJ, Munie GE, Rao S, Shieh HS, Stegeman R, Stevens AM, Villamil CI",,106604,DTCT0024002,725806,DTCC00240431,1392082,3985
CHEMBL309465,P45452,,SMUHFCXUZGSRMF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11549451,ACTIVITY,=,12,NM,,,,,,,,,,,,,,Inhibitory activity against human Matrix metalloprotease-13,,"Selective, orally active MMP inhibitors with an aryl backbone.",Bioorg. Med. Chem. Lett.,2001,11,18,"Barta TE, Becker DP, Bedell LJ, De Crescenzo GA, McDonald JJ, Mehta P, Munie GE, Villamil CI",,106466,DTCT0024002,1647347,DTCC00240431,1403313,4449
CHEMBL309492,P45452,,SRPXVKQVZQEPFT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773042,IC50,=,1,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13.,,"Synthesis and structure-activity relationship of N-substituted 4-arylsulfonylpiperidine-4-hydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Davis JM, Grosu GT, Baker J, Ellingboe J, Zask A, Levin JI, Sandanayaka VP, Du M, Skotnicki JS, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R, Tillett J, Zhao W, McDevitt J, Xu ZB",,106632,DTCT0024002,510282,DTCC00235698,2012791,17340
CHEMBL309492,P45452,,SRPXVKQVZQEPFT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,6,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260826,DTCC00235698,2003628,24831
CHEMBL309539,P45452,,QTBRRNPXGRIPDP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11549451,ACTIVITY,=,1.5,NM,,,,,,,,,,,,,,Inhibitory activity against human Matrix metalloprotease-13,,"Selective, orally active MMP inhibitors with an aryl backbone.",Bioorg. Med. Chem. Lett.,2001,11,18,"Barta TE, Becker DP, Bedell LJ, De Crescenzo GA, McDonald JJ, Mehta P, Munie GE, Villamil CI",,106466,DTCT0024002,1670299,DTCC00106130,659143,4449
CHEMBL309599,P45452,,UQRFKNRXERPSMG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773041,IC50,=,37,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-13,,"Synthesis and structure-activity relationship of alpha-sulfonylhydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Grosu GT, Davis JM, Hu B, Ellingboe J, Baker JL, Skotnicki JS, Zask A, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R",,106627,DTCT0024002,813633,DTCC00234016,1100340,17339
CHEMBL310008,P45452,,QZURMXFXKAPVRT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11133099,IC50,=,33,NM,,,,,,,,,,,,,,50 percent inhibition of human Matrix metalloprotease-13 by the cleavage of fluorogenic peptide MCA-Pro-Leu-Gly-Leu-Dpa-ala-Arg-NH2,,Synthesis and activity of selective MMP inhibitors with an aryl backbone.,Bioorg. Med. Chem. Lett.,2000,10,24,"Barta TE, Becker DP, Bedell LJ, De Crescenzo GA, McDonald JJ, Munie GE, Rao S, Shieh HS, Stegeman R, Stevens AM, Villamil CI",,106604,DTCT0024002,713037,DTCC00241016,1714093,3985
CHEMBL310008,P45452,,QZURMXFXKAPVRT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11549451,ACTIVITY,=,33,NM,,,,,,,,,,,,,,Inhibitory activity against human Matrix metalloprotease-13,,"Selective, orally active MMP inhibitors with an aryl backbone.",Bioorg. Med. Chem. Lett.,2001,11,18,"Barta TE, Becker DP, Bedell LJ, De Crescenzo GA, McDonald JJ, Mehta P, Munie GE, Villamil CI",,106466,DTCT0024002,1664146,DTCC00241016,1723056,4449
CHEMBL310008,P45452,,QZURMXFXKAPVRT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23287054,IC50,=,33,NM,,,,,,,,,,,,,,Inhibition of MMP13 (unknown origin),,Sulphonamides: Deserving class as MMP inhibitors?,Eur. J. Med. Chem.,2013,60,,"Jain P, Saravanan C, Singh SK",,944584,DTCT0024002,11835685,DTCC00241016,1736689,53820
CHEMBL310057,P45452,,KASLMAICRUMQME-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773042,IC50,=,9,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13.,,"Synthesis and structure-activity relationship of N-substituted 4-arylsulfonylpiperidine-4-hydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Davis JM, Grosu GT, Baker J, Ellingboe J, Zask A, Levin JI, Sandanayaka VP, Du M, Skotnicki JS, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R, Tillett J, Zhao W, McDevitt J, Xu ZB",,106632,DTCT0024002,502951,DTCC00235869,401029,17340
CHEMBL310057,P45452,,KASLMAICRUMQME-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,5.05,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260821,DTCC00235869,391961,24831
CHEMBL310060,P45452,,SWDPDYNSAGSRKE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11549451,ACTIVITY,=,3.7,NM,,,,,,,,,,,,,,Inhibitory activity against human Matrix metalloprotease-13,,"Selective, orally active MMP inhibitors with an aryl backbone.",Bioorg. Med. Chem. Lett.,2001,11,18,"Barta TE, Becker DP, Bedell LJ, De Crescenzo GA, McDonald JJ, Mehta P, Munie GE, Villamil CI",,106466,DTCT0024002,1641464,DTCC00241070,1338357,4449
CHEMBL310270,P45452,,PPTRNTHJEHNDDP-ZBAATNBSSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12824028,IC50,=,18,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13,,Phosphinic acid-based MMP-13 inhibitors that spare MMP-1 and MMP-3.,Bioorg. Med. Chem. Lett.,2003,13,14,"Reiter LA, Mitchell PG, Martinelli GJ, Lopresti-Morrow LL, Yocum SA, Eskra JD",,106640,DTCT0024002,1504055,DTCC00232501,368214,5648
CHEMBL310324,P45452,,UZVVYDVVOHQVFV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773042,IC50,=,38,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13.,,"Synthesis and structure-activity relationship of N-substituted 4-arylsulfonylpiperidine-4-hydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Davis JM, Grosu GT, Baker J, Ellingboe J, Zask A, Levin JI, Sandanayaka VP, Du M, Skotnicki JS, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R, Tillett J, Zhao W, McDevitt J, Xu ZB",,106632,DTCT0024002,510272,DTCC00235796,1338306,17340
CHEMBL310324,P45452,,UZVVYDVVOHQVFV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,4.42,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260791,DTCC00235796,1329173,24831
CHEMBL310338,P45452,,JQVXQUOPUHBHAD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773041,IC50,=,16,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,"Synthesis and structure-activity relationship of alpha-sulfonylhydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Grosu GT, Davis JM, Hu B, Ellingboe J, Baker JL, Skotnicki JS, Zask A, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R",,106630,DTCT0024002,785569,DTCC00234433,1488455,17339
CHEMBL310340,P45452,,MIMMUUIYLKITIG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773042,IC50,=,1.4,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13.,,"Synthesis and structure-activity relationship of N-substituted 4-arylsulfonylpiperidine-4-hydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Davis JM, Grosu GT, Baker J, Ellingboe J, Zask A, Levin JI, Sandanayaka VP, Du M, Skotnicki JS, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R, Tillett J, Zhao W, McDevitt J, Xu ZB",,106632,DTCT0024002,486995,DTCC00235086,1693446,17340
CHEMBL310342,P45452,,MWFBMGWABXFCCK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773042,IC50,=,33,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13.,,"Synthesis and structure-activity relationship of N-substituted 4-arylsulfonylpiperidine-4-hydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Davis JM, Grosu GT, Baker J, Ellingboe J, Zask A, Levin JI, Sandanayaka VP, Du M, Skotnicki JS, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R, Tillett J, Zhao W, McDevitt J, Xu ZB",,106632,DTCT0024002,508982,DTCC00236268,562091,17340
CHEMBL310342,P45452,,MWFBMGWABXFCCK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,4.48,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260789,DTCC00236268,553262,24831
CHEMBL310359,P45452,,PXEJSEMEBWDTJZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11206468,IC50,,,,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 (Not tested),Not Determined,Heteroaryl and cycloalkyl sulfonamide hydroxamic acid inhibitors of matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2001,11,2,"Levin JI, Gu Y, Nelson FC, Zask A, DiJoseph JF, Sharr MA, Sung A, Jin G, Cowling R, Chanda P, Cosmi S, Hsiao CL, Edris W, Wilhelm J, Killar LM, Skotnicki JS",,106637,DTCT0024002,1306008,DTCC00237034,1596776,4516
CHEMBL310388,P45452,,JVWFOTNQRDMUFU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11549451,ACTIVITY,=,2.7,NM,,,,,,,,,,,,,,Inhibitory activity against human Matrix metalloprotease-13,,"Selective, orally active MMP inhibitors with an aryl backbone.",Bioorg. Med. Chem. Lett.,2001,11,18,"Barta TE, Becker DP, Bedell LJ, De Crescenzo GA, McDonald JJ, Mehta P, Munie GE, Villamil CI",,106466,DTCT0024002,1675048,DTCC00106119,1403312,4449
CHEMBL310472,P45452,,BLCLPMFYNMXITO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773041,IC50,=,2,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-13,,"Synthesis and structure-activity relationship of alpha-sulfonylhydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Grosu GT, Davis JM, Hu B, Ellingboe J, Baker JL, Skotnicki JS, Zask A, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R",,106627,DTCT0024002,796731,DTCC00233912,356484,17339
CHEMBL310545,P45452,,PDGCWNNXCULGFK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11549451,ACTIVITY,=,19,NM,,,,,,,,,,,,,,Inhibitory activity against human Matrix metalloprotease-13,,"Selective, orally active MMP inhibitors with an aryl backbone.",Bioorg. Med. Chem. Lett.,2001,11,18,"Barta TE, Becker DP, Bedell LJ, De Crescenzo GA, McDonald JJ, Mehta P, Munie GE, Villamil CI",,106466,DTCT0024002,1642639,DTCC00240810,2045133,4449
CHEMBL310608,P45452,,BCVFMUCILNFXOC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773041,IC50,=,22,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-13,,"Synthesis and structure-activity relationship of alpha-sulfonylhydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Grosu GT, Davis JM, Hu B, Ellingboe J, Baker JL, Skotnicki JS, Zask A, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R",,106627,DTCT0024002,795311,DTCC00105982,96681,17339
CHEMBL310649,P45452,,YEKVTHFNPVYQBX-DJZRFWRSSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,9873598,IC50,=,10.4,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13 (MMP-13),,The synthesis and biological activity of a novel series of diazepine MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,19,"Levin JI, DiJoseph JF, Killar LM, Sung A, Walter T, Sharr MA, Roth CE, Skotnicki JS, Albright JD",,106628,DTCT0024002,588045,DTCC00252090,129095,2791
CHEMBL310649,P45452,,YEKVTHFNPVYQBX-DJZRFWRSSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,9873598,INHIBITION,=,0.77,%,,organism_based,,,,,,,,,,,,In vivo inhibition of matrix metalloprotease-13 (MMP-13) in mouse dialysis tubing implant assay at 50 mg/kg po,,The synthesis and biological activity of a novel series of diazepine MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,19,"Levin JI, DiJoseph JF, Killar LM, Sung A, Walter T, Sharr MA, Roth CE, Skotnicki JS, Albright JD",,106766,DTCT0024002,588046,DTCC00252090,129095,2791
CHEMBL310655,P45452,,CTCOBJWAVVPWJG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,9873598,IC50,=,26,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13 (MMP-13),,The synthesis and biological activity of a novel series of diazepine MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,19,"Levin JI, DiJoseph JF, Killar LM, Sung A, Walter T, Sharr MA, Roth CE, Skotnicki JS, Albright JD",,106628,DTCT0024002,610096,DTCC00252278,582785,2791
CHEMBL310655,P45452,,CTCOBJWAVVPWJG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,9873598,INHIBITION,,,,,organism_based,,,,,,,,,,,,In vivo inhibition of matrix metalloprotease-13 (MMP-13) in mouse dialysis tubing implant assay at 50 mg/kg po (inactive),Not Active,The synthesis and biological activity of a novel series of diazepine MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,19,"Levin JI, DiJoseph JF, Killar LM, Sung A, Walter T, Sharr MA, Roth CE, Skotnicki JS, Albright JD",,106767,DTCT0024002,610097,DTCC00252278,582785,2791
CHEMBL310655,P45452,,CTCOBJWAVVPWJG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,IC50,=,25.7,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258757,DTCC00252278,585414,24803
CHEMBL310684,P45452,,FJXZBLKBEVSCAB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773042,IC50,=,7,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13.,,"Synthesis and structure-activity relationship of N-substituted 4-arylsulfonylpiperidine-4-hydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Davis JM, Grosu GT, Baker J, Ellingboe J, Zask A, Levin JI, Sandanayaka VP, Du M, Skotnicki JS, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R, Tillett J, Zhao W, McDevitt J, Xu ZB",,106632,DTCT0024002,495604,DTCC00235084,1403250,17340
CHEMBL310688,P45452,,XGMBTNMILCXDFB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773041,IC50,=,0.4,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-13,,"Synthesis and structure-activity relationship of alpha-sulfonylhydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Grosu GT, Davis JM, Hu B, Ellingboe J, Baker JL, Skotnicki JS, Zask A, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R",,106627,DTCT0024002,786923,DTCC00234643,421870,17339
CHEMBL311004,P45452,,FNURWSLLBXZLRC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11472202,IC50,=,1,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,106478,DTCT0024002,1291622,DTCC00242427,582684,16328
CHEMBL311004,P45452,,FNURWSLLBXZLRC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,IC50,=,1,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258649,DTCC00242427,585411,24803
CHEMBL3110281,P45452,,QQYCFXUASOHQCY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,24304348,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of MMP-13 (unknown origin) using omniMMP as fluorogenic substrate at 10 uM preincubated for 30 mins followed by substrate addition measured after 30 mins by fluorescence assay,Active,Synthesis and structure-activity relationship of 3-hydroxypyridine-2-thione-based histone deacetylase inhibitors.,J. Med. Chem.,2013,56,24,"Sodji QH, Patil V, Kornacki JR, Mrksich M, Oyelere AK",,1286646,DTCT0024002,12997861,DTCC01420618,1107623,57022
CHEMBL3110287,P45452,,YYRBBLSWPCHZTE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,24304348,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of MMP-13 (unknown origin) using omniMMP as fluorogenic substrate at 10 uM preincubated for 30 mins followed by substrate addition measured after 30 mins by fluorescence assay,Active,Synthesis and structure-activity relationship of 3-hydroxypyridine-2-thione-based histone deacetylase inhibitors.,J. Med. Chem.,2013,56,24,"Sodji QH, Patil V, Kornacki JR, Mrksich M, Oyelere AK",,1286646,DTCT0024002,12997862,DTCC01420624,945416,57022
CHEMBL311097,P45452,,SBYCYYMPCYJMTP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11472202,IC50,=,29.5,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,106478,DTCT0024002,1305053,DTCC00242342,193495,16328
CHEMBL311097,P45452,,SBYCYYMPCYJMTP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,IC50,=,29.51,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258658,DTCC00242342,196125,24803
CHEMBL311266,P45452,,YUWSFQQPCKKPJG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11472202,IC50,=,0.4,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,106478,DTCT0024002,1307406,DTCC00242099,744290,16328
CHEMBL311266,P45452,,YUWSFQQPCKKPJG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11472202,IC50,=,3.5,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,106478,DTCT0024002,1319109,DTCC00242099,744289,16328
CHEMBL311266,P45452,,YUWSFQQPCKKPJG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,IC50,=,3.47,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258650,DTCC00242099,746931,24803
CHEMBL311304,P45452,,COEXRWHXVMMHEF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773041,IC50,=,14,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-13,,"Synthesis and structure-activity relationship of alpha-sulfonylhydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Grosu GT, Davis JM, Hu B, Ellingboe J, Baker JL, Skotnicki JS, Zask A, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R",,106627,DTCT0024002,800920,DTCC00234364,841411,17339
CHEMBL311357,P45452,,DTPBPOWGEIFZGM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773042,IC50,=,1,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13.,,"Synthesis and structure-activity relationship of N-substituted 4-arylsulfonylpiperidine-4-hydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Davis JM, Grosu GT, Baker J, Ellingboe J, Zask A, Levin JI, Sandanayaka VP, Du M, Skotnicki JS, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R, Tillett J, Zhao W, McDevitt J, Xu ZB",,106632,DTCT0024002,500338,DTCC00236210,1564343,17340
CHEMBL311357,P45452,,DTPBPOWGEIFZGM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,6,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260806,DTCC00236210,1555546,24831
CHEMBL311368,P45452,,FDKIFIWQKFBOTH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11206467,IC50,=,42,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-13,,The discovery of anthranilic acid-based MMP inhibitors. Part 1: SAR of the 3-position.,Bioorg. Med. Chem. Lett.,2001,11,2,"Levin JI, Du MT, DiJoseph JF, Killar LM, Sung A, Walter T, Sharr MA, Roth CE, Moy FJ, Powers R, Jin G, Cowling R, Skotnicki JS",,106467,DTCT0024002,590577,DTCC00234927,1163670,4515
CHEMBL311368,P45452,,FDKIFIWQKFBOTH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,IC50,=,41.69,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258705,DTCC00234927,1166449,24803
CHEMBL311436,P45452,,JZKQUJKQSKTEON-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773042,IC50,=,1,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13.,,"Synthesis and structure-activity relationship of N-substituted 4-arylsulfonylpiperidine-4-hydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Davis JM, Grosu GT, Baker J, Ellingboe J, Zask A, Levin JI, Sandanayaka VP, Du M, Skotnicki JS, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R, Tillett J, Zhao W, McDevitt J, Xu ZB",,106632,DTCT0024002,497946,DTCC00236036,303007,17340
CHEMBL311436,P45452,,JZKQUJKQSKTEON-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,6,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260796,DTCC00236036,294032,24831
CHEMBL311509,P45452,,NRADMZCIASMSFG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11206467,IC50,=,138,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-13,,The discovery of anthranilic acid-based MMP inhibitors. Part 1: SAR of the 3-position.,Bioorg. Med. Chem. Lett.,2001,11,2,"Levin JI, Du MT, DiJoseph JF, Killar LM, Sung A, Walter T, Sharr MA, Roth CE, Moy FJ, Powers R, Jin G, Cowling R, Skotnicki JS",,106467,DTCT0024002,589442,DTCC00234450,647735,4515
CHEMBL311509,P45452,,NRADMZCIASMSFG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11206468,IC50,=,138,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,Heteroaryl and cycloalkyl sulfonamide hydroxamic acid inhibitors of matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2001,11,2,"Levin JI, Gu Y, Nelson FC, Zask A, DiJoseph JF, Sharr MA, Sung A, Jin G, Cowling R, Chanda P, Cosmi S, Hsiao CL, Edris W, Wilhelm J, Killar LM, Skotnicki JS",,106621,DTCT0024002,1297188,DTCC00234450,659106,4516
CHEMBL311509,P45452,,NRADMZCIASMSFG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,IC50,=,138.04,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258706,DTCC00234450,650402,24803
CHEMBL311768,P45452,,KQTIZOWWQVTBNZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11206467,IC50,=,982,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-13,,The discovery of anthranilic acid-based MMP inhibitors. Part 1: SAR of the 3-position.,Bioorg. Med. Chem. Lett.,2001,11,2,"Levin JI, Du MT, DiJoseph JF, Killar LM, Sung A, Walter T, Sharr MA, Roth CE, Moy FJ, Powers R, Jin G, Cowling R, Skotnicki JS",,106467,DTCT0024002,600965,DTCC00234593,970237,4515
CHEMBL311840,P45452,,JJTWKBAUPPWAGL-BDCODIICSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12824028,IC50,=,4.3,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13,,Phosphinic acid-based MMP-13 inhibitors that spare MMP-1 and MMP-3.,Bioorg. Med. Chem. Lett.,2003,13,14,"Reiter LA, Mitchell PG, Martinelli GJ, Lopresti-Morrow LL, Yocum SA, Eskra JD",,106640,DTCT0024002,1498793,DTCC00105902,204778,5648
CHEMBL311932,P45452,,JIRXORZYIXSWOB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20965620,KI,=,3.1,NM,,,,,,,,,,,,,,Inhibition of MMP13 by fluorimetric assay,,"Structure-based approach to nanomolar, water soluble matrix metalloproteinases inhibitors (MMPIs).",Eur. J. Med. Chem.,2010,45,12,"Attolino E, Calderone V, Dragoni E, Fragai M, Richichi B, Luchinat C, Nativi C",,694548,DTCT0024002,5018618,DTCC00243867,587481,42241
CHEMBL311932,P45452,,JIRXORZYIXSWOB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23287054,IC50,=,3,NM,,,,,,,,,,,,,,Inhibition of MMP13 (unknown origin),,Sulphonamides: Deserving class as MMP inhibitors?,Eur. J. Med. Chem.,2013,60,,"Jain P, Saravanan C, Singh SK",,944584,DTCT0024002,11835692,DTCC00243867,609579,53820
CHEMBL311966,P45452,,RKPWDSLUQARCLB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773041,IC50,=,8,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-13,,"Synthesis and structure-activity relationship of alpha-sulfonylhydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Grosu GT, Davis JM, Hu B, Ellingboe J, Baker JL, Skotnicki JS, Zask A, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R",,106627,DTCT0024002,807783,DTCC00234644,1035190,17339
CHEMBL311966,P45452,,RKPWDSLUQARCLB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,5.1,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260783,DTCC00234644,1037862,24831
CHEMBL312100,P45452,,IOANZCGEYMTXEK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11472202,IC50,=,2.4,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,106478,DTCT0024002,1301290,DTCC00242298,1773867,16328
CHEMBL312100,P45452,,IOANZCGEYMTXEK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,IC50,=,2.4,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258645,DTCC00242298,1776498,24803
CHEMBL312429,P45452,,GNNAXEPAOIUDTH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773042,IC50,=,2,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13.,,"Synthesis and structure-activity relationship of N-substituted 4-arylsulfonylpiperidine-4-hydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Davis JM, Grosu GT, Baker J, Ellingboe J, Zask A, Levin JI, Sandanayaka VP, Du M, Skotnicki JS, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R, Tillett J, Zhao W, McDevitt J, Xu ZB",,106632,DTCT0024002,491907,DTCC00235603,1723009,17340
CHEMBL312429,P45452,,GNNAXEPAOIUDTH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,5.7,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260830,DTCC00235603,675880,24831
CHEMBL312432,P45452,,GWQPVXKPORBEIM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773042,IC50,=,6,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13.,,"Synthesis and structure-activity relationship of N-substituted 4-arylsulfonylpiperidine-4-hydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Davis JM, Grosu GT, Baker J, Ellingboe J, Zask A, Levin JI, Sandanayaka VP, Du M, Skotnicki JS, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R, Tillett J, Zhao W, McDevitt J, Xu ZB",,106632,DTCT0024002,481317,DTCC00235967,853156,17340
CHEMBL312432,P45452,,GWQPVXKPORBEIM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,5.22,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260797,DTCC00235967,844229,24831
CHEMBL312585,P45452,,RBRSAOMOZVVQSQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773042,IC50,=,44,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13.,,"Synthesis and structure-activity relationship of N-substituted 4-arylsulfonylpiperidine-4-hydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Davis JM, Grosu GT, Baker J, Ellingboe J, Zask A, Levin JI, Sandanayaka VP, Du M, Skotnicki JS, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R, Tillett J, Zhao W, McDevitt J, Xu ZB",,106632,DTCT0024002,504181,DTCC00235699,691269,17340
CHEMBL312585,P45452,,RBRSAOMOZVVQSQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,4.36,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260787,DTCC00235699,682328,24831
CHEMBL312770,P45452,,FTWZRZIOCFAVKU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773042,IC50,=,11,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13.,,"Synthesis and structure-activity relationship of N-substituted 4-arylsulfonylpiperidine-4-hydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Davis JM, Grosu GT, Baker J, Ellingboe J, Zask A, Levin JI, Sandanayaka VP, Du M, Skotnicki JS, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R, Tillett J, Zhao W, McDevitt J, Xu ZB",,106632,DTCT0024002,496715,DTCC00235821,2077096,17340
CHEMBL312770,P45452,,FTWZRZIOCFAVKU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,4.96,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260793,DTCC00235821,2068214,24831
CHEMBL313168,P45452,,APKANDPILBIUDO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,9873598,IC50,=,17,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13 (MMP-13),,The synthesis and biological activity of a novel series of diazepine MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,19,"Levin JI, DiJoseph JF, Killar LM, Sung A, Walter T, Sharr MA, Roth CE, Skotnicki JS, Albright JD",,106628,DTCT0024002,606778,DTCC00252091,1806451,2791
CHEMBL313168,P45452,,APKANDPILBIUDO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,9873598,INHIBITION,,,,,organism_based,,,,,,,,,,,,In vivo inhibition of matrix metalloprotease-13 (MMP-13) in mouse dialysis tubing implant assay at 50 mg/kg po (inactive),Not Active,The synthesis and biological activity of a novel series of diazepine MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,19,"Levin JI, DiJoseph JF, Killar LM, Sung A, Walter T, Sharr MA, Roth CE, Skotnicki JS, Albright JD",,106767,DTCT0024002,360906,DTCC00252091,1806451,2791
CHEMBL313168,P45452,,APKANDPILBIUDO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,IC50,=,16.98,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258755,DTCC00252091,1808956,24803
CHEMBL313340,P45452,,IMQVPVWXNJYVAS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11472202,IC50,=,55.3,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,106478,DTCT0024002,1297514,DTCC00242488,577853,16328
CHEMBL313340,P45452,,IMQVPVWXNJYVAS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,IC50,=,54.95,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258648,DTCC00242488,682322,24803
CHEMBL315114,P45452,,IIBGHLQTRXDEKI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11472202,IC50,=,1,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,106478,DTCT0024002,1297521,DTCC00106157,1838801,16328
CHEMBL315114,P45452,,IIBGHLQTRXDEKI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,IC50,=,1,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258643,DTCC00106157,1841441,24803
CHEMBL316122,P45452,,TZYXPQOEDPWOHU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11591509,IC50,=,24000,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,alpha-Amino-beta-sulphone hydroxamates as potent MMP-13 inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2001,11,20,"Becker DP, Barta TE, Bedell L, DeCrescenzo G, Freskos J, Getman DP, Hockerman SL, Li M, Mehta P, Mischke B, Munie GE, Swearingen C, Villamil CI",,106603,DTCT0024002,675758,DTCC00255240,1596975,4540
CHEMBL316293,P45452,,MLONDWWDPWNWGR-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11591509,IC50,=,400,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,alpha-Amino-beta-sulphone hydroxamates as potent MMP-13 inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2001,11,20,"Becker DP, Barta TE, Bedell L, DeCrescenzo G, Freskos J, Getman DP, Hockerman SL, Li M, Mehta P, Mischke B, Munie GE, Swearingen C, Villamil CI",,106603,DTCT0024002,662265,DTCC00254469,1273261,4540
CHEMBL316298,P45452,,TXTZEVLHPGQYAR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12873518,IC50,=,5,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotein 13,,Acetylenic TACE inhibitors. Part 1. SAR of the acyclic sulfonamide hydroxamates.,Bioorg. Med. Chem. Lett.,2003,13,16,"Levin JI, Chen JM, Cheung K, Cole D, Crago C, Santos ED, Du X, Khafizova G, MacEwan G, Niu C, Salaski EJ, Zask A, Cummons T, Sung A, Xu J, Zhang Y, Xu W, Ayral-Kaloustian S, Jin G, Cowling R, Barone D, Mohler KM, Black RA, Skotnicki JS",,106634,DTCT0024002,772476,DTCC00260167,679858,5733
CHEMBL316489,P45452,,UGMUJIKGJCCUOY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12270165,IC50,=,2,NM,,,,,,,,,,,,,,Concentration required in vitro to inhibit Matrix metalloprotease-13,,Benzodiazepine inhibitors of the MMPs and TACE.,Bioorg. Med. Chem. Lett.,2002,12,20,"Nelson FC, Delos Santos E, Levin JI, Chen JM, Skotnicki JS, DiJoseph JF, Sharr MA, Sung A, Killar LM, Cowling R, Jin G, Roth CE, Albright JD",,106631,DTCT0024002,1535233,DTCC00263295,270284,5143
CHEMBL316822,P45452,,UTFGYUICVDXOSK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12270165,IC50,=,2,NM,,,,,,,,,,,,,,Concentration required in vitro to inhibit Matrix metalloprotease-13,,Benzodiazepine inhibitors of the MMPs and TACE.,Bioorg. Med. Chem. Lett.,2002,12,20,"Nelson FC, Delos Santos E, Levin JI, Chen JM, Skotnicki JS, DiJoseph JF, Sharr MA, Sung A, Killar LM, Cowling R, Jin G, Roth CE, Albright JD",,106631,DTCT0024002,1529291,DTCC00263703,368551,5143
CHEMBL316928,P45452,,AYPPVQRNMZPQMU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12873518,IC50,=,8,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotein 13,,Acetylenic TACE inhibitors. Part 1. SAR of the acyclic sulfonamide hydroxamates.,Bioorg. Med. Chem. Lett.,2003,13,16,"Levin JI, Chen JM, Cheung K, Cole D, Crago C, Santos ED, Du X, Khafizova G, MacEwan G, Niu C, Salaski EJ, Zask A, Cummons T, Sung A, Xu J, Zhang Y, Xu W, Ayral-Kaloustian S, Jin G, Cowling R, Barone D, Mohler KM, Black RA, Skotnicki JS",,106634,DTCT0024002,783671,DTCC00260084,1294087,5733
CHEMBL316954,P45452,,OHZMUNMVWGUMMY-PKTZIBPZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10522712,IC50,,,,,,,,,,,,,,,,,"Inhibition of Collagenase-3, MMP-13 (Not determined)",Not Determined,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,101905,DTCT0024002,1466338,DTCC00264378,1723295,3373
CHEMBL316978,P45452,,KCKFHONGIZWYTN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11543675,IC50,=,14,NM,,,,,,,,,,,,,,In vitro inhibition of human matrix metalloprotease-13,,"N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: further probing of the S(1), S(1)', and S(2)' pockets.",J. Med. Chem.,2001,44,19,"Hanessian S, Moitessier N, Gauchet C, Viau M",,106474,DTCT0024002,1381868,DTCC00273603,530282,16392
CHEMBL317132,P45452,,VGAPHGIXAQRVAL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11212095,IC50,=,0.016,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,General synthesis of alpha-substituted 3-bisaryloxy propionic acid derivatives as specific MMP inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,3,"Chollet AM, Le Diguarher T, Murray L, Bertrand M, Tucker GC, Sabatini M, Pierré A, Atassi G, Bonnet J, Casara P",,106483,DTCT0024002,649005,DTCC00269579,1067913,4635
CHEMBL317508,P45452,,ITDDXQSXMTUIFM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11212095,IC50,=,0.6,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,General synthesis of alpha-substituted 3-bisaryloxy propionic acid derivatives as specific MMP inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,3,"Chollet AM, Le Diguarher T, Murray L, Bertrand M, Tucker GC, Sabatini M, Pierré A, Atassi G, Bonnet J, Casara P",,106483,DTCT0024002,625727,DTCC00269558,1067912,4635
CHEMBL317624,P45452,,GHKVZKUXCOXDAW-AWEZNQCLSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12873518,IC50,=,41,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotein 13,,Acetylenic TACE inhibitors. Part 1. SAR of the acyclic sulfonamide hydroxamates.,Bioorg. Med. Chem. Lett.,2003,13,16,"Levin JI, Chen JM, Cheung K, Cole D, Crago C, Santos ED, Du X, Khafizova G, MacEwan G, Niu C, Salaski EJ, Zask A, Cummons T, Sung A, Xu J, Zhang Y, Xu W, Ayral-Kaloustian S, Jin G, Cowling R, Barone D, Mohler KM, Black RA, Skotnicki JS",,106634,DTCT0024002,777891,DTCC00260027,1132719,5733
CHEMBL318023,P45452,,ARFFCGXUOISSHZ-UXHICEINSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10522712,IC50,=,200,NM,,,,,,,,,,,,,,Inhibition of Coll-3 MMP-13,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,101904,DTCT0024002,1464023,DTCC00264599,1371183,3373
CHEMBL318023,P45452,,ARFFCGXUOISSHZ-UXHICEINSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,IC50,=,199.53,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258636,DTCC00264599,1361901,24803
CHEMBL318190,P45452,,MVEPSFJZKBVDHV-UXHICEINSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10522712,IC50,=,100,NM,,,,,,,,,,,,,,Inhibition of Coll-3 MMP-13,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,101904,DTCT0024002,1478674,DTCC00264484,949983,3373
CHEMBL318252,P45452,,ODPDWLUYVWCNHO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15125955,IC50,=,40000,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,Reverse hydroxamate-based selective TACE inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,11,"Kamei N, Tanaka T, Kawai K, Miyawaki K, Okuyama A, Murakami Y, Arakawa Y, Haino M, Harada T, Shimano M",,106641,DTCT0024002,1378638,DTCC00265469,917418,6400
CHEMBL318252,P45452,,ODPDWLUYVWCNHO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18790648,IC50,=,40000,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497406,DTCT0024002,2456478,DTCC00265469,920644,32556
CHEMBL318455,P45452,,VWOQXPBXOWHZCH-MSOLQXFVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10522712,IC50,=,600,NM,,,,,,,,,,,,,,Inhibition of Coll-3 MMP-13,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,101904,DTCT0024002,1457855,DTCC00263986,1240611,3373
CHEMBL318455,P45452,,VWOQXPBXOWHZCH-MSOLQXFVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,IC50,=,602.56,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258634,DTCC00263986,1231164,24803
CHEMBL318716,P45452,,LRVIJTRFTUQDKW-CABCVRRESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10522712,IC50,=,40,NM,,,,,,,,,,,,,,Inhibition of Coll-3 MMP-13,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,101904,DTCT0024002,1477307,DTCC00264594,335905,3373
CHEMBL318716,P45452,,LRVIJTRFTUQDKW-CABCVRRESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,IC50,=,39.81,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258630,DTCC00264594,326644,24803
CHEMBL318795,P45452,,QYMKPTMAFMKKTC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11212095,IC50,=,485,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,General synthesis of alpha-substituted 3-bisaryloxy propionic acid derivatives as specific MMP inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,3,"Chollet AM, Le Diguarher T, Murray L, Bertrand M, Tucker GC, Sabatini M, Pierré A, Atassi G, Bonnet J, Casara P",,106483,DTCT0024002,633446,DTCC00269560,1871037,4635
CHEMBL318922,P45452,,SDPZKVFCJYXZLE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11677139,IC50,=,20,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-13.,,The discovery of anthranilic acid-based MMP inhibitors. Part 3: incorporation of basic amines.,Bioorg. Med. Chem. Lett.,2001,11,22,"Levin JI, Chen JM, Du MT, Nelson FC, Wehr T, DiJoseph JF, Killar LM, Skala S, Sung A, Sharr MA, Roth CE, Jin G, Cowling R, Di L, Sherman M, Xu ZB, March CJ, Mohler KM, Black RA, Skotnicki JS",,106763,DTCT0024002,1619954,DTCC00268369,1618093,4590
CHEMBL319040,P45452,,MVTUAPMXVXQWFM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11543675,IC50,=,3.8,NM,,,,,,,,,,,,,,In vitro inhibition of human matrix metalloprotease-13,,"N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: further probing of the S(1), S(1)', and S(2)' pockets.",J. Med. Chem.,2001,44,19,"Hanessian S, Moitessier N, Gauchet C, Viau M",,106474,DTCT0024002,1404227,DTCC00273183,1980402,16392
CHEMBL319055,P45452,,YTDQNSGULXQVKB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11133099,IC50,=,1000,NM,,,,,,,,,,,,,,50 percent inhibition of human Matrix metalloprotease-13 by the cleavage of fluorogenic peptide MCA-Pro-Leu-Gly-Leu-Dpa-ala-Arg-NH2,,Synthesis and activity of selective MMP inhibitors with an aryl backbone.,Bioorg. Med. Chem. Lett.,2000,10,24,"Barta TE, Becker DP, Bedell LJ, De Crescenzo GA, McDonald JJ, Munie GE, Rao S, Shieh HS, Stegeman R, Stevens AM, Villamil CI",,106604,DTCT0024002,707419,DTCC00260695,1774074,3985
CHEMBL319075,P45452,,LLVLFZAKVKFNSB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15163180,KI,>,5025,NM,,,,,,,,,,,,,,Inhibition of recombinant human Matrix metalloprotease-13,,Sultam hydroxamates as novel matrix metalloproteinase inhibitors.,J. Med. Chem.,2004,47,12,"Cherney RJ, Mo R, Meyer DT, Hardman KD, Liu RQ, Covington MB, Qian M, Wasserman ZR, Christ DD, Trzaskos JM, Newton RC, Decicco CP",,106611,DTCT0024002,655348,DTCC00269143,1935390,18131
CHEMBL319341,P45452,,YYZDREAOBMTNAP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11677139,IC50,=,0.8,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-13.,,The discovery of anthranilic acid-based MMP inhibitors. Part 3: incorporation of basic amines.,Bioorg. Med. Chem. Lett.,2001,11,22,"Levin JI, Chen JM, Du MT, Nelson FC, Wehr T, DiJoseph JF, Killar LM, Skala S, Sung A, Sharr MA, Roth CE, Jin G, Cowling R, Di L, Sherman M, Xu ZB, March CJ, Mohler KM, Black RA, Skotnicki JS",,106763,DTCT0024002,1632658,DTCC00269065,1456234,4590
CHEMBL319341,P45452,,YYZDREAOBMTNAP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23287054,IC50,=,0.8,NM,,,,,,,,,,,,,,Inhibition of MMP13 (unknown origin),,Sulphonamides: Deserving class as MMP inhibitors?,Eur. J. Med. Chem.,2013,60,,"Jain P, Saravanan C, Singh SK",,944584,DTCT0024002,11835680,DTCC00269065,1482994,53820
CHEMBL319782,P45452,,QBIHWFSRXVWUDN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15125955,IC50,=,7000,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,Reverse hydroxamate-based selective TACE inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,11,"Kamei N, Tanaka T, Kawai K, Miyawaki K, Okuyama A, Murakami Y, Arakawa Y, Haino M, Harada T, Shimano M",,106641,DTCT0024002,1398532,DTCC00265485,1338612,6400
CHEMBL319808,P45452,,QRDJMZMVDBUNNQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12270165,IC50,=,317,NM,,,,,,,,,,,,,,Concentration required in vitro to inhibit Matrix metalloprotease-13,,Benzodiazepine inhibitors of the MMPs and TACE.,Bioorg. Med. Chem. Lett.,2002,12,20,"Nelson FC, Delos Santos E, Levin JI, Chen JM, Skotnicki JS, DiJoseph JF, Sharr MA, Sung A, Killar LM, Cowling R, Jin G, Roth CE, Albright JD",,106631,DTCT0024002,1523653,DTCC00263064,1980295,5143
CHEMBL319887,P45452,,HEYGZWVOCCBCPY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11677139,IC50,=,6,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-13.,,The discovery of anthranilic acid-based MMP inhibitors. Part 3: incorporation of basic amines.,Bioorg. Med. Chem. Lett.,2001,11,22,"Levin JI, Chen JM, Du MT, Nelson FC, Wehr T, DiJoseph JF, Killar LM, Skala S, Sung A, Sharr MA, Roth CE, Jin G, Cowling R, Di L, Sherman M, Xu ZB, March CJ, Mohler KM, Black RA, Skotnicki JS",,106763,DTCT0024002,1600781,DTCC00269081,193779,4590
CHEMBL319902,P45452,,JIYWMQDJGOAJMD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11677139,IC50,=,3,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-13.,,The discovery of anthranilic acid-based MMP inhibitors. Part 3: incorporation of basic amines.,Bioorg. Med. Chem. Lett.,2001,11,22,"Levin JI, Chen JM, Du MT, Nelson FC, Wehr T, DiJoseph JF, Killar LM, Skala S, Sung A, Sharr MA, Roth CE, Jin G, Cowling R, Di L, Sherman M, Xu ZB, March CJ, Mohler KM, Black RA, Skotnicki JS",,106763,DTCT0024002,1633949,DTCC00268967,193778,4590
CHEMBL320383,P45452,,IPNPHTJFPPPVQA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11677139,IC50,=,19,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-13.,,The discovery of anthranilic acid-based MMP inhibitors. Part 3: incorporation of basic amines.,Bioorg. Med. Chem. Lett.,2001,11,22,"Levin JI, Chen JM, Du MT, Nelson FC, Wehr T, DiJoseph JF, Killar LM, Skala S, Sung A, Sharr MA, Roth CE, Jin G, Cowling R, Di L, Sherman M, Xu ZB, March CJ, Mohler KM, Black RA, Skotnicki JS",,106763,DTCT0024002,1622502,DTCC00268367,841777,4590
CHEMBL320402,P45452,,TWQZYQBXMVVVCY-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11543676,IC50,=,12,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,Design and synthesis of matrix metalloproteinase inhibitors guided by molecular modeling. Picking the S(1) pocket using conformationally constrained inhibitors.,J. Med. Chem.,2001,44,19,"Hanessian S, MacKay DB, Moitessier N",,106482,DTCT0024002,1182607,DTCC00273854,1521206,16385
CHEMBL320442,P45452,,NQHPVFGLBXTGFR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11543675,IC50,=,5.1,NM,,,,,,,,,,,,,,In vitro inhibition of human matrix metalloprotease-13,,"N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: further probing of the S(1), S(1)', and S(2)' pockets.",J. Med. Chem.,2001,44,19,"Hanessian S, Moitessier N, Gauchet C, Viau M",,106474,DTCT0024002,1381863,DTCC00273104,627204,16392
CHEMBL321055,P45452,,QDICWLMZEKDVEQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15163180,KI,>,5025,NM,,,,,,,,,,,,,,Inhibition of recombinant human Matrix metalloprotease-13,,Sultam hydroxamates as novel matrix metalloproteinase inhibitors.,J. Med. Chem.,2004,47,12,"Cherney RJ, Mo R, Meyer DT, Hardman KD, Liu RQ, Covington MB, Qian M, Wasserman ZR, Christ DD, Trzaskos JM, Newton RC, Decicco CP",,106611,DTCT0024002,461445,DTCC00269070,1392183,18131
CHEMBL321213,P45452,,UVGAWIJNBYCHSP-LBPRGKRZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11563922,KI,=,260,NM,,,,,,,,,,,,,,In Vitro inhibitory activity against the catalytic domain of the matrix metalloprotease-13,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,106610,DTCT0024002,1681723,DTCC00282582,874479,16424
CHEMBL321257,P45452,,CYZMUIMLRBJSRO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15177439,IC50,=,1.2,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP-13),,Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2004,14,13,"Reiter LA, Robinson RP, McClure KF, Jones CS, Reese MR, Mitchell PG, Otterness IG, Bliven ML, Liras J, Cortina SR, Donahue KM, Eskra JD, Griffiths RJ, Lame ME, Lopez-Anaya A, Martinelli GJ, McGahee SM, Yocum SA, Lopresti-Morrow LL, Tobiassen LM, Vaughn-Bowser ML",,106600,DTCT0024002,1490187,DTCC00287960,141196,6475
CHEMBL321257,P45452,,CYZMUIMLRBJSRO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15177439,INHIBITION,<,48,%,,organism_based,,,,,,,,,,,,Inhibition of MMP-13 induced experimental arthritis in hamster knee by 30 mg/kg p.o.,,Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2004,14,13,"Reiter LA, Robinson RP, McClure KF, Jones CS, Reese MR, Mitchell PG, Otterness IG, Bliven ML, Liras J, Cortina SR, Donahue KM, Eskra JD, Griffiths RJ, Lame ME, Lopez-Anaya A, Martinelli GJ, McGahee SM, Yocum SA, Lopresti-Morrow LL, Tobiassen LM, Vaughn-Bowser ML",,82692,DTCT0024002,1490192,DTCC00287960,141196,6475
CHEMBL321556,P45452,,DQDPBMDGDOPPLK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12873518,IC50,=,99,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotein 13,,Acetylenic TACE inhibitors. Part 1. SAR of the acyclic sulfonamide hydroxamates.,Bioorg. Med. Chem. Lett.,2003,13,16,"Levin JI, Chen JM, Cheung K, Cole D, Crago C, Santos ED, Du X, Khafizova G, MacEwan G, Niu C, Salaski EJ, Zask A, Cummons T, Sung A, Xu J, Zhang Y, Xu W, Ayral-Kaloustian S, Jin G, Cowling R, Barone D, Mohler KM, Black RA, Skotnicki JS",,106634,DTCT0024002,814659,DTCC00259627,550742,5733
CHEMBL321556,P45452,,DQDPBMDGDOPPLK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17289381,KI,=,17,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Novel thiol-based TACE inhibitors: rational design, synthesis, and SAR of thiol-containing aryl sulfonamides.",Bioorg. Med. Chem. Lett.,2007,17,8,"Govinda Rao B, Bandarage UK, Wang T, Come JH, Perola E, Wei Y, Tian SK, Saunders JO",,442207,DTCT0024002,2162340,DTCC00259627,564440,23225
CHEMBL321633,P45452,,REZSPXZZCJTZIK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15177439,IC50,=,0.5,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP-13),,Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2004,14,13,"Reiter LA, Robinson RP, McClure KF, Jones CS, Reese MR, Mitchell PG, Otterness IG, Bliven ML, Liras J, Cortina SR, Donahue KM, Eskra JD, Griffiths RJ, Lame ME, Lopez-Anaya A, Martinelli GJ, McGahee SM, Yocum SA, Lopresti-Morrow LL, Tobiassen LM, Vaughn-Bowser ML",,106600,DTCT0024002,1495021,DTCC00288306,1915036,6475
CHEMBL321633,P45452,,REZSPXZZCJTZIK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15177439,IC50,=,3.3,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP-13),,Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2004,14,13,"Reiter LA, Robinson RP, McClure KF, Jones CS, Reese MR, Mitchell PG, Otterness IG, Bliven ML, Liras J, Cortina SR, Donahue KM, Eskra JD, Griffiths RJ, Lame ME, Lopez-Anaya A, Martinelli GJ, McGahee SM, Yocum SA, Lopresti-Morrow LL, Tobiassen LM, Vaughn-Bowser ML",,106600,DTCT0024002,1491457,DTCC00288306,1915035,6475
CHEMBL321633,P45452,,REZSPXZZCJTZIK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15177439,INHIBITION,=,54,%,,organism_based,,,,,,,,,,,,Inhibition of MMP-13 induced experimental arthritis in hamster knee by 30 mg/kg p.o.,,Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2004,14,13,"Reiter LA, Robinson RP, McClure KF, Jones CS, Reese MR, Mitchell PG, Otterness IG, Bliven ML, Liras J, Cortina SR, Donahue KM, Eskra JD, Griffiths RJ, Lame ME, Lopez-Anaya A, Martinelli GJ, McGahee SM, Yocum SA, Lopresti-Morrow LL, Tobiassen LM, Vaughn-Bowser ML",,82692,DTCT0024002,1495028,DTCC00288306,1915036,6475
CHEMBL3221863,P45452,,BJIOETDXHXZDRQ-LEAFIULHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,IC50,=,1230,NM,,,,,,,,,,,,,,Inhibition of MMP13 (unknown origin) by fluorescence-based FRET assay,,,MedChemComm,2011,2,10,,,1328287,DTCT0024002,13574318,DTCC01468798,1845949,39059
CHEMBL3221864,P45452,,OKHKINWJYOOKOF-GGXMVOPNSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,IC50,=,1114,NM,,,,,,,,,,,,,,Inhibition of MMP13 (unknown origin) by fluorescence-based FRET assay,,,MedChemComm,2011,2,10,,,1328287,DTCT0024002,13574319,DTCC01468799,396851,39059
CHEMBL322412,P45452,,ZAVWWISQYKVWCT-GFOWMXPYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11543676,IC50,=,44.2,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,Design and synthesis of matrix metalloproteinase inhibitors guided by molecular modeling. Picking the S(1) pocket using conformationally constrained inhibitors.,J. Med. Chem.,2001,44,19,"Hanessian S, MacKay DB, Moitessier N",,106482,DTCT0024002,1194621,DTCC00273571,615409,16385
CHEMBL322433,P45452,,NVAYQDCPVGCOHV-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15163180,KI,=,3,NM,,,,,,,,,,,,,,Inhibition of recombinant human Matrix metalloprotease-13,,Sultam hydroxamates as novel matrix metalloproteinase inhibitors.,J. Med. Chem.,2004,47,12,"Cherney RJ, Mo R, Meyer DT, Hardman KD, Liu RQ, Covington MB, Qian M, Wasserman ZR, Christ DD, Trzaskos JM, Newton RC, Decicco CP",,106611,DTCT0024002,659120,DTCC00269212,1839095,18131
CHEMBL322476,P45452,,YSMSZPWEAVKTEN-VBKZILBWSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12951101,IC50,=,127,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-13.,,Synthesis and biological activity of piperazine-based dual MMP-13 and TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,19,"Letavic MA, Barberia JT, Carty TJ, Hardink JR, Liras J, Lopresti-Morrow LL, Mitchell PG, Noe MC, Reeves LM, Snow SL, Stam EJ, Sweeney FJ, Vaughn ML, Yu CH",,106625,DTCT0024002,677023,DTCC00282926,1164242,5809
CHEMBL322705,P45452,,NOTPJXXSHYGYMI-OXJNMPFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12951101,IC50,,,,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13 (not determined),Not Determined,Synthesis and biological activity of piperazine-based dual MMP-13 and TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,19,"Letavic MA, Barberia JT, Carty TJ, Hardink JR, Liras J, Lopresti-Morrow LL, Mitchell PG, Noe MC, Reeves LM, Snow SL, Stam EJ, Sweeney FJ, Vaughn ML, Yu CH",,106626,DTCT0024002,465968,DTCC00282531,226305,5809
CHEMBL322795,P45452,,LEDMBBYIVRLZAS-GFCCVEGCSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11563922,KI,=,300,NM,,,,,,,,,,,,,,In Vitro inhibitory activity against the catalytic domain of the matrix metalloprotease-13,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,106610,DTCT0024002,1707162,DTCC00282335,389662,16424
CHEMBL322888,P45452,,VOEOVKSVTSGALB-ZGTCLIOFSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11543676,IC50,=,218,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,Design and synthesis of matrix metalloproteinase inhibitors guided by molecular modeling. Picking the S(1) pocket using conformationally constrained inhibitors.,J. Med. Chem.,2001,44,19,"Hanessian S, MacKay DB, Moitessier N",,106482,DTCT0024002,1183568,DTCC00273544,583007,16385
CHEMBL323148,P45452,,YUYXLIRWRFFNDS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11212095,IC50,=,84,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,General synthesis of alpha-substituted 3-bisaryloxy propionic acid derivatives as specific MMP inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,3,"Chollet AM, Le Diguarher T, Murray L, Bertrand M, Tucker GC, Sabatini M, Pierré A, Atassi G, Bonnet J, Casara P",,106483,DTCT0024002,640136,DTCC00269613,615363,4635
CHEMBL323371,P45452,,PRCRNUDMWULKSO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11212095,IC50,=,3,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,General synthesis of alpha-substituted 3-bisaryloxy propionic acid derivatives as specific MMP inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,3,"Chollet AM, Le Diguarher T, Murray L, Bertrand M, Tucker GC, Sabatini M, Pierré A, Atassi G, Bonnet J, Casara P",,106483,DTCT0024002,640142,DTCC00269593,389494,4635
CHEMBL3235416,P45452,,QEPAXTJXHXPFJN-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,24735644,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13-mediated amyloid beta hydrolysis after 10 mins by fluorimetry assay,,"Imidazole-derived 2-[N-carbamoylmethyl-alkylamino]acetic acids, substrate-dependent modulators of insulin-degrading enzyme in amyloid-ß hydrolysis.",Eur. J. Med. Chem.,2014,79,,"Charton J, Gauriot M, Guo Q, Hennuyer N, Marechal X, Dumont J, Hamdane M, Pottiez V, Landry V, Sperandio O, Flipo M, Buee L, Staels B, Leroux F, Tang WJ, Deprez B, Deprez-Poulain R",,1339915,DTCT0024002,13609095,DTCC01474446,977836,57952
CHEMBL323575,P45452,,WNQMYJZKTYVQPU-BPGUCPLFSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11543676,IC50,=,22.3,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,Design and synthesis of matrix metalloproteinase inhibitors guided by molecular modeling. Picking the S(1) pocket using conformationally constrained inhibitors.,J. Med. Chem.,2001,44,19,"Hanessian S, MacKay DB, Moitessier N",,106482,DTCT0024002,1180468,DTCC00273545,1742428,16385
CHEMBL323612,P45452,CP-471474,QCOQJYRPDUMCNP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15177439,IC50,=,0.9,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP-13),,Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2004,14,13,"Reiter LA, Robinson RP, McClure KF, Jones CS, Reese MR, Mitchell PG, Otterness IG, Bliven ML, Liras J, Cortina SR, Donahue KM, Eskra JD, Griffiths RJ, Lame ME, Lopez-Anaya A, Martinelli GJ, McGahee SM, Yocum SA, Lopresti-Morrow LL, Tobiassen LM, Vaughn-Bowser ML",,106600,DTCT0024002,1484344,DTCC01742415,1435822,6475
CHEMBL323612,P45452,CP-471474,QCOQJYRPDUMCNP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15177439,INHIBITION,=,56,%,,organism_based,,,,,,,,,,,,Inhibition of MMP-13 induced experimental arthritis in hamster knee by 30 mg/kg p.o.,,Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2004,14,13,"Reiter LA, Robinson RP, McClure KF, Jones CS, Reese MR, Mitchell PG, Otterness IG, Bliven ML, Liras J, Cortina SR, Donahue KM, Eskra JD, Griffiths RJ, Lame ME, Lopez-Anaya A, Martinelli GJ, McGahee SM, Yocum SA, Lopresti-Morrow LL, Tobiassen LM, Vaughn-Bowser ML",,82692,DTCT0024002,1484351,DTCC01742415,1435822,6475
CHEMBL323885,P45452,,NRVATKFKFLOMDK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,14711305,KI,=,200000,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,Evaluation of P1'-diversified phosphinic peptides leads to the development of highly selective inhibitors of MMP-11.,J. Med. Chem.,2004,47,2,"Matziari M, Beau F, Cuniasse P, Dive V, Yiotakis A",,106771,DTCT0024002,1265943,DTCC00287362,1079825,17924
CHEMBL324555,P45452,,ONGCECNMBMSPOG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15177439,IC50,=,210,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP-13),,Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2004,14,13,"Reiter LA, Robinson RP, McClure KF, Jones CS, Reese MR, Mitchell PG, Otterness IG, Bliven ML, Liras J, Cortina SR, Donahue KM, Eskra JD, Griffiths RJ, Lame ME, Lopez-Anaya A, Martinelli GJ, McGahee SM, Yocum SA, Lopresti-Morrow LL, Tobiassen LM, Vaughn-Bowser ML",,106600,DTCT0024002,1509271,DTCC00288636,237873,6475
CHEMBL324578,P45452,,FWHAUZNOWRAZOA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15177439,IC50,=,24,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP-13),,Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2004,14,13,"Reiter LA, Robinson RP, McClure KF, Jones CS, Reese MR, Mitchell PG, Otterness IG, Bliven ML, Liras J, Cortina SR, Donahue KM, Eskra JD, Griffiths RJ, Lame ME, Lopez-Anaya A, Martinelli GJ, McGahee SM, Yocum SA, Lopresti-Morrow LL, Tobiassen LM, Vaughn-Bowser ML",,106600,DTCT0024002,1490201,DTCC00288167,1175920,6475
CHEMBL324615,P45452,,QWBFNTUMBVGNBO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15177439,IC50,=,6.5,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP-13),,Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2004,14,13,"Reiter LA, Robinson RP, McClure KF, Jones CS, Reese MR, Mitchell PG, Otterness IG, Bliven ML, Liras J, Cortina SR, Donahue KM, Eskra JD, Griffiths RJ, Lame ME, Lopez-Anaya A, Martinelli GJ, McGahee SM, Yocum SA, Lopresti-Morrow LL, Tobiassen LM, Vaughn-Bowser ML",,106600,DTCT0024002,1499591,DTCC00288170,1435823,6475
CHEMBL324615,P45452,,QWBFNTUMBVGNBO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15177439,INHIBITION,=,11,%,,organism_based,,,,,,,,,,,,Inhibition of MMP-13 induced experimental arthritis in hamster knee by 30 mg/kg p.o.,,Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2004,14,13,"Reiter LA, Robinson RP, McClure KF, Jones CS, Reese MR, Mitchell PG, Otterness IG, Bliven ML, Liras J, Cortina SR, Donahue KM, Eskra JD, Griffiths RJ, Lame ME, Lopez-Anaya A, Martinelli GJ, McGahee SM, Yocum SA, Lopresti-Morrow LL, Tobiassen LM, Vaughn-Bowser ML",,82692,DTCT0024002,1499595,DTCC00288170,1435823,6475
CHEMBL324806,P45452,,MEDAEECOIUAMSO-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15177439,IC50,=,0.93,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP-13),,Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2004,14,13,"Reiter LA, Robinson RP, McClure KF, Jones CS, Reese MR, Mitchell PG, Otterness IG, Bliven ML, Liras J, Cortina SR, Donahue KM, Eskra JD, Griffiths RJ, Lame ME, Lopez-Anaya A, Martinelli GJ, McGahee SM, Yocum SA, Lopresti-Morrow LL, Tobiassen LM, Vaughn-Bowser ML",,106600,DTCT0024002,1507023,DTCC00288257,1403850,6475
CHEMBL324891,P45452,,YDDMVPLLJTZTQL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,14711305,KI,=,15700,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,Evaluation of P1'-diversified phosphinic peptides leads to the development of highly selective inhibitors of MMP-11.,J. Med. Chem.,2004,47,2,"Matziari M, Beau F, Cuniasse P, Dive V, Yiotakis A",,106771,DTCT0024002,1257648,DTCC00287325,30861,17924
CHEMBL325150,P45452,,NKDZJRDULDIJON-HFZDXXHNSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12951101,IC50,,,,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13 (not determined),Not Determined,Synthesis and biological activity of piperazine-based dual MMP-13 and TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,19,"Letavic MA, Barberia JT, Carty TJ, Hardink JR, Liras J, Lopresti-Morrow LL, Mitchell PG, Noe MC, Reeves LM, Snow SL, Stam EJ, Sweeney FJ, Vaughn ML, Yu CH",,106626,DTCT0024002,660993,DTCC00283047,1682555,5809
CHEMBL325163,P45452,,RWKJBOMUESGCBO-REUBFRLUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11585440,KI,=,653,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,"Discovery of macrocyclic hydroxamic acids containing biphenylmethyl derivatives at P1', a series of selective TNF-alpha converting enzyme inhibitors with potent cellular activity in the inhibition of TNF-alpha release.",J. Med. Chem.,2001,44,21,"Xue CB, He X, Corbett RL, Roderick J, Wasserman ZR, Liu RQ, Jaffee BD, Covington MB, Qian M, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,106614,DTCT0024002,1311927,DTCC00287408,1500490,16439
CHEMBL325163,P45452,,RWKJBOMUESGCBO-REUBFRLUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18790648,KI,=,653,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497406,DTCT0024002,2457313,DTCC00287408,1503285,32556
CHEMBL325678,P45452,,OGAPQRGMHIGAGP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15177439,IC50,=,0.65,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP-13),,Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2004,14,13,"Reiter LA, Robinson RP, McClure KF, Jones CS, Reese MR, Mitchell PG, Otterness IG, Bliven ML, Liras J, Cortina SR, Donahue KM, Eskra JD, Griffiths RJ, Lame ME, Lopez-Anaya A, Martinelli GJ, McGahee SM, Yocum SA, Lopresti-Morrow LL, Tobiassen LM, Vaughn-Bowser ML",,106600,DTCT0024002,1485651,DTCC00289031,1079840,6475
CHEMBL325903,P45452,,QVDLODFAOYNBNI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15177439,IC50,=,5,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP-13),,Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2004,14,13,"Reiter LA, Robinson RP, McClure KF, Jones CS, Reese MR, Mitchell PG, Otterness IG, Bliven ML, Liras J, Cortina SR, Donahue KM, Eskra JD, Griffiths RJ, Lame ME, Lopez-Anaya A, Martinelli GJ, McGahee SM, Yocum SA, Lopresti-Morrow LL, Tobiassen LM, Vaughn-Bowser ML",,106600,DTCT0024002,1515016,DTCC00288461,270555,6475
CHEMBL326221,P45452,,BVVZNDQVRQLIPW-OXJNMPFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12951101,IC50,=,4,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-13.,,Synthesis and biological activity of piperazine-based dual MMP-13 and TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,19,"Letavic MA, Barberia JT, Carty TJ, Hardink JR, Liras J, Lopresti-Morrow LL, Mitchell PG, Noe MC, Reeves LM, Snow SL, Stam EJ, Sweeney FJ, Vaughn ML, Yu CH",,106625,DTCT0024002,669402,DTCC00283097,615501,5809
CHEMBL326369,P45452,,MEDAEECOIUAMSO-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15177439,IC50,=,0.37,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP-13),,Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2004,14,13,"Reiter LA, Robinson RP, McClure KF, Jones CS, Reese MR, Mitchell PG, Otterness IG, Bliven ML, Liras J, Cortina SR, Donahue KM, Eskra JD, Griffiths RJ, Lame ME, Lopez-Anaya A, Martinelli GJ, McGahee SM, Yocum SA, Lopresti-Morrow LL, Tobiassen LM, Vaughn-Bowser ML",,106600,DTCT0024002,1484352,DTCC00288256,2077685,6475
CHEMBL326489,P45452,,MDNBGABATBOAOY-YCLCTBJKSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12877590,NT,,,,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 (Not tested),Not Determined,"A potent, selective inhibitor of matrix metalloproteinase-3 for the topical treatment of chronic dermal ulcers.",J. Med. Chem.,2003,46,16,"Fray MJ, Dickinson RP, Huggins JP, Occleston NL",,106615,DTCT0024002,1547326,DTCC00293235,258687,17445
CHEMBL327002,P45452,WAY-170523,FARMEEAGJWMFSZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15214773,IC50,=,17,NM,,,,,,,,,,,,,,Inhibition of Matrix Metalloprotease-13 (MMP-13),,Fragment-based drug discovery.,J. Med. Chem.,2004,47,14,"Erlanson DA, McDowell RS, O'Brien T",,106644,DTCT0024002,637219,DTCC01742508,336206,17883
CHEMBL327108,P45452,,ONKQNWHNBOMBCR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,14711305,KI,=,4700,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,Evaluation of P1'-diversified phosphinic peptides leads to the development of highly selective inhibitors of MMP-11.,J. Med. Chem.,2004,47,2,"Matziari M, Beau F, Cuniasse P, Dive V, Yiotakis A",,106771,DTCT0024002,1256341,DTCC00287264,917661,17924
CHEMBL327202,P45452,,URDGWSJUKZHMCI-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11591509,IC50,=,2000,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,alpha-Amino-beta-sulphone hydroxamates as potent MMP-13 inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2001,11,20,"Becker DP, Barta TE, Bedell L, DeCrescenzo G, Freskos J, Getman DP, Hockerman SL, Li M, Mehta P, Mischke B, Munie GE, Swearingen C, Villamil CI",,106603,DTCT0024002,693369,DTCC00106471,1144443,4540
CHEMBL327442,P45452,,RWPUCYUUOPJZLU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,9873598,IC50,=,4.6,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13 (MMP-13),,The synthesis and biological activity of a novel series of diazepine MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,19,"Levin JI, DiJoseph JF, Killar LM, Sung A, Walter T, Sharr MA, Roth CE, Skotnicki JS, Albright JD",,106628,DTCT0024002,606774,DTCC00252084,1456056,2791
CHEMBL327442,P45452,,RWPUCYUUOPJZLU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,9873598,INHIBITION,=,0.51,%,,organism_based,,,,,,,,,,,,In vivo inhibition of matrix metalloprotease-13 (MMP-13) in mouse dialysis tubing implant assay at 50 mg/kg po,,The synthesis and biological activity of a novel series of diazepine MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,19,"Levin JI, DiJoseph JF, Killar LM, Sung A, Walter T, Sharr MA, Roth CE, Skotnicki JS, Albright JD",,106766,DTCT0024002,606775,DTCC00252084,1456056,2791
CHEMBL327442,P45452,,RWPUCYUUOPJZLU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,IC50,=,4.57,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258761,DTCC00252084,1458611,24803
CHEMBL327621,P45452,,KPJZJSWNHXZALM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,9873598,IC50,=,2.2,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13 (MMP-13),,The synthesis and biological activity of a novel series of diazepine MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,19,"Levin JI, DiJoseph JF, Killar LM, Sung A, Walter T, Sharr MA, Roth CE, Skotnicki JS, Albright JD",,106628,DTCT0024002,592626,DTCC00251938,1100515,2791
CHEMBL327621,P45452,,KPJZJSWNHXZALM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,9873598,INHIBITION,=,0.92,%,,organism_based,,,,,,,,,,,,In vivo inhibition of matrix metalloprotease-13 (MMP-13) in mouse dialysis tubing implant assay at 50 mg/kg po,,The synthesis and biological activity of a novel series of diazepine MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,19,"Levin JI, DiJoseph JF, Killar LM, Sung A, Walter T, Sharr MA, Roth CE, Skotnicki JS, Albright JD",,106766,DTCT0024002,592627,DTCC00251938,1100515,2791
CHEMBL327621,P45452,,KPJZJSWNHXZALM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,IC50,=,2.19,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258764,DTCC00251938,1103040,24803
CHEMBL327901,P45452,,CYDZPIZPTPHWDD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11591509,IC50,=,15000,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,alpha-Amino-beta-sulphone hydroxamates as potent MMP-13 inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2001,11,20,"Becker DP, Barta TE, Bedell L, DeCrescenzo G, Freskos J, Getman DP, Hockerman SL, Li M, Mehta P, Mischke B, Munie GE, Swearingen C, Villamil CI",,106603,DTCT0024002,675755,DTCC00255229,1596976,4540
CHEMBL328121,P45452,,HFRVBHDSTQXYIU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11591509,IC50,=,800,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,alpha-Amino-beta-sulphone hydroxamates as potent MMP-13 inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2001,11,20,"Becker DP, Barta TE, Bedell L, DeCrescenzo G, Freskos J, Getman DP, Hockerman SL, Li M, Mehta P, Mischke B, Munie GE, Swearingen C, Villamil CI",,106603,DTCT0024002,683480,DTCC00255798,205048,4540
CHEMBL328162,P45452,,IRBWGGQXMBAYQL-YADHBBJMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10522712,IC50,=,20,NM,,,,,,,,,,,,,,Inhibition of Coll-3 MMP-13,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,101904,DTCT0024002,1453244,DTCC00264512,1014649,3373
CHEMBL328162,P45452,,IRBWGGQXMBAYQL-YADHBBJMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,IC50,=,19.95,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258640,DTCC00264512,1005460,24803
CHEMBL328199,P45452,,GZISYEQJJGPWOA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15125955,IC50,=,7300,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,Reverse hydroxamate-based selective TACE inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,11,"Kamei N, Tanaka T, Kawai K, Miyawaki K, Okuyama A, Murakami Y, Arakawa Y, Haino M, Harada T, Shimano M",,106641,DTCT0024002,1365849,DTCC00265331,1047084,6400
CHEMBL328255,P45452,,ZMAQPMCPZORBHF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,9873598,IC50,=,11,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13 (MMP-13),,The synthesis and biological activity of a novel series of diazepine MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,19,"Levin JI, DiJoseph JF, Killar LM, Sung A, Walter T, Sharr MA, Roth CE, Skotnicki JS, Albright JD",,106628,DTCT0024002,605616,DTCC00252298,1520943,2791
CHEMBL328255,P45452,,ZMAQPMCPZORBHF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,9873598,IC50,,,,,organism_based,,,,,,,,,,,,In vivo inhibition of matrix metalloprotease-13 (MMP-13) in mouse dialysis tubing implant assay at 50 mg/kg po (Not tested),Not Determined,The synthesis and biological activity of a novel series of diazepine MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,19,"Levin JI, DiJoseph JF, Killar LM, Sung A, Walter T, Sharr MA, Roth CE, Skotnicki JS, Albright JD",,106629,DTCT0024002,605617,DTCC00252298,1520943,2791
CHEMBL328255,P45452,,ZMAQPMCPZORBHF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,IC50,=,10.96,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258758,DTCC00252298,1523435,24803
CHEMBL328346,P45452,,UPPWLWGJBCEKOO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11591510,IC50,=,24,NM,,,,,,,,,,,,,,Inhibitory activity against human Matrix metalloprotease-13,,alpha-Alkyl-alpha-amino-beta-sulphone hydroxamates as potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2001,11,20,"Becker DP, DeCrescenzo G, Freskos J, Getman DP, Hockerman SL, Li M, Mehta P, Munie GE, Swearingen C",,106599,DTCT0024002,1073542,DTCC00255283,108412,4541
CHEMBL328381,P45452,,NFRICHJLQIOONF-SJORKVTESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10522712,IC50,=,100,NM,,,,,,,,,,,,,,Inhibition of Coll-3 MMP-13,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,101904,DTCT0024002,1478669,DTCC00264486,1693757,3373
CHEMBL328645,P45452,,HAKDXLDJTCFTIE-HFTWOUSFSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15125955,IC50,=,7000,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,Reverse hydroxamate-based selective TACE inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,11,"Kamei N, Tanaka T, Kawai K, Miyawaki K, Okuyama A, Murakami Y, Arakawa Y, Haino M, Harada T, Shimano M",,106641,DTCT0024002,1386235,DTCC00265462,982320,6400
CHEMBL328751,P45452,,LAGAITXTFHYXGS-CQSZACIVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12873518,IC50,=,18,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotein 13,,Acetylenic TACE inhibitors. Part 1. SAR of the acyclic sulfonamide hydroxamates.,Bioorg. Med. Chem. Lett.,2003,13,16,"Levin JI, Chen JM, Cheung K, Cole D, Crago C, Santos ED, Du X, Khafizova G, MacEwan G, Niu C, Salaski EJ, Zask A, Cummons T, Sung A, Xu J, Zhang Y, Xu W, Ayral-Kaloustian S, Jin G, Cowling R, Barone D, Mohler KM, Black RA, Skotnicki JS",,106634,DTCT0024002,807312,DTCC00260082,1774064,5733
CHEMBL328792,P45452,,BRZDUGZXGNCHQO-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11591509,IC50,=,300,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,alpha-Amino-beta-sulphone hydroxamates as potent MMP-13 inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2001,11,20,"Becker DP, Barta TE, Bedell L, DeCrescenzo G, Freskos J, Getman DP, Hockerman SL, Li M, Mehta P, Mischke B, Munie GE, Swearingen C, Villamil CI",,106603,DTCT0024002,689632,DTCC00255844,626979,4540
CHEMBL329043,P45452,,WEJRAOYHTAOVFY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15163180,KI,=,904,NM,,,,,,,,,,,,,,Inhibition of recombinant human Matrix metalloprotease-13,,Sultam hydroxamates as novel matrix metalloproteinase inhibitors.,J. Med. Chem.,2004,47,12,"Cherney RJ, Mo R, Meyer DT, Hardman KD, Liu RQ, Covington MB, Qian M, Wasserman ZR, Christ DD, Trzaskos JM, Newton RC, Decicco CP",,106611,DTCT0024002,693861,DTCC00269044,1633413,18131
CHEMBL329104,P45452,,VNVKXUSHBXIMRF-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11591509,IC50,=,300,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,alpha-Amino-beta-sulphone hydroxamates as potent MMP-13 inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2001,11,20,"Becker DP, Barta TE, Bedell L, DeCrescenzo G, Freskos J, Getman DP, Hockerman SL, Li M, Mehta P, Mischke B, Munie GE, Swearingen C, Villamil CI",,106603,DTCT0024002,668268,DTCC00255156,1882475,4540
CHEMBL329287,P45452,,PTYZKNZXNKWTEF-MSOLQXFVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10522712,IC50,=,200,NM,,,,,,,,,,,,,,Inhibition of Coll-3 MMP-13,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,101904,DTCT0024002,1476067,DTCC00264543,465152,3373
CHEMBL329287,P45452,,PTYZKNZXNKWTEF-MSOLQXFVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,IC50,=,199.53,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258637,DTCC00264543,455575,24803
CHEMBL329298,P45452,,GWEITLSXCOXESW-RTWAWAEBSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10522712,IC50,=,20,NM,,,,,,,,,,,,,,Inhibition of Coll-3 MMP-13,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,101904,DTCT0024002,1444454,DTCC00264987,205150,3373
CHEMBL329298,P45452,,GWEITLSXCOXESW-RTWAWAEBSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,IC50,=,19.95,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258628,DTCC00264987,196121,24803
CHEMBL329313,P45452,,OKYUILRERWOFCH-RTWAWAEBSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10522712,IC50,=,10,NM,,,,,,,,,,,,,,Inhibition of Coll-3 MMP-13,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,101904,DTCT0024002,1457860,DTCC00265034,853467,3373
CHEMBL329313,P45452,,OKYUILRERWOFCH-RTWAWAEBSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,IC50,=,10,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258632,DTCC00265034,844215,24803
CHEMBL329558,P45452,,AQVWDVBVCMNHDC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,9873598,IC50,=,6.2,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13 (MMP-13),,The synthesis and biological activity of a novel series of diazepine MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,19,"Levin JI, DiJoseph JF, Killar LM, Sung A, Walter T, Sharr MA, Roth CE, Skotnicki JS, Albright JD",,106628,DTCT0024002,598595,DTCC00252299,582786,2791
CHEMBL329558,P45452,,AQVWDVBVCMNHDC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,9873598,INHIBITION,,,,,organism_based,,,,,,,,,,,,In vivo inhibition of matrix metalloprotease-13 (MMP-13) in mouse dialysis tubing implant assay at 50 mg/kg po (inactive),Not Active,The synthesis and biological activity of a novel series of diazepine MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,19,"Levin JI, DiJoseph JF, Killar LM, Sung A, Walter T, Sharr MA, Roth CE, Skotnicki JS, Albright JD",,106767,DTCT0024002,598596,DTCC00252299,582786,2791
CHEMBL329558,P45452,,AQVWDVBVCMNHDC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,IC50,=,6.17,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258762,DTCC00252299,585413,24803
CHEMBL329599,P45452,,CSOXBXQTKUQXJU-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11591509,IC50,=,800,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,alpha-Amino-beta-sulphone hydroxamates as potent MMP-13 inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2001,11,20,"Becker DP, Barta TE, Bedell L, DeCrescenzo G, Freskos J, Getman DP, Hockerman SL, Li M, Mehta P, Mischke B, Munie GE, Swearingen C, Villamil CI",,106603,DTCT0024002,675761,DTCC00254704,917284,4540
CHEMBL329659,P45452,,JSZJOMOAWAHHBK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11591510,IC50,=,580,NM,,,,,,,,,,,,,,Inhibitory activity against human Matrix metalloprotease-13,,alpha-Alkyl-alpha-amino-beta-sulphone hydroxamates as potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2001,11,20,"Becker DP, DeCrescenzo G, Freskos J, Getman DP, Hockerman SL, Li M, Mehta P, Munie GE, Swearingen C",,106599,DTCT0024002,1071319,DTCC00255273,76163,4541
CHEMBL329686,P45452,,UTECJZZQGIQNIQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11591509,IC50,=,15000,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,alpha-Amino-beta-sulphone hydroxamates as potent MMP-13 inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2001,11,20,"Becker DP, Barta TE, Bedell L, DeCrescenzo G, Freskos J, Getman DP, Hockerman SL, Li M, Mehta P, Mischke B, Munie GE, Swearingen C, Villamil CI",,106603,DTCT0024002,656219,DTCC00255707,270168,4540
CHEMBL329967,P45452,,BVQJLICESKJIJB-IADYIPOJSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15125955,IC50,=,4000,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,Reverse hydroxamate-based selective TACE inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,11,"Kamei N, Tanaka T, Kawai K, Miyawaki K, Okuyama A, Murakami Y, Arakawa Y, Haino M, Harada T, Shimano M",,106641,DTCT0024002,1388723,DTCC00265510,659401,6400
CHEMBL330028,P45452,,BGKNBDGHNBOSGD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23287054,IC50,=,0.062,NM,,,,,,,,,,,,,,Inhibition of MMP13 (unknown origin),,Sulphonamides: Deserving class as MMP inhibitors?,Eur. J. Med. Chem.,2013,60,,"Jain P, Saravanan C, Singh SK",,944584,DTCT0024002,11835691,DTCC00252259,1158307,53820
CHEMBL330078,P45452,,LGHHCGQENBRXEW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11133099,IC50,=,2000,NM,,,,,,,,,,,,,,50 percent inhibition of human Matrix metalloprotease-13 by the cleavage of fluorogenic peptide MCA-Pro-Leu-Gly-Leu-Dpa-ala-Arg-NH2,,Synthesis and activity of selective MMP inhibitors with an aryl backbone.,Bioorg. Med. Chem. Lett.,2000,10,24,"Barta TE, Becker DP, Bedell LJ, De Crescenzo GA, McDonald JJ, Munie GE, Rao S, Shieh HS, Stegeman R, Stevens AM, Villamil CI",,106604,DTCT0024002,701668,DTCC00260404,648007,3985
CHEMBL330588,P45452,,PAAGUAHWPSXIJP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12270165,IC50,=,2,NM,,,,,,,,,,,,,,Concentration required in vitro to inhibit Matrix metalloprotease-13,,Benzodiazepine inhibitors of the MMPs and TACE.,Bioorg. Med. Chem. Lett.,2002,12,20,"Nelson FC, Delos Santos E, Levin JI, Chen JM, Skotnicki JS, DiJoseph JF, Sharr MA, Sung A, Killar LM, Cowling R, Jin G, Roth CE, Albright JD",,106631,DTCT0024002,1541054,DTCC00263354,1785726,5143
CHEMBL331095,P45452,,CRPDTHYTIJXWLZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10669564,IC50,=,1.9,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13 (MMP-13),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,106473,DTCT0024002,1715019,DTCC00302754,1714460,16065
CHEMBL331095,P45452,,CRPDTHYTIJXWLZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,IC50,=,1.91,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258778,DTCC00302754,1716222,24803
CHEMBL331834,P45452,,ZVFJPOKDCLPATG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15214773,IC50,=,15,NM,,,,,,,,,,,,,,Inhibition of Matrix Metalloprotease-13 (MMP-13),,Fragment-based drug discovery.,J. Med. Chem.,2004,47,14,"Erlanson DA, McDowell RS, O'Brien T",,106644,DTCT0024002,628271,DTCC00292028,1947611,17883
CHEMBL332134,P45452,,DNGGPLKVDUPXFN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10669564,IC50,=,1.3,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13 (MMP-13),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,106473,DTCT0024002,1708421,DTCC00302701,712684,16065
CHEMBL332302,P45452,,YGXMCNARAMUPPX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10669564,IC50,=,1,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13 (MMP-13),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,106473,DTCT0024002,1680206,DTCC00303015,1164477,16065
CHEMBL332302,P45452,,YGXMCNARAMUPPX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,IC50,=,1,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258784,DTCC00303015,1166450,24803
CHEMBL333586,P45452,,QYFKTMNLZHLRIH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10669564,IC50,=,0.7,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13 (MMP-13),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,106473,DTCT0024002,1718039,DTCC00303017,907231,16065
CHEMBL3337460,P45452,,PDVHEDQOHGFDFR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25192810,IC50,=,220,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain using fluorescence peptide Cy3-PLGLK(Cy5Q)AR-NH2 substrate by fluorescence assay,,"Thieno[2,3-d]pyrimidine-2-carboxamides bearing a carboxybenzene group at 5-position: highly potent, selective, and orally available MMP-13 inhibitors interacting with the S1¿ binding site.",Bioorg. Med. Chem.,2014,22,19,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1442057,DTCT0024002,13992277,DTCC01523399,1096455,59837
CHEMBL3337869,P45452,,AARSEFXVCWMMKV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25192810,IC50,=,12,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain using fluorescence peptide Cy3-PLGLK(Cy5Q)AR-NH2 substrate by fluorescence assay,,"Thieno[2,3-d]pyrimidine-2-carboxamides bearing a carboxybenzene group at 5-position: highly potent, selective, and orally available MMP-13 inhibitors interacting with the S1¿ binding site.",Bioorg. Med. Chem.,2014,22,19,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1442057,DTCT0024002,13987779,DTCC01523362,1322384,59837
CHEMBL3337869,P45452,,AARSEFXVCWMMKV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25264600,IC50,=,12,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Cy3-PLGLK(Cy5Q)AR-NH2 as substrate after 40 mins by spectrofluorimetry,,"Discovery of Novel, Highly Potent, and Selective Quinazoline-2-carboxamide-Based Matrix Metalloproteinase (MMP)-13 Inhibitors without a Zinc Binding Group Using a Structure-Based Design Approach.",J. Med. Chem.,2014,57,21,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1431418,DTCT0024002,13989144,DTCC01523362,1302071,60036
CHEMBL3337870,P45452,,WIKLMKXCZSVVKK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25192810,IC50,=,29,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain using fluorescence peptide Cy3-PLGLK(Cy5Q)AR-NH2 substrate by fluorescence assay,,"Thieno[2,3-d]pyrimidine-2-carboxamides bearing a carboxybenzene group at 5-position: highly potent, selective, and orally available MMP-13 inhibitors interacting with the S1¿ binding site.",Bioorg. Med. Chem.,2014,22,19,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1442057,DTCT0024002,13987777,DTCC01523363,1931018,59837
CHEMBL3337870,P45452,,WIKLMKXCZSVVKK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25264600,IC50,=,29,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Cy3-PLGLK(Cy5Q)AR-NH2 as substrate after 40 mins by spectrofluorimetry,,"Discovery of Novel, Highly Potent, and Selective Quinazoline-2-carboxamide-Based Matrix Metalloproteinase (MMP)-13 Inhibitors without a Zinc Binding Group Using a Structure-Based Design Approach.",J. Med. Chem.,2014,57,21,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1431418,DTCT0024002,13989129,DTCC01523363,1910989,60036
CHEMBL3337871,P45452,,UIQPCRVISURTNS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25192810,IC50,=,26,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain using fluorescence peptide Cy3-PLGLK(Cy5Q)AR-NH2 substrate by fluorescence assay,,"Thieno[2,3-d]pyrimidine-2-carboxamides bearing a carboxybenzene group at 5-position: highly potent, selective, and orally available MMP-13 inhibitors interacting with the S1¿ binding site.",Bioorg. Med. Chem.,2014,22,19,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1442057,DTCT0024002,13987776,DTCC01523364,1387761,59837
CHEMBL3337871,P45452,,UIQPCRVISURTNS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25264600,IC50,=,26,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Cy3-PLGLK(Cy5Q)AR-NH2 as substrate after 40 mins by spectrofluorimetry,,"Discovery of Novel, Highly Potent, and Selective Quinazoline-2-carboxamide-Based Matrix Metalloproteinase (MMP)-13 Inhibitors without a Zinc Binding Group Using a Structure-Based Design Approach.",J. Med. Chem.,2014,57,21,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1431418,DTCT0024002,13989142,DTCC01523364,1367376,60036
CHEMBL3337872,P45452,,CMOTYRWCMLXWLA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25192810,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain using fluorescence peptide Cy3-PLGLK(Cy5Q)AR-NH2 substrate by fluorescence assay,,"Thieno[2,3-d]pyrimidine-2-carboxamides bearing a carboxybenzene group at 5-position: highly potent, selective, and orally available MMP-13 inhibitors interacting with the S1¿ binding site.",Bioorg. Med. Chem.,2014,22,19,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1442057,DTCT0024002,13987775,DTCC01523365,772366,59837
CHEMBL3337873,P45452,,QGDJZPKWNFFIOT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25192810,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain using fluorescence peptide Cy3-PLGLK(Cy5Q)AR-NH2 substrate by fluorescence assay,,"Thieno[2,3-d]pyrimidine-2-carboxamides bearing a carboxybenzene group at 5-position: highly potent, selective, and orally available MMP-13 inhibitors interacting with the S1¿ binding site.",Bioorg. Med. Chem.,2014,22,19,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1442057,DTCT0024002,13987774,DTCC01523366,966348,59837
CHEMBL3337874,P45452,,ACBQOZROXNTLCH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25192810,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain using fluorescence peptide Cy3-PLGLK(Cy5Q)AR-NH2 substrate by fluorescence assay,,"Thieno[2,3-d]pyrimidine-2-carboxamides bearing a carboxybenzene group at 5-position: highly potent, selective, and orally available MMP-13 inhibitors interacting with the S1¿ binding site.",Bioorg. Med. Chem.,2014,22,19,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1442057,DTCT0024002,13987773,DTCC01523367,1289862,59837
CHEMBL3337875,P45452,,KTASZCQNPZRXCW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25192810,IC50,=,1.1,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain using fluorescence peptide Cy3-PLGLK(Cy5Q)AR-NH2 substrate by fluorescence assay,,"Thieno[2,3-d]pyrimidine-2-carboxamides bearing a carboxybenzene group at 5-position: highly potent, selective, and orally available MMP-13 inhibitors interacting with the S1¿ binding site.",Bioorg. Med. Chem.,2014,22,19,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1442057,DTCT0024002,13987772,DTCC01523368,934152,59837
CHEMBL3337876,P45452,,UUVXPBWBRGSPKZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25192810,IC50,=,1.2,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain using fluorescence peptide Cy3-PLGLK(Cy5Q)AR-NH2 substrate by fluorescence assay,,"Thieno[2,3-d]pyrimidine-2-carboxamides bearing a carboxybenzene group at 5-position: highly potent, selective, and orally available MMP-13 inhibitors interacting with the S1¿ binding site.",Bioorg. Med. Chem.,2014,22,19,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1442057,DTCT0024002,13987771,DTCC01523369,221795,59837
CHEMBL3337877,P45452,,KQRXGMWNYNPXDQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25192810,IC50,=,3.1,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain using fluorescence peptide Cy3-PLGLK(Cy5Q)AR-NH2 substrate by fluorescence assay,,"Thieno[2,3-d]pyrimidine-2-carboxamides bearing a carboxybenzene group at 5-position: highly potent, selective, and orally available MMP-13 inhibitors interacting with the S1¿ binding site.",Bioorg. Med. Chem.,2014,22,19,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1442057,DTCT0024002,13987770,DTCC01523370,1581073,59837
CHEMBL3337878,P45452,,BUQBGKBPZHVKRF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25192810,IC50,=,12,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain using fluorescence peptide Cy3-PLGLK(Cy5Q)AR-NH2 substrate by fluorescence assay,,"Thieno[2,3-d]pyrimidine-2-carboxamides bearing a carboxybenzene group at 5-position: highly potent, selective, and orally available MMP-13 inhibitors interacting with the S1¿ binding site.",Bioorg. Med. Chem.,2014,22,19,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1442057,DTCT0024002,13987769,DTCC01523371,1866715,59837
CHEMBL3337879,P45452,,KPNIESKPDDKLQX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25192810,IC50,=,14,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain using fluorescence peptide Cy3-PLGLK(Cy5Q)AR-NH2 substrate by fluorescence assay,,"Thieno[2,3-d]pyrimidine-2-carboxamides bearing a carboxybenzene group at 5-position: highly potent, selective, and orally available MMP-13 inhibitors interacting with the S1¿ binding site.",Bioorg. Med. Chem.,2014,22,19,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1442057,DTCT0024002,13987780,DTCC01523372,740275,59837
CHEMBL3337880,P45452,,JPBBHSUAQAWXHO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25192810,IC50,=,16,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain using fluorescence peptide Cy3-PLGLK(Cy5Q)AR-NH2 substrate by fluorescence assay,,"Thieno[2,3-d]pyrimidine-2-carboxamides bearing a carboxybenzene group at 5-position: highly potent, selective, and orally available MMP-13 inhibitors interacting with the S1¿ binding site.",Bioorg. Med. Chem.,2014,22,19,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1442057,DTCT0024002,13987782,DTCC01523373,418007,59837
CHEMBL3337881,P45452,,JBLVGKQIAQNLEM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25192810,IC50,=,24,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain using fluorescence peptide Cy3-PLGLK(Cy5Q)AR-NH2 substrate by fluorescence assay,,"Thieno[2,3-d]pyrimidine-2-carboxamides bearing a carboxybenzene group at 5-position: highly potent, selective, and orally available MMP-13 inhibitors interacting with the S1¿ binding site.",Bioorg. Med. Chem.,2014,22,19,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1442057,DTCT0024002,13987783,DTCC01523374,1516834,59837
CHEMBL3337882,P45452,,OGXYBTIUHLJOKO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25192810,IC50,=,29,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain using fluorescence peptide Cy3-PLGLK(Cy5Q)AR-NH2 substrate by fluorescence assay,,"Thieno[2,3-d]pyrimidine-2-carboxamides bearing a carboxybenzene group at 5-position: highly potent, selective, and orally available MMP-13 inhibitors interacting with the S1¿ binding site.",Bioorg. Med. Chem.,2014,22,19,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1442057,DTCT0024002,13987784,DTCC01523375,2029769,59837
CHEMBL3337883,P45452,,SNZDISBOFDJZQE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25192810,IC50,=,65,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain using fluorescence peptide Cy3-PLGLK(Cy5Q)AR-NH2 substrate by fluorescence assay,,"Thieno[2,3-d]pyrimidine-2-carboxamides bearing a carboxybenzene group at 5-position: highly potent, selective, and orally available MMP-13 inhibitors interacting with the S1¿ binding site.",Bioorg. Med. Chem.,2014,22,19,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1442057,DTCT0024002,13987785,DTCC01523376,1931019,59837
CHEMBL3337884,P45452,,RXDZSKPIHGVXOC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25192810,IC50,=,200,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain using fluorescence peptide Cy3-PLGLK(Cy5Q)AR-NH2 substrate by fluorescence assay,,"Thieno[2,3-d]pyrimidine-2-carboxamides bearing a carboxybenzene group at 5-position: highly potent, selective, and orally available MMP-13 inhibitors interacting with the S1¿ binding site.",Bioorg. Med. Chem.,2014,22,19,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1442057,DTCT0024002,13987786,DTCC01523377,92677,59837
CHEMBL3337885,P45452,,IPEOVTMHXAYGKM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25192810,IC50,=,760,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain using fluorescence peptide Cy3-PLGLK(Cy5Q)AR-NH2 substrate by fluorescence assay,,"Thieno[2,3-d]pyrimidine-2-carboxamides bearing a carboxybenzene group at 5-position: highly potent, selective, and orally available MMP-13 inhibitors interacting with the S1¿ binding site.",Bioorg. Med. Chem.,2014,22,19,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1442057,DTCT0024002,13987787,DTCC01523378,934153,59837
CHEMBL3337886,P45452,,RQGQQGMCHUKSDE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25192810,IC50,=,3200,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain using fluorescence peptide Cy3-PLGLK(Cy5Q)AR-NH2 substrate by fluorescence assay,,"Thieno[2,3-d]pyrimidine-2-carboxamides bearing a carboxybenzene group at 5-position: highly potent, selective, and orally available MMP-13 inhibitors interacting with the S1¿ binding site.",Bioorg. Med. Chem.,2014,22,19,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1442057,DTCT0024002,13987788,DTCC01523379,870089,59837
CHEMBL3337887,P45452,,JSYCWYGCWPUYSY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25192810,IC50,=,0.19,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain using fluorescence peptide Cy3-PLGLK(Cy5Q)AR-NH2 substrate by fluorescence assay,,"Thieno[2,3-d]pyrimidine-2-carboxamides bearing a carboxybenzene group at 5-position: highly potent, selective, and orally available MMP-13 inhibitors interacting with the S1¿ binding site.",Bioorg. Med. Chem.,2014,22,19,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1442057,DTCT0024002,13987789,DTCC01523380,1645949,59837
CHEMBL3337888,P45452,,VZRVVPSBDIALQP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25192810,IC50,=,0.13,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain using fluorescence peptide Cy3-PLGLK(Cy5Q)AR-NH2 substrate by fluorescence assay,,"Thieno[2,3-d]pyrimidine-2-carboxamides bearing a carboxybenzene group at 5-position: highly potent, selective, and orally available MMP-13 inhibitors interacting with the S1¿ binding site.",Bioorg. Med. Chem.,2014,22,19,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1442057,DTCT0024002,13987790,DTCC01523381,1096434,59837
CHEMBL3337889,P45452,,VLLLXGJPGWTEHU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25192810,IC50,=,0.032,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain using fluorescence peptide Cy3-PLGLK(Cy5Q)AR-NH2 substrate by fluorescence assay,,"Thieno[2,3-d]pyrimidine-2-carboxamides bearing a carboxybenzene group at 5-position: highly potent, selective, and orally available MMP-13 inhibitors interacting with the S1¿ binding site.",Bioorg. Med. Chem.,2014,22,19,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1442057,DTCT0024002,13987791,DTCC01523382,448637,59837
CHEMBL3337890,P45452,,RTIBCEGUDLBWSW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25192810,IC50,=,0.08,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain using fluorescence peptide Cy3-PLGLK(Cy5Q)AR-NH2 substrate by fluorescence assay,,"Thieno[2,3-d]pyrimidine-2-carboxamides bearing a carboxybenzene group at 5-position: highly potent, selective, and orally available MMP-13 inhibitors interacting with the S1¿ binding site.",Bioorg. Med. Chem.,2014,22,19,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1442057,DTCT0024002,13987792,DTCC01523383,1931047,59837
CHEMBL3337891,P45452,,ZLNFRXBYCZFBMI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25192810,IC50,=,0.018,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain using fluorescence peptide Cy3-PLGLK(Cy5Q)AR-NH2 substrate by fluorescence assay,,"Thieno[2,3-d]pyrimidine-2-carboxamides bearing a carboxybenzene group at 5-position: highly potent, selective, and orally available MMP-13 inhibitors interacting with the S1¿ binding site.",Bioorg. Med. Chem.,2014,22,19,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1442057,DTCT0024002,13987793,DTCC01523384,643729,59837
CHEMBL3337892,P45452,,BYKRNLFTDCQMFW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25192810,IC50,=,0.015,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain using fluorescence peptide Cy3-PLGLK(Cy5Q)AR-NH2 substrate by fluorescence assay,,"Thieno[2,3-d]pyrimidine-2-carboxamides bearing a carboxybenzene group at 5-position: highly potent, selective, and orally available MMP-13 inhibitors interacting with the S1¿ binding site.",Bioorg. Med. Chem.,2014,22,19,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1442057,DTCT0024002,13987794,DTCC01523385,1128411,59837
CHEMBL3337893,P45452,,XRVYXOPVSGAELN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25192810,IC50,=,0.029,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain using fluorescence peptide Cy3-PLGLK(Cy5Q)AR-NH2 substrate by fluorescence assay,,"Thieno[2,3-d]pyrimidine-2-carboxamides bearing a carboxybenzene group at 5-position: highly potent, selective, and orally available MMP-13 inhibitors interacting with the S1¿ binding site.",Bioorg. Med. Chem.,2014,22,19,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1442057,DTCT0024002,13987795,DTCC01523386,1802440,59837
CHEMBL3337894,P45452,,CDQRIIUMNLMHRH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25192810,IC50,=,0.0069,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain using fluorescence peptide Cy3-PLGLK(Cy5Q)AR-NH2 substrate by fluorescence assay,,"Thieno[2,3-d]pyrimidine-2-carboxamides bearing a carboxybenzene group at 5-position: highly potent, selective, and orally available MMP-13 inhibitors interacting with the S1¿ binding site.",Bioorg. Med. Chem.,2014,22,19,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1442057,DTCT0024002,13987796,DTCC01523387,966370,59837
CHEMBL3337895,P45452,,FITQSJBSXMDHOS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25192810,IC50,=,39,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain using fluorescence peptide Cy3-PLGLK(Cy5Q)AR-NH2 substrate by fluorescence assay,,"Thieno[2,3-d]pyrimidine-2-carboxamides bearing a carboxybenzene group at 5-position: highly potent, selective, and orally available MMP-13 inhibitors interacting with the S1¿ binding site.",Bioorg. Med. Chem.,2014,22,19,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1442057,DTCT0024002,13987797,DTCC01523388,1289876,59837
CHEMBL3337896,P45452,,CJGGFMKXKLWKKP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25192810,IC50,=,0.028,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain using fluorescence peptide Cy3-PLGLK(Cy5Q)AR-NH2 substrate by fluorescence assay,,"Thieno[2,3-d]pyrimidine-2-carboxamides bearing a carboxybenzene group at 5-position: highly potent, selective, and orally available MMP-13 inhibitors interacting with the S1¿ binding site.",Bioorg. Med. Chem.,2014,22,19,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1442057,DTCT0024002,13987798,DTCC01523389,1322400,59837
CHEMBL3337897,P45452,,GZABBXNLPOOGJA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25192810,IC50,=,0.005,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain using fluorescence peptide Cy3-PLGLK(Cy5Q)AR-NH2 substrate by fluorescence assay,,"Thieno[2,3-d]pyrimidine-2-carboxamides bearing a carboxybenzene group at 5-position: highly potent, selective, and orally available MMP-13 inhibitors interacting with the S1¿ binding site.",Bioorg. Med. Chem.,2014,22,19,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1442057,DTCT0024002,13987799,DTCC01523390,1899027,59837
CHEMBL3337898,P45452,,UDNFOSNJEJROIQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25192810,IC50,=,0.018,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain using fluorescence peptide Cy3-PLGLK(Cy5Q)AR-NH2 substrate by fluorescence assay,,"Thieno[2,3-d]pyrimidine-2-carboxamides bearing a carboxybenzene group at 5-position: highly potent, selective, and orally available MMP-13 inhibitors interacting with the S1¿ binding site.",Bioorg. Med. Chem.,2014,22,19,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1442057,DTCT0024002,13987800,DTCC01523391,1420105,59837
CHEMBL3337899,P45452,,XCGPWAJNKVUUIC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25192810,IC50,=,0.0022,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain using fluorescence peptide Cy3-PLGLK(Cy5Q)AR-NH2 substrate by fluorescence assay,,"Thieno[2,3-d]pyrimidine-2-carboxamides bearing a carboxybenzene group at 5-position: highly potent, selective, and orally available MMP-13 inhibitors interacting with the S1¿ binding site.",Bioorg. Med. Chem.,2014,22,19,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1442057,DTCT0024002,13987801,DTCC01523392,448638,59837
CHEMBL3337900,P45452,,RJDMHZAXFSSFQP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25192810,IC50,=,0.026,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain using fluorescence peptide Cy3-PLGLK(Cy5Q)AR-NH2 substrate by fluorescence assay,,"Thieno[2,3-d]pyrimidine-2-carboxamides bearing a carboxybenzene group at 5-position: highly potent, selective, and orally available MMP-13 inhibitors interacting with the S1¿ binding site.",Bioorg. Med. Chem.,2014,22,19,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1442057,DTCT0024002,13987802,DTCC01523393,966371,59837
CHEMBL3337901,P45452,,SNWPGDNSLLYFSW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25192810,IC50,=,0.0077,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain using fluorescence peptide Cy3-PLGLK(Cy5Q)AR-NH2 substrate by fluorescence assay,,"Thieno[2,3-d]pyrimidine-2-carboxamides bearing a carboxybenzene group at 5-position: highly potent, selective, and orally available MMP-13 inhibitors interacting with the S1¿ binding site.",Bioorg. Med. Chem.,2014,22,19,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1442057,DTCT0024002,13987803,DTCC01523394,966372,59837
CHEMBL3337902,P45452,,UGULCVOOFKSZON-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25192810,IC50,=,0.053,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain using fluorescence peptide Cy3-PLGLK(Cy5Q)AR-NH2 substrate by fluorescence assay,,"Thieno[2,3-d]pyrimidine-2-carboxamides bearing a carboxybenzene group at 5-position: highly potent, selective, and orally available MMP-13 inhibitors interacting with the S1¿ binding site.",Bioorg. Med. Chem.,2014,22,19,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1442057,DTCT0024002,13987804,DTCC01523395,1420106,59837
CHEMBL3337903,P45452,,ANZKOKJZQMPKFT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25192810,IC50,=,0.021,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain using fluorescence peptide Cy3-PLGLK(Cy5Q)AR-NH2 substrate by fluorescence assay,,"Thieno[2,3-d]pyrimidine-2-carboxamides bearing a carboxybenzene group at 5-position: highly potent, selective, and orally available MMP-13 inhibitors interacting with the S1¿ binding site.",Bioorg. Med. Chem.,2014,22,19,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1442057,DTCT0024002,13987805,DTCC01523396,1899028,59837
CHEMBL3337904,P45452,,PPCNPOBPAYKEDY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25192810,IC50,=,0.66,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain using fluorescence peptide Cy3-PLGLK(Cy5Q)AR-NH2 substrate by fluorescence assay,,"Thieno[2,3-d]pyrimidine-2-carboxamides bearing a carboxybenzene group at 5-position: highly potent, selective, and orally available MMP-13 inhibitors interacting with the S1¿ binding site.",Bioorg. Med. Chem.,2014,22,19,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1442057,DTCT0024002,13987807,DTCC01523397,92699,59837
CHEMBL3337905,P45452,,TYPCKUZMTVATJX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25192810,IC50,=,1100,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain using fluorescence peptide Cy3-PLGLK(Cy5Q)AR-NH2 substrate by fluorescence assay,,"Thieno[2,3-d]pyrimidine-2-carboxamides bearing a carboxybenzene group at 5-position: highly potent, selective, and orally available MMP-13 inhibitors interacting with the S1¿ binding site.",Bioorg. Med. Chem.,2014,22,19,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1442057,DTCT0024002,13987808,DTCC01523398,1451873,59837
CHEMBL334909,P45452,,RMKNDVDQYWXAON-LBPRGKRZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10579818,IC50,=,2.7,NM,,,,,,,,,,,,,,In vitro inhibitory activity against collagenase-3 (matrix metalloprotease-13).,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,106469,DTCT0024002,1399355,DTCC00325503,2078085,15412
CHEMBL3350246,P45452,,RBRFAUFMZOIMMS-OSPHWJPCSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15566296,IC50,=,150,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Synthesis and structure-activity relationships of 4-alkynyloxy phenyl sulfanyl, sulfinyl, and sulfonyl alkyl hydroxamates as tumor necrosis factor-alpha converting enzyme and matrix metalloproteinase inhibitors.",J. Med. Chem.,2004,47,25,"Venkatesan AM, Davis JM, Grosu GT, Baker J, Zask A, Levin JI, Ellingboe J, Skotnicki JS, Dijoseph JF, Sung A, Jin G, Xu W, McCarthy DJ, Barone D",,429672,DTCT0024002,2041976,DTCC01529440,1146516,22157
CHEMBL3350685,P45452,,RBRFAUFMZOIMMS-BXKMTCNYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15566296,IC50,=,900,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Synthesis and structure-activity relationships of 4-alkynyloxy phenyl sulfanyl, sulfinyl, and sulfonyl alkyl hydroxamates as tumor necrosis factor-alpha converting enzyme and matrix metalloproteinase inhibitors.",J. Med. Chem.,2004,47,25,"Venkatesan AM, Davis JM, Grosu GT, Baker J, Zask A, Levin JI, Ellingboe J, Skotnicki JS, Dijoseph JF, Sung A, Jin G, Xu W, McCarthy DJ, Barone D",,429672,DTCT0024002,2041977,DTCC01529877,1916681,22157
CHEMBL3356186,P45452,,PMNRYCFAWDUYAJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25408833,INHIBITION,=,99,%,,,,,,,,,,,,,,Inhibition of MMP13 (unknown origin) at 15 uM,,"Synthesis, Structure, and SAR of Tetrahydropyran-Based LpxC Inhibitors.",ACS Med. Chem. Lett.,2014,5,11,"Murphy-Benenato KE, Olivier N, Choy A, Ross PL, Miller MD, Thresher J, Gao N, Hale MR",,1432689,DTCT0024002,13976530,DTCC01533621,1355240,60283
CHEMBL3356187,P45452,,RGQLOHCHGMQBNF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25408833,INHIBITION,=,82,%,,,,,,,,,,,,,,Inhibition of MMP13 (unknown origin) at 10 uM,,"Synthesis, Structure, and SAR of Tetrahydropyran-Based LpxC Inhibitors.",ACS Med. Chem. Lett.,2014,5,11,"Murphy-Benenato KE, Olivier N, Choy A, Ross PL, Miller MD, Thresher J, Gao N, Hale MR",,1432687,DTCT0024002,13976525,DTCC01533622,59603,60283
CHEMBL3356196,P45452,,IOCDLEZNUKXAIV-SZPZYZBQSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25408833,INHIBITION,=,75,%,,,,,,,,,,,,,,Inhibition of MMP13 (unknown origin) at 10 uM,,"Synthesis, Structure, and SAR of Tetrahydropyran-Based LpxC Inhibitors.",ACS Med. Chem. Lett.,2014,5,11,"Murphy-Benenato KE, Olivier N, Choy A, Ross PL, Miller MD, Thresher J, Gao N, Hale MR",,1432687,DTCT0024002,13976526,DTCC01533631,1322421,60283
CHEMBL3356583,P45452,,KRFHCIPQISWSHQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25408833,INHIBITION,=,80,%,,,,,,,,,,,,,,Inhibition of MMP13 (unknown origin) at 10 uM,,"Synthesis, Structure, and SAR of Tetrahydropyran-Based LpxC Inhibitors.",ACS Med. Chem. Lett.,2014,5,11,"Murphy-Benenato KE, Olivier N, Choy A, Ross PL, Miller MD, Thresher J, Gao N, Hale MR",,1432687,DTCT0024002,13976527,DTCC01534021,59641,60283
CHEMBL3356586,P45452,,NUBIFODTFFUFEI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25408833,INHIBITION,=,96,%,,,,,,,,,,,,,,Inhibition of MMP13 (unknown origin) at 10 uM,,"Synthesis, Structure, and SAR of Tetrahydropyran-Based LpxC Inhibitors.",ACS Med. Chem. Lett.,2014,5,11,"Murphy-Benenato KE, Olivier N, Choy A, Ross PL, Miller MD, Thresher J, Gao N, Hale MR",,1432687,DTCT0024002,13976528,DTCC01534024,221846,60283
CHEMBL3358151,P45452,,LNIRXDCIYOBRPL-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25415648,IC50,=,7000,NM,,,,,,,,,,,,,,Inhibition of human MMP13 using Mca-PQG1 peptide substrate assessed as substrate cleavage after 2 to 4 hrs,,Identification of potent and selective hydantoin inhibitors of aggrecanase-1 and aggrecanase-2 that are efficacious in both chemical and surgical models of osteoarthritis.,J. Med. Chem.,2014,57,24,"Durham TB, Klimkowski VJ, Rito CJ, Marimuthu J, Toth JL, Liu C, Durbin JD, Stout SL, Adams L, Swearingen C, Lin C, Chambers MG, Thirunavukkarasu K, Wiley MR",,1435763,DTCT0024002,14000069,DTCC01535600,2061710,60298
CHEMBL3358152,P45452,,GPHYVVDMOPSOAK-CQSZACIVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25415648,IC50,,,,,,,,,,,,,,,,,Inhibition of human MMP13 using Mca-PQG1 peptide substrate assessed as substrate cleavage after 2 to 4 hrs,Not Determined,Identification of potent and selective hydantoin inhibitors of aggrecanase-1 and aggrecanase-2 that are efficacious in both chemical and surgical models of osteoarthritis.,J. Med. Chem.,2014,57,24,"Durham TB, Klimkowski VJ, Rito CJ, Marimuthu J, Toth JL, Liu C, Durbin JD, Stout SL, Adams L, Swearingen C, Lin C, Chambers MG, Thirunavukkarasu K, Wiley MR",,1435763,DTCT0024002,14000070,DTCC01535601,1769989,60298
CHEMBL3358153,P45452,,KDEHHSHGVKUYEZ-IBGZPJMESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25415648,IC50,=,720,NM,,,,,,,,,,,,,,Inhibition of human MMP13 using Mca-PQG1 peptide substrate assessed as substrate cleavage after 2 to 4 hrs,,Identification of potent and selective hydantoin inhibitors of aggrecanase-1 and aggrecanase-2 that are efficacious in both chemical and surgical models of osteoarthritis.,J. Med. Chem.,2014,57,24,"Durham TB, Klimkowski VJ, Rito CJ, Marimuthu J, Toth JL, Liu C, Durbin JD, Stout SL, Adams L, Swearingen C, Lin C, Chambers MG, Thirunavukkarasu K, Wiley MR",,1435763,DTCT0024002,14000071,DTCC01535602,1063499,60298
CHEMBL3358154,P45452,,WIKRDIGSYVQGTH-IBGZPJMESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25415648,IC50,=,3100,NM,,,,,,,,,,,,,,Inhibition of human MMP13 using Mca-PQG1 peptide substrate assessed as substrate cleavage after 2 to 4 hrs,,Identification of potent and selective hydantoin inhibitors of aggrecanase-1 and aggrecanase-2 that are efficacious in both chemical and surgical models of osteoarthritis.,J. Med. Chem.,2014,57,24,"Durham TB, Klimkowski VJ, Rito CJ, Marimuthu J, Toth JL, Liu C, Durbin JD, Stout SL, Adams L, Swearingen C, Lin C, Chambers MG, Thirunavukkarasu K, Wiley MR",,1435763,DTCT0024002,14000072,DTCC01535603,1996998,60298
CHEMBL3358155,P45452,,LBVBVIKJOWWVJX-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25415648,IC50,=,930,NM,,,,,,,,,,,,,,Inhibition of human MMP13 using Mca-PQG1 peptide substrate assessed as substrate cleavage after 2 to 4 hrs,,Identification of potent and selective hydantoin inhibitors of aggrecanase-1 and aggrecanase-2 that are efficacious in both chemical and surgical models of osteoarthritis.,J. Med. Chem.,2014,57,24,"Durham TB, Klimkowski VJ, Rito CJ, Marimuthu J, Toth JL, Liu C, Durbin JD, Stout SL, Adams L, Swearingen C, Lin C, Chambers MG, Thirunavukkarasu K, Wiley MR",,1435763,DTCT0024002,14000074,DTCC01535604,385128,60298
CHEMBL3358156,P45452,,NPWGFJCNOCYDSO-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25415648,IC50,=,4200,NM,,,,,,,,,,,,,,Inhibition of human MMP13 using Mca-PQG1 peptide substrate assessed as substrate cleavage after 2 to 4 hrs,,Identification of potent and selective hydantoin inhibitors of aggrecanase-1 and aggrecanase-2 that are efficacious in both chemical and surgical models of osteoarthritis.,J. Med. Chem.,2014,57,24,"Durham TB, Klimkowski VJ, Rito CJ, Marimuthu J, Toth JL, Liu C, Durbin JD, Stout SL, Adams L, Swearingen C, Lin C, Chambers MG, Thirunavukkarasu K, Wiley MR",,1435763,DTCT0024002,14000075,DTCC01535605,1387876,60298
CHEMBL3358157,P45452,,SZDCEHDWAAZEPH-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25415648,IC50,=,4700,NM,,,,,,,,,,,,,,Inhibition of human MMP13 using Mca-PQG1 peptide substrate assessed as substrate cleavage after 2 to 4 hrs,,Identification of potent and selective hydantoin inhibitors of aggrecanase-1 and aggrecanase-2 that are efficacious in both chemical and surgical models of osteoarthritis.,J. Med. Chem.,2014,57,24,"Durham TB, Klimkowski VJ, Rito CJ, Marimuthu J, Toth JL, Liu C, Durbin JD, Stout SL, Adams L, Swearingen C, Lin C, Chambers MG, Thirunavukkarasu K, Wiley MR",,1435763,DTCT0024002,14000076,DTCC01535606,676013,60298
CHEMBL3358158,P45452,,PDBQNZHFRVAZBC-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25415648,IC50,=,30000,NM,,,,,,,,,,,,,,Inhibition of human MMP13 using Mca-PQG1 peptide substrate assessed as substrate cleavage after 2 to 4 hrs,,Identification of potent and selective hydantoin inhibitors of aggrecanase-1 and aggrecanase-2 that are efficacious in both chemical and surgical models of osteoarthritis.,J. Med. Chem.,2014,57,24,"Durham TB, Klimkowski VJ, Rito CJ, Marimuthu J, Toth JL, Liu C, Durbin JD, Stout SL, Adams L, Swearingen C, Lin C, Chambers MG, Thirunavukkarasu K, Wiley MR",,1435763,DTCT0024002,14000077,DTCC01535607,1128498,60298
CHEMBL3359059,P45452,,HVOMKUJEQKHPFY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25264600,IC50,=,11,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Cy3-PLGLK(Cy5Q)AR-NH2 as substrate after 40 mins by spectrofluorimetry,,"Discovery of Novel, Highly Potent, and Selective Quinazoline-2-carboxamide-Based Matrix Metalloproteinase (MMP)-13 Inhibitors without a Zinc Binding Group Using a Structure-Based Design Approach.",J. Med. Chem.,2014,57,21,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1431418,DTCT0024002,13989143,DTCC01536510,655667,60036
CHEMBL3359060,P45452,,REMCEJAOJUCELM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25264600,IC50,=,97,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Cy3-PLGLK(Cy5Q)AR-NH2 as substrate after 40 mins by spectrofluorimetry,,"Discovery of Novel, Highly Potent, and Selective Quinazoline-2-carboxamide-Based Matrix Metalloproteinase (MMP)-13 Inhibitors without a Zinc Binding Group Using a Structure-Based Design Approach.",J. Med. Chem.,2014,57,21,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1431418,DTCT0024002,13989141,DTCC01536511,1625919,60036
CHEMBL3359061,P45452,,OIMZMIJFLZMLSP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25264600,IC50,=,4,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Cy3-PLGLK(Cy5Q)AR-NH2 as substrate after 40 mins by spectrofluorimetry,,"Discovery of Novel, Highly Potent, and Selective Quinazoline-2-carboxamide-Based Matrix Metalloproteinase (MMP)-13 Inhibitors without a Zinc Binding Group Using a Structure-Based Design Approach.",J. Med. Chem.,2014,57,21,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1431418,DTCT0024002,13989140,DTCC01536512,816786,60036
CHEMBL3359062,P45452,,PHJGGEHZZVXZND-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25264600,IC50,=,2.4,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Cy3-PLGLK(Cy5Q)AR-NH2 as substrate after 40 mins by spectrofluorimetry,,"Discovery of Novel, Highly Potent, and Selective Quinazoline-2-carboxamide-Based Matrix Metalloproteinase (MMP)-13 Inhibitors without a Zinc Binding Group Using a Structure-Based Design Approach.",J. Med. Chem.,2014,57,21,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1431418,DTCT0024002,13989139,DTCC01536513,364768,60036
CHEMBL3359063,P45452,,ZJQWENDJJKTQSF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25264600,IC50,=,27,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Cy3-PLGLK(Cy5Q)AR-NH2 as substrate after 40 mins by spectrofluorimetry,,"Discovery of Novel, Highly Potent, and Selective Quinazoline-2-carboxamide-Based Matrix Metalloproteinase (MMP)-13 Inhibitors without a Zinc Binding Group Using a Structure-Based Design Approach.",J. Med. Chem.,2014,57,21,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1431418,DTCT0024002,13989138,DTCC01536514,1690051,60036
CHEMBL3359064,P45452,,MSWSZPSKFBASHC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25264600,IC50,=,110,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Cy3-PLGLK(Cy5Q)AR-NH2 as substrate after 40 mins by spectrofluorimetry,,"Discovery of Novel, Highly Potent, and Selective Quinazoline-2-carboxamide-Based Matrix Metalloproteinase (MMP)-13 Inhibitors without a Zinc Binding Group Using a Structure-Based Design Approach.",J. Med. Chem.,2014,57,21,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1431418,DTCT0024002,13989137,DTCC01536515,233915,60036
CHEMBL3359065,P45452,,GGHZJASRBSUJRQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25264600,IC50,=,1.8,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Cy3-PLGLK(Cy5Q)AR-NH2 as substrate after 40 mins by spectrofluorimetry,,"Discovery of Novel, Highly Potent, and Selective Quinazoline-2-carboxamide-Based Matrix Metalloproteinase (MMP)-13 Inhibitors without a Zinc Binding Group Using a Structure-Based Design Approach.",J. Med. Chem.,2014,57,21,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1431418,DTCT0024002,13989136,DTCC01536516,752360,60036
CHEMBL3359066,P45452,,KQUNSKKCBZIYQL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25264600,IC50,=,23,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Cy3-PLGLK(Cy5Q)AR-NH2 as substrate after 40 mins by spectrofluorimetry,,"Discovery of Novel, Highly Potent, and Selective Quinazoline-2-carboxamide-Based Matrix Metalloproteinase (MMP)-13 Inhibitors without a Zinc Binding Group Using a Structure-Based Design Approach.",J. Med. Chem.,2014,57,21,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1431418,DTCT0024002,13989135,DTCC01536517,946265,60036
CHEMBL3359067,P45452,,GZQLMXQWTJLZEA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25264600,IC50,=,9.8,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Cy3-PLGLK(Cy5Q)AR-NH2 as substrate after 40 mins by spectrofluorimetry,,"Discovery of Novel, Highly Potent, and Selective Quinazoline-2-carboxamide-Based Matrix Metalloproteinase (MMP)-13 Inhibitors without a Zinc Binding Group Using a Structure-Based Design Approach.",J. Med. Chem.,2014,57,21,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1431418,DTCT0024002,13989134,DTCC01536518,1496584,60036
CHEMBL3359068,P45452,,CHFPYKCGXBJWBP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25264600,IC50,=,6.3,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Cy3-PLGLK(Cy5Q)AR-NH2 as substrate after 40 mins by spectrofluorimetry,,"Discovery of Novel, Highly Potent, and Selective Quinazoline-2-carboxamide-Based Matrix Metalloproteinase (MMP)-13 Inhibitors without a Zinc Binding Group Using a Structure-Based Design Approach.",J. Med. Chem.,2014,57,21,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1431418,DTCT0024002,13989133,DTCC01536519,1204099,60036
CHEMBL3359069,P45452,,YKJPMZXVIFUFPW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25264600,IC50,=,2200,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Cy3-PLGLK(Cy5Q)AR-NH2 as substrate after 40 mins by spectrofluorimetry,,"Discovery of Novel, Highly Potent, and Selective Quinazoline-2-carboxamide-Based Matrix Metalloproteinase (MMP)-13 Inhibitors without a Zinc Binding Group Using a Structure-Based Design Approach.",J. Med. Chem.,2014,57,21,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1431418,DTCT0024002,13989132,DTCC01536520,169472,60036
CHEMBL3359070,P45452,,WVWASINMLXIOTI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25264600,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Cy3-PLGLK(Cy5Q)AR-NH2 as substrate after 40 mins by spectrofluorimetry,,"Discovery of Novel, Highly Potent, and Selective Quinazoline-2-carboxamide-Based Matrix Metalloproteinase (MMP)-13 Inhibitors without a Zinc Binding Group Using a Structure-Based Design Approach.",J. Med. Chem.,2014,57,21,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1431418,DTCT0024002,13989131,DTCC01536521,1690053,60036
CHEMBL3359071,P45452,,VPGPVHGVMYSIGU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25264600,IC50,=,5,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Cy3-PLGLK(Cy5Q)AR-NH2 as substrate after 40 mins by spectrofluorimetry,,"Discovery of Novel, Highly Potent, and Selective Quinazoline-2-carboxamide-Based Matrix Metalloproteinase (MMP)-13 Inhibitors without a Zinc Binding Group Using a Structure-Based Design Approach.",J. Med. Chem.,2014,57,21,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1431418,DTCT0024002,13989130,DTCC01536522,914769,60036
CHEMBL3359072,P45452,,DMYYEEBDCYKOBI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25264600,IC50,=,25,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Cy3-PLGLK(Cy5Q)AR-NH2 as substrate after 40 mins by spectrofluorimetry,,"Discovery of Novel, Highly Potent, and Selective Quinazoline-2-carboxamide-Based Matrix Metalloproteinase (MMP)-13 Inhibitors without a Zinc Binding Group Using a Structure-Based Design Approach.",J. Med. Chem.,2014,57,21,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1431418,DTCT0024002,13989128,DTCC01536523,1721253,60036
CHEMBL3359073,P45452,,FFZPLZVSLOXRLU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25264600,IC50,=,8.6,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Cy3-PLGLK(Cy5Q)AR-NH2 as substrate after 40 mins by spectrofluorimetry,,"Discovery of Novel, Highly Potent, and Selective Quinazoline-2-carboxamide-Based Matrix Metalloproteinase (MMP)-13 Inhibitors without a Zinc Binding Group Using a Structure-Based Design Approach.",J. Med. Chem.,2014,57,21,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1431418,DTCT0024002,13989127,DTCC01536524,849675,60036
CHEMBL3359074,P45452,,UXPARTXXBHEYPC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25264600,IC50,=,2.2,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Cy3-PLGLK(Cy5Q)AR-NH2 as substrate after 40 mins by spectrofluorimetry,,"Discovery of Novel, Highly Potent, and Selective Quinazoline-2-carboxamide-Based Matrix Metalloproteinase (MMP)-13 Inhibitors without a Zinc Binding Group Using a Structure-Based Design Approach.",J. Med. Chem.,2014,57,21,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1431418,DTCT0024002,13989126,DTCC01536525,655668,60036
CHEMBL3359075,P45452,,YYTBKOFXYKJOTN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25264600,IC50,=,0.53,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Cy3-PLGLK(Cy5Q)AR-NH2 as substrate after 40 mins by spectrofluorimetry,,"Discovery of Novel, Highly Potent, and Selective Quinazoline-2-carboxamide-Based Matrix Metalloproteinase (MMP)-13 Inhibitors without a Zinc Binding Group Using a Structure-Based Design Approach.",J. Med. Chem.,2014,57,21,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1431418,DTCT0024002,13989125,DTCC01536526,494305,60036
CHEMBL3359076,P45452,,WKVLYLHDNHKUCD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25264600,IC50,=,0.31,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Cy3-PLGLK(Cy5Q)AR-NH2 as substrate after 40 mins by spectrofluorimetry,,"Discovery of Novel, Highly Potent, and Selective Quinazoline-2-carboxamide-Based Matrix Metalloproteinase (MMP)-13 Inhibitors without a Zinc Binding Group Using a Structure-Based Design Approach.",J. Med. Chem.,2014,57,21,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1431418,DTCT0024002,13989124,DTCC01536527,397568,60036
CHEMBL3359077,P45452,,LRDPWSZONBEJTO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25264600,IC50,=,0.69,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Cy3-PLGLK(Cy5Q)AR-NH2 as substrate after 40 mins by spectrofluorimetry,,"Discovery of Novel, Highly Potent, and Selective Quinazoline-2-carboxamide-Based Matrix Metalloproteinase (MMP)-13 Inhibitors without a Zinc Binding Group Using a Structure-Based Design Approach.",J. Med. Chem.,2014,57,21,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1431418,DTCT0024002,13989123,DTCC01536528,364771,60036
CHEMBL3359078,P45452,,LDNNWMRHFHSZRE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25264600,IC50,=,0.52,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Cy3-PLGLK(Cy5Q)AR-NH2 as substrate after 40 mins by spectrofluorimetry,,"Discovery of Novel, Highly Potent, and Selective Quinazoline-2-carboxamide-Based Matrix Metalloproteinase (MMP)-13 Inhibitors without a Zinc Binding Group Using a Structure-Based Design Approach.",J. Med. Chem.,2014,57,21,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1431418,DTCT0024002,13989122,DTCC01536529,299577,60036
CHEMBL3359079,P45452,,FBKDKFXWDZSDMI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25264600,IC50,=,1.6,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Cy3-PLGLK(Cy5Q)AR-NH2 as substrate after 40 mins by spectrofluorimetry,,"Discovery of Novel, Highly Potent, and Selective Quinazoline-2-carboxamide-Based Matrix Metalloproteinase (MMP)-13 Inhibitors without a Zinc Binding Group Using a Structure-Based Design Approach.",J. Med. Chem.,2014,57,21,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1431418,DTCT0024002,13989121,DTCC01536530,494306,60036
CHEMBL3359080,P45452,,NJWYBMXICXPPLV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25264600,IC50,=,4.3,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Cy3-PLGLK(Cy5Q)AR-NH2 as substrate after 40 mins by spectrofluorimetry,,"Discovery of Novel, Highly Potent, and Selective Quinazoline-2-carboxamide-Based Matrix Metalloproteinase (MMP)-13 Inhibitors without a Zinc Binding Group Using a Structure-Based Design Approach.",J. Med. Chem.,2014,57,21,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1431418,DTCT0024002,13989120,DTCC01536531,1814434,60036
CHEMBL3359081,P45452,,PBTKROVWJJJATH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25264600,IC50,=,9.7,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Cy3-PLGLK(Cy5Q)AR-NH2 as substrate after 40 mins by spectrofluorimetry,,"Discovery of Novel, Highly Potent, and Selective Quinazoline-2-carboxamide-Based Matrix Metalloproteinase (MMP)-13 Inhibitors without a Zinc Binding Group Using a Structure-Based Design Approach.",J. Med. Chem.,2014,57,21,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1431418,DTCT0024002,13989119,DTCC01536532,1496585,60036
CHEMBL3359082,P45452,,VCRANPASSVNQBE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25264600,IC50,=,2.9,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Cy3-PLGLK(Cy5Q)AR-NH2 as substrate after 40 mins by spectrofluorimetry,,"Discovery of Novel, Highly Potent, and Selective Quinazoline-2-carboxamide-Based Matrix Metalloproteinase (MMP)-13 Inhibitors without a Zinc Binding Group Using a Structure-Based Design Approach.",J. Med. Chem.,2014,57,21,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1431418,DTCT0024002,13989118,DTCC01536533,137144,60036
CHEMBL3359083,P45452,,BNUUXQJKDZTLFF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25264600,IC50,=,1.7,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Cy3-PLGLK(Cy5Q)AR-NH2 as substrate after 40 mins by spectrofluorimetry,,"Discovery of Novel, Highly Potent, and Selective Quinazoline-2-carboxamide-Based Matrix Metalloproteinase (MMP)-13 Inhibitors without a Zinc Binding Group Using a Structure-Based Design Approach.",J. Med. Chem.,2014,57,21,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1431418,DTCT0024002,13989117,DTCC01536534,1464048,60036
CHEMBL3359084,P45452,,WCUPVTFYSGYEFZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25264600,IC50,=,16,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Cy3-PLGLK(Cy5Q)AR-NH2 as substrate after 40 mins by spectrofluorimetry,,"Discovery of Novel, Highly Potent, and Selective Quinazoline-2-carboxamide-Based Matrix Metalloproteinase (MMP)-13 Inhibitors without a Zinc Binding Group Using a Structure-Based Design Approach.",J. Med. Chem.,2014,57,21,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1431418,DTCT0024002,13989116,DTCC01536535,1976439,60036
CHEMBL3359085,P45452,,LJGHHXMHTIGZMH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25264600,IC50,=,0.16,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Cy3-PLGLK(Cy5Q)AR-NH2 as substrate after 40 mins by spectrofluorimetry,,"Discovery of Novel, Highly Potent, and Selective Quinazoline-2-carboxamide-Based Matrix Metalloproteinase (MMP)-13 Inhibitors without a Zinc Binding Group Using a Structure-Based Design Approach.",J. Med. Chem.,2014,57,21,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1431418,DTCT0024002,13989115,DTCC01536536,1496586,60036
CHEMBL3359086,P45452,,RPWSTFIWKPQTIS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25264600,IC50,=,0.99,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Cy3-PLGLK(Cy5Q)AR-NH2 as substrate after 40 mins by spectrofluorimetry,,"Discovery of Novel, Highly Potent, and Selective Quinazoline-2-carboxamide-Based Matrix Metalloproteinase (MMP)-13 Inhibitors without a Zinc Binding Group Using a Structure-Based Design Approach.",J. Med. Chem.,2014,57,21,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1431418,DTCT0024002,13989114,DTCC01536537,364772,60036
CHEMBL3359087,P45452,,XNWXYCUHZMPTIU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25264600,IC50,=,34,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Cy3-PLGLK(Cy5Q)AR-NH2 as substrate after 40 mins by spectrofluorimetry,,"Discovery of Novel, Highly Potent, and Selective Quinazoline-2-carboxamide-Based Matrix Metalloproteinase (MMP)-13 Inhibitors without a Zinc Binding Group Using a Structure-Based Design Approach.",J. Med. Chem.,2014,57,21,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1431418,DTCT0024002,13989113,DTCC01536538,137145,60036
CHEMBL3359088,P45452,,HQQQPSZLDUGCQW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25264600,IC50,=,0.04,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Cy3-PLGLK(Cy5Q)AR-NH2 as substrate after 40 mins by spectrofluorimetry,,"Discovery of Novel, Highly Potent, and Selective Quinazoline-2-carboxamide-Based Matrix Metalloproteinase (MMP)-13 Inhibitors without a Zinc Binding Group Using a Structure-Based Design Approach.",J. Med. Chem.,2014,57,21,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1431418,DTCT0024002,13989112,DTCC01536539,1334800,60036
CHEMBL3359089,P45452,,CGTQGAKXKXGOMB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25264600,IC50,=,0.15,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Cy3-PLGLK(Cy5Q)AR-NH2 as substrate after 40 mins by spectrofluorimetry,,"Discovery of Novel, Highly Potent, and Selective Quinazoline-2-carboxamide-Based Matrix Metalloproteinase (MMP)-13 Inhibitors without a Zinc Binding Group Using a Structure-Based Design Approach.",J. Med. Chem.,2014,57,21,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1431418,DTCT0024002,13989111,DTCC01536540,849676,60036
CHEMBL3359090,P45452,,SUSHWPWUZSOLNV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25264600,IC50,=,0.03,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Cy3-PLGLK(Cy5Q)AR-NH2 as substrate after 40 mins by spectrofluorimetry,,"Discovery of Novel, Highly Potent, and Selective Quinazoline-2-carboxamide-Based Matrix Metalloproteinase (MMP)-13 Inhibitors without a Zinc Binding Group Using a Structure-Based Design Approach.",J. Med. Chem.,2014,57,21,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1431418,DTCT0024002,13989110,DTCC01536541,266462,60036
CHEMBL3359091,P45452,,YNHGVYGMFAREOF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25264600,IC50,=,0.0039,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Cy3-PLGLK(Cy5Q)AR-NH2 as substrate after 40 mins by spectrofluorimetry,,"Discovery of Novel, Highly Potent, and Selective Quinazoline-2-carboxamide-Based Matrix Metalloproteinase (MMP)-13 Inhibitors without a Zinc Binding Group Using a Structure-Based Design Approach.",J. Med. Chem.,2014,57,21,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1431418,DTCT0024002,13989109,DTCC01536542,1108444,60036
CHEMBL337309,P45452,TAXIFOLIN,CXQWRCVTCMQVQX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22658537,IC50,=,34600,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827438,DTCT0024002,10535463,DTCC00321631,912570,48665
CHEMBL337309,P45452,TAXIFOLIN,CXQWRCVTCMQVQX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22658537,INHIBITION,>,30,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain at 10 uM incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827444,DTCT0024002,10535545,DTCC00321631,912570,48665
CHEMBL337594,P45452,,XXOLBMKULOJKQR-WUJWULDRSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10579818,IC50,=,1.4,NM,,,,,,,,,,,,,,In vitro inhibitory activity against collagenase-3 (matrix metalloprotease-13).,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,106469,DTCT0024002,1399361,DTCC00325473,1274023,15412
CHEMBL337946,P45452,,DAAIDRXNEKWJIQ-LQGLAIQGSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12930146,IC50,=,13,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP13),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,106606,DTCT0024002,522119,DTCC00304579,1436012,13726
CHEMBL337986,P45452,,FSFVECJWHSGENK-MZBJOSPHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12930146,IC50,=,296,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP13),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,106606,DTCT0024002,543946,DTCC00304730,724287,13726
CHEMBL338007,P45452,,JDOCJRYXQAWUOO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10669564,IC50,=,1,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13 (MMP-13),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,106473,DTCT0024002,1713847,DTCC00303044,938928,16065
CHEMBL338077,P45452,,QKXUIPRJJWLPIY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10669564,IC50,=,2.1,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13 (MMP-13),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,106473,DTCT0024002,1688096,DTCC00302395,324604,16065
CHEMBL338077,P45452,,QKXUIPRJJWLPIY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,IC50,=,2.19,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258780,DTCC00302395,326648,24803
CHEMBL338223,P45452,,VPTHOUBPDJAAER-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10669564,IC50,=,4.1,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13 (MMP-13),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,106473,DTCT0024002,1703166,DTCC00302941,1521507,16065
CHEMBL338453,P45452,,JZJWCJQEWXNHBE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10669564,IC50,=,21,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13 (MMP-13),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,106473,DTCT0024002,1711253,DTCC00302163,1585796,16065
CHEMBL338877,P45452,,QOOGIVWLICWQOB-HARLFGEKSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12930146,IC50,=,27,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP13),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,106606,DTCT0024002,533630,DTCC00304546,1629864,13726
CHEMBL339137,P45452,,IDKKXCKXGPPWMS-MZBJOSPHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12930146,IC50,=,391,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP13),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,106606,DTCT0024002,521066,DTCC00304581,76740,13726
CHEMBL339219,P45452,,CCVGKLVIMFBNBM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10669564,IC50,=,2.9,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13 (MMP-13),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,106473,DTCT0024002,1681656,DTCC00302907,1774584,16065
CHEMBL339315,P45452,,CJLBNTMKOCAXSY-GKCIPKSASA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12930146,IC50,>,100,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP13),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,106606,DTCT0024002,456291,DTCC00304908,1533087,13726
CHEMBL3394285,P45452,,ABKAFUZUCJSIKV-ZZXKWVIFSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,26753813,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 expressed in Escherichia coli using (5-FAM/QXLTM) FRET peptide as substrate,,Design and synthesis of an activity-based protein profiling probe derived from cinnamic hydroxamic acid.,Bioorg. Med. Chem.,2016,24,4,"Ai T, Qiu L, Xie J, Geraghty RJ, Chen L.",,1547678,DTCT0024002,50489,DTCC01541321,1869229,65891
CHEMBL339588,P45452,,QKYPFBUZQDJQHX-DQMJNTIXSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12930146,IC50,=,1.9,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP13),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,106606,DTCT0024002,539251,DTCC00304182,1915219,13726
CHEMBL339610,P45452,,FWGPCZGIMGDSOM-APTRMMRNSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12930146,IC50,=,195,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP13),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,106606,DTCT0024002,521078,DTCC00304804,1339064,13726
CHEMBL33980,P45452,,GTRSMAWFAMXNCF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12668018,IC50,=,20,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease 13 (MMP-13).,,Synthesis and SAR of bicyclic heteroaryl hydroxamic acid MMP and TACE inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,8,"Zask A, Gu Y, Albright JD, Du X, Hogan M, Levin JI, Chen JM, Killar LM, Sung A, DiJoseph JF, Sharr MA, Roth CE, Skala S, Jin G, Cowling R, Mohler KM, Barone D, Black R, March C, Skotnicki JS",,106642,DTCT0024002,1274453,DTCC00174678,1304977,6276
CHEMBL3398610,P45452,,QWEOUVPDSNDRKX-NTEUORMPSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25725607,IC50,>=,100000,NM,,,,,,,,,,,,,,Inhibition of MMP13 catalytic domain (unknown origin) assessed as reduction in hydrolysis of Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 substrate measured for 3 mins after substrate addition by fluorescence assay,,2-Benzisothiazolylimino-5-benzylidene-4-thiazolidinones as protective agents against cartilage destruction.,Bioorg. Med. Chem.,2015,23,7,"Crascì L, Vicini P, Incerti M, Cardile V, Avondo S, Panico A",,1463481,DTCT0024002,14035835,DTCC01543560,2009318,61492
CHEMBL3398611,P45452,,KSMDDSYBDLFHEC-NTEUORMPSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25725607,IC50,=,26910,NM,,,,,,,,,,,,,,Inhibition of MMP13 catalytic domain (unknown origin) assessed as reduction in hydrolysis of Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 substrate measured for 3 mins after substrate addition by fluorescence assay,,2-Benzisothiazolylimino-5-benzylidene-4-thiazolidinones as protective agents against cartilage destruction.,Bioorg. Med. Chem.,2015,23,7,"Crascì L, Vicini P, Incerti M, Cardile V, Avondo S, Panico A",,1463481,DTCT0024002,14035836,DTCC01543561,397684,61492
CHEMBL340345,P45452,,JIIMVBXHLBKVOM-SNRMKQJTSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12930146,IC50,=,682,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP13),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,106606,DTCT0024002,523136,DTCC00304892,336391,13726
CHEMBL340455,P45452,,AXIUEWMOHLWPSR-MZBJOSPHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12930146,IC50,=,129,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP13),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,106606,DTCT0024002,541134,DTCC00304315,917875,13726
CHEMBL340771,P45452,,HIYYLOFJQXHPRU-OPXMRZJTSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12930146,IC50,=,11,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP13),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,106606,DTCT0024002,526008,DTCC00304552,1786179,13726
CHEMBL340923,P45452,,BSHJFYSJFLAHQN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10669564,IC50,=,1.5,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13 (MMP-13),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,106473,DTCT0024002,1690787,DTCC00302218,842153,16065
CHEMBL340923,P45452,,BSHJFYSJFLAHQN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,IC50,=,1.51,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258782,DTCC00302218,844222,24803
CHEMBL341249,P45452,,IFCFGMLOBSUCSN-NWVWQQAFSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12930146,IC50,=,1.8,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP13),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,106606,DTCT0024002,530757,DTCC00304771,627569,13726
CHEMBL341570,P45452,,AHBFOOOWLVWQFO-MFKMUULPSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10579818,IC50,=,1.3,NM,,,,,,,,,,,,,,In vitro inhibitory activity against collagenase-3 (matrix metalloprotease-13).,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,106469,DTCT0024002,1375740,DTCC00325536,1404317,15412
CHEMBL3417742,P45452,,GHWPTWVNZOSEBR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25686153,INHIBITION,>,90,%,,,,,,,,,,,,,,Inhibition of MMP-13 (unknown origin),,"Design, synthesis, and biological evaluation of novel matrix metalloproteinase inhibitors as potent antihemorrhagic agents: from hit identification to an optimized lead.",J. Med. Chem.,2015,58,5,"Orbe J, Sánchez-Arias JA, Rabal O, Rodríguez JA, Salicio A, Ugarte A, Belzunce M, Xu M, Wu W, Tan H, Ma H, Páramo JA, Oyarzabal J",,1472749,DTCT0024002,14105248,DTCC01554158,1140955,61965
CHEMBL3417745,P45452,,PJTIDEQBVYCKIC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25686153,INHIBITION,>,90,%,,,,,,,,,,,,,,Inhibition of MMP-13 (unknown origin),,"Design, synthesis, and biological evaluation of novel matrix metalloproteinase inhibitors as potent antihemorrhagic agents: from hit identification to an optimized lead.",J. Med. Chem.,2015,58,5,"Orbe J, Sánchez-Arias JA, Rabal O, Rodríguez JA, Salicio A, Ugarte A, Belzunce M, Xu M, Wu W, Tan H, Ma H, Páramo JA, Oyarzabal J",,1472749,DTCT0024002,14105249,DTCC01554161,1561095,61965
CHEMBL3417751,P45452,,ZUZGJCNWNOCKEB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25686153,INHIBITION,>,90,%,,,,,,,,,,,,,,Inhibition of MMP-13 (unknown origin),,"Design, synthesis, and biological evaluation of novel matrix metalloproteinase inhibitors as potent antihemorrhagic agents: from hit identification to an optimized lead.",J. Med. Chem.,2015,58,5,"Orbe J, Sánchez-Arias JA, Rabal O, Rodríguez JA, Salicio A, Ugarte A, Belzunce M, Xu M, Wu W, Tan H, Ma H, Páramo JA, Oyarzabal J",,1472749,DTCT0024002,14105250,DTCC01554167,946456,61965
CHEMBL3417763,P45452,,MKCKIGOKGYMJOH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25686153,INHIBITION,>,90,%,,,,,,,,,,,,,,Inhibition of MMP-13 (unknown origin),,"Design, synthesis, and biological evaluation of novel matrix metalloproteinase inhibitors as potent antihemorrhagic agents: from hit identification to an optimized lead.",J. Med. Chem.,2015,58,5,"Orbe J, Sánchez-Arias JA, Rabal O, Rodríguez JA, Salicio A, Ugarte A, Belzunce M, Xu M, Wu W, Tan H, Ma H, Páramo JA, Oyarzabal J",,1472749,DTCT0024002,14105251,DTCC01554179,1976632,61965
CHEMBL3417764,P45452,,ZQKGUWOTJVDTGX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25686153,INHIBITION,>,90,%,,,,,,,,,,,,,,Inhibition of MMP-13 (unknown origin),,"Design, synthesis, and biological evaluation of novel matrix metalloproteinase inhibitors as potent antihemorrhagic agents: from hit identification to an optimized lead.",J. Med. Chem.,2015,58,5,"Orbe J, Sánchez-Arias JA, Rabal O, Rodríguez JA, Salicio A, Ugarte A, Belzunce M, Xu M, Wu W, Tan H, Ma H, Páramo JA, Oyarzabal J",,1472749,DTCT0024002,14105252,DTCC01554180,1943630,61965
CHEMBL342102,P45452,,TWPPWHMOPIWZMY-XJKSGUPXSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11150165,IC50,=,0.3,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease-13 (collagenase-3),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,106477,DTCT0024002,1603807,DTCC00333548,713072,16049
CHEMBL342172,P45452,,IBRCQOLHLBIVAH-AWEZNQCLSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10579818,IC50,=,0.2,NM,,,,,,,,,,,,,,In vitro inhibitory activity against collagenase-3 (matrix metalloprotease-13).,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,106469,DTCT0024002,1383318,DTCC00325535,205840,15412
CHEMBL342210,P45452,,CQRAUIRVDKNRIO-ZDUSSCGKSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10579818,IC50,=,2.1,NM,,,,,,,,,,,,,,In vitro inhibitory activity against collagenase-3 (matrix metalloprotease-13).,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,106469,DTCT0024002,1367835,DTCC00325532,238281,15412
CHEMBL342248,P45452,,RRETZYBLLSHELY-LBPRGKRZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10579818,IC50,=,4.3,NM,,,,,,,,,,,,,,In vitro inhibitory activity against collagenase-3 (matrix metalloprotease-13).,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,106469,DTCT0024002,1384559,DTCC00326418,854146,15412
CHEMBL342548,P45452,,TZQQXIZDSZWWPC-GXFFZTMASA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11150165,IC50,=,0.5,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease-13 (collagenase-3),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,106477,DTCT0024002,1601106,DTCC00333817,65497,16049
CHEMBL342570,P45452,,BGDARAHTNRWTGV-FXAWDEMLSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11150165,IC50,=,17,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease-13 (collagenase-3),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,106477,DTCT0024002,1613767,DTCC00333307,1904159,16049
CHEMBL343082,P45452,,SEQZHNNPDSVBRC-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10579818,IC50,=,2.1,NM,,,,,,,,,,,,,,In vitro inhibitory activity against collagenase-3 (matrix metalloprotease-13).,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,106469,DTCT0024002,1388160,DTCC00325373,1274022,15412
CHEMBL343220,P45452,,XSMMFHYHIAOGPC-QGTPRVQTSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11150165,IC50,=,0.8,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease-13 (collagenase-3),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,106477,DTCT0024002,1633013,DTCC00333737,680818,16049
CHEMBL343414,P45452,,REJAGHRLIZEVSB-SUMWQHHRSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11150165,IC50,=,0.7,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease-13 (collagenase-3),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,106477,DTCT0024002,1618979,DTCC00333040,1714822,16049
CHEMBL343653,P45452,,KJBQTISDZZFFDE-LAUBAEHRSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11150165,IC50,<,0.4,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease-13 (collagenase-3),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,106477,DTCT0024002,1599909,DTCC00333213,1262491,16049
CHEMBL343855,P45452,,YIYXDKFJIKECAM-KBXCAEBGSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11150165,IC50,<,0.4,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease-13 (collagenase-3),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,106477,DTCT0024002,1638036,DTCC00333078,1683203,16049
CHEMBL343860,P45452,,QXMQRADDQYZCBO-SMDDNHRTSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11150165,IC50,=,4,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease-13 (collagenase-3),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,106477,DTCT0024002,1622914,DTCC00333524,907645,16049
CHEMBL343911,P45452,,NXRASPQMAAGLPZ-DFCKQENNSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11150165,IC50,=,2,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease-13 (collagenase-3),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,106477,DTCT0024002,1624048,DTCC00333891,2034900,16049
CHEMBL34411,P45452,,AXTUTMYETKQSJS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12668018,IC50,=,1,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease 13 (MMP-13).,,Synthesis and SAR of bicyclic heteroaryl hydroxamic acid MMP and TACE inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,8,"Zask A, Gu Y, Albright JD, Du X, Hogan M, Levin JI, Chen JM, Killar LM, Sung A, DiJoseph JF, Sharr MA, Roth CE, Skala S, Jin G, Cowling R, Mohler KM, Barone D, Black R, March C, Skotnicki JS",,106642,DTCT0024002,1252334,DTCC00174308,1784775,6276
CHEMBL34418,P45452,,ZZVSRSRVYMQUCW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12668018,IC50,=,10,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease 13 (MMP-13).,,Synthesis and SAR of bicyclic heteroaryl hydroxamic acid MMP and TACE inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,8,"Zask A, Gu Y, Albright JD, Du X, Hogan M, Levin JI, Chen JM, Killar LM, Sung A, DiJoseph JF, Sharr MA, Roth CE, Skala S, Jin G, Cowling R, Mohler KM, Barone D, Black R, March C, Skotnicki JS",,106642,DTCT0024002,1252338,DTCC00175216,1849351,6276
CHEMBL34418,P45452,,ZZVSRSRVYMQUCW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19095454,IC50,=,10,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Current perspective of TACE inhibitors: a review.,Bioorg. Med. Chem.,2009,17,2,"DasGupta S, Murumkar PR, Giridhar R, Yadav MR",,495051,DTCT0024002,2594727,DTCC00175216,1853117,32093
CHEMBL344453,P45452,,MIWJQVMHJSFHGV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10579818,IC50,=,18.4,NM,,,,,,,,,,,,,,In vitro inhibitory activity against collagenase-3 (matrix metalloprotease-13).,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,106469,DTCT0024002,1386975,DTCC00326246,1723968,15412
CHEMBL344545,P45452,,WIWASQOQNPNFMY-SMDDNHRTSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11150165,IC50,=,0.4,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease-13 (collagenase-3),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,106477,DTCT0024002,1627974,DTCC00333585,1457036,16049
CHEMBL344633,P45452,,TUSYEXLVYIINDP-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10579818,IC50,<,0.2,NM,,,,,,,,,,,,,,In vitro inhibitory activity against collagenase-3 (matrix metalloprotease-13).,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,106469,DTCT0024002,1381939,DTCC00325573,1306625,15412
CHEMBL344634,P45452,,VCUJZXCWHYPIIH-SFHVURJKSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10579818,IC50,<,1,NM,,,,,,,,,,,,,,In vitro inhibitory activity against collagenase-3 (matrix metalloprotease-13).,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,106469,DTCT0024002,1369148,DTCC00325533,1176355,15412
CHEMBL344714,P45452,,NGILBKZKRQUURV-SWLSCSKDSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11150165,IC50,=,0.3,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease-13 (collagenase-3),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,106477,DTCT0024002,1608711,DTCC00333523,1521889,16049
CHEMBL344778,P45452,,HDBHDPIRGZHXCM-AZUAARDMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11150165,IC50,=,0.9,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease-13 (collagenase-3),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,106477,DTCT0024002,1631638,DTCC00333705,162628,16049
CHEMBL344828,P45452,,XGJAXXYDMLECBQ-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10579818,IC50,=,5.6,NM,,,,,,,,,,,,,,In vitro inhibitory activity against collagenase-3 (matrix metalloprotease-13).,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,106469,DTCT0024002,1394381,DTCC00325372,1404315,15412
CHEMBL344999,P45452,,PDYICDUZWJCQQF-MAUKXSAKSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11150165,IC50,=,0.6,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13 (collagenase-3),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,106616,DTCT0024002,1636640,DTCC00333620,616105,16049
CHEMBL345054,P45452,,SKVZRQFKXKDXCW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10579818,IC50,=,1,NM,,,,,,,,,,,,,,In vitro inhibitory activity against collagenase-3 (matrix metalloprotease-13).,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,106469,DTCT0024002,1381929,DTCC00325338,1112941,15412
CHEMBL346442,P45452,,YBRVBUDXSMPLGQ-YPFLROGLSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10639284,IC50,=,0.2,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant collagenase-3 (Matrix metalloprotease-13),,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,106475,DTCT0024002,490553,DTCC00340681,1145418,15546
CHEMBL34660,P45452,,NYEXRVCCRODWLT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12668018,IC50,=,16,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease 13 (MMP-13).,,Synthesis and SAR of bicyclic heteroaryl hydroxamic acid MMP and TACE inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,8,"Zask A, Gu Y, Albright JD, Du X, Hogan M, Levin JI, Chen JM, Killar LM, Sung A, DiJoseph JF, Sharr MA, Roth CE, Skala S, Jin G, Cowling R, Mohler KM, Barone D, Black R, March C, Skotnicki JS",,106642,DTCT0024002,1277920,DTCC00174410,107528,6276
CHEMBL346624,P45452,,QRDYOYPORKWZCP-YDRQLGOLSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10639284,IC50,=,0.7,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant collagenase-3 (Matrix metalloprotease-13),,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,106475,DTCT0024002,477745,DTCC00340174,1786615,15546
CHEMBL34666,P45452,,NKZQXGVLDOUMQF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12668018,IC50,>,1000,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease 13 (MMP-13).,,Synthesis and SAR of bicyclic heteroaryl hydroxamic acid MMP and TACE inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,8,"Zask A, Gu Y, Albright JD, Du X, Hogan M, Levin JI, Chen JM, Killar LM, Sung A, DiJoseph JF, Sharr MA, Roth CE, Skala S, Jin G, Cowling R, Mohler KM, Barone D, Black R, March C, Skotnicki JS",,106642,DTCT0024002,1266672,DTCC00174313,1784777,6276
CHEMBL34808,P45452,,ZORDGSDKVXISJV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12668018,IC50,=,1,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease 13 (MMP-13).,,Synthesis and SAR of bicyclic heteroaryl hydroxamic acid MMP and TACE inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,8,"Zask A, Gu Y, Albright JD, Du X, Hogan M, Levin JI, Chen JM, Killar LM, Sung A, DiJoseph JF, Sharr MA, Roth CE, Skala S, Jin G, Cowling R, Mohler KM, Barone D, Black R, March C, Skotnicki JS",,106642,DTCT0024002,1272307,DTCC00174442,1784776,6276
CHEMBL348210,P45452,,AJUUQAWYLUYLDD-SBXXRYSUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10639284,IC50,=,3,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant collagenase-3 (Matrix metalloprotease-13),,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,106475,DTCT0024002,476538,DTCC00340474,563217,15546
CHEMBL35059,P45452,,UQNGOLQNCCYWJR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12668018,IC50,=,170,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease 13 (MMP-13).,,Synthesis and SAR of bicyclic heteroaryl hydroxamic acid MMP and TACE inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,8,"Zask A, Gu Y, Albright JD, Du X, Hogan M, Levin JI, Chen JM, Killar LM, Sung A, DiJoseph JF, Sharr MA, Roth CE, Skala S, Jin G, Cowling R, Mohler KM, Barone D, Black R, March C, Skotnicki JS",,106642,DTCT0024002,1281223,DTCC00175184,107530,6276
CHEMBL35433,P45452,,KGVROUUAKSRCEI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12668018,IC50,=,3,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease 13 (MMP-13).,,Synthesis and SAR of bicyclic heteroaryl hydroxamic acid MMP and TACE inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,8,"Zask A, Gu Y, Albright JD, Du X, Hogan M, Levin JI, Chen JM, Killar LM, Sung A, DiJoseph JF, Sharr MA, Roth CE, Skala S, Jin G, Cowling R, Mohler KM, Barone D, Black R, March C, Skotnicki JS",,106642,DTCT0024002,1270178,DTCC00174561,1046111,6276
CHEMBL356011,P45452,,CYBDDZKSRZPTQR-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10639284,IC50,<,0.4,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant collagenase-3 (Matrix metalloprotease-13),,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,106475,DTCT0024002,510234,DTCC00340538,1851292,15546
CHEMBL35606,P45452,,KQYGUXCNMQFLRN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12668018,IC50,=,3,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease 13 (MMP-13).,,Synthesis and SAR of bicyclic heteroaryl hydroxamic acid MMP and TACE inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,8,"Zask A, Gu Y, Albright JD, Du X, Hogan M, Levin JI, Chen JM, Killar LM, Sung A, DiJoseph JF, Sharr MA, Roth CE, Skala S, Jin G, Cowling R, Mohler KM, Barone D, Black R, March C, Skotnicki JS",,106642,DTCT0024002,1281227,DTCC00174582,1304976,6276
CHEMBL356079,P45452,,HZELUBQHAZKZKC-SWLSCSKDSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11150165,IC50,=,1,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease-13 (collagenase-3),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,106477,DTCT0024002,1636653,DTCC00332987,551673,16049
CHEMBL356471,P45452,,RYMINZKMUZXTLF-CDCQXCROSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10639284,IC50,<,0.5,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant collagenase-3 (Matrix metalloprotease-13),,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,106475,DTCT0024002,512675,DTCC00340433,1339485,15546
CHEMBL356504,P45452,,WUVSVKLVNMIEJM-WMLDXEAASA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11150165,IC50,=,2,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease-13 (collagenase-3),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,106477,DTCT0024002,1606320,DTCC00333828,292453,16049
CHEMBL356520,P45452,,SBIQGLZKCCTUIC-HEHGZKQESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11150165,IC50,=,0.9,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease-13 (collagenase-3),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,106477,DTCT0024002,1603802,DTCC00333766,1651018,16049
CHEMBL357050,P45452,,OECFBMNWNGPPFC-RQNDZEIBSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10639284,IC50,<,0.4,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant collagenase-3 (Matrix metalloprotease-13),,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,106475,DTCT0024002,506544,DTCC00340841,756859,15546
CHEMBL35707,P45452,,CBFHYDZLOMACOM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12668018,IC50,=,3,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease 13 (MMP-13).,,Synthesis and SAR of bicyclic heteroaryl hydroxamic acid MMP and TACE inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,8,"Zask A, Gu Y, Albright JD, Du X, Hogan M, Levin JI, Chen JM, Killar LM, Sung A, DiJoseph JF, Sharr MA, Roth CE, Skala S, Jin G, Cowling R, Mohler KM, Barone D, Black R, March C, Skotnicki JS",,106642,DTCT0024002,1282475,DTCC00175185,204122,6276
CHEMBL357233,P45452,,SSVAOOCBANMUMS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10579818,IC50,=,1,NM,,,,,,,,,,,,,,In vitro inhibitory activity against collagenase-3 (matrix metalloprotease-13).,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,106469,DTCT0024002,1394372,DTCC00326279,1981003,15412
CHEMBL357728,P45452,,BUOKQWSUTKFXOW-NLKUQUHMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10639284,IC50,<,0.4,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant collagenase-3 (Matrix metalloprotease-13),,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,106475,DTCT0024002,476532,DTCC00340744,402280,15546
CHEMBL357796,P45452,,AKTPDJLIUXRMDA-SBXXRYSUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10639284,IC50,=,8,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant collagenase-3 (Matrix metalloprotease-13),,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,106475,DTCT0024002,491842,DTCC00340775,660245,15546
CHEMBL357904,P45452,,VLGURNLPQGCFIS-JOYOIKCWSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11150165,IC50,=,27,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease-13 (collagenase-3),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,106477,DTCT0024002,1630558,DTCC00333334,162629,16049
CHEMBL357934,P45452,,GWZMHEYDUOAMNJ-AFDUHFSSSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10639284,IC50,<,0.1,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant collagenase-3 (Matrix metalloprotease-13),,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,106475,DTCT0024002,495553,DTCC00340680,1113106,15546
CHEMBL358061,P45452,,HAIGFFSNUYJTQK-MAUKXSAKSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11150165,IC50,=,0.4,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease-13 (collagenase-3),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,106477,DTCT0024002,1608707,DTCC00333706,97822,16049
CHEMBL358064,P45452,,ULDXUWXTVRRUND-SWLSCSKDSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11150165,IC50,=,0.7,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease-13 (collagenase-3),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,106477,DTCT0024002,1624039,DTCC00333936,1229583,16049
CHEMBL358182,P45452,,NIUQIJFMBOIHLA-WPZCJLIBSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10639284,IC50,=,2,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant collagenase-3 (Matrix metalloprotease-13),,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,106475,DTCT0024002,502902,DTCC00340840,1786616,15546
CHEMBL358405,P45452,,RQEBSVZFRXVOLZ-CQSZACIVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10639284,IC50,=,11,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant collagenase-3 (Matrix metalloprotease-13),,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,106475,DTCT0024002,496681,DTCC00340792,1241485,15546
CHEMBL358812,P45452,,KJQLQEWCQDLQEA-GXFFZTMASA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11150165,IC50,=,0.5,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease-13 (collagenase-3),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,106477,DTCT0024002,1615063,DTCC00333618,1683204,16049
CHEMBL359502,P45452,,JVVFIHLIADCISB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15745814,IC50,=,5,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-13 at 1 uM,,Synthesis and SAR of diazepine and thiazepine TACE and MMP inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,6,"Zask A, Kaplan J, Du X, MacEwan G, Sandanayaka V, Eudy N, Levin J, Jin G, Xu J, Cummons T, Barone D, Ayral-Kaloustian S, Skotnicki J",,305328,DTCT0024002,1749514,DTCC00382998,1274716,18895
CHEMBL359502,P45452,,JVVFIHLIADCISB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,IC50,=,5.01,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258768,DTCC00382998,1264014,24803
CHEMBL359519,P45452,,SLUQTAQKAIYNRS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15780611,IC50,=,4.1,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 13,,Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.,Bioorg. Med. Chem. Lett.,2005,15,7,"Blagg JA, Noe MC, Wolf-Gouveia LA, Reiter LA, Laird ER, Chang SP, Danley DE, Downs JT, Elliott NC, Eskra JD, Griffiths RJ, Hardink JR, Haugeto AI, Jones CS, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robinson RP, Subramanyam C, Vaughn-Bowser ML, Yocum SA",,305127,DTCT0024002,1752539,DTCC00384410,1015950,18917
CHEMBL359569,P45452,,QNVRWDPZVVAENF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15357971,KI,=,603,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 (MMP-13),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302721,DTCT0024002,1769244,DTCC00387628,271775,18194
CHEMBL359625,P45452,,UJCQVXJYOKSWGB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15357971,KI,>,5000,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 (MMP-13),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302721,DTCT0024002,1767159,DTCC00387768,304744,18194
CHEMBL359669,P45452,,ASSONXJFMGBTAQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15780611,IC50,=,6,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 13,,Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.,Bioorg. Med. Chem. Lett.,2005,15,7,"Blagg JA, Noe MC, Wolf-Gouveia LA, Reiter LA, Laird ER, Chang SP, Danley DE, Downs JT, Elliott NC, Eskra JD, Griffiths RJ, Hardink JR, Haugeto AI, Jones CS, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robinson RP, Subramanyam C, Vaughn-Bowser ML, Yocum SA",,305127,DTCT0024002,1754137,DTCC00384432,1663007,18917
CHEMBL359716,P45452,,RAGDORVOHODYFH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15686921,KI,=,4.2,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,Structure-based design of potent and selective inhibitors of collagenase-3 (MMP-13).,Bioorg. Med. Chem. Lett.,2005,15,4,"Kim SH, Pudzianowski AT, Leavitt KJ, Barbosa J, McDonnell PA, Metzler WJ, Rankin BM, Liu R, Vaccaro W, Pitts W",,302508,DTCT0024002,1744790,DTCC00381579,1586741,18787
CHEMBL359716,P45452,,RAGDORVOHODYFH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,KI,=,4.17,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258731,DTCC00381579,1587774,24803
CHEMBL359873,P45452,,AHZYHNGWSULLBY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15780611,IC50,>,300,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 13,,Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.,Bioorg. Med. Chem. Lett.,2005,15,7,"Blagg JA, Noe MC, Wolf-Gouveia LA, Reiter LA, Laird ER, Chang SP, Danley DE, Downs JT, Elliott NC, Eskra JD, Griffiths RJ, Hardink JR, Haugeto AI, Jones CS, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robinson RP, Subramanyam C, Vaughn-Bowser ML, Yocum SA",,305127,DTCT0024002,1754143,DTCC00384461,271739,18917
CHEMBL35989,P45452,,RRUNLAIBQVECGY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12668018,IC50,=,27,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease 13 (MMP-13).,,Synthesis and SAR of bicyclic heteroaryl hydroxamic acid MMP and TACE inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,8,"Zask A, Gu Y, Albright JD, Du X, Hogan M, Levin JI, Chen JM, Killar LM, Sung A, DiJoseph JF, Sharr MA, Roth CE, Skala S, Jin G, Cowling R, Mohler KM, Barone D, Black R, March C, Skotnicki JS",,106642,DTCT0024002,1257118,DTCC00175314,1913717,6276
CHEMBL359920,P45452,,LFDHAXXLFUSQRL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15745814,IC50,=,225,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-13 at 1 uM,,Synthesis and SAR of diazepine and thiazepine TACE and MMP inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,6,"Zask A, Kaplan J, Du X, MacEwan G, Sandanayaka V, Eudy N, Levin J, Jin G, Xu J, Cummons T, Barone D, Ayral-Kaloustian S, Skotnicki J",,305328,DTCT0024002,1748409,DTCC00382919,1883899,18895
CHEMBL359969,P45452,,AXHCVGDTGFVLIU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15261259,IC50,=,17,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13,,Benzodiazepine inhibitors of the MMPs and TACE. Part 2.,Bioorg. Med. Chem. Lett.,2004,14,16,"Levin JI, Nelson FC, Delos Santos E, Du MT, MacEwan G, Chen JM, Ayral-Kaloustian S, Xu J, Jin G, Cummons T, Barone D",,305704,DTCT0024002,1764997,DTCC00387317,1274760,13193
CHEMBL360175,P45452,,SGQACAXGGCVZOS-TZIWHRDSSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15324896,IC50,>,300,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 13,,3-Hydroxy-4-arylsulfonyltetrahydropyranyl-3-hydroxamic acids are novel inhibitors of MMP-13 and aggrecanase.,Bioorg. Med. Chem. Lett.,2004,14,18,"Noe MC, Snow SL, Wolf-Gouveia LA, Mitchell PG, Lopresti-Morrow L, Reeves LM, Yocum SA, Liras JL, Vaughn M",,305094,DTCT0024002,1769383,DTCC00388566,1242048,18227
CHEMBL360193,P45452,,ZWTFDOKRWKJVER-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15908214,KI,>,5020,NM,,,,,,,,,,,,,,In vitro binding affinity against matrix metalloprotease 13,,"Non-hydroxamate 5-phenylpyrimidine-2,4,6-trione derivatives as selective inhibitors of tumor necrosis factor-alpha converting enzyme.",Bioorg. Med. Chem. Lett.,2005,15,12,"Duan JJ, Lu Z, Wasserman ZR, Liu RQ, Covington MB, Decicco CP",,302358,DTCT0024002,1800220,DTCC00398283,358362,16433
CHEMBL36021,P45452,,BYFPJSOGSJVRJE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12668018,IC50,=,7,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease 13 (MMP-13).,,Synthesis and SAR of bicyclic heteroaryl hydroxamic acid MMP and TACE inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,8,"Zask A, Gu Y, Albright JD, Du X, Hogan M, Levin JI, Chen JM, Killar LM, Sung A, DiJoseph JF, Sharr MA, Roth CE, Skala S, Jin G, Cowling R, Mohler KM, Barone D, Black R, March C, Skotnicki JS",,106642,DTCT0024002,1265560,DTCC00174822,107531,6276
CHEMBL360257,P45452,,FYYONZZUDPFMJO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15745814,IC50,=,32,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-13 at 1 uM,,Synthesis and SAR of diazepine and thiazepine TACE and MMP inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,6,"Zask A, Kaplan J, Du X, MacEwan G, Sandanayaka V, Eudy N, Levin J, Jin G, Xu J, Cummons T, Barone D, Ayral-Kaloustian S, Skotnicki J",,305328,DTCT0024002,1749524,DTCC00382999,77614,18895
CHEMBL360257,P45452,,FYYONZZUDPFMJO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,IC50,=,32.36,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258767,DTCC00382999,67158,24803
CHEMBL360628,P45452,,VXZXTODNXJFRKF-UYAOXDASSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15324896,IC50,=,1.3,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 13,,3-Hydroxy-4-arylsulfonyltetrahydropyranyl-3-hydroxamic acids are novel inhibitors of MMP-13 and aggrecanase.,Bioorg. Med. Chem. Lett.,2004,14,18,"Noe MC, Snow SL, Wolf-Gouveia LA, Mitchell PG, Lopresti-Morrow L, Reeves LM, Yocum SA, Liras JL, Vaughn M",,305094,DTCT0024002,1768801,DTCC00388222,757423,18227
CHEMBL360704,P45452,,LPGGJWIOKRQQAT-IEBWSBKVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15324896,IC50,=,13,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 13,,3-Hydroxy-4-arylsulfonyltetrahydropyranyl-3-hydroxamic acids are novel inhibitors of MMP-13 and aggrecanase.,Bioorg. Med. Chem. Lett.,2004,14,18,"Noe MC, Snow SL, Wolf-Gouveia LA, Mitchell PG, Lopresti-Morrow L, Reeves LM, Yocum SA, Liras JL, Vaughn M",,305094,DTCT0024002,1768941,DTCC00388348,1916139,18227
CHEMBL360916,P45452,,BIHSFSZDPRDVEE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15780611,IC50,=,0.87,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 13,,Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.,Bioorg. Med. Chem. Lett.,2005,15,7,"Blagg JA, Noe MC, Wolf-Gouveia LA, Reiter LA, Laird ER, Chang SP, Danley DE, Downs JT, Elliott NC, Eskra JD, Griffiths RJ, Hardink JR, Haugeto AI, Jones CS, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robinson RP, Subramanyam C, Vaughn-Bowser ML, Yocum SA",,305127,DTCT0024002,1753188,DTCC00384528,499439,18917
CHEMBL360925,P45452,,KOKCTGWRLDNNGZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15780611,IC50,=,150,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 13,,Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.,Bioorg. Med. Chem. Lett.,2005,15,7,"Blagg JA, Noe MC, Wolf-Gouveia LA, Reiter LA, Laird ER, Chang SP, Danley DE, Downs JT, Elliott NC, Eskra JD, Griffiths RJ, Hardink JR, Haugeto AI, Jones CS, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robinson RP, Subramanyam C, Vaughn-Bowser ML, Yocum SA",,305127,DTCT0024002,1753601,DTCC00384460,1048425,18917
CHEMBL361326,P45452,,ZEEUPEFKULHDHM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15780611,IC50,=,140,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 13,,Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.,Bioorg. Med. Chem. Lett.,2005,15,7,"Blagg JA, Noe MC, Wolf-Gouveia LA, Reiter LA, Laird ER, Chang SP, Danley DE, Downs JT, Elliott NC, Eskra JD, Griffiths RJ, Hardink JR, Haugeto AI, Jones CS, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robinson RP, Subramanyam C, Vaughn-Bowser ML, Yocum SA",,305127,DTCT0024002,1753727,DTCC00384535,628495,18917
CHEMBL361376,P45452,,JTEXDSSTTHRJGK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15357971,KI,>,5000,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 (MMP-13),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302721,DTCT0024002,1769266,DTCC00387599,1015992,18194
CHEMBL361527,P45452,,QBWALRVIJDSECI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15686921,KI,=,0.54,NM,,,,,,,,,,,,,,Binding affinity for matrix metalloprotease 13,,Structure-based design of potent and selective inhibitors of collagenase-3 (MMP-13).,Bioorg. Med. Chem. Lett.,2005,15,4,"Kim SH, Pudzianowski AT, Leavitt KJ, Barbosa J, McDonnell PA, Metzler WJ, Rankin BM, Liu R, Vaccaro W, Pitts W",,302900,DTCT0024002,1745333,DTCC00381643,1360847,18787
CHEMBL361527,P45452,,QBWALRVIJDSECI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15686921,KI,=,4.1,NM,,,,,,,,,,,,,,Binding affinity for matrix metalloprotease 13,,Structure-based design of potent and selective inhibitors of collagenase-3 (MMP-13).,Bioorg. Med. Chem. Lett.,2005,15,4,"Kim SH, Pudzianowski AT, Leavitt KJ, Barbosa J, McDonnell PA, Metzler WJ, Rankin BM, Liu R, Vaccaro W, Pitts W",,302900,DTCT0024002,1745339,DTCC00381643,1360848,18787
CHEMBL361527,P45452,,QBWALRVIJDSECI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,KI,=,4.07,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258733,DTCC00381643,1361904,24803
CHEMBL361533,P45452,,ABVSHXSHGCSUFR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15686921,KI,=,25,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,Structure-based design of potent and selective inhibitors of collagenase-3 (MMP-13).,Bioorg. Med. Chem. Lett.,2005,15,4,"Kim SH, Pudzianowski AT, Leavitt KJ, Barbosa J, McDonnell PA, Metzler WJ, Rankin BM, Liu R, Vaccaro W, Pitts W",,302508,DTCT0024002,1744789,DTCC00381761,358186,18787
CHEMBL3617400,P45452,,NUFBSNVYZRUJSW-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,26263024,IC50,=,4.6,NM,,,,,,,,,,,,,,Inhibition of recombinant human activated-MMP13 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as fluorogenic substrate incubated for 4 hrs followed by substrate addition measured every 10 secs for 20 mins by fluorometric assay,,N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity.,J. Med. Chem.,2015,58,18,"Nuti E, Cantelmo AR, Gallo C, Bruno A, Bassani B, Camodeca C, Tuccinardi T, Vera L, Orlandini E, Nencetti S, Stura EA, Martinelli A, Dive V, Albini A, Rossello A",,1518240,DTCT0024002,14545631,DTCC01663485,1291518,63632
CHEMBL3617401,P45452,,KUDQLMASLRCXLF-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,26263024,IC50,=,2.2,NM,,,,,,,,,,,,,,Inhibition of recombinant human activated-MMP13 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as fluorogenic substrate incubated for 4 hrs followed by substrate addition measured every 10 secs for 20 mins by fluorometric assay,,N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity.,J. Med. Chem.,2015,58,18,"Nuti E, Cantelmo AR, Gallo C, Bruno A, Bassani B, Camodeca C, Tuccinardi T, Vera L, Orlandini E, Nencetti S, Stura EA, Martinelli A, Dive V, Albini A, Rossello A",,1518240,DTCT0024002,14545632,DTCC01663486,839147,63632
CHEMBL3617402,P45452,,QHHHTEGVVKPDKH-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,26263024,IC50,=,0.68,NM,,,,,,,,,,,,,,Inhibition of recombinant human activated-MMP13 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as fluorogenic substrate incubated for 4 hrs followed by substrate addition measured every 10 secs for 20 mins by fluorometric assay,,N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity.,J. Med. Chem.,2015,58,18,"Nuti E, Cantelmo AR, Gallo C, Bruno A, Bassani B, Camodeca C, Tuccinardi T, Vera L, Orlandini E, Nencetti S, Stura EA, Martinelli A, Dive V, Albini A, Rossello A",,1518240,DTCT0024002,14545633,DTCC01663487,126658,63632
CHEMBL3617403,P45452,,NJZUERVIVLYZMO-RUZDIDTESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,26263024,IC50,=,1.4,NM,,,,,,,,,,,,,,Inhibition of recombinant human activated-MMP13 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as fluorogenic substrate incubated for 4 hrs followed by substrate addition measured every 10 secs for 20 mins by fluorometric assay,,N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity.,J. Med. Chem.,2015,58,18,"Nuti E, Cantelmo AR, Gallo C, Bruno A, Bassani B, Camodeca C, Tuccinardi T, Vera L, Orlandini E, Nencetti S, Stura EA, Martinelli A, Dive V, Albini A, Rossello A",,1518240,DTCT0024002,14545635,DTCC01663488,94439,63632
CHEMBL3617404,P45452,,UJKKQEHHLXCTJE-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,26263024,IC50,=,0.58,NM,,,,,,,,,,,,,,Inhibition of recombinant human activated-MMP13 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as fluorogenic substrate incubated for 4 hrs followed by substrate addition measured every 10 secs for 20 mins by fluorometric assay,,N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity.,J. Med. Chem.,2015,58,18,"Nuti E, Cantelmo AR, Gallo C, Bruno A, Bassani B, Camodeca C, Tuccinardi T, Vera L, Orlandini E, Nencetti S, Stura EA, Martinelli A, Dive V, Albini A, Rossello A",,1518240,DTCT0024002,14545636,DTCC01663489,1161438,63632
CHEMBL3617405,P45452,,WVPKYEATTXWJLC-AREMUKBSSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,26263024,IC50,=,0.25,NM,,,,,,,,,,,,,,Inhibition of recombinant human activated-MMP13 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as fluorogenic substrate incubated for 4 hrs followed by substrate addition measured every 10 secs for 20 mins by fluorometric assay,,N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity.,J. Med. Chem.,2015,58,18,"Nuti E, Cantelmo AR, Gallo C, Bruno A, Bassani B, Camodeca C, Tuccinardi T, Vera L, Orlandini E, Nencetti S, Stura EA, Martinelli A, Dive V, Albini A, Rossello A",,1518240,DTCT0024002,14545637,DTCC01663490,1739733,63632
CHEMBL3617406,P45452,,RAYJCTCOKFKWEF-CQSZACIVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,26263024,IC50,=,1800,NM,,,,,,,,,,,,,,Inhibition of recombinant human activated-MMP13 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as fluorogenic substrate incubated for 4 hrs followed by substrate addition measured every 10 secs for 20 mins by fluorometric assay,,N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity.,J. Med. Chem.,2015,58,18,"Nuti E, Cantelmo AR, Gallo C, Bruno A, Bassani B, Camodeca C, Tuccinardi T, Vera L, Orlandini E, Nencetti S, Stura EA, Martinelli A, Dive V, Albini A, Rossello A",,1518240,DTCT0024002,14545638,DTCC01663491,871801,63632
CHEMBL3617407,P45452,,WQCXDERWRJMJQA-RUZDIDTESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,26263024,IC50,=,0.19,NM,,,,,,,,,,,,,,Inhibition of recombinant human activated-MMP13 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as fluorogenic substrate incubated for 4 hrs followed by substrate addition measured every 10 secs for 20 mins by fluorometric assay,,N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity.,J. Med. Chem.,2015,58,18,"Nuti E, Cantelmo AR, Gallo C, Bruno A, Bassani B, Camodeca C, Tuccinardi T, Vera L, Orlandini E, Nencetti S, Stura EA, Martinelli A, Dive V, Albini A, Rossello A",,1518240,DTCT0024002,14545639,DTCC01663492,2063303,63632
CHEMBL361783,P45452,,FQEZYKOXVAISOF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15780611,IC50,=,3.1,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 13,,Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.,Bioorg. Med. Chem. Lett.,2005,15,7,"Blagg JA, Noe MC, Wolf-Gouveia LA, Reiter LA, Laird ER, Chang SP, Danley DE, Downs JT, Elliott NC, Eskra JD, Griffiths RJ, Hardink JR, Haugeto AI, Jones CS, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robinson RP, Subramanyam C, Vaughn-Bowser ML, Yocum SA",,305127,DTCT0024002,1754259,DTCC00384563,1048426,18917
CHEMBL361809,P45452,,AXPBXFSDSKBQDG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15745814,IC50,=,142,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-13 at 1 uM,,Synthesis and SAR of diazepine and thiazepine TACE and MMP inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,6,"Zask A, Kaplan J, Du X, MacEwan G, Sandanayaka V, Eudy N, Levin J, Jin G, Xu J, Cummons T, Barone D, Ayral-Kaloustian S, Skotnicki J",,305328,DTCT0024002,1748418,DTCC00383073,854836,18895
CHEMBL361818,P45452,,BRYABXWERJYEAH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15780611,IC50,=,3.1,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 13,,Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.,Bioorg. Med. Chem. Lett.,2005,15,7,"Blagg JA, Noe MC, Wolf-Gouveia LA, Reiter LA, Laird ER, Chang SP, Danley DE, Downs JT, Elliott NC, Eskra JD, Griffiths RJ, Hardink JR, Haugeto AI, Jones CS, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robinson RP, Subramanyam C, Vaughn-Bowser ML, Yocum SA",,305127,DTCT0024002,1753614,DTCC00384418,369928,18917
CHEMBL36191,P45452,,JAVKQWAQQAGPFN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12668018,IC50,=,6,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease 13 (MMP-13).,,Synthesis and SAR of bicyclic heteroaryl hydroxamic acid MMP and TACE inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,8,"Zask A, Gu Y, Albright JD, Du X, Hogan M, Levin JI, Chen JM, Killar LM, Sung A, DiJoseph JF, Sharr MA, Roth CE, Skala S, Jin G, Cowling R, Mohler KM, Barone D, Black R, March C, Skotnicki JS",,106642,DTCT0024002,1265555,DTCC00174276,1979257,6276
CHEMBL361959,P45452,,DOFYUNJDVUXVMB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15745814,IC50,=,9,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-13 at 1 uM,,Synthesis and SAR of diazepine and thiazepine TACE and MMP inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,6,"Zask A, Kaplan J, Du X, MacEwan G, Sandanayaka V, Eudy N, Levin J, Jin G, Xu J, Cummons T, Barone D, Ayral-Kaloustian S, Skotnicki J",,305328,DTCT0024002,1749500,DTCC00382945,725222,18895
CHEMBL361959,P45452,,DOFYUNJDVUXVMB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,IC50,=,8.91,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258771,DTCC00382945,714629,24803
CHEMBL362100,P45452,,HTTGXWWZNURROV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15357971,KI,>,5000,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 (MMP-13),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302721,DTCT0024002,1766622,DTCC00387621,337380,18194
CHEMBL362194,P45452,,YHSMTPXGPORQER-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15780611,IC50,=,18,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 13,,Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.,Bioorg. Med. Chem. Lett.,2005,15,7,"Blagg JA, Noe MC, Wolf-Gouveia LA, Reiter LA, Laird ER, Chang SP, Danley DE, Downs JT, Elliott NC, Eskra JD, Griffiths RJ, Hardink JR, Haugeto AI, Jones CS, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robinson RP, Subramanyam C, Vaughn-Bowser ML, Yocum SA",,305127,DTCT0024002,1754148,DTCC00384512,1081003,18917
CHEMBL3622483,P45452,,CDVZHXHORLPPIL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,26288689,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using 5-FAMTPGPLGL[Dap(DNP)]ARRK(5-TAMRA)-amide as substrate after 45 mins,,,ACS Med. Chem. Lett.,2015,6,8,,,1519718,DTCT0024002,14553276,DTCC01665907,1259119,63741
CHEMBL362284,P45452,,FCGHMWYAKRLIIN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15780611,IC50,=,1.4,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 13,,Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.,Bioorg. Med. Chem. Lett.,2005,15,7,"Blagg JA, Noe MC, Wolf-Gouveia LA, Reiter LA, Laird ER, Chang SP, Danley DE, Downs JT, Elliott NC, Eskra JD, Griffiths RJ, Hardink JR, Haugeto AI, Jones CS, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robinson RP, Subramanyam C, Vaughn-Bowser ML, Yocum SA",,305127,DTCT0024002,1754145,DTCC00384492,1916103,18917
CHEMBL362535,P45452,,YEBHJCQWJHLMTP-IEBWSBKVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15324896,IC50,=,1.1,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 13,,3-Hydroxy-4-arylsulfonyltetrahydropyranyl-3-hydroxamic acids are novel inhibitors of MMP-13 and aggrecanase.,Bioorg. Med. Chem. Lett.,2004,14,18,"Noe MC, Snow SL, Wolf-Gouveia LA, Mitchell PG, Lopresti-Morrow L, Reeves LM, Yocum SA, Liras JL, Vaughn M",,305094,DTCT0024002,1769497,DTCC00388514,435052,18227
CHEMBL362791,P45452,,CXYSWVJGECIJOF-VWLOTQADSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16153831,IC50,=,2.3,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-13,,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321194,DTCT0024002,1860288,DTCC00394612,206771,19837
CHEMBL362797,P45452,,UFYJMKIWYONTIU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15745814,IC50,=,36,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-13 at 1 uM,,Synthesis and SAR of diazepine and thiazepine TACE and MMP inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,6,"Zask A, Kaplan J, Du X, MacEwan G, Sandanayaka V, Eudy N, Levin J, Jin G, Xu J, Cummons T, Barone D, Ayral-Kaloustian S, Skotnicki J",,305328,DTCT0024002,1748964,DTCC00382996,1469283,18895
CHEMBL362832,P45452,,KSGNBXMXFPLVKJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15780611,IC50,=,8,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 13,,Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.,Bioorg. Med. Chem. Lett.,2005,15,7,"Blagg JA, Noe MC, Wolf-Gouveia LA, Reiter LA, Laird ER, Chang SP, Danley DE, Downs JT, Elliott NC, Eskra JD, Griffiths RJ, Hardink JR, Haugeto AI, Jones CS, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robinson RP, Subramanyam C, Vaughn-Bowser ML, Yocum SA",,305127,DTCT0024002,1752657,DTCC00384438,499438,18917
CHEMBL36309,P45452,,FHAJCDXKKGQJQW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12668018,IC50,=,150,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease 13 (MMP-13).,,Synthesis and SAR of bicyclic heteroaryl hydroxamic acid MMP and TACE inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,8,"Zask A, Gu Y, Albright JD, Du X, Hogan M, Levin JI, Chen JM, Killar LM, Sung A, DiJoseph JF, Sharr MA, Roth CE, Skala S, Jin G, Cowling R, Mohler KM, Barone D, Black R, March C, Skotnicki JS",,106642,DTCT0024002,1277924,DTCC00174418,1817295,6276
CHEMBL363261,P45452,,SGKYEMLYQFTLEW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15357971,KI,>,5000,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 (MMP-13),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302721,DTCT0024002,1768298,DTCC00387635,32986,18194
CHEMBL363451,P45452,,IGCXXFVEWDCCKV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15357971,KI,>,5000,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 (MMP-13),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302721,DTCT0024002,1766909,DTCC00387667,1598534,18194
CHEMBL363719,P45452,,VIJGBSAWWJKQHY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15908214,KI,>,5020,NM,,,,,,,,,,,,,,In vitro binding affinity against matrix metalloprotease 13,,"Non-hydroxamate 5-phenylpyrimidine-2,4,6-trione derivatives as selective inhibitors of tumor necrosis factor-alpha converting enzyme.",Bioorg. Med. Chem. Lett.,2005,15,12,"Duan JJ, Lu Z, Wasserman ZR, Liu RQ, Covington MB, Decicco CP",,302358,DTCT0024002,1800096,DTCC00398373,488094,16433
CHEMBL363732,P45452,,YDTKUAMJIYPIGB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15357971,KI,=,1758,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 (MMP-13),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302721,DTCT0024002,1769252,DTCC00387578,725267,18194
CHEMBL363758,P45452,,FKTVHOWSOLKJIV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15261259,IC50,=,33,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13,,Benzodiazepine inhibitors of the MMPs and TACE. Part 2.,Bioorg. Med. Chem. Lett.,2004,14,16,"Levin JI, Nelson FC, Delos Santos E, Du MT, MacEwan G, Chen JM, Ayral-Kaloustian S, Xu J, Jin G, Cummons T, Barone D",,305704,DTCT0024002,1764424,DTCC00387255,1177026,13193
CHEMBL363938,P45452,,GYDCBTACTORGNU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15261259,IC50,=,53,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13,,Benzodiazepine inhibitors of the MMPs and TACE. Part 2.,Bioorg. Med. Chem. Lett.,2004,14,16,"Levin JI, Nelson FC, Delos Santos E, Du MT, MacEwan G, Chen JM, Ayral-Kaloustian S, Xu J, Jin G, Cummons T, Barone D",,305704,DTCT0024002,1764531,DTCC00387225,1981681,13193
CHEMBL363968,P45452,,VACPECYZKUSTIV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15357971,KI,=,377,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 (MMP-13),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302721,DTCT0024002,1766902,DTCC00387733,304743,18194
CHEMBL3639695,P45452,,PZMQNEDVJSDLAW-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,18,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247992,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,173788,DTCC01703280,1130506,64498
CHEMBL3639744,P45452,,SAIHVCSOGMUZPK-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248026,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,179391,DTCC01708180,1615862,64498
CHEMBL364574,P45452,,LUTKRKPVCCDDOR-IEBWSBKVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15324896,IC50,=,140,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 13,,3-Hydroxy-4-arylsulfonyltetrahydropyranyl-3-hydroxamic acids are novel inhibitors of MMP-13 and aggrecanase.,Bioorg. Med. Chem. Lett.,2004,14,18,"Noe MC, Snow SL, Wolf-Gouveia LA, Mitchell PG, Lopresti-Morrow L, Reeves LM, Yocum SA, Liras JL, Vaughn M",,305094,DTCT0024002,1769503,DTCC00388075,1015995,18227
CHEMBL364589,P45452,,TUZYRFJHUHCUNQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15357971,KI,>,5000,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 (MMP-13),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302721,DTCT0024002,1768278,DTCC00387692,1501650,18194
CHEMBL364875,P45452,,MCBALNMZVCCHAP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15357971,KI,=,753,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 (MMP-13),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302721,DTCT0024002,1769396,DTCC00387548,1724710,18194
CHEMBL365031,P45452,,NGBXKQSVMZPDNE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15357971,KI,=,3869,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 (MMP-13),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302721,DTCT0024002,1769656,DTCC00387577,499471,18194
CHEMBL365167,P45452,,NPIWTBAYANSBHN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15908214,KI,>,5020,NM,,,,,,,,,,,,,,In vitro binding affinity against matrix metalloprotease 13,,"Non-hydroxamate 5-phenylpyrimidine-2,4,6-trione derivatives as selective inhibitors of tumor necrosis factor-alpha converting enzyme.",Bioorg. Med. Chem. Lett.,2005,15,12,"Duan JJ, Lu Z, Wasserman ZR, Liu RQ, Covington MB, Decicco CP",,302358,DTCT0024002,1800395,DTCC00398407,1037012,16433
CHEMBL365386,P45452,,MUEJBYPIDLKGKN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15908214,KI,>,5020,NM,,,,,,,,,,,,,,In vitro binding affinity against matrix metalloprotease 13,,"Non-hydroxamate 5-phenylpyrimidine-2,4,6-trione derivatives as selective inhibitors of tumor necrosis factor-alpha converting enzyme.",Bioorg. Med. Chem. Lett.,2005,15,12,"Duan JJ, Lu Z, Wasserman ZR, Liu RQ, Covington MB, Decicco CP",,302358,DTCT0024002,1800407,DTCC00398433,1425801,16433
CHEMBL365892,P45452,,UCKDGXYIQSPPDL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15261259,IC50,=,19,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13,,Benzodiazepine inhibitors of the MMPs and TACE. Part 2.,Bioorg. Med. Chem. Lett.,2004,14,16,"Levin JI, Nelson FC, Delos Santos E, Du MT, MacEwan G, Chen JM, Ayral-Kaloustian S, Xu J, Jin G, Cummons T, Barone D",,305704,DTCT0024002,1764003,DTCC00387454,1566028,13193
CHEMBL365905,P45452,,UXWAVVXCMUJGHD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15357971,KI,=,1206,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 (MMP-13),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302721,DTCT0024002,1768164,DTCC00387755,499472,18194
CHEMBL365947,P45452,,WXPUJRINFGPEGC-VWLOTQADSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16153831,IC50,=,3,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-13,,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321194,DTCT0024002,1860379,DTCC00407674,1695368,19837
CHEMBL366060,P45452,,HYJDMXKMWHHPTM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15908214,KI,,,,,,,,,,,,,,,,,In vitro binding affinity against matrix metalloprotease 13; NT= Not tested,Not Determined,"Non-hydroxamate 5-phenylpyrimidine-2,4,6-trione derivatives as selective inhibitors of tumor necrosis factor-alpha converting enzyme.",Bioorg. Med. Chem. Lett.,2005,15,12,"Duan JJ, Lu Z, Wasserman ZR, Liu RQ, Covington MB, Decicco CP",,302655,DTCT0024002,1798671,DTCC00398339,130820,16433
CHEMBL366111,P45452,,WJULIBHPWZXMJA-IEBWSBKVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15324896,IC50,=,0.95,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 13,,3-Hydroxy-4-arylsulfonyltetrahydropyranyl-3-hydroxamic acids are novel inhibitors of MMP-13 and aggrecanase.,Bioorg. Med. Chem. Lett.,2004,14,18,"Noe MC, Snow SL, Wolf-Gouveia LA, Mitchell PG, Lopresti-Morrow L, Reeves LM, Yocum SA, Liras JL, Vaughn M",,305094,DTCT0024002,1768932,DTCC00388400,142333,18227
CHEMBL366257,P45452,,IVXFVTBAZBQGPK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15261259,IC50,=,7,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13,,Benzodiazepine inhibitors of the MMPs and TACE. Part 2.,Bioorg. Med. Chem. Lett.,2004,14,16,"Levin JI, Nelson FC, Delos Santos E, Du MT, MacEwan G, Chen JM, Ayral-Kaloustian S, Xu J, Jin G, Cummons T, Barone D",,305704,DTCT0024002,1763999,DTCC00387480,1145971,13193
CHEMBL3670691,P45452,,FBDOWURNGYMLPJ-IBGZPJMESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,46,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247986,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,169635,DTCC01703274,839513,64498
CHEMBL3670692,P45452,,KOVQMCGGWATESY-YADHBBJMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,53,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247987,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,168333,DTCC01703275,127019,64498
CHEMBL3670693,P45452,,KOVQMCGGWATESY-FCHUYYIVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,235,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247988,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,181307,DTCC01703276,1098405,64498
CHEMBL3670694,P45452,,KOVQMCGGWATESY-FGZHOGPDSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,114,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247989,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,166600,DTCC01703277,289306,64498
CHEMBL3670695,P45452,,QCVLVTVGVJUODZ-UNMCSNQZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,30,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247990,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,175355,DTCC01703278,2031908,64498
CHEMBL3670696,P45452,,MFTZEUCXFCXINH-UNMCSNQZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,35,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247991,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,183256,DTCC01703279,1518861,64498
CHEMBL3670697,P45452,,CNPRJTXDIHRZPF-ZEQRLZLVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,191,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247993,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,172693,DTCC01703281,1357220,64498
CHEMBL3670698,P45452,,LFUNCOOVDREPBK-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,52,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247994,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,160697,DTCC01703282,1711859,64498
CHEMBL3670699,P45452,,QDHXNZRPVLUOML-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,91,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247995,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,160130,DTCC01703283,774361,64498
CHEMBL3670700,P45452,,HCTHWCGSCVVHLJ-ZDUSSCGKSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247997,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,175921,DTCC01703284,1583049,64498
CHEMBL3670701,P45452,,FFHINXVCVWQCSG-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,60,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247998,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,167819,DTCC01703285,904397,64498
CHEMBL3670702,P45452,,HXOLPPZDNXMRHR-UNMCSNQZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,36,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247999,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,175456,DTCC01703286,1357221,64498
CHEMBL3670703,P45452,,BMJUABISSDGKOA-UNMCSNQZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,30,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248000,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,171182,DTCC01703287,580739,64498
CHEMBL3670704,P45452,,NZUPMMOEPOVBQE-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,24,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248001,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,183160,DTCC01703288,1680152,64498
CHEMBL3670705,P45452,,JUEZHKLAFJJQNE-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,234,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248002,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,174248,DTCC01703289,1389860,64498
CHEMBL3670706,P45452,,OFRXWZGHEVNQHU-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,49,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248003,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,174501,DTCC01703290,1836770,64498
CHEMBL3670707,P45452,,VFEIVMVXXWQZER-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,436,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248004,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,169793,DTCC01703291,1259462,64498
CHEMBL3670708,P45452,,IIUXBHAJTPNCIR-KKSFZXQISA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,80,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248005,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,161297,DTCC01703292,1291821,64498
CHEMBL3670709,P45452,,KNJBHXZWYFARSA-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248006,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,158331,DTCC01703293,1647965,64498
CHEMBL3670710,P45452,,FRXRVVOCWBNHOQ-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,550,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248007,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,167410,DTCC01703294,1065482,64498
CHEMBL3670711,P45452,,MNXXFUIRJNLTHG-KBPBESRZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248008,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,170978,DTCC01703295,1771871,64498
CHEMBL3670712,P45452,,XNQPIVCSZRQAQO-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,900,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248009,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,181047,DTCC01703296,420053,64498
CHEMBL3670713,P45452,,ACXIBBRPTTWRDM-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,309,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248010,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,168589,DTCC01703297,839514,64498
CHEMBL3670714,P45452,,RAOGWYCOADLHPD-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,117,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248011,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,184705,DTCC01703298,548550,64498
CHEMBL3670715,P45452,,AVFCHUYQSZAIFE-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,598,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248012,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,177237,DTCC01703299,1998926,64498
CHEMBL3670716,P45452,,GSEYFLJSDKPLAI-KBPBESRZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248013,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,176071,DTCC01703300,1550906,64498
CHEMBL3670717,P45452,,VIPIKALUTUDDKU-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,641,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248014,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,171306,DTCC01703301,1771872,64498
CHEMBL3670718,P45452,,YUQQWAKBRAEWQZ-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,518,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248015,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,164924,DTCC01703302,710012,64498
CHEMBL3670719,P45452,,PLIPLRCYJWMTFY-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248016,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,172948,DTCC01703303,968343,64498
CHEMBL3670720,P45452,,BFJIOGLKGISOKV-GJZGRUSLSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,212,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248017,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,164370,DTCC01703304,1226403,64498
CHEMBL3670721,P45452,,UOTSSZSXOLHXGG-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248018,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,158464,DTCC01703305,1291822,64498
CHEMBL367133,P45452,,RLDSXGKXSYXTOQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15780611,IC50,=,0.54,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 13,,Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.,Bioorg. Med. Chem. Lett.,2005,15,7,"Blagg JA, Noe MC, Wolf-Gouveia LA, Reiter LA, Laird ER, Chang SP, Danley DE, Downs JT, Elliott NC, Eskra JD, Griffiths RJ, Hardink JR, Haugeto AI, Jones CS, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robinson RP, Subramanyam C, Vaughn-Bowser ML, Yocum SA",,305127,DTCT0024002,1754248,DTCC00384404,595977,18917
CHEMBL3675541,P45452,,RESDGLIYQGGYGR-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,240,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248019,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,173481,DTCC01708173,1615861,64498
CHEMBL3675542,P45452,,AEOWLQGPNGMHBP-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,532,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248020,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,163342,DTCC01708174,613076,64498
CHEMBL3675543,P45452,,XLKQIIIKETWLMI-HKUYNNGSSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,134,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248021,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,158498,DTCC01708175,742365,64498
CHEMBL3675544,P45452,,YWXFICBFTYVHJU-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,689,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248022,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,164895,DTCC01708176,1324414,64498
CHEMBL3675545,P45452,,JYGPMNNMAQCQMG-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,884,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248023,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,180078,DTCC01708177,645830,64498
CHEMBL3675546,P45452,,VXYUSBYRYYLNHT-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,259,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248024,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,172200,DTCC01708178,2031940,64498
CHEMBL3675547,P45452,,DKTMPYACSYBQIF-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248025,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,184190,DTCC01708179,1194373,64498
CHEMBL3675548,P45452,,IIRLMDJELCRLPB-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248027,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,182611,DTCC01708181,548584,64498
CHEMBL3675549,P45452,,MXXLMDWJDJQNCZ-KXBFYZLASA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248028,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,170708,DTCC01708182,968371,64498
CHEMBL3675550,P45452,,OTOPPWBRBAVQCM-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248029,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,158330,DTCC01708183,450759,64498
CHEMBL3675551,P45452,,LHURUBKIFBZDNZ-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248030,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,167750,DTCC01708184,2031941,64498
CHEMBL3675552,P45452,,MTMSSQNYFAAJSR-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248031,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,170856,DTCC01708185,321876,64498
CHEMBL3675553,P45452,,XTHLTIMASWPNRH-AKRCKQFNSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248032,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,157099,DTCC01708186,904423,64498
CHEMBL3675554,P45452,,SJWYFGLDVUQIEF-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248033,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,160699,DTCC01708187,1259488,64498
CHEMBL3675555,P45452,,HXQNDQXHRNVKIA-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248034,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,182803,DTCC01708188,127053,64498
CHEMBL3675556,P45452,,UIEDXQBYCVBGGE-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248035,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,174526,DTCC01708189,1966318,64498
CHEMBL3675557,P45452,,BBERXYYXGJGELS-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,436,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248036,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,178285,DTCC01708190,127054,64498
CHEMBL3675558,P45452,,YUUVADHCMFJYGO-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248037,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,180579,DTCC01708191,872152,64498
CHEMBL3675559,P45452,,MVSSFLIDOBOIBL-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248038,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,173260,DTCC01708192,1098436,64498
CHEMBL3675560,P45452,,YWAKWFLUKNCYMP-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248039,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,177973,DTCC01708193,1194374,64498
CHEMBL3675561,P45452,,FHLZDDVMTVCEOC-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248040,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,168978,DTCC01708194,1804477,64498
CHEMBL3675562,P45452,,ZQBDVTJLOHIYJN-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248041,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,169295,DTCC01708195,1550939,64498
CHEMBL3675563,P45452,,MXFJZXDWWXHXMV-UIOOFZCWSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,20,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248042,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,173569,DTCC01708196,645831,64498
CHEMBL3675563,P45452,,MXFJZXDWWXHXMV-UIOOFZCWSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,180,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248053,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,173324,DTCC01708196,645831,64498
CHEMBL3675564,P45452,,RIICMTINBCLPOY-UIOOFZCWSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,20,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248043,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,168730,DTCC01708197,806748,64498
CHEMBL3675565,P45452,,BVKYTKVUMKYONQ-NSOVKSMOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,55,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248044,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,159725,DTCC01708198,1389896,64498
CHEMBL3675566,P45452,,XHPUXKQBUUHEIP-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,23,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248045,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,164151,DTCC01708199,1130545,64498
CHEMBL3675567,P45452,,NHZSRXRDEWWJJS-CONSDPRKSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,33,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248046,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,165399,DTCC01708200,1065520,64498
CHEMBL3675568,P45452,,MDMQULYGCYNXQN-DFBJGRDBSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,16.4,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248047,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,168874,DTCC01708201,321877,64498
CHEMBL3675569,P45452,,SAJAWNZBKHGJOW-MBMZGMDYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,36,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248048,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,168273,DTCC01708202,1550940,64498
CHEMBL3675570,P45452,,ZQUJAHCTHDEZMJ-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,16.6,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248049,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,174416,DTCC01708203,211,64498
CHEMBL3675571,P45452,,CKYKLNXMCJIGPN-NSOVKSMOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,81,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248050,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,181634,DTCC01708204,839552,64498
CHEMBL3675572,P45452,,WLZQVNRDQZYTID-PEFOLFAWSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,17,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248051,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,172729,DTCC01708205,2063689,64498
CHEMBL3675573,P45452,,OUZMHHWAGJCAFA-PMERELPUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,10.2,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248052,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,174065,DTCC01708206,1000927,64498
CHEMBL3675574,P45452,,TYSBKRRVVCMKQG-NSOVKSMOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,97,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248054,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,165429,DTCC01708207,1518882,64498
CHEMBL3675575,P45452,,BICNEVCTASLTLM-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,13.5,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248055,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,172919,DTCC01708208,1161801,64498
CHEMBL3675576,P45452,,CWSSLFKLYYDKBD-CONSDPRKSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,232,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248056,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,159621,DTCC01708209,516548,64498
CHEMBL3675577,P45452,,NLIWJNDBQYUCSF-DFBJGRDBSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,427,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248057,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,157824,DTCC01708210,321878,64498
CHEMBL3675578,P45452,,KHHNQNYSKXXUCV-NSOVKSMOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,377,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248058,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,174507,DTCC01708211,2063690,64498
CHEMBL3675579,P45452,,KAUWQENTXQTKQG-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,367,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248059,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,182870,DTCC01708212,1771918,64498
CHEMBL3675580,P45452,,IADFBNIHFKDTRS-NSOVKSMOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,443,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248060,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,159889,DTCC01708213,1194375,64498
CHEMBL3675581,P45452,,CXPHOOFGGKZGTC-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,321,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248061,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,166546,DTCC01708214,212,64498
CHEMBL3675582,P45452,,GIEQMQWMJSYCKB-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,801,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248062,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,161700,DTCC01708215,1033284,64498
CHEMBL3675583,P45452,,CPYISUHNJGFCRY-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248063,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,166657,DTCC01708216,1486575,64498
CHEMBL3675584,P45452,,VCJGVCZITQVJET-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248064,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,181210,DTCC01708217,1901139,64498
CHEMBL3675585,P45452,,QQGKYSPTORHWNZ-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,584,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248065,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,182375,DTCC01708218,1804478,64498
CHEMBL3675586,P45452,,UWVBDELWTIGPFO-BBRMVZONSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248066,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,179618,DTCC01708219,62372,64498
CHEMBL3675587,P45452,,ZMGHGYMGQVMACZ-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248067,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,171749,DTCC01708220,1486576,64498
CHEMBL3675588,P45452,,GWHSSPUFNDIEEQ-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248068,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,163289,DTCC01708221,677985,64498
CHEMBL3675589,P45452,,CTCTZAXBKWKMKL-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248069,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,163980,DTCC01708222,904424,64498
CHEMBL3675590,P45452,,PXQPONLRTWLOTH-IJHRGXPZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248070,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,175145,DTCC01708223,1000928,64498
CHEMBL3675591,P45452,,DUPWUQYVKWCUOG-NRFANRHFSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,366,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248071,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,179840,DTCC01708224,839553,64498
CHEMBL3675592,P45452,,KEHDBOGRIVHUBV-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,564,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248072,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,175510,DTCC01708225,968372,64498
CHEMBL3675593,P45452,,QFGALMYSDQBVRH-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,200,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248073,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,176270,DTCC01708226,936273,64498
CHEMBL3675594,P45452,,ZWXRGJMHGHMUMB-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,33,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248074,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,178479,DTCC01708227,1740101,64498
CHEMBL3675595,P45452,,VLFDPMJDVIHWPI-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248075,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,184294,DTCC01708228,645832,64498
CHEMBL3675596,P45452,,KGPPRBTYRFIDAL-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248079,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,162867,DTCC01708229,904425,64498
CHEMBL3675597,P45452,,MUGAWCXYWNGHML-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,522,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248080,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,170239,DTCC01708230,420085,64498
CHEMBL3675598,P45452,,JMWVTDZGNUFBMO-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,559,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248081,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,175712,DTCC01708231,1740102,64498
CHEMBL3675599,P45452,,UUDTVMMARAFNKG-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,933,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248082,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,184538,DTCC01708232,904426,64498
CHEMBL3675600,P45452,,GOLLITFKIKKRMV-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,635,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248083,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,158745,DTCC01708233,1259489,64498
CHEMBL3675601,P45452,,BLDFRIYOIZRRJI-ZEQRLZLVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,563,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248084,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,164165,DTCC01708234,645833,64498
CHEMBL3675602,P45452,,FXBVEEBXIZYGRY-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248085,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,166460,DTCC01708235,580782,64498
CHEMBL3675603,P45452,,FKTHQTYGTOEBAW-MHZLTWQESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,132,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248087,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,169833,DTCC01708236,159656,64498
CHEMBL3675604,P45452,,KSDQQJBQFBNDIC-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248088,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,179878,DTCC01708237,159657,64498
CHEMBL3675605,P45452,,NIAIEBGBRXKPAO-NHTMILBNSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,198,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248225,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,170165,DTCC01708238,256074,64498
CHEMBL3675606,P45452,,MMIHYNVQXYWTFM-PKTZIBPZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20817735,KI,=,684,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024002,14739081,DTCC01708239,2106911,69686
CHEMBL3675606,P45452,,MMIHYNVQXYWTFM-PKTZIBPZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22689580,KI,=,684,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024002,14739080,DTCC01708239,2106910,68703
CHEMBL3675606,P45452,,MMIHYNVQXYWTFM-PKTZIBPZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,714,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248078,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,161138,DTCC01708239,1901140,64498
CHEMBL3675607,P45452,,KDDWLGBIYXTPJG-FQEVSTJZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22689580,KI,=,603,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024002,14759269,DTCC01708240,2111479,68703
CHEMBL3675607,P45452,,KDDWLGBIYXTPJG-FQEVSTJZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22689580,KI,=,603,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024002,14759918,DTCC01708240,2111479,68703
CHEMBL3675607,P45452,,KDDWLGBIYXTPJG-FQEVSTJZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,603,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248086,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535845,DTCT0024002,167672,DTCC01708240,289344,64498
CHEMBL368079,P45452,,QGVCPEQAAKTMNX-SECBINFHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10230616,IC50,=,475,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 (MMP-13),,Discovery of a novel series of selective MMP inhibitors: identification of the gamma-sulfone-thiols.,Bioorg. Med. Chem. Lett.,1999,9,7,"Freskos JN, Mischke BV, DeCrescenzo GA, Heintz R, Getman DP, Howard SC, Kishore NN, McDonald JJ, Munie GE, Rangwala S, Swearingen CA, Voliva C, Welsch DJ",,106484,DTCT0024002,1696306,DTCC00375483,1775392,3610
CHEMBL368347,P45452,(+)-SECOISOLARICIRESINOL,PUETUDUXMCLALY-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22658537,IC50,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain incubated for 20 mins by fluorimetric assay,Not Determined,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827438,DTCT0024002,10535465,DTCC00371311,1812173,48665
CHEMBL368972,P45452,,PKYBEORBMGUOOP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10230616,IC50,=,4,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 (MMP-13),,Discovery of a novel series of selective MMP inhibitors: identification of the gamma-sulfone-thiols.,Bioorg. Med. Chem. Lett.,1999,9,7,"Freskos JN, Mischke BV, DeCrescenzo GA, Heintz R, Getman DP, Howard SC, Kishore NN, McDonald JJ, Munie GE, Rangwala S, Swearingen CA, Voliva C, Welsch DJ",,106484,DTCT0024002,1720292,DTCC00372862,1425570,3610
CHEMBL369302,P45452,,CCGWFLCBYDXLBZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15745814,IC50,=,4,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-13 at 1 uM,,Synthesis and SAR of diazepine and thiazepine TACE and MMP inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,6,"Zask A, Kaplan J, Du X, MacEwan G, Sandanayaka V, Eudy N, Levin J, Jin G, Xu J, Cummons T, Barone D, Ayral-Kaloustian S, Skotnicki J",,305328,DTCT0024002,1749391,DTCC00382922,725221,18895
CHEMBL369302,P45452,,CCGWFLCBYDXLBZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,IC50,=,3.98,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258773,DTCC00382922,714628,24803
CHEMBL369505,P45452,,XVVZROOOIUBICS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15780611,IC50,=,5,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 13,,Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.,Bioorg. Med. Chem. Lett.,2005,15,7,"Blagg JA, Noe MC, Wolf-Gouveia LA, Reiter LA, Laird ER, Chang SP, Danley DE, Downs JT, Elliott NC, Eskra JD, Griffiths RJ, Hardink JR, Haugeto AI, Jones CS, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robinson RP, Subramanyam C, Vaughn-Bowser ML, Yocum SA",,305127,DTCT0024002,1753716,DTCC00384574,174496,18917
CHEMBL369524,P45452,,OCENTDLFDAKGHV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15780611,IC50,=,2.1,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 13,,Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.,Bioorg. Med. Chem. Lett.,2005,15,7,"Blagg JA, Noe MC, Wolf-Gouveia LA, Reiter LA, Laird ER, Chang SP, Danley DE, Downs JT, Elliott NC, Eskra JD, Griffiths RJ, Hardink JR, Haugeto AI, Jones CS, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robinson RP, Subramanyam C, Vaughn-Bowser ML, Yocum SA",,305127,DTCT0024002,1753604,DTCC00384491,1724683,18917
CHEMBL369574,P45452,,LKFNHCFYLDRUTH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15745814,IC50,=,446,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-13 at 1 uM,,Synthesis and SAR of diazepine and thiazepine TACE and MMP inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,6,"Zask A, Kaplan J, Du X, MacEwan G, Sandanayaka V, Eudy N, Levin J, Jin G, Xu J, Cummons T, Barone D, Ayral-Kaloustian S, Skotnicki J",,305328,DTCT0024002,1748429,DTCC00382963,1015940,18895
CHEMBL369773,P45452,,UCAWMWVVLBTIHU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15780611,IC50,=,56,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 13,,Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.,Bioorg. Med. Chem. Lett.,2005,15,7,"Blagg JA, Noe MC, Wolf-Gouveia LA, Reiter LA, Laird ER, Chang SP, Danley DE, Downs JT, Elliott NC, Eskra JD, Griffiths RJ, Hardink JR, Haugeto AI, Jones CS, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robinson RP, Subramanyam C, Vaughn-Bowser ML, Yocum SA",,305127,DTCT0024002,1754140,DTCC00384446,1501625,18917
CHEMBL36999,P45452,,JMTSRJRSBJJBGP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12668018,IC50,=,9,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease 13 (MMP-13).,,Synthesis and SAR of bicyclic heteroaryl hydroxamic acid MMP and TACE inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,8,"Zask A, Gu Y, Albright JD, Du X, Hogan M, Levin JI, Chen JM, Killar LM, Sung A, DiJoseph JF, Sharr MA, Roth CE, Skala S, Jin G, Cowling R, Mohler KM, Barone D, Black R, March C, Skotnicki JS",,106642,DTCT0024002,1263074,DTCC00174438,1752641,6276
CHEMBL370129,P45452,,KQEHQRICYJKJLB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16084720,IC50,=,12,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metallopeptidase 13,,Acetylenic TACE inhibitors. Part 2: SAR of six-membered cyclic sulfonamide hydroxamates.,Bioorg. Med. Chem. Lett.,2005,15,19,"Levin JI, Chen JM, Laakso LM, Du M, Du X, Venkatesan AM, Sandanayaka V, Zask A, Xu J, Xu W, Zhang Y, Skotnicki JS",,321254,DTCT0024002,1861755,DTCC00408041,1808244,19752
CHEMBL370129,P45452,,KQEHQRICYJKJLB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16084720,IC50,=,12,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metallopeptidase 13,,Acetylenic TACE inhibitors. Part 2: SAR of six-membered cyclic sulfonamide hydroxamates.,Bioorg. Med. Chem. Lett.,2005,15,19,"Levin JI, Chen JM, Laakso LM, Du M, Du X, Venkatesan AM, Sandanayaka V, Zask A, Xu J, Xu W, Zhang Y, Skotnicki JS",,321254,DTCT0024002,1862274,DTCC00408041,1808245,19752
CHEMBL370312,P45452,,UWPHCZNYIWQCKD-APWZRJJASA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15911259,IC50,=,1.4,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-13 (MMP-13),,"Discovery of 3,3-dimethyl-5-hydroxypipecolic hydroxamate-based inhibitors of aggrecanase and MMP-13.",Bioorg. Med. Chem. Lett.,2005,15,11,"Noe MC, Natarajan V, Snow SL, Mitchell PG, Lopresti-Morrow L, Reeves LM, Yocum SA, Carty TJ, Barberia JA, Sweeney FJ, Liras JL, Vaughn M, Hardink JR, Hawkins JM, Tokar C",,304865,DTCT0024002,1813344,DTCC00398887,1840589,18491
CHEMBL370333,P45452,,HOXYEQZQHOZJQN-NDEPHWFRSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16153831,IC50,=,27,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-13,,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321194,DTCT0024002,1860427,DTCC00407680,370185,19837
CHEMBL370351,P45452,,GXOXVMQTJCQLGA-VWLOTQADSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16153831,IC50,=,9.5,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-13,,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321194,DTCT0024002,1860309,DTCC00407629,660937,19837
CHEMBL370351,P45452,,GXOXVMQTJCQLGA-VWLOTQADSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19625186,IC50,=,9.5,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"3,4-Disubstituted benzofuran P1' MMP-13 inhibitors: optimization of selectivity and reduction of protein binding.",Bioorg. Med. Chem. Lett.,2009,19,16,"Li W, Hu Y, Li J, Thomason JR, DeVincentis D, Du X, Wu J, Hotchandani R, Rush TS, Skotnicki JS, Tam S, Chockalingam PS, Morris EA, Levin JI",,581466,DTCT0024002,2904472,DTCC00407629,651474,35265
CHEMBL370631,P45452,,RPOIZUWTBLHTNU-YTTGMZPUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16153831,IC50,=,67,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-13,,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321194,DTCT0024002,1860424,DTCC00407679,1566231,19837
CHEMBL370667,P45452,,LUACGTLZVKVKKY-VWLOTQADSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16153831,IC50,=,55,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-13,,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321194,DTCT0024002,1860319,DTCC00407650,1534242,19837
CHEMBL370825,P45452,,SQODILRODCBOCF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16084720,IC50,=,97,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metallopeptidase 13,,Acetylenic TACE inhibitors. Part 2: SAR of six-membered cyclic sulfonamide hydroxamates.,Bioorg. Med. Chem. Lett.,2005,15,19,"Levin JI, Chen JM, Laakso LM, Du M, Du X, Venkatesan AM, Sandanayaka V, Zask A, Xu J, Xu W, Zhang Y, Skotnicki JS",,321254,DTCT0024002,1861792,DTCC00408078,1554839,19752
CHEMBL370825,P45452,,SQODILRODCBOCF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16084720,IC50,=,97,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metallopeptidase 13,,Acetylenic TACE inhibitors. Part 2: SAR of six-membered cyclic sulfonamide hydroxamates.,Bioorg. Med. Chem. Lett.,2005,15,19,"Levin JI, Chen JM, Laakso LM, Du M, Du X, Venkatesan AM, Sandanayaka V, Zask A, Xu J, Xu W, Zhang Y, Skotnicki JS",,321254,DTCT0024002,1862310,DTCC00408078,1554843,19752
CHEMBL371199,P45452,,CKPNTYRTTDOFLD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15908214,KI,>,5020,NM,,,,,,,,,,,,,,In vitro binding affinity against matrix metalloprotease 13,,"Non-hydroxamate 5-phenylpyrimidine-2,4,6-trione derivatives as selective inhibitors of tumor necrosis factor-alpha converting enzyme.",Bioorg. Med. Chem. Lett.,2005,15,12,"Duan JJ, Lu Z, Wasserman ZR, Liu RQ, Covington MB, Decicco CP",,302358,DTCT0024002,1800413,DTCC00398230,843308,16433
CHEMBL371781,P45452,,WZUCVDGGDSHNQU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15908214,KI,>,5020,NM,,,,,,,,,,,,,,In vitro binding affinity against matrix metalloprotease 13,,"Non-hydroxamate 5-phenylpyrimidine-2,4,6-trione derivatives as selective inhibitors of tumor necrosis factor-alpha converting enzyme.",Bioorg. Med. Chem. Lett.,2005,15,12,"Duan JJ, Lu Z, Wasserman ZR, Liu RQ, Covington MB, Decicco CP",,302358,DTCT0024002,1800226,DTCC00398284,1361040,16433
CHEMBL372261,P45452,,MRBPTYYVXXZQBB-BEFAXECRSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15911259,IC50,=,8,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-13 (MMP-13),,"Discovery of 3,3-dimethyl-5-hydroxypipecolic hydroxamate-based inhibitors of aggrecanase and MMP-13.",Bioorg. Med. Chem. Lett.,2005,15,11,"Noe MC, Natarajan V, Snow SL, Mitchell PG, Lopresti-Morrow L, Reeves LM, Yocum SA, Carty TJ, Barberia JA, Sweeney FJ, Liras JL, Vaughn M, Hardink JR, Hawkins JM, Tokar C",,304865,DTCT0024002,1814462,DTCC00398886,1619560,18491
CHEMBL372405,P45452,,CNVJYZPKUZXAML-MUUNZHRXSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16275085,IC50,=,4.4,NM,,,,,,,,,,,,,,Inhibitory activity against MMP13,,Synthesis and biological evaluation of biphenylsulfonamide carboxylate aggrecanase-1 inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,2,"Xiang JS, Hu Y, Rush TS, Thomason JR, Ipek M, Sum PE, Abrous L, Sabatini JJ, Georgiadis K, Reifenberg E, Majumdar M, Morris EA, Tam S",,327744,DTCT0024002,1878759,DTCC00411555,1490519,19995
CHEMBL372659,P45452,,CPNHPERKWKQFHI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15908214,KI,>,5020,NM,,,,,,,,,,,,,,In vitro binding affinity against matrix metalloprotease 13,,"Non-hydroxamate 5-phenylpyrimidine-2,4,6-trione derivatives as selective inhibitors of tumor necrosis factor-alpha converting enzyme.",Bioorg. Med. Chem. Lett.,2005,15,12,"Duan JJ, Lu Z, Wasserman ZR, Liu RQ, Covington MB, Decicco CP",,302358,DTCT0024002,1800084,DTCC00398190,130821,16433
CHEMBL372878,P45452,,CWBVJJZJNOSACP-BEFAXECRSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15911259,IC50,=,0.5,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-13 (MMP-13),,"Discovery of 3,3-dimethyl-5-hydroxypipecolic hydroxamate-based inhibitors of aggrecanase and MMP-13.",Bioorg. Med. Chem. Lett.,2005,15,11,"Noe MC, Natarajan V, Snow SL, Mitchell PG, Lopresti-Morrow L, Reeves LM, Yocum SA, Carty TJ, Barberia JA, Sweeney FJ, Liras JL, Vaughn M, Hardink JR, Hawkins JM, Tokar C",,304865,DTCT0024002,1812760,DTCC00398600,1554729,18491
CHEMBL372908,P45452,,XRGWUGBXRHDGDG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16084720,IC50,=,9,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metallopeptidase 13,,Acetylenic TACE inhibitors. Part 2: SAR of six-membered cyclic sulfonamide hydroxamates.,Bioorg. Med. Chem. Lett.,2005,15,19,"Levin JI, Chen JM, Laakso LM, Du M, Du X, Venkatesan AM, Sandanayaka V, Zask A, Xu J, Xu W, Zhang Y, Skotnicki JS",,321254,DTCT0024002,1861780,DTCC00408063,66390,19752
CHEMBL372908,P45452,,XRGWUGBXRHDGDG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16084720,IC50,=,9,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metallopeptidase 13,,Acetylenic TACE inhibitors. Part 2: SAR of six-membered cyclic sulfonamide hydroxamates.,Bioorg. Med. Chem. Lett.,2005,15,19,"Levin JI, Chen JM, Laakso LM, Du M, Du X, Venkatesan AM, Sandanayaka V, Zask A, Xu J, Xu W, Zhang Y, Skotnicki JS",,321254,DTCT0024002,1862300,DTCC00408063,66391,19752
CHEMBL373154,P45452,,WOGNSQDLIXXYFU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15908214,KI,=,5020,NM,,,,,,,,,,,,,,In vitro binding affinity against matrix metalloprotease 13,,"Non-hydroxamate 5-phenylpyrimidine-2,4,6-trione derivatives as selective inhibitors of tumor necrosis factor-alpha converting enzyme.",Bioorg. Med. Chem. Lett.,2005,15,12,"Duan JJ, Lu Z, Wasserman ZR, Liu RQ, Covington MB, Decicco CP",,302358,DTCT0024002,1800238,DTCC00398286,1715489,16433
CHEMBL373217,P45452,,GXFNBOPPVZGKBI-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16153831,IC50,=,3,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-13,,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321194,DTCT0024002,1860312,DTCC00407636,1598757,19837
CHEMBL373261,P45452,,DZOZBHZWCFMSKH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16392792,IC50,=,20,NM,,,,,,,,,,,,,,Binding affinity to MMP13,,Matrix metalloproteinase target family landscape: a chemometrical approach to ligand selectivity based on protein binding site analysis.,J. Med. Chem.,2006,49,1,"Pirard B, Matter H",,329823,DTCT0024002,1880245,DTCC00411745,1230448,20214
CHEMBL373311,P45452,,LAHYEFDNWASMJY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15908214,KI,=,4020,NM,,,,,,,,,,,,,,In vitro binding affinity against matrix metalloprotease 13,,"Non-hydroxamate 5-phenylpyrimidine-2,4,6-trione derivatives as selective inhibitors of tumor necrosis factor-alpha converting enzyme.",Bioorg. Med. Chem. Lett.,2005,15,12,"Duan JJ, Lu Z, Wasserman ZR, Liu RQ, Covington MB, Decicco CP",,302358,DTCT0024002,1800072,DTCC00398032,2035576,16433
CHEMBL373438,P45452,,VEMPUXZNKSUVFD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15566296,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Synthesis and structure-activity relationships of 4-alkynyloxy phenyl sulfanyl, sulfinyl, and sulfonyl alkyl hydroxamates as tumor necrosis factor-alpha converting enzyme and matrix metalloproteinase inhibitors.",J. Med. Chem.,2004,47,25,"Venkatesan AM, Davis JM, Grosu GT, Baker J, Zask A, Levin JI, Ellingboe J, Skotnicki JS, Dijoseph JF, Sung A, Jin G, Xu W, McCarthy DJ, Barone D",,429672,DTCT0024002,2041967,DTCC00444513,305297,22157
CHEMBL373675,P45452,,DGZLJIUYIIKNRM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16942871,IC50,=,3.9,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Potent, selective pyrimidinetrione-based inhibitors of MMP-13.",Bioorg. Med. Chem. Lett.,2006,16,22,"Reiter LA, Freeman-Cook KD, Jones CS, Martinelli GJ, Antipas AS, Berliner MA, Datta K, Downs JT, Eskra JD, Forman MD, Greer EM, Guzman R, Hardink JR, Janat F, Keene NF, Laird ER, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robertson D, Sperger D, Vaughn-Bowser ML, Waller DM, Yocum SA",,424283,DTCT0024002,2011691,DTCC00440828,1502205,21753
CHEMBL373694,P45452,,CDIBBFPULKXHGN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15566296,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Synthesis and structure-activity relationships of 4-alkynyloxy phenyl sulfanyl, sulfinyl, and sulfonyl alkyl hydroxamates as tumor necrosis factor-alpha converting enzyme and matrix metalloproteinase inhibitors.",J. Med. Chem.,2004,47,25,"Venkatesan AM, Davis JM, Grosu GT, Baker J, Zask A, Levin JI, Ellingboe J, Skotnicki JS, Dijoseph JF, Sung A, Jin G, Xu W, McCarthy DJ, Barone D",,429672,DTCT0024002,2041971,DTCC00444500,855451,22157
CHEMBL373831,P45452,,XAUUSUAZNMIGRK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15566296,IC50,=,7,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Synthesis and structure-activity relationships of 4-alkynyloxy phenyl sulfanyl, sulfinyl, and sulfonyl alkyl hydroxamates as tumor necrosis factor-alpha converting enzyme and matrix metalloproteinase inhibitors.",J. Med. Chem.,2004,47,25,"Venkatesan AM, Davis JM, Grosu GT, Baker J, Zask A, Levin JI, Ellingboe J, Skotnicki JS, Dijoseph JF, Sung A, Jin G, Xu W, McCarthy DJ, Barone D",,429672,DTCT0024002,2041986,DTCC00444490,1049041,22157
CHEMBL374015,P45452,,QKSNNIINMGAXNH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16942871,IC50,=,0.54,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Potent, selective pyrimidinetrione-based inhibitors of MMP-13.",Bioorg. Med. Chem. Lett.,2006,16,22,"Reiter LA, Freeman-Cook KD, Jones CS, Martinelli GJ, Antipas AS, Berliner MA, Datta K, Downs JT, Eskra JD, Forman MD, Greer EM, Guzman R, Hardink JR, Janat F, Keene NF, Laird ER, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robertson D, Sperger D, Vaughn-Bowser ML, Waller DM, Yocum SA",,424283,DTCT0024002,2011675,DTCC00440852,403405,21753
CHEMBL374041,P45452,,ABCSNHDQYHOLOO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16942871,IC50,=,0.4,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Potent, selective pyrimidinetrione-based inhibitors of MMP-13.",Bioorg. Med. Chem. Lett.,2006,16,22,"Reiter LA, Freeman-Cook KD, Jones CS, Martinelli GJ, Antipas AS, Berliner MA, Datta K, Downs JT, Eskra JD, Forman MD, Greer EM, Guzman R, Hardink JR, Janat F, Keene NF, Laird ER, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robertson D, Sperger D, Vaughn-Bowser ML, Waller DM, Yocum SA",,424283,DTCT0024002,2011690,DTCC00440834,78184,21753
CHEMBL374114,P45452,,MDNQMINKKFNDQI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15566296,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Synthesis and structure-activity relationships of 4-alkynyloxy phenyl sulfanyl, sulfinyl, and sulfonyl alkyl hydroxamates as tumor necrosis factor-alpha converting enzyme and matrix metalloproteinase inhibitors.",J. Med. Chem.,2004,47,25,"Venkatesan AM, Davis JM, Grosu GT, Baker J, Zask A, Levin JI, Ellingboe J, Skotnicki JS, Dijoseph JF, Sung A, Jin G, Xu W, McCarthy DJ, Barone D",,429672,DTCT0024002,2041956,DTCC00444446,757982,22157
CHEMBL374364,P45452,,FFZJOTGZMQUHMZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16942871,IC50,=,8,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Potent, selective pyrimidinetrione-based inhibitors of MMP-13.",Bioorg. Med. Chem. Lett.,2006,16,22,"Reiter LA, Freeman-Cook KD, Jones CS, Martinelli GJ, Antipas AS, Berliner MA, Datta K, Downs JT, Eskra JD, Forman MD, Greer EM, Guzman R, Hardink JR, Janat F, Keene NF, Laird ER, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robertson D, Sperger D, Vaughn-Bowser ML, Waller DM, Yocum SA",,424283,DTCT0024002,2011695,DTCC00440906,1209679,21753
CHEMBL374377,P45452,,VWKXFDZWHLCIIU-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17088065,IC50,=,13,NM,,,,,,,,,,,,,,Inhibition of MMP13,,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432508,DTCT0024002,2061872,DTCC00447804,1684492,22402
CHEMBL374770,P45452,,JFTXMXVXCKLYHG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16942871,IC50,=,0.63,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Potent, selective pyrimidinetrione-based inhibitors of MMP-13.",Bioorg. Med. Chem. Lett.,2006,16,22,"Reiter LA, Freeman-Cook KD, Jones CS, Martinelli GJ, Antipas AS, Berliner MA, Datta K, Downs JT, Eskra JD, Forman MD, Greer EM, Guzman R, Hardink JR, Janat F, Keene NF, Laird ER, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robertson D, Sperger D, Vaughn-Bowser ML, Waller DM, Yocum SA",,424283,DTCT0024002,2011666,DTCC00441024,499978,21753
CHEMBL374915,P45452,,WKFZJKDVVULWLA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16942871,IC50,=,0.93,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Potent, selective pyrimidinetrione-based inhibitors of MMP-13.",Bioorg. Med. Chem. Lett.,2006,16,22,"Reiter LA, Freeman-Cook KD, Jones CS, Martinelli GJ, Antipas AS, Berliner MA, Datta K, Downs JT, Eskra JD, Forman MD, Greer EM, Guzman R, Hardink JR, Janat F, Keene NF, Laird ER, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robertson D, Sperger D, Vaughn-Bowser ML, Waller DM, Yocum SA",,424283,DTCT0024002,2011673,DTCC00440868,272285,21753
CHEMBL374915,P45452,,WKFZJKDVVULWLA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17935984,IC50,=,0.93,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Potent, selective spiropyrrolidine pyrimidinetrione inhibitors of MMP-13.",Bioorg. Med. Chem. Lett.,2007,17,23,"Freeman-Cook KD, Reiter LA, Noe MC, Antipas AS, Danley DE, Datta K, Downs JT, Eisenbeis S, Eskra JD, Garmene DJ, Greer EM, Griffiths RJ, Guzman R, Hardink JR, Janat F, Jones CS, Martinelli GJ, Mitchell PG, Laird ER, Liras JL, Lopresti-Morrow LL, Pandit J, Reilly UD, Robertson D, Vaughn-Bowser ML, Wolf-Gouviea LA, Yocum SA",,458357,DTCT0024002,2254804,DTCC00440868,260704,24756
CHEMBL374953,P45452,,RLWLGGMXWQFGGX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15566296,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Synthesis and structure-activity relationships of 4-alkynyloxy phenyl sulfanyl, sulfinyl, and sulfonyl alkyl hydroxamates as tumor necrosis factor-alpha converting enzyme and matrix metalloproteinase inhibitors.",J. Med. Chem.,2004,47,25,"Venkatesan AM, Davis JM, Grosu GT, Baker J, Zask A, Levin JI, Ellingboe J, Skotnicki JS, Dijoseph JF, Sung A, Jin G, Xu W, McCarthy DJ, Barone D",,429672,DTCT0024002,2041958,DTCC00444440,1787760,22157
CHEMBL375013,P45452,,IWSABXACJQMTBL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15566296,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Synthesis and structure-activity relationships of 4-alkynyloxy phenyl sulfanyl, sulfinyl, and sulfonyl alkyl hydroxamates as tumor necrosis factor-alpha converting enzyme and matrix metalloproteinase inhibitors.",J. Med. Chem.,2004,47,25,"Venkatesan AM, Davis JM, Grosu GT, Baker J, Zask A, Levin JI, Ellingboe J, Skotnicki JS, Dijoseph JF, Sung A, Jin G, Xu W, McCarthy DJ, Barone D",,429672,DTCT0024002,2041961,DTCC00444530,1566561,22157
CHEMBL3751997,P45452,,,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,26810711,IC50,=,5.37,NM,,,,,,,,,,,,,,"Inhibition of MMP13 (unknown origin) using (7-methoxycoumarin-4-yl) acetyl pro-Leu-Gly-Leu-[3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl]-Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by microplate reader analysis",,Fluorinated matrix metalloproteinases inhibitors--Phosphonate based potential probes for positron emission tomography.,Bioorg. Med. Chem.,2016,24,4,"Beutel B, Daniliuc CG, Riemann B, Schafers M, Haufe G.",,1549578,DTCT0024002,50644,DTCC00072284,355028,65936
CHEMBL3752419,P45452,,,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,26810711,IC50,=,93.8,NM,,,,,,,,,,,,,,"Inhibition of MMP13 (unknown origin) using (7-methoxycoumarin-4-yl) acetyl pro-Leu-Gly-Leu-[3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl]-Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by microplate reader analysis",,Fluorinated matrix metalloproteinases inhibitors--Phosphonate based potential probes for positron emission tomography.,Bioorg. Med. Chem.,2016,24,4,"Beutel B, Daniliuc CG, Riemann B, Schafers M, Haufe G.",,1549578,DTCT0024002,50645,DTCC00072285,1804884,65936
CHEMBL3752564,P45452,,,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,26810711,IC50,=,2.17,NM,,,,,,,,,,,,,,"Inhibition of MMP13 (unknown origin) using (7-methoxycoumarin-4-yl) acetyl pro-Leu-Gly-Leu-[3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl]-Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by microplate reader analysis",,Fluorinated matrix metalloproteinases inhibitors--Phosphonate based potential probes for positron emission tomography.,Bioorg. Med. Chem.,2016,24,4,"Beutel B, Daniliuc CG, Riemann B, Schafers M, Haufe G.",,1549578,DTCT0024002,50638,DTCC00072278,95261,65936
CHEMBL3752747,P45452,,,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,26810711,IC50,=,1030,NM,,,,,,,,,,,,,,"Inhibition of MMP13 (unknown origin) using (7-methoxycoumarin-4-yl) acetyl pro-Leu-Gly-Leu-[3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl]-Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by microplate reader analysis",,Fluorinated matrix metalloproteinases inhibitors--Phosphonate based potential probes for positron emission tomography.,Bioorg. Med. Chem.,2016,24,4,"Beutel B, Daniliuc CG, Riemann B, Schafers M, Haufe G.",,1549578,DTCT0024002,50640,DTCC00072280,1324856,65936
CHEMBL3752826,P45452,,,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,26810711,IC50,>,100000,NM,,,,,,,,,,,,,,"Inhibition of MMP13 (unknown origin) using (7-methoxycoumarin-4-yl) acetyl pro-Leu-Gly-Leu-[3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl]-Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by microplate reader analysis",,Fluorinated matrix metalloproteinases inhibitors--Phosphonate based potential probes for positron emission tomography.,Bioorg. Med. Chem.,2016,24,4,"Beutel B, Daniliuc CG, Riemann B, Schafers M, Haufe G.",,1549578,DTCT0024002,50641,DTCC00072281,1933521,65936
CHEMBL375318,P45452,,XKOVTPPNKADGLU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15566296,INHIBITION,=,63,%,,,,,,,,,,,,,,Inhibition of MMP13 at 10 uM,,"Synthesis and structure-activity relationships of 4-alkynyloxy phenyl sulfanyl, sulfinyl, and sulfonyl alkyl hydroxamates as tumor necrosis factor-alpha converting enzyme and matrix metalloproteinase inhibitors.",J. Med. Chem.,2004,47,25,"Venkatesan AM, Davis JM, Grosu GT, Baker J, Zask A, Levin JI, Ellingboe J, Skotnicki JS, Dijoseph JF, Sung A, Jin G, Xu W, McCarthy DJ, Barone D",,429673,DTCT0024002,2041984,DTCC00444456,1534612,22157
CHEMBL375319,P45452,2-(4-METHOXYBENZENESULFONYL)OCTANOIC ACID HYDROXYAMIDE,VMCQYTNLTZJCIG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15566296,IC50,=,12,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Synthesis and structure-activity relationships of 4-alkynyloxy phenyl sulfanyl, sulfinyl, and sulfonyl alkyl hydroxamates as tumor necrosis factor-alpha converting enzyme and matrix metalloproteinase inhibitors.",J. Med. Chem.,2004,47,25,"Venkatesan AM, Davis JM, Grosu GT, Baker J, Zask A, Levin JI, Ellingboe J, Skotnicki JS, Dijoseph JF, Sung A, Jin G, Xu W, McCarthy DJ, Barone D",,429672,DTCT0024002,2041979,DTCC00002420,1755544,22157
CHEMBL375342,P45452,,ASJAUOVNUCTXEI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16942871,IC50,=,0.84,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Potent, selective pyrimidinetrione-based inhibitors of MMP-13.",Bioorg. Med. Chem. Lett.,2006,16,22,"Reiter LA, Freeman-Cook KD, Jones CS, Martinelli GJ, Antipas AS, Berliner MA, Datta K, Downs JT, Eskra JD, Forman MD, Greer EM, Guzman R, Hardink JR, Janat F, Keene NF, Laird ER, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robertson D, Sperger D, Vaughn-Bowser ML, Waller DM, Yocum SA",,424283,DTCT0024002,2011681,DTCC00440807,305237,21753
CHEMBL3754243,P45452,,,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,26810711,IC50,=,2.41,NM,,,,,,,,,,,,,,"Inhibition of MMP13 (unknown origin) using (7-methoxycoumarin-4-yl) acetyl pro-Leu-Gly-Leu-[3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl]-Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by microplate reader analysis",,Fluorinated matrix metalloproteinases inhibitors--Phosphonate based potential probes for positron emission tomography.,Bioorg. Med. Chem.,2016,24,4,"Beutel B, Daniliuc CG, Riemann B, Schafers M, Haufe G.",,1549578,DTCT0024002,50639,DTCC00072279,1869235,65936
CHEMBL3754302,P45452,,,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,26810711,IC50,=,73.1,NM,,,,,,,,,,,,,,"Inhibition of MMP13 (unknown origin) using (7-methoxycoumarin-4-yl) acetyl pro-Leu-Gly-Leu-[3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl]-Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by microplate reader analysis",,Fluorinated matrix metalloproteinases inhibitors--Phosphonate based potential probes for positron emission tomography.,Bioorg. Med. Chem.,2016,24,4,"Beutel B, Daniliuc CG, Riemann B, Schafers M, Haufe G.",,1549578,DTCT0024002,50642,DTCC00072282,840009,65936
CHEMBL3754314,P45452,,,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,26810711,IC50,>,100000,NM,,,,,,,,,,,,,,"Inhibition of MMP13 (unknown origin) using (7-methoxycoumarin-4-yl) acetyl pro-Leu-Gly-Leu-[3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl]-Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by microplate reader analysis",,Fluorinated matrix metalloproteinases inhibitors--Phosphonate based potential probes for positron emission tomography.,Bioorg. Med. Chem.,2016,24,4,"Beutel B, Daniliuc CG, Riemann B, Schafers M, Haufe G.",,1549578,DTCT0024002,50643,DTCC00072283,62801,65936
CHEMBL375667,P45452,,NWCAKMHOURFTPM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16942871,IC50,=,0.84,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Potent, selective pyrimidinetrione-based inhibitors of MMP-13.",Bioorg. Med. Chem. Lett.,2006,16,22,"Reiter LA, Freeman-Cook KD, Jones CS, Martinelli GJ, Antipas AS, Berliner MA, Datta K, Downs JT, Eskra JD, Forman MD, Greer EM, Guzman R, Hardink JR, Janat F, Keene NF, Laird ER, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robertson D, Sperger D, Vaughn-Bowser ML, Waller DM, Yocum SA",,424283,DTCT0024002,2011656,DTCC00110910,564232,21753
CHEMBL375818,P45452,,PPZSDUZHUBNDCN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16942871,IC50,=,12,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Potent, selective pyrimidinetrione-based inhibitors of MMP-13.",Bioorg. Med. Chem. Lett.,2006,16,22,"Reiter LA, Freeman-Cook KD, Jones CS, Martinelli GJ, Antipas AS, Berliner MA, Datta K, Downs JT, Eskra JD, Forman MD, Greer EM, Guzman R, Hardink JR, Janat F, Keene NF, Laird ER, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robertson D, Sperger D, Vaughn-Bowser ML, Waller DM, Yocum SA",,424283,DTCT0024002,2011682,DTCC00440915,790081,21753
CHEMBL3758194,P45452,,,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,26653735,KI,=,0.2,NM,,,,,,,,,,,,,,Inhibition of full length human recombinant MMP13 using MCA-Arg-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-Glu-Arg-NH2 as substrate preincubated for 60 mins followed by substrate addition by fluorescence assay,,"Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis.",J. Med. Chem.,2016,59,1,"Ruminski PG, Massa M, Strohbach J, Hanau CE, Schmidt M, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Shieh HS, Caspers N, Collins B, Grapperhaus M, Palmquist KE, Collins J, Baldus JE, Hitchcock J, Kleine HP, Rogers MD, McDonald J, Munie GE, Messing DM, Portolan S, Whiteley LO, Sunyer T, Schnute ME.",,1552458,DTCT0024002,73355,DTCC00074436,786847,65989
CHEMBL3758273,P45452,,,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,26653735,KI,=,47.2,NM,,,,,,,,,,,,,,Inhibition of full length human recombinant MMP13 using MCA-Arg-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-Glu-Arg-NH2 as substrate preincubated for 60 mins followed by substrate addition by fluorescence assay,,"Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis.",J. Med. Chem.,2016,59,1,"Ruminski PG, Massa M, Strohbach J, Hanau CE, Schmidt M, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Shieh HS, Caspers N, Collins B, Grapperhaus M, Palmquist KE, Collins J, Baldus JE, Hitchcock J, Kleine HP, Rogers MD, McDonald J, Munie GE, Messing DM, Portolan S, Whiteley LO, Sunyer T, Schnute ME.",,1552458,DTCT0024002,72577,DTCC00074426,432308,65989
CHEMBL3758299,P45452,,,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,26653735,KI,=,4.2,NM,,,,,,,,,,,,,,Inhibition of full length human recombinant MMP13 using MCA-Arg-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-Glu-Arg-NH2 as substrate preincubated for 60 mins followed by substrate addition by fluorescence assay,,"Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis.",J. Med. Chem.,2016,59,1,"Ruminski PG, Massa M, Strohbach J, Hanau CE, Schmidt M, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Shieh HS, Caspers N, Collins B, Grapperhaus M, Palmquist KE, Collins J, Baldus JE, Hitchcock J, Kleine HP, Rogers MD, McDonald J, Munie GE, Messing DM, Portolan S, Whiteley LO, Sunyer T, Schnute ME.",,1552458,DTCT0024002,72568,DTCC00074435,561086,65989
CHEMBL3758350,P45452,,,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,26653735,KI,=,16.5,NM,,,,,,,,,,,,,,Inhibition of full length human recombinant MMP13 using MCA-Arg-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-Glu-Arg-NH2 as substrate preincubated for 60 mins followed by substrate addition by fluorescence assay,,"Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis.",J. Med. Chem.,2016,59,1,"Ruminski PG, Massa M, Strohbach J, Hanau CE, Schmidt M, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Shieh HS, Caspers N, Collins B, Grapperhaus M, Palmquist KE, Collins J, Baldus JE, Hitchcock J, Kleine HP, Rogers MD, McDonald J, Munie GE, Messing DM, Portolan S, Whiteley LO, Sunyer T, Schnute ME.",,1552458,DTCT0024002,73232,DTCC00074407,948585,65989
CHEMBL3758421,P45452,,,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,26653735,KI,=,21.2,NM,,,,,,,,,,,,,,Inhibition of full length human recombinant MMP13 using MCA-Arg-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-Glu-Arg-NH2 as substrate preincubated for 60 mins followed by substrate addition by fluorescence assay,,"Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis.",J. Med. Chem.,2016,59,1,"Ruminski PG, Massa M, Strohbach J, Hanau CE, Schmidt M, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Shieh HS, Caspers N, Collins B, Grapperhaus M, Palmquist KE, Collins J, Baldus JE, Hitchcock J, Kleine HP, Rogers MD, McDonald J, Munie GE, Messing DM, Portolan S, Whiteley LO, Sunyer T, Schnute ME.",,1552458,DTCT0024002,73225,DTCC00074414,2011710,65989
CHEMBL3758441,P45452,,,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,26653735,KI,=,6.3,NM,,,,,,,,,,,,,,Inhibition of full length human recombinant MMP13 using MCA-Arg-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-Glu-Arg-NH2 as substrate preincubated for 60 mins followed by substrate addition by fluorescence assay,,"Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis.",J. Med. Chem.,2016,59,1,"Ruminski PG, Massa M, Strohbach J, Hanau CE, Schmidt M, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Shieh HS, Caspers N, Collins B, Grapperhaus M, Palmquist KE, Collins J, Baldus JE, Hitchcock J, Kleine HP, Rogers MD, McDonald J, Munie GE, Messing DM, Portolan S, Whiteley LO, Sunyer T, Schnute ME.",,1552458,DTCT0024002,72572,DTCC00074431,139583,65989
CHEMBL3758501,P45452,,,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,26653735,KI,=,4.5,NM,,,,,,,,,,,,,,Inhibition of full length human recombinant MMP13 using MCA-Arg-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-Glu-Arg-NH2 as substrate preincubated for 60 mins followed by substrate addition by fluorescence assay,,"Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis.",J. Med. Chem.,2016,59,1,"Ruminski PG, Massa M, Strohbach J, Hanau CE, Schmidt M, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Shieh HS, Caspers N, Collins B, Grapperhaus M, Palmquist KE, Collins J, Baldus JE, Hitchcock J, Kleine HP, Rogers MD, McDonald J, Munie GE, Messing DM, Portolan S, Whiteley LO, Sunyer T, Schnute ME.",,1552458,DTCT0024002,73227,DTCC00074412,1304589,65989
CHEMBL3758508,P45452,,,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,26653735,KI,=,119,NM,,,,,,,,,,,,,,Inhibition of full length human recombinant MMP13 using MCA-Arg-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-Glu-Arg-NH2 as substrate preincubated for 60 mins followed by substrate addition by fluorescence assay,,"Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis.",J. Med. Chem.,2016,59,1,"Ruminski PG, Massa M, Strohbach J, Hanau CE, Schmidt M, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Shieh HS, Caspers N, Collins B, Grapperhaus M, Palmquist KE, Collins J, Baldus JE, Hitchcock J, Kleine HP, Rogers MD, McDonald J, Munie GE, Messing DM, Portolan S, Whiteley LO, Sunyer T, Schnute ME.",,1552458,DTCT0024002,72581,DTCC00074422,786846,65989
CHEMBL3758625,P45452,,,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,26653735,KI,=,0.25,NM,,,,,,,,,,,,,,Inhibition of full length human recombinant MMP13 using MCA-Arg-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-Glu-Arg-NH2 as substrate preincubated for 60 mins followed by substrate addition by fluorescence assay,,"Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis.",J. Med. Chem.,2016,59,1,"Ruminski PG, Massa M, Strohbach J, Hanau CE, Schmidt M, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Shieh HS, Caspers N, Collins B, Grapperhaus M, Palmquist KE, Collins J, Baldus JE, Hitchcock J, Kleine HP, Rogers MD, McDonald J, Munie GE, Messing DM, Portolan S, Whiteley LO, Sunyer T, Schnute ME.",,1552458,DTCT0024002,72587,DTCC00074416,74878,65989
CHEMBL3758657,P45452,,,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,26653735,KI,=,2.7,NM,,,,,,,,,,,,,,Inhibition of full length human recombinant MMP13 using MCA-Arg-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-Glu-Arg-NH2 as substrate preincubated for 60 mins followed by substrate addition by fluorescence assay,,"Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis.",J. Med. Chem.,2016,59,1,"Ruminski PG, Massa M, Strohbach J, Hanau CE, Schmidt M, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Shieh HS, Caspers N, Collins B, Grapperhaus M, Palmquist KE, Collins J, Baldus JE, Hitchcock J, Kleine HP, Rogers MD, McDonald J, Munie GE, Messing DM, Portolan S, Whiteley LO, Sunyer T, Schnute ME.",,1552458,DTCT0024002,73224,DTCC00074415,1271994,65989
CHEMBL3758659,P45452,,,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,26653735,KI,=,5.8,NM,,,,,,,,,,,,,,Inhibition of full length human recombinant MMP13 using MCA-Arg-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-Glu-Arg-NH2 as substrate preincubated for 60 mins followed by substrate addition by fluorescence assay,,"Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis.",J. Med. Chem.,2016,59,1,"Ruminski PG, Massa M, Strohbach J, Hanau CE, Schmidt M, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Shieh HS, Caspers N, Collins B, Grapperhaus M, Palmquist KE, Collins J, Baldus JE, Hitchcock J, Kleine HP, Rogers MD, McDonald J, Munie GE, Messing DM, Portolan S, Whiteley LO, Sunyer T, Schnute ME.",,1552458,DTCT0024002,72570,DTCC00074433,819184,65989
CHEMBL3758726,P45452,,,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,26653735,KI,=,7.7,NM,,,,,,,,,,,,,,Inhibition of full length human recombinant MMP13 using MCA-Arg-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-Glu-Arg-NH2 as substrate preincubated for 60 mins followed by substrate addition by fluorescence assay,,"Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis.",J. Med. Chem.,2016,59,1,"Ruminski PG, Massa M, Strohbach J, Hanau CE, Schmidt M, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Shieh HS, Caspers N, Collins B, Grapperhaus M, Palmquist KE, Collins J, Baldus JE, Hitchcock J, Kleine HP, Rogers MD, McDonald J, Munie GE, Messing DM, Portolan S, Whiteley LO, Sunyer T, Schnute ME.",,1552458,DTCT0024002,72560,DTCC00074406,754684,65989
CHEMBL3758726,P45452,,,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,26653735,KI,=,16.8,NM,,,,,,,,,,,,,,Inhibition of full length human recombinant MMP13 using MCA-Arg-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-Glu-Arg-NH2 as substrate preincubated for 60 mins followed by substrate addition by fluorescence assay,,"Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis.",J. Med. Chem.,2016,59,1,"Ruminski PG, Massa M, Strohbach J, Hanau CE, Schmidt M, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Shieh HS, Caspers N, Collins B, Grapperhaus M, Palmquist KE, Collins J, Baldus JE, Hitchcock J, Kleine HP, Rogers MD, McDonald J, Munie GE, Messing DM, Portolan S, Whiteley LO, Sunyer T, Schnute ME.",,1552458,DTCT0024002,73233,DTCC00074406,754685,65989
CHEMBL3758757,P45452,,,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,26653735,KI,=,10.9,NM,,,,,,,,,,,,,,Inhibition of full length human recombinant MMP13 using MCA-Arg-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-Glu-Arg-NH2 as substrate preincubated for 60 mins followed by substrate addition by fluorescence assay,,"Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis.",J. Med. Chem.,2016,59,1,"Ruminski PG, Massa M, Strohbach J, Hanau CE, Schmidt M, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Shieh HS, Caspers N, Collins B, Grapperhaus M, Palmquist KE, Collins J, Baldus JE, Hitchcock J, Kleine HP, Rogers MD, McDonald J, Munie GE, Messing DM, Portolan S, Whiteley LO, Sunyer T, Schnute ME.",,1552458,DTCT0024002,73226,DTCC00074413,1434205,65989
CHEMBL3758763,P45452,,,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,26653735,KI,=,14.1,NM,,,,,,,,,,,,,,Inhibition of full length human recombinant MMP13 using MCA-Arg-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-Glu-Arg-NH2 as substrate preincubated for 60 mins followed by substrate addition by fluorescence assay,,"Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis.",J. Med. Chem.,2016,59,1,"Ruminski PG, Massa M, Strohbach J, Hanau CE, Schmidt M, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Shieh HS, Caspers N, Collins B, Grapperhaus M, Palmquist KE, Collins J, Baldus JE, Hitchcock J, Kleine HP, Rogers MD, McDonald J, Munie GE, Messing DM, Portolan S, Whiteley LO, Sunyer T, Schnute ME.",,1552458,DTCT0024002,73231,DTCC00074408,74877,65989
CHEMBL3758783,P45452,,,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,26653735,KI,=,29.3,NM,,,,,,,,,,,,,,Inhibition of full length human recombinant MMP13 using MCA-Arg-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-Glu-Arg-NH2 as substrate preincubated for 60 mins followed by substrate addition by fluorescence assay,,"Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis.",J. Med. Chem.,2016,59,1,"Ruminski PG, Massa M, Strohbach J, Hanau CE, Schmidt M, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Shieh HS, Caspers N, Collins B, Grapperhaus M, Palmquist KE, Collins J, Baldus JE, Hitchcock J, Kleine HP, Rogers MD, McDonald J, Munie GE, Messing DM, Portolan S, Whiteley LO, Sunyer T, Schnute ME.",,1552458,DTCT0024002,72575,DTCC00074428,139582,65989
CHEMBL3759003,P45452,,,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,26653735,KI,=,5.8,NM,,,,,,,,,,,,,,Inhibition of full length human recombinant MMP13 using MCA-Arg-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-Glu-Arg-NH2 as substrate preincubated for 60 mins followed by substrate addition by fluorescence assay,,"Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis.",J. Med. Chem.,2016,59,1,"Ruminski PG, Massa M, Strohbach J, Hanau CE, Schmidt M, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Shieh HS, Caspers N, Collins B, Grapperhaus M, Palmquist KE, Collins J, Baldus JE, Hitchcock J, Kleine HP, Rogers MD, McDonald J, Munie GE, Messing DM, Portolan S, Whiteley LO, Sunyer T, Schnute ME.",,1552458,DTCT0024002,72582,DTCC00074421,1402218,65989
CHEMBL3759011,P45452,,,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,26653735,KI,=,3.8,NM,,,,,,,,,,,,,,Inhibition of full length human recombinant MMP13 using MCA-Arg-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-Glu-Arg-NH2 as substrate preincubated for 60 mins followed by substrate addition by fluorescence assay,,"Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis.",J. Med. Chem.,2016,59,1,"Ruminski PG, Massa M, Strohbach J, Hanau CE, Schmidt M, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Shieh HS, Caspers N, Collins B, Grapperhaus M, Palmquist KE, Collins J, Baldus JE, Hitchcock J, Kleine HP, Rogers MD, McDonald J, Munie GE, Messing DM, Portolan S, Whiteley LO, Sunyer T, Schnute ME.",,1552458,DTCT0024002,72573,DTCC00074430,302013,65989
CHEMBL3759109,P45452,,,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,26653735,KI,=,110,NM,,,,,,,,,,,,,,Inhibition of full length human recombinant MMP13 using MCA-Arg-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-Glu-Arg-NH2 as substrate preincubated for 60 mins followed by substrate addition by fluorescence assay,,"Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis.",J. Med. Chem.,2016,59,1,"Ruminski PG, Massa M, Strohbach J, Hanau CE, Schmidt M, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Shieh HS, Caspers N, Collins B, Grapperhaus M, Palmquist KE, Collins J, Baldus JE, Hitchcock J, Kleine HP, Rogers MD, McDonald J, Munie GE, Messing DM, Portolan S, Whiteley LO, Sunyer T, Schnute ME.",,1552458,DTCT0024002,72579,DTCC00074424,463717,65989
CHEMBL3759287,P45452,,,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,26653735,KI,=,11.7,NM,,,,,,,,,,,,,,Inhibition of full length human recombinant MMP13 using MCA-Arg-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-Glu-Arg-NH2 as substrate preincubated for 60 mins followed by substrate addition by fluorescence assay,,"Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis.",J. Med. Chem.,2016,59,1,"Ruminski PG, Massa M, Strohbach J, Hanau CE, Schmidt M, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Shieh HS, Caspers N, Collins B, Grapperhaus M, Palmquist KE, Collins J, Baldus JE, Hitchcock J, Kleine HP, Rogers MD, McDonald J, Munie GE, Messing DM, Portolan S, Whiteley LO, Sunyer T, Schnute ME.",,1552458,DTCT0024002,73228,DTCC00074411,1110924,65989
CHEMBL3759380,P45452,,,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,26653735,KI,=,38.5,NM,,,,,,,,,,,,,,Inhibition of full length human recombinant MMP13 using MCA-Arg-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-Glu-Arg-NH2 as substrate preincubated for 60 mins followed by substrate addition by fluorescence assay,,"Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis.",J. Med. Chem.,2016,59,1,"Ruminski PG, Massa M, Strohbach J, Hanau CE, Schmidt M, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Shieh HS, Caspers N, Collins B, Grapperhaus M, Palmquist KE, Collins J, Baldus JE, Hitchcock J, Kleine HP, Rogers MD, McDonald J, Munie GE, Messing DM, Portolan S, Whiteley LO, Sunyer T, Schnute ME.",,1552458,DTCT0024002,72578,DTCC00074425,1206482,65989
CHEMBL3759445,P45452,,,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,26653735,KI,=,32.9,NM,,,,,,,,,,,,,,Inhibition of full length human recombinant MMP13 using MCA-Arg-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-Glu-Arg-NH2 as substrate preincubated for 60 mins followed by substrate addition by fluorescence assay,,"Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis.",J. Med. Chem.,2016,59,1,"Ruminski PG, Massa M, Strohbach J, Hanau CE, Schmidt M, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Shieh HS, Caspers N, Collins B, Grapperhaus M, Palmquist KE, Collins J, Baldus JE, Hitchcock J, Kleine HP, Rogers MD, McDonald J, Munie GE, Messing DM, Portolan S, Whiteley LO, Sunyer T, Schnute ME.",,1552458,DTCT0024002,72580,DTCC00074423,463716,65989
CHEMBL3759468,P45452,,,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,26653735,KI,=,1.5,NM,,,,,,,,,,,,,,Inhibition of full length human recombinant MMP13 using MCA-Arg-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-Glu-Arg-NH2 as substrate preincubated for 60 mins followed by substrate addition by fluorescence assay,,"Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis.",J. Med. Chem.,2016,59,1,"Ruminski PG, Massa M, Strohbach J, Hanau CE, Schmidt M, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Shieh HS, Caspers N, Collins B, Grapperhaus M, Palmquist KE, Collins J, Baldus JE, Hitchcock J, Kleine HP, Rogers MD, McDonald J, Munie GE, Messing DM, Portolan S, Whiteley LO, Sunyer T, Schnute ME.",,1552458,DTCT0024002,72569,DTCC00074434,722469,65989
CHEMBL3759511,P45452,,,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,26653735,KI,=,8.2,NM,,,,,,,,,,,,,,Inhibition of full length human recombinant MMP13 using MCA-Arg-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-Glu-Arg-NH2 as substrate preincubated for 60 mins followed by substrate addition by fluorescence assay,,"Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis.",J. Med. Chem.,2016,59,1,"Ruminski PG, Massa M, Strohbach J, Hanau CE, Schmidt M, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Shieh HS, Caspers N, Collins B, Grapperhaus M, Palmquist KE, Collins J, Baldus JE, Hitchcock J, Kleine HP, Rogers MD, McDonald J, Munie GE, Messing DM, Portolan S, Whiteley LO, Sunyer T, Schnute ME.",,1552458,DTCT0024002,72585,DTCC00074418,981031,65989
CHEMBL3759520,P45452,,,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,26653735,KI,=,2.1,NM,,,,,,,,,,,,,,Inhibition of full length human recombinant MMP13 using MCA-Arg-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-Glu-Arg-NH2 as substrate preincubated for 60 mins followed by substrate addition by fluorescence assay,,"Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis.",J. Med. Chem.,2016,59,1,"Ruminski PG, Massa M, Strohbach J, Hanau CE, Schmidt M, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Shieh HS, Caspers N, Collins B, Grapperhaus M, Palmquist KE, Collins J, Baldus JE, Hitchcock J, Kleine HP, Rogers MD, McDonald J, Munie GE, Messing DM, Portolan S, Whiteley LO, Sunyer T, Schnute ME.",,1552458,DTCT0024002,73230,DTCC00074409,302011,65989
CHEMBL3759716,P45452,,,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,26653735,KI,=,4.1,NM,,,,,,,,,,,,,,Inhibition of full length human recombinant MMP13 using MCA-Arg-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-Glu-Arg-NH2 as substrate preincubated for 60 mins followed by substrate addition by fluorescence assay,,"Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis.",J. Med. Chem.,2016,59,1,"Ruminski PG, Massa M, Strohbach J, Hanau CE, Schmidt M, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Shieh HS, Caspers N, Collins B, Grapperhaus M, Palmquist KE, Collins J, Baldus JE, Hitchcock J, Kleine HP, Rogers MD, McDonald J, Munie GE, Messing DM, Portolan S, Whiteley LO, Sunyer T, Schnute ME.",,1552458,DTCT0024002,73229,DTCC00074410,561085,65989
CHEMBL3759727,P45452,,,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,26653735,KI,=,1.4,NM,,,,,,,,,,,,,,Inhibition of full length human recombinant MMP13 using MCA-Arg-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-Glu-Arg-NH2 as substrate preincubated for 60 mins followed by substrate addition by fluorescence assay,,"Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis.",J. Med. Chem.,2016,59,1,"Ruminski PG, Massa M, Strohbach J, Hanau CE, Schmidt M, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Shieh HS, Caspers N, Collins B, Grapperhaus M, Palmquist KE, Collins J, Baldus JE, Hitchcock J, Kleine HP, Rogers MD, McDonald J, Munie GE, Messing DM, Portolan S, Whiteley LO, Sunyer T, Schnute ME.",,1552458,DTCT0024002,72584,DTCC00074419,884425,65989
CHEMBL3759741,P45452,,,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,26653735,KI,=,4,NM,,,,,,,,,,,,,,Inhibition of full length human recombinant MMP13 using MCA-Arg-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-Glu-Arg-NH2 as substrate preincubated for 60 mins followed by substrate addition by fluorescence assay,,"Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis.",J. Med. Chem.,2016,59,1,"Ruminski PG, Massa M, Strohbach J, Hanau CE, Schmidt M, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Shieh HS, Caspers N, Collins B, Grapperhaus M, Palmquist KE, Collins J, Baldus JE, Hitchcock J, Kleine HP, Rogers MD, McDonald J, Munie GE, Messing DM, Portolan S, Whiteley LO, Sunyer T, Schnute ME.",,1552458,DTCT0024002,72574,DTCC00074429,268875,65989
CHEMBL3759811,P45452,,,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,26653735,KI,=,1.2,NM,,,,,,,,,,,,,,Inhibition of full length human recombinant MMP13 using MCA-Arg-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-Glu-Arg-NH2 as substrate preincubated for 60 mins followed by substrate addition by fluorescence assay,,"Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis.",J. Med. Chem.,2016,59,1,"Ruminski PG, Massa M, Strohbach J, Hanau CE, Schmidt M, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Shieh HS, Caspers N, Collins B, Grapperhaus M, Palmquist KE, Collins J, Baldus JE, Hitchcock J, Kleine HP, Rogers MD, McDonald J, Munie GE, Messing DM, Portolan S, Whiteley LO, Sunyer T, Schnute ME.",,1552458,DTCT0024002,72571,DTCC00074432,528829,65989
CHEMBL3759910,P45452,,,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,26653735,KI,=,23.8,NM,,,,,,,,,,,,,,Inhibition of full length human recombinant MMP13 using MCA-Arg-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-Glu-Arg-NH2 as substrate preincubated for 60 mins followed by substrate addition by fluorescence assay,,"Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis.",J. Med. Chem.,2016,59,1,"Ruminski PG, Massa M, Strohbach J, Hanau CE, Schmidt M, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Shieh HS, Caspers N, Collins B, Grapperhaus M, Palmquist KE, Collins J, Baldus JE, Hitchcock J, Kleine HP, Rogers MD, McDonald J, Munie GE, Messing DM, Portolan S, Whiteley LO, Sunyer T, Schnute ME.",,1552458,DTCT0024002,72576,DTCC00074427,2044073,65989
CHEMBL3759916,P45452,,,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,26653735,KI,=,16.6,NM,,,,,,,,,,,,,,Inhibition of full length human recombinant MMP13 using MCA-Arg-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-Glu-Arg-NH2 as substrate preincubated for 60 mins followed by substrate addition by fluorescence assay,,"Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis.",J. Med. Chem.,2016,59,1,"Ruminski PG, Massa M, Strohbach J, Hanau CE, Schmidt M, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Shieh HS, Caspers N, Collins B, Grapperhaus M, Palmquist KE, Collins J, Baldus JE, Hitchcock J, Kleine HP, Rogers MD, McDonald J, Munie GE, Messing DM, Portolan S, Whiteley LO, Sunyer T, Schnute ME.",,1552458,DTCT0024002,72583,DTCC00074420,268874,65989
CHEMBL3759952,P45452,,,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,26653735,KI,=,33.6,NM,,,,,,,,,,,,,,Inhibition of full length human recombinant MMP13 using MCA-Arg-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-Glu-Arg-NH2 as substrate preincubated for 60 mins followed by substrate addition by fluorescence assay,,"Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis.",J. Med. Chem.,2016,59,1,"Ruminski PG, Massa M, Strohbach J, Hanau CE, Schmidt M, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Shieh HS, Caspers N, Collins B, Grapperhaus M, Palmquist KE, Collins J, Baldus JE, Hitchcock J, Kleine HP, Rogers MD, McDonald J, Munie GE, Messing DM, Portolan S, Whiteley LO, Sunyer T, Schnute ME.",,1552458,DTCT0024002,72561,DTCC00074405,1369818,65989
CHEMBL3759997,P45452,,,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,26653735,KI,=,2,NM,,,,,,,,,,,,,,Inhibition of full length human recombinant MMP13 using MCA-Arg-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-Glu-Arg-NH2 as substrate preincubated for 60 mins followed by substrate addition by fluorescence assay,,"Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis.",J. Med. Chem.,2016,59,1,"Ruminski PG, Massa M, Strohbach J, Hanau CE, Schmidt M, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Shieh HS, Caspers N, Collins B, Grapperhaus M, Palmquist KE, Collins J, Baldus JE, Hitchcock J, Kleine HP, Rogers MD, McDonald J, Munie GE, Messing DM, Portolan S, Whiteley LO, Sunyer T, Schnute ME.",,1552458,DTCT0024002,72586,DTCC00074417,107149,65989
CHEMBL376010,P45452,,ONEARHBMUZXDAC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16942871,IC50,=,2,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Potent, selective pyrimidinetrione-based inhibitors of MMP-13.",Bioorg. Med. Chem. Lett.,2006,16,22,"Reiter LA, Freeman-Cook KD, Jones CS, Martinelli GJ, Antipas AS, Berliner MA, Datta K, Downs JT, Eskra JD, Forman MD, Greer EM, Guzman R, Hardink JR, Janat F, Keene NF, Laird ER, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robertson D, Sperger D, Vaughn-Bowser ML, Waller DM, Yocum SA",,424283,DTCT0024002,2011676,DTCC00440844,822489,21753
CHEMBL376299,P45452,,HKBSSSQFZVTLRZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16942871,IC50,=,1.7,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Potent, selective pyrimidinetrione-based inhibitors of MMP-13.",Bioorg. Med. Chem. Lett.,2006,16,22,"Reiter LA, Freeman-Cook KD, Jones CS, Martinelli GJ, Antipas AS, Berliner MA, Datta K, Downs JT, Eskra JD, Forman MD, Greer EM, Guzman R, Hardink JR, Janat F, Keene NF, Laird ER, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robertson D, Sperger D, Vaughn-Bowser ML, Waller DM, Yocum SA",,424283,DTCT0024002,2011687,DTCC00440873,1755485,21753
CHEMBL376314,P45452,,TXIMSNHHNJBLTN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15566296,IC50,=,500,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Synthesis and structure-activity relationships of 4-alkynyloxy phenyl sulfanyl, sulfinyl, and sulfonyl alkyl hydroxamates as tumor necrosis factor-alpha converting enzyme and matrix metalloproteinase inhibitors.",J. Med. Chem.,2004,47,25,"Venkatesan AM, Davis JM, Grosu GT, Baker J, Zask A, Levin JI, Ellingboe J, Skotnicki JS, Dijoseph JF, Sung A, Jin G, Xu W, McCarthy DJ, Barone D",,429672,DTCT0024002,2041975,DTCC00444493,564292,22157
CHEMBL376557,P45452,,BUKCBCDGRPOFJP-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17088065,IC50,=,5.3,NM,,,,,,,,,,,,,,Inhibition of MMP13,,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432508,DTCT0024002,2061871,DTCC00447810,1005132,22402
CHEMBL376859,P45452,,GVNHCTDFGAQJEV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16942871,IC50,=,1.4,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Potent, selective pyrimidinetrione-based inhibitors of MMP-13.",Bioorg. Med. Chem. Lett.,2006,16,22,"Reiter LA, Freeman-Cook KD, Jones CS, Martinelli GJ, Antipas AS, Berliner MA, Datta K, Downs JT, Eskra JD, Forman MD, Greer EM, Guzman R, Hardink JR, Janat F, Keene NF, Laird ER, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robertson D, Sperger D, Vaughn-Bowser ML, Waller DM, Yocum SA",,424283,DTCT0024002,2011674,DTCC00440860,984232,21753
CHEMBL377272,P45452,,LIJQQAFTSYEDRO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16723229,IC50,=,13,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Design and synthesis of butynyloxyphenyl beta-sulfone piperidine hydroxamates as TACE inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,15,"Park K, Aplasca A, Du MT, Sun L, Zhu Y, Zhang Y, Levin JI",,377988,DTCT0024002,1969701,DTCC00428526,1004972,21111
CHEMBL377317,P45452,,SFHMNFHDIRPFKM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16723229,IC50,=,21,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Design and synthesis of butynyloxyphenyl beta-sulfone piperidine hydroxamates as TACE inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,15,"Park K, Aplasca A, Du MT, Sun L, Zhu Y, Zhang Y, Levin JI",,377988,DTCT0024002,1969645,DTCC00428531,778474,21111
CHEMBL377317,P45452,,SFHMNFHDIRPFKM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17064892,IC50,=,21.5,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440764,DTCT0024002,2152410,DTCC00428531,778734,23077
CHEMBL377862,P45452,,KRGBAILWDVNOCW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16723229,IC50,=,79,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Design and synthesis of butynyloxyphenyl beta-sulfone piperidine hydroxamates as TACE inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,15,"Park K, Aplasca A, Du MT, Sun L, Zhu Y, Zhang Y, Levin JI",,377988,DTCT0024002,1969630,DTCC00428540,649907,21111
CHEMBL37788,P45452,,XPLPBRFYVPFHDL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12668018,IC50,=,2,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease 13 (MMP-13).,,Synthesis and SAR of bicyclic heteroaryl hydroxamic acid MMP and TACE inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,8,"Zask A, Gu Y, Albright JD, Du X, Hogan M, Levin JI, Chen JM, Killar LM, Sung A, DiJoseph JF, Sharr MA, Roth CE, Skala S, Jin G, Cowling R, Mohler KM, Barone D, Black R, March C, Skotnicki JS",,106642,DTCT0024002,1248966,DTCC00174389,1206846,6276
CHEMBL37837,P45452,,ULIBGNMOWDICPU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12668018,IC50,=,2,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease 13 (MMP-13).,,Synthesis and SAR of bicyclic heteroaryl hydroxamic acid MMP and TACE inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,8,"Zask A, Gu Y, Albright JD, Du X, Hogan M, Levin JI, Chen JM, Killar LM, Sung A, DiJoseph JF, Sharr MA, Roth CE, Skala S, Jin G, Cowling R, Mohler KM, Barone D, Black R, March C, Skotnicki JS",,106642,DTCT0024002,1270170,DTCC00174855,400345,6276
CHEMBL379287,P45452,,RBTIHKNARDNLNU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16723229,IC50,=,74,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Design and synthesis of butynyloxyphenyl beta-sulfone piperidine hydroxamates as TACE inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,15,"Park K, Aplasca A, Du MT, Sun L, Zhu Y, Zhang Y, Levin JI",,377988,DTCT0024002,1969582,DTCC00428563,617188,21111
CHEMBL379469,P45452,,IGMJBXNPPIZSAX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16289878,KI,>,5025,NM,,,,,,,,,,,,,,Binding affinity to MMP13,,Conversion of potent MMP inhibitors into selective TACE inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,4,"Cherney RJ, King BW, Gilmore JL, Liu RQ, Covington MB, Duan JJ, Decicco CP",,334537,DTCT0024002,1895739,DTCC00415423,1242357,20373
CHEMBL380049,P45452,,NPWNPFHGYNOBOO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16723229,IC50,=,155,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Design and synthesis of butynyloxyphenyl beta-sulfone piperidine hydroxamates as TACE inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,15,"Park K, Aplasca A, Du MT, Sun L, Zhu Y, Zhang Y, Levin JI",,377988,DTCT0024002,1969716,DTCC00428568,1393760,21111
CHEMBL380049,P45452,,NPWNPFHGYNOBOO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19464885,IC50,=,155,NM,,,,,,,,,,,,,,inhibition of human recombinant MMP13 catalytic domain,,Synthesis and activity of quinolinylmethyl P1' alpha-sulfone piperidine hydroxamate inhibitors of TACE.,Bioorg. Med. Chem. Lett.,2009,19,13,"Zhang C, Lovering F, Behnke M, Zask A, Sandanayaka V, Sun L, Zhu Y, Xu W, Zhang Y, Levin JI",,523796,DTCT0024002,2832605,DTCC00428568,1406775,33699
CHEMBL380343,P45452,,HKAXLEJIOVCYCD-IBGZPJMESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16426848,IC50,=,7,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Acetylenic TACE inhibitors. Part 3: Thiomorpholine sulfonamide hydroxamates.,Bioorg. Med. Chem. Lett.,2006,16,6,"Levin JI, Chen JM, Laakso LM, Du M, Schmid J, Xu W, Cummons T, Xu J, Jin G, Barone D, Skotnicki JS",,339181,DTCT0024002,1909212,DTCC00418028,206870,14616
CHEMBL380439,P45452,,SHTYCRVVDNRZDY-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16426848,IC50,=,9,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Acetylenic TACE inhibitors. Part 3: Thiomorpholine sulfonamide hydroxamates.,Bioorg. Med. Chem. Lett.,2006,16,6,"Levin JI, Chen JM, Laakso LM, Du M, Schmid J, Xu W, Cummons T, Xu J, Jin G, Barone D, Skotnicki JS",,339181,DTCT0024002,1909220,DTCC00418094,206869,14616
CHEMBL380895,P45452,,YVFLHFYMDLEMFY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16516466,KI,>,5025,NM,,,,,,,,,,,,,,Binding affinity to MMP13,,"Synthesis and structure-activity relationship of a novel, achiral series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2006,16,10,"Gilmore JL, King BW, Harris C, Maduskuie T, Mercer SE, Liu RQ, Covington MB, Qian M, Ribadeneria MD, Vaddi K, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,354462,DTCT0024002,1926550,DTCC00110328,520521,20786
CHEMBL38106,P45452,,JXIIDVGEPSOIKK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12668018,IC50,=,5,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease 13 (MMP-13).,,Synthesis and SAR of bicyclic heteroaryl hydroxamic acid MMP and TACE inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,8,"Zask A, Gu Y, Albright JD, Du X, Hogan M, Levin JI, Chen JM, Killar LM, Sung A, DiJoseph JF, Sharr MA, Roth CE, Skala S, Jin G, Cowling R, Mohler KM, Barone D, Black R, March C, Skotnicki JS",,106642,DTCT0024002,1272311,DTCC00174560,690615,6276
CHEMBL381163,P45452,,VDJRMQXPNKTLQA-YOEHRIQHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16426848,IC50,=,7,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Acetylenic TACE inhibitors. Part 3: Thiomorpholine sulfonamide hydroxamates.,Bioorg. Med. Chem. Lett.,2006,16,6,"Levin JI, Chen JM, Laakso LM, Du M, Schmid J, Xu W, Cummons T, Xu J, Jin G, Barone D, Skotnicki JS",,339181,DTCT0024002,1909205,DTCC00418384,1695460,14616
CHEMBL381173,P45452,,SFSKPKLATIXRLH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16516466,KI,>,5025,NM,,,,,,,,,,,,,,Binding affinity to MMP13,,"Synthesis and structure-activity relationship of a novel, achiral series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2006,16,10,"Gilmore JL, King BW, Harris C, Maduskuie T, Mercer SE, Liu RQ, Covington MB, Qian M, Ribadeneria MD, Vaddi K, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,354462,DTCT0024002,1926534,DTCC00421728,1165867,20786
CHEMBL381224,P45452,,QFTWPDUNHCKGKX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16084720,IC50,=,119,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metallopeptidase 13,,Acetylenic TACE inhibitors. Part 2: SAR of six-membered cyclic sulfonamide hydroxamates.,Bioorg. Med. Chem. Lett.,2005,15,19,"Levin JI, Chen JM, Laakso LM, Du M, Du X, Venkatesan AM, Sandanayaka V, Zask A, Xu J, Xu W, Zhang Y, Skotnicki JS",,321254,DTCT0024002,1861775,DTCC00408055,1295815,19752
CHEMBL381224,P45452,,QFTWPDUNHCKGKX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16084720,IC50,=,119,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metallopeptidase 13,,Acetylenic TACE inhibitors. Part 2: SAR of six-membered cyclic sulfonamide hydroxamates.,Bioorg. Med. Chem. Lett.,2005,15,19,"Levin JI, Chen JM, Laakso LM, Du M, Du X, Venkatesan AM, Sandanayaka V, Zask A, Xu J, Xu W, Zhang Y, Skotnicki JS",,321254,DTCT0024002,1862295,DTCC00408055,1295816,19752
CHEMBL3814018,P45452,,,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,26881908,IC50,=,6,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 (85 to 255 residues) expressed in Escherichia coli using 5-FAM/QXLTM as substrate by fluorometric assay,,De Novo Design at the Edge of Chaos.,J. Med. Chem.,2016,59,9,"Schneider P, Schneider G.",,1582257,DTCT0024002,282164,DTCC00096097,2064337,67217
CHEMBL381505,P45452,,NGEXELWTFRTJEQ-NRFANRHFSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16426848,IC50,=,4,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Acetylenic TACE inhibitors. Part 3: Thiomorpholine sulfonamide hydroxamates.,Bioorg. Med. Chem. Lett.,2006,16,6,"Levin JI, Chen JM, Laakso LM, Du M, Schmid J, Xu W, Cummons T, Xu J, Jin G, Barone D, Skotnicki JS",,339181,DTCT0024002,1909210,DTCC00417945,1820042,14616
CHEMBL381554,P45452,,MGQZHWBYKGXMDX-RDJZCZTQSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16426848,IC50,=,23,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Acetylenic TACE inhibitors. Part 3: Thiomorpholine sulfonamide hydroxamates.,Bioorg. Med. Chem. Lett.,2006,16,6,"Levin JI, Chen JM, Laakso LM, Du M, Schmid J, Xu W, Cummons T, Xu J, Jin G, Barone D, Skotnicki JS",,339181,DTCT0024002,1909201,DTCC00418428,1340386,14616
CHEMBL38180,P45452,,XQRSTZJAXGSSTI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12668018,IC50,=,1,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease 13 (MMP-13).,,Synthesis and SAR of bicyclic heteroaryl hydroxamic acid MMP and TACE inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,8,"Zask A, Gu Y, Albright JD, Du X, Hogan M, Levin JI, Chen JM, Killar LM, Sung A, DiJoseph JF, Sharr MA, Roth CE, Skala S, Jin G, Cowling R, Mohler KM, Barone D, Black R, March C, Skotnicki JS",,106642,DTCT0024002,1279048,DTCC00174371,2044435,6276
CHEMBL381953,P45452,,QRWVORUSUQDRRN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16516466,KI,>,5025,NM,,,,,,,,,,,,,,Binding affinity to MMP13,,"Synthesis and structure-activity relationship of a novel, achiral series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2006,16,10,"Gilmore JL, King BW, Harris C, Maduskuie T, Mercer SE, Liu RQ, Covington MB, Qian M, Ribadeneria MD, Vaddi K, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,354462,DTCT0024002,1926535,DTCC00421715,7598,20786
CHEMBL382201,P45452,,BZVYQWLRCHLAGK-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17088065,INHIBITION,=,68,%,,,,,,,,,,,,,,Inhibition of MMP13 at 100 uM,,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432514,DTCT0024002,2061733,DTCC00413190,552885,22402
CHEMBL382352,P45452,,MJYOLQLJRBLLML-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16516466,KI,>,5025,NM,,,,,,,,,,,,,,Binding affinity to MMP13,,"Synthesis and structure-activity relationship of a novel, achiral series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2006,16,10,"Gilmore JL, King BW, Harris C, Maduskuie T, Mercer SE, Liu RQ, Covington MB, Qian M, Ribadeneria MD, Vaddi K, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,354462,DTCT0024002,1926539,DTCC00421659,227888,20786
CHEMBL382585,P45452,,ZWHIVWLHYJCFFA-SFHVURJKSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16426848,IC50,=,17,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Acetylenic TACE inhibitors. Part 3: Thiomorpholine sulfonamide hydroxamates.,Bioorg. Med. Chem. Lett.,2006,16,6,"Levin JI, Chen JM, Laakso LM, Du M, Schmid J, Xu W, Cummons T, Xu J, Jin G, Barone D, Skotnicki JS",,339181,DTCT0024002,1909214,DTCC00417698,1275027,14616
CHEMBL382705,P45452,,NRCQPJPKKZDRND-HRCADAONSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16516469,KI,=,2,NM,,,,,,,,,,,,,,Binding affinity to recombinant MMP13,,A cassette-dosing approach for improvement of oral bioavailability of dual TACE/MMP inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,10,"Janser P, Neumann U, Miltz W, Feifel R, Buhl T",,354053,DTCT0024002,1926041,DTCC00422716,1307795,20779
CHEMBL382975,P45452,,CVZIHNYAZLXRRS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16084720,IC50,=,3,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metallopeptidase 13,,Acetylenic TACE inhibitors. Part 2: SAR of six-membered cyclic sulfonamide hydroxamates.,Bioorg. Med. Chem. Lett.,2005,15,19,"Levin JI, Chen JM, Laakso LM, Du M, Du X, Venkatesan AM, Sandanayaka V, Zask A, Xu J, Xu W, Zhang Y, Skotnicki JS",,321254,DTCT0024002,1861802,DTCC00408095,681606,19752
CHEMBL382975,P45452,,CVZIHNYAZLXRRS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16084720,IC50,=,3,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metallopeptidase 13,,Acetylenic TACE inhibitors. Part 2: SAR of six-membered cyclic sulfonamide hydroxamates.,Bioorg. Med. Chem. Lett.,2005,15,19,"Levin JI, Chen JM, Laakso LM, Du M, Du X, Venkatesan AM, Sandanayaka V, Zask A, Xu J, Xu W, Zhang Y, Skotnicki JS",,321254,DTCT0024002,1862320,DTCC00408095,681608,19752
CHEMBL382975,P45452,,CVZIHNYAZLXRRS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17064892,IC50,=,9,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440764,DTCT0024002,2153874,DTCC00408095,682039,23077
CHEMBL383028,P45452,,YTTGWCXMRQNZJI-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16426848,IC50,=,9,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Acetylenic TACE inhibitors. Part 3: Thiomorpholine sulfonamide hydroxamates.,Bioorg. Med. Chem. Lett.,2006,16,6,"Levin JI, Chen JM, Laakso LM, Du M, Schmid J, Xu W, Cummons T, Xu J, Jin G, Barone D, Skotnicki JS",,339181,DTCT0024002,1909207,DTCC00418009,822266,14616
CHEMBL383079,P45452,,ZYZUZMRFPDIWGW-RGDDUWESSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16426848,IC50,=,2,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Acetylenic TACE inhibitors. Part 3: Thiomorpholine sulfonamide hydroxamates.,Bioorg. Med. Chem. Lett.,2006,16,6,"Levin JI, Chen JM, Laakso LM, Du M, Schmid J, Xu W, Cummons T, Xu J, Jin G, Barone D, Skotnicki JS",,339181,DTCT0024002,1909221,DTCC00418085,1949093,14616
CHEMBL38352,P45452,,GKDAXRUOVHMLSA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12668018,IC50,=,1,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease 13 (MMP-13).,,Synthesis and SAR of bicyclic heteroaryl hydroxamic acid MMP and TACE inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,8,"Zask A, Gu Y, Albright JD, Du X, Hogan M, Levin JI, Chen JM, Killar LM, Sung A, DiJoseph JF, Sharr MA, Roth CE, Skala S, Jin G, Cowling R, Mohler KM, Barone D, Black R, March C, Skotnicki JS",,106642,DTCT0024002,1270174,DTCC00174852,1272408,6276
CHEMBL384665,P45452,,CWGOBWMKFRWKPM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15566296,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Synthesis and structure-activity relationships of 4-alkynyloxy phenyl sulfanyl, sulfinyl, and sulfonyl alkyl hydroxamates as tumor necrosis factor-alpha converting enzyme and matrix metalloproteinase inhibitors.",J. Med. Chem.,2004,47,25,"Venkatesan AM, Davis JM, Grosu GT, Baker J, Zask A, Levin JI, Ellingboe J, Skotnicki JS, Dijoseph JF, Sung A, Jin G, Xu W, McCarthy DJ, Barone D",,429672,DTCT0024002,2041955,DTCC00444447,1982245,22157
CHEMBL385312,P45452,,KRJQQXQOPZJOSC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15566296,IC50,=,47,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Synthesis and structure-activity relationships of 4-alkynyloxy phenyl sulfanyl, sulfinyl, and sulfonyl alkyl hydroxamates as tumor necrosis factor-alpha converting enzyme and matrix metalloproteinase inhibitors.",J. Med. Chem.,2004,47,25,"Venkatesan AM, Davis JM, Grosu GT, Baker J, Zask A, Levin JI, Ellingboe J, Skotnicki JS, Dijoseph JF, Sung A, Jin G, Xu W, McCarthy DJ, Barone D",,429672,DTCT0024002,2041985,DTCC00444483,629107,22157
CHEMBL385821,P45452,,HTEPICDCVMJOSJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19464885,IC50,=,1900,NM,,,,,,,,,,,,,,inhibition of human recombinant MMP13 catalytic domain,,Synthesis and activity of quinolinylmethyl P1' alpha-sulfone piperidine hydroxamate inhibitors of TACE.,Bioorg. Med. Chem. Lett.,2009,19,13,"Zhang C, Lovering F, Behnke M, Zask A, Sandanayaka V, Sun L, Zhu Y, Xu W, Zhang Y, Levin JI",,523796,DTCT0024002,2832601,DTCC00428534,1535724,33699
CHEMBL386954,P45452,,WQEWUDDCLBFKFR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16942871,IC50,=,0.57,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Potent, selective pyrimidinetrione-based inhibitors of MMP-13.",Bioorg. Med. Chem. Lett.,2006,16,22,"Reiter LA, Freeman-Cook KD, Jones CS, Martinelli GJ, Antipas AS, Berliner MA, Datta K, Downs JT, Eskra JD, Forman MD, Greer EM, Guzman R, Hardink JR, Janat F, Keene NF, Laird ER, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robertson D, Sperger D, Vaughn-Bowser ML, Waller DM, Yocum SA",,424283,DTCT0024002,2011670,DTCC00440890,757931,21753
CHEMBL387079,P45452,,XIQNNSMTTLQUTR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16723229,IC50,=,114,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Design and synthesis of butynyloxyphenyl beta-sulfone piperidine hydroxamates as TACE inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,15,"Park K, Aplasca A, Du MT, Sun L, Zhu Y, Zhang Y, Levin JI",,377988,DTCT0024002,1969729,DTCC00428561,1970456,21111
CHEMBL387079,P45452,,XIQNNSMTTLQUTR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17064892,IC50,=,114,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440764,DTCT0024002,2154032,DTCC00428561,1970726,23077
CHEMBL387343,P45452,,PZJOQCRQBQNZOO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16942871,IC50,=,0.88,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Potent, selective pyrimidinetrione-based inhibitors of MMP-13.",Bioorg. Med. Chem. Lett.,2006,16,22,"Reiter LA, Freeman-Cook KD, Jones CS, Martinelli GJ, Antipas AS, Berliner MA, Datta K, Downs JT, Eskra JD, Forman MD, Greer EM, Guzman R, Hardink JR, Janat F, Keene NF, Laird ER, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robertson D, Sperger D, Vaughn-Bowser ML, Waller DM, Yocum SA",,424283,DTCT0024002,2011667,DTCC00441019,919421,21753
CHEMBL38851,P45452,,XZWFHJUEAVOHHG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11212095,IC50,=,64,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,General synthesis of alpha-substituted 3-bisaryloxy propionic acid derivatives as specific MMP inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,3,"Chollet AM, Le Diguarher T, Murray L, Bertrand M, Tucker GC, Sabatini M, Pierré A, Atassi G, Bonnet J, Casara P",,106483,DTCT0024002,643368,DTCC00180222,1261750,4635
CHEMBL38853,P45452,,QIQXXEZQGKSKFZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10915056,IC50,=,6100,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,Difluoroketones as inhibitors of matrix metalloprotease-13.,Bioorg. Med. Chem. Lett.,2000,10,14,"Reiter LA, Martinelli GJ, Reeves LA, Mitchell PG",,106764,DTCT0024002,1498866,DTCC00181143,981465,3800
CHEMBL389020,P45452,,NEGPFWDWNNSJRQ-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17591762,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440142,DTCT0024002,2113805,DTCC00452712,195826,23023
CHEMBL389020,P45452,,NEGPFWDWNNSJRQ-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17591762,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of MMP13 at 10 uM,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440148,DTCT0024002,2113833,DTCC00452712,195826,23023
CHEMBL389020,P45452,,NEGPFWDWNNSJRQ-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17591762,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of MMP13 at 100 uM,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440154,DTCT0024002,2113862,DTCC00452712,195826,23023
CHEMBL389020,P45452,,NEGPFWDWNNSJRQ-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17591762,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of MMP13 at 30 uM,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440160,DTCT0024002,2113890,DTCC00452712,195826,23023
CHEMBL389020,P45452,,NEGPFWDWNNSJRQ-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18790648,KI,=,91000,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497406,DTCT0024002,2457530,DTCC00452712,208200,32556
CHEMBL389594,P45452,,BLIQFUCBRCDFAI-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17289381,KI,=,1200,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Novel thiol-based TACE inhibitors: rational design, synthesis, and SAR of thiol-containing aryl sulfonamides.",Bioorg. Med. Chem. Lett.,2007,17,8,"Govinda Rao B, Bandarage UK, Wang T, Come JH, Perola E, Wei Y, Tian SK, Saunders JO",,442207,DTCT0024002,2162214,DTCC00463661,564439,23225
CHEMBL389898,P45452,,HTKNWYDCBWYORK-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17088065,IC50,,,,,,,,,,,,,,,,,Inhibition of MMP13,Not Determined,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432508,DTCT0024002,2061993,DTCC00447846,1555210,22402
CHEMBL391288,P45452,,VDZXMXGMCNRNLP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17027261,KI,=,1310,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,1,"Duan JJ, Chen L, Lu Z, Jiang B, Asakawa N, Sheppeck JE, Liu RQ, Covington MB, Pitts W, Kim SH, Decicco CP",,452976,DTCT0024002,2215485,DTCC00477194,1313064,24158
CHEMBL391362,P45452,,SXQXJOREJVFQQR-BKMJKUGQSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17188863,KI,>,5025,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Discovery of novel hydantoins as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,5,"Sheppeck JE, Gilmore JL, Yang A, Chen XT, Xue CB, Roderick J, Liu RQ, Covington MB, Decicco CP, Duan JJ",,453872,DTCT0024002,2221464,DTCC00478077,99287,24252
CHEMBL391376,P45452,,BIMPKRWFMWVAKJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17027261,KI,>,5210,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,1,"Duan JJ, Chen L, Lu Z, Jiang B, Asakawa N, Sheppeck JE, Liu RQ, Covington MB, Pitts W, Kim SH, Decicco CP",,452976,DTCT0024002,2215483,DTCC00477196,310264,24158
CHEMBL391388,P45452,,CYAPFFVOYRXNFZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17576061,KI,>,5025,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Synthesis and structure-activity relationship of a novel, non-hydroxamate series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,16,"Gilmore JL, King BW, Asakawa N, Harrison K, Tebben A, Sheppeck JE, Liu RQ, Covington M, Duan JJ",,456579,DTCT0024002,2240599,DTCC00479007,83226,24538
CHEMBL391676,P45452,,LNLWALQGRPVSTA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17064892,IC50,=,38,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440764,DTCT0024002,2153961,DTCC00461919,424415,23077
CHEMBL391880,P45452,,GGDBCZZATDMWMQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17064892,IC50,=,117,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440764,DTCT0024002,2153957,DTCC00461923,1070028,23077
CHEMBL391881,P45452,,IDHBZDJZPPEMGC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17064892,IC50,=,449,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440764,DTCT0024002,2154033,DTCC00461928,1166191,23077
CHEMBL392088,P45452,,BXSPGECKGKAUCR-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17956082,IC50,=,1340,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET.,J. Med. Chem.,2007,50,23,"Wagner S, Breyholz HJ, Law MP, Faust A, Höltke C, Schröer S, Haufe G, Levkau B, Schober O, Schäfers M, Kopka K",,451368,DTCT0024002,2204624,DTCC00471851,714474,24059
CHEMBL392172,P45452,,PFPQINANHHJKFH-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17188863,KI,>,5025,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Discovery of novel hydantoins as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,5,"Sheppeck JE, Gilmore JL, Yang A, Chen XT, Xue CB, Roderick J, Liu RQ, Covington MB, Decicco CP, Duan JJ",,453872,DTCT0024002,2221474,DTCC00478065,1620305,24252
CHEMBL392231,P45452,,ONXPGSKZKJFIFD-RBBKRZOGSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17576061,KI,>,5025,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Synthesis and structure-activity relationship of a novel, non-hydroxamate series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,16,"Gilmore JL, King BW, Asakawa N, Harrison K, Tebben A, Sheppeck JE, Liu RQ, Covington M, Duan JJ",,456579,DTCT0024002,2240693,DTCC00479021,472421,24538
CHEMBL392232,P45452,,HOQRRVLBMMILPN-JTHBVZDNSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17576061,KI,>,5025,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Synthesis and structure-activity relationship of a novel, non-hydroxamate series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,16,"Gilmore JL, King BW, Asakawa N, Harrison K, Tebben A, Sheppeck JE, Liu RQ, Covington M, Duan JJ",,456579,DTCT0024002,2240689,DTCC00479025,1921648,24538
CHEMBL392294,P45452,,LYGIRBLDUCXHDY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17064892,IC50,=,295,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440764,DTCT0024002,2153977,DTCC00461902,650171,23077
CHEMBL392295,P45452,,RCCBHNFHHCGOQM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17064892,IC50,=,136,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440764,DTCT0024002,2153976,DTCC00461903,1037559,23077
CHEMBL392308,P45452,,KJOVWWTWOVUHSB-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17956082,IC50,=,10,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET.,J. Med. Chem.,2007,50,23,"Wagner S, Breyholz HJ, Law MP, Faust A, Höltke C, Schröer S, Haufe G, Levkau B, Schober O, Schäfers M, Kopka K",,451368,DTCT0024002,2204620,DTCC00471855,1873303,24059
CHEMBL392312,P45452,,VMWZNZVYBAZMKQ-UKILVPOCSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17276676,IC50,>,5000,NM,,,,,,,,,,,,,,Inhibition of MMP13,,A new 4-(2-methylquinolin-4-ylmethyl)phenyl P1' group for the beta-amino hydroxamic acid derived TACE inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,7,"Chen XT, Ghavimi B, Corbett RL, Xue CB, Liu RQ, Covington MB, Qian M, Vaddi KG, Christ DD, Hartman KD, Ribadeneira MD, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,447089,DTCT0024002,2169372,DTCC00464766,260535,23623
CHEMBL392505,P45452,,HQGORWGMKQFFGB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17064892,IC50,=,1159,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440764,DTCT0024002,2153972,DTCC00461907,682040,23077
CHEMBL392571,P45452,,PUBARVPHTAEUJQ-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17956082,IC50,=,0.8,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET.,J. Med. Chem.,2007,50,23,"Wagner S, Breyholz HJ, Law MP, Faust A, Höltke C, Schröer S, Haufe G, Levkau B, Schober O, Schäfers M, Kopka K",,451368,DTCT0024002,2204618,DTCC00471857,1905592,24059
CHEMBL392572,P45452,,DFWYBNIMFAUWSX-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17956082,IC50,=,59,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET.,J. Med. Chem.,2007,50,23,"Wagner S, Breyholz HJ, Law MP, Faust A, Höltke C, Schröer S, Haufe G, Levkau B, Schober O, Schäfers M, Kopka K",,451368,DTCT0024002,2204615,DTCC00471860,99252,24059
CHEMBL392837,P45452,,XDKBCKDIDNIGIV-RBBKRZOGSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17576061,KI,>,5025,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Synthesis and structure-activity relationship of a novel, non-hydroxamate series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,16,"Gilmore JL, King BW, Asakawa N, Harrison K, Tebben A, Sheppeck JE, Liu RQ, Covington M, Duan JJ",,456579,DTCT0024002,2240701,DTCC00479013,795216,24538
CHEMBL392867,P45452,,AJLMUTLJMXTHCS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17027261,KI,,,,,,,,,,,,,,,,,Inhibition of MMP13,Not Determined,Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,1,"Duan JJ, Chen L, Lu Z, Jiang B, Asakawa N, Sheppeck JE, Liu RQ, Covington MB, Pitts W, Kim SH, Decicco CP",,452976,DTCT0024002,2215486,DTCC00477193,2020086,24158
CHEMBL392974,P45452,,UEVLLYXFWPWEDN-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17956082,IC50,=,34000,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET.,J. Med. Chem.,2007,50,23,"Wagner S, Breyholz HJ, Law MP, Faust A, Höltke C, Schröer S, Haufe G, Levkau B, Schober O, Schäfers M, Kopka K",,451368,DTCT0024002,2204614,DTCC00471861,293894,24059
CHEMBL393443,P45452,,JCIVWVZJOHHYOB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17576061,KI,>,5025,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Synthesis and structure-activity relationship of a novel, non-hydroxamate series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,16,"Gilmore JL, King BW, Asakawa N, Harrison K, Tebben A, Sheppeck JE, Liu RQ, Covington M, Duan JJ",,456579,DTCT0024002,2240702,DTCC00479012,1668694,24538
CHEMBL393444,P45452,,UEOYACNTKVVWRI-HFZDXXHNSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17188863,KI,=,392,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Discovery of novel hydantoins as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,5,"Sheppeck JE, Gilmore JL, Yang A, Chen XT, Xue CB, Roderick J, Liu RQ, Covington MB, Decicco CP, Duan JJ",,453872,DTCT0024002,2221459,DTCC00478068,424602,24252
CHEMBL393445,P45452,,SSOHCNKODIJGFS-WINIVTDRSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17188863,KI,>,5025,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Discovery of novel hydantoins as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,5,"Sheppeck JE, Gilmore JL, Yang A, Chen XT, Xue CB, Roderick J, Liu RQ, Covington MB, Decicco CP, Duan JJ",,453872,DTCT0024002,2221467,DTCC00478074,424603,24252
CHEMBL393550,P45452,,XWVXWDVYQZEQBA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17064892,IC50,=,56,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440764,DTCT0024002,2153967,DTCC00461912,1587505,23077
CHEMBL39371,P45452,,SZIJXTFJHLDRAN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10915056,IC50,=,12000,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,Difluoroketones as inhibitors of matrix metalloprotease-13.,Bioorg. Med. Chem. Lett.,2000,10,14,"Reiter LA, Martinelli GJ, Reeves LA, Mitchell PG",,106764,DTCT0024002,1498865,DTCC00181467,916414,3800
CHEMBL393750,P45452,,UHWQCCAGEXNQTH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17064892,IC50,=,385,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440764,DTCT0024002,2153964,DTCC00461915,1970725,23077
CHEMBL393793,P45452,,NKCMINBLFYGDJZ-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17956082,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET.,J. Med. Chem.,2007,50,23,"Wagner S, Breyholz HJ, Law MP, Faust A, Höltke C, Schröer S, Haufe G, Levkau B, Schober O, Schäfers M, Kopka K",,451368,DTCT0024002,2204625,DTCC00471850,1329038,24059
CHEMBL393828,P45452,,FGEXLQKMIJWUIY-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17956082,IC50,=,384,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET.,J. Med. Chem.,2007,50,23,"Wagner S, Breyholz HJ, Law MP, Faust A, Höltke C, Schröer S, Haufe G, Levkau B, Schober O, Schäfers M, Kopka K",,451368,DTCT0024002,2204630,DTCC00471838,1361759,24059
CHEMBL393829,P45452,,NVEOTSPQRXNTEA-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17956082,IC50,=,9140,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET.,J. Med. Chem.,2007,50,23,"Wagner S, Breyholz HJ, Law MP, Faust A, Höltke C, Schröer S, Haufe G, Levkau B, Schober O, Schäfers M, Kopka K",,451368,DTCT0024002,2204629,DTCC00471839,1491085,24059
CHEMBL393863,P45452,,MKDLVNDURLPYMP-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17188863,KI,>,5025,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Discovery of novel hydantoins as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,5,"Sheppeck JE, Gilmore JL, Yang A, Chen XT, Xue CB, Roderick J, Liu RQ, Covington MB, Decicco CP, Duan JJ",,453872,DTCT0024002,2221477,DTCC00477930,1296486,24252
CHEMBL394003,P45452,,SVFGAFGHEBEAJE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17606376,IC50,=,12000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,Structure-based design of TACE selective inhibitors: manipulations in the S1'-S3' pocket.,Bioorg. Med. Chem.,2007,15,18,"Huang A, Joseph-McCarthy D, Lovering F, Sun L, Wang W, Xu W, Zhu Y, Cui J, Zhang Y, Levin JI",,448560,DTCT0024002,2180831,DTCC00470414,228329,23780
CHEMBL394084,P45452,,FREFRJYSKQLKFN-PZJWPPBQSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17576061,KI,>,5025,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Synthesis and structure-activity relationship of a novel, non-hydroxamate series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,16,"Gilmore JL, King BW, Asakawa N, Harrison K, Tebben A, Sheppeck JE, Liu RQ, Covington M, Duan JJ",,456579,DTCT0024002,2240699,DTCC00479015,730895,24538
CHEMBL394294,P45452,,DRAXUTSANKJHDR-LADGPHEKSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17576061,KI,=,2462,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Synthesis and structure-activity relationship of a novel, non-hydroxamate series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,16,"Gilmore JL, King BW, Asakawa N, Harrison K, Tebben A, Sheppeck JE, Liu RQ, Covington M, Duan JJ",,456579,DTCT0024002,2240697,DTCC00479017,537223,24538
CHEMBL398405,P45452,,SFWRCXWXHAIKBP-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17956082,IC50,=,24,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET.,J. Med. Chem.,2007,50,23,"Wagner S, Breyholz HJ, Law MP, Faust A, Höltke C, Schröer S, Haufe G, Levkau B, Schober O, Schäfers M, Kopka K",,451368,DTCT0024002,2204612,DTCC00471864,2036268,24059
CHEMBL398468,P45452,,CLNPMAFVUZNDSG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17935984,IC50,=,0.12,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Potent, selective spiropyrrolidine pyrimidinetrione inhibitors of MMP-13.",Bioorg. Med. Chem. Lett.,2007,17,23,"Freeman-Cook KD, Reiter LA, Noe MC, Antipas AS, Danley DE, Datta K, Downs JT, Eisenbeis S, Eskra JD, Garmene DJ, Greer EM, Griffiths RJ, Guzman R, Hardink JR, Janat F, Jones CS, Martinelli GJ, Mitchell PG, Laird ER, Liras JL, Lopresti-Morrow LL, Pandit J, Reilly UD, Robertson D, Vaughn-Bowser ML, Wolf-Gouviea LA, Yocum SA",,458357,DTCT0024002,2254805,DTCC00484175,617688,24756
CHEMBL398468,P45452,,CLNPMAFVUZNDSG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17935984,IC50,=,12,NM,,,,,,,,,,,,,,Inhibition of MMP13-mediated bovine nasal cartilage degradation assessed as hydroxyprole release,,"Potent, selective spiropyrrolidine pyrimidinetrione inhibitors of MMP-13.",Bioorg. Med. Chem. Lett.,2007,17,23,"Freeman-Cook KD, Reiter LA, Noe MC, Antipas AS, Danley DE, Datta K, Downs JT, Eisenbeis S, Eskra JD, Garmene DJ, Greer EM, Griffiths RJ, Guzman R, Hardink JR, Janat F, Jones CS, Martinelli GJ, Mitchell PG, Laird ER, Liras JL, Lopresti-Morrow LL, Pandit J, Reilly UD, Robertson D, Vaughn-Bowser ML, Wolf-Gouviea LA, Yocum SA",,458365,DTCT0024002,2254783,DTCC00484175,617688,24756
CHEMBL398602,P45452,,SAQZCMSCRMAPLW-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17956082,IC50,=,3260,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET.,J. Med. Chem.,2007,50,23,"Wagner S, Breyholz HJ, Law MP, Faust A, Höltke C, Schröer S, Haufe G, Levkau B, Schober O, Schäfers M, Kopka K",,451368,DTCT0024002,2204611,DTCC00471865,1684738,24059
CHEMBL398934,P45452,,XAFAGZRSAJKMCV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17935984,IC50,=,0.11,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Potent, selective spiropyrrolidine pyrimidinetrione inhibitors of MMP-13.",Bioorg. Med. Chem. Lett.,2007,17,23,"Freeman-Cook KD, Reiter LA, Noe MC, Antipas AS, Danley DE, Datta K, Downs JT, Eisenbeis S, Eskra JD, Garmene DJ, Greer EM, Griffiths RJ, Guzman R, Hardink JR, Janat F, Jones CS, Martinelli GJ, Mitchell PG, Laird ER, Liras JL, Lopresti-Morrow LL, Pandit J, Reilly UD, Robertson D, Vaughn-Bowser ML, Wolf-Gouviea LA, Yocum SA",,458357,DTCT0024002,2254795,DTCC00484207,1744641,24756
CHEMBL398966,P45452,,AOSUTMRBALZLRS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17935984,IC50,=,1.57,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Potent, selective spiropyrrolidine pyrimidinetrione inhibitors of MMP-13.",Bioorg. Med. Chem. Lett.,2007,17,23,"Freeman-Cook KD, Reiter LA, Noe MC, Antipas AS, Danley DE, Datta K, Downs JT, Eisenbeis S, Eskra JD, Garmene DJ, Greer EM, Griffiths RJ, Guzman R, Hardink JR, Janat F, Jones CS, Martinelli GJ, Mitchell PG, Laird ER, Liras JL, Lopresti-Morrow LL, Pandit J, Reilly UD, Robertson D, Vaughn-Bowser ML, Wolf-Gouviea LA, Yocum SA",,458357,DTCT0024002,2254809,DTCC00484145,1263990,24756
CHEMBL398966,P45452,,AOSUTMRBALZLRS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17935984,IC50,=,1.6,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Potent, selective spiropyrrolidine pyrimidinetrione inhibitors of MMP-13.",Bioorg. Med. Chem. Lett.,2007,17,23,"Freeman-Cook KD, Reiter LA, Noe MC, Antipas AS, Danley DE, Datta K, Downs JT, Eisenbeis S, Eskra JD, Garmene DJ, Greer EM, Griffiths RJ, Guzman R, Hardink JR, Janat F, Jones CS, Martinelli GJ, Mitchell PG, Laird ER, Liras JL, Lopresti-Morrow LL, Pandit J, Reilly UD, Robertson D, Vaughn-Bowser ML, Wolf-Gouviea LA, Yocum SA",,458357,DTCT0024002,2254807,DTCC00484145,1263991,24756
CHEMBL399096,P45452,,AGMWQNDXCWDRDZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17531482,IC50,=,1170,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Design and synthesis of 3,3-piperidine hydroxamate analogs as selective TACE inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,15,"Lombart HG, Feyfant E, Joseph-McCarthy D, Huang A, Lovering F, Sun L, Zhu Y, Zeng C, Zhang Y, Levin J",,456210,DTCT0024002,2237284,DTCC00480950,876605,24495
CHEMBL399096,P45452,,AGMWQNDXCWDRDZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18790648,IC50,=,1170,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497406,DTCT0024002,2456485,DTCC00480950,888688,32556
CHEMBL399097,P45452,,JQJWNYAMOJOHCE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17531482,IC50,=,840,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Design and synthesis of 3,3-piperidine hydroxamate analogs as selective TACE inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,15,"Lombart HG, Feyfant E, Joseph-McCarthy D, Huang A, Lovering F, Sun L, Zhu Y, Zeng C, Zhang Y, Levin J",,456210,DTCT0024002,2237280,DTCC00480954,844149,24495
CHEMBL399098,P45452,,LEMMSOIQHPOJRA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17531482,IC50,=,1370,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Design and synthesis of 3,3-piperidine hydroxamate analogs as selective TACE inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,15,"Lombart HG, Feyfant E, Joseph-McCarthy D, Huang A, Lovering F, Sun L, Zhu Y, Zeng C, Zhang Y, Levin J",,456210,DTCT0024002,2237278,DTCC00480957,1744582,24495
CHEMBL399400,P45452,,HPBWNXRDTAWPAP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17606376,IC50,=,1038,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,Structure-based design of TACE selective inhibitors: manipulations in the S1'-S3' pocket.,Bioorg. Med. Chem.,2007,15,18,"Huang A, Joseph-McCarthy D, Lovering F, Sun L, Wang W, Xu W, Zhu Y, Cui J, Zhang Y, Levin JI",,448560,DTCT0024002,2180840,DTCC00470405,876483,23780
CHEMBL399401,P45452,,HGILVKJBXAXGDH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17606376,IC50,=,772,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,Structure-based design of TACE selective inhibitors: manipulations in the S1'-S3' pocket.,Bioorg. Med. Chem.,2007,15,18,"Huang A, Joseph-McCarthy D, Lovering F, Sun L, Wang W, Xu W, Zhu Y, Cui J, Zhang Y, Levin JI",,448560,DTCT0024002,2180836,DTCC00470409,2003456,23780
CHEMBL399929,P45452,,NSSBNBOQWRPCCV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17531482,IC50,=,1740,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Design and synthesis of 3,3-piperidine hydroxamate analogs as selective TACE inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,15,"Lombart HG, Feyfant E, Joseph-McCarthy D, Huang A, Lovering F, Sun L, Zhu Y, Zeng C, Zhang Y, Levin J",,456210,DTCT0024002,2237274,DTCC00480962,359147,24495
CHEMBL400206,P45452,,BUDIJDXJWOVXRJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17064892,IC50,=,4000,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440764,DTCT0024002,2153875,DTCC00461899,972679,23077
CHEMBL400430,P45452,,CBEZXYHTYKUDTE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17606376,IC50,=,2476,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,Structure-based design of TACE selective inhibitors: manipulations in the S1'-S3' pocket.,Bioorg. Med. Chem.,2007,15,18,"Huang A, Joseph-McCarthy D, Lovering F, Sun L, Wang W, Xu W, Zhu Y, Cui J, Zhang Y, Levin JI",,448560,DTCT0024002,2180834,DTCC00470411,424535,23780
CHEMBL400591,P45452,,PJEQSSFWNBHRSL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,5.7,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260837,DTCC00486077,1426649,24831
CHEMBL400994,P45452,,AMHKVYCKWPXXHK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,5.15,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260828,DTCC00112357,488948,24831
CHEMBL401199,P45452,,HQIWKIYXGMOLSK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17935984,IC50,=,7.33,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Potent, selective spiropyrrolidine pyrimidinetrione inhibitors of MMP-13.",Bioorg. Med. Chem. Lett.,2007,17,23,"Freeman-Cook KD, Reiter LA, Noe MC, Antipas AS, Danley DE, Datta K, Downs JT, Eisenbeis S, Eskra JD, Garmene DJ, Greer EM, Griffiths RJ, Guzman R, Hardink JR, Janat F, Jones CS, Martinelli GJ, Mitchell PG, Laird ER, Liras JL, Lopresti-Morrow LL, Pandit J, Reilly UD, Robertson D, Vaughn-Bowser ML, Wolf-Gouviea LA, Yocum SA",,458357,DTCT0024002,2254813,DTCC00484130,1005452,24756
CHEMBL401414,P45452,,CWOIBYBXJSRSGT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17935984,IC50,=,0.6,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Potent, selective spiropyrrolidine pyrimidinetrione inhibitors of MMP-13.",Bioorg. Med. Chem. Lett.,2007,17,23,"Freeman-Cook KD, Reiter LA, Noe MC, Antipas AS, Danley DE, Datta K, Downs JT, Eisenbeis S, Eskra JD, Garmene DJ, Greer EM, Griffiths RJ, Guzman R, Hardink JR, Janat F, Jones CS, Martinelli GJ, Mitchell PG, Laird ER, Liras JL, Lopresti-Morrow LL, Pandit J, Reilly UD, Robertson D, Vaughn-Bowser ML, Wolf-Gouviea LA, Yocum SA",,458357,DTCT0024002,2254808,DTCC00484149,521134,24756
CHEMBL401435,P45452,,OYDZMCCYUDYFHU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17804234,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"5'-Phenyl-3'H-spiro[indoline-3,2'-[1,3,4]thiadiazol]-2-one inhibitors of ADAMTS-5 (aggrecanase-2).",Bioorg. Med. Chem. Lett.,2007,17,20,"Bursavich MG, Gilbert AM, Lombardi S, Georgiadis KE, Reifenberg E, Flannery CR, Morris EA",,449411,DTCT0024002,2188836,DTCC00467584,1921519,23878
CHEMBL401435,P45452,,OYDZMCCYUDYFHU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18790648,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497406,DTCT0024002,2457522,DTCC00467584,1917703,32556
CHEMBL401453,P45452,,JRRSWIJDZJXIAR-LADGPHEKSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17276676,IC50,>,5000,NM,,,,,,,,,,,,,,Inhibition of MMP13,,A new 4-(2-methylquinolin-4-ylmethyl)phenyl P1' group for the beta-amino hydroxamic acid derived TACE inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,7,"Chen XT, Ghavimi B, Corbett RL, Xue CB, Liu RQ, Covington MB, Qian M, Vaddi KG, Christ DD, Hartman KD, Ribadeneira MD, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,447089,DTCT0024002,2169368,DTCC00464770,1328990,23623
CHEMBL401454,P45452,,CKGRNUKOQHVJOB-RBBKRZOGSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17276676,IC50,>,5000,NM,,,,,,,,,,,,,,Inhibition of MMP13,,A new 4-(2-methylquinolin-4-ylmethyl)phenyl P1' group for the beta-amino hydroxamic acid derived TACE inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,7,"Chen XT, Ghavimi B, Corbett RL, Xue CB, Liu RQ, Covington MB, Qian M, Vaddi KG, Christ DD, Hartman KD, Ribadeneira MD, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,447089,DTCT0024002,2169362,DTCC00464776,617508,23623
CHEMBL402393,P45452,,SXDMGWZDRWQMPS-DLBZAZTESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18282708,KI,>,5025,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Potent, selective, orally bioavailable inhibitors of tumor necrosis factor-alpha converting enzyme (TACE): discovery of indole, benzofuran, imidazopyridine and pyrazolopyridine P1' substituents.",Bioorg. Med. Chem. Lett.,2008,18,6,"Lu Z, Ott GR, Anand R, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Trzaskos J, Duan JJ",,463868,DTCT0024002,2317289,DTCC00499750,957099,25272
CHEMBL402393,P45452,,SXDMGWZDRWQMPS-DLBZAZTESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18790648,KI,>,5025,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497406,DTCT0024002,2456527,DTCC00499750,952985,32556
CHEMBL402436,P45452,,SDNMPMDMJTYOAW-AZUAARDMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18242982,KI,>,5025,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.",Bioorg. Med. Chem. Lett.,2008,18,5,"Ott GR, Asakawa N, Lu Z, Anand R, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Trzaskos JM, Duan JJ",,462370,DTCT0024002,2282336,DTCC00488433,1873486,25163
CHEMBL402745,P45452,,LFOGEPKUSWRLCL-QFIPXVFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11472202,IC50,=,6.9,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,106478,DTCT0024002,1316695,DTCC00487205,808682,16328
CHEMBL402745,P45452,,LFOGEPKUSWRLCL-QFIPXVFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,IC50,=,6.92,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258653,DTCC00487205,811349,24803
CHEMBL402747,P45452,,CARKQNSZFCLNKM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18054488,KI,=,1700,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Novel thiol-based TACE inhibitors. Part 2: Rational design, synthesis, and SAR of thiol-containing aryl sulfones.",Bioorg. Med. Chem. Lett.,2008,18,1,"Bandarage UK, Wang T, Come JH, Perola E, Wei Y, Rao BG",,461731,DTCT0024002,2277152,DTCC00487839,196172,25093
CHEMBL402747,P45452,,CARKQNSZFCLNKM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18790648,KI,=,1700,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497406,DTCT0024002,2456471,DTCC00487839,208204,32556
CHEMBL403186,P45452,,WMWPLQAXVKBJIC-PZJWPPBQSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18242982,KI,>,5025,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.",Bioorg. Med. Chem. Lett.,2008,18,5,"Ott GR, Asakawa N, Lu Z, Anand R, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Trzaskos JM, Duan JJ",,462370,DTCT0024002,2282345,DTCC00488436,260773,25163
CHEMBL406160,P45452,,BTVFBQCKHQGEQX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18251495,IC50,=,130,NM,,,,,,,,,,,,,,Inhibition of human MMP13 catalytic domain,,"Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2008,51,4,"Li JJ, Nahra J, Johnson AR, Bunker A, O'Brien P, Yue WS, Ortwine DF, Man CF, Baragi V, Kilgore K, Dyer RD, Han HK",,465537,DTCT0024002,2311337,DTCC00503666,83346,25409
CHEMBL406831,P45452,,HDNMYVBBUPHVAM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18251495,IC50,=,61.2,NM,,,,,,,,,,,,,,Inhibition of human MMP13 catalytic domain,,"Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2008,51,4,"Li JJ, Nahra J, Johnson AR, Bunker A, O'Brien P, Yue WS, Ortwine DF, Man CF, Baragi V, Kilgore K, Dyer RD, Han HK",,465537,DTCT0024002,2311339,DTCC00503706,1021717,25409
CHEMBL406831,P45452,,HDNMYVBBUPHVAM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18251495,IC50,=,610,NM,,,,,,,,,,,,,,Inhibition of human MMP13,,"Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2008,51,4,"Li JJ, Nahra J, Johnson AR, Bunker A, O'Brien P, Yue WS, Ortwine DF, Man CF, Baragi V, Kilgore K, Dyer RD, Han HK",,465538,DTCT0024002,2311369,DTCC00503706,1021717,25409
CHEMBL406919,P45452,,PUJZVNVUMWERAI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18251495,IC50,=,19.3,NM,,,,,,,,,,,,,,Inhibition of human MMP13 catalytic domain,,"Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2008,51,4,"Li JJ, Nahra J, Johnson AR, Bunker A, O'Brien P, Yue WS, Ortwine DF, Man CF, Baragi V, Kilgore K, Dyer RD, Han HK",,465537,DTCT0024002,2311319,DTCC00504041,1921784,25409
CHEMBL406919,P45452,,PUJZVNVUMWERAI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18251495,IC50,=,120,NM,,,,,,,,,,,,,,Inhibition of human MMP13,,"Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2008,51,4,"Li JJ, Nahra J, Johnson AR, Bunker A, O'Brien P, Yue WS, Ortwine DF, Man CF, Baragi V, Kilgore K, Dyer RD, Han HK",,465538,DTCT0024002,2311350,DTCC00504041,1921784,25409
CHEMBL407090,P45452,,RCZSEZGNROFIGF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18251495,IC50,=,36.3,NM,,,,,,,,,,,,,,Inhibition of human MMP13 catalytic domain,,"Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2008,51,4,"Li JJ, Nahra J, Johnson AR, Bunker A, O'Brien P, Yue WS, Ortwine DF, Man CF, Baragi V, Kilgore K, Dyer RD, Han HK",,465537,DTCT0024002,2311340,DTCC00503709,957117,25409
CHEMBL407090,P45452,,RCZSEZGNROFIGF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18251495,IC50,=,122,NM,,,,,,,,,,,,,,Inhibition of human MMP13,,"Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2008,51,4,"Li JJ, Nahra J, Johnson AR, Bunker A, O'Brien P, Yue WS, Ortwine DF, Man CF, Baragi V, Kilgore K, Dyer RD, Han HK",,465538,DTCT0024002,2311370,DTCC00503709,957117,25409
CHEMBL407151,P45452,,JYMZMJPXMAFCPA-ZROIWOOFSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25725607,IC50,=,64000,NM,,,,,,,,,,,,,,Inhibition of MMP13 catalytic domain (unknown origin) assessed as reduction in hydrolysis of Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 substrate measured for 3 mins after substrate addition by fluorescence assay,,2-Benzisothiazolylimino-5-benzylidene-4-thiazolidinones as protective agents against cartilage destruction.,Bioorg. Med. Chem.,2015,23,7,"Crascì L, Vicini P, Incerti M, Cardile V, Avondo S, Panico A",,1463481,DTCT0024002,14035839,DTCC00495878,978589,61492
CHEMBL407443,P45452,,PONKMSIAUNHYAM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11543675,IC50,=,2.3,NM,,,,,,,,,,,,,,In vitro inhibition of human matrix metalloprotease-13,,"N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: further probing of the S(1), S(1)', and S(2)' pockets.",J. Med. Chem.,2001,44,19,"Hanessian S, Moitessier N, Gauchet C, Viau M",,106474,DTCT0024002,1373018,DTCC00273294,1723389,16392
CHEMBL407640,P45452,,WTVDGWPQROHFND-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11297453,IC50,=,2037,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-13 in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,106481,DTCT0024002,950842,DTCC00138732,239822,16645
CHEMBL407640,P45452,,WTVDGWPQROHFND-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12217355,IC50,=,2041.74,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant human matrix metalloprotease-13,,Analogue based design of MMP-13 (Collagenase-3) inhibitors.,Bioorg. Med. Chem. Lett.,2002,12,19,"Sarma JA, Rambabu G, Srikanth K, Raveendra D, Vithal M",,106465,DTCT0024002,785212,DTCC00138732,237449,5083
CHEMBL408366,P45452,,WIAJGSYMEDWMGP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17981034,IC50,=,6.8,NM,,,,,,,,,,,,,,Inhibition of MMP13,,1-Hydroxy-2-pyridinone-based MMP inhibitors: synthesis and biological evaluation for the treatment of ischemic stroke.,Bioorg. Med. Chem. Lett.,2008,18,1,"Zhang YM, Fan X, Chakaravarty D, Xiang B, Scannevin RH, Huang Z, Ma J, Burke SL, Karnachi P, Rhodes KJ, Jackson PF",,469434,DTCT0024002,2289326,DTCC00501132,1971170,25715
CHEMBL408646,P45452,,XOJGZFAHUIZIPI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18251495,IC50,=,7.82,NM,,,,,,,,,,,,,,Inhibition of human MMP13 catalytic domain,,"Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2008,51,4,"Li JJ, Nahra J, Johnson AR, Bunker A, O'Brien P, Yue WS, Ortwine DF, Man CF, Baragi V, Kilgore K, Dyer RD, Han HK",,465537,DTCT0024002,2311331,DTCC00504018,310491,25409
CHEMBL408646,P45452,,XOJGZFAHUIZIPI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18251495,IC50,=,57,NM,,,,,,,,,,,,,,Inhibition of human MMP13,,"Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2008,51,4,"Li JJ, Nahra J, Johnson AR, Bunker A, O'Brien P, Yue WS, Ortwine DF, Man CF, Baragi V, Kilgore K, Dyer RD, Han HK",,465538,DTCT0024002,2311363,DTCC00504018,310491,25409
CHEMBL409111,P45452,,URVUJTFFOUHNFN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18251495,IC50,=,9.95,NM,,,,,,,,,,,,,,Inhibition of human MMP13 catalytic domain,,"Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2008,51,4,"Li JJ, Nahra J, Johnson AR, Bunker A, O'Brien P, Yue WS, Ortwine DF, Man CF, Baragi V, Kilgore K, Dyer RD, Han HK",,465537,DTCT0024002,2311323,DTCC00503628,1119439,25409
CHEMBL409111,P45452,,URVUJTFFOUHNFN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18251495,IC50,=,28,NM,,,,,,,,,,,,,,Inhibition of human MMP13,,"Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2008,51,4,"Li JJ, Nahra J, Johnson AR, Bunker A, O'Brien P, Yue WS, Ortwine DF, Man CF, Baragi V, Kilgore K, Dyer RD, Han HK",,465538,DTCT0024002,2311355,DTCC00503628,1119439,25409
CHEMBL409223,P45452,,AURPLPVPCDLQBS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18251495,IC50,=,728,NM,,,,,,,,,,,,,,Inhibition of human MMP13 catalytic domain,,"Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2008,51,4,"Li JJ, Nahra J, Johnson AR, Bunker A, O'Brien P, Yue WS, Ortwine DF, Man CF, Baragi V, Kilgore K, Dyer RD, Han HK",,465537,DTCT0024002,2311327,DTCC00503746,439452,25409
CHEMBL409223,P45452,,AURPLPVPCDLQBS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18251495,IC50,=,10000,NM,,,,,,,,,,,,,,Inhibition of human MMP13,,"Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2008,51,4,"Li JJ, Nahra J, Johnson AR, Bunker A, O'Brien P, Yue WS, Ortwine DF, Man CF, Baragi V, Kilgore K, Dyer RD, Han HK",,465538,DTCT0024002,2311359,DTCC00503746,439452,25409
CHEMBL409502,P45452,,SFZMBRAWNOHSKH-UVTDQMKNSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25725607,IC50,=,32000,NM,,,,,,,,,,,,,,Inhibition of MMP13 catalytic domain (unknown origin) assessed as reduction in hydrolysis of Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 substrate measured for 3 mins after substrate addition by fluorescence assay,,2-Benzisothiazolylimino-5-benzylidene-4-thiazolidinones as protective agents against cartilage destruction.,Bioorg. Med. Chem.,2015,23,7,"Crascì L, Vicini P, Incerti M, Cardile V, Avondo S, Panico A",,1463481,DTCT0024002,14035845,DTCC00495941,1879030,61492
CHEMBL409536,P45452,,PLBINCOCFGQAJM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17623656,IC50,=,30,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain,,Discovery and characterization of a novel inhibitor of matrix metalloprotease-13 that reduces cartilage damage in vivo without joint fibroplasia side effects.,J. Biol. Chem.,2007,282,38,"Johnson AR, Pavlovsky AG, Ortwine DF, Prior F, Man CF, Bornemeier DA, Banotai CA, Mueller WT, McConnell P, Yan C, Baragi V, Lesch C, Roark WH, Wilson M, Datta K, Guzman R, Han HK, Dyer RD",,507870,DTCT0024002,2388615,DTCC00503784,1950627,29282
CHEMBL409536,P45452,,PLBINCOCFGQAJM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17623656,IC50,=,51,NM,,,,,,,,,,,,,,Inhibition of human recombinant full length MMP13-mediated type 2 collagen cleavage,,Discovery and characterization of a novel inhibitor of matrix metalloprotease-13 that reduces cartilage damage in vivo without joint fibroplasia side effects.,J. Biol. Chem.,2007,282,38,"Johnson AR, Pavlovsky AG, Ortwine DF, Prior F, Man CF, Bornemeier DA, Banotai CA, Mueller WT, McConnell P, Yan C, Baragi V, Lesch C, Roark WH, Wilson M, Datta K, Guzman R, Han HK, Dyer RD",,507896,DTCT0024002,2388587,DTCC00503784,1950627,29282
CHEMBL409536,P45452,,PLBINCOCFGQAJM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17623656,KI,=,64,NM,,,,,,,,,,,,,,Inhibition of human recombinant full length MMP13 by steady state kinetic assay,,Discovery and characterization of a novel inhibitor of matrix metalloprotease-13 that reduces cartilage damage in vivo without joint fibroplasia side effects.,J. Biol. Chem.,2007,282,38,"Johnson AR, Pavlovsky AG, Ortwine DF, Prior F, Man CF, Bornemeier DA, Banotai CA, Mueller WT, McConnell P, Yan C, Baragi V, Lesch C, Roark WH, Wilson M, Datta K, Guzman R, Han HK, Dyer RD",,507885,DTCT0024002,2388592,DTCC00503784,1950627,29282
CHEMBL409536,P45452,,PLBINCOCFGQAJM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17623656,KM,=,48000,NM,,,,,,,,,,,,,,Activity of human recombinant full length MMP13 by steady state kinetic assay,,Discovery and characterization of a novel inhibitor of matrix metalloprotease-13 that reduces cartilage damage in vivo without joint fibroplasia side effects.,J. Biol. Chem.,2007,282,38,"Johnson AR, Pavlovsky AG, Ortwine DF, Prior F, Man CF, Bornemeier DA, Banotai CA, Mueller WT, McConnell P, Yan C, Baragi V, Lesch C, Roark WH, Wilson M, Datta K, Guzman R, Han HK, Dyer RD",,507895,DTCT0024002,2388595,DTCC00503784,1950627,29282
CHEMBL409536,P45452,,PLBINCOCFGQAJM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17623656,VMAX,=,402,PMOL/MIN,,,,,,,,,,,,,,Activity of human recombinant full length MMP13 by steady state kinetic assay,,Discovery and characterization of a novel inhibitor of matrix metalloprotease-13 that reduces cartilage damage in vivo without joint fibroplasia side effects.,J. Biol. Chem.,2007,282,38,"Johnson AR, Pavlovsky AG, Ortwine DF, Prior F, Man CF, Bornemeier DA, Banotai CA, Mueller WT, McConnell P, Yan C, Baragi V, Lesch C, Roark WH, Wilson M, Datta K, Guzman R, Han HK, Dyer RD",,507895,DTCT0024002,2388594,DTCC00503784,1950627,29282
CHEMBL409536,P45452,,PLBINCOCFGQAJM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18251495,IC50,=,23,NM,,,,,,,,,,,,,,Inhibition of human MMP13 catalytic domain,,"Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2008,51,4,"Li JJ, Nahra J, Johnson AR, Bunker A, O'Brien P, Yue WS, Ortwine DF, Man CF, Baragi V, Kilgore K, Dyer RD, Han HK",,465537,DTCT0024002,2311304,DTCC00503784,1954666,25409
CHEMBL409536,P45452,,PLBINCOCFGQAJM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18790648,IC50,=,30,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497406,DTCT0024002,2457342,DTCC00503784,1950505,32556
CHEMBL409536,P45452,,PLBINCOCFGQAJM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25265401,IC50,=,30,NM,,,,,,,,,,,,,,Inhibition of MMP13 (unknown origin),,"Targeting matrix metalloproteinases: exploring the dynamics of the s1' pocket in the design of selective, small molecule inhibitors.",J. Med. Chem.,2014,57,24,"Fabre B, Ramos A, de Pascual-Teresa B",,1433222,DTCT0024002,13993823,DTCC00503784,1943413,60040
CHEMBL410029,P45452,,HGWNWHHVVVGHQI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18251495,IC50,=,0.15,NM,,,,,,,,,,,,,,Inhibition of human MMP13 catalytic domain,,"Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2008,51,4,"Li JJ, Nahra J, Johnson AR, Bunker A, O'Brien P, Yue WS, Ortwine DF, Man CF, Baragi V, Kilgore K, Dyer RD, Han HK",,465537,DTCT0024002,2311336,DTCC00503632,1636498,25409
CHEMBL410029,P45452,,HGWNWHHVVVGHQI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18251495,IC50,=,0.78,NM,,,,,,,,,,,,,,Inhibition of human MMP13,,"Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2008,51,4,"Li JJ, Nahra J, Johnson AR, Bunker A, O'Brien P, Yue WS, Ortwine DF, Man CF, Baragi V, Kilgore K, Dyer RD, Han HK",,465538,DTCT0024002,2311367,DTCC00503632,1636498,25409
CHEMBL410322,P45452,,VTTPLBXIWFSZRK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18251495,IC50,=,95.6,NM,,,,,,,,,,,,,,Inhibition of human MMP13 catalytic domain,,"Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2008,51,4,"Li JJ, Nahra J, Johnson AR, Bunker A, O'Brien P, Yue WS, Ortwine DF, Man CF, Baragi V, Kilgore K, Dyer RD, Han HK",,465537,DTCT0024002,2311316,DTCC00504014,860783,25409
CHEMBL410322,P45452,,VTTPLBXIWFSZRK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18251495,IC50,=,1900,NM,,,,,,,,,,,,,,Inhibition of human MMP13,,"Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2008,51,4,"Li JJ, Nahra J, Johnson AR, Bunker A, O'Brien P, Yue WS, Ortwine DF, Man CF, Baragi V, Kilgore K, Dyer RD, Han HK",,465538,DTCT0024002,2311347,DTCC00504014,860783,25409
CHEMBL410649,P45452,,PLFJMTKUJWPCGG-ZROIWOOFSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25725607,IC50,=,55880,NM,,,,,,,,,,,,,,Inhibition of MMP13 catalytic domain (unknown origin) assessed as reduction in hydrolysis of Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 substrate measured for 3 mins after substrate addition by fluorescence assay,,2-Benzisothiazolylimino-5-benzylidene-4-thiazolidinones as protective agents against cartilage destruction.,Bioorg. Med. Chem.,2015,23,7,"Crascì L, Vicini P, Incerti M, Cardile V, Avondo S, Panico A",,1463481,DTCT0024002,14035844,DTCC00495839,1140869,61492
CHEMBL410737,P45452,,LYAHBKLKJSTSGZ-OTNCWRBYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11454461,IC50,=,81,NM,,,,,,,,,,,,,,In vitro inhibitory concentration against Matrix metalloprotease-13,,The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold.,Bioorg. Med. Chem. Lett.,2001,11,15,"Tullis JS, Laufersweiler MJ, VanRens JC, Natchus MG, Bookland RG, Almstead NG, Pikul S, De B, Hsieh LC, Janusz MJ, Branch TM, Peng SX, Jin YY, Hudlicky T, Oppong K",,106479,DTCT0024002,1536368,DTCC00209222,1817659,4358
CHEMBL412064,P45452,,UDEPBQKCNHEJQR-ZROIWOOFSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25725607,IC50,>=,100000,NM,,,,,,,,,,,,,,Inhibition of MMP13 catalytic domain (unknown origin) assessed as reduction in hydrolysis of Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 substrate measured for 3 mins after substrate addition by fluorescence assay,,2-Benzisothiazolylimino-5-benzylidene-4-thiazolidinones as protective agents against cartilage destruction.,Bioorg. Med. Chem.,2015,23,7,"Crascì L, Vicini P, Incerti M, Cardile V, Avondo S, Panico A",,1463481,DTCT0024002,14035838,DTCC00495837,1943511,61492
CHEMBL412644,P45452,,UKXUDXJOLHHNPH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10915056,IC50,>,30000,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,Difluoroketones as inhibitors of matrix metalloprotease-13.,Bioorg. Med. Chem. Lett.,2000,10,14,"Reiter LA, Martinelli GJ, Reeves LA, Mitchell PG",,106764,DTCT0024002,1490728,DTCC00181487,1078644,3800
CHEMBL412910,P45452,,HDOJQDDADGGFGH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12270165,IC50,=,3,NM,,,,,,,,,,,,,,Concentration required in vitro to inhibit Matrix metalloprotease-13,,Benzodiazepine inhibitors of the MMPs and TACE.,Bioorg. Med. Chem. Lett.,2002,12,20,"Nelson FC, Delos Santos E, Levin JI, Chen JM, Skotnicki JS, DiJoseph JF, Sharr MA, Sung A, Killar LM, Cowling R, Jin G, Roth CE, Albright JD",,106631,DTCT0024002,1537569,DTCC00263141,1207792,5143
CHEMBL41318,P45452,,ZRQDNSXPNYIHKO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10915056,IC50,=,27000,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,Difluoroketones as inhibitors of matrix metalloprotease-13.,Bioorg. Med. Chem. Lett.,2000,10,14,"Reiter LA, Martinelli GJ, Reeves LA, Mitchell PG",,106764,DTCT0024002,1483665,DTCC00181444,1305046,3800
CHEMBL416173,P45452,,UFJYSWCFYDZPKS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11934587,IC50,=,701,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,Anthranilate sulfonamide hydroxamate TACE inhibitors. Part 1: Structure-based design of novel acetylenic P1' groups.,Bioorg. Med. Chem. Lett.,2002,12,8,"Chen JM, Jin G, Sung A, Levin JI",,106633,DTCT0024002,1098333,DTCC00149696,1146885,5358
CHEMBL416173,P45452,,UFJYSWCFYDZPKS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11934588,IC50,=,701,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 activity,,Anthranilate sulfonamide hydroxamate TACE inhibitors. Part 2: SAR of the acetylenic P1' group.,Bioorg. Med. Chem. Lett.,2002,12,8,"Levin JI, Chen JM, Du MT, Nelson FC, Killar LM, Skala S, Sung A, Jin G, Cowling R, Barone D, March CJ, Mohler KM, Black RA, Skotnicki JS",,106622,DTCT0024002,816032,DTCC00149696,1131549,5465
CHEMBL41622,P45452,,DPAHQUXWZUTATE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10915056,IC50,>,30000,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,Difluoroketones as inhibitors of matrix metalloprotease-13.,Bioorg. Med. Chem. Lett.,2000,10,14,"Reiter LA, Martinelli GJ, Reeves LA, Mitchell PG",,106764,DTCT0024002,1509620,DTCC00181114,367652,3800
CHEMBL417144,P45452,,ZAXFGRVMMQJZLL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12668018,IC50,=,34,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease 13 (MMP-13).,,Synthesis and SAR of bicyclic heteroaryl hydroxamic acid MMP and TACE inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,8,"Zask A, Gu Y, Albright JD, Du X, Hogan M, Levin JI, Chen JM, Killar LM, Sung A, DiJoseph JF, Sharr MA, Roth CE, Skala S, Jin G, Cowling R, Mohler KM, Barone D, Black R, March C, Skotnicki JS",,106642,DTCT0024002,1279055,DTCC00174415,690614,6276
CHEMBL417977,P45452,,SCKGCOPJBBAWME-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11297453,IC50,>,1600,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-13 in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,106481,DTCT0024002,956221,DTCC00138723,1340877,16645
CHEMBL418053,P45452,,DCWUWJBJOHDJGB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12668018,IC50,=,7,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease 13 (MMP-13).,,Synthesis and SAR of bicyclic heteroaryl hydroxamic acid MMP and TACE inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,8,"Zask A, Gu Y, Albright JD, Du X, Hogan M, Levin JI, Chen JM, Killar LM, Sung A, DiJoseph JF, Sharr MA, Roth CE, Skala S, Jin G, Cowling R, Mohler KM, Barone D, Black R, March C, Skotnicki JS",,106642,DTCT0024002,1259396,DTCC00174540,1596083,6276
CHEMBL418442,P45452,,INVXSBCIDABVMG-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10649971,IC50,=,43,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant matrix metalloprotease-13 (MMP-13),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,106476,DTCT0024002,904796,DTCC00186442,1046249,15892
CHEMBL418442,P45452,,INVXSBCIDABVMG-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12798337,INHIBITION EFFECT,=,0.918,,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-13 at 20 nM,,Synthesis of radiolabeled biphenylsulfonamide matrix metalloproteinase inhibitors as new potential PET cancer imaging agents.,Bioorg. Med. Chem. Lett.,2003,13,13,"Fei X, Zheng QH, Liu X, Wang JQ, Sun HB, Mock BH, Stone KL, Miller KD, Sledge GW, Hutchins GD",,106607,DTCT0024002,1368754,DTCC00186442,1046642,5629
CHEMBL418442,P45452,,INVXSBCIDABVMG-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17088065,IC50,=,43,NM,,,,,,,,,,,,,,Inhibition of MMP13,,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432508,DTCT0024002,2061975,DTCC00186442,1037472,22402
CHEMBL418461,P45452,,LYRRCUUSLOFAKG-JXALWOEJSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11454461,IC50,=,100,NM,,,,,,,,,,,,,,In vitro inhibitory concentration against Matrix metalloprotease-13,,The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold.,Bioorg. Med. Chem. Lett.,2001,11,15,"Tullis JS, Laufersweiler MJ, VanRens JC, Natchus MG, Bookland RG, Almstead NG, Pikul S, De B, Hsieh LC, Janusz MJ, Branch TM, Peng SX, Jin YY, Hudlicky T, Oppong K",,106479,DTCT0024002,1522366,DTCC00208258,75665,4358
CHEMBL418639,P45452,,KHCVBQLHKXPRJT-GMLYINLCSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11454461,IC50,=,26,NM,,,,,,,,,,,,,,In vitro inhibitory concentration against Matrix metalloprotease-13,,The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold.,Bioorg. Med. Chem. Lett.,2001,11,15,"Tullis JS, Laufersweiler MJ, VanRens JC, Natchus MG, Bookland RG, Almstead NG, Pikul S, De B, Hsieh LC, Janusz MJ, Branch TM, Peng SX, Jin YY, Hudlicky T, Oppong K",,106479,DTCT0024002,1543376,DTCC00208671,691009,4358
CHEMBL418737,P45452,,PTUSTBHDXAVNPJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11934588,IC50,=,321,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 activity,,Anthranilate sulfonamide hydroxamate TACE inhibitors. Part 2: SAR of the acetylenic P1' group.,Bioorg. Med. Chem. Lett.,2002,12,8,"Levin JI, Chen JM, Du MT, Nelson FC, Killar LM, Skala S, Sung A, Jin G, Cowling R, Barone D, March CJ, Mohler KM, Black RA, Skotnicki JS",,106622,DTCT0024002,779297,DTCC00150827,451786,5465
CHEMBL41924,P45452,,GXVIGVLZKIVXMN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10915056,IC50,=,290,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,Difluoroketones as inhibitors of matrix metalloprotease-13.,Bioorg. Med. Chem. Lett.,2000,10,14,"Reiter LA, Martinelli GJ, Reeves LA, Mitchell PG",,106764,DTCT0024002,1515357,DTCC00181083,690673,3800
CHEMBL419315,P45452,,AWEAPFWTHDDCFJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11591510,IC50,=,161,NM,,,,,,,,,,,,,,Inhibitory activity against human Matrix metalloprotease-13,,alpha-Alkyl-alpha-amino-beta-sulphone hydroxamates as potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2001,11,20,"Becker DP, DeCrescenzo G, Freskos J, Getman DP, Hockerman SL, Li M, Mehta P, Munie GE, Swearingen C",,106599,DTCT0024002,1073620,DTCC00255150,335810,4541
CHEMBL419430,P45452,,GUHYZHHGWPARCR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10669564,IC50,=,2.8,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13 (MMP-13),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,106473,DTCT0024002,1700468,DTCC00302952,2066272,16065
CHEMBL419607,P45452,,WQCOVODIHQDZNG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10669564,IC50,=,27,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13 (MMP-13),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,106473,DTCT0024002,1698006,DTCC00303281,1101115,16065
CHEMBL419607,P45452,,WQCOVODIHQDZNG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,IC50,=,26.92,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258775,DTCC00303281,1103041,24803
CHEMBL419648,P45452,,NLPICQLAIKGJBE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773042,IC50,=,2,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13.,,"Synthesis and structure-activity relationship of N-substituted 4-arylsulfonylpiperidine-4-hydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Davis JM, Grosu GT, Baker J, Ellingboe J, Zask A, Levin JI, Sandanayaka VP, Du M, Skotnicki JS, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R, Tillett J, Zhao W, McDevitt J, Xu ZB",,106632,DTCT0024002,500332,DTCC00235460,1370861,17340
CHEMBL419648,P45452,,NLPICQLAIKGJBE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,5.7,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260812,DTCC00235460,1361910,24831
CHEMBL419750,P45452,,VTRJTXRAOIMSTL-ZDUSSCGKSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11563922,KI,=,1330,NM,,,,,,,,,,,,,,In Vitro inhibitory activity against the catalytic domain of the matrix metalloprotease-13,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,106610,DTCT0024002,1719489,DTCC00282282,258562,16424
CHEMBL419868,P45452,,TVHNMQFVUGWIID-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,9873598,IC50,=,65,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13 (MMP-13),,The synthesis and biological activity of a novel series of diazepine MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,19,"Levin JI, DiJoseph JF, Killar LM, Sung A, Walter T, Sharr MA, Roth CE, Skotnicki JS, Albright JD",,106628,DTCT0024002,606770,DTCC00252056,356696,2791
CHEMBL419868,P45452,,TVHNMQFVUGWIID-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,9873598,INHIBITION,=,0.89,%,,organism_based,,,,,,,,,,,,In vivo inhibition of matrix metalloprotease-13 (MMP-13) in mouse dialysis tubing implant assay at 50 mg/kg po,,The synthesis and biological activity of a novel series of diazepine MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,19,"Levin JI, DiJoseph JF, Killar LM, Sung A, Walter T, Sharr MA, Roth CE, Skotnicki JS, Albright JD",,106766,DTCT0024002,606771,DTCC00252056,356696,2791
CHEMBL419868,P45452,,TVHNMQFVUGWIID-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,IC50,=,64.57,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258754,DTCC00252056,359211,24803
CHEMBL419875,P45452,,TTXZWLDILJPYPT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11591509,IC50,=,1100,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,alpha-Amino-beta-sulphone hydroxamates as potent MMP-13 inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2001,11,20,"Becker DP, Barta TE, Bedell L, DeCrescenzo G, Freskos J, Getman DP, Hockerman SL, Li M, Mehta P, Mischke B, Munie GE, Swearingen C, Villamil CI",,106603,DTCT0024002,654951,DTCC00255269,626978,4540
CHEMBL419896,P45452,,KBRVEWFSDCONMH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15125955,IC50,=,5000,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,Reverse hydroxamate-based selective TACE inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,11,"Kamei N, Tanaka T, Kawai K, Miyawaki K, Okuyama A, Murakami Y, Arakawa Y, Haino M, Harada T, Shimano M",,106641,DTCT0024002,1403502,DTCC00265483,1047085,6400
CHEMBL419995,P45452,,WYWAKLNLTJVWAB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11514167,IC50,=,39,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,The discovery of anthranilic acid-based MMP inhibitors. Part 2: SAR of the 5-position and P1(1) groups.,Bioorg. Med. Chem. Lett.,2001,11,16,"Levin JI, Chen J, Du M, Hogan M, Kincaid S, Nelson FC, Venkatesan AM, Wehr T, Zask A, DiJoseph J, Killar LM, Skala S, Sung A, Sharr M, Roth C, Jin G, Cowling R, Mohler KM, Black RA, March CJ, Skotnicki JS",,106636,DTCT0024002,984283,DTCC00223183,1713683,4353
CHEMBL420023,P45452,,HUTRBECWDORHKF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773042,IC50,=,2,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13.,,"Synthesis and structure-activity relationship of N-substituted 4-arylsulfonylpiperidine-4-hydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Davis JM, Grosu GT, Baker J, Ellingboe J, Zask A, Levin JI, Sandanayaka VP, Du M, Skotnicki JS, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R, Tillett J, Zhao W, McDevitt J, Xu ZB",,106632,DTCT0024002,502956,DTCC00235854,1240290,17340
CHEMBL420023,P45452,,HUTRBECWDORHKF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,5.7,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260810,DTCC00235854,1231177,24831
CHEMBL420656,P45452,,WHTRIFCXCJYQKX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11543675,IC50,=,4.5,NM,,,,,,,,,,,,,,In vitro inhibition of human matrix metalloprotease-13,,"N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: further probing of the S(1), S(1)', and S(2)' pockets.",J. Med. Chem.,2001,44,19,"Hanessian S, Moitessier N, Gauchet C, Viau M",,106474,DTCT0024002,1400615,DTCC00273612,2013184,16392
CHEMBL420657,P45452,,ZPNXAVJYHSAOKF-YSSMNDQQSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11543676,IC50,=,3.7,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,Design and synthesis of matrix metalloproteinase inhibitors guided by molecular modeling. Picking the S(1) pocket using conformationally constrained inhibitors.,J. Med. Chem.,2001,44,19,"Hanessian S, MacKay DB, Moitessier N",,106482,DTCT0024002,1176099,DTCC00273546,1424440,16385
CHEMBL42067,P45452,,UKLIIGXGTPSYBF-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10649971,IC50,=,580,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant matrix metalloprotease-13 (MMP-13),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,106476,DTCT0024002,901110,DTCC00186535,658583,15892
CHEMBL420758,P45452,,DMUZNXFYXIXAFS-FUJFQHJFSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12824028,IC50,=,54,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13,,Phosphinic acid-based MMP-13 inhibitors that spare MMP-1 and MMP-3.,Bioorg. Med. Chem. Lett.,2003,13,14,"Reiter LA, Mitchell PG, Martinelli GJ, Lopresti-Morrow LL, Yocum SA, Eskra JD",,106640,DTCT0024002,1504058,DTCC00231964,29792,5648
CHEMBL421029,P45452,,UGEYJONPMBOKNN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11543675,IC50,=,1.6,NM,,,,,,,,,,,,,,In vitro inhibition of human matrix metalloprotease-13,,"N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: further probing of the S(1), S(1)', and S(2)' pockets.",J. Med. Chem.,2001,44,19,"Hanessian S, Moitessier N, Gauchet C, Viau M",,106474,DTCT0024002,1404223,DTCC00273395,562502,16392
CHEMBL421131,P45452,,ZXJIVLSCJKOYTD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11206468,IC50,,,,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 (Not tested),Not Determined,Heteroaryl and cycloalkyl sulfonamide hydroxamic acid inhibitors of matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2001,11,2,"Levin JI, Gu Y, Nelson FC, Zask A, DiJoseph JF, Sharr MA, Sung A, Jin G, Cowling R, Chanda P, Cosmi S, Hsiao CL, Edris W, Wilhelm J, Killar LM, Skotnicki JS",,106637,DTCT0024002,337374,DTCC00237580,1499945,4516
CHEMBL42114,P45452,,LKVAANCBUJLQIE-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10649971,IC50,=,105,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant matrix metalloprotease-13 (MMP-13),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,106476,DTCT0024002,901104,DTCC00186439,1046251,15892
CHEMBL421372,P45452,,MNSCIDWEUDHWNR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11133099,IC50,>,10000,NM,,,,,,,,,,,,,,50 percent inhibition of human Matrix metalloprotease-13 by the cleavage of fluorogenic peptide MCA-Pro-Leu-Gly-Leu-Dpa-ala-Arg-NH2,,Synthesis and activity of selective MMP inhibitors with an aryl backbone.,Bioorg. Med. Chem. Lett.,2000,10,24,"Barta TE, Becker DP, Bedell LJ, De Crescenzo GA, McDonald JJ, Munie GE, Rao S, Shieh HS, Stegeman R, Stevens AM, Villamil CI",,106604,DTCT0024002,705206,DTCC00261183,1100607,3985
CHEMBL421530,P45452,,NBKLHSQMSJZFJF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11549451,ACTIVITY,=,7.7,NM,,,,,,,,,,,,,,Inhibitory activity against human Matrix metalloprotease-13,,"Selective, orally active MMP inhibitors with an aryl backbone.",Bioorg. Med. Chem. Lett.,2001,11,18,"Barta TE, Becker DP, Bedell LJ, De Crescenzo GA, McDonald JJ, Mehta P, Munie GE, Villamil CI",,106466,DTCT0024002,1642645,DTCC00240809,1014403,4449
CHEMBL421644,P45452,,XSGJDCITTFQFMZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10669564,IC50,=,3,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13 (MMP-13),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,106473,DTCT0024002,1681652,DTCC00302815,648521,16065
CHEMBL421644,P45452,,XSGJDCITTFQFMZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,IC50,=,3.02,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258779,DTCC00302815,650403,24803
CHEMBL421699,P45452,,XFKRGURHEZYQDK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11206468,IC50,=,47,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,Heteroaryl and cycloalkyl sulfonamide hydroxamic acid inhibitors of matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2001,11,2,"Levin JI, Gu Y, Nelson FC, Zask A, DiJoseph JF, Sharr MA, Sung A, Jin G, Cowling R, Chanda P, Cosmi S, Hsiao CL, Edris W, Wilhelm J, Killar LM, Skotnicki JS",,106621,DTCT0024002,1293504,DTCC00237568,1111984,4516
CHEMBL421699,P45452,,XFKRGURHEZYQDK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23287054,IC50,=,47,NM,,,,,,,,,,,,,,Inhibition of MMP13 (unknown origin),,Sulphonamides: Deserving class as MMP inhibitors?,Eur. J. Med. Chem.,2013,60,,"Jain P, Saravanan C, Singh SK",,944584,DTCT0024002,11835689,DTCC00237568,1126998,53820
CHEMBL421766,P45452,,MTGNBEKVSCTMSE-OXJNMPFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11150165,IC50,<,0.4,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease-13 (collagenase-3),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,106477,DTCT0024002,1620381,DTCC00332988,648884,16049
CHEMBL421882,P45452,,GJOCABIDMCKCEG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23287054,IC50,=,0.008,NM,,,,,,,,,,,,,,Inhibition of MMP13 (unknown origin),,Sulphonamides: Deserving class as MMP inhibitors?,Eur. J. Med. Chem.,2013,60,,"Jain P, Saravanan C, Singh SK",,944584,DTCT0024002,11835690,DTCC00252532,1158308,53820
CHEMBL421932,P45452,,ZHLANTZRDCBWFM-AWEZNQCLSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10579818,IC50,=,3.3,NM,,,,,,,,,,,,,,In vitro inhibitory activity against collagenase-3 (matrix metalloprotease-13).,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,106469,DTCT0024002,1385768,DTCC00325502,238280,15412
CHEMBL421966,P45452,,KXEGEKRSCUZQMH-OJSPLJLUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10639284,IC50,=,0.8,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant collagenase-3 (Matrix metalloprotease-13),,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,106475,DTCT0024002,495547,DTCC00340473,1724168,15546
CHEMBL422250,P45452,,IIABJCHWKFZJBK-ZDUSSCGKSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11563922,KI,=,250,NM,,,,,,,,,,,,,,In Vitro inhibitory activity against the catalytic domain of the matrix metalloprotease-13,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,106610,DTCT0024002,1708545,DTCC00281784,389664,16424
CHEMBL422251,P45452,,JOKZNFFZUNYVMR-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11563922,KI,>,15000,NM,,,,,,,,,,,,,,In Vitro inhibitory activity against the catalytic domain of the matrix metalloprotease-13,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,106610,DTCT0024002,1719505,DTCC00282610,906992,16424
CHEMBL422848,P45452,,ITNSNSYBFZWVPE-OXJNMPFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11150165,IC50,<,0.4,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease-13 (collagenase-3),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,106477,DTCT0024002,1605203,DTCC00333431,1683202,16049
CHEMBL423015,P45452,,QGTWMCXPSZIGIN-XJKSGUPXSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11150165,IC50,<,0.5,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13 (collagenase-3),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,106616,DTCT0024002,1626774,DTCC00333068,1229582,16049
CHEMBL42420,P45452,PD-169469,GJOCABIDMCKCEG-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10649971,IC50,=,16,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant matrix metalloprotease-13 (MMP-13),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,106476,DTCT0024002,927058,DTCC01739891,1272542,15892
CHEMBL424311,P45452,,XXFJWMXXEYWBBT-SMDDNHRTSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11150165,IC50,=,5,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease-13 (collagenase-3),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,106477,DTCT0024002,1616289,DTCC00333805,487344,16049
CHEMBL425009,P45452,,YHIUMXFFZGJNGE-APWZRJJASA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15911259,IC50,,,,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-13 (MMP-13); ND=not determined,Not Determined,"Discovery of 3,3-dimethyl-5-hydroxypipecolic hydroxamate-based inhibitors of aggrecanase and MMP-13.",Bioorg. Med. Chem. Lett.,2005,15,11,"Noe MC, Natarajan V, Snow SL, Mitchell PG, Lopresti-Morrow L, Reeves LM, Yocum SA, Carty TJ, Barberia JA, Sweeney FJ, Liras JL, Vaughn M, Hardink JR, Hawkins JM, Tokar C",,305480,DTCT0024002,1813086,DTCC00398503,1522604,18491
CHEMBL425020,P45452,,PYNQNWZHEDOQHX-VWLOTQADSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16153831,IC50,=,4.9,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-13,,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321194,DTCT0024002,1860368,DTCC00407673,1177224,19837
CHEMBL425341,P45452,,OBJUQGMKRHTFFQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15686921,KI,=,54,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,Structure-based design of potent and selective inhibitors of collagenase-3 (MMP-13).,Bioorg. Med. Chem. Lett.,2005,15,4,"Kim SH, Pudzianowski AT, Leavitt KJ, Barbosa J, McDonnell PA, Metzler WJ, Rankin BM, Liu R, Vaccaro W, Pitts W",,302508,DTCT0024002,1744785,DTCC00381701,1457610,18787
CHEMBL425415,P45452,,PACKAWWLZSBYDP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16516466,KI,>,5025,NM,,,,,,,,,,,,,,Binding affinity to MMP13,,"Synthesis and structure-activity relationship of a novel, achiral series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2006,16,10,"Gilmore JL, King BW, Harris C, Maduskuie T, Mercer SE, Liu RQ, Covington MB, Qian M, Ribadeneria MD, Vaddi K, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,354462,DTCT0024002,1926543,DTCC00422057,98764,20786
CHEMBL425525,P45452,,RODBIJLXINIENS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15780611,IC50,=,3.6,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 13,,Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.,Bioorg. Med. Chem. Lett.,2005,15,7,"Blagg JA, Noe MC, Wolf-Gouveia LA, Reiter LA, Laird ER, Chang SP, Danley DE, Downs JT, Elliott NC, Eskra JD, Griffiths RJ, Hardink JR, Haugeto AI, Jones CS, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robinson RP, Subramanyam C, Vaughn-Bowser ML, Yocum SA",,305127,DTCT0024002,1754262,DTCC00384575,1081004,18917
CHEMBL425783,P45452,,KSOLTKWEALJMDR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16723229,IC50,=,177,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Design and synthesis of butynyloxyphenyl beta-sulfone piperidine hydroxamates as TACE inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,15,"Park K, Aplasca A, Du MT, Sun L, Zhu Y, Zhang Y, Levin JI",,377988,DTCT0024002,1969677,DTCC00428619,1296018,21111
CHEMBL426434,P45452,,YCBSBKZAEBKTSY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15357971,KI,>,5000,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 (MMP-13),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302721,DTCT0024002,1766631,DTCC00387570,1274763,18194
CHEMBL426729,P45452,,PSKIOMJBUJPQBG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15566296,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Synthesis and structure-activity relationships of 4-alkynyloxy phenyl sulfanyl, sulfinyl, and sulfonyl alkyl hydroxamates as tumor necrosis factor-alpha converting enzyme and matrix metalloproteinase inhibitors.",J. Med. Chem.,2004,47,25,"Venkatesan AM, Davis JM, Grosu GT, Baker J, Zask A, Levin JI, Ellingboe J, Skotnicki JS, Dijoseph JF, Sung A, Jin G, Xu W, McCarthy DJ, Barone D",,429672,DTCT0024002,2041960,DTCC00444431,1502269,22157
CHEMBL426833,P45452,,QMJIUHKQZQSTQO-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16153831,IC50,=,5.9,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-13,,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321194,DTCT0024002,1860314,DTCC00407639,1598758,19837
CHEMBL427138,P45452,,YTQZUTBYXGOMDQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15780611,IC50,=,15,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 13,,Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.,Bioorg. Med. Chem. Lett.,2005,15,7,"Blagg JA, Noe MC, Wolf-Gouveia LA, Reiter LA, Laird ER, Chang SP, Danley DE, Downs JT, Elliott NC, Eskra JD, Griffiths RJ, Hardink JR, Haugeto AI, Jones CS, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robinson RP, Subramanyam C, Vaughn-Bowser ML, Yocum SA",,305127,DTCT0024002,1752654,DTCC00384453,271738,18917
CHEMBL427366,P45452,,USIMDPVZFWUXPH-VWLOTQADSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16153831,IC50,=,7.1,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-13,,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321194,DTCT0024002,1860412,DTCC00407677,1113845,19837
CHEMBL428554,P45452,,SZTBUYMVXLGMJO-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17956082,IC50,=,41000,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET.,J. Med. Chem.,2007,50,23,"Wagner S, Breyholz HJ, Law MP, Faust A, Höltke C, Schröer S, Haufe G, Levkau B, Schober O, Schäfers M, Kopka K",,451368,DTCT0024002,2204616,DTCC00471859,488834,24059
CHEMBL429107,P45452,,ATCZHZRQAQJGGH-YFIOFSHDSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17188863,KI,>,5025,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Discovery of novel hydantoins as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,5,"Sheppeck JE, Gilmore JL, Yang A, Chen XT, Xue CB, Roderick J, Liu RQ, Covington MB, Decicco CP, Duan JJ",,453872,DTCT0024002,2221460,DTCC00478081,1555435,24252
CHEMBL429112,P45452,,IANBHIHXRLTEEH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17027261,KI,=,3720,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,1,"Duan JJ, Chen L, Lu Z, Jiang B, Asakawa N, Sheppeck JE, Liu RQ, Covington MB, Pitts W, Kim SH, Decicco CP",,452976,DTCT0024002,2215484,DTCC00477195,1889544,24158
CHEMBL429247,P45452,,AANVAJYRZQWBOW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18251495,IC50,=,13.8,NM,,,,,,,,,,,,,,Inhibition of human MMP13 catalytic domain,,"Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2008,51,4,"Li JJ, Nahra J, Johnson AR, Bunker A, O'Brien P, Yue WS, Ortwine DF, Man CF, Baragi V, Kilgore K, Dyer RD, Han HK",,465537,DTCT0024002,2311325,DTCC00503702,1054139,25409
CHEMBL429247,P45452,,AANVAJYRZQWBOW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18251495,IC50,=,120,NM,,,,,,,,,,,,,,Inhibition of human MMP13,,"Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2008,51,4,"Li JJ, Nahra J, Johnson AR, Bunker A, O'Brien P, Yue WS, Ortwine DF, Man CF, Baragi V, Kilgore K, Dyer RD, Han HK",,465538,DTCT0024002,2311357,DTCC00503702,1054139,25409
CHEMBL429250,P45452,,AJEGOTWMEXMHFK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18251495,IC50,=,49.4,NM,,,,,,,,,,,,,,Inhibition of human MMP13 catalytic domain,,"Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2008,51,4,"Li JJ, Nahra J, Johnson AR, Bunker A, O'Brien P, Yue WS, Ortwine DF, Man CF, Baragi V, Kilgore K, Dyer RD, Han HK",,465537,DTCT0024002,2311324,DTCC00503703,1345942,25409
CHEMBL429250,P45452,,AJEGOTWMEXMHFK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18251495,IC50,=,184,NM,,,,,,,,,,,,,,Inhibition of human MMP13,,"Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2008,51,4,"Li JJ, Nahra J, Johnson AR, Bunker A, O'Brien P, Yue WS, Ortwine DF, Man CF, Baragi V, Kilgore K, Dyer RD, Han HK",,465538,DTCT0024002,2311356,DTCC00503703,1345942,25409
CHEMBL429336,P45452,,KWWNNPAPYSJGQH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12668018,IC50,=,3,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease 13 (MMP-13).,,Synthesis and SAR of bicyclic heteroaryl hydroxamic acid MMP and TACE inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,8,"Zask A, Gu Y, Albright JD, Du X, Hogan M, Levin JI, Chen JM, Killar LM, Sung A, DiJoseph JF, Sharr MA, Roth CE, Skala S, Jin G, Cowling R, Mohler KM, Barone D, Black R, March C, Skotnicki JS",,106642,DTCT0024002,1259400,DTCC00174624,819574,6276
CHEMBL42938,P45452,,AGRDSOUIPBKOKQ-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10649971,IC50,=,53,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant matrix metalloprotease-13 (MMP-13),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,106476,DTCT0024002,930634,DTCC00185902,1531845,15892
CHEMBL429444,P45452,,VKZVNFAGQVZFTI-RBBKRZOGSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17276676,IC50,>,5000,NM,,,,,,,,,,,,,,Inhibition of MMP13,,A new 4-(2-methylquinolin-4-ylmethyl)phenyl P1' group for the beta-amino hydroxamic acid derived TACE inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,7,"Chen XT, Ghavimi B, Corbett RL, Xue CB, Liu RQ, Covington MB, Qian M, Vaddi KG, Christ DD, Hartman KD, Ribadeneira MD, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,447089,DTCT0024002,2169328,DTCC00464765,1135026,23623
CHEMBL429584,P45452,,FWRSYWBCZFQNKX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18251495,IC50,=,0.88,NM,,,,,,,,,,,,,,Inhibition of human MMP13 catalytic domain,,"Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2008,51,4,"Li JJ, Nahra J, Johnson AR, Bunker A, O'Brien P, Yue WS, Ortwine DF, Man CF, Baragi V, Kilgore K, Dyer RD, Han HK",,465537,DTCT0024002,2311312,DTCC00503785,860782,25409
CHEMBL429584,P45452,,FWRSYWBCZFQNKX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18251495,IC50,=,6.5,NM,,,,,,,,,,,,,,Inhibition of human MMP13,,"Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2008,51,4,"Li JJ, Nahra J, Johnson AR, Bunker A, O'Brien P, Yue WS, Ortwine DF, Man CF, Baragi V, Kilgore K, Dyer RD, Han HK",,465538,DTCT0024002,2311313,DTCC00503785,860782,25409
CHEMBL429596,P45452,,XCEAKWSNYWVHBQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18251495,IC50,=,11,NM,,,,,,,,,,,,,,Inhibition of human MMP13 catalytic domain,,"Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2008,51,4,"Li JJ, Nahra J, Johnson AR, Bunker A, O'Brien P, Yue WS, Ortwine DF, Man CF, Baragi V, Kilgore K, Dyer RD, Han HK",,465537,DTCT0024002,2311321,DTCC00113083,2084612,25409
CHEMBL429596,P45452,,XCEAKWSNYWVHBQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18251495,IC50,=,48,NM,,,,,,,,,,,,,,Inhibition of human MMP13,,"Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2008,51,4,"Li JJ, Nahra J, Johnson AR, Bunker A, O'Brien P, Yue WS, Ortwine DF, Man CF, Baragi V, Kilgore K, Dyer RD, Han HK",,465538,DTCT0024002,2311352,DTCC00113083,2084612,25409
CHEMBL429800,P45452,,NSDMBIOAMTZMED-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17956082,IC50,=,11,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET.,J. Med. Chem.,2007,50,23,"Wagner S, Breyholz HJ, Law MP, Faust A, Höltke C, Schröer S, Haufe G, Levkau B, Schober O, Schäfers M, Kopka K",,451368,DTCT0024002,2204622,DTCC00471853,876522,24059
CHEMBL429800,P45452,,NSDMBIOAMTZMED-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22540974,IC50,=,11,NM,,,,,,,,,,,,,,"Inhibition of MMP13 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured for 10 mins by fluorometry",,A new class of highly potent matrix metalloproteinase inhibitors based on triazole-substituted hydroxamates: (radio)synthesis and in vitro and first in vivo evaluation.,J. Med. Chem.,2012,55,10,"Hugenberg V, Breyholz HJ, Riemann B, Hermann S, Schober O, Schäfers M, Gangadharmath U, Mocharla V, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,832928,DTCT0024002,10563957,DTCC00471853,899521,48958
CHEMBL429800,P45452,,NSDMBIOAMTZMED-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23899323,IC50,=,11,NM,,,,,,,,,,,,,,Inhibition of MMP-13 (unknown origin),,"Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (radio)synthesis, in vitro and first in vivo evaluation.",J. Med. Chem.,2013,56,17,"Hugenberg V, Riemann B, Hermann S, Schober O, Schäfers M, Szardenings K, Lebedev A, Gangadharmath U, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,983286,DTCT0024002,12575112,DTCC00471853,881014,55760
CHEMBL43063,P45452,,NZVNFHULUBKMQI-VWLOTQADSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10649971,IC50,=,4,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant matrix metalloprotease-13 (MMP-13),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,106476,DTCT0024002,904826,DTCC00186612,755163,15892
CHEMBL43065,P45452,OXYRESVERATROL,PDHAOJSHSJQANO-OWOJBTEDSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22658537,IC50,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain incubated for 20 mins by fluorimetric assay,Not Determined,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827438,DTCT0024002,10535468,DTCC00185244,1169674,48665
CHEMBL430664,P45452,,LXRKTOCLXUHNEM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12270165,IC50,=,0.4,NM,,,,,,,,,,,,,,Concentration required in vitro to inhibit Matrix metalloprotease-13,,Benzodiazepine inhibitors of the MMPs and TACE.,Bioorg. Med. Chem. Lett.,2002,12,20,"Nelson FC, Delos Santos E, Levin JI, Chen JM, Skotnicki JS, DiJoseph JF, Sharr MA, Sung A, Killar LM, Cowling R, Jin G, Roth CE, Albright JD",,106631,DTCT0024002,1528068,DTCC00263053,1467892,5143
CHEMBL431015,P45452,,VAIKNTWLUDEQKJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11206468,INHIBITION,=,35,%,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 at 0.3 uM,,Heteroaryl and cycloalkyl sulfonamide hydroxamic acid inhibitors of matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2001,11,2,"Levin JI, Gu Y, Nelson FC, Zask A, DiJoseph JF, Sharr MA, Sung A, Jin G, Cowling R, Chanda P, Cosmi S, Hsiao CL, Edris W, Wilhelm J, Killar LM, Skotnicki JS",,106770,DTCT0024002,1311752,DTCC00236979,1046773,4516
CHEMBL431057,P45452,,XQJGASWZRFSCKP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12873518,IC50,=,207,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotein 13,,Acetylenic TACE inhibitors. Part 1. SAR of the acyclic sulfonamide hydroxamates.,Bioorg. Med. Chem. Lett.,2003,13,16,"Levin JI, Chen JM, Cheung K, Cole D, Crago C, Santos ED, Du X, Khafizova G, MacEwan G, Niu C, Salaski EJ, Zask A, Cummons T, Sung A, Xu J, Zhang Y, Xu W, Ayral-Kaloustian S, Jin G, Cowling R, Barone D, Mohler KM, Black RA, Skotnicki JS",,106634,DTCT0024002,807318,DTCC00260571,2034056,5733
CHEMBL43113,P45452,,MZIZOOUSSMSGAV-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10649971,IC50,=,11,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant matrix metalloprotease-13 (MMP-13),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,106476,DTCT0024002,908485,DTCC00186443,1979397,15892
CHEMBL431226,P45452,,IDKUTWZTCGVYET-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15125955,IC50,=,3300,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,Reverse hydroxamate-based selective TACE inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,11,"Kamei N, Tanaka T, Kawai K, Miyawaki K, Okuyama A, Murakami Y, Arakawa Y, Haino M, Harada T, Shimano M",,106641,DTCT0024002,1381122,DTCC00265456,982319,6400
CHEMBL43147,P45452,,BGKNBDGHNBOSGD-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10649971,IC50,=,62,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant matrix metalloprotease-13 (MMP-13),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,106476,DTCT0024002,904784,DTCC00186340,787356,15892
CHEMBL43152,P45452,PD-166793,GJOCABIDMCKCEG-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10649971,IC50,=,8,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant matrix metalloprotease-13 (MMP-13),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,106476,DTCT0024002,915396,DTCC01739899,2012246,15892
CHEMBL43152,P45452,PD-166793,GJOCABIDMCKCEG-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23287054,IC50,=,8,NM,,,,,,,,,,,,,,Inhibition of MMP13 (unknown origin),,Sulphonamides: Deserving class as MMP inhibitors?,Eur. J. Med. Chem.,2013,60,,"Jain P, Saravanan C, Singh SK",,944584,DTCT0024002,11835695,DTCC01739899,2028335,53820
CHEMBL431570,P45452,,NQECQHIRGFLISY-CRGCAJGSSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12824028,IC50,=,70,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13,,Phosphinic acid-based MMP-13 inhibitors that spare MMP-1 and MMP-3.,Bioorg. Med. Chem. Lett.,2003,13,14,"Reiter LA, Mitchell PG, Martinelli GJ, Lopresti-Morrow LL, Yocum SA, Eskra JD",,106640,DTCT0024002,1500942,DTCC00232764,1435205,5648
CHEMBL431680,P45452,,DQLDJYJWPVFOFC-REUBFRLUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11585440,KI,=,50,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,"Discovery of macrocyclic hydroxamic acids containing biphenylmethyl derivatives at P1', a series of selective TNF-alpha converting enzyme inhibitors with potent cellular activity in the inhibition of TNF-alpha release.",J. Med. Chem.,2001,44,21,"Xue CB, He X, Corbett RL, Roderick J, Wasserman ZR, Liu RQ, Jaffee BD, Covington MB, Qian M, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,106614,DTCT0024002,1294917,DTCC00286954,336147,16439
CHEMBL43206,P45452,,NEOOWKPSCAQYPI-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10649971,IC50,=,710,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant matrix metalloprotease-13 (MMP-13),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,106476,DTCT0024002,931898,DTCC00186341,1111450,15892
CHEMBL432307,P45452,,UJVIDDIDLMDARE-JTQLQIEISA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10649971,IC50,=,10,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant matrix metalloprotease-13 (MMP-13),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,106476,DTCT0024002,911874,DTCC00186526,1467007,15892
CHEMBL43276,P45452,,GSCKLBZEPMMUCA-FQEVSTJZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10649971,IC50,=,21,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant matrix metalloprotease-13 (MMP-13),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,106476,DTCT0024002,906088,DTCC00185835,658585,15892
CHEMBL432834,P45452,,IEJULHWWGPPJNO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15177439,IC50,=,0.56,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP-13),,Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2004,14,13,"Reiter LA, Robinson RP, McClure KF, Jones CS, Reese MR, Mitchell PG, Otterness IG, Bliven ML, Liras J, Cortina SR, Donahue KM, Eskra JD, Griffiths RJ, Lame ME, Lopez-Anaya A, Martinelli GJ, McGahee SM, Yocum SA, Lopresti-Morrow LL, Tobiassen LM, Vaughn-Bowser ML",,106600,DTCT0024002,1510450,DTCC00289000,1629692,6475
CHEMBL432871,P45452,,KVNBSMBKXVJFRN-NQIIRXRSSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11454461,IC50,=,13,NM,,,,,,,,,,,,,,In vitro inhibitory concentration against Matrix metalloprotease-13,,The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold.,Bioorg. Med. Chem. Lett.,2001,11,15,"Tullis JS, Laufersweiler MJ, VanRens JC, Natchus MG, Bookland RG, Almstead NG, Pikul S, De B, Hsieh LC, Janusz MJ, Branch TM, Peng SX, Jin YY, Hudlicky T, Oppong K",,106479,DTCT0024002,1555881,DTCC00208346,1661039,4358
CHEMBL432882,P45452,,NQPIHEUUYRAYII-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10649971,IC50,=,2,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant matrix metalloprotease-13 (MMP-13),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,106476,DTCT0024002,917734,DTCC00186511,2044570,15892
CHEMBL433063,P45452,,LJNWPYWHBAYDNO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11454461,IC50,=,8,NM,,,,,,,,,,,,,,In vitro inhibitory concentration against Matrix metalloprotease-13,,The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold.,Bioorg. Med. Chem. Lett.,2001,11,15,"Tullis JS, Laufersweiler MJ, VanRens JC, Natchus MG, Bookland RG, Almstead NG, Pikul S, De B, Hsieh LC, Janusz MJ, Branch TM, Peng SX, Jin YY, Hudlicky T, Oppong K",,106479,DTCT0024002,1536366,DTCC00209041,949376,4358
CHEMBL433171,P45452,,IXBLAZNLURBEMT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11591510,IC50,=,2.4,NM,,,,,,,,,,,,,,Inhibitory activity against human Matrix metalloprotease-13,,alpha-Alkyl-alpha-amino-beta-sulphone hydroxamates as potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2001,11,20,"Becker DP, DeCrescenzo G, Freskos J, Getman DP, Hockerman SL, Li M, Mehta P, Munie GE, Swearingen C",,106599,DTCT0024002,1089329,DTCC00255274,401245,4541
CHEMBL433262,P45452,,VHCRBJFCQRNNFG-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10649971,IC50,=,2,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant matrix metalloprotease-13 (MMP-13),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,106476,DTCT0024002,934331,DTCC00185901,1660789,15892
CHEMBL433415,P45452,,XZLXJYHIADSFPG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11133099,IC50,=,6700,NM,,,,,,,,,,,,,,50 percent inhibition of human Matrix metalloprotease-13 by the cleavage of fluorogenic peptide MCA-Pro-Leu-Gly-Leu-Dpa-ala-Arg-NH2,,Synthesis and activity of selective MMP inhibitors with an aryl backbone.,Bioorg. Med. Chem. Lett.,2000,10,24,"Barta TE, Becker DP, Bedell LJ, De Crescenzo GA, McDonald JJ, Munie GE, Rao S, Shieh HS, Stegeman R, Stevens AM, Villamil CI",,106604,DTCT0024002,717479,DTCC00260366,808880,3985
CHEMBL433567,P45452,,OFXJMYWLEABUGO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15780611,IC50,=,5.9,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 13,,Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.,Bioorg. Med. Chem. Lett.,2005,15,7,"Blagg JA, Noe MC, Wolf-Gouveia LA, Reiter LA, Laird ER, Chang SP, Danley DE, Downs JT, Elliott NC, Eskra JD, Griffiths RJ, Hardink JR, Haugeto AI, Jones CS, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robinson RP, Subramanyam C, Vaughn-Bowser ML, Yocum SA",,305127,DTCT0024002,1753730,DTCC00384548,2078781,18917
CHEMBL434187,P45452,,LMASIGSKSCEZDY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16084720,IC50,=,11,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metallopeptidase 13,,Acetylenic TACE inhibitors. Part 2: SAR of six-membered cyclic sulfonamide hydroxamates.,Bioorg. Med. Chem. Lett.,2005,15,19,"Levin JI, Chen JM, Laakso LM, Du M, Du X, Venkatesan AM, Sandanayaka V, Zask A, Xu J, Xu W, Zhang Y, Skotnicki JS",,321254,DTCT0024002,1861817,DTCC00408121,163466,19752
CHEMBL434187,P45452,,LMASIGSKSCEZDY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16084720,IC50,=,11,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metallopeptidase 13,,Acetylenic TACE inhibitors. Part 2: SAR of six-membered cyclic sulfonamide hydroxamates.,Bioorg. Med. Chem. Lett.,2005,15,19,"Levin JI, Chen JM, Laakso LM, Du M, Du X, Venkatesan AM, Sandanayaka V, Zask A, Xu J, Xu W, Zhang Y, Skotnicki JS",,321254,DTCT0024002,1862335,DTCC00408121,163469,19752
CHEMBL434348,P45452,,HUNBFLZYPNPINY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15357971,KI,>,5000,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 (MMP-13),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302721,DTCT0024002,1768808,DTCC00387612,77658,18194
CHEMBL434505,P45452,,YBPDYJXZXAPGSU-MAUKXSAKSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11150165,IC50,=,0.4,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease-13 (collagenase-3),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,106477,DTCT0024002,1618984,DTCC00333855,292454,16049
CHEMBL434539,P45452,,GTDCFHNWSMUQSI-PBHICJAKSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15911259,IC50,,,,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-13 (MMP-13); ND=not determined,Not Determined,"Discovery of 3,3-dimethyl-5-hydroxypipecolic hydroxamate-based inhibitors of aggrecanase and MMP-13.",Bioorg. Med. Chem. Lett.,2005,15,11,"Noe MC, Natarajan V, Snow SL, Mitchell PG, Lopresti-Morrow L, Reeves LM, Yocum SA, Carty TJ, Barberia JA, Sweeney FJ, Liras JL, Vaughn M, Hardink JR, Hawkins JM, Tokar C",,305480,DTCT0024002,1813135,DTCC00398538,940053,18491
CHEMBL43479,P45452,,UKLIIGXGTPSYBF-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10649971,IC50,=,1,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant matrix metalloprotease-13 (MMP-13),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,106476,DTCT0024002,910704,DTCC00186429,107667,15892
CHEMBL436205,P45452,,NOXYNXIAEWTFQX-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10579818,IC50,=,0.4,NM,,,,,,,,,,,,,,In vitro inhibitory activity against collagenase-3 (matrix metalloprotease-13).,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,106469,DTCT0024002,1370531,DTCC00325471,1754229,15412
CHEMBL436324,P45452,,ZTVJLUOPMWIKSV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16084720,IC50,=,8,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metallopeptidase 13,,Acetylenic TACE inhibitors. Part 2: SAR of six-membered cyclic sulfonamide hydroxamates.,Bioorg. Med. Chem. Lett.,2005,15,19,"Levin JI, Chen JM, Laakso LM, Du M, Du X, Venkatesan AM, Sandanayaka V, Zask A, Xu J, Xu W, Zhang Y, Skotnicki JS",,321254,DTCT0024002,1861760,DTCC00408047,584672,19752
CHEMBL436324,P45452,,ZTVJLUOPMWIKSV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16084720,IC50,=,8,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metallopeptidase 13,,Acetylenic TACE inhibitors. Part 2: SAR of six-membered cyclic sulfonamide hydroxamates.,Bioorg. Med. Chem. Lett.,2005,15,19,"Levin JI, Chen JM, Laakso LM, Du M, Du X, Venkatesan AM, Sandanayaka V, Zask A, Xu J, Xu W, Zhang Y, Skotnicki JS",,321254,DTCT0024002,1862279,DTCC00408047,584674,19752
CHEMBL43644,P45452,,VHCRBJFCQRNNFG-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10649971,IC50,=,650,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant matrix metalloprotease-13 (MMP-13),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,106476,DTCT0024002,904836,DTCC00186536,172340,15892
CHEMBL436950,P45452,,ISGKPJSIGMKCEK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16516466,KI,>,5025,NM,,,,,,,,,,,,,,Binding affinity to MMP13,,"Synthesis and structure-activity relationship of a novel, achiral series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2006,16,10,"Gilmore JL, King BW, Harris C, Maduskuie T, Mercer SE, Liu RQ, Covington MB, Qian M, Ribadeneria MD, Vaddi K, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,354462,DTCT0024002,1926552,DTCC00421635,908661,20786
CHEMBL436977,P45452,2-(4-METHOXYBENZENESULFANYL)OCTANOIC ACID HYDROXYAMIDE,WEBZGXZPLFJJPD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15566296,INHIBITION,=,55,%,,,,,,,,,,,,,,Inhibition of MMP13 at 10 uM,,"Synthesis and structure-activity relationships of 4-alkynyloxy phenyl sulfanyl, sulfinyl, and sulfonyl alkyl hydroxamates as tumor necrosis factor-alpha converting enzyme and matrix metalloproteinase inhibitors.",J. Med. Chem.,2004,47,25,"Venkatesan AM, Davis JM, Grosu GT, Baker J, Zask A, Levin JI, Ellingboe J, Skotnicki JS, Dijoseph JF, Sung A, Jin G, Xu W, McCarthy DJ, Barone D",,429673,DTCT0024002,2041863,DTCC00002419,1884528,22157
CHEMBL437499,P45452,,GTOFARSZXYDPTC-SFHVURJKSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16426848,IC50,=,4,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Acetylenic TACE inhibitors. Part 3: Thiomorpholine sulfonamide hydroxamates.,Bioorg. Med. Chem. Lett.,2006,16,6,"Levin JI, Chen JM, Laakso LM, Du M, Schmid J, Xu W, Cummons T, Xu J, Jin G, Barone D, Skotnicki JS",,339181,DTCT0024002,1909213,DTCC00417732,1405362,14616
CHEMBL438964,P45452,,MHYRZRJQEBSULL-ZWKOTPCHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16516469,KI,=,19,NM,,,,,,,,,,,,,,Binding affinity to recombinant MMP13,,A cassette-dosing approach for improvement of oral bioavailability of dual TACE/MMP inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,10,"Janser P, Neumann U, Miltz W, Feifel R, Buhl T",,354053,DTCT0024002,1926045,DTCC00422273,1372962,20779
CHEMBL439012,P45452,,JBPHFUSOSQRLMX-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17591762,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440142,DTCT0024002,2113804,DTCC00452723,1715977,23023
CHEMBL439012,P45452,,JBPHFUSOSQRLMX-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17591762,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of MMP13 at 10 uM,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440148,DTCT0024002,2113832,DTCC00452723,1715977,23023
CHEMBL439012,P45452,,JBPHFUSOSQRLMX-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17591762,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of MMP13 at 100 uM,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440154,DTCT0024002,2113861,DTCC00452723,1715977,23023
CHEMBL439012,P45452,,JBPHFUSOSQRLMX-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17591762,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of MMP13 at 30 uM,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440160,DTCT0024002,2113889,DTCC00452723,1715977,23023
CHEMBL439330,P45452,,COUUBDFXGTZTPW-HRCADAONSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16516469,KI,=,10,NM,,,,,,,,,,,,,,Binding affinity to recombinant MMP13,,A cassette-dosing approach for improvement of oral bioavailability of dual TACE/MMP inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,10,"Janser P, Neumann U, Miltz W, Feifel R, Buhl T",,354053,DTCT0024002,1926043,DTCC00422638,337728,20779
CHEMBL440178,P45452,,UBBBKPVDKLDZNE-AXVPLRHPSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10639284,IC50,=,0.1,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant collagenase-3 (Matrix metalloprotease-13),,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,106475,DTCT0024002,506550,DTCC00340689,1047919,15546
CHEMBL440355,P45452,,XJMLKUIRAXOATH-YZYPPFLQSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10639284,IC50,=,0.5,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant collagenase-3 (Matrix metalloprotease-13),,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,106475,DTCT0024002,484627,DTCC00340443,1598008,15546
CHEMBL440498,P45452,RS-130830,ROSNVSQTEGHUKU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10669559,KI,=,0.52,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13 (MMP-13).,,Protease inhibitors: current status and future prospects.,J. Med. Chem.,2000,43,3,"Leung D, Abbenante G, Fairlie DP",,106612,DTCT0024002,1060827,DTCC01741261,583202,16063
CHEMBL440498,P45452,RS-130830,ROSNVSQTEGHUKU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11133099,IC50,=,0.6,NM,,,,,,,,,,,,,,50 percent inhibition of human Matrix metalloprotease-13 by the cleavage of fluorogenic peptide MCA-Pro-Leu-Gly-Leu-Dpa-ala-Arg-NH2,,Synthesis and activity of selective MMP inhibitors with an aryl backbone.,Bioorg. Med. Chem. Lett.,2000,10,24,"Barta TE, Becker DP, Bedell LJ, De Crescenzo GA, McDonald JJ, Munie GE, Rao S, Shieh HS, Stegeman R, Stevens AM, Villamil CI",,106604,DTCT0024002,699284,DTCC01741261,582874,3985
CHEMBL440498,P45452,RS-130830,ROSNVSQTEGHUKU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11549451,ACTIVITY,=,0.6,NM,,,,,,,,,,,,,,Inhibitory activity against human Matrix metalloprotease-13,,"Selective, orally active MMP inhibitors with an aryl backbone.",Bioorg. Med. Chem. Lett.,2001,11,18,"Barta TE, Becker DP, Bedell LJ, De Crescenzo GA, McDonald JJ, Mehta P, Munie GE, Villamil CI",,106466,DTCT0024002,1642627,DTCC01741261,594329,4449
CHEMBL440498,P45452,RS-130830,ROSNVSQTEGHUKU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773042,IC50,=,2,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13.,,"Synthesis and structure-activity relationship of N-substituted 4-arylsulfonylpiperidine-4-hydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Davis JM, Grosu GT, Baker J, Ellingboe J, Zask A, Levin JI, Sandanayaka VP, Du M, Skotnicki JS, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R, Tillett J, Zhao W, McDevitt J, Xu ZB",,106632,DTCT0024002,488099,DTCC01741261,594282,17340
CHEMBL440498,P45452,RS-130830,ROSNVSQTEGHUKU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15686921,KI,=,0.52,NM,,,,,,,,,,,,,,Binding affinity for matrix metalloprotease 13,,Structure-based design of potent and selective inhibitors of collagenase-3 (MMP-13).,Bioorg. Med. Chem. Lett.,2005,15,4,"Kim SH, Pudzianowski AT, Leavitt KJ, Barbosa J, McDonnell PA, Metzler WJ, Rankin BM, Liu R, Vaccaro W, Pitts W",,302900,DTCT0024002,1745328,DTCC01741261,584379,18787
CHEMBL440498,P45452,RS-130830,ROSNVSQTEGHUKU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16220987,KI,=,0.6,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024002,14741467,DTCC01741261,2107724,69259
CHEMBL440498,P45452,RS-130830,ROSNVSQTEGHUKU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,0.3,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500573,DTCT0024002,2844278,DTCC01741261,585998,33635
CHEMBL440498,P45452,RS-130830,ROSNVSQTEGHUKU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,2,NM,,,,,,,,,,,,,,Inhibition of MMP13 in presence of 1% bovine serum albumin,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500574,DTCT0024002,2844279,DTCC01741261,585998,33635
CHEMBL440498,P45452,RS-130830,ROSNVSQTEGHUKU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,KI,=,0.28,NM,,,,,,,,,,,,,,Inhibition of MMP13 assessed as dissociation constant,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500964,DTCT0024002,2824197,DTCC01741261,585998,33635
CHEMBL440498,P45452,RS-130830,ROSNVSQTEGHUKU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,RATIO IC50,=,10,,,,,,,,,,,,,,,Selectivity ratio of IC50 for MMP13 to IC50 for MMP13 in presence of 1% bovine serum albumin,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500577,DTCT0024002,2824245,DTCC01741261,585998,33635
CHEMBL440498,P45452,RS-130830,ROSNVSQTEGHUKU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25192810,IC50,=,34,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain using fluorescence peptide Cy3-PLGLK(Cy5Q)AR-NH2 substrate by fluorescence assay,,"Thieno[2,3-d]pyrimidine-2-carboxamides bearing a carboxybenzene group at 5-position: highly potent, selective, and orally available MMP-13 inhibitors interacting with the S1¿ binding site.",Bioorg. Med. Chem.,2014,22,19,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1442057,DTCT0024002,13987806,DTCC01741261,611029,59837
CHEMBL440498,P45452,RS-130830,ROSNVSQTEGHUKU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25264600,IC50,=,0.01,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 using Cy3-PLGLK(Cy5Q)AR-NH2 as substrate after 40 mins by spectrofluorimetry,,"Discovery of Novel, Highly Potent, and Selective Quinazoline-2-carboxamide-Based Matrix Metalloproteinase (MMP)-13 Inhibitors without a Zinc Binding Group Using a Structure-Based Design Approach.",J. Med. Chem.,2014,57,21,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1431418,DTCT0024002,13989108,DTCC01741261,590804,60036
CHEMBL44062,P45452,,QVNUOLHHXUUNEH-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10649971,IC50,=,5,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant matrix metalloprotease-13 (MMP-13),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,106476,DTCT0024002,927034,DTCC00104684,367719,15892
CHEMBL440945,P45452,,IXEFVZDHNHSUSD-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16426848,IC50,=,11,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Acetylenic TACE inhibitors. Part 3: Thiomorpholine sulfonamide hydroxamates.,Bioorg. Med. Chem. Lett.,2006,16,6,"Levin JI, Chen JM, Laakso LM, Du M, Schmid J, Xu W, Cummons T, Xu J, Jin G, Barone D, Skotnicki JS",,339181,DTCT0024002,1909218,DTCC00418420,822265,14616
CHEMBL441177,P45452,,LWZOHIDILGLXGF-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16426848,IC50,=,8,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Acetylenic TACE inhibitors. Part 3: Thiomorpholine sulfonamide hydroxamates.,Bioorg. Med. Chem. Lett.,2006,16,6,"Levin JI, Chen JM, Laakso LM, Du M, Schmid J, Xu W, Cummons T, Xu J, Jin G, Barone D, Skotnicki JS",,339181,DTCT0024002,1909222,DTCC00418084,725572,14616
CHEMBL441662,P45452,,AKNDZTHCJLFZCF-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10579818,IC50,=,1,NM,,,,,,,,,,,,,,In vitro inhibitory activity against collagenase-3 (matrix metalloprotease-13).,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,106469,DTCT0024002,1367843,DTCC00326356,1565298,15412
CHEMBL442421,P45452,,RWKNBRIIHLUCGT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17188863,KI,>,5025,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Discovery of novel hydantoins as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,5,"Sheppeck JE, Gilmore JL, Yang A, Chen XT, Xue CB, Roderick J, Liu RQ, Covington MB, Decicco CP, Duan JJ",,453872,DTCT0024002,2221472,DTCC00478066,488866,24252
CHEMBL442423,P45452,,ODDQJXJHWIBVKQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17027261,KI,,,,,,,,,,,,,,,,,Inhibition of MMP13,Not Determined,Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,1,"Duan JJ, Chen L, Lu Z, Jiang B, Asakawa N, Sheppeck JE, Liu RQ, Covington MB, Pitts W, Kim SH, Decicco CP",,452976,DTCT0024002,2215274,DTCC00477189,147993,24158
CHEMBL442435,P45452,,UUCAXRPZQYPLCB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,5.7,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260813,DTCC00486084,1166455,24831
CHEMBL44383,P45452,,MDWFJTBWOFNAQX-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10649971,IC50,=,6,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant matrix metalloprotease-13 (MMP-13),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,106476,DTCT0024002,920973,DTCC00186509,593751,15892
CHEMBL44383,P45452,,MDWFJTBWOFNAQX-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11472202,IC50,=,24.2,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,106478,DTCT0024002,1297402,DTCC00186509,582683,16328
CHEMBL44383,P45452,,MDWFJTBWOFNAQX-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12798337,IC50,=,6,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-13,,Synthesis of radiolabeled biphenylsulfonamide matrix metalloproteinase inhibitors as new potential PET cancer imaging agents.,Bioorg. Med. Chem. Lett.,2003,13,13,"Fei X, Zheng QH, Liu X, Wang JQ, Sun HB, Mock BH, Stone KL, Miller KD, Sledge GW, Hutchins GD",,106605,DTCT0024002,1398935,DTCC00186509,594169,5629
CHEMBL44383,P45452,,MDWFJTBWOFNAQX-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12798337,INHIBITION EFFECT,=,0.938,,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-13 at 20 nM,,Synthesis of radiolabeled biphenylsulfonamide matrix metalloproteinase inhibitors as new potential PET cancer imaging agents.,Bioorg. Med. Chem. Lett.,2003,13,13,"Fei X, Zheng QH, Liu X, Wang JQ, Sun HB, Mock BH, Stone KL, Miller KD, Sledge GW, Hutchins GD",,106607,DTCT0024002,1398936,DTCC00186509,594169,5629
CHEMBL44455,P45452,,PLCPLXITTDSMSK-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10649971,IC50,=,102,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant matrix metalloprotease-13 (MMP-13),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,106476,DTCT0024002,923308,DTCC00186527,626251,15892
CHEMBL44455,P45452,,PLCPLXITTDSMSK-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12798337,INHIBITION EFFECT,=,0.897,,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-13 at 20 nM,,Synthesis of radiolabeled biphenylsulfonamide matrix metalloproteinase inhibitors as new potential PET cancer imaging agents.,Bioorg. Med. Chem. Lett.,2003,13,13,"Fei X, Zheng QH, Liu X, Wang JQ, Sun HB, Mock BH, Stone KL, Miller KD, Sledge GW, Hutchins GD",,106607,DTCT0024002,1396370,DTCC00186527,626647,5629
CHEMBL445140,P45452,,JIAWWQZPHLPQPH-IEBWSBKVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15324896,IC50,=,0.39,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 13,,3-Hydroxy-4-arylsulfonyltetrahydropyranyl-3-hydroxamic acids are novel inhibitors of MMP-13 and aggrecanase.,Bioorg. Med. Chem. Lett.,2004,14,18,"Noe MC, Snow SL, Wolf-Gouveia LA, Mitchell PG, Lopresti-Morrow L, Reeves LM, Yocum SA, Liras JL, Vaughn M",,305094,DTCT0024002,1769509,DTCC00388327,1981691,18227
CHEMBL445894,P45452,,RPNGFLLEKVAIHJ-ZBAATNBSSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12824028,IC50,=,19,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13,,Phosphinic acid-based MMP-13 inhibitors that spare MMP-1 and MMP-3.,Bioorg. Med. Chem. Lett.,2003,13,14,"Reiter LA, Mitchell PG, Martinelli GJ, Lopresti-Morrow LL, Yocum SA, Eskra JD",,106640,DTCT0024002,1489387,DTCC00232325,433291,5648
CHEMBL446456,P45452,,UAIMSPBCAMKARB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17531482,IC50,>,16666,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Design and synthesis of 3,3-piperidine hydroxamate analogs as selective TACE inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,15,"Lombart HG, Feyfant E, Joseph-McCarthy D, Huang A, Lovering F, Sun L, Zhu Y, Zeng C, Zhang Y, Levin J",,456210,DTCT0024002,2237272,DTCC00480964,1102977,24495
CHEMBL446694,P45452,,ZXSHUUVACBVHFP-IEBWSBKVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15324896,IC50,=,9.8,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 13,,3-Hydroxy-4-arylsulfonyltetrahydropyranyl-3-hydroxamic acids are novel inhibitors of MMP-13 and aggrecanase.,Bioorg. Med. Chem. Lett.,2004,14,18,"Noe MC, Snow SL, Wolf-Gouveia LA, Mitchell PG, Lopresti-Morrow L, Reeves LM, Yocum SA, Liras JL, Vaughn M",,305094,DTCT0024002,1769388,DTCC00388504,660756,18227
CHEMBL446939,P45452,,LULDMUCKTFCMAU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15780611,IC50,=,2,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 13,,Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.,Bioorg. Med. Chem. Lett.,2005,15,7,"Blagg JA, Noe MC, Wolf-Gouveia LA, Reiter LA, Laird ER, Chang SP, Danley DE, Downs JT, Elliott NC, Eskra JD, Griffiths RJ, Hardink JR, Haugeto AI, Jones CS, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robinson RP, Subramanyam C, Vaughn-Bowser ML, Yocum SA",,305127,DTCT0024002,1752661,DTCC00384558,1242004,18917
CHEMBL447275,P45452,,AAVVXYJNWGIBPT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19464885,IC50,=,80,NM,,,,,,,,,,,,,,inhibition of human recombinant MMP13 catalytic domain,,Synthesis and activity of quinolinylmethyl P1' alpha-sulfone piperidine hydroxamate inhibitors of TACE.,Bioorg. Med. Chem. Lett.,2009,19,13,"Zhang C, Lovering F, Behnke M, Zask A, Sandanayaka V, Sun L, Zhu Y, Xu W, Zhang Y, Levin JI",,523796,DTCT0024002,2832618,DTCC00554162,1821394,33699
CHEMBL447457,P45452,,YDDMVPLLJTZTQL-LAABSITASA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18790648,KI,=,15.7,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497406,DTCT0024002,2457431,DTCC00115970,79316,32556
CHEMBL447787,P45452,,HWRTYSUSQVJAGF-RBBKRZOGSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18242982,KI,>,5025,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.",Bioorg. Med. Chem. Lett.,2008,18,5,"Ott GR, Asakawa N, Lu Z, Anand R, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Trzaskos JM, Duan JJ",,462370,DTCT0024002,2282354,DTCC00488438,1684915,25163
CHEMBL448246,P45452,,RRXQHLQCQYPPMF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18358729,ACTIVITY,=,15,%,,,,,,,,,,,,,,Activity of human recombinant MMP13,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518897,DTCT0024002,2708899,DTCC00516462,2047968,32215
CHEMBL448246,P45452,,RRXQHLQCQYPPMF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18358729,IC50,=,4800,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 expressed in Escherichia coli,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518658,DTCT0024002,2708819,DTCC00516462,2047968,32215
CHEMBL448246,P45452,,RRXQHLQCQYPPMF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18364257,IC50,=,1300,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 by fluorogenic substrate assay,,Ranking the selectivity of PubChem screening hits by activity-based protein profiling: MMP13 as a case study.,Bioorg. Med. Chem.,2009,17,3,"Nakai R, Salisbury CM, Rosen H, Cravatt BF",,518902,DTCT0024002,2708984,DTCC00516462,2047969,32218
CHEMBL448246,P45452,,RRXQHLQCQYPPMF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18364257,IC50,=,27000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 by HxBPyne probe-based competitive activity based protein profiling assay,,Ranking the selectivity of PubChem screening hits by activity-based protein profiling: MMP13 as a case study.,Bioorg. Med. Chem.,2009,17,3,"Nakai R, Salisbury CM, Rosen H, Cravatt BF",,518903,DTCT0024002,2708978,DTCC00516462,2047969,32218
CHEMBL44898,P45452,,YWAPUIQWVUXRRW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10649971,IC50,=,26,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant matrix metalloprotease-13 (MMP-13),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,106476,DTCT0024002,902230,DTCC00104686,1046250,15892
CHEMBL449228,P45452,,YGNCGRVNRKDKCS-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19278250,IC50,=,2500,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 expressed in Escherichia coli,,"A selective matrix metalloprotease 12 inhibitor for potential treatment of chronic obstructive pulmonary disease (COPD): discovery of (S)-2-(8-(methoxycarbonylamino)dibenzo[b,d]furan-3-sulfonamido)-3-methylbutanoic acid (MMP408).",J. Med. Chem.,2009,52,7,"Li W, Li J, Wu Y, Wu J, Hotchandani R, Cunningham K, McFadyen I, Bard J, Morgan P, Schlerman F, Xu X, Tam S, Goldman SJ, Williams C, Sypek J, Mansour TS",,566183,DTCT0024002,2482735,DTCC00533999,1653228,33018
CHEMBL449228,P45452,,YGNCGRVNRKDKCS-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19725580,IC50,=,2500,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthma.,J. Med. Chem.,2009,52,17,"Li W, Li J, Wu Y, Rancati F, Vallese S, Raveglia L, Wu J, Hotchandani R, Fuller N, Cunningham K, Morgan P, Fish S, Krykbaev R, Xu X, Tam S, Goldman SJ, Abraham W, Williams C, Sypek J, Mansour TS",,579100,DTCT0024002,2894816,DTCC00533999,1653760,34869
CHEMBL45040,P45452,,AGRDSOUIPBKOKQ-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10649971,IC50,=,37,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant matrix metalloprotease-13 (MMP-13),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,106476,DTCT0024002,930622,DTCC00186467,1467008,15892
CHEMBL450549,P45452,,HFUOQSPXLWRCGA-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19278250,IC50,=,25446,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 expressed in Escherichia coli,,"A selective matrix metalloprotease 12 inhibitor for potential treatment of chronic obstructive pulmonary disease (COPD): discovery of (S)-2-(8-(methoxycarbonylamino)dibenzo[b,d]furan-3-sulfonamido)-3-methylbutanoic acid (MMP408).",J. Med. Chem.,2009,52,7,"Li W, Li J, Wu Y, Wu J, Hotchandani R, Cunningham K, McFadyen I, Bard J, Morgan P, Schlerman F, Xu X, Tam S, Goldman SJ, Williams C, Sypek J, Mansour TS",,566183,DTCT0024002,2482748,DTCC00534178,1745222,33018
CHEMBL45162,P45452,,CQIQKDQFHVTTKM-NDEPHWFRSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10397503,IC50,=,20,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,"Picking the S1, S1' and S2' pockets of matrix metalloproteinases. A niche for potent acyclic sulfonamide inhibitors.",Bioorg. Med. Chem. Lett.,1999,9,12,"Hanessian S, Bouzbouz S, Boudon A, Tucker GC, Peyroulan D",,101903,DTCT0024002,528390,DTCC00188800,1099852,3181
CHEMBL45357,P45452,,FCYBWLNLMVDLRH-AWEZNQCLSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10397503,IC50,=,96,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,"Picking the S1, S1' and S2' pockets of matrix metalloproteinases. A niche for potent acyclic sulfonamide inhibitors.",Bioorg. Med. Chem. Lett.,1999,9,12,"Hanessian S, Bouzbouz S, Boudon A, Tucker GC, Peyroulan D",,101903,DTCT0024002,539688,DTCC00188708,808145,3181
CHEMBL457317,P45452,SA-6541,HLSVAMGQMKPXOP-RISCZKNCSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19042128,IC50,,,,,,,,,,,,,,,,,Inhibition of type 3 collagenase,Not Active,Synthesis and biological evaluation of N-mercaptoacylcysteine derivatives as leukotriene A4 hydrolase inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,2,"Enomoto H, Morikawa Y, Miyake Y, Tsuji F, Mizuchi M, Suhara H, Fujimura K, Horiuchi M, Ban M",,544521,DTCT0024002,2822290,DTCC00007834,1588558,33473
CHEMBL460515,P45452,,XDKOSPFALAXPJO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18358729,IC50,=,13300,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 expressed in Escherichia coli,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518658,DTCT0024002,2708798,DTCC00516386,1664338,32215
CHEMBL460516,P45452,,IAAWEMZTVNQNIH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18358729,IC50,=,4700,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 expressed in Escherichia coli,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518658,DTCT0024002,2708799,DTCC00516387,1438212,32215
CHEMBL460725,P45452,,QHDIXGPUTSAIJX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19173605,IC50,<,25,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,Extra binding region induced by non-zinc chelating inhibitors into the S1' subsite of matrix metalloproteinase 8 (MMP-8).,J. Med. Chem.,2009,52,4,"Pochetti G, Montanari R, Gege C, Chevrier C, Taveras AG, Mazza F",,494623,DTCT0024002,2596040,DTCC00517113,715017,32135
CHEMBL460899,P45452,,ITADELAVAWJACR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19173605,IC50,<,25,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,Extra binding region induced by non-zinc chelating inhibitors into the S1' subsite of matrix metalloproteinase 8 (MMP-8).,J. Med. Chem.,2009,52,4,"Pochetti G, Montanari R, Gege C, Chevrier C, Taveras AG, Mazza F",,494623,DTCT0024002,2596049,DTCC00114032,1166828,32135
CHEMBL460899,P45452,,ITADELAVAWJACR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22689580,IC50,=,25,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024002,14718585,DTCC00114032,2101638,68703
CHEMBL462627,P45452,,MNYLANCSXOSQBA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18358729,ACTIVITY,=,35,%,,,,,,,,,,,,,,Activity of human recombinant MMP13,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518897,DTCT0024002,2708894,DTCC00516390,758694,32215
CHEMBL462627,P45452,,MNYLANCSXOSQBA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18358729,IC50,=,16500,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 expressed in Escherichia coli,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518658,DTCT0024002,2708811,DTCC00516390,758694,32215
CHEMBL462628,P45452,,ITQDPSGUKJGOJF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18358729,ACTIVITY,=,14,%,,,,,,,,,,,,,,Activity of human recombinant MMP13,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518897,DTCT0024002,2708895,DTCC00516392,565008,32215
CHEMBL462628,P45452,,ITQDPSGUKJGOJF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18358729,IC50,=,3600,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 expressed in Escherichia coli,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518658,DTCT0024002,2708813,DTCC00516392,565008,32215
CHEMBL462629,P45452,,XEXZOINHSIFHFY-XFXZXTDPSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18358729,ACTIVITY,=,62,%,,,,,,,,,,,,,,Activity of human recombinant MMP13,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518897,DTCT0024002,2708896,DTCC00516393,175688,32215
CHEMBL462629,P45452,,XEXZOINHSIFHFY-XFXZXTDPSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18358729,IC50,=,3400,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 expressed in Escherichia coli,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518658,DTCT0024002,2708814,DTCC00516393,175688,32215
CHEMBL463395,P45452,,OPSGGAROSGLASJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19410464,IC50,=,4440,NM,,,,,,,,,,,,,,Inhibition of MMP13 by FLIPR assay,,Synthesis and activity of tryptophan sulfonamide derivatives as novel non-hydroxamate TNF-alpha converting enzyme (TACE) inhibitors.,Bioorg. Med. Chem.,2009,17,11,"Park K, Gopalsamy A, Aplasca A, Ellingboe JW, Xu W, Zhang Y, Levin JI",,545899,DTCT0024002,2499018,DTCC00571420,1104052,33915
CHEMBL466024,P45452,,WCUFVZOKFLTYIS-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,0.6,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500573,DTCT0024002,2824068,DTCC00536556,650964,33635
CHEMBL466024,P45452,,WCUFVZOKFLTYIS-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,14.4,NM,,,,,,,,,,,,,,Inhibition of MMP13 in presence of 1% bovine serum albumin,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500574,DTCT0024002,2824069,DTCC00536556,650964,33635
CHEMBL466045,P45452,,WKPWAURYICIYJL-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,11,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500573,DTCT0024002,2844284,DTCC00535991,1716778,33635
CHEMBL466045,P45452,,WKPWAURYICIYJL-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,47,NM,,,,,,,,,,,,,,Inhibition of MMP13 in presence of 1% bovine serum albumin,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500574,DTCT0024002,2844285,DTCC00535991,1716778,33635
CHEMBL466052,P45452,,IMLFQSRCUZAGNQ-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,1.6,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500573,DTCT0024002,2824080,DTCC00536663,1620973,33635
CHEMBL466052,P45452,,IMLFQSRCUZAGNQ-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,19.5,NM,,,,,,,,,,,,,,Inhibition of MMP13 in presence of 1% bovine serum albumin,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500574,DTCT0024002,2824081,DTCC00536663,1620973,33635
CHEMBL466059,P45452,,GYETWAWIKBOMPE-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,0.5,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500573,DTCT0024002,2824029,DTCC00536373,164710,33635
CHEMBL466059,P45452,,GYETWAWIKBOMPE-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,37.8,NM,,,,,,,,,,,,,,Inhibition of MMP13 in presence of 1% bovine serum albumin,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500574,DTCT0024002,2824030,DTCC00536373,164710,33635
CHEMBL466059,P45452,,GYETWAWIKBOMPE-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,KI,=,0.19,NM,,,,,,,,,,,,,,Inhibition of MMP13 assessed as dissociation constant,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500964,DTCT0024002,2824198,DTCC00536373,164710,33635
CHEMBL466060,P45452,,CODHXMDFRPLWJO-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,0.8,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500573,DTCT0024002,2824032,DTCC00536374,618298,33635
CHEMBL466060,P45452,,CODHXMDFRPLWJO-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,57,NM,,,,,,,,,,,,,,Inhibition of MMP13 in presence of 1% bovine serum albumin,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500574,DTCT0024002,2824033,DTCC00536374,618298,33635
CHEMBL466118,P45452,,OJALZWLVBUFAQK-HHHXNRCGSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19329309,IC50,=,2.2,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Synthesis and biological evaluation of ((4-keto)-phenoxy)methyl biphenyl-4-sulfonamides: a class of potent aggrecanase-1 inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,9,"Hopper DW, Vera MD, How D, Sabatini J, Xiang JS, Ipek M, Thomason J, Hu Y, Feyfant E, Wang Q, Georgiadis KE, Reifenberg E, Sheldon RT, Keohan CC, Majumdar MK, Morris EA, Skotnicki J, Sum PE",,500227,DTCT0024002,2723478,DTCC00536890,1983077,34185
CHEMBL466208,P45452,,OFCXTZZJEVUZRH-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,4,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500573,DTCT0024002,2824035,DTCC00536375,1620969,33635
CHEMBL466208,P45452,,OFCXTZZJEVUZRH-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,390,NM,,,,,,,,,,,,,,Inhibition of MMP13 in presence of 1% bovine serum albumin,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500574,DTCT0024002,2824036,DTCC00536375,1620969,33635
CHEMBL466237,P45452,,RTBMQALBDMCUCU-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,0.4,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500573,DTCT0024002,2824074,DTCC00536661,747536,33635
CHEMBL466237,P45452,,RTBMQALBDMCUCU-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,7,NM,,,,,,,,,,,,,,Inhibition of MMP13 in presence of 1% bovine serum albumin,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500574,DTCT0024002,2824075,DTCC00536661,747536,33635
CHEMBL466249,P45452,,JWKIHGMBZXIUII-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,0.8,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500573,DTCT0024002,2824083,DTCC00536664,1620974,33635
CHEMBL466249,P45452,,JWKIHGMBZXIUII-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,13.5,NM,,,,,,,,,,,,,,Inhibition of MMP13 in presence of 1% bovine serum albumin,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500574,DTCT0024002,2824084,DTCC00536664,1620974,33635
CHEMBL466445,P45452,,OPQNDFWCTZLCMD-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,6.9,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500573,DTCT0024002,2824126,DTCC00535935,2037007,33635
CHEMBL466445,P45452,,OPQNDFWCTZLCMD-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,143,NM,,,,,,,,,,,,,,Inhibition of MMP13 in presence of 1% bovine serum albumin,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500574,DTCT0024002,2824127,DTCC00535935,2037007,33635
CHEMBL466460,P45452,,XUPXHPTUIUTEGR-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,28,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500573,DTCT0024002,2824135,DTCC00535995,229089,33635
CHEMBL466460,P45452,,XUPXHPTUIUTEGR-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,188,NM,,,,,,,,,,,,,,Inhibition of MMP13 in presence of 1% bovine serum albumin,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500574,DTCT0024002,2824136,DTCC00535995,229089,33635
CHEMBL466461,P45452,,PJSCGRJWOYRILP-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,49,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500573,DTCT0024002,2824138,DTCC00535996,779544,33635
CHEMBL466461,P45452,,PJSCGRJWOYRILP-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,325,NM,,,,,,,,,,,,,,Inhibition of MMP13 in presence of 1% bovine serum albumin,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500574,DTCT0024002,2824139,DTCC00535996,779544,33635
CHEMBL466625,P45452,,RTLFSPXRTHASTA-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,50,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500573,DTCT0024002,2844305,DTCC00536120,618295,33635
CHEMBL466625,P45452,,RTLFSPXRTHASTA-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,2500,NM,,,,,,,,,,,,,,Inhibition of MMP13 in presence of 1% bovine serum albumin,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500574,DTCT0024002,2844306,DTCC00536120,618295,33635
CHEMBL466625,P45452,,RTLFSPXRTHASTA-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,RATIO IC50,<,100,,,,,,,,,,,,,,,Selectivity ratio of IC50 for MMP13 to IC50 for MMP13 in presence of 1% bovine serum albumin,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500577,DTCT0024002,2824204,DTCC00536120,618295,33635
CHEMBL466656,P45452,,XGIFEMLRFPKIQV-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,0.75,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500573,DTCT0024002,2844287,DTCC00535992,1167028,33635
CHEMBL466656,P45452,,XGIFEMLRFPKIQV-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,63,NM,,,,,,,,,,,,,,Inhibition of MMP13 in presence of 1% bovine serum albumin,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500574,DTCT0024002,2844288,DTCC00535992,1167028,33635
CHEMBL466657,P45452,,LBRZHKNWLBUBRK-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,12.7,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500573,DTCT0024002,2824129,DTCC00535993,553850,33635
CHEMBL466657,P45452,,LBRZHKNWLBUBRK-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,123,NM,,,,,,,,,,,,,,Inhibition of MMP13 in presence of 1% bovine serum albumin,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500574,DTCT0024002,2824130,DTCC00535993,553850,33635
CHEMBL466663,P45452,,CIXCMGCFZKHJDV-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,1058,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500573,DTCT0024002,2844293,DTCC00536038,1873998,33635
CHEMBL466663,P45452,,CIXCMGCFZKHJDV-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,14500,NM,,,,,,,,,,,,,,Inhibition of MMP13 in presence of 1% bovine serum albumin,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500574,DTCT0024002,2844294,DTCC00536038,1873998,33635
CHEMBL466664,P45452,,OXUYNOUZQXZGFK-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,575,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500573,DTCT0024002,2844296,DTCC00536039,1841987,33635
CHEMBL466664,P45452,,OXUYNOUZQXZGFK-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP13 in presence of 1% bovine serum albumin,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500574,DTCT0024002,2844297,DTCC00536039,1841987,33635
CHEMBL467257,P45452,,ZZLSYACKYTYUGI-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,0.7,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500573,DTCT0024002,2844314,DTCC00536176,1777109,33635
CHEMBL467257,P45452,,ZZLSYACKYTYUGI-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,72,NM,,,,,,,,,,,,,,Inhibition of MMP13 in presence of 1% bovine serum albumin,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500574,DTCT0024002,2844315,DTCC00536176,1777109,33635
CHEMBL467262,P45452,,VZIBNJOTVVYOSZ-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,0.6,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500573,DTCT0024002,2824059,DTCC00536490,877261,33635
CHEMBL467262,P45452,,VZIBNJOTVVYOSZ-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,105,NM,,,,,,,,,,,,,,Inhibition of MMP13 in presence of 1% bovine serum albumin,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500574,DTCT0024002,2824060,DTCC00536490,877261,33635
CHEMBL467459,P45452,,VJHXJEDXSPNSEK-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,1.3,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500573,DTCT0024002,2824041,DTCC00536426,1038442,33635
CHEMBL467459,P45452,,VJHXJEDXSPNSEK-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,1160,NM,,,,,,,,,,,,,,Inhibition of MMP13 in presence of 1% bovine serum albumin,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500574,DTCT0024002,2824042,DTCC00536426,1038442,33635
CHEMBL467459,P45452,,VJHXJEDXSPNSEK-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,RATIO IC50,=,100,,,,,,,,,,,,,,,Selectivity ratio of IC50 for MMP13 to IC50 for MMP13 in presence of 1% bovine serum albumin,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500577,DTCT0024002,2824210,DTCC00536426,1038442,33635
CHEMBL467460,P45452,,SMAMMQUTTZLMCT-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,3.9,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500573,DTCT0024002,2824044,DTCC00536427,844826,33635
CHEMBL467460,P45452,,SMAMMQUTTZLMCT-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,4475,NM,,,,,,,,,,,,,,Inhibition of MMP13 in presence of 1% bovine serum albumin,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500574,DTCT0024002,2824045,DTCC00536427,844826,33635
CHEMBL467460,P45452,,SMAMMQUTTZLMCT-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,RATIO IC50,=,1000,,,,,,,,,,,,,,,Selectivity ratio of IC50 for MMP13 to IC50 for MMP13 in presence of 1% bovine serum albumin,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500577,DTCT0024002,2824209,DTCC00536427,844826,33635
CHEMBL467482,P45452,,BMHIZVXENVBSST-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,5.5,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500573,DTCT0024002,2824116,DTCC00535931,909881,33635
CHEMBL467482,P45452,,BMHIZVXENVBSST-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,230,NM,,,,,,,,,,,,,,Inhibition of MMP13 in presence of 1% bovine serum albumin,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500574,DTCT0024002,2824117,DTCC00535931,909881,33635
CHEMBL467682,P45452,,LMPLLQMOSWHDKU-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,197,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500573,DTCT0024002,2844326,DTCC00536244,1716781,33635
CHEMBL467682,P45452,,LMPLLQMOSWHDKU-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP13 in presence of 1% bovine serum albumin,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500574,DTCT0024002,2844327,DTCC00536244,1716781,33635
CHEMBL467687,P45452,,XXUQGCVNBYAYPI-RUZDIDTESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,0.7,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500573,DTCT0024002,2824113,DTCC00535932,553848,33635
CHEMBL467687,P45452,,XXUQGCVNBYAYPI-RUZDIDTESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,25,NM,,,,,,,,,,,,,,Inhibition of MMP13 in presence of 1% bovine serum albumin,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500574,DTCT0024002,2824114,DTCC00535932,553848,33635
CHEMBL467891,P45452,,CYVZQRKPMGDNKM-GDLZYMKVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19329309,IC50,=,15,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Synthesis and biological evaluation of ((4-keto)-phenoxy)methyl biphenyl-4-sulfonamides: a class of potent aggrecanase-1 inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,9,"Hopper DW, Vera MD, How D, Sabatini J, Xiang JS, Ipek M, Thomason J, Hu Y, Feyfant E, Wang Q, Georgiadis KE, Reifenberg E, Sheldon RT, Keohan CC, Majumdar MK, Morris EA, Skotnicki J, Sum PE",,500227,DTCT0024002,2723476,DTCC00536758,1950368,34185
CHEMBL468095,P45452,,VOHDRNMYQAWLKL-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,2,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500573,DTCT0024002,2824050,DTCC00536487,1491764,33635
CHEMBL468095,P45452,,VOHDRNMYQAWLKL-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,142,NM,,,,,,,,,,,,,,Inhibition of MMP13 in presence of 1% bovine serum albumin,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500574,DTCT0024002,2824051,DTCC00536487,1491764,33635
CHEMBL468096,P45452,,KLPSRFNMJRNHAH-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,0.8,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500573,DTCT0024002,2824056,DTCC00536489,521714,33635
CHEMBL468096,P45452,,KLPSRFNMJRNHAH-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,90,NM,,,,,,,,,,,,,,Inhibition of MMP13 in presence of 1% bovine serum albumin,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500574,DTCT0024002,2824057,DTCC00536489,521714,33635
CHEMBL468101,P45452,,QMVNJTOFWDRCOS-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,0.5,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500573,DTCT0024002,2844320,DTCC00536241,877258,33635
CHEMBL468101,P45452,,QMVNJTOFWDRCOS-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,9.8,NM,,,,,,,,,,,,,,Inhibition of MMP13 in presence of 1% bovine serum albumin,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500574,DTCT0024002,2844321,DTCC00536241,877258,33635
CHEMBL468102,P45452,,ODFVFJFBRZDWIG-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,61.5,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500573,DTCT0024002,2844322,DTCC00536242,1491758,33635
CHEMBL468102,P45452,,ODFVFJFBRZDWIG-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP13 in presence of 1% bovine serum albumin,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500574,DTCT0024002,2844323,DTCC00536242,1491758,33635
CHEMBL468103,P45452,,XQOVFBQWUQFERK-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,9000,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500573,DTCT0024002,2844324,DTCC00536243,456203,33635
CHEMBL468103,P45452,,XQOVFBQWUQFERK-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP13 in presence of 1% bovine serum albumin,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500574,DTCT0024002,2844325,DTCC00536243,456203,33635
CHEMBL46818,P45452,,UWHPJOBPMXNVII-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10649971,IC50,=,7,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant matrix metalloprotease-13 (MMP-13),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,106476,DTCT0024002,931904,DTCC00185806,464278,15892
CHEMBL46830,P45452,,ZGWIOFHKEXLJPC-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10649971,IC50,=,16,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant matrix metalloprotease-13 (MMP-13),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,106476,DTCT0024002,924611,DTCC00186466,1979398,15892
CHEMBL468708,P45452,,GBXQLEQZNNXPFU-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,90,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500573,DTCT0024002,2844299,DTCC00536040,1906303,33635
CHEMBL468708,P45452,,GBXQLEQZNNXPFU-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,1975,NM,,,,,,,,,,,,,,Inhibition of MMP13 in presence of 1% bovine serum albumin,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500574,DTCT0024002,2844300,DTCC00536040,1906303,33635
CHEMBL468708,P45452,,GBXQLEQZNNXPFU-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,RATIO IC50,<,100,,,,,,,,,,,,,,,Selectivity ratio of IC50 for MMP13 to IC50 for MMP13 in presence of 1% bovine serum albumin,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500577,DTCT0024002,2824203,DTCC00536040,1906303,33635
CHEMBL468722,P45452,,ZHXMXRVBOZWQPF-GDLZYMKVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19329309,IC50,=,6.3,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Synthesis and biological evaluation of ((4-keto)-phenoxy)methyl biphenyl-4-sulfonamides: a class of potent aggrecanase-1 inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,9,"Hopper DW, Vera MD, How D, Sabatini J, Xiang JS, Ipek M, Thomason J, Hu Y, Feyfant E, Wang Q, Georgiadis KE, Reifenberg E, Sheldon RT, Keohan CC, Majumdar MK, Morris EA, Skotnicki J, Sum PE",,500227,DTCT0024002,2723475,DTCC00536694,1243566,34185
CHEMBL468731,P45452,,HRESAHCPDRLLRL-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,0.5,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500573,DTCT0024002,2824071,DTCC00536557,747535,33635
CHEMBL468731,P45452,,HRESAHCPDRLLRL-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,60.6,NM,,,,,,,,,,,,,,Inhibition of MMP13 in presence of 1% bovine serum albumin,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500574,DTCT0024002,2824072,DTCC00536557,747535,33635
CHEMBL468737,P45452,,URSSKCFDTXBION-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,1.3,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500573,DTCT0024002,2844328,DTCC00536314,489483,33635
CHEMBL468737,P45452,,URSSKCFDTXBION-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,100,NM,,,,,,,,,,,,,,Inhibition of MMP13 in presence of 1% bovine serum albumin,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500574,DTCT0024002,2844329,DTCC00536314,489483,33635
CHEMBL468738,P45452,,UPNGQGNTHSPTJW-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,12.1,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500573,DTCT0024002,2844331,DTCC00536315,1971605,33635
CHEMBL468738,P45452,,UPNGQGNTHSPTJW-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,11290,NM,,,,,,,,,,,,,,Inhibition of MMP13 in presence of 1% bovine serum albumin,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500574,DTCT0024002,2844332,DTCC00536315,1971605,33635
CHEMBL468738,P45452,,UPNGQGNTHSPTJW-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,RATIO IC50,=,100,,,,,,,,,,,,,,,Selectivity ratio of IC50 for MMP13 to IC50 for MMP13 in presence of 1% bovine serum albumin,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500577,DTCT0024002,2824208,DTCC00536315,1971605,33635
CHEMBL468739,P45452,,ZVKAVYCKILWYEA-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,3.3,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500573,DTCT0024002,2844334,DTCC00536316,1038438,33635
CHEMBL468739,P45452,,ZVKAVYCKILWYEA-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,300,NM,,,,,,,,,,,,,,Inhibition of MMP13 in presence of 1% bovine serum albumin,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500574,DTCT0024002,2844335,DTCC00536316,1038438,33635
CHEMBL468900,P45452,,NHPBWKYFMTXWAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15734645,IC50,=,6600,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024002,14715934,DTCC00530186,2100284,68788
CHEMBL468900,P45452,,NHPBWKYFMTXWAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18790648,IC50,=,6600,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497406,DTCT0024002,2457352,DTCC00530186,2016158,32556
CHEMBL468900,P45452,,NHPBWKYFMTXWAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19042129,IC50,=,6600,NM,,,,,,,,,,,,,,Inhibition of human MMP13,,Calculation of binding free energies for non-zinc chelating pyrimidine dicarboxamide inhibitors with MMP-13.,Bioorg. Med. Chem. Lett.,2009,19,1,"Carrascal N, Rizzo RC",,559513,DTCT0024002,2450198,DTCC00530186,2015952,31745
CHEMBL468901,P45452,,WIUCYEOLRGUYEH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15734645,IC50,=,400,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024002,14711233,DTCC00530187,2098377,68788
CHEMBL468901,P45452,,WIUCYEOLRGUYEH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19042129,IC50,=,400,NM,,,,,,,,,,,,,,Inhibition of human MMP13,,Calculation of binding free energies for non-zinc chelating pyrimidine dicarboxamide inhibitors with MMP-13.,Bioorg. Med. Chem. Lett.,2009,19,1,"Carrascal N, Rizzo RC",,559513,DTCT0024002,2450201,DTCC00530187,1470806,31745
CHEMBL469125,P45452,,KTIMJJDBQYPXFT-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,145,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500573,DTCT0024002,2844310,DTCC00536122,1362493,33635
CHEMBL469125,P45452,,KTIMJJDBQYPXFT-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP13 in presence of 1% bovine serum albumin,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500574,DTCT0024002,2844311,DTCC00536122,1362493,33635
CHEMBL469138,P45452,,FKFXZYVMDNOTOS-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,0.4,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500573,DTCT0024002,2824062,DTCC00536554,1199501,33635
CHEMBL469138,P45452,,FKFXZYVMDNOTOS-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,60,NM,,,,,,,,,,,,,,Inhibition of MMP13 in presence of 1% bovine serum albumin,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500574,DTCT0024002,2824063,DTCC00536554,1199501,33635
CHEMBL47076,P45452,,WLJUNQUGIMIQDZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10649971,IC50,=,12,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant matrix metalloprotease-13 (MMP-13),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,106476,DTCT0024002,924617,DTCC00104690,1467009,15892
CHEMBL471537,P45452,,GSWRTFGMHRKLKT-AREMUKBSSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19053764,IC50,=,0.12,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Dual inhibitors of matrix metalloproteinases and carbonic anhydrases: iminodiacetyl-based hydroxamate-benzenesulfonamide conjugates.,J. Med. Chem.,2008,51,24,"Marques SM, Nuti E, Rossello A, Supuran CT, Tuccinardi T, Martinelli A, Santos MA",,561989,DTCT0024002,2800882,DTCC00514690,489269,31524
CHEMBL472144,P45452,,YQZBWJNBIMZQMS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18974001,IC50,>,200000,NM,,,,,,,,,,,,,,Inhibition of MMP13 by FRET assay,,N-((8-hydroxy-5-substituted-quinolin-7-yl)(phenyl)methyl)-2-phenyloxy/amino-acetamide inhibitors of ADAMTS-5 (Aggrecanase-2).,Bioorg. Med. Chem. Lett.,2008,18,24,"Gilbert AM, Bursavich MG, Lombardi S, Georgiadis KE, Reifenberg E, Flannery CR, Morris EA",,519275,DTCT0024002,2706553,DTCC00532941,2036969,32228
CHEMBL47254,P45452,,HXNNABWLGZRTMD-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10649971,IC50,=,23,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant matrix metalloprotease-13 (MMP-13),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,106476,DTCT0024002,904814,DTCC00186592,1596218,15892
CHEMBL472899,P45452,,ZRAUMSIZBNBIFE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19053764,IC50,=,1.6,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Dual inhibitors of matrix metalloproteinases and carbonic anhydrases: iminodiacetyl-based hydroxamate-benzenesulfonamide conjugates.,J. Med. Chem.,2008,51,24,"Marques SM, Nuti E, Rossello A, Supuran CT, Tuccinardi T, Martinelli A, Santos MA",,561989,DTCT0024002,2800900,DTCC00514692,1296946,31524
CHEMBL473106,P45452,,AQWLITYTSYRLNQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18358729,IC50,=,8100,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 expressed in Escherichia coli,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518658,DTCT0024002,2708822,DTCC00515623,888342,32215
CHEMBL473107,P45452,,YNKDEHKXKOAEBW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18358729,ACTIVITY,=,45,%,,,,,,,,,,,,,,Activity of human recombinant MMP13,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518897,DTCT0024002,2708901,DTCC00515624,984986,32215
CHEMBL473107,P45452,,YNKDEHKXKOAEBW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18358729,IC50,=,900,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 expressed in Escherichia coli,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518658,DTCT0024002,2708824,DTCC00515624,984986,32215
CHEMBL473313,P45452,,HLIACYSTIJITSD-CMDGGOBGSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18358729,IC50,=,12600,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 expressed in Escherichia coli,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518658,DTCT0024002,2708809,DTCC00515688,2015783,32215
CHEMBL473314,P45452,,DIPCWZOATLQURP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18358729,ACTIVITY,=,35,%,,,,,,,,,,,,,,Activity of human recombinant MMP13,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518897,DTCT0024002,2708902,DTCC00515689,305973,32215
CHEMBL473314,P45452,,DIPCWZOATLQURP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18358729,IC50,=,3500,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 expressed in Escherichia coli,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518658,DTCT0024002,2708826,DTCC00515689,305973,32215
CHEMBL473315,P45452,,NIYQMYRMPIYCDM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18358729,IC50,=,4000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 expressed in Escherichia coli,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518658,DTCT0024002,2708827,DTCC00515690,952621,32215
CHEMBL473326,P45452,,HKDAECHYHSQLRG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18358729,IC50,=,10300,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 expressed in Escherichia coli,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518658,DTCT0024002,2708815,DTCC00516458,694218,32215
CHEMBL473326,P45452,,HKDAECHYHSQLRG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18364257,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 at 200 uM by HxBPyne probe-based competitive activity based protein profiling assay in presence of 5 uM HxBpane competitor,Active,Ranking the selectivity of PubChem screening hits by activity-based protein profiling: MMP13 as a case study.,Bioorg. Med. Chem.,2009,17,3,"Nakai R, Salisbury CM, Rosen H, Cravatt BF",,518925,DTCT0024002,2708883,DTCC00516458,694221,32218
CHEMBL473326,P45452,,HKDAECHYHSQLRG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18364257,IC50,=,920,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 by fluorogenic substrate assay,,Ranking the selectivity of PubChem screening hits by activity-based protein profiling: MMP13 as a case study.,Bioorg. Med. Chem.,2009,17,3,"Nakai R, Salisbury CM, Rosen H, Cravatt BF",,518902,DTCT0024002,2708981,DTCC00516458,694221,32218
CHEMBL473326,P45452,,HKDAECHYHSQLRG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18364257,IC50,=,3800,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 by HxBPyne probe-based competitive activity based protein profiling assay,,Ranking the selectivity of PubChem screening hits by activity-based protein profiling: MMP13 as a case study.,Bioorg. Med. Chem.,2009,17,3,"Nakai R, Salisbury CM, Rosen H, Cravatt BF",,518903,DTCT0024002,2708975,DTCC00516458,694221,32218
CHEMBL473326,P45452,,HKDAECHYHSQLRG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18364257,INHIBITION,=,70,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 by fluorogenic substrate assay,,Ranking the selectivity of PubChem screening hits by activity-based protein profiling: MMP13 as a case study.,Bioorg. Med. Chem.,2009,17,3,"Nakai R, Salisbury CM, Rosen H, Cravatt BF",,518902,DTCT0024002,2708982,DTCC00516458,694221,32218
CHEMBL473326,P45452,,HKDAECHYHSQLRG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18364257,INHIBITION,=,70,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 by HxBPyne probe-based competitive activity based protein profiling assay,,Ranking the selectivity of PubChem screening hits by activity-based protein profiling: MMP13 as a case study.,Bioorg. Med. Chem.,2009,17,3,"Nakai R, Salisbury CM, Rosen H, Cravatt BF",,518903,DTCT0024002,2708976,DTCC00516458,694221,32218
CHEMBL473326,P45452,,HKDAECHYHSQLRG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22018790,ACTIVITY,=,44,%,,,,,,,,,,,,,,Inhibition of human full length recombinant MMP13 assessed as residual activity using Knight SSP as substrate at 100 uM after 1.5 to 4 hrs by spectrofluorometric analysis relative to control,,"Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds.",Bioorg. Med. Chem. Lett.,2011,21,23,"Roth J, Minond D, Darout E, Liu Q, Lauer J, Hodder P, Fields GB, Roush WR",,799334,DTCT0024002,7597017,DTCC00516458,704135,47025
CHEMBL473326,P45452,,HKDAECHYHSQLRG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22018790,INHIBITION,=,49.1,%,,,,,,,,,,,,,,Inhibition of human full length recombinant MMP13 using triple-helical fTHP-15 as substrate at 40 uM after 4 hrs by FRET assay,,"Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds.",Bioorg. Med. Chem. Lett.,2011,21,23,"Roth J, Minond D, Darout E, Liu Q, Lauer J, Hodder P, Fields GB, Roush WR",,799259,DTCT0024002,7596070,DTCC00516458,704135,47025
CHEMBL473326,P45452,,HKDAECHYHSQLRG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22018790,KI,=,3800,NM,,,,,,,,,,,,,,Noncompetitive inhibition of human full length recombinant MMP13 using triple-helical fTHP-15 as substrate by Lineweaver-Burk plot analysis,,"Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds.",Bioorg. Med. Chem. Lett.,2011,21,23,"Roth J, Minond D, Darout E, Liu Q, Lauer J, Hodder P, Fields GB, Roush WR",,799260,DTCT0024002,7596099,DTCC00516458,704135,47025
CHEMBL473326,P45452,,HKDAECHYHSQLRG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25330343,IC50,=,700,NM,,,,,,,,,,,,,,Inhibition of full-length recombinant human MMP-13 assessed as bovine type-2 collagen hydrolysis after 18 hrs by ELISA,,Characterization of selective exosite-binding inhibitors of matrix metalloproteinase 13 that prevent articular cartilage degradation in vitro.,J. Med. Chem.,2014,57,22,"Spicer TP, Jiang J, Taylor AB, Choi JY, Hart PJ, Roush WR, Fields GB, Hodder PS, Minond D",,1435002,DTCT0024002,13947428,DTCC00516458,687799,60192
CHEMBL473326,P45452,,HKDAECHYHSQLRG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25330343,IC50,=,3400,NM,,,,,,,,,,,,,,Non-competitive inhibition of full-length recombinant human MMP-13 assessed as fTHP-15 substrate hydrolysis,,Characterization of selective exosite-binding inhibitors of matrix metalloproteinase 13 that prevent articular cartilage degradation in vitro.,J. Med. Chem.,2014,57,22,"Spicer TP, Jiang J, Taylor AB, Choi JY, Hart PJ, Roush WR, Fields GB, Hodder PS, Minond D",,1434999,DTCT0024002,13947409,DTCC00516458,687799,60192
CHEMBL473326,P45452,,HKDAECHYHSQLRG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25330343,INHIBITION,=,69,%,,,,,,,,,,,,,,Inhibition of full-length recombinant human MMP-13 assessed as prevention of bovine type-2 collagen degradation at 10 uM after 18 hrs by cartilage explant assay,,Characterization of selective exosite-binding inhibitors of matrix metalloproteinase 13 that prevent articular cartilage degradation in vitro.,J. Med. Chem.,2014,57,22,"Spicer TP, Jiang J, Taylor AB, Choi JY, Hart PJ, Roush WR, Fields GB, Hodder PS, Minond D",,1435003,DTCT0024002,13947406,DTCC00516458,687799,60192
CHEMBL473326,P45452,,HKDAECHYHSQLRG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25330343,INHIBITION,>,20,%,,,,,,,,,,,,,,Inhibition of recombinant human MMP-13 using GRIGFL substrate assessed as inhibition of enzyme activity up to 20 uM,,Characterization of selective exosite-binding inhibitors of matrix metalloproteinase 13 that prevent articular cartilage degradation in vitro.,J. Med. Chem.,2014,57,22,"Spicer TP, Jiang J, Taylor AB, Choi JY, Hart PJ, Roush WR, Fields GB, Hodder PS, Minond D",,1435010,DTCT0024002,14018314,DTCC00516458,687799,60192
CHEMBL473326,P45452,,HKDAECHYHSQLRG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25330343,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of full-length recombinant human MMP-13 assessed as bovine type-2 collagen hydrolysis after 18 hrs by ELISA,Dose-dependent effect,Characterization of selective exosite-binding inhibitors of matrix metalloproteinase 13 that prevent articular cartilage degradation in vitro.,J. Med. Chem.,2014,57,22,"Spicer TP, Jiang J, Taylor AB, Choi JY, Hart PJ, Roush WR, Fields GB, Hodder PS, Minond D",,1435002,DTCT0024002,13947407,DTCC00516458,687799,60192
CHEMBL473326,P45452,,HKDAECHYHSQLRG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25330343,KB,=,3300,NM,,,,,,,,,,,,,,Non-competitive inhibition of full-length recombinant human MMP-13 assessed as fTHP-15 substrate hydrolysis by Lineweaver-Burke plot analysis,,Characterization of selective exosite-binding inhibitors of matrix metalloproteinase 13 that prevent articular cartilage degradation in vitro.,J. Med. Chem.,2014,57,22,"Spicer TP, Jiang J, Taylor AB, Choi JY, Hart PJ, Roush WR, Fields GB, Hodder PS, Minond D",,1435000,DTCT0024002,13947408,DTCC00516458,687799,60192
CHEMBL473326,P45452,,HKDAECHYHSQLRG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,IC50,=,3357,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Late stage results from the probe development efforts to identify inhibitors of Matrix Metalloprotease-13 (MMP-13). (Class of assay: screening) [Related pubchem assays (depositor defined):AID1931, AID570, AID734, AID735, AID769] Panel member name: MMP-13 [IC50 Assay]",Active,PUBCHEM BIOASSAY DATA SET,,,,,,,737461,DTCT0024002,5384333,DTCC00516458,699872,33038
CHEMBL473326,P45452,,HKDAECHYHSQLRG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,3.8,,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Late stage results from the probe development efforts to identify inhibitors of Matrix Metalloprotease-13 (MMP-13). (Class of assay: screening) [Related pubchem assays (depositor defined):AID1931, AID570, AID734, AID735, AID769] Panel member name: MMP-13 [Ki Assay]",Active,PUBCHEM BIOASSAY DATA SET,,,,,,,737462,DTCT0024002,5384341,DTCC00516458,702649,33038
CHEMBL473327,P45452,,ZHNBFYMZDUSWSL-OWBHPGMISA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18358729,ACTIVITY,=,44,%,,,,,,,,,,,,,,Activity of human recombinant MMP13,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518897,DTCT0024002,2708897,DTCC00516459,597255,32215
CHEMBL473327,P45452,,ZHNBFYMZDUSWSL-OWBHPGMISA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18358729,IC50,=,12000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 expressed in Escherichia coli,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518658,DTCT0024002,2708816,DTCC00516459,597255,32215
CHEMBL473610,P45452,,XWRCGYJBDCRHCY-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19278250,IC50,=,6000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 expressed in Escherichia coli,,"A selective matrix metalloprotease 12 inhibitor for potential treatment of chronic obstructive pulmonary disease (COPD): discovery of (S)-2-(8-(methoxycarbonylamino)dibenzo[b,d]furan-3-sulfonamido)-3-methylbutanoic acid (MMP408).",J. Med. Chem.,2009,52,7,"Li W, Li J, Wu Y, Wu J, Hotchandani R, Cunningham K, McFadyen I, Bard J, Morgan P, Schlerman F, Xu X, Tam S, Goldman SJ, Williams C, Sypek J, Mansour TS",,566183,DTCT0024002,2482741,DTCC00114991,909858,33018
CHEMBL473611,P45452,,PASQOFLVNKNUQM-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19278250,IC50,=,93,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 expressed in Escherichia coli,,"A selective matrix metalloprotease 12 inhibitor for potential treatment of chronic obstructive pulmonary disease (COPD): discovery of (S)-2-(8-(methoxycarbonylamino)dibenzo[b,d]furan-3-sulfonamido)-3-methylbutanoic acid (MMP408).",J. Med. Chem.,2009,52,7,"Li W, Li J, Wu Y, Wu J, Hotchandani R, Cunningham K, McFadyen I, Bard J, Morgan P, Schlerman F, Xu X, Tam S, Goldman SJ, Williams C, Sypek J, Mansour TS",,566183,DTCT0024002,2482742,DTCC00114992,941484,33018
CHEMBL473736,P45452,,ODVUAHLXSDZCOK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18358729,IC50,=,23300,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 expressed in Escherichia coli,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518658,DTCT0024002,2708817,DTCC00516460,597256,32215
CHEMBL473841,P45452,,CBUQIOYQSSZVDA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18974001,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP13 by FRET assay,,N-((8-hydroxy-5-substituted-quinolin-7-yl)(phenyl)methyl)-2-phenyloxy/amino-acetamide inhibitors of ADAMTS-5 (Aggrecanase-2).,Bioorg. Med. Chem. Lett.,2008,18,24,"Gilbert AM, Bursavich MG, Lombardi S, Georgiadis KE, Reifenberg E, Flannery CR, Morris EA",,519275,DTCT0024002,2706554,DTCC00533447,1491729,32228
CHEMBL47414,P45452,,MVTUAPMXVXQWFM-SANMLTNESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10397503,IC50,=,3.8,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,"Picking the S1, S1' and S2' pockets of matrix metalloproteinases. A niche for potent acyclic sulfonamide inhibitors.",Bioorg. Med. Chem. Lett.,1999,9,12,"Hanessian S, Bouzbouz S, Boudon A, Tucker GC, Peyroulan D",,101903,DTCT0024002,516294,DTCC00188667,452197,3181
CHEMBL474397,P45452,,SMWVRODLVRVTBW-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19278250,IC50,=,120,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 expressed in Escherichia coli,,"A selective matrix metalloprotease 12 inhibitor for potential treatment of chronic obstructive pulmonary disease (COPD): discovery of (S)-2-(8-(methoxycarbonylamino)dibenzo[b,d]furan-3-sulfonamido)-3-methylbutanoic acid (MMP408).",J. Med. Chem.,2009,52,7,"Li W, Li J, Wu Y, Wu J, Hotchandani R, Cunningham K, McFadyen I, Bard J, Morgan P, Schlerman F, Xu X, Tam S, Goldman SJ, Williams C, Sypek J, Mansour TS",,566183,DTCT0024002,2482739,DTCC00114989,1427193,33018
CHEMBL474398,P45452,,NSGAOCYSLOCKGW-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19278250,IC50,=,34000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 expressed in Escherichia coli,,"A selective matrix metalloprotease 12 inhibitor for potential treatment of chronic obstructive pulmonary disease (COPD): discovery of (S)-2-(8-(methoxycarbonylamino)dibenzo[b,d]furan-3-sulfonamido)-3-methylbutanoic acid (MMP408).",J. Med. Chem.,2009,52,7,"Li W, Li J, Wu Y, Wu J, Hotchandani R, Cunningham K, McFadyen I, Bard J, Morgan P, Schlerman F, Xu X, Tam S, Goldman SJ, Williams C, Sypek J, Mansour TS",,566183,DTCT0024002,2482740,DTCC00114990,1459164,33018
CHEMBL474456,P45452,,ZDYXONOHFKVMSQ-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19278250,IC50,=,500,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 expressed in Escherichia coli,,"A selective matrix metalloprotease 12 inhibitor for potential treatment of chronic obstructive pulmonary disease (COPD): discovery of (S)-2-(8-(methoxycarbonylamino)dibenzo[b,d]furan-3-sulfonamido)-3-methylbutanoic acid (MMP408).",J. Med. Chem.,2009,52,7,"Li W, Li J, Wu Y, Wu J, Hotchandani R, Cunningham K, McFadyen I, Bard J, Morgan P, Schlerman F, Xu X, Tam S, Goldman SJ, Williams C, Sypek J, Mansour TS",,566183,DTCT0024002,2482744,DTCC00534138,877236,33018
CHEMBL474457,P45452,,KKGJFHSYGOMRAH-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19278250,IC50,=,109,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 expressed in Escherichia coli,,"A selective matrix metalloprotease 12 inhibitor for potential treatment of chronic obstructive pulmonary disease (COPD): discovery of (S)-2-(8-(methoxycarbonylamino)dibenzo[b,d]furan-3-sulfonamido)-3-methylbutanoic acid (MMP408).",J. Med. Chem.,2009,52,7,"Li W, Li J, Wu Y, Wu J, Hotchandani R, Cunningham K, McFadyen I, Bard J, Morgan P, Schlerman F, Xu X, Tam S, Goldman SJ, Williams C, Sypek J, Mansour TS",,566183,DTCT0024002,2482745,DTCC00534139,811944,33018
CHEMBL474622,P45452,,FIKHJLBGJKASJJ-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19278250,IC50,=,500,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 expressed in Escherichia coli,,"A selective matrix metalloprotease 12 inhibitor for potential treatment of chronic obstructive pulmonary disease (COPD): discovery of (S)-2-(8-(methoxycarbonylamino)dibenzo[b,d]furan-3-sulfonamido)-3-methylbutanoic acid (MMP408).",J. Med. Chem.,2009,52,7,"Li W, Li J, Wu Y, Wu J, Hotchandani R, Cunningham K, McFadyen I, Bard J, Morgan P, Schlerman F, Xu X, Tam S, Goldman SJ, Williams C, Sypek J, Mansour TS",,566183,DTCT0024002,2482746,DTCC00534140,1809539,33018
CHEMBL47468,P45452,,WHTRIFCXCJYQKX-SSEXGKCCSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10397503,IC50,=,4.5,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,"Picking the S1, S1' and S2' pockets of matrix metalloproteinases. A niche for potent acyclic sulfonamide inhibitors.",Bioorg. Med. Chem. Lett.,1999,9,12,"Hanessian S, Bouzbouz S, Boudon A, Tucker GC, Peyroulan D",,101903,DTCT0024002,524555,DTCC00188664,840936,3181
CHEMBL474933,P45452,,LJIWTQZYGOAIKX-IERUDJENSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18358729,IC50,=,24700,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 expressed in Escherichia coli,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518658,DTCT0024002,2708806,DTCC00515686,436297,32215
CHEMBL475230,P45452,,MFYWCBCSORYQGC-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19278250,IC50,=,1100,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 expressed in Escherichia coli,,"A selective matrix metalloprotease 12 inhibitor for potential treatment of chronic obstructive pulmonary disease (COPD): discovery of (S)-2-(8-(methoxycarbonylamino)dibenzo[b,d]furan-3-sulfonamido)-3-methylbutanoic acid (MMP408).",J. Med. Chem.,2009,52,7,"Li W, Li J, Wu Y, Wu J, Hotchandani R, Cunningham K, McFadyen I, Bard J, Morgan P, Schlerman F, Xu X, Tam S, Goldman SJ, Williams C, Sypek J, Mansour TS",,566183,DTCT0024002,2482737,DTCC00534001,2068767,33018
CHEMBL475231,P45452,,MFYWCBCSORYQGC-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19278250,IC50,=,25000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 expressed in Escherichia coli,,"A selective matrix metalloprotease 12 inhibitor for potential treatment of chronic obstructive pulmonary disease (COPD): discovery of (S)-2-(8-(methoxycarbonylamino)dibenzo[b,d]furan-3-sulfonamido)-3-methylbutanoic acid (MMP408).",J. Med. Chem.,2009,52,7,"Li W, Li J, Wu Y, Wu J, Hotchandani R, Cunningham K, McFadyen I, Bard J, Morgan P, Schlerman F, Xu X, Tam S, Goldman SJ, Williams C, Sypek J, Mansour TS",,566183,DTCT0024002,2482738,DTCC00534002,67702,33018
CHEMBL475540,P45452,,IQGHPUPMOUUHPP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18358729,ACTIVITY,=,4,%,,,,,,,,,,,,,,Activity of human recombinant MMP13,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518897,DTCT0024002,2708891,DTCC00515616,1178193,32215
CHEMBL475540,P45452,,IQGHPUPMOUUHPP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18358729,IC50,=,2100,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 expressed in Escherichia coli,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518658,DTCT0024002,2708800,DTCC00515616,1178193,32215
CHEMBL475540,P45452,,IQGHPUPMOUUHPP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18364257,IC50,=,280,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 by fluorogenic substrate assay,,Ranking the selectivity of PubChem screening hits by activity-based protein profiling: MMP13 as a case study.,Bioorg. Med. Chem.,2009,17,3,"Nakai R, Salisbury CM, Rosen H, Cravatt BF",,518902,DTCT0024002,2708985,DTCC00515616,1178199,32218
CHEMBL475540,P45452,,IQGHPUPMOUUHPP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18364257,IC50,=,13000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 by HxBPyne probe-based competitive activity based protein profiling assay,,Ranking the selectivity of PubChem screening hits by activity-based protein profiling: MMP13 as a case study.,Bioorg. Med. Chem.,2009,17,3,"Nakai R, Salisbury CM, Rosen H, Cravatt BF",,518903,DTCT0024002,2708980,DTCC00515616,1178199,32218
CHEMBL475541,P45452,,ZQZUYCOCZVCTIC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18358729,IC50,=,9900,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 expressed in Escherichia coli,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518658,DTCT0024002,2708801,DTCC00515617,661951,32215
CHEMBL475619,P45452,,RBTRVKIWYJFOJW-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19278250,IC50,=,670,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 expressed in Escherichia coli,,"A selective matrix metalloprotease 12 inhibitor for potential treatment of chronic obstructive pulmonary disease (COPD): discovery of (S)-2-(8-(methoxycarbonylamino)dibenzo[b,d]furan-3-sulfonamido)-3-methylbutanoic acid (MMP408).",J. Med. Chem.,2009,52,7,"Li W, Li J, Wu Y, Wu J, Hotchandani R, Cunningham K, McFadyen I, Bard J, Morgan P, Schlerman F, Xu X, Tam S, Goldman SJ, Williams C, Sypek J, Mansour TS",,566183,DTCT0024002,2482743,DTCC00534137,1297166,33018
CHEMBL475742,P45452,,RLJYCZREXIWYAI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18358729,ACTIVITY,=,35,%,,,,,,,,,,,,,,Activity of human recombinant MMP13,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518897,DTCT0024002,2708892,DTCC00515618,2015780,32215
CHEMBL475742,P45452,,RLJYCZREXIWYAI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18358729,IC50,=,2500,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 expressed in Escherichia coli,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518658,DTCT0024002,2708802,DTCC00515618,2015780,32215
CHEMBL47728,P45452,,XXNCZTSFXIANIO-FQEVSTJZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10397503,IC50,=,3,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,"Picking the S1, S1' and S2' pockets of matrix metalloproteinases. A niche for potent acyclic sulfonamide inhibitors.",Bioorg. Med. Chem. Lett.,1999,9,12,"Hanessian S, Bouzbouz S, Boudon A, Tucker GC, Peyroulan D",,101903,DTCT0024002,531211,DTCC00188668,1584488,3181
CHEMBL480567,P45452,,LBWKSAOORAPGFH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18974001,IC50,>,200000,NM,,,,,,,,,,,,,,Inhibition of MMP13 by FRET assay,,N-((8-hydroxy-5-substituted-quinolin-7-yl)(phenyl)methyl)-2-phenyloxy/amino-acetamide inhibitors of ADAMTS-5 (Aggrecanase-2).,Bioorg. Med. Chem. Lett.,2008,18,24,"Gilbert AM, Bursavich MG, Lombardi S, Georgiadis KE, Reifenberg E, Flannery CR, Morris EA",,519275,DTCT0024002,2706551,DTCC00532693,1135797,32228
CHEMBL481894,P45452,,WWYHGNBGETZJPI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18974001,IC50,>,67000,NM,,,,,,,,,,,,,,Inhibition of MMP13 by FRET assay,,N-((8-hydroxy-5-substituted-quinolin-7-yl)(phenyl)methyl)-2-phenyloxy/amino-acetamide inhibitors of ADAMTS-5 (Aggrecanase-2).,Bioorg. Med. Chem. Lett.,2008,18,24,"Gilbert AM, Bursavich MG, Lombardi S, Georgiadis KE, Reifenberg E, Flannery CR, Morris EA",,519275,DTCT0024002,2706552,DTCC00532765,779510,32228
CHEMBL484261,P45452,,VMOSDDURWLNMNG-GXFFZTMASA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18790648,IC50,=,96,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497406,DTCT0024002,2456507,DTCC00115945,888681,32556
CHEMBL484262,P45452,,BBCCMNOZBPHYAJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18790648,IC50,=,2277,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497406,DTCT0024002,2456496,DTCC00546798,1470988,32556
CHEMBL48474,P45452,,XOVSRAFNJNQNRK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10406637,IC50,=,1,NM,,,,,,,,,,,,,,Inhibition of human recombinant matrix metalloprotease-13 (hMMP-13),,Synthesis and identification of conformationally constrained selective MMP inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,13,"Freskos JN, McDonald JJ, Mischke BV, Mullins PB, Shieh HS, Stegeman RA, Stevens AM",,101902,DTCT0024002,1473745,DTCC00194147,808187,3192
CHEMBL486649,P45452,,CUYKYRMAYZIOKD-XNTDXEJSSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21208635,IC50,=,36,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024002,14713494,DTCC00512423,2099190,67860
CHEMBL486649,P45452,,CUYKYRMAYZIOKD-XNTDXEJSSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,24355348,IC50,=,36,NM,,,,,,,,,,,,,,Inhibition of MMP13 (unknown origin),,4-Thiazolidinones: The advances continue….,Eur. J. Med. Chem.,2014,72,,"Tripathi AC, Gupta SJ, Fatima GN, Sonar PK, Verma A, Saraf SK",,1287616,DTCT0024002,13003105,DTCC00512423,1495729,57061
CHEMBL488851,P45452,,KXBLZBZSMUAGFG-NTEUORMPSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21208635,IC50,=,60000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024002,14717295,DTCC00512421,2100961,67860
CHEMBL489100,P45452,BMS-561392,QVNZBDLTUKCPGJ-SHQCIBLASA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,IC50,=,461,NM,,,,,,,,,,,,,,Inhibition of MMP13 (unknown origin) by fluorescence-based FRET assay,,,MedChemComm,2011,2,10,,,1328287,DTCT0024002,13574320,DTCC00005548,590183,39059
CHEMBL48969,P45452,,UGLOKYALFGIDPP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10230616,IC50,=,2,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 (MMP-13),,Discovery of a novel series of selective MMP inhibitors: identification of the gamma-sulfone-thiols.,Bioorg. Med. Chem. Lett.,1999,9,7,"Freskos JN, Mischke BV, DeCrescenzo GA, Heintz R, Getman DP, Howard SC, Kishore NN, McDonald JJ, Munie GE, Rangwala S, Swearingen CA, Voliva C, Welsch DJ",,106484,DTCT0024002,1714733,DTCC00193516,1425572,3610
CHEMBL48969,P45452,,UGLOKYALFGIDPP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10406637,IC50,=,2,NM,,,,,,,,,,,,,,Inhibition of human recombinant matrix metalloprotease-13 (hMMP-13),,Synthesis and identification of conformationally constrained selective MMP inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,13,"Freskos JN, McDonald JJ, Mischke BV, Mullins PB, Shieh HS, Stegeman RA, Stevens AM",,101902,DTCT0024002,1476110,DTCC00193516,1423570,3192
CHEMBL491287,P45452,,DDFFKEPNXVTRCY-DVECYGJZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19095454,IC50,=,3,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Current perspective of TACE inhibitors: a review.,Bioorg. Med. Chem.,2009,17,2,"DasGupta S, Murumkar PR, Giridhar R, Yadav MR",,495051,DTCT0024002,2595397,DTCC00517544,404208,32093
CHEMBL492314,P45452,,YSRLIHTZJHEXLM-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19278250,IC50,=,600,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 expressed in Escherichia coli,,"A selective matrix metalloprotease 12 inhibitor for potential treatment of chronic obstructive pulmonary disease (COPD): discovery of (S)-2-(8-(methoxycarbonylamino)dibenzo[b,d]furan-3-sulfonamido)-3-methylbutanoic acid (MMP408).",J. Med. Chem.,2009,52,7,"Li W, Li J, Wu Y, Wu J, Hotchandani R, Cunningham K, McFadyen I, Bard J, Morgan P, Schlerman F, Xu X, Tam S, Goldman SJ, Williams C, Sypek J, Mansour TS",,566183,DTCT0024002,2482747,DTCC00534177,973507,33018
CHEMBL492315,P45452,,HFUOQSPXLWRCGA-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19278250,IC50,>,25000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 expressed in Escherichia coli,,"A selective matrix metalloprotease 12 inhibitor for potential treatment of chronic obstructive pulmonary disease (COPD): discovery of (S)-2-(8-(methoxycarbonylamino)dibenzo[b,d]furan-3-sulfonamido)-3-methylbutanoic acid (MMP408).",J. Med. Chem.,2009,52,7,"Li W, Li J, Wu Y, Wu J, Hotchandani R, Cunningham K, McFadyen I, Bard J, Morgan P, Schlerman F, Xu X, Tam S, Goldman SJ, Williams C, Sypek J, Mansour TS",,566183,DTCT0024002,2482749,DTCC00534179,844798,33018
CHEMBL492383,P45452,,SDGZTDQOUHNIEB-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,3.6,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500573,DTCT0024002,2824095,DTCC00535671,261324,33635
CHEMBL492383,P45452,,SDGZTDQOUHNIEB-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,163,NM,,,,,,,,,,,,,,Inhibition of MMP13 in presence of 1% bovine serum albumin,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500574,DTCT0024002,2824096,DTCC00535671,261324,33635
CHEMBL492384,P45452,,ZUANNEACDHFGLI-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,0.9,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500573,DTCT0024002,2824098,DTCC00535737,1588414,33635
CHEMBL492384,P45452,,ZUANNEACDHFGLI-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,79.5,NM,,,,,,,,,,,,,,Inhibition of MMP13 in presence of 1% bovine serum albumin,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500574,DTCT0024002,2824099,DTCC00535737,1588414,33635
CHEMBL492531,P45452,,JFCGISGLHXBESS-QFIPXVFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19278250,IC50,=,200,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 expressed in Escherichia coli,,"A selective matrix metalloprotease 12 inhibitor for potential treatment of chronic obstructive pulmonary disease (COPD): discovery of (S)-2-(8-(methoxycarbonylamino)dibenzo[b,d]furan-3-sulfonamido)-3-methylbutanoic acid (MMP408).",J. Med. Chem.,2009,52,7,"Li W, Li J, Wu Y, Wu J, Hotchandani R, Cunningham K, McFadyen I, Bard J, Morgan P, Schlerman F, Xu X, Tam S, Goldman SJ, Williams C, Sypek J, Mansour TS",,566183,DTCT0024002,2482757,DTCC00534272,10464,33018
CHEMBL492904,P45452,,YTHUQFQHXZIQRV-SFHVURJKSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19278250,IC50,=,97,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 expressed in Escherichia coli,,"A selective matrix metalloprotease 12 inhibitor for potential treatment of chronic obstructive pulmonary disease (COPD): discovery of (S)-2-(8-(methoxycarbonylamino)dibenzo[b,d]furan-3-sulfonamido)-3-methylbutanoic acid (MMP408).",J. Med. Chem.,2009,52,7,"Li W, Li J, Wu Y, Wu J, Hotchandani R, Cunningham K, McFadyen I, Bard J, Morgan P, Schlerman F, Xu X, Tam S, Goldman SJ, Williams C, Sypek J, Mansour TS",,566183,DTCT0024002,2482764,DTCC00534400,1038415,33018
CHEMBL492905,P45452,,RJKVRZJNTANTQB-QFIPXVFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19278250,IC50,=,361,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 expressed in Escherichia coli,,"A selective matrix metalloprotease 12 inhibitor for potential treatment of chronic obstructive pulmonary disease (COPD): discovery of (S)-2-(8-(methoxycarbonylamino)dibenzo[b,d]furan-3-sulfonamido)-3-methylbutanoic acid (MMP408).",J. Med. Chem.,2009,52,7,"Li W, Li J, Wu Y, Wu J, Hotchandani R, Cunningham K, McFadyen I, Bard J, Morgan P, Schlerman F, Xu X, Tam S, Goldman SJ, Williams C, Sypek J, Mansour TS",,566183,DTCT0024002,2482765,DTCC00534401,650942,33018
CHEMBL492952,P45452,,LDOSBGUASYKJNO-NRFANRHFSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19278250,IC50,=,2.1,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 expressed in Escherichia coli,,"A selective matrix metalloprotease 12 inhibitor for potential treatment of chronic obstructive pulmonary disease (COPD): discovery of (S)-2-(8-(methoxycarbonylamino)dibenzo[b,d]furan-3-sulfonamido)-3-methylbutanoic acid (MMP408).",J. Med. Chem.,2009,52,7,"Li W, Li J, Wu Y, Wu J, Hotchandani R, Cunningham K, McFadyen I, Bard J, Morgan P, Schlerman F, Xu X, Tam S, Goldman SJ, Williams C, Sypek J, Mansour TS",,566183,DTCT0024002,2482760,DTCC00115053,67706,33018
CHEMBL493177,P45452,,KHZOOCSTBFXVQU-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,2.8,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500573,DTCT0024002,2824086,DTCC00115076,1491751,33635
CHEMBL493177,P45452,,KHZOOCSTBFXVQU-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,212,NM,,,,,,,,,,,,,,Inhibition of MMP13 in presence of 1% bovine serum albumin,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500574,DTCT0024002,2824087,DTCC00115076,1491751,33635
CHEMBL493178,P45452,,JTLSDSKNFBJVAB-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,16,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500573,DTCT0024002,2824089,DTCC00535669,1394821,33635
CHEMBL493178,P45452,,JTLSDSKNFBJVAB-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,245,NM,,,,,,,,,,,,,,Inhibition of MMP13 in presence of 1% bovine serum albumin,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500574,DTCT0024002,2824090,DTCC00535669,1394821,33635
CHEMBL493179,P45452,,GJYPNXKSSHMLOC-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,8,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500573,DTCT0024002,2824092,DTCC00535670,553847,33635
CHEMBL493179,P45452,,GJYPNXKSSHMLOC-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,250,NM,,,,,,,,,,,,,,Inhibition of MMP13 in presence of 1% bovine serum albumin,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500574,DTCT0024002,2824093,DTCC00535670,553847,33635
CHEMBL493356,P45452,,LIBJLMBRYDKFLR-QFIPXVFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19278250,IC50,=,1.1,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 expressed in Escherichia coli,,"A selective matrix metalloprotease 12 inhibitor for potential treatment of chronic obstructive pulmonary disease (COPD): discovery of (S)-2-(8-(methoxycarbonylamino)dibenzo[b,d]furan-3-sulfonamido)-3-methylbutanoic acid (MMP408).",J. Med. Chem.,2009,52,7,"Li W, Li J, Wu Y, Wu J, Hotchandani R, Cunningham K, McFadyen I, Bard J, Morgan P, Schlerman F, Xu X, Tam S, Goldman SJ, Williams C, Sypek J, Mansour TS",,566183,DTCT0024002,2482762,DTCC00534333,811949,33018
CHEMBL493750,P45452,,VFDHTLCJQNLYTR-QFIPXVFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19278250,IC50,=,180,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 expressed in Escherichia coli,,"A selective matrix metalloprotease 12 inhibitor for potential treatment of chronic obstructive pulmonary disease (COPD): discovery of (S)-2-(8-(methoxycarbonylamino)dibenzo[b,d]furan-3-sulfonamido)-3-methylbutanoic acid (MMP408).",J. Med. Chem.,2009,52,7,"Li W, Li J, Wu Y, Wu J, Hotchandani R, Cunningham K, McFadyen I, Bard J, Morgan P, Schlerman F, Xu X, Tam S, Goldman SJ, Williams C, Sypek J, Mansour TS",,566183,DTCT0024002,2482756,DTCC00534271,10463,33018
CHEMBL493958,P45452,,SKLOAVPDSDQCQV-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19278250,IC50,>,1000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 expressed in Escherichia coli,,"A selective matrix metalloprotease 12 inhibitor for potential treatment of chronic obstructive pulmonary disease (COPD): discovery of (S)-2-(8-(methoxycarbonylamino)dibenzo[b,d]furan-3-sulfonamido)-3-methylbutanoic acid (MMP408).",J. Med. Chem.,2009,52,7,"Li W, Li J, Wu Y, Wu J, Hotchandani R, Cunningham K, McFadyen I, Bard J, Morgan P, Schlerman F, Xu X, Tam S, Goldman SJ, Williams C, Sypek J, Mansour TS",,566183,DTCT0024002,2482763,DTCC00534399,844804,33018
CHEMBL493958,P45452,,SKLOAVPDSDQCQV-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19725580,IC50,=,505,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthma.,J. Med. Chem.,2009,52,17,"Li W, Li J, Wu Y, Rancati F, Vallese S, Raveglia L, Wu J, Hotchandani R, Fuller N, Cunningham K, Morgan P, Fish S, Krykbaev R, Xu X, Tam S, Goldman SJ, Abraham W, Williams C, Sypek J, Mansour TS",,579100,DTCT0024002,2894831,DTCC00534399,845354,34869
CHEMBL493989,P45452,,DMIORTQLUPECMV-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,1.4,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500573,DTCT0024002,2824104,DTCC00535861,1070890,33635
CHEMBL493989,P45452,,DMIORTQLUPECMV-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,65,NM,,,,,,,,,,,,,,Inhibition of MMP13 in presence of 1% bovine serum albumin,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500574,DTCT0024002,2824105,DTCC00535861,1070890,33635
CHEMBL494167,P45452,,VHHYCDSHISCLLA-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,1.7,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500573,DTCT0024002,2824101,DTCC00535860,1199492,33635
CHEMBL494167,P45452,,VHHYCDSHISCLLA-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,20,NM,,,,,,,,,,,,,,Inhibition of MMP13 in presence of 1% bovine serum albumin,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500574,DTCT0024002,2824102,DTCC00535860,1199492,33635
CHEMBL494528,P45452,,WDMMHRSZAREYDM-IBGZPJMESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19278250,IC50,=,10,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 expressed in Escherichia coli,,"A selective matrix metalloprotease 12 inhibitor for potential treatment of chronic obstructive pulmonary disease (COPD): discovery of (S)-2-(8-(methoxycarbonylamino)dibenzo[b,d]furan-3-sulfonamido)-3-methylbutanoic acid (MMP408).",J. Med. Chem.,2009,52,7,"Li W, Li J, Wu Y, Wu J, Hotchandani R, Cunningham K, McFadyen I, Bard J, Morgan P, Schlerman F, Xu X, Tam S, Goldman SJ, Williams C, Sypek J, Mansour TS",,566183,DTCT0024002,2482752,DTCC00534212,553831,33018
CHEMBL494529,P45452,,VYAMAYOVUONCDB-FQEVSTJZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19278250,IC50,=,10,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 expressed in Escherichia coli,,"A selective matrix metalloprotease 12 inhibitor for potential treatment of chronic obstructive pulmonary disease (COPD): discovery of (S)-2-(8-(methoxycarbonylamino)dibenzo[b,d]furan-3-sulfonamido)-3-methylbutanoic acid (MMP408).",J. Med. Chem.,2009,52,7,"Li W, Li J, Wu Y, Wu J, Hotchandani R, Cunningham K, McFadyen I, Bard J, Morgan P, Schlerman F, Xu X, Tam S, Goldman SJ, Williams C, Sypek J, Mansour TS",,566183,DTCT0024002,2482753,DTCC00534213,164690,33018
CHEMBL494823,P45452,,SNWCXQPNOQQJPW-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,1.2,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500573,DTCT0024002,2824107,DTCC00535862,1427215,33635
CHEMBL494823,P45452,,SNWCXQPNOQQJPW-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,580,NM,,,,,,,,,,,,,,Inhibition of MMP13 in presence of 1% bovine serum albumin,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500574,DTCT0024002,2824108,DTCC00535862,1427215,33635
CHEMBL494824,P45452,,WSJXJUJAODDAGQ-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,0.7,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500573,DTCT0024002,2824110,DTCC00535863,1297184,33635
CHEMBL494824,P45452,,WSJXJUJAODDAGQ-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,181,NM,,,,,,,,,,,,,,Inhibition of MMP13 in presence of 1% bovine serum albumin,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500574,DTCT0024002,2824111,DTCC00535863,1297184,33635
CHEMBL495502,P45452,,OBBSDCUMPDPHQF-BEEZEEGUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18790648,KI,>,5000,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497406,DTCT0024002,2457264,DTCC00547246,1983210,32556
CHEMBL495621,P45452,,OVRNSWPIJUFVHN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19464885,IC50,=,8624,NM,,,,,,,,,,,,,,inhibition of human recombinant MMP13 catalytic domain,,Synthesis and activity of quinolinylmethyl P1' alpha-sulfone piperidine hydroxamate inhibitors of TACE.,Bioorg. Med. Chem. Lett.,2009,19,13,"Zhang C, Lovering F, Behnke M, Zask A, Sandanayaka V, Sun L, Zhu Y, Xu W, Zhang Y, Levin JI",,523796,DTCT0024002,2832599,DTCC00553772,1178656,33699
CHEMBL495629,P45452,,PVOQKYVUWAHQSO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19464885,IC50,=,4019,NM,,,,,,,,,,,,,,inhibition of human recombinant MMP13 catalytic domain,,Synthesis and activity of quinolinylmethyl P1' alpha-sulfone piperidine hydroxamate inhibitors of TACE.,Bioorg. Med. Chem. Lett.,2009,19,13,"Zhang C, Lovering F, Behnke M, Zask A, Sandanayaka V, Sun L, Zhu Y, Xu W, Zhang Y, Levin JI",,523796,DTCT0024002,2832600,DTCC00553831,597670,33699
CHEMBL495795,P45452,,BWCDPDUCUGVEMN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19464885,IC50,=,1451,NM,,,,,,,,,,,,,,inhibition of human recombinant MMP13 catalytic domain,,Synthesis and activity of quinolinylmethyl P1' alpha-sulfone piperidine hydroxamate inhibitors of TACE.,Bioorg. Med. Chem. Lett.,2009,19,13,"Zhang C, Lovering F, Behnke M, Zask A, Sandanayaka V, Sun L, Zhu Y, Xu W, Zhang Y, Levin JI",,523796,DTCT0024002,2832616,DTCC00554044,2080564,33699
CHEMBL495831,P45452,,DVAPUVGZYOTZOY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19464885,IC50,=,440,NM,,,,,,,,,,,,,,inhibition of human recombinant MMP13 catalytic domain,,Synthesis and activity of quinolinylmethyl P1' alpha-sulfone piperidine hydroxamate inhibitors of TACE.,Bioorg. Med. Chem. Lett.,2009,19,13,"Zhang C, Lovering F, Behnke M, Zask A, Sandanayaka V, Sun L, Zhu Y, Xu W, Zhang Y, Levin JI",,523796,DTCT0024002,2832602,DTCC00553832,2048412,33699
CHEMBL496423,P45452,,JRSOKCXTAIQJPK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19464885,IC50,=,926,NM,,,,,,,,,,,,,,inhibition of human recombinant MMP13 catalytic domain,,Synthesis and activity of quinolinylmethyl P1' alpha-sulfone piperidine hydroxamate inhibitors of TACE.,Bioorg. Med. Chem. Lett.,2009,19,13,"Zhang C, Lovering F, Behnke M, Zask A, Sandanayaka V, Sun L, Zhu Y, Xu W, Zhang Y, Levin JI",,523796,DTCT0024002,2832621,DTCC00554165,856607,33699
CHEMBL496618,P45452,,MVCDTECIYPRJTL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19464885,IC50,=,72,NM,,,,,,,,,,,,,,inhibition of human recombinant MMP13 catalytic domain,,Synthesis and activity of quinolinylmethyl P1' alpha-sulfone piperidine hydroxamate inhibitors of TACE.,Bioorg. Med. Chem. Lett.,2009,19,13,"Zhang C, Lovering F, Behnke M, Zask A, Sandanayaka V, Sun L, Zhu Y, Xu W, Zhang Y, Levin JI",,523796,DTCT0024002,2832619,DTCC00554163,888770,33699
CHEMBL496619,P45452,,CXZHJWRHSTZNHB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19464885,IC50,=,393,NM,,,,,,,,,,,,,,inhibition of human recombinant MMP13 catalytic domain,,Synthesis and activity of quinolinylmethyl P1' alpha-sulfone piperidine hydroxamate inhibitors of TACE.,Bioorg. Med. Chem. Lett.,2009,19,13,"Zhang C, Lovering F, Behnke M, Zask A, Sandanayaka V, Sun L, Zhu Y, Xu W, Zhang Y, Levin JI",,523796,DTCT0024002,2832620,DTCC00554164,1374334,33699
CHEMBL496942,P45452,,FLTYDFYSVZBKOB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17623656,IC50,=,0.67,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain,,Discovery and characterization of a novel inhibitor of matrix metalloprotease-13 that reduces cartilage damage in vivo without joint fibroplasia side effects.,J. Biol. Chem.,2007,282,38,"Johnson AR, Pavlovsky AG, Ortwine DF, Prior F, Man CF, Bornemeier DA, Banotai CA, Mueller WT, McConnell P, Yan C, Baragi V, Lesch C, Roark WH, Wilson M, Datta K, Guzman R, Han HK, Dyer RD",,507870,DTCT0024002,2388617,DTCC00547183,1983321,29282
CHEMBL496942,P45452,,FLTYDFYSVZBKOB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18790648,IC50,=,0.67,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497406,DTCT0024002,2457334,DTCC00547183,1983207,32556
CHEMBL496942,P45452,,FLTYDFYSVZBKOB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22689580,IC50,=,0.67,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024002,14716159,DTCC00547183,2100367,68703
CHEMBL496942,P45452,,FLTYDFYSVZBKOB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25265401,IC50,=,0.67,NM,,,,,,,,,,,,,,Inhibition of MMP13 (unknown origin),,"Targeting matrix metalloproteinases: exploring the dynamics of the s1' pocket in the design of selective, small molecule inhibitors.",J. Med. Chem.,2014,57,24,"Fabre B, Ramos A, de Pascual-Teresa B",,1433222,DTCT0024002,13993824,DTCC00547183,1976454,60040
CHEMBL496942,P45452,,FLTYDFYSVZBKOB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25330343,IC50,=,14,NM,,,,,,,,,,,,,,Non-competitive inhibition of full-length recombinant human MMP-13 assessed as fTHP-15 substrate hydrolysis,,Characterization of selective exosite-binding inhibitors of matrix metalloproteinase 13 that prevent articular cartilage degradation in vitro.,J. Med. Chem.,2014,57,22,"Spicer TP, Jiang J, Taylor AB, Choi JY, Hart PJ, Roush WR, Fields GB, Hodder PS, Minond D",,1434999,DTCT0024002,13947461,DTCC00547183,1976388,60192
CHEMBL496942,P45452,,FLTYDFYSVZBKOB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25330343,INHIBITION,>,20,%,,,,,,,,,,,,,,Inhibition of recombinant human MMP-13 using GRIGFL substrate assessed as inhibition of enzyme activity up to 5 uM,,Characterization of selective exosite-binding inhibitors of matrix metalloproteinase 13 that prevent articular cartilage degradation in vitro.,J. Med. Chem.,2014,57,22,"Spicer TP, Jiang J, Taylor AB, Choi JY, Hart PJ, Roush WR, Fields GB, Hodder PS, Minond D",,1435724,DTCT0024002,14018281,DTCC00547183,1976388,60192
CHEMBL496942,P45452,,FLTYDFYSVZBKOB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25330343,KB,=,10,NM,,,,,,,,,,,,,,Non-competitive inhibition of full-length recombinant human MMP-13 assessed as fTHP-15 substrate hydrolysis by Lineweaver-Burke plot analysis,,Characterization of selective exosite-binding inhibitors of matrix metalloproteinase 13 that prevent articular cartilage degradation in vitro.,J. Med. Chem.,2014,57,22,"Spicer TP, Jiang J, Taylor AB, Choi JY, Hart PJ, Roush WR, Fields GB, Hodder PS, Minond D",,1435000,DTCT0024002,13947462,DTCC00547183,1976388,60192
CHEMBL497012,P45452,,XQTUJUSPSCMEOC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19464885,IC50,=,835,NM,,,,,,,,,,,,,,inhibition of human recombinant MMP13 catalytic domain,,Synthesis and activity of quinolinylmethyl P1' alpha-sulfone piperidine hydroxamate inhibitors of TACE.,Bioorg. Med. Chem. Lett.,2009,19,13,"Zhang C, Lovering F, Behnke M, Zask A, Sandanayaka V, Sun L, Zhu Y, Xu W, Zhang Y, Levin JI",,523796,DTCT0024002,2832614,DTCC00554042,1178661,33699
CHEMBL497413,P45452,,DIUYYSMPEUKBTJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19464885,IC50,=,284,NM,,,,,,,,,,,,,,inhibition of human recombinant MMP13 catalytic domain,,Synthesis and activity of quinolinylmethyl P1' alpha-sulfone piperidine hydroxamate inhibitors of TACE.,Bioorg. Med. Chem. Lett.,2009,19,13,"Zhang C, Lovering F, Behnke M, Zask A, Sandanayaka V, Sun L, Zhu Y, Xu W, Zhang Y, Levin JI",,523796,DTCT0024002,2832612,DTCC00553989,1017705,33699
CHEMBL497772,P45452,,KQIFSUSWYMDFOC-AREMUKBSSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18790648,IC50,=,1.8,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497406,DTCT0024002,2457438,DTCC00547182,823604,32556
CHEMBL497838,P45452,,LJJFKNOMQHHBEW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19464885,IC50,=,415,NM,,,,,,,,,,,,,,inhibition of human recombinant MMP13 catalytic domain,,Synthesis and activity of quinolinylmethyl P1' alpha-sulfone piperidine hydroxamate inhibitors of TACE.,Bioorg. Med. Chem. Lett.,2009,19,13,"Zhang C, Lovering F, Behnke M, Zask A, Sandanayaka V, Sun L, Zhu Y, Xu W, Zhang Y, Levin JI",,523796,DTCT0024002,2832606,DTCC00116270,726959,33699
CHEMBL497908,P45452,,QBMRYLHKTSDMJW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19410464,IC50,=,13600,NM,,,,,,,,,,,,,,Inhibition of MMP13 by FLIPR assay,,Synthesis and activity of tryptophan sulfonamide derivatives as novel non-hydroxamate TNF-alpha converting enzyme (TACE) inhibitors.,Bioorg. Med. Chem.,2009,17,11,"Park K, Gopalsamy A, Aplasca A, Ellingboe JW, Xu W, Zhang Y, Levin JI",,545899,DTCT0024002,2499023,DTCC00117363,1809997,33915
CHEMBL498032,P45452,,VOYWXVODQDUTJD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19464885,IC50,=,1336,NM,,,,,,,,,,,,,,inhibition of human recombinant MMP13 catalytic domain,,Synthesis and activity of quinolinylmethyl P1' alpha-sulfone piperidine hydroxamate inhibitors of TACE.,Bioorg. Med. Chem. Lett.,2009,19,13,"Zhang C, Lovering F, Behnke M, Zask A, Sandanayaka V, Sun L, Zhu Y, Xu W, Zhang Y, Levin JI",,523796,DTCT0024002,2832603,DTCC00553833,953057,33699
CHEMBL499159,P45452,,DLLCDWXNWWRIFJ-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,0.6,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500573,DTCT0024002,2844337,DTCC00536317,1874000,33635
CHEMBL499159,P45452,,DLLCDWXNWWRIFJ-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,68,NM,,,,,,,,,,,,,,Inhibition of MMP13 in presence of 1% bovine serum albumin,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500574,DTCT0024002,2824025,DTCC00536317,1874000,33635
CHEMBL499313,P45452,,IBMUIXAPDBZOLE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19464885,IC50,=,1110,NM,,,,,,,,,,,,,,inhibition of human recombinant MMP13 catalytic domain,,Synthesis and activity of quinolinylmethyl P1' alpha-sulfone piperidine hydroxamate inhibitors of TACE.,Bioorg. Med. Chem. Lett.,2009,19,13,"Zhang C, Lovering F, Behnke M, Zask A, Sandanayaka V, Sun L, Zhu Y, Xu W, Zhang Y, Levin JI",,523796,DTCT0024002,2832611,DTCC00553988,1341791,33699
CHEMBL499854,P45452,,GKURRRNPHZGWQU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19464885,IC50,=,57,NM,,,,,,,,,,,,,,inhibition of human recombinant MMP13 catalytic domain,,Synthesis and activity of quinolinylmethyl P1' alpha-sulfone piperidine hydroxamate inhibitors of TACE.,Bioorg. Med. Chem. Lett.,2009,19,13,"Zhang C, Lovering F, Behnke M, Zask A, Sandanayaka V, Sun L, Zhu Y, Xu W, Zhang Y, Levin JI",,523796,DTCT0024002,2832615,DTCC00554043,759132,33699
CHEMBL499905,P45452,,JUSNXCIZGYMOPC-HHHXNRCGSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19410464,IC50,=,4560,NM,,,,,,,,,,,,,,Inhibition of MMP13 by FLIPR assay,,Synthesis and activity of tryptophan sulfonamide derivatives as novel non-hydroxamate TNF-alpha converting enzyme (TACE) inhibitors.,Bioorg. Med. Chem.,2009,17,11,"Park K, Gopalsamy A, Aplasca A, Ellingboe JW, Xu W, Zhang Y, Levin JI",,545899,DTCT0024002,2499019,DTCC00570829,812391,33915
CHEMBL50,P45452,QUERCETIN,REFJWTPEDVJJIY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22658537,IC50,=,8460,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827438,DTCT0024002,10535458,DTCC00135230,18482,48665
CHEMBL50,P45452,QUERCETIN,REFJWTPEDVJJIY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22658537,INHIBITION,>,30,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain at 10 uM incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827444,DTCT0024002,10535540,DTCC00135230,18482,48665
CHEMBL500351,P45452,,XMFWHLZTTUUQHL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18358729,ACTIVITY,=,25,%,,,,,,,,,,,,,,Activity of human recombinant MMP13,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518897,DTCT0024002,2708898,DTCC00516461,984995,32215
CHEMBL500351,P45452,,XMFWHLZTTUUQHL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18358729,IC50,=,4300,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 expressed in Escherichia coli,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518658,DTCT0024002,2708818,DTCC00516461,984995,32215
CHEMBL500351,P45452,,XMFWHLZTTUUQHL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18364257,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 at 200 uM by HxBPyne probe-based competitive activity based protein profiling assay in presence of 5 uM HxBpane competitor,Active,Ranking the selectivity of PubChem screening hits by activity-based protein profiling: MMP13 as a case study.,Bioorg. Med. Chem.,2009,17,3,"Nakai R, Salisbury CM, Rosen H, Cravatt BF",,518925,DTCT0024002,2708979,DTCC00516461,984998,32218
CHEMBL500351,P45452,,XMFWHLZTTUUQHL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18364257,IC50,=,1600,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 by fluorogenic substrate assay,,Ranking the selectivity of PubChem screening hits by activity-based protein profiling: MMP13 as a case study.,Bioorg. Med. Chem.,2009,17,3,"Nakai R, Salisbury CM, Rosen H, Cravatt BF",,518902,DTCT0024002,2708983,DTCC00516461,984998,32218
CHEMBL500351,P45452,,XMFWHLZTTUUQHL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18364257,IC50,=,20000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 by HxBPyne probe-based competitive activity based protein profiling assay,,Ranking the selectivity of PubChem screening hits by activity-based protein profiling: MMP13 as a case study.,Bioorg. Med. Chem.,2009,17,3,"Nakai R, Salisbury CM, Rosen H, Cravatt BF",,518903,DTCT0024002,2708977,DTCC00516461,984998,32218
CHEMBL502796,P45452,,VNIVLVJMMLQGNQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19464885,IC50,=,204,NM,,,,,,,,,,,,,,inhibition of human recombinant MMP13 catalytic domain,,Synthesis and activity of quinolinylmethyl P1' alpha-sulfone piperidine hydroxamate inhibitors of TACE.,Bioorg. Med. Chem. Lett.,2009,19,13,"Zhang C, Lovering F, Behnke M, Zask A, Sandanayaka V, Sun L, Zhu Y, Xu W, Zhang Y, Levin JI",,523796,DTCT0024002,2832607,DTCC00116271,2016238,33699
CHEMBL502936,P45452,,VVMRGJMCVMMCMT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18358729,IC50,=,15300,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 expressed in Escherichia coli,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518658,DTCT0024002,2708804,DTCC00515620,1599758,32215
CHEMBL503067,P45452,,RPWIXTPWMSUQKW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19464885,IC50,=,349,NM,,,,,,,,,,,,,,inhibition of human recombinant MMP13 catalytic domain,,Synthesis and activity of quinolinylmethyl P1' alpha-sulfone piperidine hydroxamate inhibitors of TACE.,Bioorg. Med. Chem. Lett.,2009,19,13,"Zhang C, Lovering F, Behnke M, Zask A, Sandanayaka V, Sun L, Zhu Y, Xu W, Zhang Y, Levin JI",,523796,DTCT0024002,2832610,DTCC00553987,2016240,33699
CHEMBL503470,P45452,,HLLDDDNIWYZZJY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18358729,ACTIVITY,=,42,%,,,,,,,,,,,,,,Activity of human recombinant MMP13,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518897,DTCT0024002,2708900,DTCC00516463,1082310,32215
CHEMBL503470,P45452,,HLLDDDNIWYZZJY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18358729,IC50,=,8400,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 expressed in Escherichia coli,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518658,DTCT0024002,2708820,DTCC00516463,1082310,32215
CHEMBL504791,P45452,,UMPJRGAFFRSXRX-MHWRWJLKSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18358729,IC50,=,1700,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 expressed in Escherichia coli,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518658,DTCT0024002,2708825,DTCC00515625,726501,32215
CHEMBL504873,P45452,ISOACTEOSIDE,FNMHEHXNBNCPCI-QEOJJFGVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22658537,IC50,=,11090,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827438,DTCT0024002,10535457,DTCC00506630,1169673,48665
CHEMBL504873,P45452,ISOACTEOSIDE,FNMHEHXNBNCPCI-QEOJJFGVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22658537,INHIBITION,>,30,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain at 10 uM incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827444,DTCT0024002,10535539,DTCC00506630,1169673,48665
CHEMBL504967,P45452,,CAFFLYYBQBVROH-XNTDXEJSSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21208635,IC50,=,98000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024002,14717040,DTCC00512369,2100831,67860
CHEMBL507420,P45452,,PTUCPHGSAFOJAU-MGONOCMRSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18790648,KI,=,49,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497406,DTCT0024002,2457423,DTCC00115971,1788790,32556
CHEMBL508461,P45452,,VMTJQZUZINLEKC-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18790648,IC50,=,270,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497406,DTCT0024002,2457539,DTCC00115944,1950497,32556
CHEMBL51013,P45452,,JDPMCWHMTGTQGU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10406637,IC50,=,500,NM,,,,,,,,,,,,,,Inhibition of human recombinant matrix metalloprotease-13 (hMMP-13),,Synthesis and identification of conformationally constrained selective MMP inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,13,"Freskos JN, McDonald JJ, Mischke BV, Mullins PB, Shieh HS, Stegeman RA, Stevens AM",,101902,DTCT0024002,1482435,DTCC00194083,1099907,3192
CHEMBL511203,P45452,,JGTIIKHYSZFICL-AREMUKBSSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19329309,IC50,=,1.1,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Synthesis and biological evaluation of ((4-keto)-phenoxy)methyl biphenyl-4-sulfonamides: a class of potent aggrecanase-1 inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,9,"Hopper DW, Vera MD, How D, Sabatini J, Xiang JS, Ipek M, Thomason J, Hu Y, Feyfant E, Wang Q, Georgiadis KE, Reifenberg E, Sheldon RT, Keohan CC, Majumdar MK, Morris EA, Skotnicki J, Sum PE",,500227,DTCT0024002,2723477,DTCC00536888,1115037,34185
CHEMBL511433,P45452,,UFVAMNFOSNVREZ-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,0.9,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500573,DTCT0024002,2824065,DTCC00536555,1427221,33635
CHEMBL511433,P45452,,UFVAMNFOSNVREZ-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,172,NM,,,,,,,,,,,,,,Inhibition of MMP13 in presence of 1% bovine serum albumin,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500574,DTCT0024002,2824066,DTCC00536555,1427221,33635
CHEMBL511729,P45452,,AOBTZEZFLADCMR-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,6.8,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500573,DTCT0024002,2844290,DTCC00536037,618294,33635
CHEMBL511729,P45452,,AOBTZEZFLADCMR-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,7200,NM,,,,,,,,,,,,,,Inhibition of MMP13 in presence of 1% bovine serum albumin,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500574,DTCT0024002,2844291,DTCC00536037,618294,33635
CHEMBL511729,P45452,,AOBTZEZFLADCMR-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,RATIO IC50,=,1000,,,,,,,,,,,,,,,Selectivity ratio of IC50 for MMP13 to IC50 for MMP13 in presence of 1% bovine serum albumin,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500577,DTCT0024002,2824202,DTCC00536037,618294,33635
CHEMBL511895,P45452,,JBRUWWLFDQFJLX-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,2.4,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500573,DTCT0024002,2844316,DTCC00536177,294620,33635
CHEMBL511895,P45452,,JBRUWWLFDQFJLX-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,48,NM,,,,,,,,,,,,,,Inhibition of MMP13 in presence of 1% bovine serum albumin,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500574,DTCT0024002,2844317,DTCC00536177,294620,33635
CHEMBL511942,P45452,,GTBUZLPQANSGGE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15734645,IC50,=,72,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024002,14718574,DTCC00530188,2101636,68788
CHEMBL511942,P45452,,GTBUZLPQANSGGE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19042129,IC50,=,72,NM,,,,,,,,,,,,,,Inhibition of human MMP13,,Calculation of binding free energies for non-zinc chelating pyrimidine dicarboxamide inhibitors with MMP-13.,Bioorg. Med. Chem. Lett.,2009,19,1,"Carrascal N, Rizzo RC",,559513,DTCT0024002,2450200,DTCC00530188,1788596,31745
CHEMBL512061,P45452,,OMKBGTGZWMRDAZ-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,0.3,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500573,DTCT0024002,2844281,DTCC00535990,1906302,33635
CHEMBL512061,P45452,,OMKBGTGZWMRDAZ-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,12,NM,,,,,,,,,,,,,,Inhibition of MMP13 in presence of 1% bovine serum albumin,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500574,DTCT0024002,2844282,DTCC00535990,1906302,33635
CHEMBL512061,P45452,,OMKBGTGZWMRDAZ-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,RATIO IC50,=,40,,,,,,,,,,,,,,,Selectivity ratio of IC50 for MMP13 to IC50 for MMP13 in presence of 1% bovine serum albumin,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500577,DTCT0024002,2824201,DTCC00535990,1906302,33635
CHEMBL512081,P45452,,FQWZTIDTWFNEQD-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,0.3,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500573,DTCT0024002,2844312,DTCC00536175,294619,33635
CHEMBL512081,P45452,,FQWZTIDTWFNEQD-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,9,NM,,,,,,,,,,,,,,Inhibition of MMP13 in presence of 1% bovine serum albumin,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500574,DTCT0024002,2844313,DTCC00536175,294619,33635
CHEMBL512237,P45452,,SLNHKZUUBJBCKF-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,1.4,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500573,DTCT0024002,2824077,DTCC00536662,229094,33635
CHEMBL512237,P45452,,SLNHKZUUBJBCKF-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,110,NM,,,,,,,,,,,,,,Inhibition of MMP13 in presence of 1% bovine serum albumin,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500574,DTCT0024002,2824078,DTCC00536662,229094,33635
CHEMBL512243,P45452,,YOPWUPWVOZRKMX-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,4.7,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500573,DTCT0024002,2824122,DTCC00535934,456198,33635
CHEMBL512243,P45452,,YOPWUPWVOZRKMX-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,280,NM,,,,,,,,,,,,,,Inhibition of MMP13 in presence of 1% bovine serum albumin,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500574,DTCT0024002,2824123,DTCC00535934,456198,33635
CHEMBL512275,P45452,,IGDBRYFDPWPBAI-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,1,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500573,DTCT0024002,2824053,DTCC00536488,1394830,33635
CHEMBL512275,P45452,,IGDBRYFDPWPBAI-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,81.2,NM,,,,,,,,,,,,,,Inhibition of MMP13 in presence of 1% bovine serum albumin,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500574,DTCT0024002,2824054,DTCC00536488,1394830,33635
CHEMBL512468,P45452,,CFQILWOWWHSROR-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,1325,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500573,DTCT0024002,2844308,DTCC00536121,261328,33635
CHEMBL512468,P45452,,CFQILWOWWHSROR-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP13 in presence of 1% bovine serum albumin,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500574,DTCT0024002,2844309,DTCC00536121,261328,33635
CHEMBL512613,P45452,,WGLNCZMKYLRKRK-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,0.9,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500573,DTCT0024002,2824038,DTCC00536425,132324,33635
CHEMBL512613,P45452,,WGLNCZMKYLRKRK-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,25,NM,,,,,,,,,,,,,,Inhibition of MMP13 in presence of 1% bovine serum albumin,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500574,DTCT0024002,2824039,DTCC00536425,132324,33635
CHEMBL513148,P45452,,CLWZJBNUWLJFOR-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,2.2,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500573,DTCT0024002,2824027,DTCC00536372,1938345,33635
CHEMBL513148,P45452,,CLWZJBNUWLJFOR-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,1800,NM,,,,,,,,,,,,,,Inhibition of MMP13 in presence of 1% bovine serum albumin,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500574,DTCT0024002,2824028,DTCC00536372,1938345,33635
CHEMBL513645,P45452,,ZFNCDKWMDQLULI-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,4,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500573,DTCT0024002,2824119,DTCC00535933,682939,33635
CHEMBL513645,P45452,,ZFNCDKWMDQLULI-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,107,NM,,,,,,,,,,,,,,Inhibition of MMP13 in presence of 1% bovine serum albumin,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500574,DTCT0024002,2824120,DTCC00535933,682939,33635
CHEMBL513655,P45452,,BLICXPFZFCNEIS-RUZDIDTESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,7.6,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500573,DTCT0024002,2824132,DTCC00535994,1362491,33635
CHEMBL513655,P45452,,BLICXPFZFCNEIS-RUZDIDTESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,65,NM,,,,,,,,,,,,,,Inhibition of MMP13 in presence of 1% bovine serum albumin,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500574,DTCT0024002,2824133,DTCC00535994,1362491,33635
CHEMBL513822,P45452,,XPHVGSCFPZLZJB-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,18,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500573,DTCT0024002,2844302,DTCC00536119,1556109,33635
CHEMBL513822,P45452,,XPHVGSCFPZLZJB-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,1850,NM,,,,,,,,,,,,,,Inhibition of MMP13 in presence of 1% bovine serum albumin,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500574,DTCT0024002,2844303,DTCC00536119,1556109,33635
CHEMBL513822,P45452,,XPHVGSCFPZLZJB-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,RATIO IC50,<,100,,,,,,,,,,,,,,,Selectivity ratio of IC50 for MMP13 to IC50 for MMP13 in presence of 1% bovine serum albumin,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500577,DTCT0024002,2824205,DTCC00536119,1556109,33635
CHEMBL513823,P45452,,DRZVRHXLLPGGIL-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,3.5,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500573,DTCT0024002,2824047,DTCC00536428,359818,33635
CHEMBL513823,P45452,,DRZVRHXLLPGGIL-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,242,NM,,,,,,,,,,,,,,Inhibition of MMP13 in presence of 1% bovine serum albumin,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500574,DTCT0024002,2824048,DTCC00536428,359818,33635
CHEMBL514138,P45452,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,9873598,IC50,=,8.2,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13 (MMP-13),,The synthesis and biological activity of a novel series of diazepine MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,19,"Levin JI, DiJoseph JF, Killar LM, Sung A, Walter T, Sharr MA, Roth CE, Skotnicki JS, Albright JD",,106628,DTCT0024002,610092,DTCC00514693,1228540,2791
CHEMBL514138,P45452,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,9873598,INHIBITION,=,1,%,,organism_based,,,,,,,,,,,,In vivo inhibition of matrix metalloprotease-13 (MMP-13) in mouse dialysis tubing implant assay at 50 mg/kg po,,The synthesis and biological activity of a novel series of diazepine MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,19,"Levin JI, DiJoseph JF, Killar LM, Sung A, Walter T, Sharr MA, Roth CE, Skotnicki JS, Albright JD",,106766,DTCT0024002,610093,DTCC00514693,1228540,2791
CHEMBL514138,P45452,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10397503,IC50,=,12,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,"Picking the S1, S1' and S2' pockets of matrix metalloproteinases. A niche for potent acyclic sulfonamide inhibitors.",Bioorg. Med. Chem. Lett.,1999,9,12,"Hanessian S, Bouzbouz S, Boudon A, Tucker GC, Peyroulan D",,101903,DTCT0024002,520526,DTCC00514693,1227848,3181
CHEMBL514138,P45452,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10579818,IC50,=,4.3,NM,,,,,,,,,,,,,,In vitro inhibitory activity against collagenase-3 (matrix metalloprotease-13).,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,106469,DTCT0024002,1395527,DTCC00514693,1241292,15412
CHEMBL514138,P45452,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11206467,IC50,=,8,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-13,,The discovery of anthranilic acid-based MMP inhibitors. Part 1: SAR of the 3-position.,Bioorg. Med. Chem. Lett.,2001,11,2,"Levin JI, Du MT, DiJoseph JF, Killar LM, Sung A, Walter T, Sharr MA, Roth CE, Moy FJ, Powers R, Jin G, Cowling R, Skotnicki JS",,106467,DTCT0024002,596369,DTCC00514693,1228333,4515
CHEMBL514138,P45452,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11514167,IC50,=,8,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,The discovery of anthranilic acid-based MMP inhibitors. Part 2: SAR of the 5-position and P1(1) groups.,Bioorg. Med. Chem. Lett.,2001,11,16,"Levin JI, Chen J, Du M, Hogan M, Kincaid S, Nelson FC, Venkatesan AM, Wehr T, Zask A, DiJoseph J, Killar LM, Skala S, Sung A, Sharr M, Roth C, Jin G, Cowling R, Mohler KM, Black RA, March CJ, Skotnicki JS",,106636,DTCT0024002,987778,DTCC00514693,1228201,4353
CHEMBL514138,P45452,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11591510,IC50,=,5.1,NM,,,,,,,,,,,,,,Inhibitory activity against human Matrix metalloprotease-13,,alpha-Alkyl-alpha-amino-beta-sulphone hydroxamates as potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2001,11,20,"Becker DP, DeCrescenzo G, Freskos J, Getman DP, Hockerman SL, Li M, Mehta P, Munie GE, Swearingen C",,106599,DTCT0024002,1071323,DTCC00514693,1240485,4541
CHEMBL514138,P45452,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11677139,IC50,=,8,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,The discovery of anthranilic acid-based MMP inhibitors. Part 3: incorporation of basic amines.,Bioorg. Med. Chem. Lett.,2001,11,22,"Levin JI, Chen JM, Du MT, Nelson FC, Wehr T, DiJoseph JF, Killar LM, Skala S, Sung A, Sharr MA, Roth CE, Jin G, Cowling R, Di L, Sherman M, Xu ZB, March CJ, Mohler KM, Black RA, Skotnicki JS",,106645,DTCT0024002,1618584,DTCC00514693,1228738,4590
CHEMBL514138,P45452,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12270165,INHIBITION,=,35.3,%,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,Benzodiazepine inhibitors of the MMPs and TACE.,Bioorg. Med. Chem. Lett.,2002,12,20,"Nelson FC, Delos Santos E, Levin JI, Chen JM, Skotnicki JS, DiJoseph JF, Sharr MA, Sung A, Killar LM, Cowling R, Jin G, Roth CE, Albright JD",,106768,DTCT0024002,1535237,DTCC00514693,1240599,5143
CHEMBL514138,P45452,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773041,IC50,=,8,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-13,,"Synthesis and structure-activity relationship of alpha-sulfonylhydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Grosu GT, Davis JM, Hu B, Ellingboe J, Baker JL, Skotnicki JS, Zask A, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R",,106627,DTCT0024002,791173,DTCC00514693,1228327,17339
CHEMBL514138,P45452,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773042,IC50,=,8,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13.,,"Synthesis and structure-activity relationship of N-substituted 4-arylsulfonylpiperidine-4-hydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Davis JM, Grosu GT, Baker J, Ellingboe J, Zask A, Levin JI, Sandanayaka VP, Du M, Skotnicki JS, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R, Tillett J, Zhao W, McDevitt J, Xu ZB",,106632,DTCT0024002,477859,DTCC00514693,1240289,17340
CHEMBL514138,P45452,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12824028,IC50,=,3,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13,,Phosphinic acid-based MMP-13 inhibitors that spare MMP-1 and MMP-3.,Bioorg. Med. Chem. Lett.,2003,13,14,"Reiter LA, Mitchell PG, Martinelli GJ, Lopresti-Morrow LL, Yocum SA, Eskra JD",,106640,DTCT0024002,1517459,DTCC00514693,1240249,5648
CHEMBL514138,P45452,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12930146,IC50,=,12,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP13),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,106606,DTCT0024002,526003,DTCC00514693,1241045,13726
CHEMBL514138,P45452,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15177439,IC50,=,18,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP-13),,Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2004,14,13,"Reiter LA, Robinson RP, McClure KF, Jones CS, Reese MR, Mitchell PG, Otterness IG, Bliven ML, Liras J, Cortina SR, Donahue KM, Eskra JD, Griffiths RJ, Lame ME, Lopez-Anaya A, Martinelli GJ, McGahee SM, Yocum SA, Lopresti-Morrow LL, Tobiassen LM, Vaughn-Bowser ML",,106600,DTCT0024002,1499582,DTCC00514693,1240846,6475
CHEMBL514138,P45452,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17956082,IC50,=,34,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET.,J. Med. Chem.,2007,50,23,"Wagner S, Breyholz HJ, Law MP, Faust A, Höltke C, Schröer S, Haufe G, Levkau B, Schober O, Schäfers M, Kopka K",,451368,DTCT0024002,2204548,DTCC00514693,1231041,24059
CHEMBL514138,P45452,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19053764,IC50,=,5.5,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Dual inhibitors of matrix metalloproteinases and carbonic anhydrases: iminodiacetyl-based hydroxamate-benzenesulfonamide conjugates.,J. Med. Chem.,2008,51,24,"Marques SM, Nuti E, Rossello A, Supuran CT, Tuccinardi T, Martinelli A, Santos MA",,561989,DTCT0024002,2800907,DTCC00514693,1231512,31524
CHEMBL514138,P45452,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,1.9,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500573,DTCT0024002,2844272,DTCC00514693,1231748,33635
CHEMBL514138,P45452,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,IC50,=,4.4,NM,,,,,,,,,,,,,,Inhibition of MMP13 in presence of 1% bovine serum albumin,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500574,DTCT0024002,2844273,DTCC00514693,1231748,33635
CHEMBL514138,P45452,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19422229,KI,=,1.27,NM,,,,,,,,,,,,,,Inhibition of MMP13 assessed as dissociation constant,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500964,DTCT0024002,2824195,DTCC00514693,1231748,33635
CHEMBL514138,P45452,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21937229,IC50,=,1.2,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788431,DTCT0024002,7527143,DTCC00514693,1253389,46372
CHEMBL514138,P45452,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22540974,IC50,=,34,NM,,,,,,,,,,,,,,"Inhibition of MMP13 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured for 10 mins by fluorometry",,A new class of highly potent matrix metalloproteinase inhibitors based on triazole-substituted hydroxamates: (radio)synthesis and in vitro and first in vivo evaluation.,J. Med. Chem.,2012,55,10,"Hugenberg V, Breyholz HJ, Riemann B, Hermann S, Schober O, Schäfers M, Gangadharmath U, Mocharla V, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,832928,DTCT0024002,10563956,DTCC00514693,1254588,48958
CHEMBL514495,P45452,,PTRVCICYKILIEH-SQFISAMPSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18358729,ACTIVITY,=,36,%,,,,,,,,,,,,,,Activity of human recombinant MMP13,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518897,DTCT0024002,2708893,DTCC00515685,78922,32215
CHEMBL514495,P45452,,PTRVCICYKILIEH-SQFISAMPSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18358729,IC50,=,10900,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 expressed in Escherichia coli,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518658,DTCT0024002,2708805,DTCC00515685,78922,32215
CHEMBL514794,P45452,,PYFRREJCFXFNRR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15734645,IC50,=,8,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024002,14717748,DTCC00515691,2101174,68788
CHEMBL514794,P45452,,PYFRREJCFXFNRR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18358729,IC50,=,8,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 expressed in Escherichia coli,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518658,DTCT0024002,2708828,DTCC00515691,1664328,32215
CHEMBL514794,P45452,,PYFRREJCFXFNRR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19042129,IC50,=,8,NM,,,,,,,,,,,,,,Inhibition of human MMP13,,Calculation of binding free energies for non-zinc chelating pyrimidine dicarboxamide inhibitors with MMP-13.,Bioorg. Med. Chem. Lett.,2009,19,1,"Carrascal N, Rizzo RC",,559513,DTCT0024002,2450199,DTCC00515691,1664497,31745
CHEMBL514794,P45452,,PYFRREJCFXFNRR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22689580,IC50,=,0.67,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024002,14717747,DTCC00515691,2101173,68703
CHEMBL514794,P45452,,PYFRREJCFXFNRR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25265401,IC50,=,8,NM,,,,,,,,,,,,,,Inhibition of MMP13 (unknown origin),,"Targeting matrix metalloproteinases: exploring the dynamics of the s1' pocket in the design of selective, small molecule inhibitors.",J. Med. Chem.,2014,57,24,"Fabre B, Ramos A, de Pascual-Teresa B",,1433222,DTCT0024002,13993822,DTCC00515691,1658045,60040
CHEMBL514794,P45452,,PYFRREJCFXFNRR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25330343,IC50,=,70,NM,,,,,,,,,,,,,,Inhibition of full-length recombinant human MMP-13 assessed as bovine type-2 collagen hydrolysis after 18 hrs by ELISA,,Characterization of selective exosite-binding inhibitors of matrix metalloproteinase 13 that prevent articular cartilage degradation in vitro.,J. Med. Chem.,2014,57,22,"Spicer TP, Jiang J, Taylor AB, Choi JY, Hart PJ, Roush WR, Fields GB, Hodder PS, Minond D",,1435002,DTCT0024002,13947501,DTCC00515691,1657963,60192
CHEMBL514794,P45452,,PYFRREJCFXFNRR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25330343,IC50,=,110,NM,,,,,,,,,,,,,,Non-competitive inhibition of full-length recombinant human MMP-13 assessed as fTHP-15 substrate hydrolysis,,Characterization of selective exosite-binding inhibitors of matrix metalloproteinase 13 that prevent articular cartilage degradation in vitro.,J. Med. Chem.,2014,57,22,"Spicer TP, Jiang J, Taylor AB, Choi JY, Hart PJ, Roush WR, Fields GB, Hodder PS, Minond D",,1434999,DTCT0024002,13947425,DTCC00515691,1657963,60192
CHEMBL514794,P45452,,PYFRREJCFXFNRR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25330343,INHIBITION,>,20,%,,,,,,,,,,,,,,Inhibition of recombinant human MMP-13 using GRIGFL substrate assessed as inhibition of enzyme activity up to 5 uM,,Characterization of selective exosite-binding inhibitors of matrix metalloproteinase 13 that prevent articular cartilage degradation in vitro.,J. Med. Chem.,2014,57,22,"Spicer TP, Jiang J, Taylor AB, Choi JY, Hart PJ, Roush WR, Fields GB, Hodder PS, Minond D",,1435724,DTCT0024002,14018282,DTCC00515691,1657963,60192
CHEMBL514794,P45452,,PYFRREJCFXFNRR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25330343,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of full-length recombinant human MMP-13 assessed as bovine type-2 collagen hydrolysis after 18 hrs by ELISA,Dose-dependent effect,Characterization of selective exosite-binding inhibitors of matrix metalloproteinase 13 that prevent articular cartilage degradation in vitro.,J. Med. Chem.,2014,57,22,"Spicer TP, Jiang J, Taylor AB, Choi JY, Hart PJ, Roush WR, Fields GB, Hodder PS, Minond D",,1435002,DTCT0024002,13947427,DTCC00515691,1657963,60192
CHEMBL514794,P45452,,PYFRREJCFXFNRR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25330343,KB,=,60,NM,,,,,,,,,,,,,,Non-competitive inhibition of full-length recombinant human MMP-13 assessed as fTHP-15 substrate hydrolysis by Lineweaver-Burke plot analysis,,Characterization of selective exosite-binding inhibitors of matrix metalloproteinase 13 that prevent articular cartilage degradation in vitro.,J. Med. Chem.,2014,57,22,"Spicer TP, Jiang J, Taylor AB, Choi JY, Hart PJ, Roush WR, Fields GB, Hodder PS, Minond D",,1435000,DTCT0024002,13947426,DTCC00515691,1657963,60192
CHEMBL514794,P45452,,PYFRREJCFXFNRR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,26653735,IC50,=,0.67,NM,,,,,,,,,,,,,,Inhibition of MMP13 (unknown origin) using acetyl-Pro-Leu-Gly-[2-mercapto-4-methylpentanoyl]-Leu-Gly-O-ethyl ester as substrate by microplate reader analysis,,"Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis.",J. Med. Chem.,2016,59,1,"Ruminski PG, Massa M, Strohbach J, Hanau CE, Schmidt M, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Shieh HS, Caspers N, Collins B, Grapperhaus M, Palmquist KE, Collins J, Baldus JE, Hitchcock J, Kleine HP, Rogers MD, McDonald J, Munie GE, Messing DM, Portolan S, Whiteley LO, Sunyer T, Schnute ME.",,1552527,DTCT0024002,73317,DTCC00515691,1660273,65989
CHEMBL514794,P45452,,PYFRREJCFXFNRR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,26653735,IC50,=,8,NM,,,,,,,,,,,,,,Inhibition of MMP13 (unknown origin) using MCA-Arg-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-Glu-Arg-NH2 as substrate preincubated for 15 mins followed by substrate addition,,"Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis.",J. Med. Chem.,2016,59,1,"Ruminski PG, Massa M, Strohbach J, Hanau CE, Schmidt M, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Shieh HS, Caspers N, Collins B, Grapperhaus M, Palmquist KE, Collins J, Baldus JE, Hitchcock J, Kleine HP, Rogers MD, McDonald J, Munie GE, Messing DM, Portolan S, Whiteley LO, Sunyer T, Schnute ME.",,1552526,DTCT0024002,73316,DTCC00515691,1660273,65989
CHEMBL515083,P45452,,QVAVQQVTOJMLHH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19053764,IC50,=,213,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Dual inhibitors of matrix metalloproteinases and carbonic anhydrases: iminodiacetyl-based hydroxamate-benzenesulfonamide conjugates.,J. Med. Chem.,2008,51,24,"Marques SM, Nuti E, Rossello A, Supuran CT, Tuccinardi T, Martinelli A, Santos MA",,561989,DTCT0024002,2800893,DTCC00514691,521492,31524
CHEMBL515248,P45452,,OASXKSSRDUUVRV-NHDPSOOVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18358729,IC50,>,40000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 expressed in Escherichia coli,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518658,DTCT0024002,2708808,DTCC00515687,597248,32215
CHEMBL515439,P45452,,YGNCGRVNRKDKCS-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19278250,IC50,=,25000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 expressed in Escherichia coli,,"A selective matrix metalloprotease 12 inhibitor for potential treatment of chronic obstructive pulmonary disease (COPD): discovery of (S)-2-(8-(methoxycarbonylamino)dibenzo[b,d]furan-3-sulfonamido)-3-methylbutanoic acid (MMP408).",J. Med. Chem.,2009,52,7,"Li W, Li J, Wu Y, Wu J, Hotchandani R, Cunningham K, McFadyen I, Bard J, Morgan P, Schlerman F, Xu X, Tam S, Goldman SJ, Williams C, Sypek J, Mansour TS",,566183,DTCT0024002,2482736,DTCC00534000,811943,33018
CHEMBL515439,P45452,,YGNCGRVNRKDKCS-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19725580,IC50,=,25000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthma.,J. Med. Chem.,2009,52,17,"Li W, Li J, Wu Y, Rancati F, Vallese S, Raveglia L, Wu J, Hotchandani R, Fuller N, Cunningham K, Morgan P, Fish S, Krykbaev R, Xu X, Tam S, Goldman SJ, Abraham W, Williams C, Sypek J, Mansour TS",,579100,DTCT0024002,2894817,DTCC00534000,812495,34869
CHEMBL515767,P45452,,MURINWVRNUDOHN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18358729,IC50,=,9400,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 expressed in Escherichia coli,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518658,DTCT0024002,2708803,DTCC00515619,143608,32215
CHEMBL515980,P45452,,KBZNOZAJAJRTII-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19053764,IC50,=,0.33,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Dual inhibitors of matrix metalloproteinases and carbonic anhydrases: iminodiacetyl-based hydroxamate-benzenesulfonamide conjugates.,J. Med. Chem.,2008,51,24,"Marques SM, Nuti E, Rossello A, Supuran CT, Tuccinardi T, Martinelli A, Santos MA",,561989,DTCT0024002,2800829,DTCC00562382,2004561,31524
CHEMBL516029,P45452,,WJHMSNNJLVHLAU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18358729,IC50,=,13300,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 expressed in Escherichia coli,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518658,DTCT0024002,2708821,DTCC00515622,1632031,32215
CHEMBL516206,P45452,,QKOVHOITGZCHQW-VXNXHJTFSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19095454,IC50,=,0.1,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Current perspective of TACE inhibitors: a review.,Bioorg. Med. Chem.,2009,17,2,"DasGupta S, Murumkar PR, Giridhar R, Yadav MR",,495051,DTCT0024002,2594701,DTCC00517277,273070,32093
CHEMBL51638,P45452,,JIFLEYNNNKKNOQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10230616,IC50,=,50,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 (MMP-13),,Discovery of a novel series of selective MMP inhibitors: identification of the gamma-sulfone-thiols.,Bioorg. Med. Chem. Lett.,1999,9,7,"Freskos JN, Mischke BV, DeCrescenzo GA, Heintz R, Getman DP, Howard SC, Kishore NN, McDonald JJ, Munie GE, Rangwala S, Swearingen CA, Voliva C, Welsch DJ",,106484,DTCT0024002,1706586,DTCC00194120,1715191,3610
CHEMBL51638,P45452,,JIFLEYNNNKKNOQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10406637,IC50,=,50,NM,,,,,,,,,,,,,,Inhibition of human recombinant matrix metalloprotease-13 (hMMP-13),,Synthesis and identification of conformationally constrained selective MMP inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,13,"Freskos JN, McDonald JJ, Mischke BV, Mullins PB, Shieh HS, Stegeman RA, Stevens AM",,101902,DTCT0024002,1479984,DTCC00194120,1713372,3192
CHEMBL516952,P45452,,PQDSLWSIZBTHRV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18358729,IC50,=,7700,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 expressed in Escherichia coli,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518658,DTCT0024002,2708810,DTCC00516388,1950141,32215
CHEMBL517444,P45452,,OHMNTNAGTIOSPP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18358729,IC50,>,40000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 expressed in Escherichia coli,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518658,DTCT0024002,2708812,DTCC00516391,1599763,32215
CHEMBL519182,P45452,,QCRHPVVZVMWEGQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18790648,INHIBITION,=,56,%,,,,,,,,,,,,,,Inhibition of MMP13 at 10 uM,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,492659,DTCT0024002,2456499,DTCC00546797,273422,32556
CHEMBL523001,P45452,,OUNOAPVJMCBRTF-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19278250,IC50,=,59,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 expressed in Escherichia coli,,"A selective matrix metalloprotease 12 inhibitor for potential treatment of chronic obstructive pulmonary disease (COPD): discovery of (S)-2-(8-(methoxycarbonylamino)dibenzo[b,d]furan-3-sulfonamido)-3-methylbutanoic acid (MMP408).",J. Med. Chem.,2009,52,7,"Li W, Li J, Wu Y, Wu J, Hotchandani R, Cunningham K, McFadyen I, Bard J, Morgan P, Schlerman F, Xu X, Tam S, Goldman SJ, Williams C, Sypek J, Mansour TS",,566183,DTCT0024002,2482759,DTCC00115052,1938323,33018
CHEMBL523034,P45452,,MKAIHDAGQJQAHA-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19278250,IC50,=,120,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 expressed in Escherichia coli,,"A selective matrix metalloprotease 12 inhibitor for potential treatment of chronic obstructive pulmonary disease (COPD): discovery of (S)-2-(8-(methoxycarbonylamino)dibenzo[b,d]furan-3-sulfonamido)-3-methylbutanoic acid (MMP408).",J. Med. Chem.,2009,52,7,"Li W, Li J, Wu Y, Wu J, Hotchandani R, Cunningham K, McFadyen I, Bard J, Morgan P, Schlerman F, Xu X, Tam S, Goldman SJ, Williams C, Sypek J, Mansour TS",,566183,DTCT0024002,2482750,DTCC00534180,682924,33018
CHEMBL523034,P45452,,MKAIHDAGQJQAHA-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19725580,IC50,=,120,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthma.,J. Med. Chem.,2009,52,17,"Li W, Li J, Wu Y, Rancati F, Vallese S, Raveglia L, Wu J, Hotchandani R, Fuller N, Cunningham K, Morgan P, Fish S, Krykbaev R, Xu X, Tam S, Goldman SJ, Abraham W, Williams C, Sypek J, Mansour TS",,579100,DTCT0024002,2894815,DTCC00534180,683489,34869
CHEMBL523035,P45452,,HANNJPXOWYFOHG-SFHVURJKSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19278250,IC50,=,100,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 expressed in Escherichia coli,,"A selective matrix metalloprotease 12 inhibitor for potential treatment of chronic obstructive pulmonary disease (COPD): discovery of (S)-2-(8-(methoxycarbonylamino)dibenzo[b,d]furan-3-sulfonamido)-3-methylbutanoic acid (MMP408).",J. Med. Chem.,2009,52,7,"Li W, Li J, Wu Y, Wu J, Hotchandani R, Cunningham K, McFadyen I, Bard J, Morgan P, Schlerman F, Xu X, Tam S, Goldman SJ, Williams C, Sypek J, Mansour TS",,566183,DTCT0024002,2482751,DTCC00534211,261303,33018
CHEMBL523035,P45452,,HANNJPXOWYFOHG-SFHVURJKSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19725580,IC50,=,100,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthma.,J. Med. Chem.,2009,52,17,"Li W, Li J, Wu Y, Rancati F, Vallese S, Raveglia L, Wu J, Hotchandani R, Fuller N, Cunningham K, Morgan P, Fish S, Krykbaev R, Xu X, Tam S, Goldman SJ, Abraham W, Williams C, Sypek J, Mansour TS",,579100,DTCT0024002,2894849,DTCC00534211,261887,34869
CHEMBL523201,P45452,,YTIQSKPYJKROHS-SFHVURJKSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19278250,IC50,=,10,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 expressed in Escherichia coli,,"A selective matrix metalloprotease 12 inhibitor for potential treatment of chronic obstructive pulmonary disease (COPD): discovery of (S)-2-(8-(methoxycarbonylamino)dibenzo[b,d]furan-3-sulfonamido)-3-methylbutanoic acid (MMP408).",J. Med. Chem.,2009,52,7,"Li W, Li J, Wu Y, Wu J, Hotchandani R, Cunningham K, McFadyen I, Bard J, Morgan P, Schlerman F, Xu X, Tam S, Goldman SJ, Williams C, Sypek J, Mansour TS",,566183,DTCT0024002,2482754,DTCC00534214,327247,33018
CHEMBL523357,P45452,,QPLRROCTSCFWJD-QFIPXVFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19278250,IC50,=,220,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 expressed in Escherichia coli,,"A selective matrix metalloprotease 12 inhibitor for potential treatment of chronic obstructive pulmonary disease (COPD): discovery of (S)-2-(8-(methoxycarbonylamino)dibenzo[b,d]furan-3-sulfonamido)-3-methylbutanoic acid (MMP408).",J. Med. Chem.,2009,52,7,"Li W, Li J, Wu Y, Wu J, Hotchandani R, Cunningham K, McFadyen I, Bard J, Morgan P, Schlerman F, Xu X, Tam S, Goldman SJ, Williams C, Sypek J, Mansour TS",,566183,DTCT0024002,2482755,DTCC00534270,1745223,33018
CHEMBL523670,P45452,,OZAYVSZVQPANBZ-QHCPKHFHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19278250,IC50,=,100,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 expressed in Escherichia coli,,"A selective matrix metalloprotease 12 inhibitor for potential treatment of chronic obstructive pulmonary disease (COPD): discovery of (S)-2-(8-(methoxycarbonylamino)dibenzo[b,d]furan-3-sulfonamido)-3-methylbutanoic acid (MMP408).",J. Med. Chem.,2009,52,7,"Li W, Li J, Wu Y, Wu J, Hotchandani R, Cunningham K, McFadyen I, Bard J, Morgan P, Schlerman F, Xu X, Tam S, Goldman SJ, Williams C, Sypek J, Mansour TS",,566183,DTCT0024002,2482758,DTCC00534273,392551,33018
CHEMBL523683,P45452,,HUDBGKUNLWLMCD-FQEVSTJZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19278250,IC50,=,3.3,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 expressed in Escherichia coli,,"A selective matrix metalloprotease 12 inhibitor for potential treatment of chronic obstructive pulmonary disease (COPD): discovery of (S)-2-(8-(methoxycarbonylamino)dibenzo[b,d]furan-3-sulfonamido)-3-methylbutanoic acid (MMP408).",J. Med. Chem.,2009,52,7,"Li W, Li J, Wu Y, Wu J, Hotchandani R, Cunningham K, McFadyen I, Bard J, Morgan P, Schlerman F, Xu X, Tam S, Goldman SJ, Williams C, Sypek J, Mansour TS",,566183,DTCT0024002,2482761,DTCC00534332,1167017,33018
CHEMBL523956,P45452,,YGNQFXKRHBOPDC-CZYKHXBRSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18790648,KI,>,5000,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497406,DTCT0024002,2457513,DTCC00546724,1243693,32556
CHEMBL524281,P45452,,UZCHBPQXZPPPNZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19464885,IC50,=,136,NM,,,,,,,,,,,,,,inhibition of human recombinant MMP13 catalytic domain,,Synthesis and activity of quinolinylmethyl P1' alpha-sulfone piperidine hydroxamate inhibitors of TACE.,Bioorg. Med. Chem. Lett.,2009,19,13,"Zhang C, Lovering F, Behnke M, Zask A, Sandanayaka V, Sun L, Zhu Y, Xu W, Zhang Y, Levin JI",,523796,DTCT0024002,2832604,DTCC00553834,1756633,33699
CHEMBL524533,P45452,,WRDNQNGMPREKKZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19464885,IC50,=,266,NM,,,,,,,,,,,,,,inhibition of human recombinant MMP13 catalytic domain,,Synthesis and activity of quinolinylmethyl P1' alpha-sulfone piperidine hydroxamate inhibitors of TACE.,Bioorg. Med. Chem. Lett.,2009,19,13,"Zhang C, Lovering F, Behnke M, Zask A, Sandanayaka V, Sun L, Zhu Y, Xu W, Zhang Y, Levin JI",,523796,DTCT0024002,2832617,DTCC00554161,1632468,33699
CHEMBL526646,P45452,,WUOWVIUWLFFAMY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19464885,IC50,=,105,NM,,,,,,,,,,,,,,inhibition of human recombinant MMP13 catalytic domain,,Synthesis and activity of quinolinylmethyl P1' alpha-sulfone piperidine hydroxamate inhibitors of TACE.,Bioorg. Med. Chem. Lett.,2009,19,13,"Zhang C, Lovering F, Behnke M, Zask A, Sandanayaka V, Sun L, Zhu Y, Xu W, Zhang Y, Levin JI",,523796,DTCT0024002,2832608,DTCC00553913,565428,33699
CHEMBL527018,P45452,,SFVPXERGVLDWIS-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19410464,IC50,=,1810,NM,,,,,,,,,,,,,,Inhibition of MMP13 by FLIPR assay,,Synthesis and activity of tryptophan sulfonamide derivatives as novel non-hydroxamate TNF-alpha converting enzyme (TACE) inhibitors.,Bioorg. Med. Chem.,2009,17,11,"Park K, Gopalsamy A, Aplasca A, Ellingboe JW, Xu W, Zhang Y, Levin JI",,545899,DTCT0024002,2499016,DTCC00117362,132799,33915
CHEMBL538028,P45452,,ZBMBWHUMSXZQLX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,9873598,IC50,=,46,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13 (MMP-13),,The synthesis and biological activity of a novel series of diazepine MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,19,"Levin JI, DiJoseph JF, Killar LM, Sung A, Walter T, Sharr MA, Roth CE, Skotnicki JS, Albright JD",,106628,DTCT0024002,601984,DTCC00580479,2033969,2791
CHEMBL538028,P45452,,ZBMBWHUMSXZQLX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,9873598,INHIBITION,=,0.16,%,,organism_based,,,,,,,,,,,,In vivo inhibition of matrix metalloprotease-13 (MMP-13) in mouse dialysis tubing implant assay at 50 mg/kg po,,The synthesis and biological activity of a novel series of diazepine MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,19,"Levin JI, DiJoseph JF, Killar LM, Sung A, Walter T, Sharr MA, Roth CE, Skotnicki JS, Albright JD",,106766,DTCT0024002,601985,DTCC00580479,2033969,2791
CHEMBL538453,P45452,,YWWJREBSMRNZGO-PMERELPUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19625186,IC50,=,19,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"3,4-Disubstituted benzofuran P1' MMP-13 inhibitors: optimization of selectivity and reduction of protein binding.",Bioorg. Med. Chem. Lett.,2009,19,16,"Li W, Hu Y, Li J, Thomason JR, DeVincentis D, Du X, Wu J, Hotchandani R, Rush TS, Skotnicki JS, Tam S, Chockalingam PS, Morris EA, Levin JI",,581466,DTCT0024002,2904481,DTCC00594705,910479,35265
CHEMBL539683,P45452,,WJFKRCVNGHZYFA-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10649971,IC50,=,150,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant matrix metalloprotease-13 (MMP-13),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,106476,DTCT0024002,904808,DTCC00186441,400504,15892
CHEMBL539787,P45452,,WNDMJNCVTIBVCL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,9873598,IC50,=,5.1,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13 (MMP-13),,The synthesis and biological activity of a novel series of diazepine MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,19,"Levin JI, DiJoseph JF, Killar LM, Sung A, Walter T, Sharr MA, Roth CE, Skotnicki JS, Albright JD",,106628,DTCT0024002,591473,DTCC00580203,1002985,2791
CHEMBL539787,P45452,,WNDMJNCVTIBVCL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,9873598,INHIBITION,=,0.79,%,,organism_based,,,,,,,,,,,,In vivo inhibition of matrix metalloprotease-13 (MMP-13) in mouse dialysis tubing implant assay at 50 mg/kg po,,The synthesis and biological activity of a novel series of diazepine MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,19,"Levin JI, DiJoseph JF, Killar LM, Sung A, Walter T, Sharr MA, Roth CE, Skotnicki JS, Albright JD",,106766,DTCT0024002,591474,DTCC00580203,1002985,2791
CHEMBL539930,P45452,,LNJYGNLGJFKFCM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17981034,IC50,=,4,NM,,,,,,,,,,,,,,Inhibition of MMP13,,1-Hydroxy-2-pyridinone-based MMP inhibitors: synthesis and biological evaluation for the treatment of ischemic stroke.,Bioorg. Med. Chem. Lett.,2008,18,1,"Zhang YM, Fan X, Chakaravarty D, Xiang B, Scannevin RH, Huang Z, Ma J, Burke SL, Karnachi P, Rhodes KJ, Jackson PF",,469434,DTCT0024002,2289327,DTCC00501228,1841595,25715
CHEMBL540723,P45452,,KDBQSPNKNKKPEM-NDEPHWFRSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19625186,IC50,=,32,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"3,4-Disubstituted benzofuran P1' MMP-13 inhibitors: optimization of selectivity and reduction of protein binding.",Bioorg. Med. Chem. Lett.,2009,19,16,"Li W, Hu Y, Li J, Thomason JR, DeVincentis D, Du X, Wu J, Hotchandani R, Rush TS, Skotnicki JS, Tam S, Chockalingam PS, Morris EA, Levin JI",,581466,DTCT0024002,2904499,DTCC00589981,100586,35265
CHEMBL541218,P45452,,FECFHXJGVVXRMZ-NDEPHWFRSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19625186,IC50,=,6.4,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"3,4-Disubstituted benzofuran P1' MMP-13 inhibitors: optimization of selectivity and reduction of protein binding.",Bioorg. Med. Chem. Lett.,2009,19,16,"Li W, Hu Y, Li J, Thomason JR, DeVincentis D, Du X, Wu J, Hotchandani R, Rush TS, Skotnicki JS, Tam S, Chockalingam PS, Morris EA, Levin JI",,581466,DTCT0024002,2904526,DTCC00588393,1006580,35265
CHEMBL541447,P45452,,DMMXGBRKSOTFSC-MHZLTWQESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19625186,IC50,=,25,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"3,4-Disubstituted benzofuran P1' MMP-13 inhibitors: optimization of selectivity and reduction of protein binding.",Bioorg. Med. Chem. Lett.,2009,19,16,"Li W, Hu Y, Li J, Thomason JR, DeVincentis D, Du X, Wu J, Hotchandani R, Rush TS, Skotnicki JS, Tam S, Chockalingam PS, Morris EA, Levin JI",,581466,DTCT0024002,2904478,DTCC00586761,1330358,35265
CHEMBL541703,P45452,,JENVXNLJMJTTNA-PMERELPUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19625186,IC50,=,15,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"3,4-Disubstituted benzofuran P1' MMP-13 inhibitors: optimization of selectivity and reduction of protein binding.",Bioorg. Med. Chem. Lett.,2009,19,16,"Li W, Hu Y, Li J, Thomason JR, DeVincentis D, Du X, Wu J, Hotchandani R, Rush TS, Skotnicki JS, Tam S, Chockalingam PS, Morris EA, Levin JI",,581466,DTCT0024002,2904523,DTCC00586807,2069376,35265
CHEMBL549756,P45452,,BGPDKPPPOAJAIA-QHCPKHFHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19725580,IC50,=,235,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthma.,J. Med. Chem.,2009,52,17,"Li W, Li J, Wu Y, Rancati F, Vallese S, Raveglia L, Wu J, Hotchandani R, Fuller N, Cunningham K, Morgan P, Fish S, Krykbaev R, Xu X, Tam S, Goldman SJ, Abraham W, Williams C, Sypek J, Mansour TS",,579100,DTCT0024002,2894840,DTCC00592487,1297680,34869
CHEMBL549854,P45452,,ZAQHFZCMMMYWLV-SANMLTNESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19625186,IC50,=,7.4,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"3,4-Disubstituted benzofuran P1' MMP-13 inhibitors: optimization of selectivity and reduction of protein binding.",Bioorg. Med. Chem. Lett.,2009,19,16,"Li W, Hu Y, Li J, Thomason JR, DeVincentis D, Du X, Wu J, Hotchandani R, Rush TS, Skotnicki JS, Tam S, Chockalingam PS, Morris EA, Levin JI",,581466,DTCT0024002,2904475,DTCC00589964,618893,35265
CHEMBL549970,P45452,,HJAMHEUHISNRJU-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19725580,IC50,>,25000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthma.,J. Med. Chem.,2009,52,17,"Li W, Li J, Wu Y, Rancati F, Vallese S, Raveglia L, Wu J, Hotchandani R, Fuller N, Cunningham K, Morgan P, Fish S, Krykbaev R, Xu X, Tam S, Goldman SJ, Abraham W, Williams C, Sypek J, Mansour TS",,579100,DTCT0024002,2894825,DTCC00587751,2004738,34869
CHEMBL550038,P45452,,FWPVXLYOKAOERT-SFHVURJKSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19725580,IC50,=,106,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthma.,J. Med. Chem.,2009,52,17,"Li W, Li J, Wu Y, Rancati F, Vallese S, Raveglia L, Wu J, Hotchandani R, Fuller N, Cunningham K, Morgan P, Fish S, Krykbaev R, Xu X, Tam S, Goldman SJ, Abraham W, Williams C, Sypek J, Mansour TS",,579100,DTCT0024002,2894850,DTCC00589403,941987,34869
CHEMBL550081,P45452,,RPWGPXSVYLHGRZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19606871,IC50,=,7.2,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571086,DTCT0024002,2859492,DTCC00590514,489960,34421
CHEMBL550148,P45452,,NKGRTRASISLCCZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19606871,IC50,=,2.4,NM,,,,,,,,,,,,,,Inhibition of MMP13-mediated collagen degradation by SDS-PAGE,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571091,DTCT0024002,2859531,DTCC00592085,1588878,34421
CHEMBL550148,P45452,,NKGRTRASISLCCZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19606871,IC50,=,2.8,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571086,DTCT0024002,2859491,DTCC00592085,1588878,34421
CHEMBL550148,P45452,,NKGRTRASISLCCZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,2,NM,,,,,,,,,,,,,,Inhibition of MMP13 (unknown origin)-mediated Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorimetric assay,,,ACS Med. Chem. Lett.,2013,4,6,,,960928,DTCT0024002,12452603,DTCC00592085,1612364,54626
CHEMBL550350,P45452,,DKTYDWAJILHINP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19606871,IC50,=,19,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571086,DTCT0024002,2859495,DTCC00592090,1653714,34421
CHEMBL550350,P45452,,DKTYDWAJILHINP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19606871,KI,=,8.2,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571086,DTCT0024002,2859544,DTCC00592090,1653714,34421
CHEMBL550548,P45452,,UTCUOTDVVXFCLJ-AREMUKBSSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19606871,IC50,=,1.4,NM,,,,,,,,,,,,,,Inhibition of MMP13-mediated collagen degradation by SDS-PAGE,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571091,DTCT0024002,2859532,DTCC00592094,327760,34421
CHEMBL550548,P45452,,UTCUOTDVVXFCLJ-AREMUKBSSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19606871,IC50,=,3,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571086,DTCT0024002,2859502,DTCC00592094,327760,34421
CHEMBL550548,P45452,,UTCUOTDVVXFCLJ-AREMUKBSSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19606871,KI,=,29,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571086,DTCT0024002,2859543,DTCC00592094,327760,34421
CHEMBL550562,P45452,,SKLOAVPDSDQCQV-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19725580,IC50,=,215,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthma.,J. Med. Chem.,2009,52,17,"Li W, Li J, Wu Y, Rancati F, Vallese S, Raveglia L, Wu J, Hotchandani R, Fuller N, Cunningham K, Morgan P, Fish S, Krykbaev R, Xu X, Tam S, Goldman SJ, Abraham W, Williams C, Sypek J, Mansour TS",,579100,DTCT0024002,2894830,DTCC00592572,132886,34869
CHEMBL550628,P45452,,FRFSAUPOCJTACG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19606871,IC50,=,260,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571086,DTCT0024002,2859498,DTCC00589012,1038878,34421
CHEMBL550702,P45452,,ZTPDQAOEZMYSGR-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19725580,IC50,>,1000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthma.,J. Med. Chem.,2009,52,17,"Li W, Li J, Wu Y, Rancati F, Vallese S, Raveglia L, Wu J, Hotchandani R, Fuller N, Cunningham K, Morgan P, Fish S, Krykbaev R, Xu X, Tam S, Goldman SJ, Abraham W, Williams C, Sypek J, Mansour TS",,579100,DTCT0024002,2894832,DTCC00590831,261884,34869
CHEMBL550786,P45452,,CCTDBXLXFNHDIL-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19725580,IC50,=,1286,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthma.,J. Med. Chem.,2009,52,17,"Li W, Li J, Wu Y, Rancati F, Vallese S, Raveglia L, Wu J, Hotchandani R, Fuller N, Cunningham K, Morgan P, Fish S, Krykbaev R, Xu X, Tam S, Goldman SJ, Abraham W, Williams C, Sypek J, Mansour TS",,579100,DTCT0024002,2894846,DTCC00587856,2004752,34869
CHEMBL550907,P45452,,PEOWGCZHIMSTFM-FQEVSTJZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19725580,IC50,=,334,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthma.,J. Med. Chem.,2009,52,17,"Li W, Li J, Wu Y, Rancati F, Vallese S, Raveglia L, Wu J, Hotchandani R, Fuller N, Cunningham K, Morgan P, Fish S, Krykbaev R, Xu X, Tam S, Goldman SJ, Abraham W, Williams C, Sypek J, Mansour TS",,579100,DTCT0024002,2894836,DTCC00590838,393114,34869
CHEMBL550984,P45452,,RGCUFTVHLLFSQN-QFIPXVFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19725580,IC50,=,225,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthma.,J. Med. Chem.,2009,52,17,"Li W, Li J, Wu Y, Rancati F, Vallese S, Raveglia L, Wu J, Hotchandani R, Fuller N, Cunningham K, Morgan P, Fish S, Krykbaev R, Xu X, Tam S, Goldman SJ, Abraham W, Williams C, Sypek J, Mansour TS",,579100,DTCT0024002,2894839,DTCC00587776,554327,34869
CHEMBL551110,P45452,,JPIVNFSAQUANEQ-SFHVURJKSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19725580,IC50,=,809,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthma.,J. Med. Chem.,2009,52,17,"Li W, Li J, Wu Y, Rancati F, Vallese S, Raveglia L, Wu J, Hotchandani R, Fuller N, Cunningham K, Morgan P, Fish S, Krykbaev R, Xu X, Tam S, Goldman SJ, Abraham W, Williams C, Sypek J, Mansour TS",,579100,DTCT0024002,2894842,DTCC00590846,1104136,34869
CHEMBL551187,P45452,,DXRHJEFJSKWMEQ-QFIPXVFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19725580,IC50,=,456,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthma.,J. Med. Chem.,2009,52,17,"Li W, Li J, Wu Y, Rancati F, Vallese S, Raveglia L, Wu J, Hotchandani R, Fuller N, Cunningham K, Morgan P, Fish S, Krykbaev R, Xu X, Tam S, Goldman SJ, Abraham W, Williams C, Sypek J, Mansour TS",,579100,DTCT0024002,2894844,DTCC00587782,1459717,34869
CHEMBL551190,P45452,,BWJNOHKLFBLHOO-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19725580,IC50,=,60000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthma.,J. Med. Chem.,2009,52,17,"Li W, Li J, Wu Y, Rancati F, Vallese S, Raveglia L, Wu J, Hotchandani R, Fuller N, Cunningham K, Morgan P, Fish S, Krykbaev R, Xu X, Tam S, Goldman SJ, Abraham W, Williams C, Sypek J, Mansour TS",,579100,DTCT0024002,2894819,DTCC00587869,1556656,34869
CHEMBL551611,P45452,,QAEKGVKCHDBGEN-VWLOTQADSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19625186,IC50,=,8,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"3,4-Disubstituted benzofuran P1' MMP-13 inhibitors: optimization of selectivity and reduction of protein binding.",Bioorg. Med. Chem. Lett.,2009,19,16,"Li W, Hu Y, Li J, Thomason JR, DeVincentis D, Du X, Wu J, Hotchandani R, Rush TS, Skotnicki JS, Tam S, Chockalingam PS, Morris EA, Levin JI",,581466,DTCT0024002,2904487,DTCC00588364,456817,35265
CHEMBL551655,P45452,,KNBKYJWSHYOTTH-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19725580,IC50,=,1135,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthma.,J. Med. Chem.,2009,52,17,"Li W, Li J, Wu Y, Rancati F, Vallese S, Raveglia L, Wu J, Hotchandani R, Fuller N, Cunningham K, Morgan P, Fish S, Krykbaev R, Xu X, Tam S, Goldman SJ, Abraham W, Williams C, Sypek J, Mansour TS",,579100,DTCT0024002,2894823,DTCC00589362,1167571,34869
CHEMBL552175,P45452,,NZFXVEQIRZMPRQ-IBGZPJMESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19725580,IC50,=,40,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthma.,J. Med. Chem.,2009,52,17,"Li W, Li J, Wu Y, Rancati F, Vallese S, Raveglia L, Wu J, Hotchandani R, Fuller N, Cunningham K, Morgan P, Fish S, Krykbaev R, Xu X, Tam S, Goldman SJ, Abraham W, Williams C, Sypek J, Mansour TS",,579100,DTCT0024002,2894837,DTCC00592472,974044,34869
CHEMBL552213,P45452,,QXMXXJUEHWZLCA-MHZLTWQESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19625186,IC50,=,7.1,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"3,4-Disubstituted benzofuran P1' MMP-13 inhibitors: optimization of selectivity and reduction of protein binding.",Bioorg. Med. Chem. Lett.,2009,19,16,"Li W, Hu Y, Li J, Thomason JR, DeVincentis D, Du X, Wu J, Hotchandani R, Rush TS, Skotnicki JS, Tam S, Chockalingam PS, Morris EA, Levin JI",,581466,DTCT0024002,2904508,DTCC00588380,715781,35265
CHEMBL552313,P45452,,NKGBFKCCSGHHPF-SFHVURJKSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19725580,IC50,=,140,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthma.,J. Med. Chem.,2009,52,17,"Li W, Li J, Wu Y, Rancati F, Vallese S, Raveglia L, Wu J, Hotchandani R, Fuller N, Cunningham K, Morgan P, Fish S, Krykbaev R, Xu X, Tam S, Goldman SJ, Abraham W, Williams C, Sypek J, Mansour TS",,579100,DTCT0024002,2894852,DTCC00123371,1427730,34869
CHEMBL552362,P45452,,FFGHBWJVBSUBKN-QFIPXVFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19725580,IC50,=,187,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthma.,J. Med. Chem.,2009,52,17,"Li W, Li J, Wu Y, Rancati F, Vallese S, Raveglia L, Wu J, Hotchandani R, Fuller N, Cunningham K, Morgan P, Fish S, Krykbaev R, Xu X, Tam S, Goldman SJ, Abraham W, Williams C, Sypek J, Mansour TS",,579100,DTCT0024002,2894845,DTCC00592496,1071404,34869
CHEMBL552376,P45452,,JUTPKTDNWMOAGF-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19725580,IC50,>,25000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthma.,J. Med. Chem.,2009,52,17,"Li W, Li J, Wu Y, Rancati F, Vallese S, Raveglia L, Wu J, Hotchandani R, Fuller N, Cunningham K, Morgan P, Fish S, Krykbaev R, Xu X, Tam S, Goldman SJ, Abraham W, Williams C, Sypek J, Mansour TS",,579100,DTCT0024002,2894820,DTCC00592583,1006531,34869
CHEMBL552377,P45452,,JUTPKTDNWMOAGF-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19725580,IC50,>,25000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthma.,J. Med. Chem.,2009,52,17,"Li W, Li J, Wu Y, Rancati F, Vallese S, Raveglia L, Wu J, Hotchandani R, Fuller N, Cunningham K, Morgan P, Fish S, Krykbaev R, Xu X, Tam S, Goldman SJ, Abraham W, Williams C, Sypek J, Mansour TS",,579100,DTCT0024002,2894821,DTCC00592584,1104142,34869
CHEMBL553918,P45452,,SMJNKVQJVSTDHQ-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19725580,IC50,=,1093,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthma.,J. Med. Chem.,2009,52,17,"Li W, Li J, Wu Y, Rancati F, Vallese S, Raveglia L, Wu J, Hotchandani R, Fuller N, Cunningham K, Morgan P, Fish S, Krykbaev R, Xu X, Tam S, Goldman SJ, Abraham W, Williams C, Sypek J, Mansour TS",,579100,DTCT0024002,2894853,DTCC00123372,1297683,34869
CHEMBL554269,P45452,,OBHHLEXVYGNCHI-INFYBVPRSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19093877,ACTIVITY,,,,,,,,,,,,,,,,,Binding affinity to MMP13 assessed as enzyme mediated cleavage of compound by measuring increase in fluorescence after 16 hrs by HPLC-MS,Not Active,Photodynamic molecular beacon triggered by fibroblast activation protein on cancer-associated fibroblasts for diagnosis and treatment of epithelial cancers.,J. Med. Chem.,2009,52,2,"Lo PC, Chen J, Stefflova K, Warren MS, Navab R, Bandarchi B, Mullins S, Tsao M, Cheng JD, Zheng G",,495041,DTCT0024002,2594657,DTCC00582506,1049706,32091
CHEMBL554512,P45452,,VKMIOAOQXFVGMB-YKHFMZSMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19625186,IC50,=,13,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"3,4-Disubstituted benzofuran P1' MMP-13 inhibitors: optimization of selectivity and reduction of protein binding.",Bioorg. Med. Chem. Lett.,2009,19,16,"Li W, Hu Y, Li J, Thomason JR, DeVincentis D, Du X, Wu J, Hotchandani R, Rush TS, Skotnicki JS, Tam S, Chockalingam PS, Morris EA, Levin JI",,581466,DTCT0024002,2904553,DTCC00591520,1006583,35265
CHEMBL554512,P45452,,VKMIOAOQXFVGMB-YKHFMZSMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19625186,INH,=,406,NM,,,,,,,,,,,,,,Inhibition of MMP13 in presence of 25mg/mL rabbit serum albumin,,"3,4-Disubstituted benzofuran P1' MMP-13 inhibitors: optimization of selectivity and reduction of protein binding.",Bioorg. Med. Chem. Lett.,2009,19,16,"Li W, Hu Y, Li J, Thomason JR, DeVincentis D, Du X, Wu J, Hotchandani R, Rush TS, Skotnicki JS, Tam S, Chockalingam PS, Morris EA, Levin JI",,581469,DTCT0024002,2904543,DTCC00591520,1006583,35265
CHEMBL554512,P45452,,VKMIOAOQXFVGMB-YKHFMZSMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19625186,RATIO IC50,=,31,,,,,,,,,,,,,,,Ratio of IC50 for MMP13 in presence of rabbit serum albumin to IC50 for MMP13 in absence of rabbit serum albumin,,"3,4-Disubstituted benzofuran P1' MMP-13 inhibitors: optimization of selectivity and reduction of protein binding.",Bioorg. Med. Chem. Lett.,2009,19,16,"Li W, Hu Y, Li J, Thomason JR, DeVincentis D, Du X, Wu J, Hotchandani R, Rush TS, Skotnicki JS, Tam S, Chockalingam PS, Morris EA, Levin JI",,581470,DTCT0024002,2904544,DTCC00591520,1006583,35265
CHEMBL556645,P45452,,KNWGEVZOUCQOLE-VWLOTQADSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19625186,IC50,=,3.7,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"3,4-Disubstituted benzofuran P1' MMP-13 inhibitors: optimization of selectivity and reduction of protein binding.",Bioorg. Med. Chem. Lett.,2009,19,16,"Li W, Hu Y, Li J, Thomason JR, DeVincentis D, Du X, Wu J, Hotchandani R, Rush TS, Skotnicki JS, Tam S, Chockalingam PS, Morris EA, Levin JI",,581466,DTCT0024002,2904514,DTCC00593100,651477,35265
CHEMBL556645,P45452,,KNWGEVZOUCQOLE-VWLOTQADSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19625186,INH,=,13100,NM,,,,,,,,,,,,,,Inhibition of MMP13 in presence of 25mg/mL rabbit serum albumin,,"3,4-Disubstituted benzofuran P1' MMP-13 inhibitors: optimization of selectivity and reduction of protein binding.",Bioorg. Med. Chem. Lett.,2009,19,16,"Li W, Hu Y, Li J, Thomason JR, DeVincentis D, Du X, Wu J, Hotchandani R, Rush TS, Skotnicki JS, Tam S, Chockalingam PS, Morris EA, Levin JI",,581469,DTCT0024002,2904537,DTCC00593100,651477,35265
CHEMBL556645,P45452,,KNWGEVZOUCQOLE-VWLOTQADSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19625186,RATIO IC50,=,3257,,,,,,,,,,,,,,,Ratio of IC50 for MMP13 in presence of rabbit serum albumin to IC50 for MMP13 in absence of rabbit serum albumin,,"3,4-Disubstituted benzofuran P1' MMP-13 inhibitors: optimization of selectivity and reduction of protein binding.",Bioorg. Med. Chem. Lett.,2009,19,16,"Li W, Hu Y, Li J, Thomason JR, DeVincentis D, Du X, Wu J, Hotchandani R, Rush TS, Skotnicki JS, Tam S, Chockalingam PS, Morris EA, Levin JI",,581470,DTCT0024002,2904538,DTCC00593100,651477,35265
CHEMBL559250,P45452,,TVMGXYGVVFPAHO-SANMLTNESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19625186,IC50,=,25,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"3,4-Disubstituted benzofuran P1' MMP-13 inhibitors: optimization of selectivity and reduction of protein binding.",Bioorg. Med. Chem. Lett.,2009,19,16,"Li W, Hu Y, Li J, Thomason JR, DeVincentis D, Du X, Wu J, Hotchandani R, Rush TS, Skotnicki JS, Tam S, Chockalingam PS, Morris EA, Levin JI",,581466,DTCT0024002,2904493,DTCC00593087,1265207,35265
CHEMBL559413,P45452,,HESIRWKKCVPIEN-NDEPHWFRSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19625186,IC50,=,11,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"3,4-Disubstituted benzofuran P1' MMP-13 inhibitors: optimization of selectivity and reduction of protein binding.",Bioorg. Med. Chem. Lett.,2009,19,16,"Li W, Hu Y, Li J, Thomason JR, DeVincentis D, Du X, Wu J, Hotchandani R, Rush TS, Skotnicki JS, Tam S, Chockalingam PS, Morris EA, Levin JI",,581466,DTCT0024002,2904511,DTCC00586799,1556705,35265
CHEMBL559583,P45452,,WUJPOLIUEWWSHN-IBGZPJMESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19725580,IC50,=,147,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthma.,J. Med. Chem.,2009,52,17,"Li W, Li J, Wu Y, Rancati F, Vallese S, Raveglia L, Wu J, Hotchandani R, Fuller N, Cunningham K, Morgan P, Fish S, Krykbaev R, Xu X, Tam S, Goldman SJ, Abraham W, Williams C, Sypek J, Mansour TS",,579100,DTCT0024002,2894835,DTCC00586139,2004740,34869
CHEMBL559585,P45452,,KRVMUJILUZQWCW-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19725580,IC50,=,1353,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthma.,J. Med. Chem.,2009,52,17,"Li W, Li J, Wu Y, Rancati F, Vallese S, Raveglia L, Wu J, Hotchandani R, Fuller N, Cunningham K, Morgan P, Fish S, Krykbaev R, Xu X, Tam S, Goldman SJ, Abraham W, Williams C, Sypek J, Mansour TS",,579100,DTCT0024002,2894828,DTCC00586222,586551,34869
CHEMBL559804,P45452,,PXHGETTXNHZYEU-MHZLTWQESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19625186,IC50,=,9.5,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"3,4-Disubstituted benzofuran P1' MMP-13 inhibitors: optimization of selectivity and reduction of protein binding.",Bioorg. Med. Chem. Lett.,2009,19,16,"Li W, Hu Y, Li J, Thomason JR, DeVincentis D, Du X, Wu J, Hotchandani R, Rush TS, Skotnicki JS, Tam S, Chockalingam PS, Morris EA, Levin JI",,581466,DTCT0024002,2904520,DTCC00586806,1556707,35265
CHEMBL559805,P45452,,XDMVXFHJJTUNSB-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19625186,IC50,=,14,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"3,4-Disubstituted benzofuran P1' MMP-13 inhibitors: optimization of selectivity and reduction of protein binding.",Bioorg. Med. Chem. Lett.,2009,19,16,"Li W, Hu Y, Li J, Thomason JR, DeVincentis D, Du X, Wu J, Hotchandani R, Rush TS, Skotnicki JS, Tam S, Chockalingam PS, Morris EA, Levin JI",,581466,DTCT0024002,2904547,DTCC00586808,1685937,35265
CHEMBL559805,P45452,,XDMVXFHJJTUNSB-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19625186,INH,=,5250,NM,,,,,,,,,,,,,,Inhibition of MMP13 in presence of 25mg/mL rabbit serum albumin,,"3,4-Disubstituted benzofuran P1' MMP-13 inhibitors: optimization of selectivity and reduction of protein binding.",Bioorg. Med. Chem. Lett.,2009,19,16,"Li W, Hu Y, Li J, Thomason JR, DeVincentis D, Du X, Wu J, Hotchandani R, Rush TS, Skotnicki JS, Tam S, Chockalingam PS, Morris EA, Levin JI",,581469,DTCT0024002,2904539,DTCC00586808,1685937,35265
CHEMBL559805,P45452,,XDMVXFHJJTUNSB-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19625186,RATIO IC50,=,375,,,,,,,,,,,,,,,Ratio of IC50 for MMP13 in presence of rabbit serum albumin to IC50 for MMP13 in absence of rabbit serum albumin,,"3,4-Disubstituted benzofuran P1' MMP-13 inhibitors: optimization of selectivity and reduction of protein binding.",Bioorg. Med. Chem. Lett.,2009,19,16,"Li W, Hu Y, Li J, Thomason JR, DeVincentis D, Du X, Wu J, Hotchandani R, Rush TS, Skotnicki JS, Tam S, Chockalingam PS, Morris EA, Levin JI",,581470,DTCT0024002,2904540,DTCC00586808,1685937,35265
CHEMBL560137,P45452,,RVBSKRBWGPIJIS-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19625186,IC50,=,6.1,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"3,4-Disubstituted benzofuran P1' MMP-13 inhibitors: optimization of selectivity and reduction of protein binding.",Bioorg. Med. Chem. Lett.,2009,19,16,"Li W, Hu Y, Li J, Thomason JR, DeVincentis D, Du X, Wu J, Hotchandani R, Rush TS, Skotnicki JS, Tam S, Chockalingam PS, Morris EA, Levin JI",,581466,DTCT0024002,2904469,DTCC00585249,715778,35265
CHEMBL560837,P45452,,LBKCSOUMADYGHM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19606871,IC50,=,10,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571086,DTCT0024002,2859493,DTCC00122971,1717205,34421
CHEMBL560837,P45452,,LBKCSOUMADYGHM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19606871,KI,=,5.8,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571086,DTCT0024002,2859545,DTCC00122971,1717205,34421
CHEMBL561036,P45452,,HZTQDRLCDGHQSA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19606871,IC50,=,15,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571086,DTCT0024002,2859494,DTCC00122972,748051,34421
CHEMBL561038,P45452,,WVAIZSKMOMDPIT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19606871,IC50,=,63,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571086,DTCT0024002,2859497,DTCC00122975,910381,34421
CHEMBL561039,P45452,,KJDPTHLLJDQIMT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19606871,IC50,=,91,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571086,DTCT0024002,2859500,DTCC00122976,715703,34421
CHEMBL561310,P45452,,HJAMHEUHISNRJU-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19725580,IC50,>,25000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthma.,J. Med. Chem.,2009,52,17,"Li W, Li J, Wu Y, Rancati F, Vallese S, Raveglia L, Wu J, Hotchandani R, Fuller N, Cunningham K, Morgan P, Fish S, Krykbaev R, Xu X, Tam S, Goldman SJ, Abraham W, Williams C, Sypek J, Mansour TS",,579100,DTCT0024002,2894824,DTCC00584642,845353,34869
CHEMBL561311,P45452,,ALKUUIDKRJZTBK-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19725580,IC50,=,1.22,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthma.,J. Med. Chem.,2009,52,17,"Li W, Li J, Wu Y, Rancati F, Vallese S, Raveglia L, Wu J, Hotchandani R, Fuller N, Cunningham K, Morgan P, Fish S, Krykbaev R, Xu X, Tam S, Goldman SJ, Abraham W, Williams C, Sypek J, Mansour TS",,579100,DTCT0024002,2894826,DTCC00584643,812482,34869
CHEMBL561312,P45452,,ALKUUIDKRJZTBK-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19725580,IC50,=,65,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthma.,J. Med. Chem.,2009,52,17,"Li W, Li J, Wu Y, Rancati F, Vallese S, Raveglia L, Wu J, Hotchandani R, Fuller N, Cunningham K, Morgan P, Fish S, Krykbaev R, Xu X, Tam S, Goldman SJ, Abraham W, Williams C, Sypek J, Mansour TS",,579100,DTCT0024002,2894827,DTCC00584644,522246,34869
CHEMBL561625,P45452,,PZJJOMPTIHBGHO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19606871,IC50,=,9.4,NM,,,,,,,,,,,,,,Inhibition of MMP13-mediated collagen degradation by SDS-PAGE,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571091,DTCT0024002,2859530,DTCC00587403,1492221,34421
CHEMBL561625,P45452,,PZJJOMPTIHBGHO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19606871,IC50,=,39,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571086,DTCT0024002,2859490,DTCC00587403,1492221,34421
CHEMBL561630,P45452,,JSQUVSOHRBZSNW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19606871,IC50,=,25,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571086,DTCT0024002,2859501,DTCC00587413,489961,34421
CHEMBL561715,P45452,,ZURXLNWQPVEFOH-SFHVURJKSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19725580,IC50,=,56,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthma.,J. Med. Chem.,2009,52,17,"Li W, Li J, Wu Y, Rancati F, Vallese S, Raveglia L, Wu J, Hotchandani R, Fuller N, Cunningham K, Morgan P, Fish S, Krykbaev R, Xu X, Tam S, Goldman SJ, Abraham W, Williams C, Sypek J, Mansour TS",,579100,DTCT0024002,2894834,DTCC00584652,100521,34869
CHEMBL561963,P45452,,UMEYNLZNXJZVAP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19606871,KI,=,1.5,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571086,DTCT0024002,2859547,DTCC00585821,1104090,34421
CHEMBL562003,P45452,,FSIUHCOQNBURSE-VWLOTQADSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19625186,IC50,=,13,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"3,4-Disubstituted benzofuran P1' MMP-13 inhibitors: optimization of selectivity and reduction of protein binding.",Bioorg. Med. Chem. Lett.,2009,19,16,"Li W, Hu Y, Li J, Thomason JR, DeVincentis D, Du X, Wu J, Hotchandani R, Rush TS, Skotnicki JS, Tam S, Chockalingam PS, Morris EA, Levin JI",,581466,DTCT0024002,2904496,DTCC00586782,1071452,35265
CHEMBL562003,P45452,,FSIUHCOQNBURSE-VWLOTQADSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19625186,INH,=,9040,NM,,,,,,,,,,,,,,Inhibition of MMP13 in presence of 25mg/mL rabbit serum albumin,,"3,4-Disubstituted benzofuran P1' MMP-13 inhibitors: optimization of selectivity and reduction of protein binding.",Bioorg. Med. Chem. Lett.,2009,19,16,"Li W, Hu Y, Li J, Thomason JR, DeVincentis D, Du X, Wu J, Hotchandani R, Rush TS, Skotnicki JS, Tam S, Chockalingam PS, Morris EA, Levin JI",,581469,DTCT0024002,2904535,DTCC00586782,1071452,35265
CHEMBL562003,P45452,,FSIUHCOQNBURSE-VWLOTQADSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19625186,RATIO IC50,=,695,,,,,,,,,,,,,,,Ratio of IC50 for MMP13 in presence of rabbit serum albumin to IC50 for MMP13 in absence of rabbit serum albumin,,"3,4-Disubstituted benzofuran P1' MMP-13 inhibitors: optimization of selectivity and reduction of protein binding.",Bioorg. Med. Chem. Lett.,2009,19,16,"Li W, Hu Y, Li J, Thomason JR, DeVincentis D, Du X, Wu J, Hotchandani R, Rush TS, Skotnicki JS, Tam S, Chockalingam PS, Morris EA, Levin JI",,581470,DTCT0024002,2904536,DTCC00586782,1071452,35265
CHEMBL562114,P45452,,SQQRAMLTIHSAJA-QFIPXVFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19725580,IC50,=,217,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthma.,J. Med. Chem.,2009,52,17,"Li W, Li J, Wu Y, Rancati F, Vallese S, Raveglia L, Wu J, Hotchandani R, Fuller N, Cunningham K, Morgan P, Fish S, Krykbaev R, Xu X, Tam S, Goldman SJ, Abraham W, Williams C, Sypek J, Mansour TS",,579100,DTCT0024002,2894841,DTCC00584669,812485,34869
CHEMBL562338,P45452,,SBXVFSKKCXNEDY-AQJFCTLQSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19625186,IC50,=,35,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"3,4-Disubstituted benzofuran P1' MMP-13 inhibitors: optimization of selectivity and reduction of protein binding.",Bioorg. Med. Chem. Lett.,2009,19,16,"Li W, Hu Y, Li J, Thomason JR, DeVincentis D, Du X, Wu J, Hotchandani R, Rush TS, Skotnicki JS, Tam S, Chockalingam PS, Morris EA, Levin JI",,581466,DTCT0024002,2904556,DTCC00585300,1685939,35265
CHEMBL562338,P45452,,SBXVFSKKCXNEDY-AQJFCTLQSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19625186,INH,=,307,NM,,,,,,,,,,,,,,Inhibition of MMP13 in presence of 25mg/mL rabbit serum albumin,,"3,4-Disubstituted benzofuran P1' MMP-13 inhibitors: optimization of selectivity and reduction of protein binding.",Bioorg. Med. Chem. Lett.,2009,19,16,"Li W, Hu Y, Li J, Thomason JR, DeVincentis D, Du X, Wu J, Hotchandani R, Rush TS, Skotnicki JS, Tam S, Chockalingam PS, Morris EA, Levin JI",,581469,DTCT0024002,2904545,DTCC00585300,1685939,35265
CHEMBL562338,P45452,,SBXVFSKKCXNEDY-AQJFCTLQSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19625186,RATIO IC50,=,9,,,,,,,,,,,,,,,Ratio of IC50 for MMP13 in presence of rabbit serum albumin to IC50 for MMP13 in absence of rabbit serum albumin,,"3,4-Disubstituted benzofuran P1' MMP-13 inhibitors: optimization of selectivity and reduction of protein binding.",Bioorg. Med. Chem. Lett.,2009,19,16,"Li W, Hu Y, Li J, Thomason JR, DeVincentis D, Du X, Wu J, Hotchandani R, Rush TS, Skotnicki JS, Tam S, Chockalingam PS, Morris EA, Levin JI",,581470,DTCT0024002,2904546,DTCC00585300,1685939,35265
CHEMBL562373,P45452,,KRVMUJILUZQWCW-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19725580,IC50,=,632,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthma.,J. Med. Chem.,2009,52,17,"Li W, Li J, Wu Y, Rancati F, Vallese S, Raveglia L, Wu J, Hotchandani R, Fuller N, Cunningham K, Morgan P, Fish S, Krykbaev R, Xu X, Tam S, Goldman SJ, Abraham W, Williams C, Sypek J, Mansour TS",,579100,DTCT0024002,2894829,DTCC00586124,229599,34869
CHEMBL562374,P45452,,ZURXLNWQPVEFOH-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19725580,IC50,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,Not Determined,Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthma.,J. Med. Chem.,2009,52,17,"Li W, Li J, Wu Y, Rancati F, Vallese S, Raveglia L, Wu J, Hotchandani R, Fuller N, Cunningham K, Morgan P, Fish S, Krykbaev R, Xu X, Tam S, Goldman SJ, Abraham W, Williams C, Sypek J, Mansour TS",,579100,DTCT0024002,2894833,DTCC00586125,1653752,34869
CHEMBL562607,P45452,,WXFYHQKQOWMEDX-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19625186,IC50,=,40,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"3,4-Disubstituted benzofuran P1' MMP-13 inhibitors: optimization of selectivity and reduction of protein binding.",Bioorg. Med. Chem. Lett.,2009,19,16,"Li W, Hu Y, Li J, Thomason JR, DeVincentis D, Du X, Wu J, Hotchandani R, Rush TS, Skotnicki JS, Tam S, Chockalingam PS, Morris EA, Levin JI",,581466,DTCT0024002,2904550,DTCC00593117,845403,35265
CHEMBL562607,P45452,,WXFYHQKQOWMEDX-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19625186,INH,=,8950,NM,,,,,,,,,,,,,,Inhibition of MMP13 in presence of 25mg/mL rabbit serum albumin,,"3,4-Disubstituted benzofuran P1' MMP-13 inhibitors: optimization of selectivity and reduction of protein binding.",Bioorg. Med. Chem. Lett.,2009,19,16,"Li W, Hu Y, Li J, Thomason JR, DeVincentis D, Du X, Wu J, Hotchandani R, Rush TS, Skotnicki JS, Tam S, Chockalingam PS, Morris EA, Levin JI",,581469,DTCT0024002,2904541,DTCC00593117,845403,35265
CHEMBL562607,P45452,,WXFYHQKQOWMEDX-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19625186,RATIO IC50,=,224,,,,,,,,,,,,,,,Ratio of IC50 for MMP13 in presence of rabbit serum albumin to IC50 for MMP13 in absence of rabbit serum albumin,,"3,4-Disubstituted benzofuran P1' MMP-13 inhibitors: optimization of selectivity and reduction of protein binding.",Bioorg. Med. Chem. Lett.,2009,19,16,"Li W, Hu Y, Li J, Thomason JR, DeVincentis D, Du X, Wu J, Hotchandani R, Rush TS, Skotnicki JS, Tam S, Chockalingam PS, Morris EA, Levin JI",,581470,DTCT0024002,2904542,DTCC00593117,845403,35265
CHEMBL562850,P45452,,KNBKYJWSHYOTTH-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19725580,IC50,=,277,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthma.,J. Med. Chem.,2009,52,17,"Li W, Li J, Wu Y, Rancati F, Vallese S, Raveglia L, Wu J, Hotchandani R, Fuller N, Cunningham K, Morgan P, Fish S, Krykbaev R, Xu X, Tam S, Goldman SJ, Abraham W, Williams C, Sypek J, Mansour TS",,579100,DTCT0024002,2894822,DTCC00586236,1136377,34869
CHEMBL563026,P45452,,MRYXWLVKWYVRPC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19606871,IC50,=,600,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571086,DTCT0024002,2859499,DTCC00584342,327759,34421
CHEMBL563177,P45452,,PKQOURGVZCVPOK-SFHVURJKSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19725580,IC50,=,370,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthma.,J. Med. Chem.,2009,52,17,"Li W, Li J, Wu Y, Rancati F, Vallese S, Raveglia L, Wu J, Hotchandani R, Fuller N, Cunningham K, Morgan P, Fish S, Krykbaev R, Xu X, Tam S, Goldman SJ, Abraham W, Williams C, Sypek J, Mansour TS",,579100,DTCT0024002,2894851,DTCC00586169,1297681,34869
CHEMBL563343,P45452,,TUJKFLFRSWBCFZ-QHCPKHFHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19725580,IC50,=,200,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthma.,J. Med. Chem.,2009,52,17,"Li W, Li J, Wu Y, Rancati F, Vallese S, Raveglia L, Wu J, Hotchandani R, Fuller N, Cunningham K, Morgan P, Fish S, Krykbaev R, Xu X, Tam S, Goldman SJ, Abraham W, Williams C, Sypek J, Mansour TS",,579100,DTCT0024002,2894848,DTCC00583183,327807,34869
CHEMBL563407,P45452,,BHJRCMPVJFWSEN-FQEVSTJZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19725580,IC50,=,23,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthma.,J. Med. Chem.,2009,52,17,"Li W, Li J, Wu Y, Rancati F, Vallese S, Raveglia L, Wu J, Hotchandani R, Fuller N, Cunningham K, Morgan P, Fish S, Krykbaev R, Xu X, Tam S, Goldman SJ, Abraham W, Williams C, Sypek J, Mansour TS",,579100,DTCT0024002,2894838,DTCC00592473,1938911,34869
CHEMBL563679,P45452,,ZQBRASLBYJYZLM-CMDGGOBGSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19606871,IC50,=,41,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571086,DTCT0024002,2859496,DTCC00587409,425709,34421
CHEMBL563896,P45452,,YBWPRDKPAFCNSF-SANMLTNESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19625186,IC50,=,2.3,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"3,4-Disubstituted benzofuran P1' MMP-13 inhibitors: optimization of selectivity and reduction of protein binding.",Bioorg. Med. Chem. Lett.,2009,19,16,"Li W, Hu Y, Li J, Thomason JR, DeVincentis D, Du X, Wu J, Hotchandani R, Rush TS, Skotnicki JS, Tam S, Chockalingam PS, Morris EA, Levin JI",,581466,DTCT0024002,2904505,DTCC00591496,1717288,35265
CHEMBL564232,P45452,,NSOWFDNMRUSVGR-SANMLTNESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19625186,IC50,=,6.5,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"3,4-Disubstituted benzofuran P1' MMP-13 inhibitors: optimization of selectivity and reduction of protein binding.",Bioorg. Med. Chem. Lett.,2009,19,16,"Li W, Hu Y, Li J, Thomason JR, DeVincentis D, Du X, Wu J, Hotchandani R, Rush TS, Skotnicki JS, Tam S, Chockalingam PS, Morris EA, Levin JI",,581466,DTCT0024002,2904490,DTCC00588365,2004802,35265
CHEMBL564510,P45452,,CCTDBXLXFNHDIL-QFIPXVFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19725580,IC50,=,269,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthma.,J. Med. Chem.,2009,52,17,"Li W, Li J, Wu Y, Rancati F, Vallese S, Raveglia L, Wu J, Hotchandani R, Fuller N, Cunningham K, Morgan P, Fish S, Krykbaev R, Xu X, Tam S, Goldman SJ, Abraham W, Williams C, Sypek J, Mansour TS",,579100,DTCT0024002,2894847,DTCC00583174,425754,34869
CHEMBL564564,P45452,,UAKRFNIIOJOWLK-VWLOTQADSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19625186,IC50,=,4.8,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"3,4-Disubstituted benzofuran P1' MMP-13 inhibitors: optimization of selectivity and reduction of protein binding.",Bioorg. Med. Chem. Lett.,2009,19,16,"Li W, Hu Y, Li J, Thomason JR, DeVincentis D, Du X, Wu J, Hotchandani R, Rush TS, Skotnicki JS, Tam S, Chockalingam PS, Morris EA, Levin JI",,581466,DTCT0024002,2904502,DTCC00591495,1297731,35265
CHEMBL564897,P45452,,FZRFPHHANFQJGM-NRFANRHFSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19725580,IC50,>,1000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthma.,J. Med. Chem.,2009,52,17,"Li W, Li J, Wu Y, Rancati F, Vallese S, Raveglia L, Wu J, Hotchandani R, Fuller N, Cunningham K, Morgan P, Fish S, Krykbaev R, Xu X, Tam S, Goldman SJ, Abraham W, Williams C, Sypek J, Mansour TS",,579100,DTCT0024002,2894843,DTCC00590853,1038914,34869
CHEMBL564998,P45452,,RVXGDNRYPJLPKA-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19625186,IC50,=,4.3,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"3,4-Disubstituted benzofuran P1' MMP-13 inhibitors: optimization of selectivity and reduction of protein binding.",Bioorg. Med. Chem. Lett.,2009,19,16,"Li W, Hu Y, Li J, Thomason JR, DeVincentis D, Du X, Wu J, Hotchandani R, Rush TS, Skotnicki JS, Tam S, Chockalingam PS, Morris EA, Levin JI",,581466,DTCT0024002,2904484,DTCC00586762,1167626,35265
CHEMBL565103,P45452,,JWILGVWCZHAXFQ-SANMLTNESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19625186,IC50,=,6.1,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"3,4-Disubstituted benzofuran P1' MMP-13 inhibitors: optimization of selectivity and reduction of protein binding.",Bioorg. Med. Chem. Lett.,2009,19,16,"Li W, Hu Y, Li J, Thomason JR, DeVincentis D, Du X, Wu J, Hotchandani R, Rush TS, Skotnicki JS, Tam S, Chockalingam PS, Morris EA, Levin JI",,581466,DTCT0024002,2904517,DTCC00593106,1556706,35265
CHEMBL565561,P45452,,CVSFOKAFQYOYIW-QFIPXVFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19692239,IC50,=,25,NM,,,,,,,,,,,,,,Inhibition of human MMP13 by FRET assay,,Improving potency and selectivity of a new class of non-Zn-chelating MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,18,"Heim-Riether A, Taylor SJ, Liang S, Gao DA, Xiong Z, Michael August E, Collins BK, Farmer BT, Haverty K, Hill-Drzewi M, Junker HD, Mariana Margarit S, Moss N, Neumann T, Proudfoot JR, Keenan LS, Sekul R, Zhang Q, Li J, Farrow NA",,598067,DTCT0024002,3108495,DTCC00602465,1104295,36206
CHEMBL565751,P45452,,QUIXGNWSMNOFEM-QFIPXVFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19692239,IC50,=,180,NM,,,,,,,,,,,,,,Inhibition of human MMP13 by FRET assay,,Improving potency and selectivity of a new class of non-Zn-chelating MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,18,"Heim-Riether A, Taylor SJ, Liang S, Gao DA, Xiong Z, Michael August E, Collins BK, Farmer BT, Haverty K, Hill-Drzewi M, Junker HD, Mariana Margarit S, Moss N, Neumann T, Proudfoot JR, Keenan LS, Sekul R, Zhang Q, Li J, Farrow NA",,598067,DTCT0024002,3108480,DTCC00602463,1200114,36206
CHEMBL565958,P45452,,SQFIUEWOPGEFKI-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19692239,IC50,=,245,NM,,,,,,,,,,,,,,Inhibition of human MMP13 by FRET assay,,Improving potency and selectivity of a new class of non-Zn-chelating MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,18,"Heim-Riether A, Taylor SJ, Liang S, Gao DA, Xiong Z, Michael August E, Collins BK, Farmer BT, Haverty K, Hill-Drzewi M, Junker HD, Mariana Margarit S, Moss N, Neumann T, Proudfoot JR, Keenan LS, Sekul R, Zhang Q, Li J, Farrow NA",,598067,DTCT0024002,3108483,DTCC00602525,586706,36206
CHEMBL565959,P45452,,YVBGXCJHHIEFPR-FQEVSTJZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19692239,IC50,=,1550,NM,,,,,,,,,,,,,,Inhibition of human MMP13 by FRET assay,,Improving potency and selectivity of a new class of non-Zn-chelating MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,18,"Heim-Riether A, Taylor SJ, Liang S, Gao DA, Xiong Z, Michael August E, Collins BK, Farmer BT, Haverty K, Hill-Drzewi M, Junker HD, Mariana Margarit S, Moss N, Neumann T, Proudfoot JR, Keenan LS, Sekul R, Zhang Q, Li J, Farrow NA",,598067,DTCT0024002,3108484,DTCC00602526,1906977,36206
CHEMBL566511,P45452,,PPYPHJNYICUMPA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19703773,IC50,=,11300,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,The identification of beta-hydroxy carboxylic acids as selective MMP-12 inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,19,"Holmes IP, Gaines S, Watson SP, Lorthioir O, Walker A, Baddeley SJ, Herbert S, Egan D, Convery MA, Singh OM, Gross JW, Strelow JM, Smith RH, Amour AJ, Brown D, Martin SL",,592285,DTCT0024002,3044603,DTCC00598167,857224,35947
CHEMBL566512,P45452,,WAQGXNYSPYKOPK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19703773,IC50,=,26100,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,The identification of beta-hydroxy carboxylic acids as selective MMP-12 inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,19,"Holmes IP, Gaines S, Watson SP, Lorthioir O, Walker A, Baddeley SJ, Herbert S, Egan D, Convery MA, Singh OM, Gross JW, Strelow JM, Smith RH, Amour AJ, Brown D, Martin SL",,592285,DTCT0024002,3044609,DTCC00598168,1536318,35947
CHEMBL567628,P45452,,YJNWDJIIFRGLRO-FFYHKYONSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19899765,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of human MMP13,,Phosphinic tripeptides as dual angiotensin-converting enzyme C-domain and endothelin-converting enzyme-1 inhibitors.,J. Med. Chem.,2010,53,1,"Jullien N, Makritis A, Georgiadis D, Beau F, Yiotakis A, Dive V",,595727,DTCT0024002,3085809,DTCC00603210,1211469,36408
CHEMBL567810,P45452,,XOCYWQPZKYXIBR-QFIPXVFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19692239,IC50,=,31,NM,,,,,,,,,,,,,,Inhibition of human MMP13 by FRET assay,,Improving potency and selectivity of a new class of non-Zn-chelating MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,18,"Heim-Riether A, Taylor SJ, Liang S, Gao DA, Xiong Z, Michael August E, Collins BK, Farmer BT, Haverty K, Hill-Drzewi M, Junker HD, Mariana Margarit S, Moss N, Neumann T, Proudfoot JR, Keenan LS, Sekul R, Zhang Q, Li J, Farrow NA",,598067,DTCT0024002,3108479,DTCC00602447,1939076,36206
CHEMBL567893,P45452,GRASSYSTATIN A,JZYWSTGTBRHGTL-BIXXXADNSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19715320,ACTIVITY,=,75,%,,,,,,,,,,,,,,Inhibition of MMP13 assessed as residual activity at 10 uM after 10 to 15 mins by fluorescence assay relative to control,,"Grassystatins A-C from marine cyanobacteria, potent cathepsin E inhibitors that reduce antigen presentation.",J. Med. Chem.,2009,52,18,"Kwan JC, Eksioglu EA, Liu C, Paul VJ, Luesch H",,600022,DTCT0024002,3096290,DTCC00604795,1039098,36236
CHEMBL567893,P45452,GRASSYSTATIN A,JZYWSTGTBRHGTL-BIXXXADNSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19715320,IC50,=,5000,NM,,,,,,,,,,,,,,Inhibition of MMP13 catalytic domain after 10 to 15 mins by fluorescence assay,,"Grassystatins A-C from marine cyanobacteria, potent cathepsin E inhibitors that reduce antigen presentation.",J. Med. Chem.,2009,52,18,"Kwan JC, Eksioglu EA, Liu C, Paul VJ, Luesch H",,600079,DTCT0024002,3096347,DTCC00604795,1039098,36236
CHEMBL568025,P45452,,KTVWTLBICMQZIN-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19692239,IC50,=,17,NM,,,,,,,,,,,,,,Inhibition of human MMP13 by FRET assay,,Improving potency and selectivity of a new class of non-Zn-chelating MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,18,"Heim-Riether A, Taylor SJ, Liang S, Gao DA, Xiong Z, Michael August E, Collins BK, Farmer BT, Haverty K, Hill-Drzewi M, Junker HD, Mariana Margarit S, Moss N, Neumann T, Proudfoot JR, Keenan LS, Sekul R, Zhang Q, Li J, Farrow NA",,598067,DTCT0024002,3108482,DTCC00602513,1265300,36206
CHEMBL568430,P45452,,QZURNMPULJLKEK-IBGZPJMESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19692239,IC50,=,6000,NM,,,,,,,,,,,,,,Inhibition of human MMP13 by FRET assay,,Improving potency and selectivity of a new class of non-Zn-chelating MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,18,"Heim-Riether A, Taylor SJ, Liang S, Gao DA, Xiong Z, Michael August E, Collins BK, Farmer BT, Haverty K, Hill-Drzewi M, Junker HD, Mariana Margarit S, Moss N, Neumann T, Proudfoot JR, Keenan LS, Sekul R, Zhang Q, Li J, Farrow NA",,598067,DTCT0024002,3108485,DTCC00602437,715907,36206
CHEMBL568642,P45452,,YNDBAVWRUDYKFC-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19692239,IC50,=,40,NM,,,,,,,,,,,,,,Inhibition of human MMP13 by FRET assay,,Improving potency and selectivity of a new class of non-Zn-chelating MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,18,"Heim-Riether A, Taylor SJ, Liang S, Gao DA, Xiong Z, Michael August E, Collins BK, Farmer BT, Haverty K, Hill-Drzewi M, Junker HD, Mariana Margarit S, Moss N, Neumann T, Proudfoot JR, Keenan LS, Sekul R, Zhang Q, Li J, Farrow NA",,598067,DTCT0024002,3108493,DTCC00602438,490142,36206
CHEMBL568644,P45452,,FKSZTVMVORTQHM-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19692239,IC50,>,50000,NM,,,,,,,,,,,,,,Inhibition of human MMP13 by FRET assay,,Improving potency and selectivity of a new class of non-Zn-chelating MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,18,"Heim-Riether A, Taylor SJ, Liang S, Gao DA, Xiong Z, Michael August E, Collins BK, Farmer BT, Haverty K, Hill-Drzewi M, Junker HD, Mariana Margarit S, Moss N, Neumann T, Proudfoot JR, Keenan LS, Sekul R, Zhang Q, Li J, Farrow NA",,598067,DTCT0024002,3108489,DTCC00602498,133014,36206
CHEMBL568677,P45452,,HCMPACJNNFMHLB-IBGZPJMESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19692239,IC50,=,460,NM,,,,,,,,,,,,,,Inhibition of human MMP13 by FRET assay,,Improving potency and selectivity of a new class of non-Zn-chelating MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,18,"Heim-Riether A, Taylor SJ, Liang S, Gao DA, Xiong Z, Michael August E, Collins BK, Farmer BT, Haverty K, Hill-Drzewi M, Junker HD, Mariana Margarit S, Moss N, Neumann T, Proudfoot JR, Keenan LS, Sekul R, Zhang Q, Li J, Farrow NA",,598067,DTCT0024002,3108486,DTCC00602454,715909,36206
CHEMBL570310,P45452,,BWJNOHKLFBLHOO-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19725580,IC50,=,13800,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthma.,J. Med. Chem.,2009,52,17,"Li W, Li J, Wu Y, Rancati F, Vallese S, Raveglia L, Wu J, Hotchandani R, Fuller N, Cunningham K, Morgan P, Fish S, Krykbaev R, Xu X, Tam S, Goldman SJ, Abraham W, Williams C, Sypek J, Mansour TS",,579100,DTCT0024002,2894818,DTCC00587868,2037556,34869
CHEMBL570718,P45452,,YJNWDJIIFRGLRO-ZCLHRBOTSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19899765,KI,=,30,NM,,,,,,,,,,,,,,Inhibition of human MMP13,,Phosphinic tripeptides as dual angiotensin-converting enzyme C-domain and endothelin-converting enzyme-1 inhibitors.,J. Med. Chem.,2010,53,1,"Jullien N, Makritis A, Georgiadis D, Beau F, Yiotakis A, Dive V",,595727,DTCT0024002,3085761,DTCC00603209,1018325,36408
CHEMBL570732,P45452,,ZPFSKFCSVXPMBD-JHOVWCEZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19899765,KI,=,24,NM,,,,,,,,,,,,,,Inhibition of human MMP13,,Phosphinic tripeptides as dual angiotensin-converting enzyme C-domain and endothelin-converting enzyme-1 inhibitors.,J. Med. Chem.,2010,53,1,"Jullien N, Makritis A, Georgiadis D, Beau F, Yiotakis A, Dive V",,595727,DTCT0024002,3085758,DTCC00603211,533841,36408
CHEMBL570953,P45452,,ZPFSKFCSVXPMBD-PFESQZPFSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19899765,KI,=,4000,NM,,,,,,,,,,,,,,Inhibition of human MMP13,,Phosphinic tripeptides as dual angiotensin-converting enzyme C-domain and endothelin-converting enzyme-1 inhibitors.,J. Med. Chem.,2010,53,1,"Jullien N, Makritis A, Georgiadis D, Beau F, Yiotakis A, Dive V",,595727,DTCT0024002,3085774,DTCC00603224,1665419,36408
CHEMBL572780,P45452,,ZCRWOWSOWBMWGI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19775099,IC50,=,12,NM,,,,,,,,,,,,,,Inhibition of para-aminophenylmercuric acetate-activated human pro-MMP13 after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591604,DTCT0024002,3044397,DTCC00597333,618949,35647
CHEMBL572926,P45452,,XXZWGNHHYJXUFA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19703773,IC50,>,98000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,The identification of beta-hydroxy carboxylic acids as selective MMP-12 inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,19,"Holmes IP, Gaines S, Watson SP, Lorthioir O, Walker A, Baddeley SJ, Herbert S, Egan D, Convery MA, Singh OM, Gross JW, Strelow JM, Smith RH, Amour AJ, Brown D, Martin SL",,592285,DTCT0024002,3044612,DTCC00598205,1374947,35947
CHEMBL572947,P45452,,JPUWBNMOSGBVRW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19703773,IC50,=,95900,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,The identification of beta-hydroxy carboxylic acids as selective MMP-12 inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,19,"Holmes IP, Gaines S, Watson SP, Lorthioir O, Walker A, Baddeley SJ, Herbert S, Egan D, Convery MA, Singh OM, Gross JW, Strelow JM, Smith RH, Amour AJ, Brown D, Martin SL",,592285,DTCT0024002,3044602,DTCC00598157,1083364,35947
CHEMBL572979,P45452,,HDXADAWBGFXTBW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19703773,IC50,>,98000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,The identification of beta-hydroxy carboxylic acids as selective MMP-12 inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,19,"Holmes IP, Gaines S, Watson SP, Lorthioir O, Walker A, Baddeley SJ, Herbert S, Egan D, Convery MA, Singh OM, Gross JW, Strelow JM, Smith RH, Amour AJ, Brown D, Martin SL",,592285,DTCT0024002,3044600,DTCC00598147,1821991,35947
CHEMBL572980,P45452,,VNCUHIXOCDBZGU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19703773,IC50,=,95200,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,The identification of beta-hydroxy carboxylic acids as selective MMP-12 inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,19,"Holmes IP, Gaines S, Watson SP, Lorthioir O, Walker A, Baddeley SJ, Herbert S, Egan D, Convery MA, Singh OM, Gross JW, Strelow JM, Smith RH, Amour AJ, Brown D, Martin SL",,592285,DTCT0024002,3044601,DTCC00598156,1854062,35947
CHEMBL572982,P45452,,ILGSIIFHQGOKKV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19703773,IC50,=,9990,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,The identification of beta-hydroxy carboxylic acids as selective MMP-12 inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,19,"Holmes IP, Gaines S, Watson SP, Lorthioir O, Walker A, Baddeley SJ, Herbert S, Egan D, Convery MA, Singh OM, Gross JW, Strelow JM, Smith RH, Amour AJ, Brown D, Martin SL",,592285,DTCT0024002,3044613,DTCC00598166,824314,35947
CHEMBL572982,P45452,,ILGSIIFHQGOKKV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19703773,IC50,=,12000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,The identification of beta-hydroxy carboxylic acids as selective MMP-12 inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,19,"Holmes IP, Gaines S, Watson SP, Lorthioir O, Walker A, Baddeley SJ, Herbert S, Egan D, Convery MA, Singh OM, Gross JW, Strelow JM, Smith RH, Amour AJ, Brown D, Martin SL",,592285,DTCT0024002,3044615,DTCC00598166,824313,35947
CHEMBL572982,P45452,,ILGSIIFHQGOKKV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19703773,IC50,=,36800,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,The identification of beta-hydroxy carboxylic acids as selective MMP-12 inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,19,"Holmes IP, Gaines S, Watson SP, Lorthioir O, Walker A, Baddeley SJ, Herbert S, Egan D, Convery MA, Singh OM, Gross JW, Strelow JM, Smith RH, Amour AJ, Brown D, Martin SL",,592285,DTCT0024002,3044614,DTCC00598166,824315,35947
CHEMBL573714,P45452,,ITWGWXCEGHFMHT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19775099,IC50,=,84,NM,,,,,,,,,,,,,,Inhibition of para-aminophenylmercuric acetate-activated human pro-MMP13 after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591604,DTCT0024002,3044412,DTCC00597369,1427807,35647
CHEMBL573715,P45452,,YOMXWXIANUYIMH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19775099,IC50,=,4.1,NM,,,,,,,,,,,,,,Inhibition of para-aminophenylmercuric acetate-activated human pro-MMP13 after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591604,DTCT0024002,3044390,DTCC00597370,1297783,35647
CHEMBL573934,P45452,,OREDIHYKGISTDR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19775099,IC50,=,260,NM,,,,,,,,,,,,,,Inhibition of para-aminophenylmercuric acetate-activated human pro-MMP13 after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591604,DTCT0024002,3044428,DTCC00597353,327896,35647
CHEMBL573935,P45452,,HGICQEUHJFERNR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19775099,IC50,=,260,NM,,,,,,,,,,,,,,Inhibition of para-aminophenylmercuric acetate-activated human pro-MMP13 after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591604,DTCT0024002,3044429,DTCC00597354,393223,35647
CHEMBL573936,P45452,,FIPYOKGRSDJCAR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19775099,IC50,=,78,NM,,,,,,,,,,,,,,Inhibition of para-aminophenylmercuric acetate-activated human pro-MMP13 after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591604,DTCT0024002,3044411,DTCC00597355,1427806,35647
CHEMBL574370,P45452,,YYBFXMXFWMJGLB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19775099,IC50,=,62,NM,,,,,,,,,,,,,,Inhibition of para-aminophenylmercuric acetate-activated human pro-MMP13 after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591604,DTCT0024002,3044406,DTCC00597263,12430,35647
CHEMBL574444,P45452,,MWFQVRDQNUNZLC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19703773,IC50,=,50200,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,The identification of beta-hydroxy carboxylic acids as selective MMP-12 inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,19,"Holmes IP, Gaines S, Watson SP, Lorthioir O, Walker A, Baddeley SJ, Herbert S, Egan D, Convery MA, Singh OM, Gross JW, Strelow JM, Smith RH, Amour AJ, Brown D, Martin SL",,592285,DTCT0024002,3044608,DTCC00598116,1951146,35947
CHEMBL574445,P45452,,KOVACENWBVASDG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19703773,IC50,>,98000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,The identification of beta-hydroxy carboxylic acids as selective MMP-12 inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,19,"Holmes IP, Gaines S, Watson SP, Lorthioir O, Walker A, Baddeley SJ, Herbert S, Egan D, Convery MA, Singh OM, Gross JW, Strelow JM, Smith RH, Amour AJ, Brown D, Martin SL",,592285,DTCT0024002,3044599,DTCC00598118,598252,35947
CHEMBL574589,P45452,,WQRJSSRVHCJAKB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19775099,IC50,=,1400,NM,,,,,,,,,,,,,,Inhibition of para-aminophenylmercuric acetate-activated human pro-MMP13 after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591604,DTCT0024002,3044470,DTCC00597341,1071501,35647
CHEMBL574605,P45452,,CPUBMGYGVNFLPZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19775099,IC50,=,74,NM,,,,,,,,,,,,,,Inhibition of para-aminophenylmercuric acetate-activated human pro-MMP13 after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591604,DTCT0024002,3044410,DTCC00597298,327895,35647
CHEMBL574666,P45452,,WILNYVYWCSPWAP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19703773,IC50,=,52000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,The identification of beta-hydroxy carboxylic acids as selective MMP-12 inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,19,"Holmes IP, Gaines S, Watson SP, Lorthioir O, Walker A, Baddeley SJ, Herbert S, Egan D, Convery MA, Singh OM, Gross JW, Strelow JM, Smith RH, Amour AJ, Brown D, Martin SL",,592285,DTCT0024002,3044631,DTCC00598172,1115907,35947
CHEMBL575320,P45452,,UCRQQCAIDRYGNO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19703773,IC50,=,1130,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,The identification of beta-hydroxy carboxylic acids as selective MMP-12 inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,19,"Holmes IP, Gaines S, Watson SP, Lorthioir O, Walker A, Baddeley SJ, Herbert S, Egan D, Convery MA, Singh OM, Gross JW, Strelow JM, Smith RH, Amour AJ, Brown D, Martin SL",,592285,DTCT0024002,3044606,DTCC00598238,79990,35947
CHEMBL575534,P45452,,TZHJNXZNYZBVDK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19703773,IC50,=,3760,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,The identification of beta-hydroxy carboxylic acids as selective MMP-12 inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,19,"Holmes IP, Gaines S, Watson SP, Lorthioir O, Walker A, Baddeley SJ, Herbert S, Egan D, Convery MA, Singh OM, Gross JW, Strelow JM, Smith RH, Amour AJ, Brown D, Martin SL",,592285,DTCT0024002,3044607,DTCC00598239,1342372,35947
CHEMBL575881,P45452,,ABXUEPSHNXWTBZ-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19775099,IC50,=,7900,NM,,,,,,,,,,,,,,Inhibition of para-aminophenylmercuric acetate-activated human pro-MMP13 after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591604,DTCT0024002,3044916,DTCC00597225,1653861,35647
CHEMBL575895,P45452,,QPFIKHZWPMXTRS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19775099,IC50,=,28000,NM,,,,,,,,,,,,,,Inhibition of para-aminophenylmercuric acetate-activated human pro-MMP13 after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591604,DTCT0024002,3044516,DTCC00597330,1427805,35647
CHEMBL575896,P45452,,MYZHQACPXTZCJY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19775099,IC50,=,2700,NM,,,,,,,,,,,,,,Inhibition of para-aminophenylmercuric acetate-activated human pro-MMP13 after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591604,DTCT0024002,3044480,DTCC00597331,554423,35647
CHEMBL575946,P45452,,NNDUJQBMMUXFHC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19703773,IC50,=,33500,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,The identification of beta-hydroxy carboxylic acids as selective MMP-12 inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,19,"Holmes IP, Gaines S, Watson SP, Lorthioir O, Walker A, Baddeley SJ, Herbert S, Egan D, Convery MA, Singh OM, Gross JW, Strelow JM, Smith RH, Amour AJ, Brown D, Martin SL",,592285,DTCT0024002,3044610,DTCC00598178,1600771,35947
CHEMBL575947,P45452,,OEACPQMNTMJNAD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19703773,IC50,=,41900,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,The identification of beta-hydroxy carboxylic acids as selective MMP-12 inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,19,"Holmes IP, Gaines S, Watson SP, Lorthioir O, Walker A, Baddeley SJ, Herbert S, Egan D, Convery MA, Singh OM, Gross JW, Strelow JM, Smith RH, Amour AJ, Brown D, Martin SL",,592285,DTCT0024002,3044611,DTCC00123631,469029,35947
CHEMBL576213,P45452,,QFTBNNVRPZGDJF-SANMLTNESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19692239,IC50,=,6,NM,,,,,,,,,,,,,,Inhibition of human MMP13 by FRET assay,,Improving potency and selectivity of a new class of non-Zn-chelating MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,18,"Heim-Riether A, Taylor SJ, Liang S, Gao DA, Xiong Z, Michael August E, Collins BK, Farmer BT, Haverty K, Hill-Drzewi M, Junker HD, Mariana Margarit S, Moss N, Neumann T, Proudfoot JR, Keenan LS, Sekul R, Zhang Q, Li J, Farrow NA",,598067,DTCT0024002,3108492,DTCC00602536,1427861,36206
CHEMBL576431,P45452,,JFDVHGPZDKQUGQ-SANMLTNESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19692239,IC50,=,620,NM,,,,,,,,,,,,,,Inhibition of human MMP13 by FRET assay,,Improving potency and selectivity of a new class of non-Zn-chelating MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,18,"Heim-Riether A, Taylor SJ, Liang S, Gao DA, Xiong Z, Michael August E, Collins BK, Farmer BT, Haverty K, Hill-Drzewi M, Junker HD, Mariana Margarit S, Moss N, Neumann T, Proudfoot JR, Keenan LS, Sekul R, Zhang Q, Li J, Farrow NA",,598067,DTCT0024002,3108476,DTCC00602420,1906975,36206
CHEMBL576762,P45452,,RPBGCJQDVJCGSK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19775099,IC50,=,20000,NM,,,,,,,,,,,,,,Inhibition of para-aminophenylmercuric acetate-activated human pro-MMP13 after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591604,DTCT0024002,3044508,DTCC00597340,1265255,35647
CHEMBL577022,P45452,,YFDWVURXYYMZFN-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19692239,IC50,=,63,NM,,,,,,,,,,,,,,Inhibition of human MMP13 by FRET assay,,Improving potency and selectivity of a new class of non-Zn-chelating MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,18,"Heim-Riether A, Taylor SJ, Liang S, Gao DA, Xiong Z, Michael August E, Collins BK, Farmer BT, Haverty K, Hill-Drzewi M, Junker HD, Mariana Margarit S, Moss N, Neumann T, Proudfoot JR, Keenan LS, Sekul R, Zhang Q, Li J, Farrow NA",,598067,DTCT0024002,3108477,DTCC00602421,586701,36206
CHEMBL577705,P45452,,LSSJSWYYURXHSU-QHCPKHFHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19692239,IC50,=,57,NM,,,,,,,,,,,,,,Inhibition of human MMP13 by FRET assay,,Improving potency and selectivity of a new class of non-Zn-chelating MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,18,"Heim-Riether A, Taylor SJ, Liang S, Gao DA, Xiong Z, Michael August E, Collins BK, Farmer BT, Haverty K, Hill-Drzewi M, Junker HD, Mariana Margarit S, Moss N, Neumann T, Proudfoot JR, Keenan LS, Sekul R, Zhang Q, Li J, Farrow NA",,598067,DTCT0024002,3108478,DTCC00602431,812609,36206
CHEMBL577753,P45452,,ITMFWUAKJPURIP-XLKDAERCSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19899765,KI,=,19,NM,,,,,,,,,,,,,,Inhibition of human MMP13,,Phosphinic tripeptides as dual angiotensin-converting enzyme C-domain and endothelin-converting enzyme-1 inhibitors.,J. Med. Chem.,2010,53,1,"Jullien N, Makritis A, Georgiadis D, Beau F, Yiotakis A, Dive V",,595727,DTCT0024002,3085757,DTCC00603207,469076,36408
CHEMBL577754,P45452,,ITMFWUAKJPURIP-NINLVYDZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19899765,KI,=,1200,NM,,,,,,,,,,,,,,Inhibition of human MMP13,,Phosphinic tripeptides as dual angiotensin-converting enzyme C-domain and endothelin-converting enzyme-1 inhibitors.,J. Med. Chem.,2010,53,1,"Jullien N, Makritis A, Georgiadis D, Beau F, Yiotakis A, Dive V",,595727,DTCT0024002,3085770,DTCC00603208,2049056,36408
CHEMBL577910,P45452,,SOSADZXKACRLDA-SFHVURJKSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19692239,IC50,=,430,NM,,,,,,,,,,,,,,Inhibition of human MMP13 by FRET assay,,Improving potency and selectivity of a new class of non-Zn-chelating MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,18,"Heim-Riether A, Taylor SJ, Liang S, Gao DA, Xiong Z, Michael August E, Collins BK, Farmer BT, Haverty K, Hill-Drzewi M, Junker HD, Mariana Margarit S, Moss N, Neumann T, Proudfoot JR, Keenan LS, Sekul R, Zhang Q, Li J, Farrow NA",,598067,DTCT0024002,3108475,DTCC00602412,133013,36206
CHEMBL578139,P45452,,OQVISDBVUHNODH-QFIPXVFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19692239,IC50,=,88,NM,,,,,,,,,,,,,,Inhibition of human MMP13 by FRET assay,,Improving potency and selectivity of a new class of non-Zn-chelating MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,18,"Heim-Riether A, Taylor SJ, Liang S, Gao DA, Xiong Z, Michael August E, Collins BK, Farmer BT, Haverty K, Hill-Drzewi M, Junker HD, Mariana Margarit S, Moss N, Neumann T, Proudfoot JR, Keenan LS, Sekul R, Zhang Q, Li J, Farrow NA",,598067,DTCT0024002,3108481,DTCC00602475,1136520,36206
CHEMBL578351,P45452,,UPGFJKGFPNNDAA-QFIPXVFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19692239,IC50,=,2,NM,,,,,,,,,,,,,,Inhibition of human MMP13 by FRET assay,,Improving potency and selectivity of a new class of non-Zn-chelating MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,18,"Heim-Riether A, Taylor SJ, Liang S, Gao DA, Xiong Z, Michael August E, Collins BK, Farmer BT, Haverty K, Hill-Drzewi M, Junker HD, Mariana Margarit S, Moss N, Neumann T, Proudfoot JR, Keenan LS, Sekul R, Zhang Q, Li J, Farrow NA",,598067,DTCT0024002,3108496,DTCC00602476,1459864,36206
CHEMBL578352,P45452,,RDLXLGNXNXMEPV-IBGZPJMESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19692239,IC50,=,32,NM,,,,,,,,,,,,,,Inhibition of human MMP13 by FRET assay,,Improving potency and selectivity of a new class of non-Zn-chelating MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,18,"Heim-Riether A, Taylor SJ, Liang S, Gao DA, Xiong Z, Michael August E, Collins BK, Farmer BT, Haverty K, Hill-Drzewi M, Junker HD, Mariana Margarit S, Moss N, Neumann T, Proudfoot JR, Keenan LS, Sekul R, Zhang Q, Li J, Farrow NA",,598067,DTCT0024002,3108491,DTCC00602535,1653916,36206
CHEMBL578574,P45452,,VOKHZKLFNRVUEY-QHCPKHFHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19692239,IC50,=,4,NM,,,,,,,,,,,,,,Inhibition of human MMP13 by FRET assay,,Improving potency and selectivity of a new class of non-Zn-chelating MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,18,"Heim-Riether A, Taylor SJ, Liang S, Gao DA, Xiong Z, Michael August E, Collins BK, Farmer BT, Haverty K, Hill-Drzewi M, Junker HD, Mariana Margarit S, Moss N, Neumann T, Proudfoot JR, Keenan LS, Sekul R, Zhang Q, Li J, Farrow NA",,598067,DTCT0024002,3108497,DTCC00602489,845508,36206
CHEMBL579067,P45452,,YMAXKJGQKQACFZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19775099,IC50,=,940,NM,,,,,,,,,,,,,,Inhibition of para-aminophenylmercuric acetate-activated human pro-MMP13 after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591604,DTCT0024002,3044458,DTCC00597343,812562,35647
CHEMBL579068,P45452,,HSMGGAWDRKACFW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19775099,IC50,=,1800,NM,,,,,,,,,,,,,,Inhibition of para-aminophenylmercuric acetate-activated human pro-MMP13 after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591604,DTCT0024002,3044474,DTCC00597380,1842555,35647
CHEMBL579198,P45452,,MUVBCBMUIYHNAG-IBGZPJMESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19692239,IC50,=,480,NM,,,,,,,,,,,,,,Inhibition of human MMP13 by FRET assay,,Improving potency and selectivity of a new class of non-Zn-chelating MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,18,"Heim-Riether A, Taylor SJ, Liang S, Gao DA, Xiong Z, Michael August E, Collins BK, Farmer BT, Haverty K, Hill-Drzewi M, Junker HD, Mariana Margarit S, Moss N, Neumann T, Proudfoot JR, Keenan LS, Sekul R, Zhang Q, Li J, Farrow NA",,598067,DTCT0024002,3108487,DTCC00602488,1395539,36206
CHEMBL583238,P45452,,MHKCJBOSTYYRLA-IBGZPJMESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19692239,IC50,=,290,NM,,,,,,,,,,,,,,Inhibition of human MMP13 by FRET assay,,Improving potency and selectivity of a new class of non-Zn-chelating MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,18,"Heim-Riether A, Taylor SJ, Liang S, Gao DA, Xiong Z, Michael August E, Collins BK, Farmer BT, Haverty K, Hill-Drzewi M, Junker HD, Mariana Margarit S, Moss N, Neumann T, Proudfoot JR, Keenan LS, Sekul R, Zhang Q, Li J, Farrow NA",,598067,DTCT0024002,3108488,DTCC00602497,1104296,36206
CHEMBL583588,P45452,,YDAZWMGCTBJQEO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19703773,IC50,=,2450,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,The identification of beta-hydroxy carboxylic acids as selective MMP-12 inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,19,"Holmes IP, Gaines S, Watson SP, Lorthioir O, Walker A, Baddeley SJ, Herbert S, Egan D, Convery MA, Singh OM, Gross JW, Strelow JM, Smith RH, Amour AJ, Brown D, Martin SL",,592285,DTCT0024002,3044604,DTCC00598177,1665371,35947
CHEMBL583771,P45452,,KYPWLTXIHUQMGA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19703773,IC50,>,98000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,The identification of beta-hydroxy carboxylic acids as selective MMP-12 inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,19,"Holmes IP, Gaines S, Watson SP, Lorthioir O, Walker A, Baddeley SJ, Herbert S, Egan D, Convery MA, Singh OM, Gross JW, Strelow JM, Smith RH, Amour AJ, Brown D, Martin SL",,592285,DTCT0024002,3044598,DTCC00598117,437298,35947
CHEMBL584122,P45452,,OAJUMLCSJOEUON-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19775099,IC50,=,2700,NM,,,,,,,,,,,,,,Inhibition of para-aminophenylmercuric acetate-activated human pro-MMP13 after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591604,DTCT0024002,3044481,DTCC00597332,715843,35647
CHEMBL584147,P45452,,XORCBTCEBZUVES-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19775099,IC50,=,190,NM,,,,,,,,,,,,,,Inhibition of para-aminophenylmercuric acetate-activated human pro-MMP13 after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591604,DTCT0024002,3044424,DTCC00597381,2037631,35647
CHEMBL584365,P45452,,DJZNIZCARKSSDE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19775099,IC50,=,25,NM,,,,,,,,,,,,,,Inhibition of para-aminophenylmercuric acetate-activated human pro-MMP13 after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591604,DTCT0024002,3044399,DTCC00597271,165336,35647
CHEMBL584559,P45452,,QSVVRYPBRVSBDL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19703773,IC50,=,970,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13,,The identification of beta-hydroxy carboxylic acids as selective MMP-12 inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,19,"Holmes IP, Gaines S, Watson SP, Lorthioir O, Walker A, Baddeley SJ, Herbert S, Egan D, Convery MA, Singh OM, Gross JW, Strelow JM, Smith RH, Amour AJ, Brown D, Martin SL",,592285,DTCT0024002,3044605,DTCC00598237,1471592,35947
CHEMBL584683,P45452,,ZACZGYFEWPTMFL-NRFANRHFSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19692239,IC50,=,6,NM,,,,,,,,,,,,,,Inhibition of human MMP13 by FRET assay,,Improving potency and selectivity of a new class of non-Zn-chelating MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,18,"Heim-Riether A, Taylor SJ, Liang S, Gao DA, Xiong Z, Michael August E, Collins BK, Farmer BT, Haverty K, Hill-Drzewi M, Junker HD, Mariana Margarit S, Moss N, Neumann T, Proudfoot JR, Keenan LS, Sekul R, Zhang Q, Li J, Farrow NA",,598067,DTCT0024002,3108494,DTCC00602464,393281,36206
CHEMBL584687,P45452,,ZJODONKHBNRCFC-IBGZPJMESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19692239,IC50,=,220,NM,,,,,,,,,,,,,,Inhibition of human MMP13 by FRET assay,,Improving potency and selectivity of a new class of non-Zn-chelating MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,18,"Heim-Riether A, Taylor SJ, Liang S, Gao DA, Xiong Z, Michael August E, Collins BK, Farmer BT, Haverty K, Hill-Drzewi M, Junker HD, Mariana Margarit S, Moss N, Neumann T, Proudfoot JR, Keenan LS, Sekul R, Zhang Q, Li J, Farrow NA",,598067,DTCT0024002,3108490,DTCC00123776,1621642,36206
CHEMBL585376,P45452,,BZWDHUMJSSLVCR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,19775099,IC50,=,55000,NM,,,,,,,,,,,,,,Inhibition of para-aminophenylmercuric acetate-activated human pro-MMP13 after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591604,DTCT0024002,3044524,DTCC00597342,100632,35647
CHEMBL58553,P45452,,WKYNDNVMBNENDU-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11454461,IC50,=,36,NM,,,,,,,,,,,,,,In vitro inhibitory concentration against Matrix metalloprotease-13,,The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold.,Bioorg. Med. Chem. Lett.,2001,11,15,"Tullis JS, Laufersweiler MJ, VanRens JC, Natchus MG, Bookland RG, Almstead NG, Pikul S, De B, Hsieh LC, Janusz MJ, Branch TM, Peng SX, Jin YY, Hudlicky T, Oppong K",,106479,DTCT0024002,1542345,DTCC00208405,1629045,4358
CHEMBL58834,P45452,,RMIHUCKIXBQQLS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11454461,IC50,=,11,NM,,,,,,,,,,,,,,In vitro inhibitory concentration against Matrix metalloprotease-13,,The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold.,Bioorg. Med. Chem. Lett.,2001,11,15,"Tullis JS, Laufersweiler MJ, VanRens JC, Natchus MG, Bookland RG, Almstead NG, Pikul S, De B, Hsieh LC, Janusz MJ, Branch TM, Peng SX, Jin YY, Hudlicky T, Oppong K",,106479,DTCT0024002,1530493,DTCC00208196,1175034,4358
CHEMBL590343,P45452,,LIKQSFURRNSUMR-UKKPGEIXSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20022498,KI,=,20000,NM,,,,,,,,,,,,,,Inhibition of MMP13,,The discovery of novel tartrate-based TNF-alpha converting enzyme (TACE) inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,3,"Rosner KE, Guo Z, Orth P, Shipps GW, Belanger DB, Chan TY, Curran PJ, Dai C, Deng Y, Girijavallabhan VM, Hong L, Lavey BJ, Lee JF, Li D, Liu Z, Popovici-Muller J, Ting PC, Vaccaro H, Wang L, Wang T, Yu W, Zhou G, Niu X, Sun J, Kozlowski JA, Lundell DJ, Madison V, McKittrick B, Piwinski JJ, Shih NY, Arshad Siddiqui M, Strickland CO",,608479,DTCT0024002,3182387,DTCC00617046,100864,37349
CHEMBL59104,P45452,,HZWSSUJZEMEIID-YABDQXBESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11454461,IC50,=,17,NM,,,,,,,,,,,,,,In vitro inhibitory concentration against Matrix metalloprotease-13,,The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold.,Bioorg. Med. Chem. Lett.,2001,11,15,"Tullis JS, Laufersweiler MJ, VanRens JC, Natchus MG, Bookland RG, Almstead NG, Pikul S, De B, Hsieh LC, Janusz MJ, Branch TM, Peng SX, Jin YY, Hudlicky T, Oppong K",,106479,DTCT0024002,1532806,DTCC00208267,819932,4358
CHEMBL591774,P45452,,LRRAUDSVXJEODP-VTVVEXCCSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20022498,KI,=,510,NM,,,,,,,,,,,,,,Inhibition of MMP13,,The discovery of novel tartrate-based TNF-alpha converting enzyme (TACE) inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,3,"Rosner KE, Guo Z, Orth P, Shipps GW, Belanger DB, Chan TY, Curran PJ, Dai C, Deng Y, Girijavallabhan VM, Hong L, Lavey BJ, Lee JF, Li D, Liu Z, Popovici-Muller J, Ting PC, Vaccaro H, Wang L, Wang T, Yu W, Zhou G, Niu X, Sun J, Kozlowski JA, Lundell DJ, Madison V, McKittrick B, Piwinski JJ, Shih NY, Arshad Siddiqui M, Strickland CO",,608479,DTCT0024002,3182388,DTCC00617111,1330626,37349
CHEMBL593017,P45452,,BUCULLAUHLJMCO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20005097,KI,=,18.1,NM,,,,,,,,,,,,,,Inhibition of human recombinant full length MMP13 assessed as type 3 collagen cleavage activity after 18 hrs,,Discovery of (pyridin-4-yl)-2H-tetrazole as a novel scaffold to identify highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2010,20,2,"Schnute ME, O'Brien PM, Nahra J, Morris M, Howard Roark W, Hanau CE, Ruminski PG, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Patt WC, Shieh HS, Collins B, Pavlovsky AG, Palmquist KE, Aston KW, Hitchcock J, Rogers MD, McDonald J, Johnson AR, Munie GE, Wittwer AJ, Man CF, Settle SL, Nemirovskiy O, Vickery LE, Agawal A, Dyer RD, Sunyer T",,605223,DTCT0024002,3175268,DTCC00610488,1407568,36915
CHEMBL593034,P45452,,VMAHZFWSXKJIIT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20005097,KI,=,75.9,NM,,,,,,,,,,,,,,Inhibition of human recombinant full length MMP13 assessed as type 3 collagen cleavage activity after 18 hrs,,Discovery of (pyridin-4-yl)-2H-tetrazole as a novel scaffold to identify highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2010,20,2,"Schnute ME, O'Brien PM, Nahra J, Morris M, Howard Roark W, Hanau CE, Ruminski PG, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Patt WC, Shieh HS, Collins B, Pavlovsky AG, Palmquist KE, Aston KW, Hitchcock J, Rogers MD, McDonald J, Johnson AR, Munie GE, Wittwer AJ, Man CF, Settle SL, Nemirovskiy O, Vickery LE, Agawal A, Dyer RD, Sunyer T",,605223,DTCT0024002,3175263,DTCC00610440,1951359,36915
CHEMBL593256,P45452,,NGSHRTUKGSZFAB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20005097,KI,=,22.3,NM,,,,,,,,,,,,,,Inhibition of human recombinant full length MMP13 assessed as type 3 collagen cleavage activity after 18 hrs,,Discovery of (pyridin-4-yl)-2H-tetrazole as a novel scaffold to identify highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2010,20,2,"Schnute ME, O'Brien PM, Nahra J, Morris M, Howard Roark W, Hanau CE, Ruminski PG, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Patt WC, Shieh HS, Collins B, Pavlovsky AG, Palmquist KE, Aston KW, Hitchcock J, Rogers MD, McDonald J, Johnson AR, Munie GE, Wittwer AJ, Man CF, Settle SL, Nemirovskiy O, Vickery LE, Agawal A, Dyer RD, Sunyer T",,605223,DTCT0024002,3175270,DTCC00610490,1148516,36915
CHEMBL593257,P45452,,MQSTURZVUARWPW-RUCARUNLSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20005097,KI,=,6.7,NM,,,,,,,,,,,,,,Inhibition of human recombinant full length MMP13 assessed as type 3 collagen cleavage activity after 18 hrs,,Discovery of (pyridin-4-yl)-2H-tetrazole as a novel scaffold to identify highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2010,20,2,"Schnute ME, O'Brien PM, Nahra J, Morris M, Howard Roark W, Hanau CE, Ruminski PG, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Patt WC, Shieh HS, Collins B, Pavlovsky AG, Palmquist KE, Aston KW, Hitchcock J, Rogers MD, McDonald J, Johnson AR, Munie GE, Wittwer AJ, Man CF, Settle SL, Nemirovskiy O, Vickery LE, Agawal A, Dyer RD, Sunyer T",,605223,DTCT0024002,3175281,DTCC00610560,598448,36915
CHEMBL593258,P45452,,TYFKAJNWVJBSGT-JCNLHEQBSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20005097,KI,=,1.5,NM,,,,,,,,,,,,,,Inhibition of human recombinant full length MMP13 assessed as type 3 collagen cleavage activity after 18 hrs,,Discovery of (pyridin-4-yl)-2H-tetrazole as a novel scaffold to identify highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2010,20,2,"Schnute ME, O'Brien PM, Nahra J, Morris M, Howard Roark W, Hanau CE, Ruminski PG, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Patt WC, Shieh HS, Collins B, Pavlovsky AG, Palmquist KE, Aston KW, Hitchcock J, Rogers MD, McDonald J, Johnson AR, Munie GE, Wittwer AJ, Man CF, Settle SL, Nemirovskiy O, Vickery LE, Agawal A, Dyer RD, Sunyer T",,605223,DTCT0024002,3175282,DTCC00610561,1018473,36915
CHEMBL593272,P45452,,VMSRPNPKVKMUCO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20005097,KI,=,28.6,NM,,,,,,,,,,,,,,Inhibition of human recombinant full length MMP13 assessed as type 3 collagen cleavage activity after 18 hrs,,Discovery of (pyridin-4-yl)-2H-tetrazole as a novel scaffold to identify highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2010,20,2,"Schnute ME, O'Brien PM, Nahra J, Morris M, Howard Roark W, Hanau CE, Ruminski PG, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Patt WC, Shieh HS, Collins B, Pavlovsky AG, Palmquist KE, Aston KW, Hitchcock J, Rogers MD, McDonald J, Johnson AR, Munie GE, Wittwer AJ, Man CF, Settle SL, Nemirovskiy O, Vickery LE, Agawal A, Dyer RD, Sunyer T",,605223,DTCT0024002,3175272,DTCC00610516,2081360,36915
CHEMBL59337,P45452,,KLFOAKCPAGOTNG-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11454461,IC50,=,200,NM,,,,,,,,,,,,,,In vitro inhibitory concentration against Matrix metalloprotease-13,,The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold.,Bioorg. Med. Chem. Lett.,2001,11,15,"Tullis JS, Laufersweiler MJ, VanRens JC, Natchus MG, Bookland RG, Almstead NG, Pikul S, De B, Hsieh LC, Janusz MJ, Branch TM, Peng SX, Jin YY, Hudlicky T, Oppong K",,106479,DTCT0024002,1541004,DTCC00208349,1753036,4358
CHEMBL593983,P45452,,IPXYUVOQPGOREM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20005097,IC50,=,38,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain,,Discovery of (pyridin-4-yl)-2H-tetrazole as a novel scaffold to identify highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2010,20,2,"Schnute ME, O'Brien PM, Nahra J, Morris M, Howard Roark W, Hanau CE, Ruminski PG, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Patt WC, Shieh HS, Collins B, Pavlovsky AG, Palmquist KE, Aston KW, Hitchcock J, Rogers MD, McDonald J, Johnson AR, Munie GE, Wittwer AJ, Man CF, Settle SL, Nemirovskiy O, Vickery LE, Agawal A, Dyer RD, Sunyer T",,605071,DTCT0024002,3176004,DTCC00610437,1757407,36915
CHEMBL593983,P45452,,IPXYUVOQPGOREM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20005097,IC50,=,530,NM,,,,,,,,,,,,,,Inhibition of human recombinant full length MMP13 assessed as type 3 collagen cleavage activity after 18 hrs,,Discovery of (pyridin-4-yl)-2H-tetrazole as a novel scaffold to identify highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2010,20,2,"Schnute ME, O'Brien PM, Nahra J, Morris M, Howard Roark W, Hanau CE, Ruminski PG, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Patt WC, Shieh HS, Collins B, Pavlovsky AG, Palmquist KE, Aston KW, Hitchcock J, Rogers MD, McDonald J, Johnson AR, Munie GE, Wittwer AJ, Man CF, Settle SL, Nemirovskiy O, Vickery LE, Agawal A, Dyer RD, Sunyer T",,605223,DTCT0024002,3175259,DTCC00610437,1757407,36915
CHEMBL59472,P45452,,DHMHJSLNCAYKRH-QOMWVZHYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11454461,IC50,=,7,NM,,,,,,,,,,,,,,In vitro inhibitory concentration against Matrix metalloprotease-13,,The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold.,Bioorg. Med. Chem. Lett.,2001,11,15,"Tullis JS, Laufersweiler MJ, VanRens JC, Natchus MG, Bookland RG, Almstead NG, Pikul S, De B, Hsieh LC, Janusz MJ, Branch TM, Peng SX, Jin YY, Hudlicky T, Oppong K",,106479,DTCT0024002,1554469,DTCC00208237,2044788,4358
CHEMBL594932,P45452,,YNQZHWGWDJBKDI-KOMQPUFPSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20005097,KI,=,0.62,NM,,,,,,,,,,,,,,Inhibition of human recombinant full length MMP13 assessed as type 3 collagen cleavage activity after 18 hrs,,Discovery of (pyridin-4-yl)-2H-tetrazole as a novel scaffold to identify highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2010,20,2,"Schnute ME, O'Brien PM, Nahra J, Morris M, Howard Roark W, Hanau CE, Ruminski PG, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Patt WC, Shieh HS, Collins B, Pavlovsky AG, Palmquist KE, Aston KW, Hitchcock J, Rogers MD, McDonald J, Johnson AR, Munie GE, Wittwer AJ, Man CF, Settle SL, Nemirovskiy O, Vickery LE, Agawal A, Dyer RD, Sunyer T",,605223,DTCT0024002,3175289,DTCC00610618,1665555,36915
CHEMBL595156,P45452,,WHBYITGVDLNGEB-JCNLHEQBSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20005097,KI,=,0.3,NM,,,,,,,,,,,,,,Inhibition of human recombinant full length MMP13 assessed as type 3 collagen cleavage activity after 18 hrs,,Discovery of (pyridin-4-yl)-2H-tetrazole as a novel scaffold to identify highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2010,20,2,"Schnute ME, O'Brien PM, Nahra J, Morris M, Howard Roark W, Hanau CE, Ruminski PG, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Patt WC, Shieh HS, Collins B, Pavlovsky AG, Palmquist KE, Aston KW, Hitchcock J, Rogers MD, McDonald J, Johnson AR, Munie GE, Wittwer AJ, Man CF, Settle SL, Nemirovskiy O, Vickery LE, Agawal A, Dyer RD, Sunyer T",,605223,DTCT0024002,3175287,DTCC00610589,209111,36915
CHEMBL595842,P45452,,XEDIKHZCAARASU-KOMQPUFPSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20005097,KI,=,7.5,NM,,,,,,,,,,,,,,Inhibition of human recombinant full length MMP13 assessed as type 3 collagen cleavage activity after 18 hrs,,Discovery of (pyridin-4-yl)-2H-tetrazole as a novel scaffold to identify highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2010,20,2,"Schnute ME, O'Brien PM, Nahra J, Morris M, Howard Roark W, Hanau CE, Ruminski PG, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Patt WC, Shieh HS, Collins B, Pavlovsky AG, Palmquist KE, Aston KW, Hitchcock J, Rogers MD, McDonald J, Johnson AR, Munie GE, Wittwer AJ, Man CF, Settle SL, Nemirovskiy O, Vickery LE, Agawal A, Dyer RD, Sunyer T",,605223,DTCT0024002,3175285,DTCC00610587,1083557,36915
CHEMBL596056,P45452,,HYCDSMAFYDBXIZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20005097,KI,=,5.3,NM,,,,,,,,,,,,,,Inhibition of human recombinant full length MMP13 assessed as type 3 collagen cleavage activity after 18 hrs,,Discovery of (pyridin-4-yl)-2H-tetrazole as a novel scaffold to identify highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2010,20,2,"Schnute ME, O'Brien PM, Nahra J, Morris M, Howard Roark W, Hanau CE, Ruminski PG, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Patt WC, Shieh HS, Collins B, Pavlovsky AG, Palmquist KE, Aston KW, Hitchcock J, Rogers MD, McDonald J, Johnson AR, Munie GE, Wittwer AJ, Man CF, Settle SL, Nemirovskiy O, Vickery LE, Agawal A, Dyer RD, Sunyer T",,605223,DTCT0024002,3175271,DTCC00610491,1568416,36915
CHEMBL596071,P45452,,DDIZQGYTODZYGV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20005097,KI,=,3.6,NM,,,,,,,,,,,,,,Inhibition of human recombinant full length MMP13 assessed as type 3 collagen cleavage activity after 18 hrs,,Discovery of (pyridin-4-yl)-2H-tetrazole as a novel scaffold to identify highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2010,20,2,"Schnute ME, O'Brien PM, Nahra J, Morris M, Howard Roark W, Hanau CE, Ruminski PG, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Patt WC, Shieh HS, Collins B, Pavlovsky AG, Palmquist KE, Aston KW, Hitchcock J, Rogers MD, McDonald J, Johnson AR, Munie GE, Wittwer AJ, Man CF, Settle SL, Nemirovskiy O, Vickery LE, Agawal A, Dyer RD, Sunyer T",,605223,DTCT0024002,3175273,DTCC00610517,80174,36915
CHEMBL596083,P45452,,SPWCOBSWFOORCI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20005097,KI,=,43.4,NM,,,,,,,,,,,,,,Inhibition of human recombinant full length MMP13 assessed as type 3 collagen cleavage activity after 18 hrs,,Discovery of (pyridin-4-yl)-2H-tetrazole as a novel scaffold to identify highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2010,20,2,"Schnute ME, O'Brien PM, Nahra J, Morris M, Howard Roark W, Hanau CE, Ruminski PG, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Patt WC, Shieh HS, Collins B, Pavlovsky AG, Palmquist KE, Aston KW, Hitchcock J, Rogers MD, McDonald J, Johnson AR, Munie GE, Wittwer AJ, Man CF, Settle SL, Nemirovskiy O, Vickery LE, Agawal A, Dyer RD, Sunyer T",,605223,DTCT0024002,3175264,DTCC00610464,857456,36915
CHEMBL596273,P45452,,SMHSNYHGGYVOMD-SAABIXHNSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20005097,KI,=,0.16,NM,,,,,,,,,,,,,,Inhibition of human recombinant full length MMP13 assessed as type 3 collagen cleavage activity after 18 hrs,,Discovery of (pyridin-4-yl)-2H-tetrazole as a novel scaffold to identify highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2010,20,2,"Schnute ME, O'Brien PM, Nahra J, Morris M, Howard Roark W, Hanau CE, Ruminski PG, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Patt WC, Shieh HS, Collins B, Pavlovsky AG, Palmquist KE, Aston KW, Hitchcock J, Rogers MD, McDonald J, Johnson AR, Munie GE, Wittwer AJ, Man CF, Settle SL, Nemirovskiy O, Vickery LE, Agawal A, Dyer RD, Sunyer T",,605223,DTCT0024002,3175283,DTCC00610562,2017061,36915
CHEMBL596273,P45452,,SMHSNYHGGYVOMD-SAABIXHNSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,26653735,KI,=,0.16,NM,,,,,,,,,,,,,,Inhibition of full length human recombinant MMP13 using MCA-Arg-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-Glu-Arg-NH2 as substrate preincubated for 60 mins followed by substrate addition by fluorescence assay,,"Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis.",J. Med. Chem.,2016,59,1,"Ruminski PG, Massa M, Strohbach J, Hanau CE, Schmidt M, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Shieh HS, Caspers N, Collins B, Grapperhaus M, Palmquist KE, Collins J, Baldus JE, Hitchcock J, Kleine HP, Rogers MD, McDonald J, Munie GE, Messing DM, Portolan S, Whiteley LO, Sunyer T, Schnute ME.",,1552458,DTCT0024002,72562,DTCC00610562,2011708,65989
CHEMBL596287,P45452,,MVLDDHUTICQDIF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20005097,KI,=,4.4,NM,,,,,,,,,,,,,,Inhibition of human recombinant full length MMP13 assessed as type 3 collagen cleavage activity after 18 hrs,,Discovery of (pyridin-4-yl)-2H-tetrazole as a novel scaffold to identify highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2010,20,2,"Schnute ME, O'Brien PM, Nahra J, Morris M, Howard Roark W, Hanau CE, Ruminski PG, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Patt WC, Shieh HS, Collins B, Pavlovsky AG, Palmquist KE, Aston KW, Hitchcock J, Rogers MD, McDonald J, Johnson AR, Munie GE, Wittwer AJ, Man CF, Settle SL, Nemirovskiy O, Vickery LE, Agawal A, Dyer RD, Sunyer T",,605223,DTCT0024002,3175274,DTCC00610518,1439390,36915
CHEMBL596300,P45452,,FTLHNHBANWSGDS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20005097,KI,=,36.7,NM,,,,,,,,,,,,,,Inhibition of human recombinant full length MMP13 assessed as type 3 collagen cleavage activity after 18 hrs,,Discovery of (pyridin-4-yl)-2H-tetrazole as a novel scaffold to identify highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2010,20,2,"Schnute ME, O'Brien PM, Nahra J, Morris M, Howard Roark W, Hanau CE, Ruminski PG, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Patt WC, Shieh HS, Collins B, Pavlovsky AG, Palmquist KE, Aston KW, Hitchcock J, Rogers MD, McDonald J, Johnson AR, Munie GE, Wittwer AJ, Man CF, Settle SL, Nemirovskiy O, Vickery LE, Agawal A, Dyer RD, Sunyer T",,605223,DTCT0024002,3175265,DTCC00610465,1471803,36915
CHEMBL596301,P45452,,ZJTQSZOSAUVIRT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20005097,KI,=,227,NM,,,,,,,,,,,,,,Inhibition of human recombinant full length MMP13 assessed as type 3 collagen cleavage activity after 18 hrs,,Discovery of (pyridin-4-yl)-2H-tetrazole as a novel scaffold to identify highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2010,20,2,"Schnute ME, O'Brien PM, Nahra J, Morris M, Howard Roark W, Hanau CE, Ruminski PG, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Patt WC, Shieh HS, Collins B, Pavlovsky AG, Palmquist KE, Aston KW, Hitchcock J, Rogers MD, McDonald J, Johnson AR, Munie GE, Wittwer AJ, Man CF, Settle SL, Nemirovskiy O, Vickery LE, Agawal A, Dyer RD, Sunyer T",,605223,DTCT0024002,3175267,DTCC00610467,1984075,36915
CHEMBL596302,P45452,,OWOLTKBAJMKTQW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20005097,KI,=,2.5,NM,,,,,,,,,,,,,,Inhibition of human recombinant full length MMP13 assessed as type 3 collagen cleavage activity after 18 hrs,,Discovery of (pyridin-4-yl)-2H-tetrazole as a novel scaffold to identify highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2010,20,2,"Schnute ME, O'Brien PM, Nahra J, Morris M, Howard Roark W, Hanau CE, Ruminski PG, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Patt WC, Shieh HS, Collins B, Pavlovsky AG, Palmquist KE, Aston KW, Hitchcock J, Rogers MD, McDonald J, Johnson AR, Munie GE, Wittwer AJ, Man CF, Settle SL, Nemirovskiy O, Vickery LE, Agawal A, Dyer RD, Sunyer T",,605223,DTCT0024002,3175276,DTCC00610538,1854250,36915
CHEMBL596304,P45452,,WLQMOHBWWPKHGP-IYARVYRRSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20005097,KI,=,4.2,NM,,,,,,,,,,,,,,Inhibition of human recombinant full length MMP13 assessed as type 3 collagen cleavage activity after 18 hrs,,Discovery of (pyridin-4-yl)-2H-tetrazole as a novel scaffold to identify highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2010,20,2,"Schnute ME, O'Brien PM, Nahra J, Morris M, Howard Roark W, Hanau CE, Ruminski PG, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Patt WC, Shieh HS, Collins B, Pavlovsky AG, Palmquist KE, Aston KW, Hitchcock J, Rogers MD, McDonald J, Johnson AR, Munie GE, Wittwer AJ, Man CF, Settle SL, Nemirovskiy O, Vickery LE, Agawal A, Dyer RD, Sunyer T",,605223,DTCT0024002,3175279,DTCC00610541,144839,36915
CHEMBL596494,P45452,,FSCMLHMAYBLEAH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20005097,IC50,=,77,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain,,Discovery of (pyridin-4-yl)-2H-tetrazole as a novel scaffold to identify highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2010,20,2,"Schnute ME, O'Brien PM, Nahra J, Morris M, Howard Roark W, Hanau CE, Ruminski PG, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Patt WC, Shieh HS, Collins B, Pavlovsky AG, Palmquist KE, Aston KW, Hitchcock J, Rogers MD, McDonald J, Johnson AR, Munie GE, Wittwer AJ, Man CF, Settle SL, Nemirovskiy O, Vickery LE, Agawal A, Dyer RD, Sunyer T",,605071,DTCT0024002,3176002,DTCC00610416,1018471,36915
CHEMBL596494,P45452,,FSCMLHMAYBLEAH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20005097,IC50,=,1700,NM,,,,,,,,,,,,,,Inhibition of human recombinant full length MMP13 assessed as type 3 collagen cleavage activity after 18 hrs,,Discovery of (pyridin-4-yl)-2H-tetrazole as a novel scaffold to identify highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2010,20,2,"Schnute ME, O'Brien PM, Nahra J, Morris M, Howard Roark W, Hanau CE, Ruminski PG, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Patt WC, Shieh HS, Collins B, Pavlovsky AG, Palmquist KE, Aston KW, Hitchcock J, Rogers MD, McDonald J, Johnson AR, Munie GE, Wittwer AJ, Man CF, Settle SL, Nemirovskiy O, Vickery LE, Agawal A, Dyer RD, Sunyer T",,605223,DTCT0024002,3175258,DTCC00610416,1018471,36915
CHEMBL596522,P45452,,KRIHEVNEOOHLQA-IYARVYRRSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20005097,KI,=,31.3,NM,,,,,,,,,,,,,,Inhibition of human recombinant full length MMP13 assessed as type 3 collagen cleavage activity after 18 hrs,,Discovery of (pyridin-4-yl)-2H-tetrazole as a novel scaffold to identify highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2010,20,2,"Schnute ME, O'Brien PM, Nahra J, Morris M, Howard Roark W, Hanau CE, Ruminski PG, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Patt WC, Shieh HS, Collins B, Pavlovsky AG, Palmquist KE, Aston KW, Hitchcock J, Rogers MD, McDonald J, Johnson AR, Munie GE, Wittwer AJ, Man CF, Settle SL, Nemirovskiy O, Vickery LE, Agawal A, Dyer RD, Sunyer T",,605223,DTCT0024002,3175277,DTCC00610539,1536504,36915
CHEMBL59684,P45452,,SMIPFSAKTAQFJC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11454461,IC50,=,54,NM,,,,,,,,,,,,,,In vitro inhibitory concentration against Matrix metalloprotease-13,,The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold.,Bioorg. Med. Chem. Lett.,2001,11,15,"Tullis JS, Laufersweiler MJ, VanRens JC, Natchus MG, Bookland RG, Almstead NG, Pikul S, De B, Hsieh LC, Janusz MJ, Branch TM, Peng SX, Jin YY, Hudlicky T, Oppong K",,106479,DTCT0024002,1526928,DTCC00208656,1175033,4358
CHEMBL60179,P45452,,HVGJVSYGPSRPHL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11454461,IC50,=,11,NM,,,,,,,,,,,,,,In vitro inhibitory concentration against Matrix metalloprotease-13,,The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold.,Bioorg. Med. Chem. Lett.,2001,11,15,"Tullis JS, Laufersweiler MJ, VanRens JC, Natchus MG, Bookland RG, Almstead NG, Pikul S, De B, Hsieh LC, Janusz MJ, Branch TM, Peng SX, Jin YY, Hudlicky T, Oppong K",,106479,DTCT0024002,1519824,DTCC00208217,1207239,4358
CHEMBL602949,P45452,,YYPITAAWUASTAE-OPWSDZRHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20022498,KI,=,3600,NM,,,,,,,,,,,,,,Inhibition of MMP13,,The discovery of novel tartrate-based TNF-alpha converting enzyme (TACE) inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,3,"Rosner KE, Guo Z, Orth P, Shipps GW, Belanger DB, Chan TY, Curran PJ, Dai C, Deng Y, Girijavallabhan VM, Hong L, Lavey BJ, Lee JF, Li D, Liu Z, Popovici-Muller J, Ting PC, Vaccaro H, Wang L, Wang T, Yu W, Zhou G, Niu X, Sun J, Kozlowski JA, Lundell DJ, Madison V, McKittrick B, Piwinski JJ, Shih NY, Arshad Siddiqui M, Strickland CO",,608479,DTCT0024002,3182389,DTCC00617171,683777,37349
CHEMBL603206,P45452,,KRURVPHOIGLEOS-KOMQPUFPSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20005097,KI,=,0.26,NM,,,,,,,,,,,,,,Inhibition of human recombinant full length MMP13 assessed as type 3 collagen cleavage activity after 18 hrs,,Discovery of (pyridin-4-yl)-2H-tetrazole as a novel scaffold to identify highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2010,20,2,"Schnute ME, O'Brien PM, Nahra J, Morris M, Howard Roark W, Hanau CE, Ruminski PG, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Patt WC, Shieh HS, Collins B, Pavlovsky AG, Palmquist KE, Aston KW, Hitchcock J, Rogers MD, McDonald J, Johnson AR, Munie GE, Wittwer AJ, Man CF, Settle SL, Nemirovskiy O, Vickery LE, Agawal A, Dyer RD, Sunyer T",,605223,DTCT0024002,3175288,DTCC00610617,1342573,36915
CHEMBL603413,P45452,,XNXHEGDMZKZVKR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20005097,KI,=,16.5,NM,,,,,,,,,,,,,,Inhibition of human recombinant full length MMP13 assessed as type 3 collagen cleavage activity after 18 hrs,,Discovery of (pyridin-4-yl)-2H-tetrazole as a novel scaffold to identify highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2010,20,2,"Schnute ME, O'Brien PM, Nahra J, Morris M, Howard Roark W, Hanau CE, Ruminski PG, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Patt WC, Shieh HS, Collins B, Pavlovsky AG, Palmquist KE, Aston KW, Hitchcock J, Rogers MD, McDonald J, Johnson AR, Munie GE, Wittwer AJ, Man CF, Settle SL, Nemirovskiy O, Vickery LE, Agawal A, Dyer RD, Sunyer T",,605223,DTCT0024002,3175269,DTCC00610489,566251,36915
CHEMBL603623,P45452,,VUTBCSIBPMXNCZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20005097,IC50,=,58,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain,,Discovery of (pyridin-4-yl)-2H-tetrazole as a novel scaffold to identify highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2010,20,2,"Schnute ME, O'Brien PM, Nahra J, Morris M, Howard Roark W, Hanau CE, Ruminski PG, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Patt WC, Shieh HS, Collins B, Pavlovsky AG, Palmquist KE, Aston KW, Hitchcock J, Rogers MD, McDonald J, Johnson AR, Munie GE, Wittwer AJ, Man CF, Settle SL, Nemirovskiy O, Vickery LE, Agawal A, Dyer RD, Sunyer T",,605071,DTCT0024002,3176006,DTCC00610438,663131,36915
CHEMBL603623,P45452,,VUTBCSIBPMXNCZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20005097,IC50,=,130,NM,,,,,,,,,,,,,,Inhibition of human recombinant full length MMP13 assessed as type 3 collagen cleavage activity after 18 hrs,,Discovery of (pyridin-4-yl)-2H-tetrazole as a novel scaffold to identify highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2010,20,2,"Schnute ME, O'Brien PM, Nahra J, Morris M, Howard Roark W, Hanau CE, Ruminski PG, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Patt WC, Shieh HS, Collins B, Pavlovsky AG, Palmquist KE, Aston KW, Hitchcock J, Rogers MD, McDonald J, Johnson AR, Munie GE, Wittwer AJ, Man CF, Settle SL, Nemirovskiy O, Vickery LE, Agawal A, Dyer RD, Sunyer T",,605223,DTCT0024002,3175260,DTCC00610438,663131,36915
CHEMBL603651,P45452,,CWIUCTLMMSMTPK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20005097,KI,=,2.1,NM,,,,,,,,,,,,,,Inhibition of human recombinant full length MMP13 assessed as type 3 collagen cleavage activity after 18 hrs,,Discovery of (pyridin-4-yl)-2H-tetrazole as a novel scaffold to identify highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2010,20,2,"Schnute ME, O'Brien PM, Nahra J, Morris M, Howard Roark W, Hanau CE, Ruminski PG, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Patt WC, Shieh HS, Collins B, Pavlovsky AG, Palmquist KE, Aston KW, Hitchcock J, Rogers MD, McDonald J, Johnson AR, Munie GE, Wittwer AJ, Man CF, Settle SL, Nemirovskiy O, Vickery LE, Agawal A, Dyer RD, Sunyer T",,605223,DTCT0024002,3175266,DTCC00610466,1471804,36915
CHEMBL603656,P45452,,KOTGODCEORJYIF-QAQDUYKDSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20005097,KI,=,4.4,NM,,,,,,,,,,,,,,Inhibition of human recombinant full length MMP13 assessed as type 3 collagen cleavage activity after 18 hrs,,Discovery of (pyridin-4-yl)-2H-tetrazole as a novel scaffold to identify highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2010,20,2,"Schnute ME, O'Brien PM, Nahra J, Morris M, Howard Roark W, Hanau CE, Ruminski PG, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Patt WC, Shieh HS, Collins B, Pavlovsky AG, Palmquist KE, Aston KW, Hitchcock J, Rogers MD, McDonald J, Johnson AR, Munie GE, Wittwer AJ, Man CF, Settle SL, Nemirovskiy O, Vickery LE, Agawal A, Dyer RD, Sunyer T",,605223,DTCT0024002,3175278,DTCC00610540,534004,36915
CHEMBL603857,P45452,,WLVVEXGMOJZNFP-KESTWPANSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20005097,KI,=,1.5,NM,,,,,,,,,,,,,,Inhibition of human recombinant full length MMP13 assessed as type 3 collagen cleavage activity after 18 hrs,,Discovery of (pyridin-4-yl)-2H-tetrazole as a novel scaffold to identify highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2010,20,2,"Schnute ME, O'Brien PM, Nahra J, Morris M, Howard Roark W, Hanau CE, Ruminski PG, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Patt WC, Shieh HS, Collins B, Pavlovsky AG, Palmquist KE, Aston KW, Hitchcock J, Rogers MD, McDonald J, Johnson AR, Munie GE, Wittwer AJ, Man CF, Settle SL, Nemirovskiy O, Vickery LE, Agawal A, Dyer RD, Sunyer T",,605223,DTCT0024002,3175284,DTCC00610586,1116103,36915
CHEMBL604139,P45452,,AAZKNLZLBGJGQH-KOMQPUFPSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20005097,KI,=,1.4,NM,,,,,,,,,,,,,,Inhibition of human recombinant full length MMP13 assessed as type 3 collagen cleavage activity after 18 hrs,,Discovery of (pyridin-4-yl)-2H-tetrazole as a novel scaffold to identify highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2010,20,2,"Schnute ME, O'Brien PM, Nahra J, Morris M, Howard Roark W, Hanau CE, Ruminski PG, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Patt WC, Shieh HS, Collins B, Pavlovsky AG, Palmquist KE, Aston KW, Hitchcock J, Rogers MD, McDonald J, Johnson AR, Munie GE, Wittwer AJ, Man CF, Settle SL, Nemirovskiy O, Vickery LE, Agawal A, Dyer RD, Sunyer T",,605223,DTCT0024002,3175286,DTCC00610588,469220,36915
CHEMBL605201,P45452,,XDBOLPFDJWTESQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20005097,IC50,=,1350,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 catalytic domain,,Discovery of (pyridin-4-yl)-2H-tetrazole as a novel scaffold to identify highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2010,20,2,"Schnute ME, O'Brien PM, Nahra J, Morris M, Howard Roark W, Hanau CE, Ruminski PG, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Patt WC, Shieh HS, Collins B, Pavlovsky AG, Palmquist KE, Aston KW, Hitchcock J, Rogers MD, McDonald J, Johnson AR, Munie GE, Wittwer AJ, Man CF, Settle SL, Nemirovskiy O, Vickery LE, Agawal A, Dyer RD, Sunyer T",,605071,DTCT0024002,3175291,DTCC00610415,953811,36915
CHEMBL605201,P45452,,XDBOLPFDJWTESQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20005097,IC50,,,,,,,,,,,,,,,,,Inhibition of human recombinant full length MMP13 assessed as type 3 collagen cleavage activity after 18 hrs,Not Determined,Discovery of (pyridin-4-yl)-2H-tetrazole as a novel scaffold to identify highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2010,20,2,"Schnute ME, O'Brien PM, Nahra J, Morris M, Howard Roark W, Hanau CE, Ruminski PG, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Patt WC, Shieh HS, Collins B, Pavlovsky AG, Palmquist KE, Aston KW, Hitchcock J, Rogers MD, McDonald J, Johnson AR, Munie GE, Wittwer AJ, Man CF, Settle SL, Nemirovskiy O, Vickery LE, Agawal A, Dyer RD, Sunyer T",,605223,DTCT0024002,3175257,DTCC00610415,953811,36915
CHEMBL60567,P45452,,KVUZGLYOUHGFEF-SLXFGWRHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11454461,IC50,=,22,NM,,,,,,,,,,,,,,In vitro inhibitory concentration against Matrix metalloprotease-13,,The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold.,Bioorg. Med. Chem. Lett.,2001,11,15,"Tullis JS, Laufersweiler MJ, VanRens JC, Natchus MG, Bookland RG, Almstead NG, Pikul S, De B, Hsieh LC, Janusz MJ, Branch TM, Peng SX, Jin YY, Hudlicky T, Oppong K",,106479,DTCT0024002,1557079,DTCC00208591,302724,4358
CHEMBL605742,P45452,,NAQYQAFYLLAUJD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20005097,KI,=,0.18,NM,,,,,,,,,,,,,,Inhibition of human recombinant full length MMP13 assessed as type 3 collagen cleavage activity after 18 hrs,,Discovery of (pyridin-4-yl)-2H-tetrazole as a novel scaffold to identify highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2010,20,2,"Schnute ME, O'Brien PM, Nahra J, Morris M, Howard Roark W, Hanau CE, Ruminski PG, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Patt WC, Shieh HS, Collins B, Pavlovsky AG, Palmquist KE, Aston KW, Hitchcock J, Rogers MD, McDonald J, Johnson AR, Munie GE, Wittwer AJ, Man CF, Settle SL, Nemirovskiy O, Vickery LE, Agawal A, Dyer RD, Sunyer T",,605223,DTCT0024002,3175275,DTCC00610519,1854249,36915
CHEMBL605764,P45452,,AZEKZZSSVLIPCQ-QZTJIDSGSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20022498,KI,=,7000,NM,,,,,,,,,,,,,,Inhibition of MMP13,,The discovery of novel tartrate-based TNF-alpha converting enzyme (TACE) inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,3,"Rosner KE, Guo Z, Orth P, Shipps GW, Belanger DB, Chan TY, Curran PJ, Dai C, Deng Y, Girijavallabhan VM, Hong L, Lavey BJ, Lee JF, Li D, Liu Z, Popovici-Muller J, Ting PC, Vaccaro H, Wang L, Wang T, Yu W, Zhou G, Niu X, Sun J, Kozlowski JA, Lundell DJ, Madison V, McKittrick B, Piwinski JJ, Shih NY, Arshad Siddiqui M, Strickland CO",,608479,DTCT0024002,3182386,DTCC00617773,1232601,37349
CHEMBL605928,P45452,,YCYIBGJERWDXNO-SAABIXHNSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20005097,KI,=,0.22,NM,,,,,,,,,,,,,,Inhibition of human recombinant full length MMP13 assessed as type 3 collagen cleavage activity after 18 hrs,,Discovery of (pyridin-4-yl)-2H-tetrazole as a novel scaffold to identify highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2010,20,2,"Schnute ME, O'Brien PM, Nahra J, Morris M, Howard Roark W, Hanau CE, Ruminski PG, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Patt WC, Shieh HS, Collins B, Pavlovsky AG, Palmquist KE, Aston KW, Hitchcock J, Rogers MD, McDonald J, Johnson AR, Munie GE, Wittwer AJ, Man CF, Settle SL, Nemirovskiy O, Vickery LE, Agawal A, Dyer RD, Sunyer T",,605223,DTCT0024002,3175290,DTCC00610619,1309985,36915
CHEMBL606155,P45452,,ZXJYHWUCDSTYKD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20005097,KI,=,65.3,NM,,,,,,,,,,,,,,Inhibition of human recombinant full length MMP13 assessed as type 3 collagen cleavage activity after 18 hrs,,Discovery of (pyridin-4-yl)-2H-tetrazole as a novel scaffold to identify highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2010,20,2,"Schnute ME, O'Brien PM, Nahra J, Morris M, Howard Roark W, Hanau CE, Ruminski PG, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Patt WC, Shieh HS, Collins B, Pavlovsky AG, Palmquist KE, Aston KW, Hitchcock J, Rogers MD, McDonald J, Johnson AR, Munie GE, Wittwer AJ, Man CF, Settle SL, Nemirovskiy O, Vickery LE, Agawal A, Dyer RD, Sunyer T",,605223,DTCT0024002,3175262,DTCC00610439,1342570,36915
CHEMBL606811,P45452,,AYYZUHWODYUGMF-JCNLHEQBSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20005097,KI,=,22.1,NM,,,,,,,,,,,,,,Inhibition of human recombinant full length MMP13 assessed as type 3 collagen cleavage activity after 18 hrs,,Discovery of (pyridin-4-yl)-2H-tetrazole as a novel scaffold to identify highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2010,20,2,"Schnute ME, O'Brien PM, Nahra J, Morris M, Howard Roark W, Hanau CE, Ruminski PG, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Patt WC, Shieh HS, Collins B, Pavlovsky AG, Palmquist KE, Aston KW, Hitchcock J, Rogers MD, McDonald J, Johnson AR, Munie GE, Wittwer AJ, Man CF, Settle SL, Nemirovskiy O, Vickery LE, Agawal A, Dyer RD, Sunyer T",,605223,DTCT0024002,3175280,DTCC00610559,1244621,36915
CHEMBL607299,P45452,,QUQPREFMDUPVMG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18358729,IC50,=,6800,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP13 expressed in Escherichia coli,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518658,DTCT0024002,2708807,DTCC00625953,1341352,32215
CHEMBL61017,P45452,,KVNBSMBKXVJFRN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11454461,IC50,=,13,NM,,,,,,,,,,,,,,In vitro inhibitory concentration against Matrix metalloprotease-13,,The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold.,Bioorg. Med. Chem. Lett.,2001,11,15,"Tullis JS, Laufersweiler MJ, VanRens JC, Natchus MG, Bookland RG, Almstead NG, Pikul S, De B, Hsieh LC, Janusz MJ, Branch TM, Peng SX, Jin YY, Hudlicky T, Oppong K",,106479,DTCT0024002,1530482,DTCC00105357,1046466,4358
CHEMBL61354,P45452,,MALRHJHVJCYQHD-PUUKEUDRSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11454461,IC50,=,21,NM,,,,,,,,,,,,,,In vitro inhibitory concentration against Matrix metalloprotease-13,,The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold.,Bioorg. Med. Chem. Lett.,2001,11,15,"Tullis JS, Laufersweiler MJ, VanRens JC, Natchus MG, Bookland RG, Almstead NG, Pikul S, De B, Hsieh LC, Janusz MJ, Branch TM, Peng SX, Jin YY, Hudlicky T, Oppong K",,106479,DTCT0024002,1529262,DTCC00208378,107904,4358
CHEMBL61577,P45452,,CYDOQDKDFWIELG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11454461,IC50,=,32,NM,,,,,,,,,,,,,,In vitro inhibitory concentration against Matrix metalloprotease-13,,The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold.,Bioorg. Med. Chem. Lett.,2001,11,15,"Tullis JS, Laufersweiler MJ, VanRens JC, Natchus MG, Bookland RG, Almstead NG, Pikul S, De B, Hsieh LC, Janusz MJ, Branch TM, Peng SX, Jin YY, Hudlicky T, Oppong K",,106479,DTCT0024002,1557085,DTCC00209511,787579,4358
CHEMBL62021,P45452,,LYRRCUUSLOFAKG-YOSAUDMPSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11454461,IC50,=,37,NM,,,,,,,,,,,,,,In vitro inhibitory concentration against Matrix metalloprotease-13,,The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold.,Bioorg. Med. Chem. Lett.,2001,11,15,"Tullis JS, Laufersweiler MJ, VanRens JC, Natchus MG, Bookland RG, Almstead NG, Pikul S, De B, Hsieh LC, Janusz MJ, Branch TM, Peng SX, Jin YY, Hudlicky T, Oppong K",,106479,DTCT0024002,1521176,DTCC00208232,819931,4358
CHEMBL62089,P45452,,DVNVXZQJDUVWTB-RWWKDMOOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11454461,IC50,=,64,NM,,,,,,,,,,,,,,In vitro inhibitory concentration against Matrix metalloprotease-13,,The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold.,Bioorg. Med. Chem. Lett.,2001,11,15,"Tullis JS, Laufersweiler MJ, VanRens JC, Natchus MG, Bookland RG, Almstead NG, Pikul S, De B, Hsieh LC, Janusz MJ, Branch TM, Peng SX, Jin YY, Hudlicky T, Oppong K",,106479,DTCT0024002,1541009,DTCC00208658,1946674,4358
CHEMBL67590,P45452,,FJRQWHSKVHCEKG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11514167,IC50,=,163,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,The discovery of anthranilic acid-based MMP inhibitors. Part 2: SAR of the 5-position and P1(1) groups.,Bioorg. Med. Chem. Lett.,2001,11,16,"Levin JI, Chen J, Du M, Hogan M, Kincaid S, Nelson FC, Venkatesan AM, Wehr T, Zask A, DiJoseph J, Killar LM, Skala S, Sung A, Sharr M, Roth C, Jin G, Cowling R, Mohler KM, Black RA, March CJ, Skotnicki JS",,106636,DTCT0024002,999975,DTCC00222546,1968113,4353
CHEMBL68196,P45452,,ZQENIBLYGGLKSO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11514167,IC50,=,6,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,The discovery of anthranilic acid-based MMP inhibitors. Part 2: SAR of the 5-position and P1(1) groups.,Bioorg. Med. Chem. Lett.,2001,11,16,"Levin JI, Chen J, Du M, Hogan M, Kincaid S, Nelson FC, Venkatesan AM, Wehr T, Zask A, DiJoseph J, Killar LM, Skala S, Sung A, Sharr M, Roth C, Jin G, Cowling R, Mohler KM, Black RA, March CJ, Skotnicki JS",,106636,DTCT0024002,1001186,DTCC00222818,323651,4353
CHEMBL68212,P45452,,QYEGLTVXUKXPSD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11514167,IC50,=,4,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,The discovery of anthranilic acid-based MMP inhibitors. Part 2: SAR of the 5-position and P1(1) groups.,Bioorg. Med. Chem. Lett.,2001,11,16,"Levin JI, Chen J, Du M, Hogan M, Kincaid S, Nelson FC, Venkatesan AM, Wehr T, Zask A, DiJoseph J, Killar LM, Skala S, Sung A, Sharr M, Roth C, Jin G, Cowling R, Mohler KM, Black RA, March CJ, Skotnicki JS",,106636,DTCT0024002,1003591,DTCC00222631,1934882,4353
CHEMBL68271,P45452,,MQDWBVIPJPRWIJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11514167,IC50,=,3,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,The discovery of anthranilic acid-based MMP inhibitors. Part 2: SAR of the 5-position and P1(1) groups.,Bioorg. Med. Chem. Lett.,2001,11,16,"Levin JI, Chen J, Du M, Hogan M, Kincaid S, Nelson FC, Venkatesan AM, Wehr T, Zask A, DiJoseph J, Killar LM, Skala S, Sung A, Sharr M, Roth C, Jin G, Cowling R, Mohler KM, Black RA, March CJ, Skotnicki JS",,106636,DTCT0024002,999971,DTCC00222783,1806122,4353
CHEMBL68542,P45452,,PCSKPZLQCNGMCY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11514167,IC50,=,1,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,The discovery of anthranilic acid-based MMP inhibitors. Part 2: SAR of the 5-position and P1(1) groups.,Bioorg. Med. Chem. Lett.,2001,11,16,"Levin JI, Chen J, Du M, Hogan M, Kincaid S, Nelson FC, Venkatesan AM, Wehr T, Zask A, DiJoseph J, Killar LM, Skala S, Sung A, Sharr M, Roth C, Jin G, Cowling R, Mohler KM, Black RA, March CJ, Skotnicki JS",,106636,DTCT0024002,1013366,DTCC00222105,225597,4353
CHEMBL69048,P45452,,RISXEMMNXJMKFX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11514167,IC50,=,26,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,The discovery of anthranilic acid-based MMP inhibitors. Part 2: SAR of the 5-position and P1(1) groups.,Bioorg. Med. Chem. Lett.,2001,11,16,"Levin JI, Chen J, Du M, Hogan M, Kincaid S, Nelson FC, Venkatesan AM, Wehr T, Zask A, DiJoseph J, Killar LM, Skala S, Sung A, Sharr M, Roth C, Jin G, Cowling R, Mohler KM, Black RA, March CJ, Skotnicki JS",,106636,DTCT0024002,1005835,DTCC00222617,1293652,4353
CHEMBL69145,P45452,,WKTQKJFJPJOVNX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11514167,IC50,=,44,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,The discovery of anthranilic acid-based MMP inhibitors. Part 2: SAR of the 5-position and P1(1) groups.,Bioorg. Med. Chem. Lett.,2001,11,16,"Levin JI, Chen J, Du M, Hogan M, Kincaid S, Nelson FC, Venkatesan AM, Wehr T, Zask A, DiJoseph J, Killar LM, Skala S, Sung A, Sharr M, Roth C, Jin G, Cowling R, Mohler KM, Black RA, March CJ, Skotnicki JS",,106636,DTCT0024002,1008411,DTCC00223257,1741858,4353
CHEMBL69268,P45452,,CBKKHHSQVZVIBM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11514167,IC50,=,1,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,The discovery of anthranilic acid-based MMP inhibitors. Part 2: SAR of the 5-position and P1(1) groups.,Bioorg. Med. Chem. Lett.,2001,11,16,"Levin JI, Chen J, Du M, Hogan M, Kincaid S, Nelson FC, Venkatesan AM, Wehr T, Zask A, DiJoseph J, Killar LM, Skala S, Sung A, Sharr M, Roth C, Jin G, Cowling R, Mohler KM, Black RA, March CJ, Skotnicki JS",,106636,DTCT0024002,1010803,DTCC00222781,1649724,4353
CHEMBL69569,P45452,,ZDRROEWAOPXRJQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11514167,IC50,=,1752,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,The discovery of anthranilic acid-based MMP inhibitors. Part 2: SAR of the 5-position and P1(1) groups.,Bioorg. Med. Chem. Lett.,2001,11,16,"Levin JI, Chen J, Du M, Hogan M, Kincaid S, Nelson FC, Venkatesan AM, Wehr T, Zask A, DiJoseph J, Killar LM, Skala S, Sung A, Sharr M, Roth C, Jin G, Cowling R, Mohler KM, Black RA, March CJ, Skotnicki JS",,106636,DTCT0024002,998697,DTCC00222440,1035038,4353
CHEMBL70176,P45452,,AINJYWXKBKRQSX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11206467,IC50,=,8,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-13,,The discovery of anthranilic acid-based MMP inhibitors. Part 1: SAR of the 3-position.,Bioorg. Med. Chem. Lett.,2001,11,2,"Levin JI, Du MT, DiJoseph JF, Killar LM, Sung A, Walter T, Sharr MA, Roth CE, Moy FJ, Powers R, Jin G, Cowling R, Skotnicki JS",,106467,DTCT0024002,603579,DTCC00222284,257991,4515
CHEMBL70176,P45452,,AINJYWXKBKRQSX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11206468,IC50,=,8,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,Heteroaryl and cycloalkyl sulfonamide hydroxamic acid inhibitors of matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2001,11,2,"Levin JI, Gu Y, Nelson FC, Zask A, DiJoseph JF, Sharr MA, Sung A, Jin G, Cowling R, Chanda P, Cosmi S, Hsiao CL, Edris W, Wilhelm J, Killar LM, Skotnicki JS",,106621,DTCT0024002,1287483,DTCC00222284,269983,4516
CHEMBL70176,P45452,,AINJYWXKBKRQSX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11514167,IC50,=,8,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,The discovery of anthranilic acid-based MMP inhibitors. Part 2: SAR of the 5-position and P1(1) groups.,Bioorg. Med. Chem. Lett.,2001,11,16,"Levin JI, Chen J, Du M, Hogan M, Kincaid S, Nelson FC, Venkatesan AM, Wehr T, Zask A, DiJoseph J, Killar LM, Skala S, Sung A, Sharr M, Roth C, Jin G, Cowling R, Mohler KM, Black RA, March CJ, Skotnicki JS",,106636,DTCT0024002,988865,DTCC00222284,257857,4353
CHEMBL70176,P45452,,AINJYWXKBKRQSX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11677139,IC50,=,8,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-13.,,The discovery of anthranilic acid-based MMP inhibitors. Part 3: incorporation of basic amines.,Bioorg. Med. Chem. Lett.,2001,11,22,"Levin JI, Chen JM, Du MT, Nelson FC, Wehr T, DiJoseph JF, Killar LM, Skala S, Sung A, Sharr MA, Roth CE, Jin G, Cowling R, Di L, Sherman M, Xu ZB, March CJ, Mohler KM, Black RA, Skotnicki JS",,106763,DTCT0024002,1635162,DTCC00222284,258369,4590
CHEMBL70176,P45452,,AINJYWXKBKRQSX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11677139,IC50,=,18,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-13.,,The discovery of anthranilic acid-based MMP inhibitors. Part 3: incorporation of basic amines.,Bioorg. Med. Chem. Lett.,2001,11,22,"Levin JI, Chen JM, Du MT, Nelson FC, Wehr T, DiJoseph JF, Killar LM, Skala S, Sung A, Sharr MA, Roth CE, Jin G, Cowling R, Di L, Sherman M, Xu ZB, March CJ, Mohler KM, Black RA, Skotnicki JS",,106763,DTCT0024002,1603354,DTCC00222284,258371,4590
CHEMBL70176,P45452,,AINJYWXKBKRQSX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11677139,IC50,=,18,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-13.,,The discovery of anthranilic acid-based MMP inhibitors. Part 3: incorporation of basic amines.,Bioorg. Med. Chem. Lett.,2001,11,22,"Levin JI, Chen JM, Du MT, Nelson FC, Wehr T, DiJoseph JF, Killar LM, Skala S, Sung A, Sharr MA, Roth CE, Jin G, Cowling R, Di L, Sherman M, Xu ZB, March CJ, Mohler KM, Black RA, Skotnicki JS",,106763,DTCT0024002,1609700,DTCC00222284,258370,4590
CHEMBL70176,P45452,,AINJYWXKBKRQSX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,IC50,=,7.94,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258707,DTCC00222284,260722,24803
CHEMBL70207,P45452,,LSGQQGGAWBOKIB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11514167,IC50,=,959,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,The discovery of anthranilic acid-based MMP inhibitors. Part 2: SAR of the 5-position and P1(1) groups.,Bioorg. Med. Chem. Lett.,2001,11,16,"Levin JI, Chen J, Du M, Hogan M, Kincaid S, Nelson FC, Venkatesan AM, Wehr T, Zask A, DiJoseph J, Killar LM, Skala S, Sung A, Sharr M, Roth C, Jin G, Cowling R, Mohler KM, Black RA, March CJ, Skotnicki JS",,106636,DTCT0024002,1014666,DTCC00222731,291130,4353
CHEMBL70957,P45452,,RGJXGQMBVWRXCQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11514167,IC50,=,24,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,The discovery of anthranilic acid-based MMP inhibitors. Part 2: SAR of the 5-position and P1(1) groups.,Bioorg. Med. Chem. Lett.,2001,11,16,"Levin JI, Chen J, Du M, Hogan M, Kincaid S, Nelson FC, Venkatesan AM, Wehr T, Zask A, DiJoseph J, Killar LM, Skala S, Sung A, Sharr M, Roth C, Jin G, Cowling R, Mohler KM, Black RA, March CJ, Skotnicki JS",,106636,DTCT0024002,982029,DTCC00222702,1741859,4353
CHEMBL71007,P45452,,QVIMBPCQZGHONM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11514167,IC50,=,75,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,The discovery of anthranilic acid-based MMP inhibitors. Part 2: SAR of the 5-position and P1(1) groups.,Bioorg. Med. Chem. Lett.,2001,11,16,"Levin JI, Chen J, Du M, Hogan M, Kincaid S, Nelson FC, Venkatesan AM, Wehr T, Zask A, DiJoseph J, Killar LM, Skala S, Sung A, Sharr M, Roth C, Jin G, Cowling R, Mohler KM, Black RA, March CJ, Skotnicki JS",,106636,DTCT0024002,1005827,DTCC00222874,323652,4353
CHEMBL71227,P45452,,PYSVMZGECWVLOT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11514167,IC50,=,661,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,The discovery of anthranilic acid-based MMP inhibitors. Part 2: SAR of the 5-position and P1(1) groups.,Bioorg. Med. Chem. Lett.,2001,11,16,"Levin JI, Chen J, Du M, Hogan M, Kincaid S, Nelson FC, Venkatesan AM, Wehr T, Zask A, DiJoseph J, Killar LM, Skala S, Sung A, Sharr M, Roth C, Jin G, Cowling R, Mohler KM, Black RA, March CJ, Skotnicki JS",,106636,DTCT0024002,984287,DTCC00223155,1488329,4353
CHEMBL71309,P45452,,WRNMBFWQBKEBIX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11514167,IC50,=,113,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,The discovery of anthranilic acid-based MMP inhibitors. Part 2: SAR of the 5-position and P1(1) groups.,Bioorg. Med. Chem. Lett.,2001,11,16,"Levin JI, Chen J, Du M, Hogan M, Kincaid S, Nelson FC, Venkatesan AM, Wehr T, Zask A, DiJoseph J, Killar LM, Skala S, Sung A, Sharr M, Roth C, Jin G, Cowling R, Mohler KM, Black RA, March CJ, Skotnicki JS",,106636,DTCT0024002,1013371,DTCC00222389,1488328,4353
CHEMBL71412,P45452,,ZHFFEAWPDKTWSZ-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12798337,INHIBITION EFFECT,=,0.923,,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-13 at 20 nM,,Synthesis of radiolabeled biphenylsulfonamide matrix metalloproteinase inhibitors as new potential PET cancer imaging agents.,Bioorg. Med. Chem. Lett.,2003,13,13,"Fei X, Zheng QH, Liu X, Wang JQ, Sun HB, Mock BH, Stone KL, Miller KD, Sledge GW, Hutchins GD",,106607,DTCT0024002,1367453,DTCC00224150,140535,5629
CHEMBL71436,P45452,,MLRVULAXCZJAAN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11514167,IC50,=,142,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,The discovery of anthranilic acid-based MMP inhibitors. Part 2: SAR of the 5-position and P1(1) groups.,Bioorg. Med. Chem. Lett.,2001,11,16,"Levin JI, Chen J, Du M, Hogan M, Kincaid S, Nelson FC, Venkatesan AM, Wehr T, Zask A, DiJoseph J, Killar LM, Skala S, Sung A, Sharr M, Roth C, Jin G, Cowling R, Mohler KM, Black RA, March CJ, Skotnicki JS",,106636,DTCT0024002,1008415,DTCC00223207,1326197,4353
CHEMBL71645,P45452,,WMBVCTBFQRRSBU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11514167,IC50,=,18,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,The discovery of anthranilic acid-based MMP inhibitors. Part 2: SAR of the 5-position and P1(1) groups.,Bioorg. Med. Chem. Lett.,2001,11,16,"Levin JI, Chen J, Du M, Hogan M, Kincaid S, Nelson FC, Venkatesan AM, Wehr T, Zask A, DiJoseph J, Killar LM, Skala S, Sung A, Sharr M, Roth C, Jin G, Cowling R, Mohler KM, Black RA, March CJ, Skotnicki JS",,106636,DTCT0024002,1005831,DTCC00222542,776154,4353
CHEMBL71645,P45452,,WMBVCTBFQRRSBU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18790648,IC50,=,18,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497406,DTCT0024002,2457472,DTCC00222542,791163,32556
CHEMBL71686,P45452,,RRSNDPJAXNKWJB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11514167,IC50,=,3,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,The discovery of anthranilic acid-based MMP inhibitors. Part 2: SAR of the 5-position and P1(1) groups.,Bioorg. Med. Chem. Lett.,2001,11,16,"Levin JI, Chen J, Du M, Hogan M, Kincaid S, Nelson FC, Venkatesan AM, Wehr T, Zask A, DiJoseph J, Killar LM, Skala S, Sung A, Sharr M, Roth C, Jin G, Cowling R, Mohler KM, Black RA, March CJ, Skotnicki JS",,106636,DTCT0024002,1012110,DTCC00222576,257858,4353
CHEMBL71725,P45452,,CZYVJSTWDMVAFM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11514167,IC50,=,20,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,The discovery of anthranilic acid-based MMP inhibitors. Part 2: SAR of the 5-position and P1(1) groups.,Bioorg. Med. Chem. Lett.,2001,11,16,"Levin JI, Chen J, Du M, Hogan M, Kincaid S, Nelson FC, Venkatesan AM, Wehr T, Zask A, DiJoseph J, Killar LM, Skala S, Sung A, Sharr M, Roth C, Jin G, Cowling R, Mohler KM, Black RA, March CJ, Skotnicki JS",,106636,DTCT0024002,1002334,DTCC00222387,711786,4353
CHEMBL71805,P45452,,LUBSCKJLTZOPRJ-SFHVURJKSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12798337,INHIBITION EFFECT,=,0.939,,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-13 at 20 nM,,Synthesis of radiolabeled biphenylsulfonamide matrix metalloproteinase inhibitors as new potential PET cancer imaging agents.,Bioorg. Med. Chem. Lett.,2003,13,13,"Fei X, Zheng QH, Liu X, Wang JQ, Sun HB, Mock BH, Stone KL, Miller KD, Sledge GW, Hutchins GD",,106607,DTCT0024002,1377791,DTCC00224108,2012670,5629
CHEMBL72468,P45452,,QVRAWKWQEGMKLD-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12798337,INHIBITION EFFECT,=,0.91,,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-13 at 20 nM,,Synthesis of radiolabeled biphenylsulfonamide matrix metalloproteinase inhibitors as new potential PET cancer imaging agents.,Bioorg. Med. Chem. Lett.,2003,13,13,"Fei X, Zheng QH, Liu X, Wang JQ, Sun HB, Mock BH, Stone KL, Miller KD, Sledge GW, Hutchins GD",,106607,DTCT0024002,1380222,DTCC00224396,1979838,5629
CHEMBL72511,P45452,PKF-242-484,IOLRUMINDIUCLJ-RRFJBIMHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16516469,KI,=,0.5,NM,,,,,,,,,,,,,,Binding affinity to recombinant MMP13,,A cassette-dosing approach for improvement of oral bioavailability of dual TACE/MMP inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,10,"Janser P, Neumann U, Miltz W, Feifel R, Buhl T",,354053,DTCT0024002,1926040,DTCC01741036,855239,20779
CHEMBL72636,P45452,,ZVKUBEYOUKLQCV-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12798337,INHIBITION EFFECT,=,0.883,,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-13 at 20 nM,,Synthesis of radiolabeled biphenylsulfonamide matrix metalloproteinase inhibitors as new potential PET cancer imaging agents.,Bioorg. Med. Chem. Lett.,2003,13,13,"Fei X, Zheng QH, Liu X, Wang JQ, Sun HB, Mock BH, Stone KL, Miller KD, Sledge GW, Hutchins GD",,106607,DTCT0024002,1378994,DTCC00224171,1467463,5629
CHEMBL734,P45452,ACETOHYDROXAMIC ACID,RRUDCFGSUDOHDG-UHFFFAOYSA-N,4,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25330343,IC50,,,,,,,,,,,,,,,,,Non-competitive inhibition of full-length recombinant human MMP-13 assessed as fTHP-15 substrate hydrolysis,Not Determined,Characterization of selective exosite-binding inhibitors of matrix metalloproteinase 13 that prevent articular cartilage degradation in vitro.,J. Med. Chem.,2014,57,22,"Spicer TP, Jiang J, Taylor AB, Choi JY, Hart PJ, Roush WR, Fields GB, Hodder PS, Minond D",,1434999,DTCT0024002,13947494,DTCC00163357,623206,60192
CHEMBL734,P45452,ACETOHYDROXAMIC ACID,RRUDCFGSUDOHDG-UHFFFAOYSA-N,4,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25330343,KB,=,1200,NM,,,,,,,,,,,,,,Competitive inhibition of full-length recombinant human MMP-13 assessed as fTHP-15 substrate hydrolysis by Lineweaver-Burke plot analysis,,Characterization of selective exosite-binding inhibitors of matrix metalloproteinase 13 that prevent articular cartilage degradation in vitro.,J. Med. Chem.,2014,57,22,"Spicer TP, Jiang J, Taylor AB, Choi JY, Hart PJ, Roush WR, Fields GB, Hodder PS, Minond D",,1435001,DTCT0024002,13947495,DTCC00163357,623206,60192
CHEMBL74954,P45452,,IKJQAKILPMDYQE-ZBAATNBSSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12824028,IC50,=,44,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13,,Phosphinic acid-based MMP-13 inhibitors that spare MMP-1 and MMP-3.,Bioorg. Med. Chem. Lett.,2003,13,14,"Reiter LA, Mitchell PG, Martinelli GJ, Lopresti-Morrow LL, Yocum SA, Eskra JD",,106640,DTCT0024002,1494245,DTCC00232499,172823,5648
CHEMBL75046,P45452,,TUIHSDQRXNNCLL-HUUCEWRRSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10882354,IC50,=,3390,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,Structure-based design and synthesis of a potent matrix metalloproteinase-13 inhibitor based on a pyrrolidinone scaffold.,J. Med. Chem.,2000,43,12,"Robinson RP, Laird ER, Blake JF, Bordner J, Donahue KM, Lopresti-Morrow LL, Mitchell PG, Reese MR, Reeves LM, Stam EJ, Yocum SA",,106624,DTCT0024002,1094632,DTCC00229352,1979888,15747
CHEMBL75094,P45452,PRINOMASTAT,YKPYIPVDTNNYCN-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10579818,IC50,<,0.4,NM,,,,,,,,,,,,,,In vitro inhibitory activity against collagenase-3 (matrix metalloprotease-13).,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,106469,DTCT0024002,1369142,DTCC00231104,336627,15412
CHEMBL75094,P45452,PRINOMASTAT,YKPYIPVDTNNYCN-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10579818,KI,=,0.038,NM,,,,,,,,,,,,,,Inhibition of collagenase (Matrix metalloprotease-13),,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,106609,DTCT0024002,1369143,DTCC00231104,336627,15412
CHEMBL75094,P45452,PRINOMASTAT,YKPYIPVDTNNYCN-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10669559,KI,=,0.038,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13 (MMP-13).,,Protease inhibitors: current status and future prospects.,J. Med. Chem.,2000,43,3,"Leung D, Abbenante G, Fairlie DP",,106612,DTCT0024002,1072600,DTCC00231104,324460,16063
CHEMBL75094,P45452,PRINOMASTAT,YKPYIPVDTNNYCN-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11133099,IC50,=,0.5,NM,,,,,,,,,,,,,,50 percent inhibition of human Matrix metalloprotease-13 by the cleavage of fluorogenic peptide MCA-Pro-Leu-Gly-Leu-Dpa-ala-Arg-NH2,,Synthesis and activity of selective MMP inhibitors with an aryl backbone.,Bioorg. Med. Chem. Lett.,2000,10,24,"Barta TE, Becker DP, Bedell LJ, De Crescenzo GA, McDonald JJ, Munie GE, Rao S, Shieh HS, Stegeman R, Stevens AM, Villamil CI",,106604,DTCT0024002,698094,DTCC00231104,324088,3985
CHEMBL75094,P45452,PRINOMASTAT,YKPYIPVDTNNYCN-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11212095,IC50,=,1.5,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,General synthesis of alpha-substituted 3-bisaryloxy propionic acid derivatives as specific MMP inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,3,"Chollet AM, Le Diguarher T, Murray L, Bertrand M, Tucker GC, Sabatini M, Pierré A, Atassi G, Bonnet J, Casara P",,106483,DTCT0024002,628951,DTCC00231104,324195,4635
CHEMBL75094,P45452,PRINOMASTAT,YKPYIPVDTNNYCN-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11549451,ACTIVITY,=,0.5,NM,,,,,,,,,,,,,,Inhibitory activity against human Matrix metalloprotease-13,,"Selective, orally active MMP inhibitors with an aryl backbone.",Bioorg. Med. Chem. Lett.,2001,11,18,"Barta TE, Becker DP, Bedell LJ, De Crescenzo GA, McDonald JJ, Mehta P, Munie GE, Villamil CI",,106466,DTCT0024002,1673838,DTCC00231104,335657,4449
CHEMBL75094,P45452,PRINOMASTAT,YKPYIPVDTNNYCN-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11754593,IC50,=,0.2,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 (MMP-13) in fluorimetric assay,,"Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitors.",J. Med. Chem.,2002,45,1,"Wada CK, Holms JH, Curtin ML, Dai Y, Florjancic AS, Garland RB, Guo Y, Heyman HR, Stacey JR, Steinman DH, Albert DH, Bouska JJ, Elmore IN, Goodfellow CL, Marcotte PA, Tapang P, Morgan DW, Michaelides MR, Davidsen SK",,106639,DTCT0024002,1565057,DTCC00231104,323739,16699
CHEMBL75094,P45452,PRINOMASTAT,YKPYIPVDTNNYCN-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12930146,IC50,=,1.5,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13 (MMP13),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,106606,DTCT0024002,532648,DTCC00231104,336390,13726
CHEMBL75433,P45452,3-BENZENESULFINYL-HEPTANOIC ACID HYDROXYAMIDE,SQIUCETXNXHTSW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10882358,IC50,=,,,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,Not Determined,Hydroxamic acid derivatives as potent peptide deformylase inhibitors and antibacterial agents.,J. Med. Chem.,2000,43,12,"Apfel C, Banner DW, Bur D, Dietz M, Hirata T, Hubschwerlen C, Locher H, Page MG, Pirson W, Rossé G, Specklin JL",,104572,DTCT0024002,554381,DTCC01741122,1722969,15751
CHEMBL75641,P45452,,OQOVBCVMAHMMFY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773041,IC50,=,13,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-13,,"Synthesis and structure-activity relationship of alpha-sulfonylhydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Grosu GT, Davis JM, Hu B, Ellingboe J, Baker JL, Skotnicki JS, Zask A, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R",,106627,DTCT0024002,773000,DTCC00233928,1903002,17339
CHEMBL75702,P45452,,UNQHIMAGAUGZGX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773041,IC50,=,19,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-13,,"Synthesis and structure-activity relationship of alpha-sulfonylhydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Grosu GT, Davis JM, Hu B, Ellingboe J, Baker JL, Skotnicki JS, Zask A, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R",,106627,DTCT0024002,811948,DTCC00235118,1968256,17339
CHEMBL75735,P45452,,CMYVGFHFZHAJLK-LSDHHAIUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10882354,IC50,>,30000,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,Structure-based design and synthesis of a potent matrix metalloproteinase-13 inhibitor based on a pyrrolidinone scaffold.,J. Med. Chem.,2000,43,12,"Robinson RP, Laird ER, Blake JF, Bordner J, Donahue KM, Lopresti-Morrow LL, Mitchell PG, Reese MR, Reeves LM, Stam EJ, Yocum SA",,106624,DTCT0024002,1108019,DTCC00229355,204742,15747
CHEMBL75925,P45452,,JEALYKJUQQXXBO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773041,IC50,=,85,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-13,,"Synthesis and structure-activity relationship of alpha-sulfonylhydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Grosu GT, Davis JM, Hu B, Ellingboe J, Baker JL, Skotnicki JS, Zask A, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R",,106627,DTCT0024002,773004,DTCC00233980,647729,17339
CHEMBL76038,P45452,,UZMHOPNYRMEVNJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773041,IC50,=,85,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-13,,"Synthesis and structure-activity relationship of alpha-sulfonylhydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Grosu GT, Davis JM, Hu B, Ellingboe J, Baker JL, Skotnicki JS, Zask A, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R",,106627,DTCT0024002,779776,DTCC00234584,518429,17339
CHEMBL76137,P45452,,UTDYWIPXAVCYCE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773042,IC50,=,3,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13.,,"Synthesis and structure-activity relationship of N-substituted 4-arylsulfonylpiperidine-4-hydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Davis JM, Grosu GT, Baker J, Ellingboe J, Zask A, Levin JI, Sandanayaka VP, Du M, Skotnicki JS, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R, Tillett J, Zhao W, McDevitt J, Xu ZB",,106632,DTCT0024002,486990,DTCC00235111,529874,17340
CHEMBL76137,P45452,,UTDYWIPXAVCYCE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,5.52,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260829,DTCC00235111,521159,24831
CHEMBL76356,P45452,,XGFRXSAFARHCLC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773041,IC50,=,55,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-13,,"Synthesis and structure-activity relationship of alpha-sulfonylhydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Grosu GT, Davis JM, Hu B, Ellingboe J, Baker JL, Skotnicki JS, Zask A, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R",,106627,DTCT0024002,785574,DTCC00234583,2065482,17339
CHEMBL76488,P45452,,BKJCTJQMBGJOHN-RMKNXTFCSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773041,IC50,=,12,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-13,,"Synthesis and structure-activity relationship of alpha-sulfonylhydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Grosu GT, Davis JM, Hu B, Ellingboe J, Baker JL, Skotnicki JS, Zask A, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R",,106627,DTCT0024002,796723,DTCC00234578,1649862,17339
CHEMBL76488,P45452,,BKJCTJQMBGJOHN-RMKNXTFCSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,4.92,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260779,DTCC00234578,1652649,24831
CHEMBL76606,P45452,,DLFIQQOMKGGVGI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11206467,IC50,=,50,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-13,,The discovery of anthranilic acid-based MMP inhibitors. Part 1: SAR of the 3-position.,Bioorg. Med. Chem. Lett.,2001,11,2,"Levin JI, Du MT, DiJoseph JF, Killar LM, Sung A, Walter T, Sharr MA, Roth CE, Moy FJ, Powers R, Jin G, Cowling R, Skotnicki JS",,106467,DTCT0024002,592895,DTCC00234734,1391811,4515
CHEMBL76606,P45452,,DLFIQQOMKGGVGI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,IC50,=,50.12,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258708,DTCC00234734,1394253,24803
CHEMBL76619,P45452,,PPTJZFSGDMWVFF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773041,IC50,=,6,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-13,,"Synthesis and structure-activity relationship of alpha-sulfonylhydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Grosu GT, Davis JM, Hu B, Ellingboe J, Baker JL, Skotnicki JS, Zask A, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R",,106627,DTCT0024002,789481,DTCC00234556,2033780,17339
CHEMBL76673,P45452,,XBLZKAPRZBJHCZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773041,IC50,=,11,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-13,,"Synthesis and structure-activity relationship of alpha-sulfonylhydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Grosu GT, Davis JM, Hu B, Ellingboe J, Baker JL, Skotnicki JS, Zask A, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R",,106627,DTCT0024002,782819,DTCC00234511,1391807,17339
CHEMBL76674,P45452,,CEYDMEZCBBKZBI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773041,IC50,=,15,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-13,,"Synthesis and structure-activity relationship of alpha-sulfonylhydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Grosu GT, Davis JM, Hu B, Ellingboe J, Baker JL, Skotnicki JS, Zask A, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R",,106627,DTCT0024002,806445,DTCC00234579,1455888,17339
CHEMBL76836,P45452,,PRBMKJZQAUSBQV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773042,IC50,=,3,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13.,,"Synthesis and structure-activity relationship of N-substituted 4-arylsulfonylpiperidine-4-hydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Davis JM, Grosu GT, Baker J, Ellingboe J, Zask A, Levin JI, Sandanayaka VP, Du M, Skotnicki JS, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R, Tillett J, Zhao W, McDevitt J, Xu ZB",,106632,DTCT0024002,490638,DTCC00235113,1693445,17340
CHEMBL76836,P45452,,PRBMKJZQAUSBQV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,5.52,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260815,DTCC00235113,1684878,24831
CHEMBL76847,P45452,,YJOSMOCGEMCNLK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773042,IC50,=,3,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13.,,"Synthesis and structure-activity relationship of N-substituted 4-arylsulfonylpiperidine-4-hydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Davis JM, Grosu GT, Baker J, Ellingboe J, Zask A, Levin JI, Sandanayaka VP, Du M, Skotnicki JS, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R, Tillett J, Zhao W, McDevitt J, Xu ZB",,106632,DTCT0024002,507900,DTCC00236332,1111969,17340
CHEMBL76847,P45452,,YJOSMOCGEMCNLK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,5.52,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260817,DTCC00236332,1103047,24831
CHEMBL76856,P45452,,KLYIBVBIKFMTRO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773042,IC50,=,2,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13.,,"Synthesis and structure-activity relationship of N-substituted 4-arylsulfonylpiperidine-4-hydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Davis JM, Grosu GT, Baker J, Ellingboe J, Zask A, Levin JI, Sandanayaka VP, Du M, Skotnicki JS, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R, Tillett J, Zhao W, McDevitt J, Xu ZB",,106632,DTCT0024002,508987,DTCC00235473,917080,17340
CHEMBL76856,P45452,,KLYIBVBIKFMTRO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,5.7,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260823,DTCC00235473,909295,24831
CHEMBL76878,P45452,,FVYBFRCALRJYHO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773041,IC50,=,32,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-13,,"Synthesis and structure-activity relationship of alpha-sulfonylhydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Grosu GT, Davis JM, Hu B, Ellingboe J, Baker JL, Skotnicki JS, Zask A, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R",,106627,DTCT0024002,809315,DTCC00233595,1617699,17339
CHEMBL76888,P45452,,QDJTVBZWIYKRMZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773041,IC50,=,3,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-13,,"Synthesis and structure-activity relationship of alpha-sulfonylhydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Grosu GT, Davis JM, Hu B, Ellingboe J, Baker JL, Skotnicki JS, Zask A, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R",,106627,DTCT0024002,799534,DTCC00105981,744206,17339
CHEMBL76970,P45452,,COMDPQPBGQXLMK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773041,IC50,=,39,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-13,,"Synthesis and structure-activity relationship of alpha-sulfonylhydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Grosu GT, Davis JM, Hu B, Ellingboe J, Baker JL, Skotnicki JS, Zask A, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R",,106627,DTCT0024002,792612,DTCC00234499,128900,17339
CHEMBL76970,P45452,,COMDPQPBGQXLMK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,4.41,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260780,DTCC00234499,131674,24831
CHEMBL76974,P45452,,WUQMFARMJJXJMN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11206467,IC50,=,4,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-13,,The discovery of anthranilic acid-based MMP inhibitors. Part 1: SAR of the 3-position.,Bioorg. Med. Chem. Lett.,2001,11,2,"Levin JI, Du MT, DiJoseph JF, Killar LM, Sung A, Walter T, Sharr MA, Roth CE, Moy FJ, Powers R, Jin G, Cowling R, Skotnicki JS",,106467,DTCT0024002,617535,DTCC00234562,744210,4515
CHEMBL76974,P45452,,WUQMFARMJJXJMN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,IC50,=,3.98,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258700,DTCC00234562,746932,24803
CHEMBL77125,P45452,,KDJZFDKCOPXERM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773041,IC50,=,31,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-13,,"Synthesis and structure-activity relationship of alpha-sulfonylhydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Grosu GT, Davis JM, Hu B, Ellingboe J, Baker JL, Skotnicki JS, Zask A, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R",,106627,DTCT0024002,815166,DTCC00233913,776279,17339
CHEMBL77128,P45452,,WALHBIOGMPBGKI-NLIBRCFJSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12824028,IC50,=,13,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13,,Phosphinic acid-based MMP-13 inhibitors that spare MMP-1 and MMP-3.,Bioorg. Med. Chem. Lett.,2003,13,14,"Reiter LA, Mitchell PG, Martinelli GJ, Lopresti-Morrow LL, Yocum SA, Eskra JD",,106640,DTCT0024002,1508508,DTCC00231962,1882239,5648
CHEMBL77163,P45452,,VAQVSMUJBPTVIS-ZBAATNBSSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12824028,IC50,=,8.3,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13,,Phosphinic acid-based MMP-13 inhibitors that spare MMP-1 and MMP-3.,Bioorg. Med. Chem. Lett.,2003,13,14,"Reiter LA, Mitchell PG, Martinelli GJ, Lopresti-Morrow LL, Yocum SA, Eskra JD",,106640,DTCT0024002,1491828,DTCC00232704,1403218,5648
CHEMBL77176,P45452,,CWVWYGJTCDBSIW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773042,IC50,=,2,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13.,,"Synthesis and structure-activity relationship of N-substituted 4-arylsulfonylpiperidine-4-hydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Davis JM, Grosu GT, Baker J, Ellingboe J, Zask A, Levin JI, Sandanayaka VP, Du M, Skotnicki JS, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R, Tillett J, Zhao W, McDevitt J, Xu ZB",,106632,DTCT0024002,512797,DTCC00235142,1947019,17340
CHEMBL77176,P45452,,CWVWYGJTCDBSIW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,5.7,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260831,DTCC00235142,1937758,24831
CHEMBL77207,P45452,,ZGEUEQMPAIUHSM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773041,IC50,=,319,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-13,,"Synthesis and structure-activity relationship of alpha-sulfonylhydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Grosu GT, Davis JM, Hu B, Ellingboe J, Baker JL, Skotnicki JS, Zask A, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R",,106627,DTCT0024002,809311,DTCC00235130,1838712,17339
CHEMBL77207,P45452,,ZGEUEQMPAIUHSM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,3.5,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260774,DTCC00235130,1841450,24831
CHEMBL77237,P45452,,WTWNYQALQSSSPL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11206467,IC50,=,717,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-13,,The discovery of anthranilic acid-based MMP inhibitors. Part 1: SAR of the 3-position.,Bioorg. Med. Chem. Lett.,2001,11,2,"Levin JI, Du MT, DiJoseph JF, Killar LM, Sung A, Walter T, Sharr MA, Roth CE, Moy FJ, Powers R, Jin G, Cowling R, Skotnicki JS",,106467,DTCT0024002,600968,DTCC00234311,1067511,4515
CHEMBL77258,P45452,3-CYCLOHEXANESULFONYL-HEPTANOIC ACID HYDROXYAMIDE,LUHJAOVICRNTRC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10882358,IC50,=,100,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,Hydroxamic acid derivatives as potent peptide deformylase inhibitors and antibacterial agents.,J. Med. Chem.,2000,43,12,"Apfel C, Banner DW, Bur D, Dietz M, Hirata T, Hubschwerlen C, Locher H, Page MG, Pirson W, Rossé G, Specklin JL",,104572,DTCT0024002,567396,DTCC01741115,1273025,15751
CHEMBL77505,P45452,,MLJSRWALBCZDCB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773042,IC50,=,148,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13.,,"Synthesis and structure-activity relationship of N-substituted 4-arylsulfonylpiperidine-4-hydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Davis JM, Grosu GT, Baker J, Ellingboe J, Zask A, Levin JI, Sandanayaka VP, Du M, Skotnicki JS, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R, Tillett J, Zhao W, McDevitt J, Xu ZB",,106632,DTCT0024002,495610,DTCC00235797,1111968,17340
CHEMBL77505,P45452,,MLJSRWALBCZDCB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,3.83,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260792,DTCC00235797,1103045,24831
CHEMBL77567,P45452,,ZEVIMTDFAJSFBC-ZBAATNBSSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12824028,IC50,=,13,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13,,Phosphinic acid-based MMP-13 inhibitors that spare MMP-1 and MMP-3.,Bioorg. Med. Chem. Lett.,2003,13,14,"Reiter LA, Mitchell PG, Martinelli GJ, Lopresti-Morrow LL, Yocum SA, Eskra JD",,106640,DTCT0024002,1518630,DTCC00232796,1175293,5648
CHEMBL77614,P45452,,VHCKBWRQDKOUOA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11206468,IC50,,,,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 (Not tested),Not Determined,Heteroaryl and cycloalkyl sulfonamide hydroxamic acid inhibitors of matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2001,11,2,"Levin JI, Gu Y, Nelson FC, Zask A, DiJoseph JF, Sharr MA, Sung A, Jin G, Cowling R, Chanda P, Cosmi S, Hsiao CL, Edris W, Wilhelm J, Killar LM, Skotnicki JS",,106637,DTCT0024002,1300997,DTCC00237033,2045094,4516
CHEMBL77630,P45452,,JUCUDUBNTIXZOX-FUJFQHJFSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12824028,IC50,=,7.7,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13,,Phosphinic acid-based MMP-13 inhibitors that spare MMP-1 and MMP-3.,Bioorg. Med. Chem. Lett.,2003,13,14,"Reiter LA, Mitchell PG, Martinelli GJ, Lopresti-Morrow LL, Yocum SA, Eskra JD",,106640,DTCT0024002,1494242,DTCC00105893,269927,5648
CHEMBL77666,P45452,,PAICNGFUXUHAMP-ZBAATNBSSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12824028,IC50,=,31,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13,,Phosphinic acid-based MMP-13 inhibitors that spare MMP-1 and MMP-3.,Bioorg. Med. Chem. Lett.,2003,13,14,"Reiter LA, Mitchell PG, Martinelli GJ, Lopresti-Morrow LL, Yocum SA, Eskra JD",,106640,DTCT0024002,1509558,DTCC00232528,981997,5648
CHEMBL77667,P45452,,XOYCZHYJWUFTBH-ZGVDRVBQSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12824028,IC50,=,11,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13,,Phosphinic acid-based MMP-13 inhibitors that spare MMP-1 and MMP-3.,Bioorg. Med. Chem. Lett.,2003,13,14,"Reiter LA, Mitchell PG, Martinelli GJ, Lopresti-Morrow LL, Yocum SA, Eskra JD",,106640,DTCT0024002,1518636,DTCC00232529,368213,5648
CHEMBL77923,P45452,,YZKBLJHHYZDROJ-BDCODIICSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12824028,IC50,=,7.7,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13,,Phosphinic acid-based MMP-13 inhibitors that spare MMP-1 and MMP-3.,Bioorg. Med. Chem. Lett.,2003,13,14,"Reiter LA, Mitchell PG, Martinelli GJ, Lopresti-Morrow LL, Yocum SA, Eskra JD",,106640,DTCT0024002,1509555,DTCC00232379,853100,5648
CHEMBL77946,P45452,,IQFZAFZQQFAEFD-ZBAATNBSSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12824028,IC50,=,10,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13,,Phosphinic acid-based MMP-13 inhibitors that spare MMP-1 and MMP-3.,Bioorg. Med. Chem. Lett.,2003,13,14,"Reiter LA, Mitchell PG, Martinelli GJ, Lopresti-Morrow LL, Yocum SA, Eskra JD",,106640,DTCT0024002,1514071,DTCC00232797,981999,5648
CHEMBL77972,P45452,,BOXSOXSFZRZIAF-ZBAATNBSSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12824028,IC50,=,9.4,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13,,Phosphinic acid-based MMP-13 inhibitors that spare MMP-1 and MMP-3.,Bioorg. Med. Chem. Lett.,2003,13,14,"Reiter LA, Mitchell PG, Martinelli GJ, Lopresti-Morrow LL, Yocum SA, Eskra JD",,106640,DTCT0024002,1493010,DTCC00232380,917032,5648
CHEMBL77995,P45452,,WFQFQAQNCYHBTC-FUJFQHJFSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12824028,IC50,=,7,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13,,Phosphinic acid-based MMP-13 inhibitors that spare MMP-1 and MMP-3.,Bioorg. Med. Chem. Lett.,2003,13,14,"Reiter LA, Mitchell PG, Martinelli GJ, Lopresti-Morrow LL, Yocum SA, Eskra JD",,106640,DTCT0024002,1497633,DTCC00232836,820189,5648
CHEMBL78001,P45452,,YPLGVMIJHPJLRA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10882358,IC50,=,9,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,Hydroxamic acid derivatives as potent peptide deformylase inhibitors and antibacterial agents.,J. Med. Chem.,2000,43,12,"Apfel C, Banner DW, Bur D, Dietz M, Hirata T, Hubschwerlen C, Locher H, Page MG, Pirson W, Rossé G, Specklin JL",,104572,DTCT0024002,579708,DTCC00105871,1305574,15751
CHEMBL78027,P45452,,WQBGDXSBXSZKTO-BDCODIICSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12824028,IC50,>,300,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13,,Phosphinic acid-based MMP-13 inhibitors that spare MMP-1 and MMP-3.,Bioorg. Med. Chem. Lett.,2003,13,14,"Reiter LA, Mitchell PG, Martinelli GJ, Lopresti-Morrow LL, Yocum SA, Eskra JD",,106640,DTCT0024002,1507396,DTCC00232326,1979917,5648
CHEMBL78031,P45452,,XUHCFLAIQCGOLL-BDCODIICSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12824028,IC50,=,24,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13,,Phosphinic acid-based MMP-13 inhibitors that spare MMP-1 and MMP-3.,Bioorg. Med. Chem. Lett.,2003,13,14,"Reiter LA, Mitchell PG, Martinelli GJ, Lopresti-Morrow LL, Yocum SA, Eskra JD",,106640,DTCT0024002,1505199,DTCC00232456,723505,5648
CHEMBL78066,P45452,,WNPLPMIXLXNWFU-BDCODIICSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12824028,IC50,=,29,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13,,Phosphinic acid-based MMP-13 inhibitors that spare MMP-1 and MMP-3.,Bioorg. Med. Chem. Lett.,2003,13,14,"Reiter LA, Mitchell PG, Martinelli GJ, Lopresti-Morrow LL, Yocum SA, Eskra JD",,106640,DTCT0024002,1508505,DTCC00232837,2077053,5648
CHEMBL78102,P45452,,HLPVNHUQEVIWBT-FUJFQHJFSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12824028,IC50,=,43,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13,,Phosphinic acid-based MMP-13 inhibitors that spare MMP-1 and MMP-3.,Bioorg. Med. Chem. Lett.,2003,13,14,"Reiter LA, Mitchell PG, Martinelli GJ, Lopresti-Morrow LL, Yocum SA, Eskra JD",,106640,DTCT0024002,1483599,DTCC00232442,335547,5648
CHEMBL78111,P45452,,WQBAMGDQVHWIOJ-ZBAATNBSSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12824028,IC50,=,58,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13,,Phosphinic acid-based MMP-13 inhibitors that spare MMP-1 and MMP-3.,Bioorg. Med. Chem. Lett.,2003,13,14,"Reiter LA, Mitchell PG, Martinelli GJ, Lopresti-Morrow LL, Yocum SA, Eskra JD",,106640,DTCT0024002,1498796,DTCC00232500,204777,5648
CHEMBL78233,P45452,,ROFAQOFULLWONA-FOIFJWKZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12824028,IC50,=,210,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-13,,Phosphinic acid-based MMP-13 inhibitors that spare MMP-1 and MMP-3.,Bioorg. Med. Chem. Lett.,2003,13,14,"Reiter LA, Mitchell PG, Martinelli GJ, Lopresti-Morrow LL, Yocum SA, Eskra JD",,106640,DTCT0024002,1501940,DTCC00232527,335546,5648
CHEMBL78255,P45452,,YMQWZRPLMNNHEU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773042,IC50,=,2,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13.,,"Synthesis and structure-activity relationship of N-substituted 4-arylsulfonylpiperidine-4-hydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Davis JM, Grosu GT, Baker J, Ellingboe J, Zask A, Levin JI, Sandanayaka VP, Du M, Skotnicki JS, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R, Tillett J, Zhao W, McDevitt J, Xu ZB",,106632,DTCT0024002,511557,DTCC00235631,1240288,17340
CHEMBL78255,P45452,,YMQWZRPLMNNHEU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15566296,IC50,=,2,NM,,,,,,,,,,,,,,Inhibition of MMP13,,"Synthesis and structure-activity relationships of 4-alkynyloxy phenyl sulfanyl, sulfinyl, and sulfonyl alkyl hydroxamates as tumor necrosis factor-alpha converting enzyme and matrix metalloproteinase inhibitors.",J. Med. Chem.,2004,47,25,"Venkatesan AM, Davis JM, Grosu GT, Baker J, Zask A, Levin JI, Ellingboe J, Skotnicki JS, Dijoseph JF, Sung A, Jin G, Xu W, McCarthy DJ, Barone D",,429672,DTCT0024002,2041953,DTCC00235631,1242637,22157
CHEMBL78255,P45452,,YMQWZRPLMNNHEU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,5.7,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260827,DTCC00235631,1231176,24831
CHEMBL78299,P45452,,FLIOXLIZONFFSH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773041,IC50,=,1,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-13,,"Synthesis and structure-activity relationship of alpha-sulfonylhydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Grosu GT, Davis JM, Hu B, Ellingboe J, Baker JL, Skotnicki JS, Zask A, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R",,106627,DTCT0024002,806439,DTCC00233654,1163666,17339
CHEMBL78299,P45452,,FLIOXLIZONFFSH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773042,IC50,=,1,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13.,,"Synthesis and structure-activity relationship of N-substituted 4-arylsulfonylpiperidine-4-hydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Davis JM, Grosu GT, Baker J, Ellingboe J, Zask A, Levin JI, Sandanayaka VP, Du M, Skotnicki JS, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R, Tillett J, Zhao W, McDevitt J, Xu ZB",,106632,DTCT0024002,494368,DTCC00233654,1175336,17340
CHEMBL78337,P45452,,WUWBMHSDQYCLTI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773042,IC50,=,2,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13.,,"Synthesis and structure-activity relationship of N-substituted 4-arylsulfonylpiperidine-4-hydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Davis JM, Grosu GT, Baker J, Ellingboe J, Zask A, Levin JI, Sandanayaka VP, Du M, Skotnicki JS, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R, Tillett J, Zhao W, McDevitt J, Xu ZB",,106632,DTCT0024002,496720,DTCC00236212,1596758,17340
CHEMBL78337,P45452,,WUWBMHSDQYCLTI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,5.7,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260808,DTCC00236212,1587779,24831
CHEMBL78369,P45452,,ATFPFLNWBZIBTJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773042,IC50,=,1,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13.,,"Synthesis and structure-activity relationship of N-substituted 4-arylsulfonylpiperidine-4-hydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Davis JM, Grosu GT, Baker J, Ellingboe J, Zask A, Levin JI, Sandanayaka VP, Du M, Skotnicki JS, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R, Tillett J, Zhao W, McDevitt J, Xu ZB",,106632,DTCT0024002,477855,DTCC00236026,1144221,17340
CHEMBL78369,P45452,,ATFPFLNWBZIBTJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773042,IC50,=,16,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13.,,"Synthesis and structure-activity relationship of N-substituted 4-arylsulfonylpiperidine-4-hydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Davis JM, Grosu GT, Baker J, Ellingboe J, Zask A, Levin JI, Sandanayaka VP, Du M, Skotnicki JS, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R, Tillett J, Zhao W, McDevitt J, Xu ZB",,106632,DTCT0024002,501544,DTCC00236026,1144222,17340
CHEMBL78369,P45452,,ATFPFLNWBZIBTJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,4.8,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260809,DTCC00236026,1135247,24831
CHEMBL78478,P45452,,NAXMTMYDSBOGMZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773042,IC50,=,1,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13.,,"Synthesis and structure-activity relationship of N-substituted 4-arylsulfonylpiperidine-4-hydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Davis JM, Grosu GT, Baker J, Ellingboe J, Zask A, Levin JI, Sandanayaka VP, Du M, Skotnicki JS, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R, Tillett J, Zhao W, McDevitt J, Xu ZB",,106632,DTCT0024002,511563,DTCC00235843,1111970,17340
CHEMBL78478,P45452,,NAXMTMYDSBOGMZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,6,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260820,DTCC00235843,1103046,24831
CHEMBL78508,P45452,,CXFQYPXLXLPGNM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773042,IC50,=,2,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13.,,"Synthesis and structure-activity relationship of N-substituted 4-arylsulfonylpiperidine-4-hydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Davis JM, Grosu GT, Baker J, Ellingboe J, Zask A, Levin JI, Sandanayaka VP, Du M, Skotnicki JS, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R, Tillett J, Zhao W, McDevitt J, Xu ZB",,106632,DTCT0024002,491920,DTCC00235770,1403251,17340
CHEMBL78508,P45452,,CXFQYPXLXLPGNM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,5.7,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260803,DTCC00235770,1394260,24831
CHEMBL78549,P45452,,AUWOIDNULNLPBA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773042,IC50,=,1,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13.,,"Synthesis and structure-activity relationship of N-substituted 4-arylsulfonylpiperidine-4-hydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Davis JM, Grosu GT, Baker J, Ellingboe J, Zask A, Levin JI, Sandanayaka VP, Du M, Skotnicki JS, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R, Tillett J, Zhao W, McDevitt J, Xu ZB",,106632,DTCT0024002,491913,DTCC00236211,303008,17340
CHEMBL78549,P45452,,AUWOIDNULNLPBA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,6,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260807,DTCC00236211,294031,24831
CHEMBL78611,P45452,,WWVKBGIBCFSFOJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773042,IC50,=,1,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13.,,"Synthesis and structure-activity relationship of N-substituted 4-arylsulfonylpiperidine-4-hydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Davis JM, Grosu GT, Baker J, Ellingboe J, Zask A, Levin JI, Sandanayaka VP, Du M, Skotnicki JS, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R, Tillett J, Zhao W, McDevitt J, Xu ZB",,106632,DTCT0024002,506608,DTCC00235866,1693444,17340
CHEMBL78611,P45452,,WWVKBGIBCFSFOJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,6,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260818,DTCC00235866,1684877,24831
CHEMBL78709,P45452,,IEGOFALJZJPJJD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773042,IC50,=,34,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13.,,"Synthesis and structure-activity relationship of N-substituted 4-arylsulfonylpiperidine-4-hydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Davis JM, Grosu GT, Baker J, Ellingboe J, Zask A, Levin JI, Sandanayaka VP, Du M, Skotnicki JS, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R, Tillett J, Zhao W, McDevitt J, Xu ZB",,106632,DTCT0024002,510277,DTCC00236199,1753310,17340
CHEMBL78709,P45452,,IEGOFALJZJPJJD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,4.47,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260788,DTCC00236199,1744667,24831
CHEMBL78798,P45452,,GQEYBNSJJQDDLY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773042,IC50,=,1,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13.,,"Synthesis and structure-activity relationship of N-substituted 4-arylsulfonylpiperidine-4-hydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Davis JM, Grosu GT, Baker J, Ellingboe J, Zask A, Levin JI, Sandanayaka VP, Du M, Skotnicki JS, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R, Tillett J, Zhao W, McDevitt J, Xu ZB",,106632,DTCT0024002,483515,DTCC00235788,562092,17340
CHEMBL78798,P45452,,GQEYBNSJJQDDLY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,6,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260814,DTCC00235788,553263,24831
CHEMBL78826,P45452,,QCBWOUQUDIILOW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11206468,IC50,=,427,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,Heteroaryl and cycloalkyl sulfonamide hydroxamic acid inhibitors of matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2001,11,2,"Levin JI, Gu Y, Nelson FC, Zask A, DiJoseph JF, Sharr MA, Sung A, Jin G, Cowling R, Chanda P, Cosmi S, Hsiao CL, Edris W, Wilhelm J, Killar LM, Skotnicki JS",,106638,DTCT0024002,1302179,DTCC00237661,853169,4516
CHEMBL78826,P45452,,QCBWOUQUDIILOW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23287054,IC50,=,427,NM,,,,,,,,,,,,,,Inhibition of MMP13 (unknown origin),,Sulphonamides: Deserving class as MMP inhibitors?,Eur. J. Med. Chem.,2013,60,,"Jain P, Saravanan C, Singh SK",,944584,DTCT0024002,11835687,DTCC00237661,868683,53820
CHEMBL78909,P45452,,WZTNVCMELDPHHH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773042,IC50,=,1,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13.,,"Synthesis and structure-activity relationship of N-substituted 4-arylsulfonylpiperidine-4-hydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Davis JM, Grosu GT, Baker J, Ellingboe J, Zask A, Levin JI, Sandanayaka VP, Du M, Skotnicki JS, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R, Tillett J, Zhao W, McDevitt J, Xu ZB",,106632,DTCT0024002,484687,DTCC00236008,1014343,17340
CHEMBL78909,P45452,,WZTNVCMELDPHHH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,6,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260795,DTCC00236008,1005469,24831
CHEMBL78934,P45452,,NYBGUTIMRHCTPX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773042,IC50,=,5,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13.,,"Synthesis and structure-activity relationship of N-substituted 4-arylsulfonylpiperidine-4-hydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Davis JM, Grosu GT, Baker J, Ellingboe J, Zask A, Levin JI, Sandanayaka VP, Du M, Skotnicki JS, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R, Tillett J, Zhao W, McDevitt J, Xu ZB",,106632,DTCT0024002,477850,DTCC00236028,2077097,17340
CHEMBL78934,P45452,,NYBGUTIMRHCTPX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,5.3,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260798,DTCC00236028,2068215,24831
CHEMBL78962,P45452,,NPFGSGCFKYSLPI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773042,IC50,=,2,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13.,,"Synthesis and structure-activity relationship of N-substituted 4-arylsulfonylpiperidine-4-hydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Davis JM, Grosu GT, Baker J, Ellingboe J, Zask A, Levin JI, Sandanayaka VP, Du M, Skotnicki JS, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R, Tillett J, Zhao W, McDevitt J, Xu ZB",,106632,DTCT0024002,510269,DTCC00235604,335601,17340
CHEMBL78962,P45452,,NPFGSGCFKYSLPI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,5.7,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260832,DTCC00235604,326659,24831
CHEMBL79111,P45452,,WRYYVCSFLUPFIQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773042,IC50,=,2,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13.,,"Synthesis and structure-activity relationship of N-substituted 4-arylsulfonylpiperidine-4-hydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Davis JM, Grosu GT, Baker J, Ellingboe J, Zask A, Levin JI, Sandanayaka VP, Du M, Skotnicki JS, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R, Tillett J, Zhao W, McDevitt J, Xu ZB",,106632,DTCT0024002,482347,DTCC00235855,1499929,17340
CHEMBL79111,P45452,,WRYYVCSFLUPFIQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,5.7,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260811,DTCC00235855,1491230,24831
CHEMBL79267,P45452,,UYFGGWJRPCRSHW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11472202,IC50,=,13.9,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,106478,DTCT0024002,1322797,DTCC00242002,1163761,16328
CHEMBL79267,P45452,,UYFGGWJRPCRSHW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,IC50,=,13.8,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258652,DTCC00242002,1166448,24803
CHEMBL79433,P45452,,IMKDKHQDFFLOKK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773042,IC50,=,1,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13.,,"Synthesis and structure-activity relationship of N-substituted 4-arylsulfonylpiperidine-4-hydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Davis JM, Grosu GT, Baker J, Ellingboe J, Zask A, Levin JI, Sandanayaka VP, Du M, Skotnicki JS, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R, Tillett J, Zhao W, McDevitt J, Xu ZB",,106632,DTCT0024002,494312,DTCC00235743,75938,17340
CHEMBL79433,P45452,,IMKDKHQDFFLOKK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,6,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260805,DTCC00235743,67167,24831
CHEMBL79438,P45452,,NICYWIBCSYQDRP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11549451,ACTIVITY,=,250,NM,,,,,,,,,,,,,,Inhibitory activity against human Matrix metalloprotease-13,,"Selective, orally active MMP inhibitors with an aryl backbone.",Bioorg. Med. Chem. Lett.,2001,11,18,"Barta TE, Becker DP, Bedell LJ, De Crescenzo GA, McDonald JJ, Mehta P, Munie GE, Villamil CI",,106466,DTCT0024002,1647341,DTCC00241069,75995,4449
CHEMBL79450,P45452,,RFLCSJBVTOHUGE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11549451,ACTIVITY,=,6.7,NM,,,,,,,,,,,,,,Inhibitory activity against human Matrix metalloprotease-13,,"Selective, orally active MMP inhibitors with an aryl backbone.",Bioorg. Med. Chem. Lett.,2001,11,18,"Barta TE, Becker DP, Bedell LJ, De Crescenzo GA, McDonald JJ, Mehta P, Munie GE, Villamil CI",,106466,DTCT0024002,1668900,DTCC00241094,1144285,4449
CHEMBL79619,P45452,,DOCKNIJXKGCWQV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11549451,ACTIVITY,=,4.3,NM,,,,,,,,,,,,,,Inhibitory activity against human Matrix metalloprotease-13,,"Selective, orally active MMP inhibitors with an aryl backbone.",Bioorg. Med. Chem. Lett.,2001,11,18,"Barta TE, Becker DP, Bedell LJ, De Crescenzo GA, McDonald JJ, Mehta P, Munie GE, Villamil CI",,106466,DTCT0024002,1661468,DTCC00240866,723611,4449
CHEMBL79837,P45452,,ZJECTIJIWXIEHB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11549451,ACTIVITY,=,18,NM,,,,,,,,,,,,,,Inhibitory activity against human Matrix metalloprotease-13,,"Selective, orally active MMP inhibitors with an aryl backbone.",Bioorg. Med. Chem. Lett.,2001,11,18,"Barta TE, Becker DP, Bedell LJ, De Crescenzo GA, McDonald JJ, Mehta P, Munie GE, Villamil CI",,106466,DTCT0024002,1643895,DTCC00240945,755723,4449
CHEMBL79906,P45452,,QPSBVVFMTSFAJY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11472202,IC50,=,264,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,106478,DTCT0024002,1313206,DTCC00242125,1903109,16328
CHEMBL80146,P45452,,NPMTYGOUEKCULB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773041,IC50,=,11,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-13,,"Synthesis and structure-activity relationship of alpha-sulfonylhydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Grosu GT, Davis JM, Hu B, Ellingboe J, Baker JL, Skotnicki JS, Zask A, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R",,106627,DTCT0024002,782823,DTCC00234502,1326328,17339
CHEMBL80183,P45452,,RHTOEITZKIINCY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773042,IC50,=,3,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13.,,"Synthesis and structure-activity relationship of N-substituted 4-arylsulfonylpiperidine-4-hydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Davis JM, Grosu GT, Baker J, Ellingboe J, Zask A, Levin JI, Sandanayaka VP, Du M, Skotnicki JS, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R, Tillett J, Zhao W, McDevitt J, Xu ZB",,106632,DTCT0024002,495620,DTCC00236108,464823,17340
CHEMBL80183,P45452,,RHTOEITZKIINCY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,5.52,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260800,DTCC00236108,455590,24831
CHEMBL80248,P45452,,HBIQJOZNDMPMAG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773041,IC50,=,100,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-13,,"Synthesis and structure-activity relationship of alpha-sulfonylhydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Grosu GT, Davis JM, Hu B, Ellingboe J, Baker JL, Skotnicki JS, Zask A, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R",,106627,DTCT0024002,813630,DTCC00234535,1261382,17339
CHEMBL80248,P45452,,HBIQJOZNDMPMAG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,4,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260758,DTCC00234535,1264018,24831
CHEMBL80272,P45452,,CBMKHOZXSARYNG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11206467,IC50,=,1,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-13,,The discovery of anthranilic acid-based MMP inhibitors. Part 1: SAR of the 3-position.,Bioorg. Med. Chem. Lett.,2001,11,2,"Levin JI, Du MT, DiJoseph JF, Killar LM, Sung A, Walter T, Sharr MA, Roth CE, Moy FJ, Powers R, Jin G, Cowling R, Skotnicki JS",,106467,DTCT0024002,584834,DTCC00234861,1359148,4515
CHEMBL80272,P45452,,CBMKHOZXSARYNG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,IC50,=,1,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258702,DTCC00234861,1361903,24803
CHEMBL80300,P45452,,CXRZYJPQMZBWAW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11206467,IC50,=,6,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-13,,The discovery of anthranilic acid-based MMP inhibitors. Part 1: SAR of the 3-position.,Bioorg. Med. Chem. Lett.,2001,11,2,"Levin JI, Du MT, DiJoseph JF, Killar LM, Sung A, Walter T, Sharr MA, Roth CE, Moy FJ, Powers R, Jin G, Cowling R, Skotnicki JS",,106467,DTCT0024002,608112,DTCC00234829,1035195,4515
CHEMBL80300,P45452,,CXRZYJPQMZBWAW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,IC50,=,6.03,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258701,DTCC00234829,1037852,24803
CHEMBL80321,P45452,,KHORRYDPPCADSY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773042,IC50,=,5,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13.,,"Synthesis and structure-activity relationship of N-substituted 4-arylsulfonylpiperidine-4-hydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Davis JM, Grosu GT, Baker J, Ellingboe J, Zask A, Levin JI, Sandanayaka VP, Du M, Skotnicki JS, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R, Tillett J, Zhao W, McDevitt J, Xu ZB",,106632,DTCT0024002,495614,DTCC00236078,949647,17340
CHEMBL80322,P45452,,LKRHPZIUVGMVCY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11206467,IC50,=,728,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-13,,The discovery of anthranilic acid-based MMP inhibitors. Part 1: SAR of the 3-position.,Bioorg. Med. Chem. Lett.,2001,11,2,"Levin JI, Du MT, DiJoseph JF, Killar LM, Sung A, Walter T, Sharr MA, Roth CE, Moy FJ, Powers R, Jin G, Cowling R, Skotnicki JS",,106467,DTCT0024002,617532,DTCC00234772,744209,4515
CHEMBL80361,P45452,,VEUYFZWVWBJLBT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773041,IC50,=,24,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-13,,"Synthesis and structure-activity relationship of alpha-sulfonylhydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Grosu GT, Davis JM, Hu B, Ellingboe J, Baker JL, Skotnicki JS, Zask A, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R",,106627,DTCT0024002,796727,DTCC00235159,1326330,17339
CHEMBL80378,P45452,,JGDVFBCMNUSQQW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773041,IC50,=,90,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-13,,"Synthesis and structure-activity relationship of alpha-sulfonylhydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Grosu GT, Davis JM, Hu B, Ellingboe J, Baker JL, Skotnicki JS, Zask A, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R",,106627,DTCT0024002,793974,DTCC00234445,356485,17339
CHEMBL80401,P45452,,QZAKHVZDCIZWMH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773042,IC50,=,5,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13.,,"Synthesis and structure-activity relationship of N-substituted 4-arylsulfonylpiperidine-4-hydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Davis JM, Grosu GT, Baker J, Ellingboe J, Zask A, Levin JI, Sandanayaka VP, Du M, Skotnicki JS, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R, Tillett J, Zhao W, McDevitt J, Xu ZB",,106632,DTCT0024002,500327,DTCC00235502,368246,17340
CHEMBL80401,P45452,,QZAKHVZDCIZWMH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,5.3,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260824,DTCC00235502,359220,24831
CHEMBL80412,P45452,,UVYWXUJXEFVRIM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773041,IC50,=,64,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-13,,"Synthesis and structure-activity relationship of alpha-sulfonylhydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Grosu GT, Davis JM, Hu B, Ellingboe J, Baker JL, Skotnicki JS, Zask A, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R",,106627,DTCT0024002,793970,DTCC00235160,1682007,17339
CHEMBL80412,P45452,,UVYWXUJXEFVRIM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,4.19,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260776,DTCC00235160,1684876,24831
CHEMBL80413,P45452,,ZUJXLCINYDKZGV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773041,IC50,=,188,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-13,,"Synthesis and structure-activity relationship of alpha-sulfonylhydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Grosu GT, Davis JM, Hu B, Ellingboe J, Baker JL, Skotnicki JS, Zask A, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R",,106627,DTCT0024002,816481,DTCC00235161,841412,17339
CHEMBL80413,P45452,,ZUJXLCINYDKZGV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,3.73,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260777,DTCC00235161,844227,24831
CHEMBL80453,P45452,,FBLQAKOTTHGGBJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773042,IC50,=,4,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13.,,"Synthesis and structure-activity relationship of N-substituted 4-arylsulfonylpiperidine-4-hydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Davis JM, Grosu GT, Baker J, Ellingboe J, Zask A, Levin JI, Sandanayaka VP, Du M, Skotnicki JS, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R, Tillett J, Zhao W, McDevitt J, Xu ZB",,106632,DTCT0024002,480111,DTCC00235840,1564342,17340
CHEMBL80453,P45452,,FBLQAKOTTHGGBJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,5.4,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260819,DTCC00235840,1555545,24831
CHEMBL80496,P45452,,WJPFHUMULGZBAI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773041,IC50,=,6,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-13,,"Synthesis and structure-activity relationship of alpha-sulfonylhydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Grosu GT, Davis JM, Hu B, Ellingboe J, Baker JL, Skotnicki JS, Zask A, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R",,106627,DTCT0024002,788064,DTCC00234526,711907,17339
CHEMBL80565,P45452,,FQZUGHBEAWJYRZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773041,IC50,=,141,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-13,,"Synthesis and structure-activity relationship of alpha-sulfonylhydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Grosu GT, Davis JM, Hu B, Ellingboe J, Baker JL, Skotnicki JS, Zask A, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R",,106627,DTCT0024002,785561,DTCC00234549,3717,17339
CHEMBL80565,P45452,,FQZUGHBEAWJYRZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,3.85,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260778,DTCC00234549,8973,24831
CHEMBL80732,P45452,,HHLQXXSIVVEBOY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773042,IC50,=,2,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13.,,"Synthesis and structure-activity relationship of N-substituted 4-arylsulfonylpiperidine-4-hydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Davis JM, Grosu GT, Baker J, Ellingboe J, Zask A, Levin JI, Sandanayaka VP, Du M, Skotnicki JS, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R, Tillett J, Zhao W, McDevitt J, Xu ZB",,106632,DTCT0024002,493172,DTCC00235771,1370860,17340
CHEMBL80732,P45452,,HHLQXXSIVVEBOY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,5.7,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260804,DTCC00235771,1361911,24831
CHEMBL80798,P45452,,UYOSMJLYSRXRLI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773042,IC50,=,2,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13.,,"Synthesis and structure-activity relationship of N-substituted 4-arylsulfonylpiperidine-4-hydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Davis JM, Grosu GT, Baker J, Ellingboe J, Zask A, Levin JI, Sandanayaka VP, Du M, Skotnicki JS, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R, Tillett J, Zhao W, McDevitt J, Xu ZB",,106632,DTCT0024002,505403,DTCC00236064,2012792,17340
CHEMBL80798,P45452,,UYOSMJLYSRXRLI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,5.7,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260799,DTCC00236064,2003629,24831
CHEMBL80814,P45452,,VUXKPYYMTYYYCJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773042,IC50,=,2,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13.,,"Synthesis and structure-activity relationship of N-substituted 4-arylsulfonylpiperidine-4-hydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Davis JM, Grosu GT, Baker J, Ellingboe J, Zask A, Levin JI, Sandanayaka VP, Du M, Skotnicki JS, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R, Tillett J, Zhao W, McDevitt J, Xu ZB",,106632,DTCT0024002,476637,DTCC00235499,1207516,17340
CHEMBL80814,P45452,,VUXKPYYMTYYYCJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,5.7,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260822,DTCC00235499,1198932,24831
CHEMBL80894,P45452,,IEYUPLSSJBQATP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11206467,IC50,=,531,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-13,,The discovery of anthranilic acid-based MMP inhibitors. Part 1: SAR of the 3-position.,Bioorg. Med. Chem. Lett.,2001,11,2,"Levin JI, Du MT, DiJoseph JF, Killar LM, Sung A, Walter T, Sharr MA, Roth CE, Moy FJ, Powers R, Jin G, Cowling R, Skotnicki JS",,106467,DTCT0024002,613851,DTCC00234863,1838715,4515
CHEMBL80894,P45452,,IEYUPLSSJBQATP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,IC50,=,537.03,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258704,DTCC00234863,1841442,24803
CHEMBL80911,P45452,,DDHYHOSBNZTEDO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773042,IC50,=,2,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13.,,"Synthesis and structure-activity relationship of N-substituted 4-arylsulfonylpiperidine-4-hydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Davis JM, Grosu GT, Baker J, Ellingboe J, Zask A, Levin JI, Sandanayaka VP, Du M, Skotnicki JS, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R, Tillett J, Zhao W, McDevitt J, Xu ZB",,106632,DTCT0024002,510289,DTCC00235759,594283,17340
CHEMBL80969,P45452,,NZSGHPOSLLMCJS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773042,IC50,=,2,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13.,,"Synthesis and structure-activity relationship of N-substituted 4-arylsulfonylpiperidine-4-hydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Davis JM, Grosu GT, Baker J, Ellingboe J, Zask A, Levin JI, Sandanayaka VP, Du M, Skotnicki JS, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R, Tillett J, Zhao W, McDevitt J, Xu ZB",,106632,DTCT0024002,484683,DTCC00234610,820230,17340
CHEMBL80969,P45452,,NZSGHPOSLLMCJS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,5.7,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260834,DTCC00234610,811358,24831
CHEMBL81113,P45452,,BDCJZZXWIQJYLP-FIWHBWSRSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11206468,IC50,=,233,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,Heteroaryl and cycloalkyl sulfonamide hydroxamic acid inhibitors of matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2001,11,2,"Levin JI, Gu Y, Nelson FC, Zask A, DiJoseph JF, Sharr MA, Sung A, Jin G, Cowling R, Chanda P, Cosmi S, Hsiao CL, Edris W, Wilhelm J, Killar LM, Skotnicki JS",,106638,DTCT0024002,1318849,DTCC00237078,1785427,4516
CHEMBL81113,P45452,,BDCJZZXWIQJYLP-FIWHBWSRSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23287054,IC50,=,233,NM,,,,,,,,,,,,,,Inhibition of MMP13 (unknown origin),,Sulphonamides: Deserving class as MMP inhibitors?,Eur. J. Med. Chem.,2013,60,,"Jain P, Saravanan C, Singh SK",,944584,DTCT0024002,11835688,DTCC00237078,1800998,53820
CHEMBL81333,P45452,,DGOJEEWMDRDFIF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11549451,ACTIVITY,=,13,NM,,,,,,,,,,,,,,Inhibitory activity against human Matrix metalloprotease-13,,"Selective, orally active MMP inhibitors with an aryl backbone.",Bioorg. Med. Chem. Lett.,2001,11,18,"Barta TE, Becker DP, Bedell LJ, De Crescenzo GA, McDonald JJ, Mehta P, Munie GE, Villamil CI",,106466,DTCT0024002,1652654,DTCC00240433,1403314,4449
CHEMBL81763,P45452,,GJICTISPMDMSQH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12773042,IC50,=,29,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13.,,"Synthesis and structure-activity relationship of N-substituted 4-arylsulfonylpiperidine-4-hydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Davis JM, Grosu GT, Baker J, Ellingboe J, Zask A, Levin JI, Sandanayaka VP, Du M, Skotnicki JS, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R, Tillett J, Zhao W, McDevitt J, Xu ZB",,106632,DTCT0024002,497941,DTCC00236269,755674,17340
CHEMBL81763,P45452,,GJICTISPMDMSQH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17590339,LOG(10^6/IC50),=,4.54,,,,,,,,,,,,,,,Inhibition of MMP13,,QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.,Bioorg. Med. Chem.,2007,15,18,"Fernández M, Caballero J",,459103,DTCT0024002,2260790,DTCC00236269,746937,24831
CHEMBL81865,P45452,,HSFVQJYOIWZCLO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11206468,IC50,,,,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13 (Not tested),Not Determined,Heteroaryl and cycloalkyl sulfonamide hydroxamic acid inhibitors of matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2001,11,2,"Levin JI, Gu Y, Nelson FC, Zask A, DiJoseph JF, Sharr MA, Sung A, Jin G, Cowling R, Chanda P, Cosmi S, Hsiao CL, Edris W, Wilhelm J, Killar LM, Skotnicki JS",,106637,DTCT0024002,1293508,DTCC00237600,269984,4516
CHEMBL82092,P45452,,JXCJPSURORGUCZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11549451,ACTIVITY,=,2.2,NM,,,,,,,,,,,,,,Inhibitory activity against human Matrix metalloprotease-13,,"Selective, orally active MMP inhibitors with an aryl backbone.",Bioorg. Med. Chem. Lett.,2001,11,18,"Barta TE, Becker DP, Bedell LJ, De Crescenzo GA, McDonald JJ, Mehta P, Munie GE, Villamil CI",,106466,DTCT0024002,1647353,DTCC00240841,1112008,4449
CHEMBL82113,P45452,,PYGZWPVJQNBFNS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11472202,IC50,=,140,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,106478,DTCT0024002,1290354,DTCC00242452,1773868,16328
CHEMBL82113,P45452,,PYGZWPVJQNBFNS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,IC50,=,141.25,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258647,DTCC00242452,1776497,24803
CHEMBL82169,P45452,,LFOGEPKUSWRLCL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11472202,IC50,=,0.7,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,106478,DTCT0024002,1298769,DTCC00241974,550551,16328
CHEMBL82169,P45452,,LFOGEPKUSWRLCL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,IC50,=,0.708,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258655,DTCC00241974,553253,24803
CHEMBL82217,P45452,,VSSBMKQTJZCDML-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11549451,ACTIVITY,=,110,NM,,,,,,,,,,,,,,Inhibitory activity against human Matrix metalloprotease-13,,"Selective, orally active MMP inhibitors with an aryl backbone.",Bioorg. Med. Chem. Lett.,2001,11,18,"Barta TE, Becker DP, Bedell LJ, De Crescenzo GA, McDonald JJ, Mehta P, Munie GE, Villamil CI",,106466,DTCT0024002,1645103,DTCC00240811,108262,4449
CHEMBL82487,P45452,,OCVZODLPTGAJKD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11206468,IC50,=,290,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,Heteroaryl and cycloalkyl sulfonamide hydroxamic acid inhibitors of matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2001,11,2,"Levin JI, Gu Y, Nelson FC, Zask A, DiJoseph JF, Sharr MA, Sung A, Jin G, Cowling R, Chanda P, Cosmi S, Hsiao CL, Edris W, Wilhelm J, Killar LM, Skotnicki JS",,106638,DTCT0024002,1318844,DTCC00237282,433336,4516
CHEMBL82499,P45452,,DLQDIVPCTCJXSZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11549451,ACTIVITY,=,14,NM,,,,,,,,,,,,,,Inhibitory activity against human Matrix metalloprotease-13,,"Selective, orally active MMP inhibitors with an aryl backbone.",Bioorg. Med. Chem. Lett.,2001,11,18,"Barta TE, Becker DP, Bedell LJ, De Crescenzo GA, McDonald JJ, Mehta P, Munie GE, Villamil CI",,106466,DTCT0024002,1642633,DTCC00240910,594330,4449
CHEMBL82842,P45452,,AYFOFUUKQJIUFR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11549451,ACTIVITY,=,2500,NM,,,,,,,,,,,,,,Inhibitory activity against human Matrix metalloprotease-13,,"Selective, orally active MMP inhibitors with an aryl backbone.",Bioorg. Med. Chem. Lett.,2001,11,18,"Barta TE, Becker DP, Bedell LJ, De Crescenzo GA, McDonald JJ, Mehta P, Munie GE, Villamil CI",,106466,DTCT0024002,1648730,DTCC00240868,1370912,4449
CHEMBL83209,P45452,,URNFYSXQOHQAJN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11133099,IC50,=,28,NM,,,,,,,,,,,,,,50 percent inhibition of human Matrix metalloprotease-13 by the cleavage of fluorogenic peptide MCA-Pro-Leu-Gly-Leu-Dpa-ala-Arg-NH2,,Synthesis and activity of selective MMP inhibitors with an aryl backbone.,Bioorg. Med. Chem. Lett.,2000,10,24,"Barta TE, Becker DP, Bedell LJ, De Crescenzo GA, McDonald JJ, Munie GE, Rao S, Shieh HS, Stegeman R, Stevens AM, Villamil CI",,106604,DTCT0024002,728380,DTCC00240463,1968542,3985
CHEMBL83209,P45452,,URNFYSXQOHQAJN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11549451,ACTIVITY,=,27,NM,,,,,,,,,,,,,,Inhibitory activity against human Matrix metalloprotease-13,,"Selective, orally active MMP inhibitors with an aryl backbone.",Bioorg. Med. Chem. Lett.,2001,11,18,"Barta TE, Becker DP, Bedell LJ, De Crescenzo GA, McDonald JJ, Mehta P, Munie GE, Villamil CI",,106466,DTCT0024002,1650143,DTCC00240463,1980028,4449
CHEMBL83209,P45452,,URNFYSXQOHQAJN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,23287054,IC50,=,28,NM,,,,,,,,,,,,,,Inhibition of MMP13 (unknown origin),,Sulphonamides: Deserving class as MMP inhibitors?,Eur. J. Med. Chem.,2013,60,,"Jain P, Saravanan C, Singh SK",,944584,DTCT0024002,11835684,DTCC00240463,1995454,53820
CHEMBL83282,P45452,,ICFOTHUAZLHTNP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11472202,IC50,=,1.8,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,106478,DTCT0024002,1292791,DTCC00242039,1585074,16328
CHEMBL83282,P45452,,ICFOTHUAZLHTNP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,IC50,=,1.82,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258651,DTCC00242039,1587772,24803
CHEMBL83368,P45452,,HGCZRPPCNXJXAB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11472202,IC50,=,1,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,106478,DTCT0024002,1287857,DTCC00242344,323868,16328
CHEMBL83368,P45452,,HGCZRPPCNXJXAB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,IC50,=,1,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258656,DTCC00242344,326645,24803
CHEMBL83508,P45452,,WLZISXXOYYGJNT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,,KI,=,8,NM,,,,,,,,,,,,,,Inhibition of MMP13 (unknown origin)-mediated Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorimetric assay,,,ACS Med. Chem. Lett.,2013,4,6,,,960928,DTCT0024002,12452608,DTCC00243572,252699,54626
CHEMBL83616,P45452,,JXAGDPXECXQWBC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11472202,IC50,=,1570,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,106478,DTCT0024002,1310938,DTCC00242500,1773869,16328
CHEMBL83955,P45452,,ILTCMGUVAAYHSE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11472202,IC50,=,5.4,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,106478,DTCT0024002,1316686,DTCC00242203,1067615,16328
CHEMBL83955,P45452,,ILTCMGUVAAYHSE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,IC50,=,5.37,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258657,DTCC00242203,1070280,24803
CHEMBL85026,P45452,,IRVGVLJCCVMVAY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11472202,IC50,=,791,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,106478,DTCT0024002,1286654,DTCC00242319,421955,16328
CHEMBL85026,P45452,,IRVGVLJCCVMVAY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,IC50,=,794.33,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258646,DTCC00242319,424709,24803
CHEMBL85255,P45452,,LGSJACYKGMNZKT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11549451,ACTIVITY,=,14.8,NM,,,,,,,,,,,,,,Inhibitory activity against human Matrix metalloprotease-13,,"Selective, orally active MMP inhibitors with an aryl backbone.",Bioorg. Med. Chem. Lett.,2001,11,18,"Barta TE, Becker DP, Bedell LJ, De Crescenzo GA, McDonald JJ, Mehta P, Munie GE, Villamil CI",,106466,DTCT0024002,1653845,DTCC00240904,1370909,4449
CHEMBL85374,P45452,,BLYHHTXBRXLLOI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11472202,IC50,=,3,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,106478,DTCT0024002,1320332,DTCC00242381,1455978,16328
CHEMBL858,P45452,EDETIC ACID,KCXVZYZYPLLWCC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,25330343,INHIBITION,=,70,%,,,,,,,,,,,,,,Inhibition of full-length recombinant human MMP-13 assessed as prevention of bovine type-2 collagen degradation at 50 uM after 18 hrs by cartilage explant assay,,Characterization of selective exosite-binding inhibitors of matrix metalloproteinase 13 that prevent articular cartilage degradation in vitro.,J. Med. Chem.,2014,57,22,"Spicer TP, Jiang J, Taylor AB, Choi JY, Hart PJ, Roush WR, Fields GB, Hodder PS, Minond D",,1435004,DTCT0024002,13947496,DTCC00186270,1010772,60192
CHEMBL88520,P45452,,HFAGTNGCAZYYLZ-OTWHNJEPSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11472217,KI,=,0.45,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,"Design, synthesis, and structure-activity relationships of macrocyclic hydroxamic acids that inhibit tumor necrosis factor alpha release in vitro and in vivo.",J. Med. Chem.,2001,44,16,"Xue CB, Voss ME, Nelson DJ, Duan JJ, Cherney RJ, Jacobson IC, He X, Roderick J, Chen L, Corbett RL, Wang L, Meyer DT, Kennedy K, DeGradodagger WF, Hardman KD, Teleha CA, Jaffee BD, Liu RQ, Copeland RA, Covington MB, Christ DD, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,106613,DTCT0024002,1674085,DTCC00251150,291473,16346
CHEMBL88559,P45452,,NAVKLAFIVRMQMW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,9873598,IC50,=,16,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13 (MMP-13),,The synthesis and biological activity of a novel series of diazepine MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,19,"Levin JI, DiJoseph JF, Killar LM, Sung A, Walter T, Sharr MA, Roth CE, Skotnicki JS, Albright JD",,106628,DTCT0024002,604478,DTCC00252279,1456057,2791
CHEMBL88559,P45452,,NAVKLAFIVRMQMW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,9873598,INHIBITION,=,0.41,%,,organism_based,,,,,,,,,,,,In vivo inhibition of matrix metalloprotease-13 (MMP-13) in mouse dialysis tubing implant assay at 50 mg/kg po,,The synthesis and biological activity of a novel series of diazepine MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,19,"Levin JI, DiJoseph JF, Killar LM, Sung A, Walter T, Sharr MA, Roth CE, Skotnicki JS, Albright JD",,106766,DTCT0024002,604479,DTCC00252279,1456057,2791
CHEMBL90057,P45452,,UOAUOOSBTBZJIS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11591509,IC50,=,15000,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,alpha-Amino-beta-sulphone hydroxamates as potent MMP-13 inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2001,11,20,"Becker DP, Barta TE, Bedell L, DeCrescenzo G, Freskos J, Getman DP, Hockerman SL, Li M, Mehta P, Mischke B, Munie GE, Swearingen C, Villamil CI",,106603,DTCT0024002,689626,DTCC00255230,1914617,4540
CHEMBL90211,P45452,,IYMQHQXCXLDREF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11591510,IC50,=,1.6,NM,,,,,,,,,,,,,,Inhibitory activity against human Matrix metalloprotease-13,,alpha-Alkyl-alpha-amino-beta-sulphone hydroxamates as potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2001,11,20,"Becker DP, DeCrescenzo G, Freskos J, Getman DP, Hockerman SL, Li M, Mehta P, Munie GE, Swearingen C",,106599,DTCT0024002,1082010,DTCC00255143,1850277,4541
CHEMBL90456,P45452,,XKKRDGGNAWMGHM-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11591509,IC50,=,4000,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,alpha-Amino-beta-sulphone hydroxamates as potent MMP-13 inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2001,11,20,"Becker DP, Barta TE, Bedell L, DeCrescenzo G, Freskos J, Getman DP, Hockerman SL, Li M, Mehta P, Mischke B, Munie GE, Swearingen C, Villamil CI",,106603,DTCT0024002,688466,DTCC00255221,401241,4540
CHEMBL90487,P45452,,WGRMVARLTSCXRH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11591510,IC50,=,160,NM,,,,,,,,,,,,,,Inhibitory activity against human Matrix metalloprotease-13,,alpha-Alkyl-alpha-amino-beta-sulphone hydroxamates as potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2001,11,20,"Becker DP, DeCrescenzo G, Freskos J, Getman DP, Hockerman SL, Li M, Mehta P, Munie GE, Swearingen C",,106599,DTCT0024002,1059266,DTCC00255302,1818149,4541
CHEMBL90604,P45452,,XNXRFZXNILAYGC-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11591509,IC50,=,400,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,alpha-Amino-beta-sulphone hydroxamates as potent MMP-13 inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2001,11,20,"Becker DP, Barta TE, Bedell L, DeCrescenzo G, Freskos J, Getman DP, Hockerman SL, Li M, Mehta P, Mischke B, Munie GE, Swearingen C, Villamil CI",,106603,DTCT0024002,669435,DTCC00255127,108411,4540
CHEMBL90762,P45452,,HXBXLCOXHVGSLM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11591510,IC50,=,2.4,NM,,,,,,,,,,,,,,Inhibitory activity against human Matrix metalloprotease-13,,alpha-Alkyl-alpha-amino-beta-sulphone hydroxamates as potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2001,11,20,"Becker DP, DeCrescenzo G, Freskos J, Getman DP, Hockerman SL, Li M, Mehta P, Munie GE, Swearingen C",,106599,DTCT0024002,1055870,DTCC00255151,1629523,4541
CHEMBL90764,P45452,,RWNXWLHJCHZBET-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11591509,IC50,=,600,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,alpha-Amino-beta-sulphone hydroxamates as potent MMP-13 inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2001,11,20,"Becker DP, Barta TE, Bedell L, DeCrescenzo G, Freskos J, Getman DP, Hockerman SL, Li M, Mehta P, Mischke B, Munie GE, Swearingen C, Villamil CI",,106603,DTCT0024002,674451,DTCC00255171,1273262,4540
CHEMBL90978,P45452,,AOPSFGSGYVNAEJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,9873598,IC50,=,1.3,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13 (MMP-13),,The synthesis and biological activity of a novel series of diazepine MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,19,"Levin JI, DiJoseph JF, Killar LM, Sung A, Walter T, Sharr MA, Roth CE, Skotnicki JS, Albright JD",,106628,DTCT0024002,614801,DTCC00252083,1424235,2791
CHEMBL90978,P45452,,AOPSFGSGYVNAEJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,9873598,INHIBITION,=,1,%,,organism_based,,,,,,,,,,,,In vivo inhibition of matrix metalloprotease-13 (MMP-13) in mouse dialysis tubing implant assay at 50 mg/kg po,,The synthesis and biological activity of a novel series of diazepine MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,19,"Levin JI, DiJoseph JF, Killar LM, Sung A, Walter T, Sharr MA, Roth CE, Skotnicki JS, Albright JD",,106766,DTCT0024002,614802,DTCC00252083,1424235,2791
CHEMBL90978,P45452,,AOPSFGSGYVNAEJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,IC50,=,1.29,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258763,DTCC00252083,1426644,24803
CHEMBL91124,P45452,,UDYKJHQVNSKFHV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11591510,IC50,=,0.3,NM,,,,,,,,,,,,,,Inhibitory activity against human Matrix metalloprotease-13,,alpha-Alkyl-alpha-amino-beta-sulphone hydroxamates as potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2001,11,20,"Becker DP, DeCrescenzo G, Freskos J, Getman DP, Hockerman SL, Li M, Mehta P, Munie GE, Swearingen C",,106599,DTCT0024002,1057005,DTCC00255250,1882477,4541
CHEMBL91254,P45452,,APFJCMUPKFEDTC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12217355,IC50,=,87.1,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant human matrix metalloprotease-13,,Analogue based design of MMP-13 (Collagenase-3) inhibitors.,Bioorg. Med. Chem. Lett.,2002,12,19,"Sarma JA, Rambabu G, Srikanth K, Raveendra D, Vithal M",,106465,DTCT0024002,776572,DTCC00253654,530042,5083
CHEMBL91434,P45452,,XIOQDQAMCAXVAV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11591510,IC50,=,0.2,NM,,,,,,,,,,,,,,Inhibitory activity against human Matrix metalloprotease-13,,alpha-Alkyl-alpha-amino-beta-sulphone hydroxamates as potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2001,11,20,"Becker DP, DeCrescenzo G, Freskos J, Getman DP, Hockerman SL, Li M, Mehta P, Munie GE, Swearingen C",,106599,DTCT0024002,1055775,DTCC00255252,1785626,4541
CHEMBL91608,P45452,,XNXRFZXNILAYGC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11591509,IC50,=,3700,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,alpha-Amino-beta-sulphone hydroxamates as potent MMP-13 inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2001,11,20,"Becker DP, Barta TE, Bedell L, DeCrescenzo G, Freskos J, Getman DP, Hockerman SL, Li M, Mehta P, Mischke B, Munie GE, Swearingen C, Villamil CI",,106603,DTCT0024002,692102,DTCC00254851,497970,4540
CHEMBL91636,P45452,,DONMTDNLNMLOIC-OTWHNJEPSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11472217,KI,=,2.3,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,"Design, synthesis, and structure-activity relationships of macrocyclic hydroxamic acids that inhibit tumor necrosis factor alpha release in vitro and in vivo.",J. Med. Chem.,2001,44,16,"Xue CB, Voss ME, Nelson DJ, Duan JJ, Cherney RJ, Jacobson IC, He X, Roderick J, Chen L, Corbett RL, Wang L, Meyer DT, Kennedy K, DeGradodagger WF, Hardman KD, Teleha CA, Jaffee BD, Liu RQ, Copeland RA, Covington MB, Christ DD, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,106613,DTCT0024002,1647512,DTCC00251443,1261581,16346
CHEMBL91639,P45452,,DCYXSVHFPQZDLY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12217355,IC50,=,89.13,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant human matrix metalloprotease-13,,Analogue based design of MMP-13 (Collagenase-3) inhibitors.,Bioorg. Med. Chem. Lett.,2002,12,19,"Sarma JA, Rambabu G, Srikanth K, Raveendra D, Vithal M",,106465,DTCT0024002,797617,DTCC00252461,1693629,5083
CHEMBL91668,P45452,,ZNJTZTNWABBABD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11591509,IC50,=,1100,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,alpha-Amino-beta-sulphone hydroxamates as potent MMP-13 inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2001,11,20,"Becker DP, Barta TE, Bedell L, DeCrescenzo G, Freskos J, Getman DP, Hockerman SL, Li M, Mehta P, Mischke B, Munie GE, Swearingen C, Villamil CI",,106603,DTCT0024002,669432,DTCC00255172,1850276,4540
CHEMBL92327,P45452,,TWTZRHWHKRIAHT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11591510,IC50,=,41.5,NM,,,,,,,,,,,,,,Inhibitory activity against human Matrix metalloprotease-13,,alpha-Alkyl-alpha-amino-beta-sulphone hydroxamates as potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2001,11,20,"Becker DP, DeCrescenzo G, Freskos J, Getman DP, Hockerman SL, Li M, Mehta P, Munie GE, Swearingen C",,106599,DTCT0024002,1078289,DTCC00255226,820444,4541
CHEMBL92778,P45452,,MHIFGXNSNUWQOT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11591510,IC50,=,1.4,NM,,,,,,,,,,,,,,Inhibitory activity against human Matrix metalloprotease-13,,alpha-Alkyl-alpha-amino-beta-sulphone hydroxamates as potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2001,11,20,"Becker DP, DeCrescenzo G, Freskos J, Getman DP, Hockerman SL, Li M, Mehta P, Munie GE, Swearingen C",,106599,DTCT0024002,1093220,DTCC00255197,1882476,4541
CHEMBL92847,P45452,,MQNIUGNKHHOHOT-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11591509,IC50,=,200,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,alpha-Amino-beta-sulphone hydroxamates as potent MMP-13 inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2001,11,20,"Becker DP, Barta TE, Bedell L, DeCrescenzo G, Freskos J, Getman DP, Hockerman SL, Li M, Mehta P, Mischke B, Munie GE, Swearingen C, Villamil CI",,106603,DTCT0024002,688469,DTCC00255824,691461,4540
CHEMBL92899,P45452,,BHBGOKVZFAQJAD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11591510,IC50,<,0.1,NM,,,,,,,,,,,,,,Inhibitory activity against human Matrix metalloprotease-13,,alpha-Alkyl-alpha-amino-beta-sulphone hydroxamates as potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2001,11,20,"Becker DP, DeCrescenzo G, Freskos J, Getman DP, Hockerman SL, Li M, Mehta P, Munie GE, Swearingen C",,106599,DTCT0024002,1064249,DTCC00255132,562291,4541
CHEMBL92899,P45452,,BHBGOKVZFAQJAD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11591510,IC50,=,1.3,NM,,,,,,,,,,,,,,Inhibitory activity against human Matrix metalloprotease-13,,alpha-Alkyl-alpha-amino-beta-sulphone hydroxamates as potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2001,11,20,"Becker DP, DeCrescenzo G, Freskos J, Getman DP, Hockerman SL, Li M, Mehta P, Munie GE, Swearingen C",,106599,DTCT0024002,1074861,DTCC00255132,562292,4541
CHEMBL92899,P45452,,BHBGOKVZFAQJAD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11591510,IC50,=,60,NM,,,,,,,,,,,,,,Inhibitory activity against human Matrix metalloprotease-13,,alpha-Alkyl-alpha-amino-beta-sulphone hydroxamates as potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2001,11,20,"Becker DP, DeCrescenzo G, Freskos J, Getman DP, Hockerman SL, Li M, Mehta P, Munie GE, Swearingen C",,106599,DTCT0024002,1086891,DTCC00255132,562290,4541
CHEMBL92923,P45452,,DSBXKNRWNDALKK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11591510,IC50,=,1.1,NM,,,,,,,,,,,,,,Inhibitory activity against human Matrix metalloprotease-13,,alpha-Alkyl-alpha-amino-beta-sulphone hydroxamates as potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2001,11,20,"Becker DP, DeCrescenzo G, Freskos J, Getman DP, Hockerman SL, Li M, Mehta P, Munie GE, Swearingen C",,106599,DTCT0024002,1060602,DTCC00255196,1785625,4541
CHEMBL92927,P45452,,ZOPDCQZNGWSOLM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12873518,IC50,=,20,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotein 13,,Acetylenic TACE inhibitors. Part 1. SAR of the acyclic sulfonamide hydroxamates.,Bioorg. Med. Chem. Lett.,2003,13,16,"Levin JI, Chen JM, Cheung K, Cole D, Crago C, Santos ED, Du X, Khafizova G, MacEwan G, Niu C, Salaski EJ, Zask A, Cummons T, Sung A, Xu J, Zhang Y, Xu W, Ayral-Kaloustian S, Jin G, Cowling R, Barone D, Mohler KM, Black RA, Skotnicki JS",,106634,DTCT0024002,783665,DTCC00259628,1456145,5733
CHEMBL93058,P45452,,LNMDTXFZBLSAOK-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11591509,IC50,=,2900,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,alpha-Amino-beta-sulphone hydroxamates as potent MMP-13 inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2001,11,20,"Becker DP, Barta TE, Bedell L, DeCrescenzo G, Freskos J, Getman DP, Hockerman SL, Li M, Mehta P, Mischke B, Munie GE, Swearingen C, Villamil CI",,106603,DTCT0024002,689629,DTCC00255128,1980185,4540
CHEMBL93074,P45452,,LNMDTXFZBLSAOK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11591509,IC50,=,5900,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,alpha-Amino-beta-sulphone hydroxamates as potent MMP-13 inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2001,11,20,"Becker DP, Barta TE, Bedell L, DeCrescenzo G, Freskos J, Getman DP, Hockerman SL, Li M, Mehta P, Mischke B, Munie GE, Swearingen C, Villamil CI",,106603,DTCT0024002,692099,DTCC00255708,820442,4540
CHEMBL93231,P45452,,HDTLIPGODNAYEM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11591510,IC50,=,0.4,NM,,,,,,,,,,,,,,Inhibitory activity against human Matrix metalloprotease-13,,alpha-Alkyl-alpha-amino-beta-sulphone hydroxamates as potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2001,11,20,"Becker DP, DeCrescenzo G, Freskos J, Getman DP, Hockerman SL, Li M, Mehta P, Munie GE, Swearingen C",,106599,DTCT0024002,1065404,DTCC00255209,1818148,4541
CHEMBL93725,P45452,,XYKIOHRETKWUIG-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11591509,IC50,=,200,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,alpha-Amino-beta-sulphone hydroxamates as potent MMP-13 inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2001,11,20,"Becker DP, Barta TE, Bedell L, DeCrescenzo G, Freskos J, Getman DP, Hockerman SL, Li M, Mehta P, Mischke B, Munie GE, Swearingen C, Villamil CI",,106603,DTCT0024002,692106,DTCC00255270,1723207,4540
CHEMBL93742,P45452,,IRASJBKLPWXCBM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11591509,IC50,<,1000,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,alpha-Amino-beta-sulphone hydroxamates as potent MMP-13 inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2001,11,20,"Becker DP, Barta TE, Bedell L, DeCrescenzo G, Freskos J, Getman DP, Hockerman SL, Li M, Mehta P, Mischke B, Munie GE, Swearingen C, Villamil CI",,106603,DTCT0024002,683477,DTCC00254879,1305814,4540
CHEMBL93993,P45452,,DBPSXGXUBBENDT-OAHLLOKOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11591509,IC50,=,400,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,alpha-Amino-beta-sulphone hydroxamates as potent MMP-13 inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2001,11,20,"Becker DP, Barta TE, Bedell L, DeCrescenzo G, Freskos J, Getman DP, Hockerman SL, Li M, Mehta P, Mischke B, Munie GE, Swearingen C, Villamil CI",,106603,DTCT0024002,675765,DTCC00254679,1723208,4540
CHEMBL94185,P45452,,XNEDUJHGWLQJFQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11591509,IC50,=,400,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-13,,alpha-Amino-beta-sulphone hydroxamates as potent MMP-13 inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2001,11,20,"Becker DP, Barta TE, Bedell L, DeCrescenzo G, Freskos J, Getman DP, Hockerman SL, Li M, Mehta P, Mischke B, Munie GE, Swearingen C, Villamil CI",,106603,DTCT0024002,679585,DTCC00255683,2045277,4540
CHEMBL94248,P45452,,HYJOVEQOBWVFPG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11591510,IC50,=,0.6,NM,,,,,,,,,,,,,,Inhibitory activity against human Matrix metalloprotease-13,,alpha-Alkyl-alpha-amino-beta-sulphone hydroxamates as potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2001,11,20,"Becker DP, DeCrescenzo G, Freskos J, Getman DP, Hockerman SL, Li M, Mehta P, Munie GE, Swearingen C",,106599,DTCT0024002,1059261,DTCC00254882,594477,4541
CHEMBL94324,P45452,,YOZFGFQUBUJIAN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11133099,IC50,=,9000,NM,,,,,,,,,,,,,,50 percent inhibition of human Matrix metalloprotease-13 by the cleavage of fluorogenic peptide MCA-Pro-Leu-Gly-Leu-Dpa-ala-Arg-NH2,,Synthesis and activity of selective MMP inhibitors with an aryl backbone.,Bioorg. Med. Chem. Lett.,2000,10,24,"Barta TE, Becker DP, Bedell LJ, De Crescenzo GA, McDonald JJ, Munie GE, Rao S, Shieh HS, Stegeman R, Stevens AM, Villamil CI",,106604,DTCT0024002,724659,DTCC00261065,129182,3985
CHEMBL94357,P45452,,AOGWJSJATLXUOJ-OAHLLOKOSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12873518,IC50,=,38,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotein 13,,Acetylenic TACE inhibitors. Part 1. SAR of the acyclic sulfonamide hydroxamates.,Bioorg. Med. Chem. Lett.,2003,13,16,"Levin JI, Chen JM, Cheung K, Cole D, Crago C, Santos ED, Du X, Khafizova G, MacEwan G, Niu C, Salaski EJ, Zask A, Cummons T, Sung A, Xu J, Zhang Y, Xu W, Ayral-Kaloustian S, Jin G, Cowling R, Barone D, Mohler KM, Black RA, Skotnicki JS",,106634,DTCT0024002,797551,DTCC00260144,776546,5733
CHEMBL94363,P45452,,LRYRCUJGWNCKPO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12873518,IC50,=,396,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotein 13,,Acetylenic TACE inhibitors. Part 1. SAR of the acyclic sulfonamide hydroxamates.,Bioorg. Med. Chem. Lett.,2003,13,16,"Levin JI, Chen JM, Cheung K, Cole D, Crago C, Santos ED, Du X, Khafizova G, MacEwan G, Niu C, Salaski EJ, Zask A, Cummons T, Sung A, Xu J, Zhang Y, Xu W, Ayral-Kaloustian S, Jin G, Cowling R, Barone D, Mohler KM, Black RA, Skotnicki JS",,106634,DTCT0024002,788893,DTCC00260174,422142,5733
CHEMBL94386,P45452,,DFRHCKHXGKQVLI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12873518,IC50,=,751,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotein 13,,Acetylenic TACE inhibitors. Part 1. SAR of the acyclic sulfonamide hydroxamates.,Bioorg. Med. Chem. Lett.,2003,13,16,"Levin JI, Chen JM, Cheung K, Cole D, Crago C, Santos ED, Du X, Khafizova G, MacEwan G, Niu C, Salaski EJ, Zask A, Cummons T, Sung A, Xu J, Zhang Y, Xu W, Ayral-Kaloustian S, Jin G, Cowling R, Barone D, Mohler KM, Black RA, Skotnicki JS",,106634,DTCT0024002,801721,DTCC00260505,582862,5733
CHEMBL94467,P45452,,RMDGEXDQWGEALM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11133099,IC50,=,900,NM,,,,,,,,,,,,,,50 percent inhibition of human Matrix metalloprotease-13 by the cleavage of fluorogenic peptide MCA-Pro-Leu-Gly-Leu-Dpa-ala-Arg-NH2,,Synthesis and activity of selective MMP inhibitors with an aryl backbone.,Bioorg. Med. Chem. Lett.,2000,10,24,"Barta TE, Becker DP, Bedell LJ, De Crescenzo GA, McDonald JJ, Munie GE, Rao S, Shieh HS, Stegeman R, Stevens AM, Villamil CI",,106604,DTCT0024002,699280,DTCC00260727,1003058,3985
CHEMBL94518,P45452,,RLUGMDBAWBLDJQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12873518,IC50,=,84,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotein 13,,Acetylenic TACE inhibitors. Part 1. SAR of the acyclic sulfonamide hydroxamates.,Bioorg. Med. Chem. Lett.,2003,13,16,"Levin JI, Chen JM, Cheung K, Cole D, Crago C, Santos ED, Du X, Khafizova G, MacEwan G, Niu C, Salaski EJ, Zask A, Cummons T, Sung A, Xu J, Zhang Y, Xu W, Ayral-Kaloustian S, Jin G, Cowling R, Barone D, Mohler KM, Black RA, Skotnicki JS",,106634,DTCT0024002,776440,DTCC00260575,938424,5733
CHEMBL94643,P45452,,RMUMGJZUGCOZOV-LLVKDONJSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12873518,IC50,=,28,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotein 13,,Acetylenic TACE inhibitors. Part 1. SAR of the acyclic sulfonamide hydroxamates.,Bioorg. Med. Chem. Lett.,2003,13,16,"Levin JI, Chen JM, Cheung K, Cole D, Crago C, Santos ED, Du X, Khafizova G, MacEwan G, Niu C, Salaski EJ, Zask A, Cummons T, Sung A, Xu J, Zhang Y, Xu W, Ayral-Kaloustian S, Jin G, Cowling R, Barone D, Mohler KM, Black RA, Skotnicki JS",,106634,DTCT0024002,814664,DTCC00260178,1100601,5733
CHEMBL94715,P45452,,XRLMAIWPTHLVKY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12873518,IC50,=,185,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotein 13,,Acetylenic TACE inhibitors. Part 1. SAR of the acyclic sulfonamide hydroxamates.,Bioorg. Med. Chem. Lett.,2003,13,16,"Levin JI, Chen JM, Cheung K, Cole D, Crago C, Santos ED, Du X, Khafizova G, MacEwan G, Niu C, Salaski EJ, Zask A, Cummons T, Sung A, Xu J, Zhang Y, Xu W, Ayral-Kaloustian S, Jin G, Cowling R, Barone D, Mohler KM, Black RA, Skotnicki JS",,106634,DTCT0024002,775108,DTCC00260052,1585289,5733
CHEMBL94828,P45452,,UNYWJVNGOZMHAU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11133099,IC50,>,10000,NM,,,,,,,,,,,,,,50 percent inhibition of human Matrix metalloprotease-13 by the cleavage of fluorogenic peptide MCA-Pro-Leu-Gly-Leu-Dpa-ala-Arg-NH2,,Synthesis and activity of selective MMP inhibitors with an aryl backbone.,Bioorg. Med. Chem. Lett.,2000,10,24,"Barta TE, Becker DP, Bedell LJ, De Crescenzo GA, McDonald JJ, Munie GE, Rao S, Shieh HS, Stegeman R, Stevens AM, Villamil CI",,106604,DTCT0024002,715145,DTCC00261092,161812,3985
CHEMBL94872,P45452,,RGHANNJVNFHOMO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11133099,IC50,=,520,NM,,,,,,,,,,,,,,50 percent inhibition of human Matrix metalloprotease-13 by the cleavage of fluorogenic peptide MCA-Pro-Leu-Gly-Leu-Dpa-ala-Arg-NH2,,Synthesis and activity of selective MMP inhibitors with an aryl backbone.,Bioorg. Med. Chem. Lett.,2000,10,24,"Barta TE, Becker DP, Bedell LJ, De Crescenzo GA, McDonald JJ, Munie GE, Rao S, Shieh HS, Stegeman R, Stevens AM, Villamil CI",,106604,DTCT0024002,723511,DTCC00261093,1968541,3985
CHEMBL94948,P45452,,FNRFZJFDQHKMHF-SNVBAGLBSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12873518,IC50,=,195,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotein 13,,Acetylenic TACE inhibitors. Part 1. SAR of the acyclic sulfonamide hydroxamates.,Bioorg. Med. Chem. Lett.,2003,13,16,"Levin JI, Chen JM, Cheung K, Cole D, Crago C, Santos ED, Du X, Khafizova G, MacEwan G, Niu C, Salaski EJ, Zask A, Cummons T, Sung A, Xu J, Zhang Y, Xu W, Ayral-Kaloustian S, Jin G, Cowling R, Barone D, Mohler KM, Black RA, Skotnicki JS",,106634,DTCT0024002,807306,DTCC00259598,486464,5733
CHEMBL95262,P45452,,DWAPKTBJQHYHER-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12270165,IC50,=,34.6,NM,,,,,,,,,,,,,,Concentration required in vitro to inhibit Matrix metalloprotease-13,,Benzodiazepine inhibitors of the MMPs and TACE.,Bioorg. Med. Chem. Lett.,2002,12,20,"Nelson FC, Delos Santos E, Levin JI, Chen JM, Skotnicki JS, DiJoseph JF, Sharr MA, Sung A, Killar LM, Cowling R, Jin G, Roth CE, Albright JD",,106631,DTCT0024002,1536388,DTCC00263282,270283,5143
CHEMBL95414,P45452,,FUYGKZYSHSZHFI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15125955,IC50,=,7000,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,Reverse hydroxamate-based selective TACE inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,11,"Kamei N, Tanaka T, Kawai K, Miyawaki K, Okuyama A, Murakami Y, Arakawa Y, Haino M, Harada T, Shimano M",,106641,DTCT0024002,1401125,DTCC00264967,1079590,6400
CHEMBL95460,P45452,,BLQAAMGUGMNRQN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12270165,IC50,=,29,NM,,,,,,,,,,,,,,Concentration required in vitro to inhibit Matrix metalloprotease-13,,Benzodiazepine inhibitors of the MMPs and TACE.,Bioorg. Med. Chem. Lett.,2002,12,20,"Nelson FC, Delos Santos E, Levin JI, Chen JM, Skotnicki JS, DiJoseph JF, Sharr MA, Sung A, Killar LM, Cowling R, Jin G, Roth CE, Albright JD",,106631,DTCT0024002,1534014,DTCC00263280,1629611,5143
CHEMBL95483,P45452,,DYYRCQAVWNBEBP-MNOVXSKESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10522712,IC50,,,,,,,,,,,,,,,,,"Inhibition of Collagenase-3, MMP-13 (Not determined)",Not Determined,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,101905,DTCT0024002,1457845,DTCC00264377,917407,3373
CHEMBL95486,P45452,,ZMVFZGHWXXXQJL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12270165,IC50,=,3,NM,,,,,,,,,,,,,,Concentration required in vitro to inhibit Matrix metalloprotease-13,,Benzodiazepine inhibitors of the MMPs and TACE.,Bioorg. Med. Chem. Lett.,2002,12,20,"Nelson FC, Delos Santos E, Levin JI, Chen JM, Skotnicki JS, DiJoseph JF, Sharr MA, Sung A, Killar LM, Cowling R, Jin G, Roth CE, Albright JD",,106631,DTCT0024002,1541050,DTCC00263781,368552,5143
CHEMBL95614,P45452,,QHRUJPVXLYJUEM-MSOLQXFVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10522712,IC50,=,100,NM,,,,,,,,,,,,,,Inhibition of Coll-3 MMP-13,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,101904,DTCT0024002,1451872,DTCC00264573,205149,3373
CHEMBL95614,P45452,,QHRUJPVXLYJUEM-MSOLQXFVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,IC50,=,100,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258635,DTCC00264573,196120,24803
CHEMBL95693,P45452,,ASLUWSDEBRNVJV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12270165,IC50,=,9.5,NM,,,,,,,,,,,,,,Concentration required in vitro to inhibit Matrix metalloprotease-13,,Benzodiazepine inhibitors of the MMPs and TACE.,Bioorg. Med. Chem. Lett.,2002,12,20,"Nelson FC, Delos Santos E, Levin JI, Chen JM, Skotnicki JS, DiJoseph JF, Sharr MA, Sung A, Killar LM, Cowling R, Jin G, Roth CE, Albright JD",,106631,DTCT0024002,1557109,DTCC00263252,853457,5143
CHEMBL95708,P45452,,FMPSZEWYBZCYDN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12270165,IC50,=,2,NM,,,,,,,,,,,,,,Concentration required in vitro to inhibit Matrix metalloprotease-13,,Benzodiazepine inhibitors of the MMPs and TACE.,Bioorg. Med. Chem. Lett.,2002,12,20,"Nelson FC, Delos Santos E, Levin JI, Chen JM, Skotnicki JS, DiJoseph JF, Sharr MA, Sung A, Killar LM, Cowling R, Jin G, Roth CE, Albright JD",,106631,DTCT0024002,1528072,DTCC00263067,1014632,5143
CHEMBL95807,P45452,,VCKCQHDSLLCTDH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12270165,IC50,=,1,NM,,,,,,,,,,,,,,Concentration required in vitro to inhibit Matrix metalloprotease-13,,Benzodiazepine inhibitors of the MMPs and TACE.,Bioorg. Med. Chem. Lett.,2002,12,20,"Nelson FC, Delos Santos E, Levin JI, Chen JM, Skotnicki JS, DiJoseph JF, Sharr MA, Sung A, Killar LM, Cowling R, Jin G, Roth CE, Albright JD",,106631,DTCT0024002,1524644,DTCC00263111,30422,5143
CHEMBL95807,P45452,,VCKCQHDSLLCTDH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12951101,IC50,=,1,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-13.,,Synthesis and biological activity of piperazine-based dual MMP-13 and TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,19,"Letavic MA, Barberia JT, Carty TJ, Hardink JR, Liras J, Lopresti-Morrow LL, Mitchell PG, Noe MC, Reeves LM, Snow SL, Stam EJ, Sweeney FJ, Vaughn ML, Yu CH",,106625,DTCT0024002,675697,DTCC00263111,4784,5809
CHEMBL96049,P45452,,DIIAIQCOHXBJHI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12270165,IC50,=,0.4,NM,,,,,,,,,,,,,,Concentration required in vitro to inhibit Matrix metalloprotease-13,,Benzodiazepine inhibitors of the MMPs and TACE.,Bioorg. Med. Chem. Lett.,2002,12,20,"Nelson FC, Delos Santos E, Levin JI, Chen JM, Skotnicki JS, DiJoseph JF, Sharr MA, Sung A, Killar LM, Cowling R, Jin G, Roth CE, Albright JD",,106631,DTCT0024002,1534007,DTCC00263035,1980294,5143
CHEMBL96396,P45452,,XDSILIXRMZXTNX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12873518,IC50,=,28,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotein 13,,Acetylenic TACE inhibitors. Part 1. SAR of the acyclic sulfonamide hydroxamates.,Bioorg. Med. Chem. Lett.,2003,13,16,"Levin JI, Chen JM, Cheung K, Cole D, Crago C, Santos ED, Du X, Khafizova G, MacEwan G, Niu C, Salaski EJ, Zask A, Cummons T, Sung A, Xu J, Zhang Y, Xu W, Ayral-Kaloustian S, Jin G, Cowling R, Barone D, Mohler KM, Black RA, Skotnicki JS",,106634,DTCT0024002,793499,DTCC00106556,841675,5733
CHEMBL96417,P45452,,VMOSDDURWLNMNG-JLOHTSLTSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12873518,IC50,=,86,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotein 13,,Acetylenic TACE inhibitors. Part 1. SAR of the acyclic sulfonamide hydroxamates.,Bioorg. Med. Chem. Lett.,2003,13,16,"Levin JI, Chen JM, Cheung K, Cole D, Crago C, Santos ED, Du X, Khafizova G, MacEwan G, Niu C, Salaski EJ, Zask A, Cummons T, Sung A, Xu J, Zhang Y, Xu W, Ayral-Kaloustian S, Jin G, Cowling R, Barone D, Mohler KM, Black RA, Skotnicki JS",,106634,DTCT0024002,810079,DTCC00260137,1553080,5733
CHEMBL96419,P45452,,RWOPWLLDIYQNCW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12873518,IC50,=,57,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotein 13 at 10 uM,,Acetylenic TACE inhibitors. Part 1. SAR of the acyclic sulfonamide hydroxamates.,Bioorg. Med. Chem. Lett.,2003,13,16,"Levin JI, Chen JM, Cheung K, Cole D, Crago C, Santos ED, Du X, Khafizova G, MacEwan G, Niu C, Salaski EJ, Zask A, Cummons T, Sung A, Xu J, Zhang Y, Xu W, Ayral-Kaloustian S, Jin G, Cowling R, Barone D, Mohler KM, Black RA, Skotnicki JS",,106635,DTCT0024002,803113,DTCC00260569,258277,5733
CHEMBL96636,P45452,,BTZMVJPRQAIPRP-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12873518,IC50,=,146,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotein 13,,Acetylenic TACE inhibitors. Part 1. SAR of the acyclic sulfonamide hydroxamates.,Bioorg. Med. Chem. Lett.,2003,13,16,"Levin JI, Chen JM, Cheung K, Cole D, Crago C, Santos ED, Du X, Khafizova G, MacEwan G, Niu C, Salaski EJ, Zask A, Cummons T, Sung A, Xu J, Zhang Y, Xu W, Ayral-Kaloustian S, Jin G, Cowling R, Barone D, Mohler KM, Black RA, Skotnicki JS",,106634,DTCT0024002,792002,DTCC00260134,96942,5733
CHEMBL96637,P45452,,JBVXKMHBLNDBBV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12873518,IC50,=,2,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotein 13,,Acetylenic TACE inhibitors. Part 1. SAR of the acyclic sulfonamide hydroxamates.,Bioorg. Med. Chem. Lett.,2003,13,16,"Levin JI, Chen JM, Cheung K, Cole D, Crago C, Santos ED, Du X, Khafizova G, MacEwan G, Niu C, Salaski EJ, Zask A, Cummons T, Sung A, Xu J, Zhang Y, Xu W, Ayral-Kaloustian S, Jin G, Cowling R, Barone D, Mohler KM, Black RA, Skotnicki JS",,106634,DTCT0024002,801716,DTCC00260135,518705,5733
CHEMBL97382,P45452,,ZNTBEHZFMMNDRG-CABCVRRESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10522712,IC50,,,,,,,,,,,,,,,,,"Inhibition of Collagenase-3, MMP-13 (Not determined)",Not Determined,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,101905,DTCT0024002,1448191,DTCC00264485,433638,3373
CHEMBL97478,P45452,,SCJDSSFAEYTLGW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11133099,IC50,=,2200,NM,,,,,,,,,,,,,,50 percent inhibition of human Matrix metalloprotease-13 by the cleavage of fluorogenic peptide MCA-Pro-Leu-Gly-Leu-Dpa-ala-Arg-NH2,,Synthesis and activity of selective MMP inhibitors with an aryl backbone.,Bioorg. Med. Chem. Lett.,2000,10,24,"Barta TE, Becker DP, Bedell LJ, De Crescenzo GA, McDonald JJ, Munie GE, Rao S, Shieh HS, Stegeman R, Stevens AM, Villamil CI",,106604,DTCT0024002,710858,DTCC00261094,1359441,3985
CHEMBL97762,P45452,,LXSYXSGOVAASBA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12873518,IC50,=,37,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotein 13 at 10 uM,,Acetylenic TACE inhibitors. Part 1. SAR of the acyclic sulfonamide hydroxamates.,Bioorg. Med. Chem. Lett.,2003,13,16,"Levin JI, Chen JM, Cheung K, Cole D, Crago C, Santos ED, Du X, Khafizova G, MacEwan G, Niu C, Salaski EJ, Zask A, Cummons T, Sung A, Xu J, Zhang Y, Xu W, Ayral-Kaloustian S, Jin G, Cowling R, Barone D, Mohler KM, Black RA, Skotnicki JS",,106635,DTCT0024002,804506,DTCC00260537,1196503,5733
CHEMBL97788,P45452,,YQCWPKHRHVYSBQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12270165,IC50,=,4,NM,,,,,,,,,,,,,,Concentration required in vitro to inhibit Matrix metalloprotease-13,,Benzodiazepine inhibitors of the MMPs and TACE.,Bioorg. Med. Chem. Lett.,2002,12,20,"Nelson FC, Delos Santos E, Levin JI, Chen JM, Skotnicki JS, DiJoseph JF, Sharr MA, Sung A, Killar LM, Cowling R, Jin G, Roth CE, Albright JD",,106631,DTCT0024002,1524650,DTCC00263190,885716,5143
CHEMBL97790,P45452,,PRQWPDFKJBVNKQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12270165,IC50,=,77,NM,,,,,,,,,,,,,,Concentration required in vitro to inhibit Matrix metalloprotease-13,,Benzodiazepine inhibitors of the MMPs and TACE.,Bioorg. Med. Chem. Lett.,2002,12,20,"Nelson FC, Delos Santos E, Levin JI, Chen JM, Skotnicki JS, DiJoseph JF, Sharr MA, Sung A, Killar LM, Cowling R, Jin G, Roth CE, Albright JD",,106631,DTCT0024002,1548149,DTCC00263227,1273366,5143
CHEMBL97790,P45452,,PRQWPDFKJBVNKQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15261259,IC50,=,77,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13,,Benzodiazepine inhibitors of the MMPs and TACE. Part 2.,Bioorg. Med. Chem. Lett.,2004,14,16,"Levin JI, Nelson FC, Delos Santos E, Du MT, MacEwan G, Chen JM, Ayral-Kaloustian S, Xu J, Jin G, Cummons T, Barone D",,305704,DTCT0024002,1763991,DTCC00263227,1274762,13193
CHEMBL97898,P45452,,PLYLMXDSDZFWLJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12270165,IC50,=,2,NM,,,,,,,,,,,,,,Concentration required in vitro to inhibit Matrix metalloprotease-13,,Benzodiazepine inhibitors of the MMPs and TACE.,Bioorg. Med. Chem. Lett.,2002,12,20,"Nelson FC, Delos Santos E, Levin JI, Chen JM, Skotnicki JS, DiJoseph JF, Sharr MA, Sung A, Killar LM, Cowling R, Jin G, Roth CE, Albright JD",,106631,DTCT0024002,1549328,DTCC00262551,1564629,5143
CHEMBL97908,P45452,,XJFYJIMKKGZKGX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12270165,IC50,=,7,NM,,,,,,,,,,,,,,Concentration required in vitro to inhibit Matrix metalloprotease-13,,Benzodiazepine inhibitors of the MMPs and TACE.,Bioorg. Med. Chem. Lett.,2002,12,20,"Nelson FC, Delos Santos E, Levin JI, Chen JM, Skotnicki JS, DiJoseph JF, Sharr MA, Sung A, Killar LM, Cowling R, Jin G, Roth CE, Albright JD",,106631,DTCT0024002,1543427,DTCC00263178,270282,5143
CHEMBL97936,P45452,,FCGVXISUYVDDPU-RPWUZVMVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10522712,IC50,=,8,NM,,,,,,,,,,,,,,Inhibition of Coll-3 MMP-13,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,101904,DTCT0024002,1457850,DTCC00264930,401357,3373
CHEMBL97936,P45452,,FCGVXISUYVDDPU-RPWUZVMVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,IC50,=,7.94,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258638,DTCC00264930,391949,24803
CHEMBL97962,P45452,,YPEMWYFQTIBRAB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12270165,IC50,=,2,NM,,,,,,,,,,,,,,Concentration required in vitro to inhibit Matrix metalloprotease-13,,Benzodiazepine inhibitors of the MMPs and TACE.,Bioorg. Med. Chem. Lett.,2002,12,20,"Nelson FC, Delos Santos E, Levin JI, Chen JM, Skotnicki JS, DiJoseph JF, Sharr MA, Sung A, Killar LM, Cowling R, Jin G, Roth CE, Albright JD",,106631,DTCT0024002,1543423,DTCC00263179,1597073,5143
CHEMBL98017,P45452,,OEPLGUBYTRYCJX-CABCVRRESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10522712,IC50,=,80,NM,,,,,,,,,,,,,,Inhibition of Coll-3 MMP-13,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,101904,DTCT0024002,1451877,DTCC00264988,2013090,3373
CHEMBL98017,P45452,,OEPLGUBYTRYCJX-CABCVRRESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,IC50,=,79.43,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258629,DTCC00264988,2003620,24803
CHEMBL98044,P45452,,MVRHXCGLUWVMKH-CVEARBPZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10522712,IC50,=,400,NM,,,,,,,,,,,,,,Inhibition of Coll-3 MMP-13,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,101904,DTCT0024002,1474978,DTCC00264954,76259,3373
CHEMBL98044,P45452,,MVRHXCGLUWVMKH-CVEARBPZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,IC50,=,398.11,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258642,DTCC00264954,67153,24803
CHEMBL98044,P45452,,MVRHXCGLUWVMKH-CVEARBPZSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,18790648,IC50,=,400,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497406,DTCT0024002,2457479,DTCC00264954,79308,32556
CHEMBL98061,P45452,,QCHHXEMLMRDLDA-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12873518,IC50,=,27,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotein 13,,Acetylenic TACE inhibitors. Part 1. SAR of the acyclic sulfonamide hydroxamates.,Bioorg. Med. Chem. Lett.,2003,13,16,"Levin JI, Chen JM, Cheung K, Cole D, Crago C, Santos ED, Du X, Khafizova G, MacEwan G, Niu C, Salaski EJ, Zask A, Cummons T, Sung A, Xu J, Zhang Y, Xu W, Ayral-Kaloustian S, Jin G, Cowling R, Barone D, Mohler KM, Black RA, Skotnicki JS",,106634,DTCT0024002,782234,DTCC00260544,1650137,5733
CHEMBL98202,P45452,,KQXZHGMAVQYCLA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15125955,IC50,=,25000,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,Reverse hydroxamate-based selective TACE inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,11,"Kamei N, Tanaka T, Kawai K, Miyawaki K, Okuyama A, Murakami Y, Arakawa Y, Haino M, Harada T, Shimano M",,106641,DTCT0024002,1386241,DTCC00265444,401371,6400
CHEMBL98390,P45452,,AYWKRESAZCSENH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15125955,IC50,=,4000,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,Reverse hydroxamate-based selective TACE inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,11,"Kamei N, Tanaka T, Kawai K, Miyawaki K, Okuyama A, Murakami Y, Arakawa Y, Haino M, Harada T, Shimano M",,106641,DTCT0024002,1403508,DTCC00265682,691581,6400
CHEMBL98852,P45452,,VDOSRWCTGZRCFD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15125955,IC50,=,22000,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,Reverse hydroxamate-based selective TACE inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,11,"Kamei N, Tanaka T, Kawai K, Miyawaki K, Okuyama A, Murakami Y, Arakawa Y, Haino M, Harada T, Shimano M",,106641,DTCT0024002,1364698,DTCC00265511,949990,6400
CHEMBL98917,P45452,,OVICMAJBKGLSNC-KGLIPLIRSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10522712,IC50,,,,,,,,,,,,,,,,,"Inhibition of Collagenase-3, MMP-13 (Not determined)",Not Determined,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,101905,DTCT0024002,1472419,DTCC00264408,755981,3373
CHEMBL99045,P45452,,QSRYPQMSBYPAQC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15125955,IC50,=,25000,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,Reverse hydroxamate-based selective TACE inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,11,"Kamei N, Tanaka T, Kawai K, Miyawaki K, Okuyama A, Murakami Y, Arakawa Y, Haino M, Harada T, Shimano M",,106641,DTCT0024002,1382457,DTCC00264808,1403621,6400
CHEMBL99072,P45452,,OOCSYABQMHKMLM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,12270165,IC50,=,1,NM,,,,,,,,,,,,,,Concentration required in vitro to inhibit Matrix metalloprotease-13,,Benzodiazepine inhibitors of the MMPs and TACE.,Bioorg. Med. Chem. Lett.,2002,12,20,"Nelson FC, Delos Santos E, Levin JI, Chen JM, Skotnicki JS, DiJoseph JF, Sharr MA, Sung A, Killar LM, Cowling R, Jin G, Roth CE, Albright JD",,106631,DTCT0024002,1523646,DTCC00262903,1785725,5143
CHEMBL99148,P45452,,ZVAKMIZOMSWYGQ-SJORKVTESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10522712,IC50,=,40,NM,,,,,,,,,,,,,,Inhibition of Coll-3 MMP-13,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,101904,DTCT0024002,1450627,DTCC00264513,788198,3373
CHEMBL99148,P45452,,ZVAKMIZOMSWYGQ-SJORKVTESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,IC50,=,39.81,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258641,DTCC00264513,778988,24803
CHEMBL99189,P45452,,YLYMDJMYRSEUOA-SJORKVTESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10522712,IC50,=,40,NM,,,,,,,,,,,,,,Inhibition of Coll-3 MMP-13,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,101904,DTCT0024002,1466343,DTCC00265032,1532650,3373
CHEMBL99189,P45452,,YLYMDJMYRSEUOA-SJORKVTESA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,IC50,=,39.81,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258631,DTCC00265032,1523430,24803
CHEMBL99365,P45452,,YFYQFPIGOKJLFD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15125955,IC50,=,3300,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,Reverse hydroxamate-based selective TACE inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,11,"Kamei N, Tanaka T, Kawai K, Miyawaki K, Okuyama A, Murakami Y, Arakawa Y, Haino M, Harada T, Shimano M",,106641,DTCT0024002,1394863,DTCC00265479,562406,6400
CHEMBL99733,P45452,,PIZFUXJESIVHOO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15163180,KI,=,1055,NM,,,,,,,,,,,,,,Inhibition of recombinant human Matrix metalloprotease-13,,Sultam hydroxamates as novel matrix metalloproteinase inhibitors.,J. Med. Chem.,2004,47,12,"Cherney RJ, Mo R, Meyer DT, Hardman KD, Liu RQ, Covington MB, Qian M, Wasserman ZR, Christ DD, Trzaskos JM, Newton RC, Decicco CP",,106611,DTCT0024002,671275,DTCC00269145,582953,18131
CHEMBL99745,P45452,,KSLUOGMHCJCRLQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,11677139,IC50,=,3,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-13.,,The discovery of anthranilic acid-based MMP inhibitors. Part 3: incorporation of basic amines.,Bioorg. Med. Chem. Lett.,2001,11,22,"Levin JI, Chen JM, Du MT, Nelson FC, Wehr T, DiJoseph JF, Killar LM, Skala S, Sung A, Sharr MA, Roth CE, Jin G, Cowling R, Di L, Sherman M, Xu ZB, March CJ, Mohler KM, Black RA, Skotnicki JS",,106763,DTCT0024002,1602202,DTCC00269611,1132821,4590
CHEMBL99981,P45452,,ZBTKKYFIZQHNDQ-MSOLQXFVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,10522712,IC50,=,40,NM,,,,,,,,,,,,,,Inhibition of Coll-3 MMP-13,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,101904,DTCT0024002,1456614,DTCC00265035,173185,3373
CHEMBL99981,P45452,,ZBTKKYFIZQHNDQ-MSOLQXFVSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,17275314,IC50,=,39.81,NM,,,,,,,,,,,,,,Inhibition of MMP13,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458933,DTCT0024002,2258633,DTCC00265035,164159,24803
CHEMBL99995,P45452,,CDDCBQKBUFNWAE-NTBLAEGASA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,15125955,IC50,=,15000,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-13,,Reverse hydroxamate-based selective TACE inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,11,"Kamei N, Tanaka T, Kawai K, Miyawaki K, Okuyama A, Murakami Y, Arakawa Y, Haino M, Harada T, Shimano M",,106641,DTCT0024002,1383853,DTCC00265558,853474,6400
,P45452,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16220987,KI,=,0.2,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024002,14745305,DTCC01744004,2108945,69259
,P45452,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16220987,KI,=,8,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024002,14754611,DTCC01744004,2108945,69259
,P45452,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16899369,IC50,=,778000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024002,14708324,DTCC01744004,2096656,67898
,P45452,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,20817735,KI,=,49,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024002,14753304,DTCC01744004,2110394,69686
,P45452,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21208635,IC50,=,158,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024002,14725123,DTCC01744004,2096616,67860
,P45452,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21208635,IC50,=,20000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024002,14726257,DTCC01744004,2096616,67860
,P45452,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21208635,IC50,=,25000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024002,14708389,DTCC01744004,2096616,67860
,P45452,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21208635,IC50,=,32000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024002,14704825,DTCC01744004,2096616,67860
,P45452,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21208635,IC50,=,45000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024002,14724188,DTCC01744004,2096616,67860
,P45452,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,21208635,IC50,=,55900,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024002,14708163,DTCC01744004,2096616,67860
,P45452,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22689580,IC50,=,33.4,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024002,14710107,DTCC01744004,2098141,68703
,P45452,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22689580,IC50,=,46,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024002,14725223,DTCC01744004,2098141,68703
,P45452,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22689580,KI,=,18,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024002,14751483,DTCC01744004,2098141,68703
,P45452,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22689580,KI,=,49,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024002,14753321,DTCC01744004,2098141,68703
,P45452,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22689580,KI,=,338,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024002,14745580,DTCC01744004,2098141,68703
,P45452,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22689580,KI,=,468,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024002,14748227,DTCC01744004,2098141,68703
,P45452,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,22689580,KI,=,501,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024002,14746893,DTCC01744004,2098141,68703
,P45452,AGN-PC-00A9Z8,WRQYAPDRSRSBNV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16220987,KI,=,0.1,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024002,14733959,DTCC01745945,2105094,69259
,P45452,AGN-PC-00AW7I,ZBOSPOSQGJWURE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16220987,KI,=,0.8,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024002,14746237,DTCC01746086,2109118,69259
,P45452,AGN-PC-00B1B8,QVHYJMPAZNGFHN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16220987,KI,=,0.1,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024002,14753707,DTCC01745743,2103471,69259
,P45452,AGN-PC-00B1IZ,BEQXRWLSEUIFKP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16220987,KI,=,0.5,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024002,14747801,DTCC01746160,2109488,69259
,P45452,AGN-PC-00B6KS,FQPCVUZCOHLRGT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16220987,KI,=,0.3,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024002,14750740,DTCC01746416,2109959,69259
,P45452,AGN-PC-00BMEK,QYCUMAKSYBUWER-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16220987,KI,=,0.22,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024002,14753767,DTCC01746699,2110472,69259
,P45452,AGN-PC-00C7AZ,SWYRTBQMGJFWDS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16220987,KI,=,0.1,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024002,14729792,DTCC01745814,2103978,69259
,P45452,AGN-PC-00COJ9,WDPVPUZANMBBLA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16220987,KI,=,0.4,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024002,14732730,DTCC01745926,2104739,69259
,P45452,AGN-PC-00D2VZ,NKHJMAWHLPBSOA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16220987,KI,=,0.68,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024002,14752277,DTCC01746561,2110229,69259
,P45452,AGN-PC-00E2QR,JQESDCUCXWEIBZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16220987,KI,=,0.8,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024002,14753812,DTCC01746703,2110478,69259
,P45452,AGN-PC-00ERPQ,YLRBOIVJMWEGGX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16220987,KI,=,0.3,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024002,14745118,DTCC01745987,2108904,69259
,P45452,ALPHA-SULFONE 13,VFZUVETVSPJFEB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16220987,KI,=,5.1,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024002,14755250,DTCC01746812,2110672,69259
,P45452,ALPHA-SULFONE 17,DZCKADUBMZPQDB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16220987,KI,=,0.25,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024002,14748830,DTCC01746261,2109668,69259
,P45452,ALPHA-SULFONE 27A,FAOIZSVKMZLOCI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16220987,KI,=,0.3,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024002,14750211,DTCC01746370,2109869,69259
,P45452,ALPHA-SULFONE 27B,LFIZWBFUWVSLOR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16220987,KI,=,0.37,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024002,14755211,DTCC01746809,2110669,69259
,P45452,ALPHA-SULFONE 27H,IBMBDMBDQPRIQW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16220987,KI,=,0.1,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024002,14750600,DTCC01746401,2109934,69259
,P45452,ALPHA-SULFONE 27I,NWFAIXPOXVQZQD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16220987,KI,=,0.5,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024002,14757533,DTCC01746901,2111161,69259
,P45452,ALPHA-SULFONE 35G,KLWUGXOQJJWEBZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16220987,KI,=,0.6,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024002,14754585,DTCC01746770,2110582,69259
,P45452,ALPHA-SULFONE 35H,XJMDDZUUIUEEJH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16220987,KI,=,2.6,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024002,14746920,DTCC01746132,2109290,69259
,P45452,BETA-SULFONE 7A,XXKPJSZGWAMVSD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 13,MMP13,Enzyme,,,16220987,KI,=,0.2,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024002,14745407,DTCC01746015,2108961,69259
